Citrus Sinensis ID: 015237
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 411 | 2.2.26 [Sep-21-2011] | |||||||
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.335 | 0.150 | 0.424 | 4e-28 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.345 | 0.221 | 0.430 | 5e-28 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.340 | 0.084 | 0.425 | 8e-27 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.345 | 0.205 | 0.409 | 3e-26 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.335 | 0.084 | 0.410 | 1e-25 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.338 | 0.356 | 0.388 | 5e-25 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.347 | 0.174 | 0.422 | 1e-24 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.357 | 0.290 | 0.402 | 5e-24 | |
| P00521 | 746 | Tyrosine-protein kinase t | yes | no | 0.394 | 0.217 | 0.337 | 6e-24 | |
| P00520 | 1123 | Tyrosine-protein kinase A | yes | no | 0.394 | 0.144 | 0.337 | 8e-24 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 125 bits (315), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 59/139 (42%), Positives = 92/139 (66%), Gaps = 1/139 (0%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIK-VLTNEHLNENIRREFAQEVHIMRKV 299
EI S LK K+ G++ +YKG + VAIK + NE +N + EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
RH N+V + ACT PP L +TE++ GGS+YD LH +K + + L ++AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 360 HRNNIIHRDLKAANLLMNE 378
H + +IHRD+K+ NLL++E
Sbjct: 776 HLSGVIHRDIKSLNLLLDE 794
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 62/144 (43%), Positives = 96/144 (66%), Gaps = 2/144 (1%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D +ID +K +I G+Y ++Y G + VA+K L ++NENI +EF +E+++M+
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 424
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
+RH NV+QF+G+C PP + I TE+M GS+Y LH Q L+ LL+++ ID +KG+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 358 YLHRNN--IIHRDLKAANLLMNEN 379
YLH + I+HRDLK+ NLL++EN
Sbjct: 485 YLHNSTPVILHRDLKSHNLLVDEN 508
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 60/141 (42%), Positives = 90/141 (63%), Gaps = 1/141 (0%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D WE+D L F + SG +++K + +VA+K L N ++ ++ R F QE+H M
Sbjct: 784 DEWEVDFHELDFMESLGSGGSGEVFKAMWKGTEVAVKKLVNSNITKDAERNFKQEIHRMT 843
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLL-LRVAIDVSKGM 356
+RH NVV F+ A TRPP + IV EFMS GS+YD L + P+L +R+A +KGM
Sbjct: 844 SLRHPNVVLFMAASTRPPNMCIVMEFMSLGSLYDLLGNELVTEIPPVLRIRIAYQAAKGM 903
Query: 357 NYLHRNNIIHRDLKAANLLMN 377
++LH ++I+HRDLK+ NLL++
Sbjct: 904 HFLHSSDIVHRDLKSLNLLLD 924
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 59/144 (40%), Positives = 94/144 (65%), Gaps = 2/144 (1%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D +ID +K +I G++ ++Y G + VA+K L ++NENI +EF +E+++M+
Sbjct: 382 DGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 441
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
+RH NV+QF+G+C P + I TE+M GS+Y LH +K + L+ R+ ID +KG+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 358 YLHRNN--IIHRDLKAANLLMNEN 379
YLH + I+HRDLK+ NLL++EN
Sbjct: 502 YLHGSTPVILHRDLKSHNLLVDEN 525
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 117 bits (294), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 57/139 (41%), Positives = 93/139 (66%), Gaps = 1/139 (0%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
WEID S L+ + +G Y ++YK + +VA+K+++++H+++++ R F +EV IM +
Sbjct: 779 WEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTSL 838
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNY 358
RH NVV F+ A T+ P + IV EFMS GS+YD L + + L +++A SKGM++
Sbjct: 839 RHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQASKGMHF 898
Query: 359 LHRNNIIHRDLKAANLLMN 377
LH + I+HRDLK+ NLL++
Sbjct: 899 LHSSGIVHRDLKSLNLLLD 917
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 115 bits (289), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 56/144 (38%), Positives = 92/144 (63%), Gaps = 5/144 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLT----NEHLNENIRREFAQEVHI 295
W D S L +K SG++ +Y+G + + VA+K++ E + ++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSK 354
+ ++ H N+VQFI AC +PP I+TE+MS G++ YL+K++ L + +LR+A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 355 GMNYLHRNNIIHRDLKAANLLMNE 378
GM YLH +IHRDLK+ NLL+N+
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLND 222
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (285), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 63/149 (42%), Positives = 95/149 (63%), Gaps = 6/149 (4%)
Query: 236 GIDVWEIDASL--LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEV 293
G+D ++D L + KI +GS+ +++ + DVA+K+L + + EF +EV
Sbjct: 538 GLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREV 597
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAID 351
IM+++RH N+V F+GA T+PP L IVTE++S GS+Y LHK +L L +A D
Sbjct: 598 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 657
Query: 352 VSKGMNYLHRNN--IIHRDLKAANLLMNE 378
V+KGMNYLH N I+HRDLK+ NLL+++
Sbjct: 658 VAKGMNYLHNRNPPIVHRDLKSPNLLVDK 686
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (280), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 60/149 (40%), Positives = 90/149 (60%), Gaps = 2/149 (1%)
Query: 233 PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQE 292
P E EI + FE I +GS+ +YKG + VA+K+L ++ + F +E
Sbjct: 10 PEERSGPPEIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKE 69
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
VH+M K+ H N+ F+GACT P R IVTE + G++ LH QK L L L +R+A D
Sbjct: 70 VHLMSKIYHPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDA 129
Query: 353 SKGMNYLHRNN--IIHRDLKAANLLMNEN 379
+ G+N+LH +N +HRD+K++NLL++EN
Sbjct: 130 ALGINWLHESNPVFVHRDIKSSNLLVDEN 158
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P00521|ABL_MLVAB Tyrosine-protein kinase transforming protein Abl OS=Abelson murine leukemia virus GN=ABL PE=3 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (280), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 100/181 (55%), Gaps = 19/181 (10%)
Query: 212 HHHVV----------YPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDL 261
HHH YP ++ + I V + D WE++ + + +HK+ G Y ++
Sbjct: 86 HHHSTVADGLITTLHYPAPKRNKPTIYGV---SPNYDKWEMERTDITMKHKLGGGQYGEV 142
Query: 262 YKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
Y+G + +S VA+K L + + EF +E +M++++H N+VQ +G CTR P +I
Sbjct: 143 YEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 199
Query: 320 VTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
+TEFM+ G++ DYL + + + +LL +A +S M YL + N IHRDL A N L+ E
Sbjct: 200 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 259
Query: 379 N 379
N
Sbjct: 260 N 260
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P00520|ABL1_MOUSE Tyrosine-protein kinase ABL1 OS=Mus musculus GN=Abl1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 111 bits (278), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 61/181 (33%), Positives = 100/181 (55%), Gaps = 19/181 (10%)
Query: 212 HHHVV----------YPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDL 261
HHH YP ++ + I V + D WE++ + + +HK+ G Y ++
Sbjct: 200 HHHSTVADGLITTLHYPAPKRNKPTIYGV---SPNYDKWEMERTDITMKHKLGGGQYGEV 256
Query: 262 YKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
Y+G + +S VA+K L + + EF +E +M++++H N+VQ +G CTR P +I
Sbjct: 257 YEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 313
Query: 320 VTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
+TEFM+ G++ DYL + + + +LL +A +S M YL + N IHRDL A N L+ E
Sbjct: 314 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 373
Query: 379 N 379
N
Sbjct: 374 N 374
|
Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 411 | ||||||
| 297744550 | 580 | unnamed protein product [Vitis vinifera] | 0.924 | 0.655 | 0.6 | 1e-135 | |
| 255539096 | 749 | protein kinase, putative [Ricinus commun | 0.912 | 0.500 | 0.660 | 1e-134 | |
| 359474826 | 1515 | PREDICTED: uncharacterized mscS family p | 0.924 | 0.250 | 0.568 | 1e-132 | |
| 449454245 | 573 | PREDICTED: protein-tyrosine kinase 2-bet | 0.924 | 0.663 | 0.598 | 1e-131 | |
| 224080668 | 494 | predicted protein [Populus trichocarpa] | 0.824 | 0.686 | 0.645 | 1e-127 | |
| 283132359 | 578 | ACT-domain-containing protein kinase [Lo | 0.927 | 0.659 | 0.559 | 1e-124 | |
| 255560441 | 558 | protein kinase, putative [Ricinus commun | 0.892 | 0.657 | 0.576 | 1e-124 | |
| 224143785 | 539 | predicted protein [Populus trichocarpa] | 0.907 | 0.692 | 0.617 | 1e-122 | |
| 224083191 | 556 | predicted protein [Populus trichocarpa] | 0.909 | 0.672 | 0.599 | 1e-121 | |
| 224065733 | 565 | predicted protein [Populus trichocarpa] | 0.902 | 0.656 | 0.589 | 1e-121 |
| >gi|297744550|emb|CBI37812.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 261/435 (60%), Positives = 303/435 (69%), Gaps = 55/435 (12%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
MVM D ES SSR D S ++SR+QR K++VYNE+L RLK S+ EE +P F+++LWAH
Sbjct: 1 MVMEDNESCSSRVHDSS-SPAQSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGFDEELWAH 59
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS 120
F RLP+RYALDVN+ERAEDVL HKRLLH+A DP PAIEVRLV V S N+ S
Sbjct: 60 FVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQVHPISDGIHGNIADS 119
Query: 121 ------------GSPRYLYTQ-------FSCYP--------------------------- 134
GSP+Y Q F P
Sbjct: 120 IHSNSPTIGPAHGSPKYSSKQSILPPPAFGSSPNLEALAIEANNSHVQDGDGDDSVHASS 179
Query: 135 YKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQE 194
R MHEIT S++DKPKLLSQLT LLSE+ LNIQEAHAFSTVDGYSLDVFVVDGWP +E
Sbjct: 180 QYSRPMHEITFSSDDKPKLLSQLTCLLSELELNIQEAHAFSTVDGYSLDVFVVDGWPYEE 239
Query: 195 TEQLRNVLAKEIPKVEN----HHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASL 246
TEQLR L KE+ K+E +HH + P GEQE++GI + V IP +G DVWEID
Sbjct: 240 TEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEETGIKCESDFVTIPNDGTDVWEIDVRQ 299
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
LKFE+K+ SGSY DLYKG + SQ+VAIKVL E LN ++++EFAQEV IMRKVRH NVVQ
Sbjct: 300 LKFENKVASGSYGDLYKGTYCSQEVAIKVLKPERLNSDMQKEFAQEVFIMRKVRHKNVVQ 359
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
FIGACTRPP L+IVTEFMSGGS+YDYLHKQK KLP LL+V+IDVSKGMNYLH+NNIIH
Sbjct: 360 FIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVFKLPALLKVSIDVSKGMNYLHQNNIIH 419
Query: 367 RDLKAANLLMNENGV 381
RDLKAANLLM+EN V
Sbjct: 420 RDLKAANLLMDENEV 434
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539096|ref|XP_002510613.1| protein kinase, putative [Ricinus communis] gi|223551314|gb|EEF52800.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1249), Expect = e-134, Method: Compositional matrix adjust.
Identities = 266/403 (66%), Positives = 305/403 (75%), Gaps = 28/403 (6%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGD ES SSRAVDFV S+SRKQR V VYNE+L RLK SN+E T+ P FED+LW HF+
Sbjct: 1 MGDAESCSSRAVDFV--PSQSRKQRQTVDVYNEVLCRLKDSNDEATKLPGFEDELWTHFH 58
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFS------- 115
RLP+RYA+DVN ERA+DVLMHKRLL +A DP+ PAI+VRLV V+ + S
Sbjct: 59 RLPTRYAMDVNAERAQDVLMHKRLLQLAHDPSTRPAIDVRLVQVRIQDSGIDSLEALLPP 118
Query: 116 ---------NLVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGL 166
LV G + + T S P RLMHEITISTNDKPKLLSQLTSLLSEIGL
Sbjct: 119 PAFGSLPQRKLVRDGRDKDI-TMISS-PLYSRLMHEITISTNDKPKLLSQLTSLLSEIGL 176
Query: 167 NIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVENHHHV----VYPVGEQ 222
NI EAHAFST+DGYSLDVFVVD W +ETE+LR +L KEI + E + +YP +Q
Sbjct: 177 NITEAHAFSTIDGYSLDVFVVDNWAHEETERLRTMLLKEIKEFEKSTQLKTNAIYPAVKQ 236
Query: 223 EQSGIN----HVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTN 278
EQ GIN HVNIPA+ +DVWEID SLLK+E KI SGS+ DLYKG F++QDVAIKVL
Sbjct: 237 EQKGINLMCDHVNIPADRMDVWEIDPSLLKYEIKIASGSHGDLYKGTFYTQDVAIKVLRT 296
Query: 279 EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC 338
EHLN+ +R+EFAQEV+IMRKVRH NVVQFIGACTRPP L IVTEFM GGS++D+LHKQK
Sbjct: 297 EHLNDKLRKEFAQEVYIMRKVRHKNVVQFIGACTRPPSLCIVTEFMCGGSMFDFLHKQKQ 356
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L LLRVAIDVSKGMNYLH+NNIIHRDLKAANLLM+EN V
Sbjct: 357 SLDLQSLLRVAIDVSKGMNYLHQNNIIHRDLKAANLLMDENKV 399
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474826|ref|XP_002280985.2| PREDICTED: uncharacterized mscS family protein At1g78610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1225), Expect = e-132, Method: Compositional matrix adjust.
Identities = 262/461 (56%), Positives = 308/461 (66%), Gaps = 81/461 (17%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
MVM D ES SSR D S ++SR+QR K++VYNE+L RLK S+ EE +P F+++LWAH
Sbjct: 1 MVMEDNESCSSRVHDSS-SPAQSRQQRQKLEVYNEVLRRLKDSDNEEAFEPGFDEELWAH 59
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLV---------------- 104
F RLP+RYALDVN+ERAEDVL HKRLLH+A DP PAIEVRLV
Sbjct: 60 FVRLPTRYALDVNVERAEDVLTHKRLLHLAHDPTNRPAIEVRLVQFGKFDVSHKRYVRCG 119
Query: 105 --LVQGAST--------------RHFSNLVHS---------GSPRYLYTQ-------FSC 132
L QG + ++ +HS GSP+Y Q F
Sbjct: 120 WALRQGKRNIISLTVHPISDGIHGNIADSIHSNSPTIGPAHGSPKYSSKQSILPPPAFGS 179
Query: 133 YPYKKRL------------------------MHEITISTNDKPKLLSQLTSLLSEIGLNI 168
P + L MHEIT S++DKPKLLSQLT LLSE+ LNI
Sbjct: 180 SPNLEALAIEANNSHVQDGDGDDSVHASSQPMHEITFSSDDKPKLLSQLTCLLSELELNI 239
Query: 169 QEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVEN----HHHVVYPVGEQEQ 224
QEAHAFSTVDGYSLDVFVVDGWP +ETEQLR L KE+ K+E +HH + P GEQE+
Sbjct: 240 QEAHAFSTVDGYSLDVFVVDGWPYEETEQLRTALEKEVFKIEKQSWPNHHSLSPTGEQEE 299
Query: 225 SGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEH 280
+GI + V IP +G DVWEID LKFE+K+ SGSY DLYKG + SQ+VAIKVL E
Sbjct: 300 TGIKCESDFVTIPNDGTDVWEIDVRQLKFENKVASGSYGDLYKGTYCSQEVAIKVLKPER 359
Query: 281 LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL 340
LN ++++EFAQEV IMRKVRH NVVQFIGACTRPP L+IVTEFMSGGS+YDYLHKQK
Sbjct: 360 LNSDMQKEFAQEVFIMRKVRHKNVVQFIGACTRPPSLYIVTEFMSGGSVYDYLHKQKGVF 419
Query: 341 KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
KLP LL+V+IDVSKGMNYLH+NNIIHRDLKAANLLM+EN V
Sbjct: 420 KLPALLKVSIDVSKGMNYLHQNNIIHRDLKAANLLMDENEV 460
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454245|ref|XP_004144866.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] gi|449528766|ref|XP_004171374.1| PREDICTED: protein-tyrosine kinase 2-beta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1220), Expect = e-131, Method: Compositional matrix adjust.
Identities = 256/428 (59%), Positives = 295/428 (68%), Gaps = 48/428 (11%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
MVM D ES SRA D + S ++SR+QR K +VYNE+L RLK SN EE QP F+D+LW H
Sbjct: 1 MVMEDNESCGSRAYDLL-SPAQSRQQRQKFEVYNEVLRRLKDSNNEEAIQPGFDDELWVH 59
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS 120
F RLP+RYALDVN+ERAEDVLMHKRLL A DPA PAIEVRLV VQ S H ++ S
Sbjct: 60 FNRLPTRYALDVNVERAEDVLMHKRLLQFAHDPANRPAIEVRLVQVQAVSDEHSADFADS 119
Query: 121 --------GSPRYLYTQ-------FSCYPYKK-------------------------RLM 140
S L Q F P + R M
Sbjct: 120 CPVKDTDHNSSNCLSRQSMHPPPAFGSSPNLEALALEANNTQDLEVDQSVHARTQFFRPM 179
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRN 200
HEIT ST+DKPKLLSQLTSLL+EIGLNIQEAHAFSTVDGYSLDVFVVDGWP +ETE+L+
Sbjct: 180 HEITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETERLKT 239
Query: 201 VLAKEIPKVEN----HHHVVYPVGEQEQSG---INHVNIPAEGIDVWEIDASLLKFEHKI 253
L E+ VE + PVGE + + + V IP +G DVWEI+ LKFEHK+
Sbjct: 240 ALESEVLLVERRGWPNQKSSSPVGELDITAKCESDRVEIPTDGTDVWEINPRHLKFEHKV 299
Query: 254 VSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313
SGSY DLYKG + SQ+VAIKVL E +N +++ EFAQEV+IMRKVRH NVVQFIGACT+
Sbjct: 300 ASGSYGDLYKGTYCSQEVAIKVLKTERVNTDMQSEFAQEVYIMRKVRHKNVVQFIGACTK 359
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
PP L IVTEFMSGGS+YDYLHKQK +LP LL+VAIDVSKGMNYLH+NNIIHRDLKAAN
Sbjct: 360 PPSLCIVTEFMSGGSVYDYLHKQKGTFRLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAAN 419
Query: 374 LLMNENGV 381
LLM+EN V
Sbjct: 420 LLMDENEV 427
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080668|ref|XP_002306203.1| predicted protein [Populus trichocarpa] gi|222849167|gb|EEE86714.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1184), Expect = e-127, Method: Compositional matrix adjust.
Identities = 233/361 (64%), Positives = 278/361 (77%), Gaps = 22/361 (6%)
Query: 29 KVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLH 88
K++VYNEIL RL++SN EE P F+D LW HF LP+RYALDVN+ERAEDVL HKRLL
Sbjct: 4 KLEVYNEILRRLQESNHEEANLPGFDDQLWTHFNSLPTRYALDVNVERAEDVLTHKRLLR 63
Query: 89 VARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCYPYKKRLMHEITISTN 148
+A DPA PAIE+RLV +TR F VH S R ++ F Y MHEIT ST+
Sbjct: 64 LAHDPANRPAIEIRLV----QTTRGF---VHDTSFRQVFLGFEGY------MHEITFSTD 110
Query: 149 DKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPK 208
DKPKLLSQLTSL+++IGLNIQEAHAFSTVDGYSLDVFVVDGWP +ETEQLR+ LAKE+ K
Sbjct: 111 DKPKLLSQLTSLVADIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEETEQLRDALAKEVSK 170
Query: 209 VENHHHVVYPV--------GEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCD 260
+E + + P+ G++ + NHV IP +G DVWEID LKFE+K+ SGSY D
Sbjct: 171 IEEFNSGI-PISNSYSTGNGQEIKCDTNHVAIPNDGTDVWEIDPKYLKFENKVASGSYGD 229
Query: 261 LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320
LYKG + SQ+VAIK+L E +N ++++EFAQEV+IMRKVRH NVVQFIGACT+PP L IV
Sbjct: 230 LYKGTYCSQEVAIKILKPERVNSDLQKEFAQEVYIMRKVRHKNVVQFIGACTKPPSLCIV 289
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
TEFM GGS+YDYLHKQ+ KLP LL+VAIDVSKGM+YLH+NNIIHRDLK ANLLM+EN
Sbjct: 290 TEFMHGGSVYDYLHKQRGVFKLPNLLKVAIDVSKGMDYLHQNNIIHRDLKGANLLMDENE 349
Query: 381 V 381
V
Sbjct: 350 V 350
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|283132359|dbj|BAI63585.1| ACT-domain-containing protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1160), Expect = e-124, Method: Compositional matrix adjust.
Identities = 240/429 (55%), Positives = 289/429 (67%), Gaps = 48/429 (11%)
Query: 1 MVMGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAH 60
+V+ D ++S + S S++R+ R KV+VYNEIL RL S E QP F D LWAH
Sbjct: 4 VVVDDNDTSGTSNHRATPSPSQTRQHRHKVEVYNEILRRLNDSGNPEALQPGFHDQLWAH 63
Query: 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS 120
F RLP+RYALDVN+ERA DVLMHKRLLH+A DPA P+IEVRLV V S + ++ HS
Sbjct: 64 FNRLPARYALDVNVERAADVLMHKRLLHLAHDPANRPSIEVRLVQVHPTSDGNSADSFHS 123
Query: 121 GSPR----------------YLYTQFSCYP------------------------YKKRLM 140
SP + F P R M
Sbjct: 124 DSPGTESGQSSSKYSSRQSIHPPPAFGSSPNLEALALEENNSEDIDERSVHASVQYSRPM 183
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRN 200
HEIT ST DKPKLLSQLT+LL+EIGLNIQEAHAFST DGYSLDVFVVDGWP +ETE+L+
Sbjct: 184 HEITFSTEDKPKLLSQLTALLAEIGLNIQEAHAFSTSDGYSLDVFVVDGWPYEETEKLKV 243
Query: 201 VLAKEIPKVE----NHHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHK 252
L KEI K+E ++ V E +Q+ + +H+ IP +G DVWEIDA L + ++
Sbjct: 244 ALEKEILKIERQARSNQQSVSSADEPDQARMKHEQDHLTIPNDGTDVWEIDAKHLTYGNQ 303
Query: 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312
I SGSY +L+KG + SQ+VAIKVL EH+N ++REF QEV+IMRKVRH NVVQFIGACT
Sbjct: 304 IASGSYGELFKGTYCSQEVAIKVLKGEHVNAEMQREFVQEVYIMRKVRHKNVVQFIGACT 363
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+PPRL I+TEFMSGGS+YDYLHKQK K P LL+VAIDVSKGMNYLH++NIIHRDLK A
Sbjct: 364 KPPRLCIITEFMSGGSVYDYLHKQKGFFKFPSLLKVAIDVSKGMNYLHQHNIIHRDLKGA 423
Query: 373 NLLMNENGV 381
NLLM+ENGV
Sbjct: 424 NLLMDENGV 432
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560441|ref|XP_002521235.1| protein kinase, putative [Ricinus communis] gi|223539503|gb|EEF41091.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-124, Method: Compositional matrix adjust.
Identities = 244/423 (57%), Positives = 286/423 (67%), Gaps = 56/423 (13%)
Query: 1 MVMGDTESSSSRAVDFVWSES----KSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDD 56
++M + ES SR D S R QR K++VYNE+L RLK+SN EE QP F+D+
Sbjct: 3 VMMEENESCGSRVQDSTTSSPSPSHAGRNQRQKLEVYNEVLRRLKESNNEEANQPGFDDE 62
Query: 57 LWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSN 116
LW+HF+RLP+RYALDVN+ERAEDVLMHKRLL +A DP PAIE+RLV V S + ++
Sbjct: 63 LWSHFHRLPTRYALDVNVERAEDVLMHKRLLQLAHDPDNRPAIEIRLVQVPPVSDGNSAD 122
Query: 117 LVHSGSPRYLYTQ-----------FSCYP-----------------------YKKRLMHE 142
SGSPR TQ F P Y + MHE
Sbjct: 123 SDLSGSPRKGDTQSNRKSIHPPPAFGSSPNLEALALEAINPKMXXLGNSDLLYHLQPMHE 182
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
IT ST+DKPKLLSQLTSLL+EIGLNIQEAHAFSTVDGYSLDVFVVDGWP ++ L
Sbjct: 183 ITFSTDDKPKLLSQLTSLLAEIGLNIQEAHAFSTVDGYSLDVFVVDGWPYEKHTWPTLSL 242
Query: 203 AKEIPKVENHHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGSY 258
+ P E +Q+ I +HV IP +G DVWEID LKFE+K+ SGSY
Sbjct: 243 S--------------PSSEHKQTKIKCDPDHVTIPNDGTDVWEIDPKNLKFENKVASGSY 288
Query: 259 CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318
DLYKG + SQ+VAIK+L E +N ++ +EFAQEV IMRKVRH NVVQFIGACT+PP L
Sbjct: 289 GDLYKGTYCSQEVAIKILKPERINSDLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPSLC 348
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
IVTEFMSGGS+YDYLHKQK KLP LL+VAIDVSKGMNYLH+NNIIHRDLKAANLLM+E
Sbjct: 349 IVTEFMSGGSVYDYLHKQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKAANLLMDE 408
Query: 379 NGV 381
N V
Sbjct: 409 NEV 411
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143785|ref|XP_002336079.1| predicted protein [Populus trichocarpa] gi|222871184|gb|EEF08315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1145), Expect = e-122, Method: Compositional matrix adjust.
Identities = 252/408 (61%), Positives = 295/408 (72%), Gaps = 35/408 (8%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGDTES SSRAVDFV R QR K+ V+N++ +RLK+SN+EE + FE++LWAHF
Sbjct: 1 MGDTESCSSRAVDFV-----PRNQRQKLDVFNDVFYRLKESNDEEASRLGFEEELWAHFL 55
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVH--- 119
R P RYA+DVN ERAEDV+MHKRLL +A +PA PAIEVRLV + AS L+H
Sbjct: 56 RFPPRYAMDVNAERAEDVIMHKRLLQMAHNPATRPAIEVRLVQL-NASRLILGLLMHVMH 114
Query: 120 --SGSPRYLYTQFS----------------CYPYKKRLMHEITISTNDKPKLLSQLTSLL 161
S P + S P RL+HEITIST D+PKLLSQLTSLL
Sbjct: 115 HKSIHPPPAFGSLSDSELLHKYQDKDITVITGPLCFRLVHEITISTIDQPKLLSQLTSLL 174
Query: 162 SEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVE----NHHHVVY 217
SEIGLNIQEAHAFST DGYSLDVFVVD PL++TE+LR+++ KEIPK+E + H VY
Sbjct: 175 SEIGLNIQEAHAFSTTDGYSLDVFVVDNMPLEDTERLRSMVFKEIPKIEEDADSKSHAVY 234
Query: 218 PVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAI 273
V EQ+Q GI N +N+PA+ IDVWEIDA L E KI +GS DLYKG F SQDVAI
Sbjct: 235 RVTEQDQIGISLVSNLMNVPADSIDVWEIDARQLIREKKIANGSSGDLYKGTFCSQDVAI 294
Query: 274 KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL 333
KVL EHLN ++ EF QEV IMRKVRH NVV+FIGACTRPP L I+TEFMSGGS+YD+L
Sbjct: 295 KVLRGEHLNNKLQSEFYQEVSIMRKVRHKNVVKFIGACTRPPSLCIITEFMSGGSMYDFL 354
Query: 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
HKQK L L LLRVAIDVSKGM+ LH+NNI+HRDLK+ANLLM+ENGV
Sbjct: 355 HKQKGSLSLQSLLRVAIDVSKGMHCLHQNNIVHRDLKSANLLMDENGV 402
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224083191|ref|XP_002306961.1| predicted protein [Populus trichocarpa] gi|222856410|gb|EEE93957.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-121, Method: Compositional matrix adjust.
Identities = 254/424 (59%), Positives = 297/424 (70%), Gaps = 50/424 (11%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGDTES SS AVDFV R QR K+ V+N++L+RLK+SN+EE + FED+LWAHF
Sbjct: 1 MGDTESGSSGAVDFV-----PRNQRQKLDVFNDVLYRLKESNDEEASRLGFEDELWAHFC 55
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHS-- 120
R P+RYA+DV ERAEDV+MHKRLL +A +PA PAIEVRLV V S H + V S
Sbjct: 56 RFPTRYAMDVIAERAEDVIMHKRLLQMAHNPATRPAIEVRLVQVPFQSDGHPGDSVDSEL 115
Query: 121 --------GSPRYLYTQFSCYP---------------YKK------------RLMHEITI 145
G R+ +P Y+ RL+HEITI
Sbjct: 116 QLQYFDYLGKHRHGCANIFIHPPPAFGSLSDSELLHKYQDKDITVITGPLCFRLVHEITI 175
Query: 146 STNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205
ST DKPKLLSQLTSLLSEIGLNIQEAHAFST DGYSLDVFVVD PL++TE+LR+++ KE
Sbjct: 176 STIDKPKLLSQLTSLLSEIGLNIQEAHAFSTTDGYSLDVFVVDNMPLEDTERLRSMVFKE 235
Query: 206 IPKVE----NHHHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFEHKIVSGS 257
IPK+E + H VY V EQ+Q GI N +N+PA+ IDVWEIDA L E KI +GS
Sbjct: 236 IPKIEEDADSKSHAVYRVTEQDQIGISLVSNLMNVPADSIDVWEIDARQLIREKKIANGS 295
Query: 258 YCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317
DLYKG F SQDVAIKVL EHLN ++ EF QEV IMRKVRH NVV+FIGACTRPP L
Sbjct: 296 SGDLYKGTFCSQDVAIKVLRGEHLNNKLQSEFYQEVSIMRKVRHKNVVKFIGACTRPPSL 355
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
I+TEFMSGGS+YD+LHKQK L L LLRVAIDVSKGM+ LH+NNI+HRDLK+ANLLM+
Sbjct: 356 CIITEFMSGGSMYDFLHKQKGSLSLQSLLRVAIDVSKGMHCLHQNNIVHRDLKSANLLMD 415
Query: 378 ENGV 381
ENGV
Sbjct: 416 ENGV 419
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065733|ref|XP_002301944.1| predicted protein [Populus trichocarpa] gi|222843670|gb|EEE81217.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-121, Method: Compositional matrix adjust.
Identities = 254/431 (58%), Positives = 301/431 (69%), Gaps = 60/431 (13%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFY 62
MGDTES SSRAVDFV R QR K+ V+N++L LK+SN++E +P FE++LW HF
Sbjct: 1 MGDTESCSSRAVDFV-----PRNQRQKLDVFNDVLCHLKESNDKEATRPGFENELWTHFC 55
Query: 63 RLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLV------------LVQG-- 108
RLP+RYA+DVN ERA+DV+MHKRLL +AR+PA PAIEVRLV + Q
Sbjct: 56 RLPARYAMDVNAERAQDVIMHKRLLQMARNPATRPAIEVRLVQHYYIAVAALITICQPFI 115
Query: 109 ASTRH----FSNLVHSGSPRYLYTQF------------------SCYPYKKRLMHEITIS 146
A H F +H T F S Y + LMHEITIS
Sbjct: 116 AGKWHLVLFFICSIHPPPAFGSLTDFELLHKNQNDDITAFTRQNSAY---QELMHEITIS 172
Query: 147 TNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEI 206
TNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV+ W ++TE+LR++L KEI
Sbjct: 173 TNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVNNWEPEDTERLRSMLVKEI 232
Query: 207 PKVENH------------HHVVYPVGEQEQSGI----NHVNIPAEGIDVWEIDASLLKFE 250
PK+E + VYPV EQ+Q GI +H+N+PA+ IDVWEIDA L FE
Sbjct: 233 PKIEVALLNVTFILNWMLKNAVYPVAEQDQRGIRLVSSHMNVPADSIDVWEIDAHRLLFE 292
Query: 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
KI +GS DLYKG F SQDVAIKVL EHL++ ++ EF QEV IMRKVRH NVVQFIG+
Sbjct: 293 RKIATGSSGDLYKGTFCSQDVAIKVLRGEHLDDKLQSEFVQEVSIMRKVRHKNVVQFIGS 352
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
CTRPP L IVTEFMSGGS+YD+LHKQK L L LLRVAIDVSKGM+ L++N+IIHRDLK
Sbjct: 353 CTRPPSLCIVTEFMSGGSMYDFLHKQKGSLNLQSLLRVAIDVSKGMHCLNQNHIIHRDLK 412
Query: 371 AANLLMNENGV 381
+AN+LM+ENGV
Sbjct: 413 SANILMDENGV 423
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 411 | ||||||
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.593 | 0.424 | 0.673 | 4.8e-114 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.591 | 0.445 | 0.626 | 1.2e-104 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.591 | 0.426 | 0.615 | 4.6e-101 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.338 | 0.216 | 0.432 | 1.5e-27 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.379 | 0.170 | 0.412 | 1.7e-27 | |
| DICTYBASE|DDB_G0289709 | 690 | drkB "DRK subfamily protein ki | 0.338 | 0.201 | 0.411 | 1.6e-25 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.316 | 0.126 | 0.462 | 5.7e-25 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.386 | 0.207 | 0.407 | 1.5e-24 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.372 | 0.372 | 0.388 | 2.7e-24 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.681 | 0.318 | 0.277 | 4.1e-24 |
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 4.8e-114, Sum P(2) = 4.8e-114
Identities = 169/251 (67%), Positives = 192/251 (76%)
Query: 138 RLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQ 197
R +HEIT ST DKPKLL QLT+LL+E+GLNIQEAHAFST DGYSLDVFVVDGWP +ETE+
Sbjct: 174 RPLHEITFSTEDKPKLLFQLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETER 233
Query: 198 LRNVLAKEIPKVENH------HHVVYPVGEQEQSGIN-HVNIPAEGIDVWEIDASLLKFE 250
LR L KE K+E P E Q+G HV IP +G DVWEI+ LKF
Sbjct: 234 LRISLEKEAAKIELQSQSWPMQQSFSPEKENGQTGARTHVPIPNDGTDVWEINLKHLKFG 293
Query: 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
HKI SGSY DLYKG + SQ+VAIKVL E L+ ++ +EFAQEV IMRKVRH NVVQFIGA
Sbjct: 294 HKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIGA 353
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
CT+PP L IVTEFM GGS+YDYLHKQK KLP L +VAID+ KGM+YLH+NNIIHRDLK
Sbjct: 354 CTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLK 413
Query: 371 AANLLMNENGV 381
AANLLM+EN V
Sbjct: 414 AANLLMDENEV 424
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 1.2e-104, Sum P(2) = 1.2e-104
Identities = 158/252 (62%), Positives = 192/252 (76%)
Query: 138 RLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQ 197
R MHEIT ST DKPKLLSQLTSLL E+GLNIQEAHAFSTVDG+SLDVFVVDGW +ET+
Sbjct: 170 RPMHEITFSTIDKPKLLSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDG 229
Query: 198 LRNVLAKEIPKVENH---HHVVYPVGEQEQSGINH-----VNIPAEGIDVWEIDASLLKF 249
LR+ L+KEI K+++ E ++S N + IP +G D WEID + LK
Sbjct: 230 LRDALSKEILKLKDQPGSKQKSISFFEHDKSS-NELIPACIEIPTDGTDEWEIDVTQLKI 288
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
E K+ SGSY DL++G + SQ+VAIK L + +N + REF+QEV IMRKVRH NVVQF+G
Sbjct: 289 EKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLG 348
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
ACTR P L IVTEFM+ GSIYD+LHKQKC KL LL+VA+DV+KGM+YLH+NNIIHRDL
Sbjct: 349 ACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDL 408
Query: 370 KAANLLMNENGV 381
K ANLLM+E+G+
Sbjct: 409 KTANLLMDEHGL 420
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 4.6e-101, Sum P(2) = 4.6e-101
Identities = 155/252 (61%), Positives = 186/252 (73%)
Query: 138 RLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQ 197
R MHEIT ST D+PKLLSQLTS+L E+GLNIQEAHAFST DG+SLDVFVVDGW +ETE
Sbjct: 176 RPMHEITFSTIDRPKLLSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEG 235
Query: 198 LRNVLAKEIPKVENH---HHVVYPVGEQEQSGINH-----VNIPAEGIDVWEIDASLLKF 249
L++ L KEI K ++ E ++S N V IP +G D WEID LK
Sbjct: 236 LKDALKKEIRKFKDQPCSKQKSITFFEHDKS-TNELLPACVEIPTDGTDEWEIDMKQLKI 294
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
E K+ GSY +L++G + SQ+VAIK+L E +N + REF+QEV+IMRKVRH NVVQFIG
Sbjct: 295 EKKVACGSYGELFRGTYCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIG 354
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
ACTR P L IVTEFM+ GSIYD+LHK K K+ LL+VA+DVSKGMNYLH+NNIIHRDL
Sbjct: 355 ACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDL 414
Query: 370 KAANLLMNENGV 381
K ANLLM+E+ V
Sbjct: 415 KTANLLMDEHEV 426
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 316 (116.3 bits), Expect = 1.5e-27, P = 1.5e-27
Identities = 61/141 (43%), Positives = 95/141 (67%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
+ID +K +I G+Y ++Y G + VA+K L ++NENI +EF +E+++M+ +R
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H NV+QF+G+C PP + I TE+M GS+Y LH Q L+ LL+++ ID +KG+ YLH
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLH 487
Query: 361 RNN--IIHRDLKAANLLMNEN 379
+ I+HRDLK+ NLL++EN
Sbjct: 488 NSTPVILHRDLKSHNLLVDEN 508
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 1.7e-27, P = 1.7e-27
Identities = 66/160 (41%), Positives = 101/160 (63%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIK-VLTNEHLNENIRREFAQEVHIMRKV 299
EI S LK K+ G++ +YKG + VAIK + NE +N + EF +E+ I+ ++
Sbjct: 656 EISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRL 715
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
RH N+V + ACT PP L +TE++ GGS+YD LH +K + + L ++AI +++GMNYL
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775
Query: 360 HRNNIIHRDLKAANLLMNEN-GVRDSDIHCYLSNFLSIST 398
H + +IHRD+K+ NLL++E+ V+ D LS S ST
Sbjct: 776 HLSGVIHRDIKSLNLLLDEHMNVKICDFG--LSKLKSKST 813
|
|
| DICTYBASE|DDB_G0289709 drkB "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 301 (111.0 bits), Expect = 1.6e-25, P = 1.6e-25
Identities = 58/141 (41%), Positives = 93/141 (65%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
+ID +K +I G++ ++Y G + VA+K L ++NENI +EF +E+++M+ +R
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H NV+QF+G+C P + I TE+M GS+Y LH +K + L+ R+ ID +KG+ YLH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504
Query: 361 RNN--IIHRDLKAANLLMNEN 379
+ I+HRDLK+ NLL++EN
Sbjct: 505 GSTPVILHRDLKSHNLLVDEN 525
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 297 (109.6 bits), Expect = 5.7e-25, Sum P(2) = 5.7e-25
Identities = 61/132 (46%), Positives = 87/132 (65%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311
+I GSY ++Y+G + +VA+K ++ L EF EV IM+K+RH N+V F+GA
Sbjct: 753 RIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLRHPNIVLFMGAV 812
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDL 369
TRPP L IVTEF+ GS+Y +H+ L LR+A+D ++GMNYLH N I+HRDL
Sbjct: 813 TRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHSCNPMIVHRDL 872
Query: 370 KAANLLMNENGV 381
K+ NLL+++N V
Sbjct: 873 KSPNLLVDKNWV 884
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 298 (110.0 bits), Expect = 1.5e-24, P = 1.5e-24
Identities = 66/162 (40%), Positives = 100/162 (61%)
Query: 220 GEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNE 279
G S +N V++ ++ +D +EI L +I GS +Y G +F DVA+KV + +
Sbjct: 461 GSTSSSVMNKVDMDSDCLD-YEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQ 519
Query: 280 HLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG 339
+E I F QEV +M+++RH NV+ F+GA P RL IVTEF+ GS++ L + K
Sbjct: 520 EYSEEIITSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSK 579
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNEN 379
L L + +A D+++GMNYLH + IIHRDLK++NLL++ N
Sbjct: 580 LDLRRRIHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRN 621
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 288 (106.4 bits), Expect = 2.7e-24, P = 2.7e-24
Identities = 63/162 (38%), Positives = 98/162 (60%)
Query: 233 PAEGI---DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTN-EHLNEN---I 285
P EG+ D W ID L G++ LYKG + +DVAIK+L E+ E +
Sbjct: 113 PTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFM 172
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-HKQKCGLKLPL 344
++F QEV ++ ++H N+V+FIGAC +P IVTE+ GGS+ +L +Q + L L
Sbjct: 173 EQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 232
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVRDSD 385
++ A+DV++GM Y+H N IHRDLK+ NLL++ + ++ +D
Sbjct: 233 AVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIAD 274
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 296 (109.3 bits), Expect = 4.1e-24, P = 4.1e-24
Identities = 85/306 (27%), Positives = 154/306 (50%)
Query: 93 PAATPAIEVRLV---LVQGASTRHFSNLVH-----SGS--PRYLYTQFSCYPYK-KRLMH 141
P ++V+ V ++ A F+ +H SG+ P L+ + + + K L+
Sbjct: 449 PTCAQKVKVKNVSKYVISAAKNPEFAQKLHAVLLESGASPPPDLFMDINPHNLRGKNLLQ 508
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYS----LDVFVVDGWPLQETEQ 197
E+ +++ ++S + ++ ++E+ T + Y +D+ + + L T +
Sbjct: 509 ELRQESSNS--MVSGIPCYPEKVAEQLRESERNPTAESYQQSVEVDLSMKRNFDLDNTGK 566
Query: 198 LRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGS 257
+ E+ + V + GIN + E WEI L+ +I GS
Sbjct: 567 ASSSENMEVGTADGESAVC----DSHDQGINP--LLGEAAK-WEIMWEDLQIGERIGIGS 619
Query: 258 YCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317
Y ++Y+ + +VA+K ++ + + +F E+ IM ++RH NVV F+GA TRPP
Sbjct: 620 YGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRLRHPNVVLFMGAVTRPPNF 679
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLL 375
I+TEF+ GS+Y LH+ L +R+A+DV+KGMNYLH ++ ++HRDLK+ NLL
Sbjct: 680 SILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNYLHTSHPTVVHRDLKSPNLL 739
Query: 376 MNENGV 381
+++N V
Sbjct: 740 VDKNWV 745
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 411 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 2e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-26 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-16 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-08 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-06 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 4e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd02116 | 60 | cd02116, ACT, ACT domains are commonly involved in | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd04899 | 70 | cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domain | 2e-05 | |
| COG2844 | 867 | COG2844, GlnD, UTP:GlnB (protein PII) uridylyltran | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| PRK00275 | 895 | PRK00275, glnD, PII uridylyl-transferase; Provisio | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| pfam01842 | 66 | pfam01842, ACT, ACT domain | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-04 | |
| PRK05007 | 884 | PRK05007, PRK05007, PII uridylyl-transferase; Prov | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| PRK05092 | 931 | PRK05092, PRK05092, PII uridylyl-transferase; Prov | 0.002 | |
| TIGR01693 | 850 | TIGR01693, UTase_glnD, [Protein-PII] uridylyltrans | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd04926 | 72 | cd04926, ACT_ACR_4, C-terminal ACT domain, of a no | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 57/141 (40%), Positives = 83/141 (58%), Gaps = 7/141 (4%)
Query: 247 LKFEHKIVSGSYCDLYKG------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
L+ K+ G++ ++YKG VA+K L E +E R EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLS 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+V+ +G CT+ L+IVTE+M GG + D+L K L L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 361 RNNIIHRDLKAANLLMNENGV 381
N +HRDL A N L+ EN V
Sbjct: 120 SKNFVHRDLAARNCLVTENLV 140
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 56/141 (39%), Positives = 78/141 (55%), Gaps = 7/141 (4%)
Query: 247 LKFEHKIVSGSYCDLYKG------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
L K+ G++ ++YKG +VA+K L + +E EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H NVV+ +G CT L+IV E+M GG + YL K + L L LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 361 RNNIIHRDLKAANLLMNENGV 381
N IHRDL A N L+ EN V
Sbjct: 120 SKNFIHRDLAARNCLVGENLV 140
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 58/147 (39%), Positives = 81/147 (55%), Gaps = 9/147 (6%)
Query: 247 LKFEHKIVSGSYCDLYKG------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
L K+ G++ ++YKG +VA+K L + + I EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLD 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYL 359
H N+V+ +G CT L IV E+M GG + DYL K + L L LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 360 HRNNIIHRDLKAANLLMNENG-VRDSD 385
N IHRDL A N L+ EN V+ SD
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISD 146
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 52/143 (36%), Positives = 79/143 (55%), Gaps = 14/143 (9%)
Query: 252 KIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
K+ G++ ++YKG + +VA+K L + E R++F +E +M+K+ H NVV+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVR 60
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--------LKLPLLLRVAIDVSKGMNY 358
+G CT L++V E+M GG + DYL K + L L LL AI ++KGM Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
L +HRDL A N L+ E+ V
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLV 143
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 42/141 (29%), Positives = 74/141 (52%), Gaps = 8/141 (5%)
Query: 255 SGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312
G + +Y + VAIK++ E + E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL-LEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
L++V E+ GGS+ D L + + L +LR+ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 373 NLLMNENGVRDSDIHCYLSNF 393
N+L++ + + L++F
Sbjct: 122 NILLDSD-----NGKVKLADF 137
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 46/137 (33%), Positives = 76/137 (55%), Gaps = 3/137 (2%)
Query: 247 LKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
+ K+ SGS+ +YK + VA+K+L + +E+ I+R++ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V+ I A L++V E+ GG ++DYL + L ++A+ + +G+ YLH N I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHSNGI 119
Query: 365 IHRDLKAANLLMNENGV 381
IHRDLK N+L++ENGV
Sbjct: 120 IHRDLKPENILLDENGV 136
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 34/113 (30%), Positives = 62/113 (54%), Gaps = 2/113 (1%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ VAIKV+ + + ++ R +E+ I++K++H N+V+ +L++V E+ GG
Sbjct: 25 KLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGD 83
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
++D L K+ L + + YLH I+HRDLK N+L++E+G
Sbjct: 84 LFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGH 135
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 53/145 (36%), Positives = 89/145 (61%), Gaps = 6/145 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
WE++ + + +HK+ G Y ++Y+G + +S VA+K L + + EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGM 356
+++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + + +LL +A +S M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 357 NYLHRNNIIHRDLKAANLLMNENGV 381
YL + N IHRDL A N L+ EN +
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHL 142
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 52/144 (36%), Positives = 82/144 (56%), Gaps = 5/144 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEID + ++ K+ +G + ++++G + + VA+K L ++ +F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
+RH ++Q CT ++IVTE M GS+ +YL LKLP L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
YL N IHRDL A N+L+ EN +
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNI 141
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-29
Identities = 44/67 (65%), Positives = 51/67 (76%)
Query: 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLR 199
MHEIT + DKPKLLSQL+SLL ++GLNI EAHAFST DG +LD+FVV GW ET L
Sbjct: 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALG 60
Query: 200 NVLAKEI 206
+ L KEI
Sbjct: 61 HALQKEI 67
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 54/141 (38%), Positives = 83/141 (58%), Gaps = 4/141 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID S L F ++ SG + ++ G + + DVAIK++ ++E+ +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+VQ G CT+ +FIVTE+M+ G + +YL ++K L LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGV 381
N IHRDL A N L+ E+ V
Sbjct: 118 SNGFIHRDLAARNCLVGEDNV 138
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 50/143 (34%), Positives = 82/143 (57%), Gaps = 5/143 (3%)
Query: 246 LLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
L + KI G + ++YK ++VAIKV+ + ++ + + E+ I++K +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
+V++ G+ + L+IV EF SGGS+ D L L + V ++ KG+ YLH N
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 364 IIHRDLKAANLLMNENG-VRDSD 385
IIHRD+KAAN+L+ +G V+ D
Sbjct: 119 IIHRDIKAANILLTSDGEVKLID 141
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 54/142 (38%), Positives = 83/142 (58%), Gaps = 5/142 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI LK E K+ +G + +++ G + + VA+K L ++ F QE IM+K
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
+RH +VQ C+ ++IVTE+MS GS+ D+L + L+LP L+ +A +++GM
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 358 YLHRNNIIHRDLKAANLLMNEN 379
YL N IHRDL A N+L+ EN
Sbjct: 118 YLESRNYIHRDLAARNILVGEN 139
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 51/131 (38%), Positives = 79/131 (60%), Gaps = 2/131 (1%)
Query: 252 KIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
KI G++ D+YKG +VA+K L +++R+F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
C + ++IV E + GGS+ +L K+K L + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 371 AANLLMNENGV 381
A N L+ EN V
Sbjct: 121 ARNCLVGENNV 131
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 52/143 (36%), Positives = 80/143 (55%), Gaps = 4/143 (2%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W I++ LK I G + D+ G + Q VA+K L + + + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH-KQKCGLKLPLLLRVAIDVSKGMNY 358
RH N+VQ +G + L+IVTE+M+ GS+ DYL + + + L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
L N +HRDL A N+L++E+ V
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLV 140
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 54/141 (38%), Positives = 83/141 (58%), Gaps = 4/141 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
I+ S L F ++ SG + ++ G + +Q VAIK + ++E +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT+ L+IVTEFM G + +YL +++ L +LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGV 381
RN+ IHRDL A N L++ GV
Sbjct: 118 RNSFIHRDLAARNCLVSSTGV 138
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 49/148 (33%), Positives = 80/148 (54%), Gaps = 10/148 (6%)
Query: 247 LKFEHKIVSGSYCDLYKGAF-FSQD-----VAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
LKF ++ G + + + D VA+K L N E R +F +E+ I+R +
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLD 64
Query: 301 HMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
H N+V++ G C +P L ++ E++ GS+ DYL + + + L LL + + KGM+Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 359 LHRNNIIHRDLKAANLLM-NENGVRDSD 385
L IHRDL A N+L+ +E+ V+ SD
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISD 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 8e-24
Identities = 51/141 (36%), Positives = 75/141 (53%), Gaps = 4/141 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
I S L +I SG + ++ G + + VAIK + ++E +F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT + +V EFM G + DYL Q+ LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGV 381
+N+IHRDL A N L+ EN V
Sbjct: 118 SSNVIHRDLAARNCLVGENQV 138
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 49/157 (31%), Positives = 91/157 (57%), Gaps = 14/157 (8%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WE+ LK K+ +G + +++ G + VAIK L ++ F E ++M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGM 356
++H +V+ T+ P ++I+TE+M GS+ D+L K G+KL + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGM 115
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
++ R N IHRDL+AAN+L++E + C +++F
Sbjct: 116 AFIERKNYIHRDLRAANILVSET------LCCKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 47/137 (34%), Positives = 75/137 (54%), Gaps = 6/137 (4%)
Query: 248 KFE--HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+E +I SG+Y D+YK + VAIKV+ E ++ QE+ ++++ RH N
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKECRHPN 61
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
+V + G+ R +L+IV E+ GGS+ D + L + V + KG+ YLH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 364 IIHRDLKAANLLMNENG 380
IHRD+K AN+L+ E+G
Sbjct: 122 KIHRDIKGANILLTEDG 138
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 5e-23
Identities = 56/156 (35%), Positives = 90/156 (57%), Gaps = 12/156 (7%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI L+ E K+ G + +++ G + + VAIK L ++ F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
+RH +VQ + P ++IVTE+MS GS+ D+L + L+LP L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
Y+ R N +HRDL+AAN+L+ EN V C +++F
Sbjct: 117 YVERMNYVHRDLRAANILVGENLV------CKVADF 146
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 8e-23
Identities = 39/137 (28%), Positives = 72/137 (52%), Gaps = 9/137 (6%)
Query: 251 HKIVSGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+ GS+ +Y +D +A+K + +E +E+ I+ ++H N+V+
Sbjct: 6 ELLGRGSFGSVYLA--LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 307 FIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
+ G+ + L I E++SGGS+ L K L P++ + + +G+ YLH N I
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 365 IHRDLKAANLLMNENGV 381
+HRD+K AN+L++ +GV
Sbjct: 123 VHRDIKGANILVDSDGV 139
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 47/127 (37%), Positives = 74/127 (58%), Gaps = 2/127 (1%)
Query: 256 GSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314
G++ +++KG + VA+K E L + ++ +F E I+++ H N+V+ IG CT+
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR 64
Query: 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
++IV E + GG +L K+K LK L++ A+D + GM YL N IHRDL A N
Sbjct: 65 QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124
Query: 375 LMNENGV 381
L+ EN V
Sbjct: 125 LVGENNV 131
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 43/142 (30%), Positives = 80/142 (56%), Gaps = 4/142 (2%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WE E K+ SG + ++++G + VAIK+L ++ + +++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMN 357
+RH +++ C+ ++I+TE M GS+ +L + L + L+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 358 YLHRNNIIHRDLKAANLLMNEN 379
YL N IHRDL A N+L+ E+
Sbjct: 119 YLEEQNSIHRDLAARNILVGED 140
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-22
Identities = 50/141 (35%), Positives = 78/141 (55%), Gaps = 4/141 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID L F ++ +G + + G + Q DVAIK++ ++E+ EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT+ ++IVTE+MS G + +YL + + LL + DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGV 381
IHRDL A N L+++ G
Sbjct: 118 SKQFIHRDLAARNCLVDDQGC 138
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 6/144 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W ++ LK I G + D+ G + VA+K + N+ + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMTQL 56
Query: 300 RHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMN 357
RH N+VQ +G L+IVTE+M+ GS+ DYL + + L LL+ ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
YL NN +HRDL A N+L++E+ V
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNV 140
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-22
Identities = 54/156 (34%), Positives = 89/156 (57%), Gaps = 12/156 (7%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI L+ K+ +G + +++ G + + VA+K L ++ F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMN 357
+RH +VQ + P ++IVTE+MS GS+ D+L + LKLP L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 358 YLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
Y+ R N IHRDL++AN+L+ + V C +++F
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLV------CKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 6e-22
Identities = 58/157 (36%), Positives = 89/157 (56%), Gaps = 14/157 (8%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI L+ + K+ G + +++ G + + VAIK L + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP---EAFLQEAQIMKK 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--LKLPLLLRVAIDVSKGM 356
+RH +V + P ++IVTEFM GS+ D+L K+ G LKLP L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGM 115
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
Y+ R N IHRDL+AAN+L+ +N V C +++F
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLV------CKIADF 146
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH 301
L K KI G+ ++YK + ++VAIK + L + + E+ IM+ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKH 74
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
N+V + + L++V E+M GGS+ D + + + P + V +V +G+ YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 362 NNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
N+IHRD+K+ N+L++++G L++F
Sbjct: 135 QNVIHRDIKSDNILLSKDG------SVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIM 296
ID S + E I G + ++ +G DVAIK L ++ R +F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIM 59
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H N+++ G T+ + I+TE+M GS+ +L + + L+ + ++ GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
YL N +HRDL A N+L+N N V C +S+F
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLV------CKVSDF 150
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 3/111 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K + + +E R++ +E+ +R VV+ GA + + IV E+M GGS+
Sbjct: 29 YALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA 87
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG 380
D L K+ + P+L +A + KG++YLH +IIHRD+K +NLL+N G
Sbjct: 88 D-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG 137
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 48/143 (33%), Positives = 73/143 (51%), Gaps = 15/143 (10%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM 302
L I GS+ ++YK Q VAIKV+ E + I + QE+ + + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSP 59
Query: 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMN 357
+ ++ G+ + +L+I+ E+ GGS D L K G KL +LR +V G+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPG-KLDETYIAFILR---EVLLGLE 112
Query: 358 YLHRNNIIHRDLKAANLLMNENG 380
YLH IHRD+KAAN+L++E G
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEG 135
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 15/147 (10%)
Query: 252 KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
I G++ +YKG VAIK ++ E + E + QE+ +++ ++H N+V++IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS---KGMNYLHRNNIIH 366
+ L+I+ E+ GS+ + K P L VA+ V +G+ YLH +IH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFG---PFPESL-VAVYVYQVLQGLAYLHEQGVIH 122
Query: 367 RDLKAANLLMNENGVRDSDIHCYLSNF 393
RD+KAAN+L ++GV L++F
Sbjct: 123 RDIKAANILTTKDGV------VKLADF 143
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 3/107 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L ++ L++ + +F +E IM + H N+++ G P L +VTE GS+
Sbjct: 26 VAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLL 83
Query: 331 DYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
D L K G + L A+ ++ GM YL IHRDL A N+L+
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 45/141 (31%), Positives = 85/141 (60%), Gaps = 5/141 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI +K K+ +G + +++ G + S VA+K L ++ + F +E ++M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKT 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
++H +V+ T+ ++I+TE+M+ GS+ D+L + G + LP L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 358 YLHRNNIIHRDLKAANLLMNE 378
Y+ R N IHRDL+AAN+L++E
Sbjct: 118 YIERKNYIHRDLRAANVLVSE 138
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 43/143 (30%), Positives = 79/143 (55%), Gaps = 6/143 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W ++ L I G + + +G + Q VA+K + + + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQ----AFLEETAVMTKL 56
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNY 358
H N+V+ +G L+IV E MS G++ ++L + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
L ++HRDL A N+L++E+GV
Sbjct: 116 LESKKLVHRDLAARNILVSEDGV 138
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVH 294
+EI + I G + D+Y+G + S + VA+K N + ++R +F QE +
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAY 59
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
IMR+ H ++V+ IG T P ++IV E G + YL K L L L+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 355 GMNYLHRNNIIHRDLKAANLL 375
+ YL +HRD+ A N+L
Sbjct: 119 ALAYLESKRFVHRDIAARNVL 139
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 31/114 (27%), Positives = 58/114 (50%), Gaps = 3/114 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
+K + +++E R + EV I++K+ H N++++ + +L IV E+ GG +
Sbjct: 28 YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87
Query: 331 DYLHKQKCGLKL---PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ KQK K +L + + + YLH I+HRD+K N+ + NG+
Sbjct: 88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 35/111 (31%), Positives = 63/111 (56%), Gaps = 1/111 (0%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK +E++++ +EV ++R++RH N+V A R RL++V E++ ++
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLL 87
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L GL + + + + Y H +NIIHRD+K N+L++E+GV
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG---AFFSQD----VAIKVLTNEHLNENIRREFAQE 292
WE+ + ++ GS+ +Y+G + VAIK + NE+ + R EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-NENASMRERIEFLNE 59
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK------CGLKLP--- 343
+M++ +VV+ +G + +V E M+ G + YL ++ GL P
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+++A +++ GM YL +HRDL A N ++ E+
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL 156
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 7e-19
Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ GSY +YK Q VAIKV+ E + I +E + I+++ +V++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI--DVSKGMNYLHRNNIIHR 367
+ + L+IV E+ GS+ D + + L AI KG+ YLH N IHR
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 368 DLKAANLLMNENGVRDSDIHCYLSNF 393
D+KA N+L+NE G L++F
Sbjct: 124 DIKAGNILLNEEG------QAKLADF 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 38/114 (33%), Positives = 65/114 (57%), Gaps = 2/114 (1%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ +A+K + E +NE I+++ +E+ I+ K +V F GA + I E+M GG
Sbjct: 26 GKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG 380
S+ L + + + +L ++A+ V KG+ YLH IIHRD+K +N+L+N G
Sbjct: 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG 138
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 5e-18
Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
ID S +K E I +G + ++ +G VAIK L + + E RR+F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIM 59
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H N++ G T+ + I+TEFM G++ +L + + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
YL N +HRDL A N+L+N N V C +S+F
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLV------CKVSDF 150
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 6e-18
Identities = 32/114 (28%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K + ++ E I +E+ ++++++H N+V+ + +L++V E+
Sbjct: 27 VALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD----M 82
Query: 331 D---YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
D YL K+ L L+ + + +G+ Y H + I+HRDLK N+L+N +GV
Sbjct: 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV 136
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-18
Identities = 42/136 (30%), Positives = 77/136 (56%), Gaps = 2/136 (1%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLT-NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
+I G++ +++ G + + + V + E L +++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
CT+ ++IV E + GG +L + LK+ L+++ + + GM YL + IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 371 AANLLMNE-NGVRDSD 385
A N L+ E N ++ SD
Sbjct: 122 ARNCLVTEKNVLKISD 137
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 41/127 (32%), Positives = 68/127 (53%), Gaps = 8/127 (6%)
Query: 255 SGSYCDLYKGAFFSQ------DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + + VAIKVL E + + E E ++M V H +VV+ +
Sbjct: 17 SGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASVDHPHVVRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C ++ ++T+ M G + DY+ K + LL + ++KGM+YL ++HRD
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134
Query: 369 LKAANLL 375
L A N+L
Sbjct: 135 LAARNVL 141
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 41/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
+VA+K L EH+ ++EF +E +M ++ H +V+ IG C P L +V E G +
Sbjct: 25 EVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPL 82
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN-LLMNENGVRDSD 385
YL K++ + + L +A V+ GM YL + +HRDL A N LL+N + + SD
Sbjct: 83 LKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISD 138
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 3/112 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK + E ++ E +EV M + H NVV++ + L++V ++SGGS+
Sbjct: 29 VAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 331 DYL-HKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
D + G L ++ V +V KG+ YLH N IHRD+KA N+L+ E+G
Sbjct: 88 DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG 139
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 15/140 (10%)
Query: 255 SGSYCDLYKGAFFSQD--------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
SG++ ++Y+G VA+K L ++ ++EF +E H+M H N+V+
Sbjct: 5 SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNIVK 63
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC------GLKLPLLLRVAIDVSKGMNYLH 360
+G C +I+ E M GG + YL + L L LL + +DV+KG YL
Sbjct: 64 LLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123
Query: 361 RNNIIHRDLKAANLLMNENG 380
+ + IHRDL A N L++E G
Sbjct: 124 QMHFIHRDLAARNCLVSEKG 143
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 24/169 (14%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEV 293
EI S ++F ++ G++ +YKG + VAIK L +++EF QE
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEA 59
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------HKQKC 338
+M ++H N+V +G CT+ ++ E+++ G ++++L K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVRDSDI 386
L L +AI ++ GM YL ++ +HRDL A N L+ E V+ SD
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDF 168
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 16/139 (11%)
Query: 253 IVSGSYCDLY------KGAFFSQDVAIK---VLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ SGS+ +Y G FF A+K + + + ++ QE+ ++ K++H N
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFF----AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRN 362
+VQ++G L+I E + GGS+ L +K G P++ + G+ YLH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 363 NIIHRDLKAANLLMNENGV 381
N +HRD+K AN+L++ NGV
Sbjct: 122 NTVHRDIKGANILVDTNGV 140
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 33/115 (28%), Positives = 61/115 (53%), Gaps = 4/115 (3%)
Query: 269 QDVAIKVLTNEHLNENIRRE---FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+++A+K + + + ++E E+ +++ ++H +VQ+ G L I E+M
Sbjct: 28 RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMP 87
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
GGS+ D L K L + + + +G+ YLH N I+HRD+K AN+L + G
Sbjct: 88 GGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG 141
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 42/140 (30%), Positives = 80/140 (57%), Gaps = 6/140 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRK 298
WEI LK E K+ +G + +++ + VA+K + ++ F E ++M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
++H +V+ T+ P ++I+TEFM+ GS+ D+L + LP L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 358 YLHRNNIIHRDLKAANLLMN 377
++ + N IHRDL+AAN+L++
Sbjct: 117 FIEQRNYIHRDLRAANILVS 136
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 52/157 (33%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVHIM 296
IDAS +K E I +G + ++ G VAIK L + E RR+F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIM 59
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H N++ G T+ + IVTE+M GS+ +L K + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
YL +HRDL A N+L+N N V C +S+F
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLV------CKVSDF 150
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 3/132 (2%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK + VAIK + +E I + +E+ +++++ H N+++ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
L++V EFM +Y + ++ GL L+ + +G+ + H + I+HRDL
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 370 KAANLLMNENGV 381
K NLL+N GV
Sbjct: 125 KPENLLINTEGV 136
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 12/152 (7%)
Query: 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDV--AIKVLTNEHLNENIRREFAQEVH 294
D+WEI L G++ +YK + A K++ E +E +F E+
Sbjct: 4 NDIWEIIGEL-------GDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEID 54
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
I+ + +H N+V A +L+I+ EF GG++ + + + GL P + V + +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 355 GMNYLHRNNIIHRDLKAANLLMN-ENGVRDSD 385
+N+LH + +IHRDLKA N+L+ + V+ +D
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLAD 146
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 4e-16
Identities = 28/65 (43%), Positives = 41/65 (63%), Gaps = 3/65 (4%)
Query: 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQETE 196
E+ I T D+P L +++ L ++GLNI +A F+T DGY+LD FVV DG P+ E E
Sbjct: 1 GTEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERE 60
Query: 197 QLRNV 201
+L +
Sbjct: 61 RLARI 65
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 40/118 (33%), Positives = 68/118 (57%), Gaps = 4/118 (3%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTEFMSGGS 328
VA+K L E +I + +E+ I+R + H N+V++ G CT + ++ EF+ GS
Sbjct: 36 VAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM-NENGVRDSD 385
+ +YL + K + L L+ A+ + KGM+YL +HRDL A N+L+ +E+ V+ D
Sbjct: 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 35/113 (30%), Positives = 66/113 (58%), Gaps = 1/113 (0%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q VAIK ++ +++ +E+ +++++RH N+V I R RL++V EF+ +
Sbjct: 27 QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-T 85
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ D L K GL + + + +G+ + H +NIIHRD+K N+L++++GV
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 23/154 (14%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
+KFE I G++ + + A +D AIK+L E +EN R+FA E+ ++ K+
Sbjct: 4 IKFEDVIGEGNFGQVIR-AMIKKDGLKMNAAIKML-KEFASENDHRDFAGELEVLCKLGH 61
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GLKLPLL 345
H N++ +GAC L+I E+ G++ D+L K + L L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
L+ A DV+ GM YL IHRDL A N+L+ EN
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 10/117 (8%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTEFMSGGS- 328
A+K +T + N +++++ +E+ I + + +V++ GA + I E+ GGS
Sbjct: 30 ALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL 88
Query: 329 --IYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
IY + K+ + G K+ L ++A V KG++YLH IIHRD+K +N+L+ G
Sbjct: 89 DSIYKKVKKRGGRIGEKV--LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ 143
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 39/119 (32%), Positives = 61/119 (51%), Gaps = 11/119 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+KVL ++N R +F +EV I+ ++ N+ + +G CT P L ++ E+M G +
Sbjct: 49 VAVKVL-RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 331 DYLHK-------QKCGLKLP---LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+L K C K LL +A ++ GM YL N +HRDL N L+ +N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN 166
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 48/138 (34%), Positives = 75/138 (54%), Gaps = 9/138 (6%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + + VAIK+L NE EF E IM + H ++V+ +
Sbjct: 17 SGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMDEALIMASMDHPHLVRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C P + +VT+ M G + DY+H+ K + LLL + ++KGM YL ++HRD
Sbjct: 76 GVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 134
Query: 369 LKAANLLMNE-NGVRDSD 385
L A N+L+ N V+ +D
Sbjct: 135 LAARNVLVKSPNHVKITD 152
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 49/139 (35%), Positives = 72/139 (51%), Gaps = 16/139 (11%)
Query: 256 GSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
G++ ++Y+G + +D VA+K L E +E +F E IM K H N+V+ I
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLP-ESCSEQDESDFLMEALIMSKFNHQNIVRLI 75
Query: 309 GAC-TRPPRLFIVTEFMSGGSIYDYLHK------QKCGLKLPLLLRVAIDVSKGMNYLHR 361
G R PR FI+ E M+GG + +L + + L + LL A DV+KG YL
Sbjct: 76 GVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134
Query: 362 NNIIHRDLKAANLLMNENG 380
N+ IHRD+ A N L+ G
Sbjct: 135 NHFIHRDIAARNCLLTCKG 153
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 43/118 (36%), Positives = 66/118 (55%), Gaps = 5/118 (4%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGS 328
VA+K L +H R+F +E+ I++ ++H N+V++ G C R L +V E++ GS
Sbjct: 36 VAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM-NENGVRDSD 385
+ DYL K + L LL A + KGM YL +HRDL N+L+ +EN V+ D
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 256 GSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313
GSY +YK S Q A+K + +++ R + E+ I+ V H N++ + A
Sbjct: 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKL---PLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
+L IV E+ G + + K+K KL + R+ I + +G+ LH I+HRDLK
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK 130
Query: 371 AANLLMNENGV 381
+AN+L+ N +
Sbjct: 131 SANILLVANDL 141
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 29/147 (19%)
Query: 251 HKIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
+I G+Y +YK G VA+K + E+ E +E+ +++K+RH N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGEL----VALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 305 VQFIGACTRPPR--LFIVTEFMS---GGSIYDYLHK----Q-KCGLKLPLLLRVAIDVSK 354
V+ T + +++V E+M G + K Q KC +K LL +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-QLL--------E 111
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGV 381
G+ YLH N I+HRD+K +N+L+N +GV
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGV 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 75.2 bits (183), Expect = 7e-15
Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 5/132 (3%)
Query: 255 SGSYCDLYKGAFFSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRH-MNVVQFIGACT 312
GS+ ++Y A + VA+KVL + ++ F +E+ I+ + H N+V+
Sbjct: 10 EGSFGEVYL-ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ 68
Query: 313 RPPRLFIVTEFMSGGSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
L++V E++ GGS+ D L K +K L L + + + YLH IIHRD+K
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK 128
Query: 371 AANLLMNENGVR 382
N+L++ +G
Sbjct: 129 PENILLDRDGRV 140
|
Length = 384 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 43/122 (35%), Positives = 64/122 (52%), Gaps = 11/122 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG------ACTRPPRLFIVTE 322
Q VA+K+L + + + EF +E M++ H NV++ IG A R P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 323 FMSGGSIYDYLHKQKCG-----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
FM G ++ +L + G L L L+R ID++ GM YL N IHRDL A N ++N
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 378 EN 379
EN
Sbjct: 148 EN 149
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 253 IVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309
I G+Y +YK Q VAIK++ + E+ E +E +I+RK H N+ F G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 310 A------CTRPPRLFIVTEFMSGGSIYDY---LHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
A +L++V E GGS+ D L K+ LK + + + +G+ YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 361 RNNIIHRDLKAANLLMNENG 380
N +IHRD+K N+L+ +N
Sbjct: 131 ENKVIHRDIKGQNILLTKNA 150
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 39/134 (29%), Positives = 70/134 (52%), Gaps = 14/134 (10%)
Query: 261 LYKGAFFS---------QDVAIKVL----TNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
L KGA+ + Q +A+K + +N E + +EV +++ ++H+N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
+G C + I EF+ GGSI L + L P+ + + G+ YLH N ++HR
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 368 DLKAANLLMNENGV 381
D+K N+++ NG+
Sbjct: 127 DIKGNNVMLMPNGI 140
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 31/180 (17%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQ 291
WE+ L + G++ + K D VA+K+L + E +
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS 64
Query: 292 EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-----QKCG------ 339
E+ +M+ + +H N++ +G CT+ L++V E+ + G++ D+L +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 340 ----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD-------SDIHC 388
L L+ A V++GM +L IHRDL A N+L+ E+ V DIH
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 17/126 (13%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
D AIK + E+ +++ R+FA E+ ++ K+ H N++ +GAC L++ E+ G+
Sbjct: 24 DAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 82
Query: 329 IYDYLHKQKC---------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
+ D+L K + L LL A DV++GM+YL + IHRDL A N
Sbjct: 83 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 142
Query: 374 LLMNEN 379
+L+ EN
Sbjct: 143 ILVGEN 148
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 39/123 (31%), Positives = 61/123 (49%), Gaps = 11/123 (8%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC------TRPPRLFIVT 321
VA+K + + + EF E M+ H NV++ IG C + P+ ++
Sbjct: 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 322 EFMSGGSIYDYLHKQKCG---LKLPL--LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
FM G ++ +L + G KLPL LL+ +D++ GM YL N IHRDL A N ++
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML 146
Query: 377 NEN 379
E+
Sbjct: 147 RED 149
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVL-TNEHLNENIRREFAQ 291
WE + L F + +G++ + + + VA+K+L H +E R
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE--REALMS 87
Query: 292 EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVA 349
E+ IM + H N+V +GACT + ++TE+ G + ++L +++ L L LL +
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
V+KGM +L N IHRDL A N+L+ +
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKI 179
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 35/135 (25%), Positives = 74/135 (54%), Gaps = 7/135 (5%)
Query: 251 HKIVSGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+KI G++ +Y + D +A+K + + + +E A E+ ++ ++H N+V+
Sbjct: 6 NKIGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ G +++I E+ SGG++ + L + L ++ + + +G+ YLH + I+H
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 367 RDLKAANLLMNENGV 381
RD+K AN+ ++ NGV
Sbjct: 123 RDIKPANIFLDHNGV 137
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 21/160 (13%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
++ + +KF+ I G++ + K D AIK + E+ +++ R+FA E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLC 62
Query: 298 KV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GLK 341
K+ H N++ +GAC L++ E+ G++ D+L K + L
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
LL A DV++GM+YL + IHRDL A N+L+ EN V
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 47/136 (34%), Positives = 77/136 (56%), Gaps = 7/136 (5%)
Query: 255 SGSYCDLYKGAFFSQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
SG++ + KG + + DVAIKVL NE+ +++R E +E IM ++ + +V+ IG
Sbjct: 5 SGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
C L +V E SGG + +L +K + + ++ + VS GM YL N +HRDL
Sbjct: 64 C-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122
Query: 371 AANLLM-NENGVRDSD 385
A N+L+ N++ + SD
Sbjct: 123 ARNVLLVNQHYAKISD 138
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 46/135 (34%), Positives = 73/135 (54%), Gaps = 11/135 (8%)
Query: 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFA---QEVHIMRKVRHMNVV 305
+I SG+Y D+YK + + AIKV+ E +FA QE+ +M+ +H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIV 69
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ G+ R +L+I EF GGS+ D H L + V+ + +G+ YLH +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 366 HRDLKAANLLMNENG 380
HRD+K AN+L+ +NG
Sbjct: 129 HRDIKGANILLTDNG 143
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 32/120 (26%), Positives = 63/120 (52%), Gaps = 12/120 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L + + + R +F +E+ IM ++++ N+++ +G C L ++TE+M G +
Sbjct: 47 VAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 331 DYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+L +++ LL +A+ ++ GM YL N +HRDL N L+ +
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
EI S + + I +G + ++++G VAIK L + E R++F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASI 59
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M + H N+++ G T+ I+TE+M G++ YL L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
M YL N +HRDL A N+L+N S++ C +S+F
Sbjct: 120 MKYLSDMNYVHRDLAARNILVN------SNLECKVSDF 151
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 14/122 (11%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L N+ R++F +E ++ +H N+V+F G CT +V E+M G +
Sbjct: 38 VAVKTLKETASND-ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96
Query: 331 DYLH------------KQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
+L G L L LL++A+ ++ GM YL + +HRDL N L+
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156
Query: 378 EN 379
+
Sbjct: 157 YD 158
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 33/123 (26%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+KVL + + + E E +I+ ++ H +V+ A +L++V E+ GG ++
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390
+L K+ A ++ + YLH II+RDLK N+L++ +G H L
Sbjct: 82 SHLSKEGR-FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG------HIKL 134
Query: 391 SNF 393
++F
Sbjct: 135 TDF 137
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 34/131 (25%), Positives = 64/131 (48%), Gaps = 5/131 (3%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ ++K + + A+K + +N R E E ++ K+ ++++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHR 367
+ +L IV E+ G ++ L Q+ G LP + R I + G+ +LH I+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 368 DLKAANLLMNE 378
D+K+ NL ++
Sbjct: 126 DIKSLNLFLDA 136
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 19/127 (14%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L + N+N R +F +EV I+ +++ N+++ +G C L ++TE+M G +
Sbjct: 49 VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 331 DYLHKQK----------------CGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+L C + LL VA+ ++ GM YL N +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 373 NLLMNEN 379
N L+ EN
Sbjct: 168 NCLVGEN 174
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVTEFMSGGS 328
VA+K L E +N + +E++I++ + H N+V++ G C+ L ++ E++ GS
Sbjct: 36 VAVKTLKRECGQQN-TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM-NENGVRDSD 385
+ DYL K K L LL A + +GM YLH + IHRDL A N+L+ N+ V+ D
Sbjct: 95 LRDYLPKHKLNLAQLLLF--AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 40/131 (30%), Positives = 75/131 (57%), Gaps = 5/131 (3%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
+I GS+ ++YKG + VAIK++ E + I + QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYG 69
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ + +L+I+ E++ GGS D L + L+ + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 370 KAANLLMNENG 380
KAAN+L++E G
Sbjct: 128 KAANVLLSEQG 138
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD 331
A+KV+ H + +RR+ +E+ I+R V H NVV+ + ++ EFM GGS
Sbjct: 103 ALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS--- 158
Query: 332 YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
L L VA + G+ YLHR +I+HRD+K +NLL+N
Sbjct: 159 -LEGTHIA-DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 15/131 (11%)
Query: 264 GAFFS----QDV------AIKVLT----NEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
GAF S +DV A+K +T E + +E+ +M ++ H ++++ +G
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
A + E+M+GGS+ L K K +++ + +G++YLH N IIHRD+
Sbjct: 71 ATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDV 129
Query: 370 KAANLLMNENG 380
K ANLL++ G
Sbjct: 130 KGANLLIDSTG 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 7/103 (6%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
E+ ++ + H+N+VQ++G T L I E++ GGSI L + L+
Sbjct: 57 SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTE 115
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
V +G+ YLH I+HRDLKA NLL++ +G+ C +S+F
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLVDADGI------CKISDF 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 38/134 (28%), Positives = 73/134 (54%), Gaps = 16/134 (11%)
Query: 256 GSYCDLYKGAFFSQD--VAIKVL---TNEHLNENIRREFAQEVHIMRKVRHM---NVVQF 307
G+Y +Y+G VA+K++ T + +I+RE A ++ ++R N+ ++
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA----LLSQLRQSQPPNITKY 67
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLK-LPLLLRVAIDVSKGMNYLHRNNIIH 366
G+ + PRL+I+ E+ GGS+ + K + +++R +V + Y+H+ +IH
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR---EVLVALKYIHKVGVIH 124
Query: 367 RDLKAANLLMNENG 380
RD+KAAN+L+ G
Sbjct: 125 RDIKAANILVTNTG 138
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-13
Identities = 42/132 (31%), Positives = 76/132 (57%), Gaps = 7/132 (5%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ +++KG + VAIK++ E + I + QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ + +L+I+ E++ GGS D L ++ +LR ++ KG++YLH IHRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSEKKIHRD 126
Query: 369 LKAANLLMNENG 380
+KAAN+L++E+G
Sbjct: 127 IKAANVLLSEHG 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-13
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
E+D +K E + +G + +L +G VAI L ++ RR F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALT 59
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+ + H N+V+ G TR + IVTE+MS G++ +L K + L L+ + ++ G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
M YL +H+ L A +L+N SD+ C +S F
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVN------SDLVCKISGF 151
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 1/111 (0%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K + L I + +E+ ++ +H VV+ + +V E+M +
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS 86
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L ++ L + + KG+ Y+H N I+HRDLK ANLL++ +GV
Sbjct: 87 EVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV 137
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 43/147 (29%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
A + + + +G+Y +YKG Q AIKV+ + E+ E E+++++K
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSH 71
Query: 301 HMNVVQFIGACTR--PP----RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVS 353
H N+ + GA + PP +L++V EF GS+ D + K LK + + ++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENG 380
+G+ +LH + +IHRD+K N+L+ EN
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENA 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + + VAIK L E + +E E ++M V + +V + +
Sbjct: 17 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C + ++T+ M G + DY+ + K + LL + ++KGMNYL ++HRD
Sbjct: 76 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRD 134
Query: 369 LKAANLLM-NENGVRDSD 385
L A N+L+ V+ +D
Sbjct: 135 LAARNVLVKTPQHVKITD 152
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 41/132 (31%), Positives = 75/132 (56%), Gaps = 7/132 (5%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
+I GS+ +++KG Q VAIK++ E + I + QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYG 69
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ + +L+I+ E++ GGS D L ++ +L+ ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 369 LKAANLLMNENG 380
+KAAN+L++E G
Sbjct: 127 IKAANVLLSEQG 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 16/125 (12%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L + +E+ R++F +E ++ ++H ++V+F G CT L +V E+M G +
Sbjct: 38 VAVKAL--KEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 331 DYLHK-------------QKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
+L G L L +L +A ++ GM YL + +HRDL N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 377 NENGV 381
+ V
Sbjct: 156 GQGLV 160
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPP---RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV 348
E+ +++ +RH +VQ+ G C R P +L I E+M GGSI D L K L + R
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ +G++YLH N I+HRD+K AN+L + G
Sbjct: 112 TRQILQGVSYLHSNMIVHRDIKGANILRDSAG 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 43/147 (29%), Positives = 79/147 (53%), Gaps = 13/147 (8%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
A + + + +G+Y +YKG Q AIKV+ + + E QE+++++K
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSH 61
Query: 301 HMNVVQFIGACTR--PP----RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVS 353
H N+ + GA + PP +L++V EF GS+ D + K LK + + ++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENG 380
+G+++LH++ +IHRD+K N+L+ EN
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENA 148
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 32/123 (26%), Positives = 62/123 (50%), Gaps = 3/123 (2%)
Query: 261 LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320
LY+ V K + L+E RR+ E+ I+ ++H N++ + L I
Sbjct: 18 LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77
Query: 321 TEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
E+ +GG++YD + +QK G ++L + ++Y+H+ I+HRD+K N+ + +
Sbjct: 78 MEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK 136
Query: 379 NGV 381
G+
Sbjct: 137 AGL 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 29/121 (23%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 259 CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318
L + + V IK + E + ++ R E +++ + H N++++ L
Sbjct: 16 VHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
IV E+ GG++ +Y+ K+ C L +L + + ++++H I+HRDLK N+L+
Sbjct: 76 IVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL 134
Query: 377 N 377
+
Sbjct: 135 D 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 36/141 (25%), Positives = 62/141 (43%), Gaps = 13/141 (9%)
Query: 248 KFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV----- 299
KF I GS+ + A +++ AIK+L L I+ + + V I ++V
Sbjct: 4 KFGKIIGEGSFSTVVL-AKEKETNKEYAIKILDKRQL---IKEKKVKYVKIEKEVLTRLN 59
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
H +++ L+ V E+ G + Y+ K L A ++ + YL
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYL 118
Query: 360 HRNNIIHRDLKAANLLMNENG 380
H IIHRDLK N+L++++
Sbjct: 119 HSKGIIHRDLKPENILLDKDM 139
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 34/97 (35%), Positives = 60/97 (61%), Gaps = 2/97 (2%)
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
A+E+ ++++++H N+VQ++G+ L I E++ GGS+ L+ + L+
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFV 112
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLM-NENGVRDSD 385
+ KG+NYLH IIHRD+K AN+L+ N+ G++ SD
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD 149
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 228 NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRR 287
HV + +VWEI L G++ +YK E +E
Sbjct: 2 EHVRRDLDPNEVWEIIGEL-------GDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 54
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347
++ E+ I+ H +V+ +GA +L+I+ EF GG++ + + GL P +
Sbjct: 55 DYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ + + + YLH IIHRDLKA N+L+ +G
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG 147
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 36/126 (28%), Positives = 66/126 (52%), Gaps = 6/126 (4%)
Query: 255 SGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
SG++ + KG + + VA+K+L N++ + ++ E +E ++M+++ + +V+ IG
Sbjct: 5 SGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
C +V E G + +L K K + + + VS GM YL N +HRDL
Sbjct: 65 C-EAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLA 122
Query: 371 AANLLM 376
A N+L+
Sbjct: 123 ARNVLL 128
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 39/129 (30%), Positives = 72/129 (55%), Gaps = 21/129 (16%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L ++ ++++ + E+ +M+ + +H N++ +GACT+ L+++ E+ S G++
Sbjct: 47 VAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 330 YDYLHKQK----------CGLKLPL-------LLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+YL ++ C KLP L+ A V++GM YL IHRDL A
Sbjct: 106 REYLRARRPPGMDYSFDTC--KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163
Query: 373 NLLMNENGV 381
N+L+ E+ V
Sbjct: 164 NVLVTEDNV 172
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 11/120 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------PRLFIVTEFM 324
VA+K + + +F E M++ H NV++ IG C + P ++ FM
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 325 SGGSIYDYLHKQKCG---LKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
G ++ +L + G LP +L++ D++ GM YL + IHRDL A N ++NEN
Sbjct: 89 KHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN 148
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 33/127 (25%), Positives = 67/127 (52%), Gaps = 17/127 (13%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L + ++++ + E+ +M+ + +H N++ +G CT+ L+++ E+ + G++
Sbjct: 47 VAVKMLKDNATDKDLA-DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 330 YDYLHKQKCG---------------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
++L ++ L L+ A V++GM YL IHRDL A N+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 375 LMNENGV 381
L+ E+ V
Sbjct: 166 LVTEDNV 172
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 34/119 (28%), Positives = 61/119 (51%), Gaps = 11/119 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L E N+N R +F +E+ IM +++ N+++ + C L ++TE+M G +
Sbjct: 49 VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 331 DYLHK----------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+L + + L+ +A ++ GM YL N +HRDL N L+ +N
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 37/127 (29%), Positives = 69/127 (54%), Gaps = 17/127 (13%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L ++ +++ + E+ +M+ + +H N++ +GACT+ L+++ E+ S G++
Sbjct: 53 VAVKMLKSDATEKDLS-DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 330 YDYLHKQK------C---------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
+YL ++ C L L+ A V++GM YL IHRDL A N+
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171
Query: 375 LMNENGV 381
L+ E+ V
Sbjct: 172 LVTEDNV 178
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 39/136 (28%), Positives = 72/136 (52%), Gaps = 13/136 (9%)
Query: 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
++ SG+Y D+YK + A+K++ E ++ QE+ ++++ +H N+V +
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYF 72
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL----LLRVAIDVSKGMNYLHRNNI 364
G+ +L+I E+ GGS+ D H + PL + V + +G+ YLH
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 365 IHRDLKAANLLMNENG 380
+HRD+K AN+L+ +NG
Sbjct: 128 MHRDIKGANILLTDNG 143
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G++ +++K Q VA+K + E+ E +E+ I++ ++H NVV I
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 310 ACTRPPR--------LFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNY 358
C ++V EF +D L + L + +V + G+ Y
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
+HRN I+HRD+KAAN+L+ ++G+
Sbjct: 135 IHRNKILHRDMKAANILITKDGI 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 28/114 (24%), Positives = 59/114 (51%), Gaps = 4/114 (3%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +KVL ++H F + +M ++ H ++V+ G C R + +V E++ G +
Sbjct: 33 VVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLD 88
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
+LH++K + L L VA ++ ++YL ++H ++ N+L+ G+ +
Sbjct: 89 VFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEG 142
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 35/127 (27%), Positives = 67/127 (52%), Gaps = 17/127 (13%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K+L ++ +++ + E+ +M+ + +H N++ +GACT+ L+++ E+ S G++
Sbjct: 50 VAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 330 YDYLHKQKC---------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
+YL ++ + L+ V++GM YL IHRDL A N+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168
Query: 375 LMNENGV 381
L+ EN V
Sbjct: 169 LVTENNV 175
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 34/132 (25%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L E + +++ +F +E +M + H N+V+ +G C + ++ E+M+ G +
Sbjct: 38 VAVKML-KEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 331 DYLHKQ---------------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
++L + L L +A V+ GM YL +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 370 KAANLLMNENGV 381
N L+ EN V
Sbjct: 157 ATRNCLVGENMV 168
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 30/151 (19%)
Query: 248 KFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHL---NENIRREFAQEVHIMRK 298
+ K+ G+Y +YK +D VAIK + + I +E+ ++++
Sbjct: 3 EKGKKLGEGTYAVVYKA----RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE 58
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSG--------GSIYDYLHKQKCGLKLPLLLRVAI 350
++H N++ + + +V EFM SI K + + L
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTL------ 112
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+G+ YLH N I+HRDLK NLL+ +GV
Sbjct: 113 ---RGLEYLHSNWILHRDLKPNNLLIASDGV 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 5/134 (3%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YKG Q VA+K + E E + +E+ ++++++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLL--RVAIDVSKGMNYLHRNNIIHR 367
+ RL+++ EF+S + YL G + L + +G+ + H ++HR
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 368 DLKAANLLMNENGV 381
DLK NLL++ GV
Sbjct: 126 DLKPQNLLIDNKGV 139
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 38/136 (27%), Positives = 76/136 (55%), Gaps = 9/136 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNV 304
+FE KI G+ +Y + Q+VAIK + +L + ++E E+ +MR+ +H N+
Sbjct: 23 RFE-KIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNI 78
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V ++ + L++V E+++GGS+ D + + + + V + + + +LH N +
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 365 IHRDLKAANLLMNENG 380
IHRD+K+ N+L+ +G
Sbjct: 137 IHRDIKSDNILLGMDG 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 24/169 (14%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVH 294
E+ S ++F ++ ++ +YKG + +Q VAIK L + N EF QE
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEAS 59
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-----HKQ-----------KC 338
+M ++ H N+V +G T+ + ++ E+++ G ++++L H K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVRDSDI 386
L L +AI ++ GM YL + +H+DL A N+L+ E V+ SD+
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDL 168
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 271 VAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
AIKV+ + +N + E I+ + + VV+ + L++V E++ GG +
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 330 YDYLHKQKCGLKLP-LLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
L L + R+ I ++ + YLH N IIHRDLK N+L++ NG
Sbjct: 81 ASLLENVGS---LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG 130
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 17/123 (13%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG-ACTRPPR-------LFIVTE 322
VA+K + + + +E+ I++K++H NVV I A RP + +++VT
Sbjct: 36 VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP 95
Query: 323 FM----SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
+M SG + + +K +L + +G+NYLH N+I+HRD+KAAN+L++
Sbjct: 96 YMDHDLSGLLENPSVKLTESQIKCYML-----QLLEGINYLHENHILHRDIKAANILIDN 150
Query: 379 NGV 381
G+
Sbjct: 151 QGI 153
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 292 EVHIMRKVRHMNVVQFIGACTR---PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV 348
E+ +++ ++H +VQ+ G C R L I E+M GGS+ D L K L + +
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKY 111
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ +GM+YLH N I+HRD+K AN+L + G
Sbjct: 112 TRQILEGMSYLHSNMIVHRDIKGANILRDSAG 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 43/138 (31%), Positives = 72/138 (52%), Gaps = 9/138 (6%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG++ +YKG + VAIKVL E+ + +E E ++M V V + +
Sbjct: 17 SGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C + +VT+ M G + DY+ + K + LL + ++KGM+YL ++HRD
Sbjct: 76 GICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRD 134
Query: 369 LKAANLLM-NENGVRDSD 385
L A N+L+ + N V+ +D
Sbjct: 135 LAARNVLVKSPNHVKITD 152
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 6/110 (5%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
+A+KV+ + + ++++ E+ I+ K ++ F GA R+ I TEFM GGS+
Sbjct: 29 LAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
Y + +L R+A+ V KG+ YL I+HRD+K +N+L+N G
Sbjct: 88 VYRK-----IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG 132
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 38/132 (28%), Positives = 70/132 (53%), Gaps = 3/132 (2%)
Query: 252 KIVSGSYCDLY--KGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ +Y K S+ IK + + + +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL-KLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ RLFIV E+ GG + +++Q+ L +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 369 LKAANLLMNENG 380
+K+ N+ +++NG
Sbjct: 127 IKSQNIFLSKNG 138
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 40/169 (23%), Positives = 81/169 (47%), Gaps = 24/169 (14%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEV 293
EI+ S ++F ++ + +YKG F +Q VAIK L ++ +R EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-----HKQ----------KC 338
+ +++H N+V +G T+ L ++ + S ++++L H K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVRDSDI 386
L+ + + ++ GM +L ++++H+DL N+L+ + V+ SD+
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDL 168
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 24/131 (18%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L E+ + + R+ E +++++V H +V++ GAC++ L ++ E+ GS+
Sbjct: 33 VAVKML-KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91
Query: 331 DYL---HKQKCG--------------------LKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
+L K L + L+ A +S+GM YL ++HR
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151
Query: 368 DLKAANLLMNE 378
DL A N+L+ E
Sbjct: 152 DLAARNVLVAE 162
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 33/101 (32%), Positives = 60/101 (59%), Gaps = 6/101 (5%)
Query: 283 ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL 342
++R++ +E+ IM + R +V F GA + + EFM GS+ D ++K+ + +
Sbjct: 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPV 102
Query: 343 PLLLRVAIDVSKGMNYL---HRNNIIHRDLKAANLLMNENG 380
+L ++A+ V +G+ YL HR I+HRD+K +N+L+N G
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRG 141
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQF 307
K+ G+Y +YKG + VA+K + HL+ E +E+ +M++++H N+V+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 308 IGACTRPPRLFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+L +V E+M Y H + L + + KG+ + H N ++H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 367 RDLKAANLLMNENG 380
RDLK NLL+N+ G
Sbjct: 124 RDLKPQNLLINKRG 137
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 37/119 (31%), Positives = 66/119 (55%), Gaps = 7/119 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K + L + RRE EV IMR +H N+V+ + L++V EF+ GG
Sbjct: 45 RQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSD 385
++ D + + + + V + V K +++LH +IHRD+K+ ++L+ +G V+ SD
Sbjct: 102 ALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSD 158
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-10
Identities = 20/69 (28%), Positives = 34/69 (49%), Gaps = 2/69 (2%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV-DGWPLQETEQLRN 200
+ + D+P LL+ +T +L+++GLNI +A ST +LDVF V D +
Sbjct: 2 VVEVYAPDRPGLLADITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIA 60
Query: 201 VLAKEIPKV 209
L + +
Sbjct: 61 RLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 33/135 (24%), Positives = 64/135 (47%), Gaps = 7/135 (5%)
Query: 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQ----F 307
I +YKG F +++V I+ H + + E+ +R++ N+++
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIH 366
I PRL ++ E+ + G + + L K+K L L +AID KG+ L++ N +
Sbjct: 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPY 146
Query: 367 RDLKAANLLMNENGV 381
++L + + L+ EN
Sbjct: 147 KNLTSVSFLVTENYK 161
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
E+ +++ + H +VQ+ G P L I E M GGSI D L K L + +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ +G++YLH N I+HRD+K AN+L + G
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVG 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL--- 342
+ +F +E R ++H N++Q +G CT +V EF G + YL + +
Sbjct: 39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD 98
Query: 343 PLLL-RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
P L R+A +++ G+ +LH+NN IH DL N L+ +
Sbjct: 99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD 136
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 14/121 (11%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L + ++N R++F +E ++ ++H ++V+F G C L +V E+M G +
Sbjct: 38 VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 331 DYLHKQ------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE 378
+L L +L +A ++ GM YL + +HRDL N L+ E
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
Query: 379 N 379
N
Sbjct: 156 N 156
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP----L 344
F QEV R++ H NV+Q +G C +V EF G + +YL + + +
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L R+A +V+ G+ +LH+ + IH DL N +
Sbjct: 102 LQRMACEVASGLLWLHQADFIHSDLALRNCQL 133
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 11/145 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDV--AIKVLTNEHLNENIRREFAQEVHI 295
+ WEI L G++ +YK V A KV+ + +E ++ E+ I
Sbjct: 5 EFWEIIGEL-------GDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+ H N+V+ + A L+I+ EF +GG++ + + + L P + V +
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 356 MNYLHRNNIIHRDLKAANLLMNENG 380
+NYLH N IIHRDLKA N+L +G
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDG 140
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQD-----VAIKVLTNEHLNENIRREFAQE 292
WE+ + ++ GS+ +Y+G +D VAIK + NE + R EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 59
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH------KQKCGLKLPLL- 345
+M++ +VV+ +G ++ ++ E M+ G + YL + P L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 346 --LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+++A +++ GM YL+ N +HRDL A N ++ E+
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 33/115 (28%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 267 FSQDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
Q+VAIK + +L + ++E E+ +M+++++ N+V F+ + LF+V E+++
Sbjct: 43 TGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
GGS+ D + + C + + V + + + +LH N +IHRD+K+ N+L+ +G
Sbjct: 100 GGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 14/139 (10%)
Query: 251 HKIVSGSYCDLY--KGAFFSQDVAIKVL------TNEHLNENIRREFAQEVHIMRKVRHM 302
+I GS+ +Y + ++ VAIK + +NE + I+ EV ++++RH
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQQLRHP 75
Query: 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
N +++ G R ++V E+ G S D L K L+ + + +G+ YLH +
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 363 NIIHRDLKAANLLMNENGV 381
IHRD+KA N+L+ E G
Sbjct: 135 ERIHRDIKAGNILLTEPGT 153
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 40/126 (31%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 262 YKGAFFSQD------VAIKVLTNEHLNENIR-REFAQEVHIMRKVRHMNVVQFIGACTRP 314
+ +F++D VAIK ++ N + ++ +EV ++K+RH N +Q+ G R
Sbjct: 28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87
Query: 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
++V E+ G S D L K L+ + V +G+ YLH +N+IHRD+KA N+
Sbjct: 88 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146
Query: 375 LMNENG 380
L++E G
Sbjct: 147 LLSEPG 152
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 21/154 (13%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYK--GAFFSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D WEI ++ K G+Y ++K A+K+L H +I E E +I
Sbjct: 18 DTWEIIETIGK-------GTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNI 67
Query: 296 MRKVR-HMNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLL 346
++ + H NVV+F G + +L++V E +GGS+ D + K+ ++ P++
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ + G+ +LH N IHRD+K N+L+ G
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG 161
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 35/140 (25%), Positives = 69/140 (49%), Gaps = 6/140 (4%)
Query: 248 KFEHKIVSGSYCDLYKGA--FFSQDVAIK-VLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
K E KI G + +YK + VA+K V E ++ R++ +E+ +++++ H NV
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSI---YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
++++ + L IV E G + + KQK + + + + + + ++H
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 362 NNIIHRDLKAANLLMNENGV 381
I+HRD+K AN+ + GV
Sbjct: 125 KRIMHRDIKPANVFITATGV 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E I++ +RH +V G+ L++V E++ GG ++ +L +K G R
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSG-------RFPEP 101
Query: 352 VSK--------GMNYLHRNNIIHRDLKAANLLMNENG 380
V++ + YLH +I++RDLK NLL++ +G
Sbjct: 102 VARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 34/132 (25%), Positives = 68/132 (51%), Gaps = 4/132 (3%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK + VA+K + + E + +E+ +++++ H N+V+ +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLH-KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+L++V EF+ + ++ G+ LPL+ + +G+ + H + ++HRD
Sbjct: 67 VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 125
Query: 369 LKAANLLMNENG 380
LK NLL+N G
Sbjct: 126 LKPQNLLINTEG 137
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 2/124 (1%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
G+Y +Y S V I + + + +E+ + ++H N+VQ++G+ +
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
I E + GGS+ L + LK ++ + +G+ YLH N I+HRD+K N
Sbjct: 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138
Query: 374 LLMN 377
+L+N
Sbjct: 139 VLVN 142
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 34/117 (29%), Positives = 59/117 (50%), Gaps = 3/117 (2%)
Query: 268 SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMS 325
+VAIK+L + E+ R F +E + ++ H N+V + + PP LF V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR 382
G ++ + L L R+ + V + H I+HRDLK N+++++ GVR
Sbjct: 63 GRTLREVLAADG-ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K L + L R++F +E ++ ++H ++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDPTLAA--RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 331 DYLH---------------KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+L + K L L +L +A ++ GM YL + +HRDL N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 376 MNEN 379
+ N
Sbjct: 156 VGAN 159
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 31/114 (27%), Positives = 56/114 (49%), Gaps = 9/114 (7%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +K L + +EN++ EF +E+ + RK+ H NVV+ +G C +++ E+ G +
Sbjct: 38 VLVKAL-QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 331 DYLHKQKCG--------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
+L K L + + ++ GM++L +HRDL A N L+
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 34/128 (26%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 255 SGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
SG + ++KG + + VAIK + + + + E + M + H +V+ +
Sbjct: 17 SGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ-EITDHMLAMGSLDHAYIVRLL 75
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G C L +VT+ GS+ D++ + + L LL + ++KGM YL + ++HR+
Sbjct: 76 GICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRN 134
Query: 369 LKAANLLM 376
L A N+L+
Sbjct: 135 LAARNILL 142
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 38/119 (31%), Positives = 66/119 (55%), Gaps = 7/119 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K++ L + RRE EV IMR +H NVV+ + L+++ EF+ GG
Sbjct: 47 RQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSD 385
++ D + + + L + V V + + YLH +IHRD+K+ ++L+ +G V+ SD
Sbjct: 104 ALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSD 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 35/113 (30%), Positives = 60/113 (53%), Gaps = 6/113 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K + L + RRE EV IMR H NVV + L++V EF+ GG
Sbjct: 48 KQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
++ D + + + + V + V + ++YLH +IHRD+K+ ++L+ +G
Sbjct: 105 ALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 30/124 (24%), Positives = 61/124 (49%), Gaps = 7/124 (5%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K + + ++ + QE+ R+++H N++ ++ + L++V+ M+ GS
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 331 DYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
D L GL + + DV ++Y+H IHR +KA+++L++ +G
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG------KVV 141
Query: 390 LSNF 393
LS
Sbjct: 142 LSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 39/142 (27%), Positives = 73/142 (51%), Gaps = 13/142 (9%)
Query: 248 KFEH--KIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
K+E KI GSY ++K G Q VAIK + I++ +E+ +++++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETG----QIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
+H N+V I R +L +V E+ ++ + L K G+ L+ ++ + +N+
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 360 HRNNIIHRDLKAANLLMNENGV 381
H++N IHRD+K N+L+ + G
Sbjct: 117 HKHNCIHRDVKPENILITKQGQ 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLP--LLLRVAIDV 352
MR V V F GA R ++I E M S+ Y GL +P +L ++A+ +
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 353 SKGMNYLHRN-NIIHRDLKAANLLMNENG 380
K + YLH ++IHRD+K +N+L+N NG
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNG 141
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 6e-09
Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 45/157 (28%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTN--EHLNENIRREFAQEVHIMRK 298
+ I SG+Y G S + VAIK ++N + L + +R +E+ ++R
Sbjct: 3 ELLKPIGSGAY-----GVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKRIL-REIKLLRH 55
Query: 299 VRHMNVVQFIGACTRPPR------LFIVTEFMSGGSIYDYLHKQ-KCGLKLPL------- 344
+RH N++ + RPP ++IVTE M D LHK K L
Sbjct: 56 LRHENIIGLLDI-LRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFL 109
Query: 345 --LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+LR G+ YLH N+IHRDLK +N+L+N N
Sbjct: 110 YQILR-------GLKYLHSANVIHRDLKPSNILVNSN 139
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 31/115 (26%), Positives = 59/115 (51%), Gaps = 3/115 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +KVL H +I F + +MR+V H ++V G C R +V EF+ G +
Sbjct: 35 VILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
++H++ L P +VA ++ ++YL +++H ++ N+L+ G+ D +
Sbjct: 93 LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI-DGE 146
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 6e-09
Identities = 32/113 (28%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q+VAIK + +L + ++E E+ +MR+ ++ N+V ++ + L++V E+++GG
Sbjct: 45 QEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
S+ D + + C + + V + + +++LH N +IHRD+K+ N+L+ +G
Sbjct: 102 SLTDVV-TETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG 152
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 33/145 (22%), Positives = 64/145 (44%), Gaps = 20/145 (13%)
Query: 252 KIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
I GS+ + K G K + ++ E +++ EV+I+R+++H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKIL----VWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 306 QFIGACTRPP--RLFIVTEFMSGGSIYDYLHK-QKCGLKLP--LLLRVAIDVSKGMNYLH 360
++ L+IV E+ GG + + K +K + + R+ + + H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 361 R-----NNIIHRDLKAANLLMNENG 380
N ++HRDLK AN+ ++ N
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANN 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 39/125 (31%), Positives = 56/125 (44%), Gaps = 29/125 (23%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR------LFIVTEFM 324
VAIK + N N + +E+ ++R + H NV+ I PP ++IV E M
Sbjct: 33 VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELM 91
Query: 325 SGGSIYDYLHK----------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
LH+ C L LLR G+ Y+H N++HRDLK +NL
Sbjct: 92 DTD-----LHQIIRSSQTLSDDHCQYFLYQLLR-------GLKYIHSANVLHRDLKPSNL 139
Query: 375 LMNEN 379
L+N N
Sbjct: 140 LLNAN 144
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 36/144 (25%), Positives = 70/144 (48%), Gaps = 7/144 (4%)
Query: 244 ASLLKFE--HKIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNENIRREFAQEVHIMRKV 299
S+ +FE ++I G+Y +Y+ + VA+K + ++ + I +E+ ++ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 300 RHMNVVQF--IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
RH N+V+ + +F+V E+ + L + + + + +G+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
YLH N IIHRDLK +NLL+ + G
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGC 146
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 38/134 (28%), Positives = 73/134 (54%), Gaps = 6/134 (4%)
Query: 251 HKIVSGSYCDLY--KGAFFSQDVAIKVLT--NEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
H+I GS+ +Y + ++ VA+K ++ + NE + + +EV +++++H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHPNTIE 85
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ G + ++V E+ G S D L K L+ + + +G+ YLH +N+IH
Sbjct: 86 YKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 367 RDLKAANLLMNENG 380
RD+KA N+L+ E G
Sbjct: 145 RDIKAGNILLTEPG 158
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 39/132 (29%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNE---HLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312
G+Y +YK + + + E L+E+ + E+ I+ K +V F GA
Sbjct: 12 GNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF 69
Query: 313 RPPRLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRD 368
+++ E+M GS+ D L+ G+ +L R+ V KG+ +L +NIIHRD
Sbjct: 70 IEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128
Query: 369 LKAANLLMNENG 380
+K N+L+N NG
Sbjct: 129 VKPTNVLVNGNG 140
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 38/132 (28%), Positives = 71/132 (53%), Gaps = 4/132 (3%)
Query: 252 KIVSGSYCDLY--KGAFFSQDVAIKVLTNEHLNENIR-REFAQEVHIMRKVRHMNVVQFI 308
+I GS+ +Y + ++ VAIK ++ N + ++ +EV +++++H N +++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G R ++V E+ G S D L K L+ + + +G+ YLH +N+IHRD
Sbjct: 92 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 369 LKAANLLMNENG 380
+KA N+L+ E G
Sbjct: 151 IKAGNILLTEPG 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 38/117 (32%), Positives = 64/117 (54%), Gaps = 7/117 (5%)
Query: 271 VAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
VA+K + L + RRE EV IMR +H NVV+ + L++V EF+ GG++
Sbjct: 48 VAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSD 385
D + + + + V + V K ++ LH +IHRD+K+ ++L+ +G V+ SD
Sbjct: 105 TDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSD 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 35/132 (26%), Positives = 72/132 (54%), Gaps = 13/132 (9%)
Query: 264 GAFFSQDVAIKVLTNEHLNENIRRE--FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321
G+F+ A+KVL + + + + A+ +++ ++H +V + +L+ V
Sbjct: 20 GSFY----AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
++++GG ++ +L +++C L+ P A +V+ + YLH NII+RDLK N+L++ G
Sbjct: 76 DYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG- 133
Query: 382 RDSDIHCYLSNF 393
H L++F
Sbjct: 134 -----HVVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 33/141 (23%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIK-VLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ E KI G + ++Y+ + VA+K V E ++ R++ +E+ +++++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V++++ + L IV E G + Y KQK + + + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 361 RNNIIHRDLKAANLLMNENGV 381
++HRD+K AN+ + GV
Sbjct: 124 SRRVMHRDIKPANVFITATGV 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 7/133 (5%)
Query: 253 IVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
I G + +Y G D A+K L E + +F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVLSL 61
Query: 308 IGACTRPPRL-FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+G C +V +M G + +++ + + L+ + V+KGM YL +H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 367 RDLKAANLLMNEN 379
RDL A N +++E+
Sbjct: 122 RDLAARNCMLDES 134
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 35/125 (28%), Positives = 60/125 (48%), Gaps = 11/125 (8%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KVL + + ++ E E ++ +H + Q RLF V E+++GG +
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83
Query: 330 YDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388
H Q+ G P A ++ G+ +LH II+RDLK N+L+ DS+ H
Sbjct: 84 M--FHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL------DSEGHI 135
Query: 389 YLSNF 393
+++F
Sbjct: 136 KIADF 140
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 31/113 (27%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFA-QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q+VAI+ + +L + ++E E+ +MR+ ++ N+V ++ + L++V E+++GG
Sbjct: 46 QEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
S+ D + + C + + V + + + +LH N +IHRD+K+ N+L+ +G
Sbjct: 103 SLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 19/129 (14%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM-------RKVRHMNVVQFIGACTRPPRLFIVTEFM 324
A+KVL + + + ++ HIM + V+H +V + +L+ V +++
Sbjct: 24 AVKVLQKKAI-----LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
+GG ++ +L +++ + P A +++ + YLH NII+RDLK N+L+ DS
Sbjct: 79 NGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHSLNIIYRDLKPENILL------DS 131
Query: 385 DIHCYLSNF 393
H L++F
Sbjct: 132 QGHVVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 33/112 (29%), Positives = 65/112 (58%), Gaps = 3/112 (2%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK + NE ++ +E+ ++R ++ N+V+ A R +L++V E++ ++
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NML 87
Query: 331 DYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L + G+ P +R I + K +++ H+N+I+HRD+K NLL++ N V
Sbjct: 88 ELLEEMPNGV-PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 31/110 (28%), Positives = 60/110 (54%), Gaps = 14/110 (12%)
Query: 291 QEVHIM-------RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP 343
+E HIM + V+H +V + +L+ V ++++GG ++ +L +++C L+ P
Sbjct: 38 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-P 96
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
A +++ + YLH NI++RDLK N+L++ G H L++F
Sbjct: 97 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD---------VAIKVLTNEHLNENIRREFA 290
WE+ + ++ GS+ +Y+G ++D VA+K + NE + R EF
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEG--NARDIIKGEAETRVAVKTV-NESASLRERIEFL 57
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH------KQKCGLKLPL 344
E +M+ +VV+ +G ++ +V E M+ G + YL + G P
Sbjct: 58 NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 345 L---LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
L +++A +++ GM YL+ +HRDL A N ++ +
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 256 GSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT- 312
GSY L + + IK L + + R+ QE ++ +++H N+V + +
Sbjct: 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG 70
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLK 370
L+IV F GG +Y L +QK G LP ++ + ++ + YLH +I+HRDLK
Sbjct: 71 EDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLK 129
Query: 371 AANLLMNENGV 381
N+ + +
Sbjct: 130 TQNVFLTRTNI 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP- 343
IR + +E+ ++ + +V F GA + I E M GGS+ L K ++P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPE 102
Query: 344 -LLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENG 380
+L +V+I V KG+ YL ++ I+HRD+K +N+L+N G
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 141
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 37/143 (25%), Positives = 71/143 (49%), Gaps = 25/143 (17%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR---PPRLFIVTEFM 324
++V +K + + H +E QE ++ + H N++ + C PP F++ +M
Sbjct: 35 EEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP--FVLYPYM 91
Query: 325 SGGSIYDYLHKQKCG-------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
+ G++ +L + + G L L+ +AI ++ GM+YLH+ +IH+D+ A N +++
Sbjct: 92 NWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID 151
Query: 378 E--------NGV-RD---SDIHC 388
E N + RD D HC
Sbjct: 152 EELQVKITDNALSRDLFPMDYHC 174
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 24/161 (14%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD---VAIKVLTNEHLNENIRREFAQEVH 294
D WEI ++ K G+Y +YK +D A+K+L ++ E E +
Sbjct: 22 DTWEIIETIGK-------GTYGKVYKVTN-KKDGSLAAVKILDPI---SDVDEEIEAEYN 70
Query: 295 IMRKV-RHMNVVQFIGACTRPPR-----LFIVTEFMSGGSIYDYLHKQ-KCGLKL--PLL 345
I++ + H NVV+F G + + L++V E +GGS+ + + CG +L ++
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVRDSD 385
+ G+ +LH N IIHRD+K N+L+ E GV+ D
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 5/134 (3%)
Query: 252 KIVSGSYCD--LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS+ L K + IK + ++ R E +EV ++ ++H N+VQ+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHR 367
+ L+IV ++ GG +Y ++ Q+ G+ P +L + + + ++H I+HR
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 368 DLKAANLLMNENGV 381
D+K+ N+ + ++G
Sbjct: 126 DIKSQNIFLTKDGT 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 4/133 (3%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK + VA+K + E +E + +E+ +++++ H N+V+ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYL-HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+L++V EF+ + Y+ GL PL+ + +G+ Y H + ++HRD
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRD 124
Query: 369 LKAANLLMNENGV 381
LK NLL++ G
Sbjct: 125 LKPQNLLIDREGA 137
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +++ E+ E + EV + RH N++ T L++++ FM+ GS
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 331 DYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD----SD 385
L G+ L+ + +G+NYLH+N IHR++KA+++L++ +G+ S
Sbjct: 88 SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSH 147
Query: 386 IHCYLSN---------FLSISTVILVIFSCILVR 410
++ + N F ST +L S L+R
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR 181
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 32/138 (23%), Positives = 61/138 (44%), Gaps = 11/138 (7%)
Query: 256 GSYCDLYKG---------AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
G++ ++KG +V +KVL H N F + +M ++ H ++V
Sbjct: 6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVL 63
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
G C +V E++ GS+ YL K K + + L VA ++ +++L + H
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTH 123
Query: 367 RDLKAANLLMNENGVRDS 384
++ A N+L+ R +
Sbjct: 124 GNVCAKNVLLIREEDRKT 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 252 KIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ G+Y +YKG D VA+K + EH E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYL-------HKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
L +V E++ + YL + L L LLR G+NY HR
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHRR 123
Query: 363 NIIHRDLKAANLLMNENG 380
++HRDLK NLL+NE G
Sbjct: 124 KVLHRDLKPQNLLINERG 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 2/97 (2%)
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
IR + +E+ ++ + +V F GA + I E M GGS+ D + K+ + +
Sbjct: 42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENI 100
Query: 345 LLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG 380
L +++I V +G+ YL I+HRD+K +N+L+N G
Sbjct: 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG 137
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 40/159 (25%), Positives = 57/159 (35%), Gaps = 38/159 (23%)
Query: 54 EDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRH 113
+ D A+ R Y L V+L+ H R + A D A EVR +G +
Sbjct: 680 KADRDAYLARHYPAYWLAVDLD---TQARHARFIRDADDAGRPLATEVRPDPARGVT--- 733
Query: 114 FSNLVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHA 173
E+T+ D P L S++ + G NI +A
Sbjct: 734 ----------------------------EVTVLAADHPGLFSRIAGACAAAGANIVDARI 765
Query: 174 FSTVDGYSLDVFVV---DGWPLQETEQLRNVLAKEIPKV 209
F+T DG +LD F + G E +L LAK I
Sbjct: 766 FTTTDGRALDTFWIQDAFGRDEDEPRRLAR-LAKAIEDA 803
|
Length = 931 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 32/166 (19%)
Query: 248 KFEHKIVSGSYCDLYK------GAFFSQDVAIKVLTN-----EHLNENIRREFAQEVHIM 296
K KI G++ ++ K G + AIK + E +N N+R E+ +
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMKKHFKSLEQVN-NLR-----EIQAL 51
Query: 297 RKVR-HMNVVQFIGACTRPP--RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS 353
R++ H N+++ I RL +V E M ++Y+ + +K L + +
Sbjct: 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLL 110
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399
K ++++HRN I HRD+K N+L+ D L++F S +
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIK-------DDILKLADFGSCRGI 149
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 34/113 (30%), Positives = 64/113 (56%), Gaps = 7/113 (6%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSI 329
A+KV+ E +N++ ++ Q E H+ + + + + +C + RLF V E+++GG +
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 330 YDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
++ +Q+ KLP + ++S +NYLH II+RDLK N+L++ G
Sbjct: 84 MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 133
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 30/141 (21%), Positives = 66/141 (46%), Gaps = 6/141 (4%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAI---KVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ E KI G + ++Y+ V + KV + ++ R + +E+ +++++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSI---YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V+++ + L IV E G + + KQK + + + + + + ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 361 RNNIIHRDLKAANLLMNENGV 381
++HRD+K AN+ + GV
Sbjct: 124 SRRVMHRDIKPANVFITATGV 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP- 343
IR + +E+ ++ + +V F GA + I E M GGS+ L + K ++P
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPE 102
Query: 344 -LLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENG 380
+L +V+I V +G+ YL ++ I+HRD+K +N+L+N G
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG 141
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 37/130 (28%), Positives = 70/130 (53%), Gaps = 13/130 (10%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTR-PPRLFIVTEFMS 325
+ A+KV+ E +N++ ++ Q E H+ + + + +C + RLF V EF+S
Sbjct: 20 RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79
Query: 326 GGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383
GG + ++ +Q+ KLP + ++S +N+LH II+RDLK N+L+ D
Sbjct: 80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL------D 130
Query: 384 SDIHCYLSNF 393
++ H L+++
Sbjct: 131 AEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 2/113 (1%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
V +KVL H +I F + +M +V H+++ G C R +V EF+ G +
Sbjct: 47 VVLKVLDPSH--RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383
L K+K + + + VA ++ ++YL N++H ++ A N+L+ G+ +
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 2/97 (2%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI-YDYLHKQKCGLKLPLLLRVAI 350
E I+ KV +V A L +V M+GG + Y + + G + A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDI 386
+ G+ +LH+ I++RDLK N+L++++G VR SD+
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDL 139
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 26/77 (33%), Positives = 41/77 (53%), Gaps = 7/77 (9%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
L++V E+++GG L K GL + +V G+ LH+ IIHRD+K NLL+
Sbjct: 72 LYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 377 NENGVRDSDIHCYLSNF 393
++ G H L++F
Sbjct: 131 DQTG------HLKLTDF 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 19/100 (19%)
Query: 292 EVHIMRKVRHMNVVQF--IGACTRPPRLFIVTEFMSGG--SIYDYLHKQ------KCGLK 341
E++I+ K++H N+V + + ++++V E++ S+ + + + KC L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC-LM 112
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L LL G+ +LH N I+HRDLK +NLL+N G+
Sbjct: 113 LQLLS--------GVAHLHDNWILHRDLKTSNLLLNNRGI 144
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 29/115 (25%), Positives = 56/115 (48%), Gaps = 8/115 (6%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-LFIVTEFMSG 326
Q+VAIK + + + +E+ +++ +RH N++ P ++ VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 327 GSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
LH+ L+ + + +G+ Y+H ++HRDLK +N+L+NEN
Sbjct: 95 D-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 11/110 (10%)
Query: 286 RREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
R A E HI+R + H +++Q G T I+ + + +Y YL ++ + +
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKR---NIAI 181
Query: 345 --LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG---VRDSDIHCY 389
+L + V + + YLH N IIHRD+KA N+ +N G + D C+
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231
|
Length = 391 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 28/120 (23%), Positives = 46/120 (38%), Gaps = 22/120 (18%)
Query: 272 AIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K + H+ E + E I+ + H +V+ ++++ E+ GG ++
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKG----------MNYLHRNNIIHRDLKAANLLMNENG 380
L R D YLH II+RDLK NLL++ NG
Sbjct: 82 TILRD-----------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG 130
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
P RLF V EF++GG + H QK A +++ + +LH II+RDLK
Sbjct: 68 PDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 373 NLLMNENGVRDSDIHCYLSNF 393
N+L++ G HC L++F
Sbjct: 126 NVLLDHEG------HCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 4/131 (3%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ GSY +YKG Q VA+KV++ + E + +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMK-TEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
L V E+M + Y+ + GL + + +G+ Y+H +I+HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 370 KAANLLMNENG 380
K NLL++ G
Sbjct: 130 KPQNLLISYLG 140
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 28/110 (25%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 273 IKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDY 332
I++ + E+ R+E ++ K++H N+V F + L+IV E+ GG +
Sbjct: 33 IRLPKSSSAVEDSRKEAV----LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQK 88
Query: 333 LHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ Q+ G P +L+ + + G+ ++H ++HRD+K+ N+ + +NG
Sbjct: 89 IKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 34/122 (27%), Positives = 63/122 (51%), Gaps = 7/122 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD 331
A+KVL L R E I+ +V H +V+ A +L+++ +F+ GG ++
Sbjct: 28 AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 87
Query: 332 YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391
L K+ + + +A +++ +++LH II+RDLK N+L++E G H L+
Sbjct: 88 RLSKEVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLT 140
Query: 392 NF 393
+F
Sbjct: 141 DF 142
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 36/128 (28%), Positives = 61/128 (47%), Gaps = 30/128 (23%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-----LFIVTEF 323
+ VAIK + + + + +E+ I+R +H N++ I RPP +++V +
Sbjct: 31 KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIA-IRDILRPPGADFKDVYVVMDL 89
Query: 324 MSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
M ++ +H + PL LLR G+ Y+H N+IHRDLK +
Sbjct: 90 M-ESDLHHIIHSDQ-----PLTEEHIRYFLYQLLR-------GLKYIHSANVIHRDLKPS 136
Query: 373 NLLMNENG 380
NLL+NE+
Sbjct: 137 NLLVNEDC 144
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 41/134 (30%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 252 KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ G+Y ++KG VA+K + EH E +EV +++ ++H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI---DVSKGMNYLHRNNIIH 366
L +V E++ + YL CG L + V I + +G++Y H+ I+H
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL--DNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 367 RDLKAANLLMNENG 380
RDLK NLL+NE G
Sbjct: 127 RDLKPQNLLINEKG 140
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 33/116 (28%), Positives = 65/116 (56%), Gaps = 7/116 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSG 326
Q A+KV+ E ++++ ++ Q E H+ + + + +C + RLF+V E+++G
Sbjct: 21 QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80
Query: 327 GSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
G + ++ +Q+ KLP A ++ +N+LH II+RDLK N+L++ +G
Sbjct: 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG 133
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/119 (26%), Positives = 45/119 (37%), Gaps = 18/119 (15%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMR----------KVRHMNVVQFIGACTRPPRLFIVT 321
AIK L + EV + RH +V + V
Sbjct: 28 AIKALKKGDIIAR------DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E+ +GG + +H P + A V G+ YLH N I++RDLK NLL++ G
Sbjct: 82 EYAAGGDLM--MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG 138
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 32/133 (24%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 252 KIVSGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF 307
KI G+Y ++K +++ VA+K + + +E + +E+ ++++++H N+V+
Sbjct: 7 KIGEGTYGTVFKAK--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
+L +V E+ + Y + ++ + KG+ + H +N++HR
Sbjct: 65 YDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123
Query: 368 DLKAANLLMNENG 380
DLK NLL+N+NG
Sbjct: 124 DLKPQNLLINKNG 136
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 36/121 (29%), Positives = 56/121 (46%), Gaps = 18/121 (14%)
Query: 269 QDVAIKVL-TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ AIK L E L + AQE I+ ++ H +V + + R++ + EF+ GG
Sbjct: 44 EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG 103
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
++ +L K R DV+K YLH +II+RDLK NLL++
Sbjct: 104 ELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK 154
Query: 380 G 380
G
Sbjct: 155 G 155
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 34/124 (27%), Positives = 66/124 (53%), Gaps = 9/124 (7%)
Query: 272 AIKVLTNEH-LNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KVL + LN ++ E +++ K V+H +V + +L+ V +F++GG +
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
+ +L +++ P A +++ + YLH NI++RDLK N+L++ G H
Sbjct: 84 FFHLQRERS-FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG------HVV 136
Query: 390 LSNF 393
L++F
Sbjct: 137 LTDF 140
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFA--QEVHIMRKVRHMNVVQF 307
K+ GSY +YKG + VA+KV+ L E F +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
L +V E++ + Y+ K GL + + +G++Y+H+ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 368 DLKAANLLMNENG 380
DLK NLL+++ G
Sbjct: 128 DLKPQNLLISDTG 140
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 252 KIVSGSYCDLYKGAFFSQD--VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
K+ G+Y ++KG + VA+K + EH E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--LKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
L +V E++ + Y+ CG + + + + +G+ Y HR ++HR
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYM--DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 368 DLKAANLLMNENG 380
DLK NLL+NE G
Sbjct: 129 DLKPQNLLINERG 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 25/66 (37%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
RL+ V E+++GG + H Q+ G K P + A ++S G+ +LHR II+RDLK N+
Sbjct: 75 RLYFVMEYVNGGDLM--YHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132
Query: 375 LMNENG 380
+++ G
Sbjct: 133 MLDSEG 138
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 25/80 (31%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
RLF V E+++GG + + + + P A +V+ + +LHR+ +I+RDLK N
Sbjct: 68 KDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDN 126
Query: 374 LLMNENGVRDSDIHCYLSNF 393
+L+ D++ HC L++F
Sbjct: 127 ILL------DAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 53/212 (25%), Positives = 81/212 (38%), Gaps = 72/212 (33%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQE 292
WE LK + G++ + + + F + VA+K+L E + + E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTE 60
Query: 293 VHIMRKV-RHMNVVQFIGACTRP--PRLFIVTEFMSGGSIYDYLH--------------- 334
+ I+ + H+NVV +GACT+P P + IV E+ G++ +YL
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTR 119
Query: 335 ----KQKCGLK-------------------------------------LPLLLRVAI--- 350
KQK G K PL L I
Sbjct: 120 KREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS 179
Query: 351 -DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
V++GM +L IHRDL A N+L++EN V
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNV 211
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 34/123 (27%), Positives = 57/123 (46%), Gaps = 21/123 (17%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-----LFIVT 321
+ VAIK + + EH+++ R +E+ ++R +RH ++V+ P R +++V
Sbjct: 26 EKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 322 EFMSGG-----SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
E M D L + L LLR + Y+H N+ HRDLK N+L
Sbjct: 84 ELMESDLHQVIKANDDLTPEHHQFFLYQLLR-------ALKYIHTANVFHRDLKPKNILA 136
Query: 377 NEN 379
N +
Sbjct: 137 NAD 139
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 3/108 (2%)
Query: 281 LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCG 339
LN N + QE ++ K+ H +V+F + I+TE+ G + L + + G
Sbjct: 41 LNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG 100
Query: 340 LKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
L + I + G++Y+H+ I+HRDLKA N+ + N ++ D
Sbjct: 101 KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGD 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 23/66 (34%), Positives = 40/66 (60%), Gaps = 3/66 (4%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
RL+ V E+++GG + H Q+ G K P + A +++ G+ +LH II+RDLK N+
Sbjct: 75 RLYFVMEYVNGGDLM--YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 375 LMNENG 380
+++ G
Sbjct: 133 MLDAEG 138
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 7/101 (6%)
Query: 106 VQGASTRHFSNLV-HSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEI 164
H +L S L P E+ I D+P L +++ L+ +
Sbjct: 636 THKEIAWHAESLRRALSSGGPLALIDGTRP---SGGTEVFIYAPDQPGLFAKVAGALAML 692
Query: 165 GLNIQEAHAFSTVDGYSLDVFVV---DGWPLQETEQLRNVL 202
L++ +A +T DG +LD FVV G P + +L
Sbjct: 693 SLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELL 733
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 4e-06
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 12/117 (10%)
Query: 271 VAIKVLTN--EHLNE--NIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMS 325
VAIK + E N+R EV +RK+ H N+V+ L+ V E+M
Sbjct: 27 VAIKKMKKKFYSWEECMNLR-----EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYME 81
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
G ++Y + +K ++R I + +G+ ++H++ HRDLK NLL++ V
Sbjct: 82 G-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV 137
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI-YDYLHKQKCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + + H + G + + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDI 386
++ G+ LH+ I++RDLK N+L++++G +R SD+
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDL 146
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 25/138 (18%)
Query: 272 AIKVLT-NEHLNEN-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KVL E + N ++R E I+ + H + + L +V ++ GG +
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL 88
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L +Q ++ +V++ + YLH I++RDLK N+L++E+G
Sbjct: 89 FRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG- 140
Query: 382 RDSDIHCYLSNF-LSIST 398
H LS+F LS +
Sbjct: 141 -----HIMLSDFDLSKQS 153
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 33/138 (23%), Positives = 62/138 (44%), Gaps = 10/138 (7%)
Query: 248 KFEHKIVSGSYCDLYKG----AFFSQDVAIKVL-TNEHLNENIRREFAQEVHIMRKVRHM 302
+ E I G+Y +YK ++ AIK ++ I + +E+ ++R+++H
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 303 NVVQFIGACTRPPR-----LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
NVV + LF E I + ++ + ++ + + G++
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 358 YLHRNNIIHRDLKAANLL 375
YLH N ++HRDLK AN+L
Sbjct: 123 YLHSNWVLHRDLKPANIL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 18/139 (12%)
Query: 251 HKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
K+ GSY +YKG Q VA+K + EH E +E +++ ++H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH-EEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL-----KLPL--LLRVAIDVSKGMNYLHR 361
L +V E++ + Y+ GL +L L LLR G+ Y H+
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQ 121
Query: 362 NNIIHRDLKAANLLMNENG 380
++HRDLK NLL++E G
Sbjct: 122 RRVLHRDLKPQNLLISERG 140
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 36/149 (24%), Positives = 62/149 (41%), Gaps = 31/149 (20%)
Query: 253 IVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
I G+Y +YK + VA+K + ++ E +E+ I+R++ H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 311 CT----------RPPRLFIVTEFM---------SGGSIYDYLHKQKCGLKLPLLLRVAID 351
T ++V E+M SG + + LL
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG--LVHFSEDHIKSFMKQLL------ 126
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+G+NY H+ N +HRD+K +N+L+N G
Sbjct: 127 --EGLNYCHKKNFLHRDIKCSNILLNNKG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 28/102 (27%), Positives = 58/102 (56%), Gaps = 7/102 (6%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +I+ V+H +V I A +L+++ E++SGG ++ +L ++ ++ ++ +
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-E 108
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+S + +LH+ II+RDLK N+L++ G H L++F
Sbjct: 109 ISLALEHLHQQGIIYRDLKPENILLDAQG------HVKLTDF 144
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 31/126 (24%)
Query: 271 VAIKVL-----TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL------FI 319
VAIK L + H +R + +E+ +++ + H NV+ + T L ++
Sbjct: 43 VAIKKLSRPFQSAIH----AKRTY-RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97
Query: 320 VTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
VT M G + + + QK L +L +G+ Y+H IIHRDLK +N
Sbjct: 98 VTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL--------RGLKYIHSAGIIHRDLKPSN 148
Query: 374 LLMNEN 379
+ +NE+
Sbjct: 149 IAVNED 154
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 27/97 (27%), Positives = 52/97 (53%), Gaps = 2/97 (2%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI-YDYLHKQKCGLKLPLLLRVAI 350
E I+ KV +V A L +V M+GG + Y + + GL++ ++ +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDI 386
++ G+ +LH +I++RD+K N+L+++ G R SD+
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDL 139
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 18/134 (13%)
Query: 264 GAFFSQDVAIKVLTNEHLNENIRREFAQEVH----IMRKVRHMNVVQFIGACTRPPRLFI 319
++ A+KV+ + E IR + Q VH ++++V H +++ L++
Sbjct: 26 EHYY----ALKVMA---IPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+ E++ GG ++ YL L A ++ + YLH I++RDLK N+L+++
Sbjct: 79 LMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137
Query: 380 GVRDSDIHCYLSNF 393
G H L++F
Sbjct: 138 G------HIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 6/100 (6%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS----IYDYLHKQKCGLKLPLLLR 347
E I+ KV +V A L +V M+GG IY+ + ++ G P
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACF 101
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDI 386
+ G+ +LH+ II+RDLK N+L++ +G VR SD+
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|153139 cd02116, ACT, ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-05
Identities = 19/62 (30%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
+T+S D+P LL+++ S+L+E G+NI ++ DG D+F+V + L +L
Sbjct: 1 LTVSGPDRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIV----VDGDGDLEKLL 56
Query: 203 AK 204
Sbjct: 57 EA 58
|
Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-prephenate dehydratase enzyme (P-protein), respectively. Aspartokinases typically consist of two C-terminal ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. ACT domain repeats have been shown to have nonequivalent ligand-binding sites with complex regulatory patterns such as those seen in the bifunctional enzyme, aspartokinase-homoserine dehydrogenase (ThrA). In other enzymes, such as phenylalanine hydroxylases, the ACT domain appears to function as a flexible small module providing allosteric regulation via transmission of conformational changes, these conformational changes are not necessarily initiated by regulatory ligand binding at the ACT domain itself. ACT domains are present either singularly, N- or C-terminal, or in pairs present C-terminal or between two catalytic domains. Unique to cyanobacteria are four ACT domains C-terminal to an aspartokinase domain. A few proteins are composed almost entirely of ACT domain repeats as seen in the four ACT domain protein, the ACR protein, found in higher plants; and the two ACT domain protein, the glycine cleavage system transcriptional repressor (GcvR) protein, found in some bacteria. Also seen are single ACT domain proteins similar to the Streptococcus pneumoniae ACT domain protein (uncharacterized pdb structure 1ZPV) found in both bacteria and archaea. Purportedly, the ACT domain is an evolutionarily mobile ligand binding regulatory module that has been fused to different enzymes at various times. Length = 60 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 24/87 (27%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +++ V H +V++ +V S +Y YL K+ L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNE 378
+ +G+ YLH IIHRD+K N+ +N+
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFIND 192
|
Length = 357 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 23/71 (32%), Positives = 42/71 (59%), Gaps = 2/71 (2%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326
+ VA+K+L + + ++ E+ IM + H+N+V +GACT+ ++I+TE+
Sbjct: 67 TMKVAVKMLKSTARSSE-KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRY 125
Query: 327 GSIYDYLHKQK 337
G + DYLH+ K
Sbjct: 126 GDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFM--SGGSIYDYLH-KQKCGLKLPLLLRVAID 351
+MR +V+F GA R +I E M S Y Y++ K + +L ++A+
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 352 VSKGMNYLHRN-NIIHRDLKAANLLMNENG 380
K +NYL IIHRD+K +N+L++ NG
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNG 145
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|153171 cd04899, ACT_ACR-UUR-like_2, C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 25/65 (38%), Positives = 37/65 (56%), Gaps = 6/65 (9%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQET--EQ 197
+ ++ D+P LL+ +T +L+E+GLNI A +T+ + DVF V DG PL E
Sbjct: 3 LELTALDRPGLLADVTRVLAELGLNIHSAKI-ATLGERAEDVFYVTDADGQPLDPERQEA 61
Query: 198 LRNVL 202
LR L
Sbjct: 62 LRAAL 66
|
This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
| >gnl|CDD|225400 COG2844, GlnD, UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 42/148 (28%)
Query: 57 LWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSN 116
LWA R + Y L + A D+ H R L R P LVL+ S
Sbjct: 640 LWA---RCYANYFLRHS---ARDIAWHARHLV--RHDLGKP-----LVLI--------SV 678
Query: 117 LVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFST 176
HSG E+ + D+P+L + + + LS GL+I +A F+T
Sbjct: 679 RPHSGGT------------------EVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTT 720
Query: 177 VDGYSLDVFVV---DGWPLQETEQLRNV 201
DGY+LD F+V DG+P++E +
Sbjct: 721 RDGYALDTFIVLEPDGFPVEEDRRAALR 748
|
Length = 867 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 22/68 (32%), Positives = 40/68 (58%), Gaps = 3/68 (4%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRDLKAA 372
L++VT++MSGG ++ H QK G + I ++ + +LH+ +I++RDLK
Sbjct: 68 DSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125
Query: 373 NLLMNENG 380
N+L++ G
Sbjct: 126 NILLDATG 133
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|234709 PRK00275, glnD, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 17/82 (20%), Positives = 40/82 (48%), Gaps = 7/82 (8%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPL----QE 194
+I I D+ + + + ++ LNI +A ++ ++LD ++V DG P+
Sbjct: 706 QIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPAR 765
Query: 195 TEQLRNVLAKEIPKVENHHHVV 216
EQ+R L + + +++ ++
Sbjct: 766 IEQIREGLTEALRNPDDYPTII 787
|
Length = 895 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 2/97 (2%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + +++ G + L A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDI 386
++ G+ LHR N ++RDLK N+L+++ G +R SD+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDL 146
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 24/93 (25%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 292 EVHIMRK-VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDY---LHKQKCGLKLPLLLR 347
EV I+++ +RH N+V++ RL+IV + + G + ++ L ++K +
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 348 VAIDVSKGMNYLHRNN-IIHRDLKAANLLMNEN 379
+ + + + YLH+ I+HRDL N+++ E+
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 30/117 (25%), Positives = 60/117 (51%), Gaps = 5/117 (4%)
Query: 260 DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
++Y ++ V ++ N E + EF Q+ R ++H N++Q +G C +
Sbjct: 15 EIYTDTGVARVVVKELKANASSKE--QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL 72
Query: 320 VTEFMSGGSIYDYLHKQKCGLK---LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
V E+ G + YL +++ + L LL R+A +++ G+ ++H++N +H DL N
Sbjct: 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRN 129
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 22/142 (15%)
Query: 250 EHKIVSGSYCDLYKGAFFSQDVAIKV-----LTNEHLNENIRRE-FAQEVHIMRKVRHMN 303
I G+ +Y F +K + L+E +RRE +E I+ K R
Sbjct: 1 MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG 60
Query: 304 V----VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
V V + P IV E++ G + D L + + LL V V K L
Sbjct: 61 VPVPIVYDV----DPDNGLIVMEYIEGELLKDALEE----ARPDLLREVGRLVGK----L 108
Query: 360 HRNNIIHRDLKAANLLMNENGV 381
H+ I+H DL +N++++ +
Sbjct: 109 HKAGIVHGDLTTSNIILSGGRI 130
|
Length = 204 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF----SQ---DVAIKVLTNEHLNENIRREFAQE 292
WE L + SG++ + +G + SQ VA+K+L + ++ E
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE-KQALMSE 90
Query: 293 VHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK 337
+ IM + H+N+V +GACT+ ++I+TE+ G + +YLHK +
Sbjct: 91 LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 24/103 (23%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
E I++++ H +V + +++V + + GG + +L ++ + + +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE 108
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
V + YLH IIHRD+K N+L++E G H ++++F
Sbjct: 109 IVL-ALEYLHSKGIIHRDIKPDNILLDEQG------HVHITDF 144
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 34/132 (25%), Positives = 63/132 (47%), Gaps = 14/132 (10%)
Query: 271 VAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
+ ++ TNE + F Q E+H+ + H N+V + L++VT FM+ GS
Sbjct: 33 INLEACTNEMVT------FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA 86
Query: 330 YDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388
D + G+ + + V K ++Y+H +HR +KA+++L++ +G
Sbjct: 87 KDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG------KV 140
Query: 389 YLSNFLSISTVI 400
YLS S ++I
Sbjct: 141 YLSGLRSNLSMI 152
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 36/130 (27%), Positives = 63/130 (48%), Gaps = 13/130 (10%)
Query: 260 DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACT---- 312
DL G F ++V T E E + +EV ++R + H NVV+ CT
Sbjct: 22 DLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78
Query: 313 -RPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
R +L +V E + + YL K + G+ + + + +G+++LH + ++HRDLK
Sbjct: 79 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137
Query: 371 AANLLMNENG 380
N+L+ +G
Sbjct: 138 PQNILVTSSG 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 32/129 (24%), Positives = 69/129 (53%), Gaps = 4/129 (3%)
Query: 252 KIVSGSYCDLYKGA--FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y +YK ++ +A+K + E +E + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI-DVSKGMNYLHRNNIIHRD 368
RL++V E++ + ++ K P L++ + + +G+ Y H + ++HRD
Sbjct: 69 VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 369 LKAANLLMN 377
LK NLL++
Sbjct: 128 LKPQNLLID 136
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 36/153 (23%)
Query: 254 VSGSYCDLY------KGAFFS-------QDVAIK--VLTNEHLNENIRREFAQEVHIMRK 298
+ Y DL G FS + VA+K VLT+ ++ RE + I+R+
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALRE----IKIIRR 58
Query: 299 VRHMNVVQF--------------IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
+ H N+V+ +G+ T ++IV E+M + + L + +
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHAR 117
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
L + +G+ Y+H N++HRDLK AN+ +N
Sbjct: 118 LF--MYQLLRGLKYIHSANVLHRDLKPANVFIN 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 2/97 (2%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAI 350
E I+ KV VV A L +V M+GG + +++ G + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDI 386
+++ G+ LHR I++RDLK N+L+++ G +R SD+
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDL 146
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 9/115 (7%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL------FIVTEFM 324
VAIK L +E + +E+ +++ ++H NV+ + T L ++V FM
Sbjct: 43 VAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM 102
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
G + + +K L + KG+ Y+H IIHRDLK NL +NE+
Sbjct: 103 -GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LF V E+++GG + H Q C LP A ++ G+ +LH I++RDLK N+L
Sbjct: 71 LFFVMEYLNGGDLM--FHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 376 MNENG 380
++ +G
Sbjct: 129 LDTDG 133
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 3/65 (4%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LF V E+++GG + H Q G A ++ G+ +LH+ II+RDLK N+L
Sbjct: 71 LFFVMEYLNGGDLM--FHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL 128
Query: 376 MNENG 380
++++G
Sbjct: 129 LDKDG 133
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 31/127 (24%)
Query: 269 QDVAIKVLTN-EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPRL------ 317
VAIK ++ EH + F Q E+ I+R+ +H N++ I RPP
Sbjct: 31 VKVAIKKISPFEH------QTFCQRTLREIKILRRFKHENIIG-ILDIIRPPSFESFNDV 83
Query: 318 FIVTEFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
+IV E M +Y + Q L +LR G+ Y+H N++HRDLK +
Sbjct: 84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------GLKYIHSANVLHRDLKPS 135
Query: 373 NLLMNEN 379
NLL+N N
Sbjct: 136 NLLLNTN 142
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 28/147 (19%)
Query: 253 IVSGSYCDLYKGAFFSQ--DVAIKVLTNEHLNEN------IRREFAQEVHIMRKVR---H 301
I G+Y +YK + VA+K + L+E +R E+ +++++ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLR-----EIALLKQLESFEH 60
Query: 302 MNVVQFIGACTRPPR-----LFIVTEFMSGGSIYDYLHKQKC---GLKLPLLLRVAIDVS 353
N+V+ + C P L +V E + + YL KC GL + + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKDLMRQLL 117
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENG 380
+G+++LH + I+HRDLK N+L+ +G
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDG 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 28/136 (20%), Positives = 61/136 (44%), Gaps = 17/136 (12%)
Query: 250 EHKIVSGSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVH-IMRKVRHMNVVQ 306
+ K++ G + + K + K++ ++ N E VH +M+ +
Sbjct: 21 KLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI---EPM--VHQLMKDNPN----- 70
Query: 307 FIG---ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
FI + T ++ +++ G ++D L K+ L + ++ + + +N LH++N
Sbjct: 71 FIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHN 129
Query: 364 IIHRDLKAANLLMNEN 379
IIH D+K N+L +
Sbjct: 130 IIHNDIKLENVLYDRA 145
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 25/83 (30%), Positives = 44/83 (53%), Gaps = 19/83 (22%)
Query: 317 LFIVTEFMSGG------SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
+++V E++ GG IY Y + + ++ +V+ ++YLHR+ IIHRDLK
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGYFDE-------EMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 371 AANLLMNENGVRDSDIHCYLSNF 393
N+L++ G H L++F
Sbjct: 132 PDNMLISNEG------HIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 10/130 (7%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
GS C Y Q VA+K L+ + R +E+ +++ ++H NV+ + T
Sbjct: 29 GSVCSAYD-TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87
Query: 316 RL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ ++VT M G + + + QK L + + + +G+ Y+H IIHRDL
Sbjct: 88 SIENFNEVYLVTNLM-GADLNNIVKCQK--LSDEHVQFLIYQLLRGLKYIHSAGIIHRDL 144
Query: 370 KAANLLMNEN 379
K +N+ +NE+
Sbjct: 145 KPSNVAVNED 154
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 22/66 (33%), Positives = 39/66 (59%), Gaps = 3/66 (4%)
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
RL+ V E+++GG + Q+ G K P + A +++ G+ +LH II+RDLK N+
Sbjct: 75 RLYFVMEYVNGGDLM--YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 375 LMNENG 380
+++ G
Sbjct: 133 MLDSEG 138
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 26/112 (23%), Positives = 55/112 (49%), Gaps = 6/112 (5%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+K+L E + + E A E +++ RH + + RL V E+ +GG
Sbjct: 24 AMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
++ +L +++ ++ + YLH ++++RDLK NL+++++G
Sbjct: 82 LFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 22/89 (24%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +++ RH + + RL V E+++GG ++ +L +++ + A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ ++YLH I++RDLK NL+++++G
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLDKDG 132
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQE 292
WE LK + G++ + + F D VA+K+L E + R E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSE 60
Query: 293 VHIMRKV-RHMNVVQFIGACTRP--PRLFIVTEFMSGGSIYDYLHKQK 337
+ I+ + H+NVV +GACT+P P L ++ EF G++ +YL ++
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 22/74 (29%), Positives = 45/74 (60%), Gaps = 2/74 (2%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
P +L + + M+GG ++ +L + + + A ++ G+ ++H +++RDLK AN
Sbjct: 69 PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRFVVYRDLKPAN 127
Query: 374 LLMNENG-VRDSDI 386
+L++E+G VR SD+
Sbjct: 128 ILLDEHGHVRISDL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|190133 pfam01842, ACT, ACT domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 2e-04
Identities = 14/66 (21%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRN 200
+ + D+P LL+++ L++ G+NI+ ++ D + VV ++ E
Sbjct: 1 TVLEVGVPDRPGLLAEVFGALADRGINIESISQSTSGDKAGIVFIVVVV-DEEDLEAALE 59
Query: 201 VLAKEI 206
L K +
Sbjct: 60 ALKKLL 65
|
This family of domains generally have a regulatory role. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Pairs of ACT domains bind specifically to a particular amino acid leading to regulation of the linked enzyme. The ACT domain is found in: D-3-phosphoglycerate dehydrogenase EC:1.1.1.95, which is inhibited by serine. Aspartokinase EC:2.7.2.4, which is regulated by lysine. Acetolactate synthase small regulatory subunit, which is inhibited by valine. Phenylalanine-4-hydroxylase EC:1.14.16.1, which is regulated by phenylalanine. Prephenate dehydrogenase EC:4.2.1.51. formyltetrahydrofolate deformylase EC:3.5.1.10, which is activated by methionine and inhibited by glycine. GTP pyrophosphokinase EC:2.7.6.5. Length = 66 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVA 349
E I+ + H V G+ L++V EF+ GG + +L + K + P + A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYA 137
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ YL NI++RDLK NLL++++G
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168
|
Length = 340 |
| >gnl|CDD|235329 PRK05007, PRK05007, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 22/76 (28%), Positives = 39/76 (51%), Gaps = 9/76 (11%)
Query: 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQE---- 194
EI I + D+P L + + + L L++ +A F++ DG ++D F+V DG PL +
Sbjct: 703 EIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQ 762
Query: 195 --TEQLRNVLAKEIPK 208
+ L L + P+
Sbjct: 763 VIRKALEQALTQSSPQ 778
|
Length = 884 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIR----RE------FAQEVHIMRKV 299
KI G+Y +YK + + VA+K E E I RE ++ ++I+R +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGG-SIYDYLHKQKCGLKLP--LLLRVAIDVSKGM 356
+V + G P L++V E++ + + + G LP + + KG+
Sbjct: 68 DVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 357 NYLHRNNIIHRDLKAANLLMNENG 380
+ H++ ++HRDLK NLL+++
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQK 147
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 24/75 (32%), Positives = 47/75 (62%), Gaps = 4/75 (5%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV-AIDVSKGMNYLHRNNIIHRDLKAA 372
P +L + + M+GG ++ +L + G+ +R A ++ G+ ++H +++RDLK A
Sbjct: 69 PDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPA 126
Query: 373 NLLMNENG-VRDSDI 386
N+L++E+G VR SD+
Sbjct: 127 NILLDEHGHVRISDL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 11/96 (11%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPR-------LFIVTEFMSGGSIYDYLHKQKCGLKLP 343
+E+ +++ ++H NV+ + T P R +++VT M G + + + QK L
Sbjct: 65 RELRLLKHMKHENVIGLLDVFT-PARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDD 120
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+ + + +G+ Y+H +IIHRDLK +NL +NE+
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 156
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 26/104 (25%), Positives = 44/104 (42%), Gaps = 22/104 (21%)
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGL------ 340
+ +E+ I++ + H ++ I A + +V + K KC L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV------------MPKYKCDLFTYVDR 178
Query: 341 KLPLLLRVAIDVSKGM----NYLHRNNIIHRDLKAANLLMNENG 380
PL L AI + + + YLH IIHRD+K N+ ++E
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE 222
|
Length = 392 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 17/40 (42%), Positives = 25/40 (62%), Gaps = 6/40 (15%)
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
K + Y+H N+IHRDLK +N+L+N SD L++F
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLN------SDCRVKLADF 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 27/156 (17%)
Query: 239 VWEIDASLLKFEHKIVSGSY---C---DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQE 292
VWE+ ++ SG+Y C D G + VAIK L+ +E + +E
Sbjct: 10 VWELPERYTSL-KQVGSGAYGSVCSAIDKRTG----EKVAIKKLSRPFQSEIFAKRAYRE 64
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRL------FIVTEFMSGGSIYDYLHKQKC-GLKLP-- 343
+ +++ ++H NV+ + T ++V +M QK G L
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-------QTDLQKIMGHPLSED 117
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+ + + G+ Y+H IIHRDLK NL +NE+
Sbjct: 118 KVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 27/122 (22%), Positives = 50/122 (40%), Gaps = 23/122 (18%)
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG-------GSIYDYLHKQKCGLKLP 343
+E+ IM +++H N++ + + +V + M+ I + KC L
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF-LSISTVILV 402
L G+N LH+ +HRDL AN+ +N G+ C +++F L+
Sbjct: 129 L---------NGLNVLHKWYFMHRDLSPANIFINSKGI------CKIADFGLARRYGYPP 173
Query: 403 IF 404
Sbjct: 174 YS 175
|
Length = 335 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 23/89 (25%), Positives = 47/89 (52%), Gaps = 1/89 (1%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
E +++ RH + A RL V E+ +GG ++ +L +++ + A
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENG 380
VS + YLH ++++RD+K NL+++++G
Sbjct: 105 VS-ALEYLHSRDVVYRDIKLENLMLDKDG 132
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 18/49 (36%), Positives = 28/49 (57%)
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
+Y YL + L L + VA + ++Y+H IIHRD+K N+L+N
Sbjct: 246 LYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294
|
Length = 461 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 20/144 (13%)
Query: 252 KIVSGSYCDLYK------GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HM 302
+I G+Y +YK G F + +++V TNE + + +EV +++++ H
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK-SVRVQTNE---DGLPLSTVREVALLKRLEAFDHP 62
Query: 303 NVVQFIGACT-----RPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGM 356
N+V+ + C R ++ +V E + + YL K GL + + +G+
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 357 NYLHRNNIIHRDLKAANLLMNENG 380
++LH N I+HRDLK N+L+ G
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 13/26 (50%), Positives = 19/26 (73%)
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENG 380
G+ Y+H N++HRDLK NLL+N +
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADC 142
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 14/26 (53%), Positives = 19/26 (73%)
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNEN 379
+G+ YLH I+HRD+K NLL+N N
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSN 139
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 20/145 (13%)
Query: 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
K + I +GS+ +Y+ S+ VAIK + + +N +E+ IM+ + H+N++
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINII 122
Query: 306 ----QFIGACTRPPR----LFIVTEFMSGGSIYDYL-HKQKCGLKLPLLL--RVAIDVSK 354
+ C + L +V EF+ +++ Y+ H + LPL L + + +
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 355 GMNYLHRNNIIHRDLKAANLLMNEN 379
+ Y+H I HRDLK NLL++ N
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPN 206
|
Length = 440 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 3/65 (4%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LF V EF++GG + H Q G L A ++ G+ +LH II+RDLK N++
Sbjct: 71 LFFVMEFLNGGDLM--FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 376 MNENG 380
++ +G
Sbjct: 129 LDRDG 133
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 35/128 (27%), Positives = 60/128 (46%), Gaps = 10/128 (7%)
Query: 268 SQDV-AIKVLTN-EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
SQ V A+K+L+ E + + F +E IM VVQ A L++V E+M
Sbjct: 67 SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
GG + + + K +V ++ +H +IHRD+K N+L++++G
Sbjct: 127 GGDLVNLMSNYDVPEKWAKFYTA--EVVLALDAIHSMGLIHRDVKPDNMLLDKHG----- 179
Query: 386 IHCYLSNF 393
H L++F
Sbjct: 180 -HLKLADF 186
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|235342 PRK05092, PRK05092, PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.002
Identities = 19/48 (39%), Positives = 27/48 (56%), Gaps = 7/48 (14%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGY---SLDVFVV 187
I ++ D+P LL LT LS++ LNI AH + Y ++DVF V
Sbjct: 846 IEVNGRDRPGLLYDLTRALSDLNLNIASAH----IATYGERAVDVFYV 889
|
Length = 931 |
| >gnl|CDD|233534 TIGR01693, UTase_glnD, [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 27/117 (23%), Positives = 46/117 (39%), Gaps = 15/117 (12%)
Query: 86 LLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCYPYKKRLMHEITI 145
L+ V A P + +HF+ + + + R + +
Sbjct: 736 LVDVLAGLAKDPDTISARRARRRRL-QHFA----------VPPRVTILNTASRKATIMEV 784
Query: 146 STNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV---DGWPLQETEQLR 199
D+P LL+++ L E+GL+IQ A +T + DVF V G L + E+ R
Sbjct: 785 RALDRPGLLARVGRTLEELGLSIQSAK-ITTFGEKAEDVFYVTDLFGLKLTDEEEQR 840
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family [Central intermediary metabolism, Nitrogen metabolism, Regulatory functions, Protein interactions]. Length = 850 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 27/107 (25%), Positives = 52/107 (48%), Gaps = 10/107 (9%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFAQE 292
WE L+ + G++ + + + F D VA+K+L E + + E
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSE 60
Query: 293 VHIMRKV-RHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQK 337
+ I+ + H+NVV +GACT+P L ++ EF G++ ++L ++
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 11/130 (8%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
G C Y A ++VAIK L+ N+ + +E+ +M+ V H N++ + T
Sbjct: 31 GIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89
Query: 316 RL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
L ++V E M ++ + + ++ LL + G+ +LH IIHRDL
Sbjct: 90 SLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRDL 145
Query: 370 KAANLLMNEN 379
K +N+++ +
Sbjct: 146 KPSNIVVKSD 155
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 31/126 (24%), Positives = 61/126 (48%), Gaps = 13/126 (10%)
Query: 263 KGAFFSQDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321
+G+ + V K + LN+ + +A+ E+H + H +V+ +L ++
Sbjct: 88 RGSDPKEKVVAKFVM---LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 322 EFMSGGSIYDYLHKQKCGLKLPL------LLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
E+ SGG + + KQ+ LP LL I ++ ++ +H ++HRDLK+AN+
Sbjct: 145 EYGSGGDLNKQI-KQRLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHRDLKSANIF 201
Query: 376 MNENGV 381
+ G+
Sbjct: 202 LMPTGI 207
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 13/131 (9%)
Query: 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
G C Y A ++VAIK L+ N+ + +E+ +M+ V H N++ + T P
Sbjct: 38 GIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT-PQ 95
Query: 316 R-------LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ ++IV E M ++ + + ++ LL + G+ +LH IIHRD
Sbjct: 96 KSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQML---CGIKHLHSAGIIHRD 151
Query: 369 LKAANLLMNEN 379
LK +N+++ +
Sbjct: 152 LKPSNIVVKSD 162
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 17/123 (13%)
Query: 274 KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFIVTEFMSGGSIYD 331
K ++ L E + + EV++MR+++H N+V++I +L+I+ EF G +
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 332 YLHKQKCGLKLPLLLRVAI-DVSK----GMNYLHR-------NNIIHRDLKAANLLMNEN 379
+ QKC + AI D+++ + Y H ++HRDLK N+ ++
Sbjct: 104 NI--QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS-T 160
Query: 380 GVR 382
G+R
Sbjct: 161 GIR 163
|
Length = 1021 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 11/85 (12%)
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
+F+V + GG ++ ++ K L +P + R A ++ ++ LHR I+ RDL N+
Sbjct: 60 VFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 375 LMNENGVRDSDIHCYLSNFLSISTV 399
L+++ G H L+ F S V
Sbjct: 117 LLDDRG------HIQLTYFSRWSEV 135
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|153198 cd04926, ACT_ACR_4, C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.003
Identities = 15/43 (34%), Positives = 23/43 (53%), Gaps = 1/43 (2%)
Query: 145 ISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV 187
+ T D+ LLS +T + E GL + A ST +++VF V
Sbjct: 6 LRTEDRVGLLSDVTRVFRENGLTVTRAE-ISTQGDMAVNVFYV 47
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 72 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
LL + V+KGM++L N IHRDL A N+L+
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILL 247
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 19/42 (45%), Positives = 26/42 (61%)
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L L+ + V+KGM +L IHRDL A N+L++EN V
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV 217
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 30/116 (25%), Positives = 51/116 (43%), Gaps = 8/116 (6%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
S LK E+ I G YKG + V +N E A M K++H N+
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNI 745
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V+ IG C +++ E++ G ++ + L L ++AI ++K + +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLH 797
|
Length = 968 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 19/67 (28%), Positives = 38/67 (56%), Gaps = 1/67 (1%)
Query: 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
P +L++V F++GG ++ +L ++ A ++ + LH+ N+I+RDLK N
Sbjct: 65 PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHKFNVIYRDLKPEN 123
Query: 374 LLMNENG 380
+L++ G
Sbjct: 124 ILLDYQG 130
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 31/111 (27%), Positives = 49/111 (44%), Gaps = 20/111 (18%)
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI------YDYLHKQKCGLKL 342
F +E IM +VQ A L++V E+M GG + YD K
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA 149
Query: 343 PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
++L A+D +H IHRD+K N+L++++G H L++F
Sbjct: 150 EVVL--ALDA------IHSMGFIHRDVKPDNMLLDKSG------HLKLADF 186
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 28/108 (25%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---SQD----VAIKVL-TNEHLNENIRREF 289
+ WE L+F + +G++ + + F +D VA+K+L + H +E R
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE--REAL 88
Query: 290 AQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ 336
E+ I+ + +H N+V +GACT + ++TE+ G + ++L K+
Sbjct: 89 MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 411 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.98 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.98 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.93 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.92 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.92 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.91 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.91 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.9 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.9 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.9 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.9 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.9 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.9 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.9 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.9 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.9 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.9 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.9 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.89 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.89 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.89 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.89 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.89 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.89 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.89 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.89 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.89 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.88 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.88 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.88 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.88 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.88 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.88 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.88 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.88 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.88 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.88 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.87 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.87 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.87 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.87 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.87 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.87 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.87 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.87 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.87 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.86 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.86 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.86 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.86 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.86 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.86 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.85 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.85 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.85 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.85 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.84 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.84 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.84 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.83 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.83 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.83 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.82 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.82 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.81 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.81 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.81 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.78 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.74 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.74 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.71 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.71 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.44 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.27 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.01 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.12 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 98.12 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.08 | |
| PRK05092 | 931 | PII uridylyl-transferase; Provisional | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.05 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 98.0 | |
| PRK03059 | 856 | PII uridylyl-transferase; Provisional | 97.91 | |
| PRK04374 | 869 | PII uridylyl-transferase; Provisional | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| PRK05007 | 884 | PII uridylyl-transferase; Provisional | 97.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 97.76 | |
| TIGR01693 | 850 | UTase_glnD [Protein-PII] uridylyltransferase. This | 97.62 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 97.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.52 | |
| PRK01759 | 854 | glnD PII uridylyl-transferase; Provisional | 97.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.15 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.07 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 97.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.03 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.95 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.6 | |
| cd04897 | 75 | ACT_ACR_3 ACT domain-containing protein which is c | 96.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.57 | |
| COG2844 | 867 | GlnD UTP:GlnB (protein PII) uridylyltransferase [P | 96.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.49 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.21 | |
| cd04895 | 72 | ACT_ACR_1 ACT domain-containing protein which is c | 96.14 | |
| cd04926 | 72 | ACT_ACR_4 C-terminal ACT domain, of a novel type o | 95.89 | |
| cd04896 | 75 | ACT_ACR-like_3 ACT domain-containing protein which | 95.79 | |
| PLN02236 | 344 | choline kinase | 95.75 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.96 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.96 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.83 | |
| PF01842 | 66 | ACT: ACT domain; InterPro: IPR002912 The ACT domai | 94.81 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=314.39 Aligned_cols=249 Identities=28% Similarity=0.385 Sum_probs=197.1
Q ss_pred CcceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEecCCCccchHHHHHHHhhccccccCCCCc
Q 015237 137 KRLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVENHHHV 215 (411)
Q Consensus 137 ~~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~~~~~~~~~~~ 215 (411)
+....+|+|+.+.|.++..+|.+.....| ++|++.. ++.++|+|+|+..+.=. ..+ ...++++.......-.
T Consensus 77 ~l~~~~Wf~~~isR~~ae~~ll~p~~~~G~flvR~se--~~~g~yslsv~~~~~~~--~~~---~v~hyri~~~~~~~~~ 149 (468)
T KOG0197|consen 77 KLSDEPWFFGKISREEAERQLLAPENKEGAFLVRESE--SDKGDYSLSVREGDSGG--LGA---KVKHYRIRQLDGGGLY 149 (468)
T ss_pred ccccCCchhccccHHHHHHhhcCCCCCccceeeeccc--CCcCCeeEEEEeccccC--Ccc---ceeeeeeeEcCCCCee
Confidence 47788999999999999999999999888 8889999 99999999999865111 000 1112333332222000
Q ss_pred cccc-----------Cccc-------cc--CCc------cccCCCC-CCCceeecCCceEEEEEEeecCceEEEEEEECC
Q 015237 216 VYPV-----------GEQE-------QS--GIN------HVNIPAE-GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS 268 (411)
Q Consensus 216 ~~~~-----------~~~~-------~~--~~~------~~~~~~~-~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~ 268 (411)
.+.. .... .. ... .+..+.. ..+.|+++++.+++.++||+|.||.||.|.|++
T Consensus 150 ~~~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~ 229 (468)
T KOG0197|consen 150 PYIDERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNG 229 (468)
T ss_pred cCCCHHHhhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcC
Confidence 0000 0000 00 000 1111112 278999999999999999999999999999998
Q ss_pred c-eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHh-cCCCCCHHHHH
Q 015237 269 Q-DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLL 346 (411)
Q Consensus 269 ~-~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~-~~~~l~~~~i~ 346 (411)
+ +||+|.++...+.. +.|.+|+++|++++|+|||+++|+|+.+..+|||||||+.|+|.+||+. .+..+..+..+
T Consensus 230 ~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll 306 (468)
T KOG0197|consen 230 STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLL 306 (468)
T ss_pred CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHH
Confidence 5 99999999876554 6788999999999999999999999998899999999999999999997 45578999999
Q ss_pred HHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 347 ~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.++.|||.||+||+++++|||||.++|||+++++ .+|++|||+|+.+..
T Consensus 307 ~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~------~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 307 DFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL------VVKISDFGLARLIGD 355 (468)
T ss_pred HHHHHHHHHHHHHHhCCccchhhhhhheeeccCc------eEEEcccccccccCC
Confidence 9999999999999999999999999999999999 499999999996543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=274.16 Aligned_cols=157 Identities=25% Similarity=0.467 Sum_probs=142.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|.+.++||.|+|+.||+|+++ +..||||.+.+..++....+.+..|+.||+.++|||||++++++..++.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 34777888999999999999986 6899999999988888888999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
||.||+|.+|++..+ .+++..+..++.|++.||++||+++||||||||.|||++.....+-...+||+|||+|+.+.++
T Consensus 90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999999875 7999999999999999999999999999999999999998733332256999999999987653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=274.27 Aligned_cols=159 Identities=41% Similarity=0.720 Sum_probs=147.0
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECCce-EEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~-VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
...|+|+...+.+.+.||+|+||+||+|.|.++. ||||++.....+....+.|.+|+.+|.+++|||||+|+|+|..++
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4679999999999999999999999999999988 999999887666555789999999999999999999999999988
Q ss_pred -eEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 316 -RLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNN-IIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 316 -~l~IV~E~~~gGsL~~~L~~-~~~~l~~~~i~~i~~qIa~gL~yLHs~g-IIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.++||||||++|+|.+++.. .+..+++..++.++.||++||+|||+++ ||||||||+|||++.++ ..+||+|
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-----~~~KI~D 187 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-----KTLKIAD 187 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-----CEEEECC
Confidence 79999999999999999988 3668999999999999999999999999 99999999999999987 2599999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||+++...
T Consensus 188 FGlsr~~~ 195 (362)
T KOG0192|consen 188 FGLSREKV 195 (362)
T ss_pred Cccceeec
Confidence 99997654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=276.16 Aligned_cols=163 Identities=22% Similarity=0.365 Sum_probs=148.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRL 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l 317 (411)
...+.|..+++||+|+||.||+++.. ++.||+|.++.+...+.......+||.||++++||||+++.+..+.. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34566778899999999999999885 68899999998877777778899999999999999999999998876 689
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+|+|||++ +|.-++....-.|+++++..++.|++.||+|||++||+|||||.+|||||.+|+ +||+|||+|.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~------LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV------LKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC------EEecccccee
Confidence 999999966 999999887778999999999999999999999999999999999999999994 9999999999
Q ss_pred cc-------ccceeeEEEEcC
Q 015237 398 TV-------ILVIFSCILVRA 411 (411)
Q Consensus 398 ~~-------~~~~~~~i~~ra 411 (411)
.+ .++.+.|+|||+
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRp 287 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRP 287 (560)
T ss_pred eccCCCCcccccceEEeeccC
Confidence 55 678899999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=253.06 Aligned_cols=159 Identities=26% Similarity=0.369 Sum_probs=145.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|..+.++|+|+||.||+++.+ |+-||||.+.....++...+-.++|+++|++++|+|+|.++.+|.....+++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4667789999999999999875 79999999987766677778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc---
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI--- 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~--- 400 (411)
|.. ++.+-|.....+++...+..++.|++.|+.|+|++++|||||||+||||+.+|+ +||||||+|+.+.
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv------vKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV------VKLCDFGFARTLSAPG 155 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc------EEeccchhhHhhcCCc
Confidence 965 777778777778999999999999999999999999999999999999999994 9999999999986
Q ss_pred ---cceeeEEEEcC
Q 015237 401 ---LVIFSCILVRA 411 (411)
Q Consensus 401 ---~~~~~~i~~ra 411 (411)
+..+.|=||||
T Consensus 156 d~YTDYVATRWYRa 169 (396)
T KOG0593|consen 156 DNYTDYVATRWYRA 169 (396)
T ss_pred chhhhhhhhhhccC
Confidence 57788999997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=249.67 Aligned_cols=160 Identities=24% Similarity=0.341 Sum_probs=142.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~IV 320 (411)
+.|+..++|++|+||.||+|+++ ++-||+|.++.+.-.....-.-++||.+|.+++|||||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778899999999999999886 5789999999876444455567899999999999999999887754 3469999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc-
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV- 399 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~- 399 (411)
||||++ +|..++..-...+....++.++.|+++|++|||.+.|+||||||+|+|++..| .+|++|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G------~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG------ILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC------cEEecccchhhhhc
Confidence 999965 99999988776899999999999999999999999999999999999999999 4999999999998
Q ss_pred -----ccceeeEEEEcC
Q 015237 400 -----ILVIFSCILVRA 411 (411)
Q Consensus 400 -----~~~~~~~i~~ra 411 (411)
.++++.|+||||
T Consensus 229 sp~k~~T~lVVTLWYRa 245 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRA 245 (419)
T ss_pred CCcccCcceEEEeeecC
Confidence 456999999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=241.42 Aligned_cols=160 Identities=24% Similarity=0.329 Sum_probs=146.7
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.+|...+++|+|.||.||+|++. ++.||||.++.....+.......+||..|+.++|+||+.++++|.....+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999999999999885 7899999999887666666788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc--
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI-- 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~-- 400 (411)
||+ .+|...++.....+....+..++.++++|++|||++.|+||||||.|+||+.+| .+||+|||+|+.+.
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g------~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG------QLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC------cEEeecccchhccCCC
Confidence 994 599999998887899999999999999999999999999999999999999999 59999999999986
Q ss_pred ----cceeeEEEEcC
Q 015237 401 ----LVIFSCILVRA 411 (411)
Q Consensus 401 ----~~~~~~i~~ra 411 (411)
+..+++=||||
T Consensus 155 ~~~~~~~V~TRWYRA 169 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRA 169 (318)
T ss_pred CcccccceeeeeccC
Confidence 45689999998
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=264.95 Aligned_cols=157 Identities=33% Similarity=0.655 Sum_probs=148.0
Q ss_pred CCCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 235 ~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...++|+|+.+.+.+.+.||+|+||+||+|.|.| +||||+++.+..+++..+.|..|+.++++-+|.||+-|+|+|..+
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3457999999999999999999999999999988 799999999998888999999999999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+. .||+.+|+|.+|+.+|+-....|.....+.|+.||++||.|||.++|||||||..||++.+++ .+||.|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~------kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL------KVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC------cEEEeccc
Confidence 76 999999999999999998877899999999999999999999999999999999999999987 59999999
Q ss_pred ccccc
Q 015237 395 SISTV 399 (411)
Q Consensus 395 la~~~ 399 (411)
++..-
T Consensus 534 Latvk 538 (678)
T KOG0193|consen 534 LATVK 538 (678)
T ss_pred ceeee
Confidence 99754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-31 Score=263.46 Aligned_cols=161 Identities=21% Similarity=0.293 Sum_probs=143.9
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCC-eEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP-RLF 318 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~-~l~ 318 (411)
-..+|++.++||.|+||.||+|+.. +..||||.++......+.. .=++|+..|++++ |||||++.+++.+.. .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467889999999999999999765 6889999999876654322 2468999999998 999999999998887 899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||| ..+|+++++.++..|++..+..|+.||++||+|+|.+|+.|||+||+|||+..+. .+||+|||+|+.
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~------~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND------VIKIADFGLARE 159 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc------eeEecccccccc
Confidence 999999 5699999999988899999999999999999999999999999999999998654 499999999999
Q ss_pred c-----ccceeeEEEEcC
Q 015237 399 V-----ILVIFSCILVRA 411 (411)
Q Consensus 399 ~-----~~~~~~~i~~ra 411 (411)
+ .+..+||=||||
T Consensus 160 v~SkpPYTeYVSTRWYRA 177 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRA 177 (538)
T ss_pred cccCCCcchhhhcccccc
Confidence 8 457899999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=248.66 Aligned_cols=155 Identities=23% Similarity=0.357 Sum_probs=134.7
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHH-----HHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN-----IRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~-----~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
+-..+.|-+.+.||+|+||.|-+|..+ ++.||||++.+...... ......+|++||++++|||||+++++|..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 335667888999999999999999764 79999999987654321 12336799999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
+...||||||+.||+|.+++-.++ .+.+..-+.++.|++.|+.|||++||+||||||+|||+..+. .++.+||+||
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~---e~~llKItDF 323 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA---EDCLLKITDF 323 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC---cceEEEeccc
Confidence 999999999999999999998765 578888899999999999999999999999999999998764 2457999999
Q ss_pred cccccc
Q 015237 394 LSISTV 399 (411)
Q Consensus 394 Gla~~~ 399 (411)
|+|+-.
T Consensus 324 GlAK~~ 329 (475)
T KOG0615|consen 324 GLAKVS 329 (475)
T ss_pred chhhcc
Confidence 999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=257.17 Aligned_cols=158 Identities=34% Similarity=0.546 Sum_probs=144.8
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-----ce-EEEEEeecc-ccCHHHHHHHHHHHHHHhhcCCCceeEEEe
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QD-VAIKVLTNE-HLNENIRREFAQEVHIMRKVRHMNVVQFIG 309 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~-VAIK~l~~~-~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g 309 (411)
...|++..++..+.++||+|+||.||+|++.- .. ||||..+.+ .......++|.+|+++|++++|||||+|||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 56799999999999999999999999998751 23 899999863 356778899999999999999999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
++....+++||||+|+||+|.++|++.+..++....+.++.+.+.||+|||++++|||||.++|||++.+++ +|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~------vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV------VK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe------EE
Confidence 999999999999999999999999998767999999999999999999999999999999999999999884 79
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++..-.
T Consensus 303 ISDFGLs~~~~ 313 (474)
T KOG0194|consen 303 ISDFGLSRAGS 313 (474)
T ss_pred eCccccccCCc
Confidence 99999987653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=246.19 Aligned_cols=155 Identities=30% Similarity=0.452 Sum_probs=139.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe-E
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-L 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-l 317 (411)
.+..++++..+.||+|+.|.||++.++ ++-+|+|++.. ..+....+++.+|++|++.++||+||.+||+|..+.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 456668888999999999999999987 68899999943 3466778999999999999999999999999999984 9
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||.+|||.+++...+ .++++.+-+++.+|++||.|||. ++||||||||+|||++..| .+||||||-+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG------eVKicDFGVS 226 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG------EVKICDFGVS 226 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC------CEEecccccc
Confidence 99999999999999998764 69999999999999999999995 9999999999999999999 6999999998
Q ss_pred cccccce
Q 015237 397 STVILVI 403 (411)
Q Consensus 397 ~~~~~~~ 403 (411)
..+.+..
T Consensus 227 ~~lvnS~ 233 (364)
T KOG0581|consen 227 GILVNSI 233 (364)
T ss_pred HHhhhhh
Confidence 8875543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=260.38 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=189.5
Q ss_pred CCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCC--Cc----cc------hHHH-HH
Q 015237 134 PYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGW--PL----QE------TEQL-RN 200 (411)
Q Consensus 134 ~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w--~~----~~------~~~l-~~ 200 (411)
++.+.+-|-|+-+++.|-.++--|++.++ --|.++|.+ |+.+.||+++.. +|- ++ .. +... ..
T Consensus 145 PvNSLeKhsWYHGpvSRsaaEy~LsSgIn-GSFLVRESE--sSpgQ~sISlRy-eGRVyHYRINt~~dgK~yvt~EsrF~ 220 (1157)
T KOG4278|consen 145 PVNSLEKHSWYHGPVSRSAAEYILSSGIN-GSFLVRESE--SSPGQYSISLRY-EGRVYHYRINTDNDGKMYVTQESRFR 220 (1157)
T ss_pred cccchhhcccccCccccchhhhhhhcCcc-cceEEeecc--CCCcceeEEEEe-cceEEEEEeeccCCccEEEeehhhhh
Confidence 34557889999999999888776655544 228889999 999999999875 321 00 00 0111 11
Q ss_pred HHhhccccccCC-----CCcccccCcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEECC--ceEEE
Q 015237 201 VLAKEIPKVENH-----HHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAI 273 (411)
Q Consensus 201 ~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAI 273 (411)
.|..-+.+.... ....+|...... ..+.--....|.||+++.++....+||-|.||+||.|.|+. -.|||
T Consensus 221 TLaELVHHHStvADGLittLhYPApK~nK---ptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAV 297 (1157)
T KOG4278|consen 221 TLAELVHHHSTVADGLITTLHYPAPKKNK---PTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAV 297 (1157)
T ss_pred HHHHHHhhccccccceeEeeeccCccCCC---CceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeeh
Confidence 111111111000 001111111100 01111122358999999999999999999999999999984 67999
Q ss_pred EEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHH
Q 015237 274 KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDV 352 (411)
Q Consensus 274 K~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qI 352 (411)
|.++.+.+. ..+|+.|..+|+.++|||+|+++|+|+....+|||+|||..|+|.+||+.... .++.-.+++++.||
T Consensus 298 KtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQI 374 (1157)
T KOG4278|consen 298 KTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQI 374 (1157)
T ss_pred hhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHH
Confidence 999877543 57899999999999999999999999999999999999999999999988643 46666778999999
Q ss_pred HHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 353 a~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+.||+||..+++|||||.++|+|+.++.+ +|++|||+++.+.+
T Consensus 375 sSaMeYLEkknFIHRDLAARNCLVgEnhi------VKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 375 SSAMEYLEKKNFIHRDLAARNCLVGENHI------VKVADFGLSRLMTG 417 (1157)
T ss_pred HHHHHHHHHhhhhhhhhhhhhccccccce------EEeeccchhhhhcC
Confidence 99999999999999999999999999984 89999999998755
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=241.92 Aligned_cols=161 Identities=24% Similarity=0.384 Sum_probs=142.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc-eeEEEeeeecCC-----
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPP----- 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~----- 315 (411)
...|...++||+|+||.||+|+.. |+.||+|.++.+...+.......+|+.+|+.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 455777788999999999999875 789999999877544445566789999999999999 999999998766
Q ss_pred -eEEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 316 -RLFIVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 316 -~l~IV~E~~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.+++|+||+ .-+|.+|+.... ..++...++.++.||+.||+|||+++|+||||||.||||+++| .+||+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G------~lKla 162 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG------VLKLA 162 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC------cEeee
Confidence 799999999 569999998765 3577788999999999999999999999999999999999999 58999
Q ss_pred eccccccc------ccceeeEEEEcC
Q 015237 392 NFLSISTV------ILVIFSCILVRA 411 (411)
Q Consensus 392 DFGla~~~------~~~~~~~i~~ra 411 (411)
|||+|+.+ .++.+.+.||||
T Consensus 163 DFGlAra~~ip~~~yt~evvTlWYRa 188 (323)
T KOG0594|consen 163 DFGLARAFSIPMRTYTPEVVTLWYRA 188 (323)
T ss_pred ccchHHHhcCCcccccccEEEeeccC
Confidence 99999987 467889999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=240.26 Aligned_cols=154 Identities=23% Similarity=0.382 Sum_probs=140.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+..++|++.+.||+|+||.||..+.. ++-+|+|++++..... ...+....|..||.+++||+||.++-.|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 455678999999999999999998764 6889999999876543 3567789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+|+||+.||.|...|++++ .+++..+..++.+|+.||.|||++|||||||||+|||+|++| .++|+|||+|+
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G------Hi~LtDFgL~k 173 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG------HIKLTDFGLCK 173 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC------cEEEeccccch
Confidence 99999999999999998765 799999999999999999999999999999999999999999 79999999999
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
....
T Consensus 174 ~~~~ 177 (357)
T KOG0598|consen 174 EDLK 177 (357)
T ss_pred hccc
Confidence 6543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=250.55 Aligned_cols=150 Identities=28% Similarity=0.418 Sum_probs=138.3
Q ss_pred CCceEEEEEEeecCceEEEEEEE--CCceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|+.++.||+|+|..||+++. +|+.||+|++.+..+ ....++.+.+||+|.++++|||||+|+++|++.+++|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 36799999999999999999987 489999999987543 345678899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.|+|..++|..+++.+ ..++++.+..++.||+.||.|||+++|||||||..|++++++. ++||+|||+|..+.
T Consensus 97 LELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~------~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM------NVKIGDFGLATQLE 169 (592)
T ss_pred EEecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC------cEEecccceeeeec
Confidence 9999999999999854 4899999999999999999999999999999999999999997 69999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=243.70 Aligned_cols=148 Identities=33% Similarity=0.536 Sum_probs=131.1
Q ss_pred CceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-eEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~l~IV~E 322 (411)
+.|.-...||+|+||.||+|...+ ..||||.+....... .++|.+|+.++.+++|||+|+++|+|.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 445556799999999999999876 899999887654321 356999999999999999999999999988 5999999
Q ss_pred cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 323 FMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNN---IIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~g---IIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||++|+|.+.|..... .++|...++|+.++|+||.|||... ||||||||+|||+|++. ++||+|||+|+.
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~------~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF------NAKLSDFGLAKL 226 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC------CEEccCccCccc
Confidence 9999999999988766 8899999999999999999999854 99999999999999887 699999999965
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 227 ~~ 228 (361)
T KOG1187|consen 227 GP 228 (361)
T ss_pred CC
Confidence 53
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=247.14 Aligned_cols=157 Identities=24% Similarity=0.361 Sum_probs=140.7
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.-...+|+|++.||.|+|++|++++.. ++.||||++.+..... .-.+...+|-.+|.+| .||.|+++|-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344677999999999999999999875 6899999998765433 2345678899999999 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+|+||+++|+|.++|++.+ .|++.....++.+|+.|++|||++|||||||||+|||+|++| .+||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm------hikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG------HIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC------cEEEeecccc
Confidence 999999999999999999875 799999999999999999999999999999999999999999 6999999999
Q ss_pred ccccccee
Q 015237 397 STVILVIF 404 (411)
Q Consensus 397 ~~~~~~~~ 404 (411)
+.+.+...
T Consensus 222 K~l~~~~~ 229 (604)
T KOG0592|consen 222 KILSPSQK 229 (604)
T ss_pred ccCChhhc
Confidence 98865443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=238.10 Aligned_cols=151 Identities=26% Similarity=0.508 Sum_probs=135.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC---HHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~ 315 (411)
.....|.+++.||+|+||.|+.|.+. +..||+|++...... ....+.+.+|+.+|+.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45567999999999999999999874 689999988765221 133456778999999998 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCcCCCccEEEEecc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~-g~~k~~~~ikL~DFG 394 (411)
.+|+||||+.||+|.+++.. .+.+.+..+.+++.|++.|++|||++||+||||||+|||++.+ + ++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~------~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG------NLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC------CEEEeccc
Confidence 99999999999999999998 5579999999999999999999999999999999999999998 6 69999999
Q ss_pred ccccc
Q 015237 395 SISTV 399 (411)
Q Consensus 395 la~~~ 399 (411)
++...
T Consensus 167 ~s~~~ 171 (370)
T KOG0583|consen 167 LSAIS 171 (370)
T ss_pred ccccc
Confidence 99876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=232.37 Aligned_cols=153 Identities=27% Similarity=0.566 Sum_probs=132.2
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC 311 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~ 311 (411)
|+++.++|++.++||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.+|+.+ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 8999999999999999999999999752 3579999987543 233456789999999999 899999999998
Q ss_pred ecC-CeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 015237 312 TRP-PRLFIVTEFMSGGSIYDYLHKQK----------------------------------------------------- 337 (411)
Q Consensus 312 ~~~-~~l~IV~E~~~gGsL~~~L~~~~----------------------------------------------------- 337 (411)
... ..+|++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 45899999999999999997532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 338 --------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 338 --------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~------~~kl~DfG~a~~~ 224 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN------VVKICDFGLARDI 224 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC------cEEEeeccccccc
Confidence 1366778889999999999999999999999999999999887 5999999999765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=238.87 Aligned_cols=151 Identities=23% Similarity=0.413 Sum_probs=138.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
..+|.+.+.||+|.||.|-+++.. |+.||||.++++.. +++..-.+.+||+||..++||||+++|.+|+....+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 356888899999999999999763 79999999998765 445667789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||..+|.|+||+..++ .+++..+..|++||..|+.|+|.++++|||||.+|||+|.|+ ++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~------NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN------NIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC------Ceeeeccchhhhhc
Confidence 99999999999998876 799999999999999999999999999999999999999999 69999999998764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 205 ~ 205 (668)
T KOG0611|consen 205 D 205 (668)
T ss_pred c
Confidence 4
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=231.36 Aligned_cols=165 Identities=23% Similarity=0.345 Sum_probs=144.8
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-- 313 (411)
..|+++..... .+.||.|+||.|+.+.++ ++.||||.+.....+.-..++..+|+.+|+.++|+||+.+++.+..
T Consensus 16 ~~~~i~~~y~~-~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 16 ELFEIPRYYVL-IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred eEEeccceecc-cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 45666654444 789999999999999875 7899999998655566677889999999999999999999998865
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 314 ---PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 314 ---~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
-..+|+|+|+| +.+|.+.++.+. .++...+..++.|+++||+|+|+.||+||||||.|+|++.++ .+|+
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c------~lKI 166 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC------DLKI 166 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC------CEEe
Confidence 23599999999 779999998765 589999999999999999999999999999999999999998 5899
Q ss_pred Eeccccccc--------ccceeeEEEEcC
Q 015237 391 SNFLSISTV--------ILVIFSCILVRA 411 (411)
Q Consensus 391 ~DFGla~~~--------~~~~~~~i~~ra 411 (411)
||||+|+.. .+..+.|-||||
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRA 195 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRA 195 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecC
Confidence 999999987 478899999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=237.06 Aligned_cols=153 Identities=20% Similarity=0.306 Sum_probs=138.7
Q ss_pred eecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+..++|.+++.||+|+||.||.++- +|..+|+|++++..+ ..+..+.+..|-.||...++|+||++|.+|.+..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34566789999999999999999965 478999999998754 335667788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
||||||++||++..+|.+.+ .|++..+..++.+++.|++-+|+.|||||||||+|+|||..| ++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G------HiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG------HIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC------CEeeccccccc
Confidence 99999999999999998765 799999999999999999999999999999999999999999 79999999996
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 290 gl~ 292 (550)
T KOG0605|consen 290 GLD 292 (550)
T ss_pred hhh
Confidence 653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.00 Aligned_cols=153 Identities=25% Similarity=0.372 Sum_probs=139.2
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
...+|++.+.||.|+||.|...+.+ +.-+|+|++++... .....+...+|..+|+.+.||+++++++.|.+...+||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3456888999999999999998775 68899999987654 23455678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||.+||.|..++++.+ .++++.+..++.||+.|++|||+++|++|||||+|||+|.+| .+||+|||.|+.+
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G------~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG------HIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC------cEEEEeccceEEe
Confidence 999999999999998876 699999999999999999999999999999999999999999 6999999999998
Q ss_pred ccc
Q 015237 400 ILV 402 (411)
Q Consensus 400 ~~~ 402 (411)
.+.
T Consensus 195 ~~r 197 (355)
T KOG0616|consen 195 SGR 197 (355)
T ss_pred cCc
Confidence 765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=227.96 Aligned_cols=150 Identities=26% Similarity=0.426 Sum_probs=132.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC--eEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RLFI 319 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--~l~I 319 (411)
..++..++.||+|+||.||.+... +...|||.+...... ..+.+.+|+.+|.+++|||||+++|...... .++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 445777889999999999999986 589999998766321 1567899999999999999999999854444 6999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCcCCCccEEEEecccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~-~g~~k~~~~ikL~DFGla~~ 398 (411)
.|||+++|+|.+++.+.++.++++.+.++..||++||.|||++|||||||||+|||++. ++ .+||+|||+++.
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~------~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG------DVKLADFGLAKK 167 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC------eEEeccCccccc
Confidence 99999999999999987667999999999999999999999999999999999999999 57 599999999998
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
..+
T Consensus 168 ~~~ 170 (313)
T KOG0198|consen 168 LES 170 (313)
T ss_pred ccc
Confidence 764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=233.26 Aligned_cols=154 Identities=22% Similarity=0.366 Sum_probs=137.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEe-eeecCCe-E
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG-ACTRPPR-L 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g-~~~~~~~-l 317 (411)
.....|+++++||.|+||.||++... +..||.|.+.-+.++...++.+..|+.+|++++|||||++++ .+..++. +
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34566899999999999999998764 789999999988888889999999999999999999999999 5555555 9
Q ss_pred EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 318 FIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHR--NN--IIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs--~g--IIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
+||||||.+|+|.+.++. ++..++++.+++++.|++.||..+|+ .+ |+||||||+||+++.+|+ +||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv------vKL 169 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV------VKL 169 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc------eee
Confidence 999999999999998864 34569999999999999999999998 44 999999999999999994 899
Q ss_pred Eeccccccccc
Q 015237 391 SNFLSISTVIL 401 (411)
Q Consensus 391 ~DFGla~~~~~ 401 (411)
.|||+++.+-+
T Consensus 170 GDfGL~r~l~s 180 (375)
T KOG0591|consen 170 GDFGLGRFLSS 180 (375)
T ss_pred ccchhHhHhcc
Confidence 99999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=221.48 Aligned_cols=152 Identities=28% Similarity=0.520 Sum_probs=132.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC------------------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF------------------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~------------------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN 303 (411)
++...|++.++||+|+||.||++.+. +..||+|++.... .......+.+|+.+|.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 45678999999999999999999753 2369999987653 3445678999999999999999
Q ss_pred eeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 015237 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK------------------CGLKLPLLLRVAIDVSKGMNYLHRNNII 365 (411)
Q Consensus 304 IV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~------------------~~l~~~~i~~i~~qIa~gL~yLHs~gII 365 (411)
|+++++++......|++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999899999999999999999986532 1356778899999999999999999999
Q ss_pred ccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 366 HRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 366 HRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||||+|||++.++ .+||+|||+++.+.
T Consensus 161 H~dlkp~Nill~~~~------~~kl~DfG~~~~~~ 189 (304)
T cd05096 161 HRDLATRNCLVGENL------TIKIADFGMSRNLY 189 (304)
T ss_pred ccCcchhheEEcCCc------cEEECCCccceecc
Confidence 999999999999887 59999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=229.87 Aligned_cols=147 Identities=19% Similarity=0.268 Sum_probs=131.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.++||+|+||.||++... ++.||||++..... .....+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5888999999999999999875 68899999876432 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 82 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~------~~kl~DfGla~~~ 151 (377)
T cd05629 82 FLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG------HIKLSDFGLSTGF 151 (377)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC------CEEEeeccccccc
Confidence 999999999997654 688999999999999999999999999999999999999888 5999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=229.23 Aligned_cols=149 Identities=21% Similarity=0.302 Sum_probs=133.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.+.||+|+||.||++... ++.||+|+++.... .......+.+|+.++..++|+||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 35889999999999999999875 68999999976532 2334567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++..+.
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~------~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG------HVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC------CEEEeeccCccccc
Confidence 9999999999998754 689999999999999999999999999999999999999988 59999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=229.74 Aligned_cols=147 Identities=19% Similarity=0.308 Sum_probs=132.1
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.+.||+|+||.||+++.. ++.||||++..... .......+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999885 57899999976543 33455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++..+
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~------~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG------HIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC------CEEEeeCcCCccc
Confidence 999999999997654 688889999999999999999999999999999999999888 5999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=227.38 Aligned_cols=157 Identities=27% Similarity=0.464 Sum_probs=144.3
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...|-+..+.|++.+.||.|..+.||+|++. ++.||||++..+..+.. ...+.+|++.|+.++||||++++..|...
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 4578899999999999999999999999885 68999999998877655 78899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|+||.||.+||+.++++.. ...+++..+..+.+++++||.|||++|.||||+|+.||||+.+| .+||+||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG------~VkLadF 170 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG------TVKLADF 170 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC------cEEEcCc
Confidence 9999999999999999999875 34699999999999999999999999999999999999999999 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|.+-.+.
T Consensus 171 gvsa~l~ 177 (516)
T KOG0582|consen 171 GVSASLF 177 (516)
T ss_pred eeeeeec
Confidence 9776554
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=227.88 Aligned_cols=149 Identities=19% Similarity=0.264 Sum_probs=133.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.+.||+|+||.||++... ++.||||+++.... .......+.+|+.+|+.++||||+++++++..+..+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999885 68899999976532 2334566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+| .++|+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~------~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG------HIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC------CEEEeecccceecc
Confidence 9999999999997654 689999999999999999999999999999999999999988 59999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=239.64 Aligned_cols=149 Identities=30% Similarity=0.477 Sum_probs=137.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|.+.+.||+|+||.||+|+.+ .+.||||.+.+...++...+.+.+|++|++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 35677788999999999999765 5889999999888777788899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+.| +|..+|...+ .+++..+..++.++..||.|||+++|+|||+||.|||++..| .+|+||||+|+...+
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~------~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG------TLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC------ceeechhhhhhhccc
Confidence 9966 9999998765 799999999999999999999999999999999999999999 599999999987644
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=224.61 Aligned_cols=155 Identities=24% Similarity=0.393 Sum_probs=136.3
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
..|.+ ..|++.+.||+|+||.||+|++. ++.||+|+++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~--~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 13 SSWKL--SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CCCCc--hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 44544 67999999999999999999885 68899999976532 223456789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~------~~kl~Dfg 163 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG------HVKVTDFG 163 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC------CEEEeecc
Confidence 99999999999999999998754 688899999999999999999999999999999999999988 59999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
++..+..
T Consensus 164 ~~~~~~~ 170 (329)
T PTZ00263 164 FAKKVPD 170 (329)
T ss_pred CceEcCC
Confidence 9987643
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=228.17 Aligned_cols=148 Identities=20% Similarity=0.295 Sum_probs=131.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+.|++.++||+|+||.||++... ++.||||++..... .......+.+|+.+|+.++|+||+++++.+...+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 35899999999999999999875 68899999875432 2233466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~------~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG------HIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC------CEEEEeCCCCccc
Confidence 9999999999997754 688899999999999999999999999999999999999888 5899999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-26 Score=228.05 Aligned_cols=147 Identities=18% Similarity=0.289 Sum_probs=131.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|.+.++||+|+||.||++... ++.||+|++..... .......+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999875 57899999976432 23445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|..+
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g------~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG------HIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------CEEEeECCCCccc
Confidence 999999999997654 688899999999999999999999999999999999999988 5999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=228.08 Aligned_cols=153 Identities=22% Similarity=0.299 Sum_probs=134.7
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
.++....|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3556678999999999999999999886 57899999975432 22334568899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+|||||++|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~------~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG------HLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC------CEEEEecccc
Confidence 99999999999999999754 478899999999999999999999999999999999999988 5999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 190 ~~~~ 193 (370)
T cd05621 190 MKMD 193 (370)
T ss_pred eecc
Confidence 8753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=210.15 Aligned_cols=158 Identities=23% Similarity=0.385 Sum_probs=143.2
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|.-.++||+|.||+||+|+.. .+-||+|.++.+..++.......+|+.+|+.++|+|||++++.......+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 455679999999999999765 578999999987766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc--
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV-- 402 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~-- 402 (411)
..+|..|...-++.++......++.|+++||.|+|++++.||||||.|+||+.+| .+||+|||+|+.|..+
T Consensus 84 -dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng------elkladfglarafgipvr 156 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG------ELKLADFGLARAFGIPVR 156 (292)
T ss_pred -hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC------cEEecccchhhhcCCceE
Confidence 5699999998888899999999999999999999999999999999999999999 5999999999988554
Q ss_pred ----eeeEEEEcC
Q 015237 403 ----IFSCILVRA 411 (411)
Q Consensus 403 ----~~~~i~~ra 411 (411)
.+.++|||-
T Consensus 157 cysaevvtlwyrp 169 (292)
T KOG0662|consen 157 CYSAEVVTLWYRP 169 (292)
T ss_pred eeeceeeeeeccC
Confidence 488999983
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=225.23 Aligned_cols=155 Identities=23% Similarity=0.355 Sum_probs=137.2
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC---ceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS---QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~---~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+.+....|++.+.||+|+||.||+|.+.+ ..||+|.+..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 456778889999999999999999998753 5799999875432 223456788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~------~ikL~DFG 176 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG------FIKMTDFG 176 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC------CEEEecCC
Confidence 99999999999999999998764 688999999999999999999999999999999999999888 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 177 ~a~~~~ 182 (340)
T PTZ00426 177 FAKVVD 182 (340)
T ss_pred CCeecC
Confidence 997653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=222.26 Aligned_cols=148 Identities=22% Similarity=0.302 Sum_probs=132.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.++||+|+||.||+|.+. ++.||||+++..... ......+.+|+.++..++||||+++++++......|||||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5889999999999999999885 689999999865322 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~kL~Dfg~a~~~~ 152 (333)
T cd05600 82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG------HIKLTDFGLSKGIV 152 (333)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC------CEEEEeCcCCcccc
Confidence 999999999997654 688999999999999999999999999999999999999988 59999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=236.35 Aligned_cols=162 Identities=24% Similarity=0.450 Sum_probs=143.1
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.-|++++.+.+.++||+|.||.|..+...+ ..||+|.++.+. ....+++|..|+++|.+|+|||||+++|+|..++.+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 458899999999999999999999998876 899999998775 445678999999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~-l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
|++||||++|+|.+|+..+... +......+++.||+.||.||.+.++|||||.+.|||++.++ ++||+|||.+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~------~iKiadfgms 684 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF------TIKIADFGMS 684 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc------cEEecCcccc
Confidence 9999999999999999987432 24455678999999999999999999999999999999988 6999999999
Q ss_pred cccccceeeEE
Q 015237 397 STVILVIFSCI 407 (411)
Q Consensus 397 ~~~~~~~~~~i 407 (411)
+.+.+...-.+
T Consensus 685 R~lysg~yy~v 695 (807)
T KOG1094|consen 685 RNLYSGDYYRV 695 (807)
T ss_pred cccccCCceee
Confidence 97655443333
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=220.70 Aligned_cols=149 Identities=20% Similarity=0.331 Sum_probs=132.8
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+|++.+.||+|+||.||++... ++.||+|++..... .....+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5888999999999999999886 68999999975432 22345668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++..+..
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~------~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG------HIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC------CEEEEecCcchhccC
Confidence 999999999997754 688999999999999999999999999999999999999888 589999999886643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=215.07 Aligned_cols=152 Identities=29% Similarity=0.484 Sum_probs=135.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+|+...|++.+.||+|+||.||+|.+. +..||+|.++... .......+.+|+.++++++||||++++|++...+
T Consensus 1 ~i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CCchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 366778999999999999999999764 4689999987653 3344567999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..|+||||+++|+|.+++......+++..++.++.|++.||.|||+++++||||||+|||++.++ .++++|||.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~------~~~l~dfg~ 153 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL------VCKISGFRR 153 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC------cEEECCCcc
Confidence 99999999999999999987655789999999999999999999999999999999999999887 589999998
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 154 ~~~~ 157 (266)
T cd05064 154 LQED 157 (266)
T ss_pred cccc
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=221.82 Aligned_cols=150 Identities=19% Similarity=0.287 Sum_probs=133.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.+.||+|+||.||+++.. ++.||+|++..... .....+.+.+|+.++..++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36889999999999999999875 68899999975322 2234566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||++||+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++..+.
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~------~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG------HIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC------CEEEEECCceeecC
Confidence 99999999999987555789999999999999999999999999999999999999888 59999999987653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-27 Score=237.59 Aligned_cols=150 Identities=29% Similarity=0.540 Sum_probs=136.5
Q ss_pred CCCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 235 ~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...+.|||+.+.+.-++-||+|+-|.||+|++.++.||||.++.- -..+|.-|++|+|+|||.|.|+|+..
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC
Confidence 345789999999999999999999999999999999999987422 23578889999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+.+|||||||+.|-|+..|+..+ .+....+..|..+|+.||.|||.+.|||||||.-||||..+.+ +||+|||
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~------VKIsDFG 257 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV------VKISDFG 257 (904)
T ss_pred ceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce------EEecccc
Confidence 99999999999999999998765 7888899999999999999999999999999999999999884 8999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
-++...
T Consensus 258 TS~e~~ 263 (904)
T KOG4721|consen 258 TSKELS 263 (904)
T ss_pred chHhhh
Confidence 987753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=228.69 Aligned_cols=156 Identities=26% Similarity=0.496 Sum_probs=135.9
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g 309 (411)
..|+++..+|++.++||+|+||.||+|++. +..||+|+++.... ....+.+.+|+.+|+.+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 469999999999999999999999999752 35799999975432 23456789999999999 8999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------------------------------------------- 337 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------------------------------------------- 337 (411)
+|......++|||||++|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986532
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 338 ----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 338 ----------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~------~~kl~DfG~ 260 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR------ITKICDFGL 260 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC------cEEEecCcc
Confidence 1366778899999999999999999999999999999999877 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 261 a~~~~ 265 (375)
T cd05104 261 ARDIR 265 (375)
T ss_pred ceecc
Confidence 97654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=223.25 Aligned_cols=149 Identities=20% Similarity=0.287 Sum_probs=134.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+|++.+.||+|+||.||++... ++.||||+++...... .....+..|+.++..++||||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5889999999999999999986 7899999998654322 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~------~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG------HIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC------CEEeecCCCCccCcc
Confidence 99999999999876 4689999999999999999999999999999999999999988 599999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=220.51 Aligned_cols=149 Identities=19% Similarity=0.278 Sum_probs=134.3
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.+.||+|+||.||++... ++.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5889999999999999999875 68899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.+| .+||+|||++..+.
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~------~~kL~Dfg~a~~~~ 153 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG------HIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC------CEEeccCCCCeECC
Confidence 9999999999988755799999999999999999999999999999999999999988 59999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=216.24 Aligned_cols=148 Identities=25% Similarity=0.389 Sum_probs=130.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||+|... ++.||+|+++..... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 356899999999999999999875 688999998754321 22346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+. |+|.+++......++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~------~~kl~DfG~~~~~ 153 (288)
T cd07871 83 EYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG------ELKLADFGLARAK 153 (288)
T ss_pred eCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------CEEECcCcceeec
Confidence 9996 599999987665688999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=219.86 Aligned_cols=150 Identities=19% Similarity=0.258 Sum_probs=132.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.++||+|+||.||+++.. ++.||+|++..... .......+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999875 57899999875322 2233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||++||+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~------~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG------HIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC------CEEEEeccceeecc
Confidence 99999999999987555789999999999999999999999999999999999999888 58999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=242.70 Aligned_cols=159 Identities=26% Similarity=0.510 Sum_probs=142.6
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEE
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~ 308 (411)
....-+|+.+++++.++||+|.||+||+|...+ +.||||.++... +.+.+++|.+|+++|..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 345679999999999999999999999997642 469999997664 455789999999999999999999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhcCC---------C----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------G----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~---------~----l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NIL 375 (411)
|+|...+.+|+|+|||..|+|.+||..... . ++..+.+.|+.|||.||.||-++.+|||||.++|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 999999999999999999999999976421 2 777889999999999999999999999999999999
Q ss_pred EccCCCcCCCccEEEEeccccccccc
Q 015237 376 MNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 376 id~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+++- .+||+|||+++.+.+
T Consensus 636 Vge~l------~VKIsDfGLsRdiYs 655 (774)
T KOG1026|consen 636 VGENL------VVKISDFGLSRDIYS 655 (774)
T ss_pred eccce------EEEecccccchhhhh
Confidence 99987 599999999998755
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=224.34 Aligned_cols=155 Identities=21% Similarity=0.279 Sum_probs=136.6
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
..+++....|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 346777889999999999999999999886 58899999875432 223345688999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+|+||||+++|+|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~------~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG------HLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC------CEEEEeCC
Confidence 9999999999999999999764 478888999999999999999999999999999999999988 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 188 ~a~~~~ 193 (371)
T cd05622 188 TCMKMN 193 (371)
T ss_pred ceeEcC
Confidence 997653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=220.04 Aligned_cols=142 Identities=19% Similarity=0.310 Sum_probs=126.5
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+.||+|+||.||++... ++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999875 68899999986532 2334466889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~------~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG------HIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC------CEEEeeCCCCccc
Confidence 9999997654 689999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=239.81 Aligned_cols=153 Identities=33% Similarity=0.533 Sum_probs=142.8
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
-||+.+.+++.+.||.|.||+||+|+.+ + ..||||.++... .+..+.+|+.|+.||.++.||||+++-|+.+..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4899999999999999999999999885 3 579999997654 567788999999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+.||+|||++|+|..||+.+.+.++..++.-+.+.|+.||+||-++|+|||||.++|||++.+-+ ||++|||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv------CKVsDFG 776 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV------CKVSDFG 776 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE------EEecccc
Confidence 9999999999999999999999888999999999999999999999999999999999999999874 9999999
Q ss_pred ccccc
Q 015237 395 SISTV 399 (411)
Q Consensus 395 la~~~ 399 (411)
+++.+
T Consensus 777 LSRvl 781 (996)
T KOG0196|consen 777 LSRVL 781 (996)
T ss_pred ceeec
Confidence 99855
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=221.68 Aligned_cols=148 Identities=21% Similarity=0.297 Sum_probs=132.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.+.||+|+||.||++... ++.||+|+++.... .......+.+|+.++..++||||+++++.+.....+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5888999999999999999875 68899999975432 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+| .++|+|||++..+.
T Consensus 82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~------~vkL~DfG~~~~~~ 152 (360)
T cd05627 82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG------HVKLSDFGLCTGLK 152 (360)
T ss_pred CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC------CEEEeeccCCcccc
Confidence 999999999997654 689999999999999999999999999999999999999988 58999999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=225.85 Aligned_cols=158 Identities=27% Similarity=0.525 Sum_probs=137.3
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
.+.|.++..+|++.+.||+|+||.||++++. ++.||+|+++.... ......+.+|+.+++.+ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 4679999999999999999999999998763 24799999976542 33456788999999999 899999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhcC---------------------------------------------------
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK--------------------------------------------------- 337 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~~--------------------------------------------------- 337 (411)
++|...+..|+|||||++|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999986431
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 338 ------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 338 ------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
..+++..+..++.||+.||.|||++||+||||||+|||+++++ .+||+|||++..+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~------~~kL~DfGla~~~ 262 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR------VAKICDFGLARDI 262 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC------eEEEeeceeeeec
Confidence 1367778899999999999999999999999999999999877 5999999999765
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 263 ~~ 264 (374)
T cd05106 263 MN 264 (374)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=223.84 Aligned_cols=155 Identities=21% Similarity=0.281 Sum_probs=136.1
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
..+++....|++.++||+|+||.||++... ++.||+|+++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345677888999999999999999999875 688999999754322 22345578899999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~------~~kL~DfG 187 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG------HLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC------CEEEEecc
Confidence 9999999999999999999754 478889999999999999999999999999999999999988 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 188 ~~~~~~ 193 (370)
T cd05596 188 TCMKMD 193 (370)
T ss_pred ceeecc
Confidence 987653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=226.16 Aligned_cols=156 Identities=29% Similarity=0.554 Sum_probs=136.4
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIG 309 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g 309 (411)
..|+++...|.++++||+|+||.||+|++.+ ..||||+++... .....+.+.+|+.+|+.+. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5799999999999999999999999998642 369999997543 3344577999999999996 999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------------------------------------------- 337 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------------------------------------------- 337 (411)
+|...+.+|||||||++|+|.+++....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999986531
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 015237 338 -------------------------------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374 (411)
Q Consensus 338 -------------------------------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NI 374 (411)
..+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1366777889999999999999999999999999999
Q ss_pred EEccCCCcCCCccEEEEecccccccc
Q 015237 375 LMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 375 Lid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|++.++ .+||+|||++..+.
T Consensus 269 ll~~~~------~~kL~DfGla~~~~ 288 (400)
T cd05105 269 LLAQGK------IVKICDFGLARDIM 288 (400)
T ss_pred EEeCCC------EEEEEeCCcceecc
Confidence 999887 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=215.74 Aligned_cols=148 Identities=26% Similarity=0.411 Sum_probs=130.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||+|+.. ++.||+|+++..... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 356899999999999999999885 688999998754322 12345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+ +++|.+++......++...+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~------~~kl~Dfg~~~~~ 153 (303)
T cd07869 83 EYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG------ELKLADFGLARAK 153 (303)
T ss_pred ECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------CEEECCCCcceec
Confidence 999 5789998887666789999999999999999999999999999999999999888 5999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=222.32 Aligned_cols=143 Identities=26% Similarity=0.393 Sum_probs=120.6
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-----CeEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRLFI 319 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~l~I 319 (411)
|.-.+.+|+|+||.||+|... ++.||||....+.. .-.+|++||+.+.|||||++.-+|... -++.+
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 666789999999999999876 58999999876542 334799999999999999998887532 24678
Q ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 320 VTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
|||||+. +|.++++.. +..++.-.++-++.||++||.|||+.||+||||||.|+|+|.+.- .+||||||+|
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-----~LKicDFGSA 173 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-----VLKICDFGSA 173 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-----eEEeccCCcc
Confidence 9999965 999998742 335777888999999999999999999999999999999998732 5999999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
+.+..
T Consensus 174 K~L~~ 178 (364)
T KOG0658|consen 174 KVLVK 178 (364)
T ss_pred eeecc
Confidence 99843
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=226.57 Aligned_cols=152 Identities=28% Similarity=0.396 Sum_probs=128.4
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHH------------HHHHHHHHHHHHhhcCCCceeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN------------IRREFAQEVHIMRKVRHMNVVQF 307 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~------------~~~~~~~Ei~iL~~l~HpNIV~l 307 (411)
...++|++++.||+|+||.|-+++.. ++.||||++.+.....+ -.+...+||.||++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45577999999999999999999875 68999999976543211 12478999999999999999999
Q ss_pred EeeeecC--CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCC
Q 015237 308 IGACTRP--PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 308 ~g~~~~~--~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~ 385 (411)
+.+..++ ..+|||+|||..|.+...- .....+.+.+++.+++++..||+|||.+|||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g----- 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG----- 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-----
Confidence 9998764 5799999999888874322 2222388999999999999999999999999999999999999999
Q ss_pred ccEEEEecccccccc
Q 015237 386 IHCYLSNFLSISTVI 400 (411)
Q Consensus 386 ~~ikL~DFGla~~~~ 400 (411)
.+||+|||.+..+.
T Consensus 248 -~VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 248 -TVKISDFGVSNEFP 261 (576)
T ss_pred -cEEeeccceeeecc
Confidence 59999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=212.22 Aligned_cols=147 Identities=21% Similarity=0.278 Sum_probs=129.2
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
|+..+.||+|+||.||++... ++.||+|.+...... ......+.+|+.+++.++|+||+++++++...+.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 678899999999999999874 789999998765432 22335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .++|+|||++..+
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~------~~kl~Dfg~~~~~ 152 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG------HIRISDLGLAVQI 152 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC------CEEEeeCCCcEEc
Confidence 99999998886543 3588999999999999999999999999999999999999887 5899999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=217.44 Aligned_cols=148 Identities=20% Similarity=0.286 Sum_probs=131.3
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+|++.++||+|+||.||++.+. ++.||+|++..... .......+..|+.++..++|+||+++++++.....+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5889999999999999999886 57899999865322 22334558889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++..+
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~------~~kL~DfG~a~~~ 152 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG------HIRLADFGSCLKL 152 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC------CEEEeecchheec
Confidence 9999999999987655789999999999999999999999999999999999999888 5899999998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=236.22 Aligned_cols=156 Identities=25% Similarity=0.471 Sum_probs=137.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-C-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeee-ec
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-S-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGAC-TR 313 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~-~~ 313 (411)
...+|....+++.+.|++|+|+.||.+... + .+||+|.+-.. ++...+.+.+||.+|++|+ |+|||.|++.. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 467899999999999999999999999886 3 79999998665 6677889999999999996 99999999943 21
Q ss_pred ---C---CeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCC
Q 015237 314 ---P---PRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 314 ---~---~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~ 384 (411)
. -.++|.||||+||+|-|+|..+ ...|++..+++|+.|+|+|+.+||... |||||||.+||||+.+|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---- 183 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---- 183 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC----
Confidence 1 2478999999999999999865 235999999999999999999999988 99999999999999999
Q ss_pred CccEEEEeccccccccc
Q 015237 385 DIHCYLSNFLSISTVIL 401 (411)
Q Consensus 385 ~~~ikL~DFGla~~~~~ 401 (411)
.+||||||+|.+..-
T Consensus 184 --~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 184 --NYKLCDFGSATTKIL 198 (738)
T ss_pred --CEEeCcccccccccC
Confidence 699999999998644
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=218.50 Aligned_cols=142 Identities=19% Similarity=0.319 Sum_probs=126.1
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+.||+|+||.||++... ++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999875 68999999986532 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC------CEEecccHHhccc
Confidence 9999887654 689999999999999999999999999999999999999988 5999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=216.67 Aligned_cols=143 Identities=26% Similarity=0.355 Sum_probs=127.0
Q ss_pred EEEeecCceEEEEEEE-----CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 251 HKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
+.||+|+||.||++.. .++.||+|+++...........+.+|+.+|++++||||+++++++...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998865 36889999998654433445667889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC------cEEEeeccCCcccC
Confidence 999999997654 689999999999999999999999999999999999999988 58999999987653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-25 Score=206.99 Aligned_cols=149 Identities=36% Similarity=0.601 Sum_probs=132.8
Q ss_pred cCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+.+.|++.+.||+|+||.||++.+.. ..+|+|.+...... ...+.+|+.+|+.++||||+++++++......|++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 45678999999999999999998864 58999998755433 356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||.+..+.
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~------~~kl~d~g~~~~~~ 151 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG------VVKVSDFGMTRYVL 151 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC------eEEECCCCCccccC
Confidence 99999999999986555688999999999999999999999999999999999999887 58999999887653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=215.71 Aligned_cols=147 Identities=19% Similarity=0.310 Sum_probs=129.3
Q ss_pred ceEEEEEEeecCceEEEEEEE-----CCceEEEEEeecccc--CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
+|++.++||+|+||.||++.. .++.||+|+++.... .....+.+..|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 378899999999999999875 357899999975432 123345688899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~------~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG------HVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC------CEEEeeCcCCc
Confidence 99999999999999997654 689999999999999999999999999999999999999988 59999999997
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 154 ~~ 155 (332)
T cd05614 154 EF 155 (332)
T ss_pred cc
Confidence 65
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-25 Score=207.85 Aligned_cols=152 Identities=36% Similarity=0.659 Sum_probs=137.2
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
||++...|++.+.||+|+||.||+|.+. ++.||+|.++..... .+.+.+|+.++++++||||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 7899999999999999999999999875 478999998765432 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++++|.+++.... ..+++..+..++.|++.|+.|||++||+|+||||+||+++.++ .++|+|||++.
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~~l~dfg~~~ 151 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN------ICKVADFGLAR 151 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC------CEEECCcceEE
Confidence 9999999999999997653 3588999999999999999999999999999999999999988 58999999988
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 152 ~~~ 154 (261)
T cd05068 152 VIK 154 (261)
T ss_pred Ecc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=215.05 Aligned_cols=146 Identities=21% Similarity=0.332 Sum_probs=126.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-----CeEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRLF 318 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~l~ 318 (411)
+|++.++||+|+||.||+|... ++.||||.+............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999875 68999999875433333345688999999999999999999988543 2489
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||| +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 81 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~------~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC------KLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC------cEEEccCccccc
Confidence 999999 579999987654 689999999999999999999999999999999999999988 599999999976
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
.
T Consensus 153 ~ 153 (338)
T cd07859 153 A 153 (338)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=217.09 Aligned_cols=142 Identities=20% Similarity=0.329 Sum_probs=126.5
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+.||+|+||.||++... ++.||+|++..... .......+.+|+.+|+.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999875 68999999986532 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~------~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG------HIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC------cEEEecCcCCccC
Confidence 9999987654 688999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=207.43 Aligned_cols=146 Identities=37% Similarity=0.653 Sum_probs=128.9
Q ss_pred eEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+++.+.||.|+||.||+|.+. +..|+||.++.. ......+.+.+|++++++++||||++++|+|...+.+++|
T Consensus 1 ~~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 1 IKLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred CEEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccc
Confidence 367889999999999999998 578999999653 3444578899999999999999999999999988889999
Q ss_pred EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 321 TEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||+++|+|.++|... ...+++..+..++.||+.||.|||+++++|+||+++||+++.++ .+||+|||++...
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~------~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG------QVKLSDFGLSRPI 153 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT------EEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccc
Confidence 9999999999999987 45789999999999999999999999999999999999999988 6999999999877
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=215.20 Aligned_cols=140 Identities=22% Similarity=0.345 Sum_probs=125.1
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||+|+||.||++++. ++.||+|+++.... .......+.+|+.++++++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999885 57899999976432 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 330 ~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~------~~kl~Dfg~~~~~ 143 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG------HIALCDFGLCKLN 143 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC------cEEEEECcccccC
Confidence 99997654 689999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=205.68 Aligned_cols=152 Identities=35% Similarity=0.579 Sum_probs=138.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
|.++...|++.+.||+|+||.||++...++.||+|.++.... ..+.+.+|+.+++.++|+||+++++++......|+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 667888999999999999999999999999999999976532 45778999999999999999999999998889999
Q ss_pred EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||||+++++|.+++..... .+++..+..++.|++.|+.|||+++++|+||||+||+++.++ .++|+|||.+..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~------~~~l~d~g~~~~ 151 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL------VAKVSDFGLAKE 151 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC------CEEEcccccccc
Confidence 9999999999999976542 589999999999999999999999999999999999999888 489999999887
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 152 ~~ 153 (256)
T cd05039 152 AS 153 (256)
T ss_pred cc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=213.94 Aligned_cols=151 Identities=27% Similarity=0.493 Sum_probs=131.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--Cc----eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+...+|+..+.||+|+||.||+|++. ++ .||+|.++... .....+.+.+|+.+++.++||||++++|+|...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 45677999999999999999999874 33 48999987543 334557799999999999999999999999865
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..++++||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~------~~kl~DfG~ 155 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ------HVKITDFGL 155 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC------cEEEccccc
Confidence 57899999999999999987666788999999999999999999999999999999999999887 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 156 a~~~~ 160 (316)
T cd05108 156 AKLLG 160 (316)
T ss_pred ccccc
Confidence 98654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=218.30 Aligned_cols=164 Identities=21% Similarity=0.361 Sum_probs=139.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-CCeE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRL 317 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~~~l 317 (411)
..|+..++||+|+||.||++... .+.+|||.++.+...........+|+.+++.++||||+.+..++.. ...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45778889999999999999543 2479999998874444455678899999999999999999998876 7789
Q ss_pred EEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 318 FIVTEFMSGGSIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
|+++||.+. +|++.++.+. ..++...+..++.||+.|+.|||++-|+||||||+|||+..+|.... .+||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG--~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERG--RVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccC--eeEeecc
Confidence 999999966 9999987643 25788899999999999999999999999999999999998854333 4899999
Q ss_pred cccccc---------ccceeeEEEEcC
Q 015237 394 LSISTV---------ILVIFSCILVRA 411 (411)
Q Consensus 394 Gla~~~---------~~~~~~~i~~ra 411 (411)
|+++.+ .++++.+|||||
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRA 207 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRA 207 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecC
Confidence 999998 457899999998
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=222.54 Aligned_cols=157 Identities=28% Similarity=0.522 Sum_probs=136.2
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~ 308 (411)
...|+++.++|.+.++||+|+||.||+|++.+ +.||+|+++.... ....+.+.+|+.+|..+. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 34699999999999999999999999998642 5799999976532 333457889999999997 99999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhcCC--------------------------------------------------
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKC-------------------------------------------------- 338 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~-------------------------------------------------- 338 (411)
++|.....+++|||||++|+|.++++..+.
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 999999999999999999999999975321
Q ss_pred -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 015237 339 -----------------------------------------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (411)
Q Consensus 339 -----------------------------------------------~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp 371 (411)
.+++..+..++.|++.||.|||+++|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 245667788999999999999999999999999
Q ss_pred CcEEEccCCCcCCCccEEEEecccccccc
Q 015237 372 ANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 372 ~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+|||+++++ .+||+|||++..+.
T Consensus 268 ~NiLl~~~~------~~kL~DfGla~~~~ 290 (401)
T cd05107 268 RNVLICEGK------LVKICDFGLARDIM 290 (401)
T ss_pred ceEEEeCCC------EEEEEecCcceecc
Confidence 999999877 58999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=226.81 Aligned_cols=158 Identities=26% Similarity=0.383 Sum_probs=138.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-C-----CceeEEEeeeecCCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-H-----MNVVQFIGACTRPPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pNIV~l~g~~~~~~~ 316 (411)
.+|.+.+.||+|+||.|.+|.+. ++.||||+++... ........|+.||..++ | -|+|+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 37889999999999999999885 6899999998763 34456778999999997 4 389999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+|||+|.+ ..+|+++|+.++. +++...+..|+.||+.||.+||+.+|||+||||+|||+..-+. ..+|++|||+
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r----~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR----SRIKVIDFGS 337 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc----CceeEEeccc
Confidence 99999999 6699999998743 6899999999999999999999999999999999999977663 2699999999
Q ss_pred ccccccceeeEEEEc
Q 015237 396 ISTVILVIFSCILVR 410 (411)
Q Consensus 396 a~~~~~~~~~~i~~r 410 (411)
|......+...|++|
T Consensus 338 Sc~~~q~vytYiQSR 352 (586)
T KOG0667|consen 338 SCFESQRVYTYIQSR 352 (586)
T ss_pred ccccCCcceeeeecc
Confidence 999888877777765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=210.45 Aligned_cols=148 Identities=22% Similarity=0.344 Sum_probs=130.0
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|++.+.||+|+||.||++++. ++.||+|+++.........+.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5889999999999999999986 57899999986654444556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
++++.+..+. .....+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++..+.
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~------~~kl~Dfg~~~~~~ 151 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND------VLKLCDFGFARNLS 151 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------cEEEeeccCccccc
Confidence 9886665444 4444689999999999999999999999999999999999999888 58999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=206.28 Aligned_cols=153 Identities=30% Similarity=0.590 Sum_probs=137.1
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+|+.+.|++.++||+|+||.||+|.+. ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 8899999999999999999999999876 47799999875432 2467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++.
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~------~~~l~dfg~~~ 151 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL------MCKIADFGLAR 151 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC------cEEECCCccce
Confidence 999999999999999764 33578888999999999999999999999999999999999888 58999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 152 ~~~~ 155 (261)
T cd05072 152 VIED 155 (261)
T ss_pred ecCC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=214.35 Aligned_cols=142 Identities=20% Similarity=0.320 Sum_probs=125.5
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+.||+|+||.||++... ++.||+|+++.... .......+..|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999874 68999999986543 2234566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.+| .+||+|||++...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~------~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG------HIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC------CEEEecCCCCeec
Confidence 9999887654 68999999999999999999997 7999999999999999988 5999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=213.46 Aligned_cols=152 Identities=26% Similarity=0.382 Sum_probs=135.5
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
++..++|++.++||+|+||.||++.+. +..||+|++.... .....+.+.+|+.+|++++||||+++++++...+.++
T Consensus 1 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 356678999999999999999999886 6789999987653 3445678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg~~~ 152 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG------EIKLCDFGVSG 152 (331)
T ss_pred EEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC------cEEEccCcccc
Confidence 9999999999999997654 588999999999999999999986 599999999999999988 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 153 ~~~ 155 (331)
T cd06649 153 QLI 155 (331)
T ss_pred ccc
Confidence 654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=205.90 Aligned_cols=151 Identities=30% Similarity=0.513 Sum_probs=135.1
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
+..+|++.+.||+|+||.||+|.+. ...||||.++... .......+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4567999999999999999999874 2479999987553 344556789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|++|||+++++|.+++......+++..+..++.|++.|+.|||+++|+|+||||+|||+++++ .++|+|||++.
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~------~~~l~dfg~~~ 154 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL------VCKVSDFGLSR 154 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC------CEEECccchhh
Confidence 999999999999999987666789999999999999999999999999999999999999887 58999999998
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 155 ~~~ 157 (266)
T cd05033 155 RLE 157 (266)
T ss_pred ccc
Confidence 774
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=205.60 Aligned_cols=150 Identities=33% Similarity=0.565 Sum_probs=133.6
Q ss_pred cCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+...|++.+.||+|+||.||.|.+.+ ..+|+|.++..... ...+.+|+.++++++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45678999999999999999998875 46999998765433 356889999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+.+|+|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.+..+..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~------~~kl~d~g~~~~~~~ 152 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG------CVKVSDFGLSRYVLD 152 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC------CEEECCCccceecCC
Confidence 99999999999987655689999999999999999999999999999999999999887 599999999886543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=213.21 Aligned_cols=147 Identities=21% Similarity=0.317 Sum_probs=128.4
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCC-ceeEEEeeeecCCeEEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHM-NVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~Hp-NIV~l~g~~~~~~~l~IV~ 321 (411)
+|++.+.||+|+||.||+|... ++.||+|+++.... .....+.+..|..++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999886 47899999986532 223456788899999999765 5888999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~------~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG------HIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC------CEEEeecCcceec
Confidence 9999999999997654 688999999999999999999999999999999999999988 5899999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=230.98 Aligned_cols=148 Identities=26% Similarity=0.398 Sum_probs=134.9
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeecc-ccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNE-HLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~-~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+++++.||.|+.|.|-.|++. |+.+|||++.+. .........+.+||-||+.+.|||++++|++++.+.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 566889999999999999885 899999999876 34444556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
++||.|++||-..+ .+++..+.+++.||+.|+.|||..+|+||||||+|+|+|.++ ++||+|||.|..-.+
T Consensus 94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~------nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN------NIKIADFGMASLEVP 164 (786)
T ss_pred cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc------CEeeeccceeecccC
Confidence 99999999998765 799999999999999999999999999999999999999998 699999999987544
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=215.02 Aligned_cols=142 Identities=25% Similarity=0.382 Sum_probs=124.6
Q ss_pred EEEeecCceEEEEEEE-----CCceEEEEEeecccc--CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 251 HKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
++||+|+||.||+++. .++.||+|+++.... .......+..|+.+|+.++||||+++++++...+.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 357899999976432 123345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++|+|.+++...+ .+.+..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG------HVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC------CEEEeeCcCCeec
Confidence 99999999997654 578888899999999999999999999999999999999988 5999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=214.60 Aligned_cols=152 Identities=27% Similarity=0.399 Sum_probs=134.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+..+.|++.++||+|+||.||++.+. +..+|+|++.... .......+.+|+++++.++||||++++++|...+.+|
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 456788999999999999999999886 5789999987653 3344567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.+| .+||+|||++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~------~~kL~Dfg~~~ 152 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG------EIKLCDFGVSG 152 (333)
T ss_pred EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC------CEEEeeCCcch
Confidence 9999999999999997654 588899999999999999999985 799999999999999888 48999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 153 ~~~ 155 (333)
T cd06650 153 QLI 155 (333)
T ss_pred hhh
Confidence 653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=214.38 Aligned_cols=145 Identities=23% Similarity=0.345 Sum_probs=125.5
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHH---hhcCCCceeEEEeeeecCCeEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIM---RKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL---~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
|++.+.||+|+||.||++.+. ++.||||+++.... .....+.+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 578899999999999999875 68899999986532 223345677776665 466799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||+++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~------~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG------FVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC------cEEeCcccCCccC
Confidence 9999999999888643 589999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=208.43 Aligned_cols=154 Identities=23% Similarity=0.449 Sum_probs=133.0
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
|+++..+|++.++||+|+||.||+|... +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 8999999999999999999999999753 2479999886543 2233456889999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~---------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
.+...|+||||+++|+|.+++.... ..+....+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--- 156 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--- 156 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC---
Confidence 9899999999999999999997532 1245667889999999999999999999999999999999887
Q ss_pred CCccEEEEecccccccc
Q 015237 384 SDIHCYLSNFLSISTVI 400 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~ 400 (411)
.++|+|||++..+.
T Consensus 157 ---~~~L~Dfg~~~~~~ 170 (288)
T cd05061 157 ---TVKIGDFGMTRDIY 170 (288)
T ss_pred ---cEEECcCCcccccc
Confidence 58999999987543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=206.53 Aligned_cols=154 Identities=25% Similarity=0.466 Sum_probs=133.7
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
|++..++|++.++||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 88889999999999999999999997642 469999986533 2334567899999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKC---------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~---------~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
.....++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++++|+||||+||++++++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--- 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--- 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC---
Confidence 88899999999999999999976321 246678889999999999999999999999999999999887
Q ss_pred CCccEEEEecccccccc
Q 015237 384 SDIHCYLSNFLSISTVI 400 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~ 400 (411)
.++|+|||++..+.
T Consensus 157 ---~~~l~dfg~~~~~~ 170 (277)
T cd05062 157 ---TVKIGDFGMTRDIY 170 (277)
T ss_pred ---CEEECCCCCccccC
Confidence 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=209.43 Aligned_cols=154 Identities=22% Similarity=0.312 Sum_probs=133.0
Q ss_pred ceeecCCceEEE--EEEeecCceEEEEEEECCceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeec--
Q 015237 239 VWEIDASLLKFE--HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (411)
Q Consensus 239 ~~ei~~~~~~~~--~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-- 313 (411)
.+.|+.++++.. ..||+|++|.||+|.+.++.||||.++..... ....+.+.+|+.+|++++||||++++|++..
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 445566666655 68999999999999999999999999765432 2335678899999999999999999999876
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 314 --PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 314 --~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
...+++||||+++|+|.+++.... .+++.....++.|++.||.|||+ .+++||||||+|||+++++ .+||
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~------~~kl 164 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY------KLKI 164 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC------cEEE
Confidence 457899999999999999998754 68889999999999999999998 4899999999999999988 5899
Q ss_pred Eeccccccc
Q 015237 391 SNFLSISTV 399 (411)
Q Consensus 391 ~DFGla~~~ 399 (411)
+|||++..+
T Consensus 165 ~dfg~~~~~ 173 (283)
T PHA02988 165 ICHGLEKIL 173 (283)
T ss_pred cccchHhhh
Confidence 999998854
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=225.06 Aligned_cols=152 Identities=28% Similarity=0.480 Sum_probs=139.8
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
....|.+.++||+|.|+.|..+++. +..||||++.+...+...++.+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3456889999999999999999885 78999999999888877777799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+.+|.+++|+.+++ .+.+..+..++.|+..+++|||+++|+|||||++|||++.+. ++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m------nikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM------NIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc------ceeeeccccceeec
Confidence 99999999999999886 455688999999999999999999999999999999999998 59999999999885
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 207 ~ 207 (596)
T KOG0586|consen 207 Y 207 (596)
T ss_pred c
Confidence 4
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=205.57 Aligned_cols=153 Identities=35% Similarity=0.653 Sum_probs=137.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
|+++...+.+.++||+|+||.||+|.+. ++.||+|+++.... ....+.+|+.+++.++|+||+++++++.....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 8899999999999999999999999885 68899999875432 246788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++++||||||+||++++++ .+||+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~------~~kl~df~~~ 151 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH------LVKVADFGLS 151 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC------cEEeCCCccc
Confidence 99999999999999997643 3588889999999999999999999999999999999999888 5899999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
.....
T Consensus 152 ~~~~~ 156 (263)
T cd05052 152 RLMTG 156 (263)
T ss_pred ccccc
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=214.16 Aligned_cols=141 Identities=28% Similarity=0.398 Sum_probs=125.6
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++.+. ++.||+|+++..... ......+..|..++..+ +||||+++++++.....+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999885 688999999875433 23456688999999998 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~------~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG------HIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC------CEEECcCccccc
Confidence 99999987654 689999999999999999999999999999999999999988 599999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=202.70 Aligned_cols=152 Identities=37% Similarity=0.666 Sum_probs=137.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+++.++|.+.++||+|+||.||++... ++.||||.+...... .+.+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 8899999999999999999999999876 478999998865443 356889999999999999999999999888899
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++++|.+++.... ..+++..+..++.|++.|+.|||+++++|+||||+||+++.++ .++|+|||++.
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~------~~~l~d~g~~~ 151 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL------VCKIADFGLAR 151 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC------CEEECccccce
Confidence 9999999999999997653 3688999999999999999999999999999999999999987 58999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 152 ~~~ 154 (261)
T cd05034 152 LIE 154 (261)
T ss_pred ecc
Confidence 664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=204.97 Aligned_cols=152 Identities=33% Similarity=0.502 Sum_probs=134.0
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
+..+|++.+.||+|+||.||+|.+. + ..+|+|.++... .....+.+..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4567899999999999999999863 2 369999987543 234456889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|++|||+++++|.+++......+++..+..++.|++.|+.|||+++++||||||+|||++.++ .++|+|||.+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~------~~~l~dfg~~~ 154 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL------VCKVSDFGLSR 154 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC------eEEeCCCCccc
Confidence 999999999999999987665789999999999999999999999999999999999999887 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd05066 155 VLED 158 (267)
T ss_pred cccc
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=218.09 Aligned_cols=154 Identities=22% Similarity=0.276 Sum_probs=140.7
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC--ceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
-.+..+++++.++||.|.-|.||.+...+ ..+|+|++.++.+. .+...+...|-.||+.++||.++.+|..|+....
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 46777889999999999999999999875 78999999887654 3455678889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.|++||||+||+|..+++++.+ .+++..+..++.+|+.||+|||..|||+|||||+||||-++| .+.|+||-+
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG------HIMLsDFDL 225 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG------HIMLSDFDL 225 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC------cEEeeeccc
Confidence 9999999999999999998844 699999999999999999999999999999999999999999 799999999
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 226 S~~~ 229 (459)
T KOG0610|consen 226 SLRC 229 (459)
T ss_pred cccC
Confidence 9876
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=228.52 Aligned_cols=152 Identities=25% Similarity=0.385 Sum_probs=135.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.+...++.+++.||.|+||.|+.+.++ ++.+|||+++++.. ..+..+....|.+|+... +||.+++++.+|.+..+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 566788999999999999999999886 57899999998764 445667788899998877 59999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||+.||++..+.+. ..++++.+..++..|+.||.|||++|||+||||.+|||+|.+| .+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG------h~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG------HVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC------cEEecccccc
Confidence 9999999999995544433 4699999999999999999999999999999999999999999 6999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
+.-.
T Consensus 516 Ke~m 519 (694)
T KOG0694|consen 516 KEGM 519 (694)
T ss_pred cccC
Confidence 9876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=238.29 Aligned_cols=155 Identities=30% Similarity=0.529 Sum_probs=139.7
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
..++++...++...||+|.||.||+|.+.+ ..||||.++... +.+...+|.+|..+|++++|||||+++|+|
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 346789999999999999999999999863 238999886553 456678899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCC
Q 015237 312 TRPPRLFIVTEFMSGGSIYDYLHKQ------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 312 ~~~~~l~IV~E~~~gGsL~~~L~~~------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~ 385 (411)
......+|++|||+||+|..||++. ...++...++.++.|||+||+||+++++|||||.++|+|+++..
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r----- 839 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR----- 839 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-----
Confidence 9999999999999999999999987 55789999999999999999999999999999999999999986
Q ss_pred ccEEEEecccccccc
Q 015237 386 IHCYLSNFLSISTVI 400 (411)
Q Consensus 386 ~~ikL~DFGla~~~~ 400 (411)
.+|++|||+|+.+.
T Consensus 840 -~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 840 -VVKIADFGLARDIY 853 (1025)
T ss_pred -cEEEcccchhHhhh
Confidence 48999999999553
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=202.98 Aligned_cols=145 Identities=35% Similarity=0.616 Sum_probs=130.6
Q ss_pred eEEEEEEeecCceEEEEEEECC--ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|++.+.||+|+||.||++...+ +.||+|++..............+|+.+++.++||||+++++++.....++++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6889999999999999999974 67999999887655444455667999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++++|.+++.... .++...+..++.|++.||.|||+++|+|+||||+||++++++ .++|+|||.+..
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~------~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG------EVKLIDFGSSVK 147 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS------EEEESSGTTTEE
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc------cccccccccccc
Confidence 9999999998443 689999999999999999999999999999999999999888 589999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=204.06 Aligned_cols=154 Identities=25% Similarity=0.463 Sum_probs=135.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
|+++.++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 78999999999999999999999998752 579999986543 2334567889999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~---------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
.....|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~--- 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL--- 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC---
Confidence 9999999999999999999997532 2367788999999999999999999999999999999999988
Q ss_pred CCccEEEEecccccccc
Q 015237 384 SDIHCYLSNFLSISTVI 400 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~ 400 (411)
.+||+|||++..+.
T Consensus 157 ---~~kl~dfg~~~~~~ 170 (277)
T cd05032 157 ---TVKIGDFGMTRDIY 170 (277)
T ss_pred ---CEEECCcccchhhc
Confidence 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=208.57 Aligned_cols=156 Identities=26% Similarity=0.524 Sum_probs=136.5
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC---------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 307 (411)
..|++..+.|.+.+.||+|+||.||++.+.+ ..+|+|.++... .......+..|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4689999999999999999999999997632 459999997653 233456788899999999 79999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
++++......|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 24788889999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEecccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++.++ .+||+|||++..+.
T Consensus 170 Nill~~~~------~~kL~dfg~a~~~~ 191 (307)
T cd05098 170 NVLVTEDN------VMKIADFGLARDIH 191 (307)
T ss_pred heEEcCCC------cEEECCCccccccc
Confidence 99999888 58999999987553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=202.71 Aligned_cols=151 Identities=34% Similarity=0.577 Sum_probs=134.4
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee-cCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~-~~~~l~ 318 (411)
|-++...|++.+.||+|+||.||++...+..||+|.++... ..+.+.+|+.+++.++|+|++++++++. .....+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 67888899999999999999999999999999999986542 2357889999999999999999999764 456789
Q ss_pred EEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~------~~kl~dfg~~~ 150 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN------VAKVSDFGLTK 150 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC------cEEecCCccce
Confidence 99999999999999987543 478899999999999999999999999999999999999988 58999999988
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 151 ~~~ 153 (256)
T cd05082 151 EAS 153 (256)
T ss_pred ecc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=203.98 Aligned_cols=149 Identities=37% Similarity=0.592 Sum_probs=132.3
Q ss_pred cCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+..++++.+.||+|+||.||++.+.+ ..+|+|++....... ..+.+|+.+++.++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45568899999999999999998864 579999987544332 46788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++++|.+++......+++..++.++.|++.|+.|||++||+||||||+||+++.++ .+||+|||.+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~------~~kl~dfg~~~~~~ 151 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN------VVKVSDFGLARYVL 151 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC------cEEECCcccceecc
Confidence 99999999999987655789999999999999999999999999999999999999988 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=215.83 Aligned_cols=147 Identities=31% Similarity=0.452 Sum_probs=128.0
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
.....|++.++||+|+||.||++++. ++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 34566788899999999999999885 6899999986543 34456779999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||+.+|+|.+.. ...+..+..++.||+.||.|||++||+||||||+|||+++++ .+||+|||++..+
T Consensus 150 v~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~------~~kL~DfG~~~~~ 218 (353)
T PLN00034 150 LLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK------NVKIADFGVSRIL 218 (353)
T ss_pred EEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC------CEEEcccccceec
Confidence 99999999986432 356677889999999999999999999999999999999988 5899999998765
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 219 ~ 219 (353)
T PLN00034 219 A 219 (353)
T ss_pred c
Confidence 4
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-24 Score=205.81 Aligned_cols=148 Identities=22% Similarity=0.289 Sum_probs=129.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.++||+|+||.||++... ++.||+|++....... .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999875 6889999997654322 233557889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++ .++|+|||++..+
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~~l~Dfg~~~~~ 152 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG------HIRISDLGLAVEI 152 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC------CEEEeeCCCceec
Confidence 999999998886543 3589999999999999999999999999999999999999887 5999999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=205.19 Aligned_cols=152 Identities=28% Similarity=0.485 Sum_probs=131.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
++.+.+++.++||+|+||.||+|.+ .+..|++|.++... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4567799999999999999999985 24679999987543 3344567899999999999999999999999989
Q ss_pred eEEEEEecCCCCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQK----------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~----------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~ 379 (411)
..|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999986432 236778889999999999999999999999999999999987
Q ss_pred CCcCCCccEEEEecccccccc
Q 015237 380 GVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 380 g~~k~~~~ikL~DFGla~~~~ 400 (411)
+ .+||+|||++..+.
T Consensus 161 ~------~~kl~dfg~~~~~~ 175 (283)
T cd05090 161 L------HVKISDLGLSREIY 175 (283)
T ss_pred C------cEEecccccccccc
Confidence 7 58999999997653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-24 Score=204.34 Aligned_cols=149 Identities=28% Similarity=0.487 Sum_probs=130.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CC
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PP 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~ 315 (411)
..+|++.+.||+|+||.||++.+. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 357889999999999999999752 578999998654 33445778999999999999999999998754 34
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~------~~~l~dfg~ 154 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN------RVKIGDFGL 154 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC------eEEECCCcc
Confidence 68999999999999999987655689999999999999999999999999999999999999887 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 155 ~~~~~ 159 (284)
T cd05081 155 TKVLP 159 (284)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=211.88 Aligned_cols=142 Identities=25% Similarity=0.396 Sum_probs=124.6
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||+|++. ++.||+|+++.... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999886 57899999976532 223445677899998876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~------~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG------HCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC------CEEEeecccceec
Confidence 99999987654 688999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=215.17 Aligned_cols=153 Identities=31% Similarity=0.570 Sum_probs=131.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC 311 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~ 311 (411)
|+++.++|++.+.||+|+||.||+|.+. ++.||||+++.... ......+.+|+.+|..+ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 8999999999999999999999999742 46899999976542 23356788999999999 689999999988
Q ss_pred ecC-CeEEEEEecCCCCCHHHHHHhcC-----------------------------------------------------
Q 015237 312 TRP-PRLFIVTEFMSGGSIYDYLHKQK----------------------------------------------------- 337 (411)
Q Consensus 312 ~~~-~~l~IV~E~~~gGsL~~~L~~~~----------------------------------------------------- 337 (411)
... ..++++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46899999999999999987532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 338 -------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 338 -------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~------~~kl~dfg~~~~~ 229 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN------VVKICDFGLARDI 229 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC------cEEEEeccccccc
Confidence 1256677888999999999999999999999999999999887 5999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=210.04 Aligned_cols=147 Identities=21% Similarity=0.323 Sum_probs=128.0
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+|++.+.||+|+||.||+|... ++.||+|+++.... .......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999886 47899999986532 223345577788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~------~~kL~DfG~~~~~ 151 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG------HIKIADFGMCKEN 151 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC------cEEEccCCCceec
Confidence 9999999999987654 688999999999999999999999999999999999999988 5899999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=208.74 Aligned_cols=148 Identities=24% Similarity=0.385 Sum_probs=129.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|.+.++||+|+||.||+|+.. ++.||+|.++..... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 356899999999999999999875 578999998755322 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||++ ++|.+++......++...+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 84 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~------~~kl~Dfg~~~~~ 154 (309)
T cd07872 84 EYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG------ELKLADFGLARAK 154 (309)
T ss_pred eCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------CEEECccccceec
Confidence 9996 589998877665688999999999999999999999999999999999999888 5899999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=211.74 Aligned_cols=142 Identities=26% Similarity=0.383 Sum_probs=125.0
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++... ++.||+|+++.... .......+..|+.++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999875 57899999986543 223455678899988877 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~------~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC------CEEEeeCCccccc
Confidence 99999887654 689999999999999999999999999999999999999988 5999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=203.52 Aligned_cols=150 Identities=36% Similarity=0.644 Sum_probs=132.5
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+++..+|++.++||+|+||.||+|++.+ ..||+|+++..... .+.+.+|+.+++.++||||+++++.+.. ...|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 78889999999999999999999998864 57999999765433 2568899999999999999999998754 5689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||.+.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~------~~~L~dfg~~~ 150 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLAR 150 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC------cEEeccCCcee
Confidence 9999999999999998643 3578899999999999999999999999999999999999887 58999999997
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 151 ~~ 152 (262)
T cd05071 151 LI 152 (262)
T ss_pred ec
Confidence 55
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=205.29 Aligned_cols=156 Identities=26% Similarity=0.513 Sum_probs=137.1
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g 309 (411)
..|+++..+|++.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4689999999999999999999999998742 569999987653 233446789999999999 8999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~---------------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NI 374 (411)
++.....+|++|||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999643 23578889999999999999999999999999999999
Q ss_pred EEccCCCcCCCccEEEEecccccccc
Q 015237 375 LMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 375 Lid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++.++ .+||+|||++..+.
T Consensus 164 l~~~~~------~~kL~Dfg~~~~~~ 183 (293)
T cd05053 164 LVTEDH------VMKIADFGLARDIH 183 (293)
T ss_pred EEcCCC------eEEeCccccccccc
Confidence 999888 58999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=210.98 Aligned_cols=142 Identities=20% Similarity=0.332 Sum_probs=122.4
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||+|.+. ++.||+|+++.... .....+.+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999886 57899999986532 222344566677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++...
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~------~~kL~Dfg~a~~~ 146 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG------HIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC------CEEEccCcCCeEC
Confidence 99999997654 689999999999999999999999999999999999999888 5999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=210.81 Aligned_cols=142 Identities=24% Similarity=0.419 Sum_probs=122.0
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHH-HHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++.+. ++.||+|++...... ......+..|.. +++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999985 688999999765322 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~------~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG------HVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC------cEEEeccCCCccc
Confidence 99999997654 688999999999999999999999999999999999999988 5899999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=225.21 Aligned_cols=156 Identities=26% Similarity=0.492 Sum_probs=140.6
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
...+++.+..+.+.++||.|.||.||+|.|.. -.||||..+.+. ..+..+.|++|..+|+.++|||||+++|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 45789999999999999999999999999963 249999987654 33447889999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
|... .+|||||.++-|.|..||+.+...++...+..++.||+.+|.|||+.++|||||.++|||+..... +||
T Consensus 460 ~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C------VKL 532 (974)
T KOG4257|consen 460 CVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC------VKL 532 (974)
T ss_pred eecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce------eee
Confidence 9886 499999999999999999998888999999999999999999999999999999999999988774 899
Q ss_pred Eecccccccc
Q 015237 391 SNFLSISTVI 400 (411)
Q Consensus 391 ~DFGla~~~~ 400 (411)
+|||+++-+.
T Consensus 533 aDFGLSR~~e 542 (974)
T KOG4257|consen 533 ADFGLSRYLE 542 (974)
T ss_pred cccchhhhcc
Confidence 9999998763
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=210.54 Aligned_cols=142 Identities=25% Similarity=0.426 Sum_probs=122.3
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHH-HHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++... ++.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999875 68999999976532 2233345556655 46779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~------~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG------HVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC------CEEEeecCCcccC
Confidence 99999887654 689999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=197.94 Aligned_cols=150 Identities=21% Similarity=0.303 Sum_probs=135.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|.+.+.||+|+||.||+++.. ++.|++|.+............+.+|+.+++.++||||+++++++...+..|++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3778899999999999999885 68899999987655566678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++... ...++...+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++..+..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~------~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD------NVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC------CEEEcccccceeccC
Confidence 9999999999875 34688899999999999999999999999999999999999887 589999999887643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=222.82 Aligned_cols=153 Identities=24% Similarity=0.354 Sum_probs=141.1
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe-EEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-LFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-l~IV~ 321 (411)
+.|..+++||.|+||.++..+++ ++.+++|.+.....+...++...+|+.++++++|||||.+.+.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999988776 5789999999988888888899999999999999999999999998888 99999
Q ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+||+||++.+.+.+++ ..+++..+..|+.|++.|+.|||+++|+|||||+.||+++.++ .++|.|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~------~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK------KVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC------ceeecchhhhhhcC
Confidence 9999999999998876 4689999999999999999999999999999999999999998 47999999999987
Q ss_pred cce
Q 015237 401 LVI 403 (411)
Q Consensus 401 ~~~ 403 (411)
+..
T Consensus 158 ~~~ 160 (426)
T KOG0589|consen 158 PED 160 (426)
T ss_pred Cch
Confidence 763
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=205.19 Aligned_cols=142 Identities=22% Similarity=0.285 Sum_probs=123.5
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||+|+||.||++.+. ++.||+|++....... ...+.+..|+.+++.++|+||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999875 6889999987653322 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 330 YDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 330 ~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++ .++|+|||++..+.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~~l~dfg~~~~~~ 148 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG------NVRISDLGLAVELK 148 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEEeeCccceecC
Confidence 9887542 23588999999999999999999999999999999999999887 58999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=200.52 Aligned_cols=143 Identities=29% Similarity=0.528 Sum_probs=127.3
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGs 328 (411)
+.||+|+||.||+|+.. ++.||+|.+.... .......+.+|+.+++.++||||++++++|......|+||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999874 6889999876442 34455779999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 329 L~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|.+++......+++..++.++.|++.||.|||+++|+|+||||+||+++.++ .+||+|||.+....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~------~~kl~dfg~~~~~~ 145 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN------VLKISDFGMSREEE 145 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC------cEEECccccCcccc
Confidence 9999977655688999999999999999999999999999999999999887 58999999987643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=210.34 Aligned_cols=142 Identities=24% Similarity=0.401 Sum_probs=121.7
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHH-HHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||+++.. ++.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999885 68899999976532 2223345555654 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~------~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG------HVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC------CEEEccCCCCccC
Confidence 99999887654 688889999999999999999999999999999999999988 5999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=209.37 Aligned_cols=146 Identities=23% Similarity=0.341 Sum_probs=127.4
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEe
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E 322 (411)
|++.+.||+|+||.||++... ++.||+|+++.... .....+.+..|..+++.+. |++|+++++++...+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 678899999999999999875 68899999986532 2233456788999998885 5778889999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 y~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~------~ikL~Dfg~~~~~ 151 (323)
T cd05615 82 YVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG------HIKIADFGMCKEH 151 (323)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC------CEEEecccccccc
Confidence 999999999997654 689999999999999999999999999999999999999988 5899999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=213.82 Aligned_cols=154 Identities=28% Similarity=0.541 Sum_probs=132.3
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGA 310 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 310 (411)
.|+++.++|++.+.||+|+||.||+|... ++.||+|+++... .....+.+.+|+.+++++ +|+||++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 39999999999999999999999999653 3579999987543 233346688899999999 89999999998
Q ss_pred eec-CCeEEEEEecCCCCCHHHHHHhcC----------------------------------------------------
Q 015237 311 CTR-PPRLFIVTEFMSGGSIYDYLHKQK---------------------------------------------------- 337 (411)
Q Consensus 311 ~~~-~~~l~IV~E~~~gGsL~~~L~~~~---------------------------------------------------- 337 (411)
|.. ...++++|||+++|+|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 864 456899999999999999986532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 338 --------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 338 --------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
..+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++..+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~------~vkL~DfG~a~~~ 223 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN------VVKICDFGLARDI 223 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC------cEEEeccccchhc
Confidence 1467888999999999999999999999999999999999887 5899999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=201.38 Aligned_cols=151 Identities=34% Similarity=0.630 Sum_probs=133.8
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+++.+.|++.++||+|+||.||++... +..+|+|.++..... .+.+.+|+.++++++|+||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 8889999999999999999999999876 478999999865443 2568899999999999999999998854 5689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++ .++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~------~~~l~dfg~~~ 150 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL------VCKIADFGLAR 150 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc------eEEeCCceeee
Confidence 9999999999999997643 3588999999999999999999999999999999999999887 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 151 ~~~ 153 (260)
T cd05070 151 LIE 153 (260)
T ss_pred ecc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=201.06 Aligned_cols=150 Identities=32% Similarity=0.516 Sum_probs=133.1
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
+...|++.+.||+|+||.||+|... + ..||||+++... .....+.|..|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3456889999999999999999875 2 359999987543 345567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++||||+++|+|.+++......+++..+..++.|++.|+.|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~------~~kl~dfg~~~ 154 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL------VCKVSDFGLSR 154 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC------cEEECCCcccc
Confidence 999999999999999987666789999999999999999999999999999999999998877 58999999987
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 155 ~~ 156 (269)
T cd05065 155 FL 156 (269)
T ss_pred cc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=210.01 Aligned_cols=142 Identities=23% Similarity=0.409 Sum_probs=120.4
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHH-HHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVH-IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++.+. ++.||+|++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999886 578999999764321 122234444544 56788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+....+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~------~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC------CEEEccCCCCccc
Confidence 99999997654 578888999999999999999999999999999999999888 5899999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=216.15 Aligned_cols=141 Identities=25% Similarity=0.377 Sum_probs=126.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
+....|++.++||+|+||.||++... ++.||+|.... ..+.+|+.+|+.++||||+++++++......|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 45567999999999999999999875 68899997532 346789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++|++ +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 161 v~e~~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~------~vkL~DFG~a~~ 231 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG------DVCLGDFGAACF 231 (391)
T ss_pred EEecC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC------CEEEEeCCcccc
Confidence 99999 579999887654 688999999999999999999999999999999999999888 589999999864
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=206.86 Aligned_cols=156 Identities=24% Similarity=0.517 Sum_probs=136.3
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 307 (411)
..|+++..+|++.++||+|+||.||+++.. ...+|+|+++... .......+..|+.+++.+ +||||+++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 468999999999999999999999999752 2469999987543 234456788999999999 69999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
+++|.....+|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 999999889999999999999999997642 24788889999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEecccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||++.++ .+||+|||+++.+.
T Consensus 164 Nill~~~~------~~kL~Dfg~~~~~~ 185 (314)
T cd05099 164 NVLVTEDN------VMKIADFGLARGVH 185 (314)
T ss_pred eEEEcCCC------cEEEcccccccccc
Confidence 99999888 58999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=205.19 Aligned_cols=146 Identities=25% Similarity=0.416 Sum_probs=123.9
Q ss_pred EEeecCceEEEEEEEC--------------------------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCcee
Q 015237 252 KIVSGSYCDLYKGAFF--------------------------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~--------------------------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV 305 (411)
+||+|+||.||+|... ...|++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6899999999999742 1348899886542 23456788999999999999999
Q ss_pred EEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCC
Q 015237 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 306 ~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~ 385 (411)
+++++|......|+||||+++|+|..++......+++..+..++.||+.||.|||+++|+||||||+|||++..+.....
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 99999999999999999999999999997766678999999999999999999999999999999999999887643222
Q ss_pred -ccEEEEeccccccc
Q 015237 386 -IHCYLSNFLSISTV 399 (411)
Q Consensus 386 -~~ikL~DFGla~~~ 399 (411)
..++++|||++...
T Consensus 160 ~~~~kl~d~g~~~~~ 174 (274)
T cd05076 160 SPFIKLSDPGVSFTA 174 (274)
T ss_pred cceeeecCCcccccc
Confidence 23799999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=206.28 Aligned_cols=155 Identities=26% Similarity=0.531 Sum_probs=135.3
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
.|++....|.+.+.||+|+||.||++++. +..||+|.++... .....+.+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 58899999999999999999999999752 2369999987543 234456789999999999 899999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
+++......|++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999997642 236778889999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEecccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||++.++ .+||+|||+++.+.
T Consensus 168 ili~~~~------~~kl~D~g~~~~~~ 188 (304)
T cd05101 168 VLVTENN------VMKIADFGLARDVN 188 (304)
T ss_pred EEEcCCC------cEEECCCccceecc
Confidence 9999887 58999999998663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=206.58 Aligned_cols=155 Identities=21% Similarity=0.407 Sum_probs=136.9
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
..|.++ ++.+++.||.|-||.||.|+.+ +--||+|++.+..... +....+.+|++|-..++||||.++|++|.+.
T Consensus 17 ~~~~l~--dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLD--DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchh--hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 446654 5889999999999999999886 3679999998765422 4557799999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|+++||.++|+++..|+.+.. .+++.....++.|++.|+.|+|.+++|||||||+|+|++.+| .+|++||
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~------~lkiAdf 168 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG------ELKIADF 168 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC------CeeccCC
Confidence 999999999999999999986543 588999999999999999999999999999999999999999 5899999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|.+..-.
T Consensus 169 GwsV~~p 175 (281)
T KOG0580|consen 169 GWSVHAP 175 (281)
T ss_pred CceeecC
Confidence 9987653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=210.30 Aligned_cols=142 Identities=25% Similarity=0.398 Sum_probs=124.4
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++... ++.||+|+++.... .....+.+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999875 57899999976532 223345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++...
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~------~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC------cEEEeeCCCCeec
Confidence 99999997654 689999999999999999999999999999999999999988 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=200.76 Aligned_cols=151 Identities=30% Similarity=0.601 Sum_probs=134.0
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+|....|++.++||+|+||.||++... ++.||+|.+...... ...+.+|+.++++++|+||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcE
Confidence 8899999999999999999999999875 588999998765543 2568899999999999999999998754 5689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~------~~~l~dfg~~~ 150 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL------CCKIADFGLAR 150 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC------CEEEccCccee
Confidence 9999999999999987643 3688899999999999999999999999999999999999887 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 151 ~~~ 153 (260)
T cd05067 151 LIE 153 (260)
T ss_pred ecC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=204.10 Aligned_cols=148 Identities=26% Similarity=0.444 Sum_probs=123.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhc---CCCceeEEEeeee-----cC
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACT-----RP 314 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~-----~~ 314 (411)
+|++.+.||+|+||.||++.+. ++.||+|.++...........+.+|+.+++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5888999999999999999873 47799999876543333345566788777765 6999999999985 24
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~------~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG------QIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC------CEEEccc
Confidence 56899999995 69999997643 3588999999999999999999999999999999999999988 5899999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++....
T Consensus 155 g~~~~~~ 161 (290)
T cd07862 155 GLARIYS 161 (290)
T ss_pred cceEecc
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=215.00 Aligned_cols=156 Identities=23% Similarity=0.347 Sum_probs=137.4
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRL 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l 317 (411)
-....|++.+.||.|.||.||+++.+ ++.+|+|++.+..... .....+.+|+.||+++. |||||+++++|+....+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34566888999999999999999875 6899999998776532 34568999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+....... ..+|++|||++.
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~--~~ik~~DFGla~ 187 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGS--GRIKLIDFGLAK 187 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCC--CcEEEeeCCCce
Confidence 9999999999999999876 389999999999999999999999999999999999997654211 258999999999
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 188 ~~~~ 191 (382)
T KOG0032|consen 188 FIKP 191 (382)
T ss_pred EccC
Confidence 8865
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=209.12 Aligned_cols=141 Identities=26% Similarity=0.382 Sum_probs=125.4
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++... ++.||+|+++..... ....+.+.+|+.++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 578999999875432 23456688999999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~------~~kl~Dfg~~~~ 145 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG------HIKLTDYGMCKE 145 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC------CEEEecccccee
Confidence 99999887654 689999999999999999999999999999999999999988 599999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=201.83 Aligned_cols=151 Identities=28% Similarity=0.484 Sum_probs=131.4
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--Cc----eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+...+|++.++||+|+||.||+|++. ++ .||+|.++... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 45677899999999999999999874 33 48999987543 344457789999999999999999999999764
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..++++||+++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~------~~kL~dfG~ 155 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN------HVKITDFGL 155 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC------cEEECCCCc
Confidence 57899999999999999987655789999999999999999999999999999999999998877 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
++.+.
T Consensus 156 ~~~~~ 160 (279)
T cd05109 156 ARLLD 160 (279)
T ss_pred eeecc
Confidence 98653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=200.26 Aligned_cols=148 Identities=27% Similarity=0.465 Sum_probs=128.4
Q ss_pred eEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe-----
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR----- 316 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 316 (411)
|++.+.||+|+||.||+|.... ..||+|.++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4678899999999999998742 579999998765555556789999999999999999999998866544
Q ss_pred -EEEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 317 -LFIVTEFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 317 -l~IV~E~~~gGsL~~~L~~~~-----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
.+++|||+++|+|..++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++ .+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~------~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM------TVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC------eEEE
Confidence 799999999999999885432 2578889999999999999999999999999999999999887 5999
Q ss_pred Eecccccccc
Q 015237 391 SNFLSISTVI 400 (411)
Q Consensus 391 ~DFGla~~~~ 400 (411)
+|||+++.+.
T Consensus 155 ~dfg~~~~~~ 164 (273)
T cd05035 155 ADFGLSKKIY 164 (273)
T ss_pred CCccceeecc
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=200.09 Aligned_cols=149 Identities=27% Similarity=0.476 Sum_probs=131.7
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...+|++.++||+|+||.||+|+.. ++.||+|++..... .....+.+|+.++++++||||+++++++.....+|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 3456888999999999999999874 68899999875532 2235678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++..+.
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~------~~~l~dfg~~~~~~ 157 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG------DVKLADFGVAAKIT 157 (267)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC------CEEECcCccceeec
Confidence 99999999999987654 688999999999999999999999999999999999999887 59999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=199.08 Aligned_cols=150 Identities=36% Similarity=0.640 Sum_probs=132.0
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|+++...|.+..+||+|+||.||++.+.+ ..+|+|.+...... .+.+.+|+.+++.++|+||+++++++.. ...|
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 78888899999999999999999998864 57999988754332 3568899999999999999999998864 5689
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++ .++|+|||++.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~------~~~l~dfg~~~ 150 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL------VCKIADFGLAR 150 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC------eEEECCCccce
Confidence 9999999999999997643 3478899999999999999999999999999999999999888 58999999997
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 151 ~~ 152 (260)
T cd05069 151 LI 152 (260)
T ss_pred Ec
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=198.50 Aligned_cols=151 Identities=28% Similarity=0.575 Sum_probs=134.0
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|++....|++.++||+|+||.||++.+. +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 8999999999999999999999999875 4679999887542 234678899999999999999999999887 6789
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~------~~~l~d~~~~~ 150 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL------VCKIADFGLAR 150 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC------cEEECCCccee
Confidence 9999999999999997643 3578888999999999999999999999999999999998887 59999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 151 ~~~ 153 (260)
T cd05073 151 VIE 153 (260)
T ss_pred ecc
Confidence 664
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=205.55 Aligned_cols=153 Identities=24% Similarity=0.482 Sum_probs=131.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECC----------------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS----------------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~----------------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI 304 (411)
|++..+|++.++||+|+||.||++...+ ..||+|.++... .......+.+|++++++++|+||
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CCchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4566789999999999999999986532 248999987643 34456679999999999999999
Q ss_pred eEEEeeeecCCeEEEEEecCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-----------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 305 V~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~-----------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
+++++++......|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999986532 135778889999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEecccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++.++ .+||+|||++..+.
T Consensus 160 ill~~~~------~~kl~dfg~~~~~~ 180 (295)
T cd05097 160 CLVGNHY------TIKIADFGMSRNLY 180 (295)
T ss_pred EEEcCCC------cEEecccccccccc
Confidence 9999877 48999999997653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=212.31 Aligned_cols=154 Identities=24% Similarity=0.374 Sum_probs=130.9
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP- 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~- 314 (411)
..|++. +.|++.+.||+|+||.||++... ++.||||++..........+.+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 9 TVWEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HHhhhh-hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 357665 56899999999999999999875 57899999876543334456678999999999999999999987543
Q ss_pred -----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 315 -----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 315 -----~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
...|+++|++ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~------~~k 158 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC------ELR 158 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC------CEE
Confidence 3479999998 88999888643 589999999999999999999999999999999999999988 589
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
|+|||++.....
T Consensus 159 l~Dfg~~~~~~~ 170 (343)
T cd07878 159 ILDFGLARQADD 170 (343)
T ss_pred EcCCccceecCC
Confidence 999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=202.74 Aligned_cols=153 Identities=30% Similarity=0.579 Sum_probs=136.2
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
||-...+|++.++||.|+||.||+|.+. ++.+++|++..... .....+..|+.+++.++|+||+++++++......|
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 6667778999999999999999999886 57899999876532 23467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|||+++|+|.+++.... ..+++..+..++.|++.|+.|||++||+|+||||+||+++.++ .+||+|||.+.
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~------~~kl~d~g~~~ 152 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL------VCKVADFGLAR 152 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc------eEEEccccchh
Confidence 9999999999999998643 3588999999999999999999999999999999999999888 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 153 ~~~ 155 (261)
T cd05148 153 LIK 155 (261)
T ss_pred hcC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=213.43 Aligned_cols=145 Identities=22% Similarity=0.329 Sum_probs=127.1
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-----eEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-----RLFI 319 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~l~I 319 (411)
|++.++||+|+||.||++... ++.||||.+..........+.+.+|+.+++.++|+||+++++++.... .+|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 677899999999999999874 689999998754434445567899999999999999999999998766 7999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 v~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~------~~kL~Dfg~a~~~ 153 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC------VLKICDFGLARVE 153 (372)
T ss_pred Eeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC------CEEeccccceeec
Confidence 999995 68888886543 689999999999999999999999999999999999999988 5999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=226.11 Aligned_cols=154 Identities=24% Similarity=0.384 Sum_probs=128.5
Q ss_pred EEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------eEEEEE
Q 015237 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------RLFIVT 321 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------~l~IV~ 321 (411)
.+.||+|+||.||+|+.+ |..||||.++... ....++...+|+++|++++|+|||+++++-.... ...++|
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 356899999999999875 8999999998754 3344677899999999999999999998765433 468999
Q ss_pred ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~--~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||+||||...|.+.. .++++..++.+..+++.||.|||++||+||||||.||++-.....+. -.||+|||.|+.+
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~--IyKLtDfG~Arel 174 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQS--IYKLTDFGAAREL 174 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCce--EEeeecccccccC
Confidence 9999999999998753 37999999999999999999999999999999999999854332222 3799999999998
Q ss_pred ccceeeE
Q 015237 400 ILVIFSC 406 (411)
Q Consensus 400 ~~~~~~~ 406 (411)
-.+....
T Consensus 175 ~d~s~~~ 181 (732)
T KOG4250|consen 175 DDNSLFT 181 (732)
T ss_pred CCCCeee
Confidence 6655433
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=217.55 Aligned_cols=150 Identities=15% Similarity=0.233 Sum_probs=130.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|.+.+.||.|+||.||++... ++.||+|.+... .......+.+|+.+|+.++||||++++++|...+.+|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 345899999999999999999764 467888876543 233446678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 321 TEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||++||+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~------~~kL~DFgla~ 217 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG------IIKLGDFGFSK 217 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC------cEEEEeCcCce
Confidence 9999999999988643 33588889999999999999999999999999999999999988 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 218 ~~~~ 221 (478)
T PTZ00267 218 QYSD 221 (478)
T ss_pred ecCC
Confidence 7643
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=207.68 Aligned_cols=156 Identities=26% Similarity=0.528 Sum_probs=135.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC---------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 307 (411)
..|++....|++.+.||+|+||.||++.+.+ ..||+|.++... .....+.+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4699999999999999999999999997531 368999887543 334457889999999999 89999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
+++|.....+|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 23677888999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEecccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||++.++ .+||+|||+++.+.
T Consensus 164 Nill~~~~------~~kL~Dfg~~~~~~ 185 (334)
T cd05100 164 NVLVTEDN------VMKIADFGLARDVH 185 (334)
T ss_pred eEEEcCCC------cEEECCcccceecc
Confidence 99999887 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=201.00 Aligned_cols=152 Identities=29% Similarity=0.511 Sum_probs=133.6
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--C----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--S----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+...+|++.+.||+|+||.||+|.+. + ..+|+|.+..... ......+.+|+.++++++||||++++++|..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345677899999999999999999874 2 2589998876543 4455678999999999999999999999987
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
...+++|||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~------~~kL~dfg 154 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ------HVKITDFG 154 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC------eEEECCCc
Confidence 679999999999999999988766789999999999999999999999999999999999999877 58999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
.++.+.
T Consensus 155 ~~~~~~ 160 (279)
T cd05057 155 LAKLLD 160 (279)
T ss_pred cccccc
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=201.11 Aligned_cols=141 Identities=25% Similarity=0.388 Sum_probs=121.3
Q ss_pred EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 252 KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++|+||+++++.+......|+||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 5899999999999753 2468888776433 3444567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKC----GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~----~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++..... ..++..+..++.||+.|+.|||+++|+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~------~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL------SVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC------cEEEecccccccc
Confidence 99999977532 245677889999999999999999999999999999999988 5899999998653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=205.28 Aligned_cols=155 Identities=28% Similarity=0.510 Sum_probs=136.7
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGA 310 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 310 (411)
.|++..++|.+.+.||+|+||.||++++. +..||+|+++.... ....+.+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 58899999999999999999999999752 24799999875532 33456789999999999 79999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
+...+.+|++|||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+|+||||+|||++.++ .++
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~~ 181 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK------IVK 181 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC------eEE
Confidence 9999999999999999999999976432 489999999999999999999999999999999999998877 589
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++..+.
T Consensus 182 l~dfg~~~~~~ 192 (302)
T cd05055 182 ICDFGLARDIM 192 (302)
T ss_pred ECCCccccccc
Confidence 99999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=202.43 Aligned_cols=151 Identities=29% Similarity=0.560 Sum_probs=131.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
++...|++.+.||+|+||.||+|...+ ..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345678999999999999999998743 469999987543 344567799999999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~ 379 (411)
...|++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 89999999999999999997642 347788899999999999999999999999999999999988
Q ss_pred CCcCCCccEEEEeccccccc
Q 015237 380 GVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 380 g~~k~~~~ikL~DFGla~~~ 399 (411)
+ .++|+|||++..+
T Consensus 161 ~------~~~L~dfg~~~~~ 174 (283)
T cd05048 161 L------TVKISDFGLSRDI 174 (283)
T ss_pred C------cEEECCCcceeec
Confidence 7 5899999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=222.04 Aligned_cols=150 Identities=27% Similarity=0.442 Sum_probs=134.4
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+...|.-.++||+|+.|.||.++.. ++.||||.+....... ++-+.+|+.+|+..+|+|||.|++.|...+.+|+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 4556777889999999999999765 6889999998765443 36689999999999999999999999888999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||+||+|.|.+.... +++.++..++++++.||+|||.+||||||||.+|||++.+| .+||+|||+|..+.
T Consensus 349 MEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g------~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG------SVKLTDFGFCAQIS 420 (550)
T ss_pred EeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC------cEEEeeeeeeeccc
Confidence 99999999999997654 89999999999999999999999999999999999999999 59999999998875
Q ss_pred cc
Q 015237 401 LV 402 (411)
Q Consensus 401 ~~ 402 (411)
..
T Consensus 421 ~~ 422 (550)
T KOG0578|consen 421 EE 422 (550)
T ss_pred cc
Confidence 43
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=219.05 Aligned_cols=154 Identities=18% Similarity=0.235 Sum_probs=134.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC---
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--- 315 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--- 315 (411)
+.....|.+.+.||+|+||.||++... ++.||||++.....+......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999874 789999999877666666778899999999999999999988775432
Q ss_pred -----eEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 316 -----RLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 316 -----~l~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~------~ 181 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG------L 181 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC------C
Confidence 378999999999999999753 23588899999999999999999999999999999999999988 5
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
+||+|||+++.+.
T Consensus 182 vkL~DFGls~~~~ 194 (496)
T PTZ00283 182 VKLGDFGFSKMYA 194 (496)
T ss_pred EEEEecccCeecc
Confidence 9999999987653
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=207.93 Aligned_cols=142 Identities=22% Similarity=0.360 Sum_probs=122.9
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||+|.+. ++.||||+++.... .......+..|..++... +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999886 57899999986532 122335567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~------~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG------HIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC------CEEEccCCcceEC
Confidence 99999997653 688999999999999999999999999999999999999988 5999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=203.02 Aligned_cols=152 Identities=25% Similarity=0.486 Sum_probs=130.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC------------------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF------------------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~------------------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN 303 (411)
++.+.|++.++||+|+||.||++.+. +..||+|.+.... .......+.+|+.+|+.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 45667999999999999999998542 2358999987543 3445678999999999999999
Q ss_pred eeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK----------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 304 IV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~----------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
|+++++++......|++|||+++|+|.+++.... ..+++..+..++.|++.|+.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999997643 135677899999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEecccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||++.++ .++|+|||++..+.
T Consensus 161 ili~~~~------~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNY------TIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCC------CEEeccCccccccc
Confidence 9999877 58999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=208.15 Aligned_cols=141 Identities=20% Similarity=0.326 Sum_probs=122.5
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++.+. ++.||+|+++..... ......+..|..++... +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999885 678999999865321 22345567788888754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~------~~kl~Dfg~~~~ 145 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG------HIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC------CEEeCccCCCee
Confidence 99999997654 688999999999999999999999999999999999999988 589999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=200.27 Aligned_cols=149 Identities=24% Similarity=0.364 Sum_probs=130.8
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|++.+.||+|+||.||+|... ++.||+|.+..........+.+.+|+.++++++|+||+++++++.....++++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5888999999999999999885 68999999875543333446688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|..++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~------~~~l~dfg~~~~~~~ 152 (286)
T cd07847 82 CDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG------QIKLCDFGFARILTG 152 (286)
T ss_pred cCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC------cEEECccccceecCC
Confidence 9988887776543 3689999999999999999999999999999999999999888 599999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=208.70 Aligned_cols=146 Identities=21% Similarity=0.298 Sum_probs=125.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 315 (411)
...|++.+.||+|+||.||++... ++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467899999999999999999875 689999999765444455677889999999999999999999986443
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+||||+. ++|.+.+.. .++...+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||+
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~------~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGL 169 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------CEEEecCCC
Confidence 4799999995 577776642 478888999999999999999999999999999999999988 599999999
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 170 a~~~ 173 (359)
T cd07876 170 ARTA 173 (359)
T ss_pred cccc
Confidence 9765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-23 Score=197.55 Aligned_cols=150 Identities=19% Similarity=0.377 Sum_probs=131.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc-cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.+.||+|+||.||+|+.. ++.||||.++... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46889999999999999999874 6899999886533 34455667899999999999999999999999989999999
Q ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 322 EFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||+++|+|.+++... ...++...+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~------~~~l~d~g~~~~ 155 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG------VVKLGDLGLGRF 155 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC------CEEECcccccee
Confidence 999999999888542 33578889999999999999999999999999999999999887 589999998876
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 156 ~~ 157 (267)
T cd08228 156 FS 157 (267)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=226.21 Aligned_cols=149 Identities=24% Similarity=0.419 Sum_probs=134.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
..|++.++||+|+||.||+|.+. ++.||||+++.... .......+..|+.+++.++||||+++++++.....+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56899999999999999999987 68999999976432 3455677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+.|++|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++....
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g------~vkL~DFGls~~~~ 155 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG------HIKLTDFGLSKVTL 155 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC------CEEEEeCCCCcccc
Confidence 9999999999997654 588899999999999999999999999999999999999887 58999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=202.37 Aligned_cols=151 Identities=27% Similarity=0.492 Sum_probs=131.3
Q ss_pred CCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--C
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--P 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~ 315 (411)
...|++.++||+|+||.||.+.+ .+..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 45578899999999999999875 25789999987553 234456799999999999999999999998765 5
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..++||||++|++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~------~~~l~dfg~ 155 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH------QVKIGDFGL 155 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC------CEEECCCcc
Confidence 68999999999999999977655689999999999999999999999999999999999999887 589999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 156 ~~~~~~ 161 (284)
T cd05079 156 TKAIET 161 (284)
T ss_pred cccccc
Confidence 986543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=199.89 Aligned_cols=147 Identities=25% Similarity=0.457 Sum_probs=125.3
Q ss_pred EEEEEEeecCceEEEEEEECC----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC------CeE
Q 015237 248 KFEHKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------PRL 317 (411)
Q Consensus 248 ~~~~~IG~Gsfg~Vy~g~~~~----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------~~l 317 (411)
.++++||+|+||.||+|.+.. ..||+|.++.........+.+.+|+.+++.++|+||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999998763 2599999877655556667899999999999999999999987432 247
Q ss_pred EEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 318 FIVTEFMSGGSIYDYLHKQ-----KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~-----~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+++++ .++|+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~kl~D 155 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM------NVCVAD 155 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC------CEEECC
Confidence 8999999999999987532 22478899999999999999999999999999999999999887 589999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||++..+.
T Consensus 156 fg~~~~~~ 163 (272)
T cd05075 156 FGLSKKIY 163 (272)
T ss_pred CCcccccC
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=200.56 Aligned_cols=147 Identities=26% Similarity=0.398 Sum_probs=129.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.++||+|+||.||+|+.. ++.||+|.++...........+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3788899999999999999875 68899999876543333446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~--~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++ ++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.+| .++|+|||++..+
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~------~~~l~dfg~~~~~ 151 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG------VIKLADFGLARAF 151 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC------cEEECcccceeec
Confidence 96 68998886543 4688999999999999999999999999999999999999988 5999999998755
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=200.91 Aligned_cols=150 Identities=24% Similarity=0.393 Sum_probs=133.8
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+.|++.+.||+|+||.||++.+. ++.||+|++..... .......+.+|+.++++++||||+++++++.....+|++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999885 68999999976543 2234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+++++|.+++.... .++...+..++.|++.||.|||++||+|+||+|+||+++.++ .+||+|||++..+..
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~------~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG------YIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC------CEEEeeCCCccccCC
Confidence 9999999999998764 689999999999999999999999999999999999999988 589999999887643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-23 Score=194.89 Aligned_cols=150 Identities=21% Similarity=0.321 Sum_probs=133.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||.|+||.||.++.. ++.+++|.+.....+....+.+.+|+.++++++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4889999999999988887664 68899999877665566667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++|+|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||++++++ .+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~------~~kl~d~~~~~~~~~ 153 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG------LIKLGDFGISKILGS 153 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC------CEEECcCcceEEccc
Confidence 9999999999875 34588999999999999999999999999999999999999887 589999999876533
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=201.96 Aligned_cols=154 Identities=25% Similarity=0.390 Sum_probs=136.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|-.+.+.|++.++||+|+||.||+|... ++.|++|++... +....+.+.+|+.+++.++|+||+++++.+....
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 345566778999999999999999999875 588999998754 3445677899999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+||||+++++|..++......+++..+..++.|++.|+.|||+++++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~kl~dfg~ 156 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG------DIKLADFGV 156 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC------CEEEccCcc
Confidence 99999999999999988876555789999999999999999999999999999999999999887 599999998
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 157 ~~~~ 160 (292)
T cd06644 157 SAKN 160 (292)
T ss_pred ceec
Confidence 8754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-23 Score=195.46 Aligned_cols=149 Identities=32% Similarity=0.503 Sum_probs=134.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.+.||+|+||.||++... ++.+++|++..... ...+.+.+|+.++++++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 467899999999999999999875 57899999976532 24578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++++|.+++......++...+..++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++..+.
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~------~~~l~d~g~~~~~~ 152 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG------DVKLADFGVSAQLT 152 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC------CEEECccccchhhh
Confidence 99999999999987655789999999999999999999999999999999999999888 58999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=206.86 Aligned_cols=141 Identities=23% Similarity=0.377 Sum_probs=124.5
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++.+. ++.||||+++.... .......+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999885 57899999986532 223445678899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+++++ .+||+|||++..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~------~~kl~Dfg~~~~ 145 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG------HIKIADFGMCKE 145 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC------cEEecccCCCee
Confidence 99999987654 689999999999999999999999999999999999999988 589999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=200.35 Aligned_cols=147 Identities=22% Similarity=0.285 Sum_probs=128.8
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
|+..+.||+|+||.||++.+. ++.||+|++....... .....+.+|+.+|+.++|+||+.+++++...+..|++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667889999999999999885 6889999987654322 2345578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~------~~kl~Dfg~~~~~ 152 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG------HIRISDLGLAVKI 152 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC------CEEEecCCcceec
Confidence 99999998886543 3689999999999999999999999999999999999999887 4899999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=198.92 Aligned_cols=149 Identities=30% Similarity=0.551 Sum_probs=131.8
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
|-++...|++.+.||+|+||.||+|...++.||+|.++... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 55666789999999999999999999889999999986542 235788999999999999999999998765 4799
Q ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 320 VTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+|||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~------~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG------VAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC------cEEECCCcccee
Confidence 999999999999997653 3578899999999999999999999999999999999999888 489999999875
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
.
T Consensus 150 ~ 150 (254)
T cd05083 150 G 150 (254)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=199.85 Aligned_cols=150 Identities=29% Similarity=0.521 Sum_probs=133.4
Q ss_pred CCceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CC
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PP 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~ 315 (411)
...|++.+.||+|+||.||++.+. ++.||+|.++..... ...+.+.+|+.+++.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356788899999999999999864 468999999866443 345789999999999999999999999877 55
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..+++|||+++++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~------~~~l~dfg~ 155 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED------LVKISDFGL 155 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC------CEEEccccc
Confidence 79999999999999999987665689999999999999999999999999999999999999887 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 156 ~~~~~ 160 (284)
T cd05038 156 AKVLP 160 (284)
T ss_pred ccccc
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-23 Score=195.34 Aligned_cols=149 Identities=35% Similarity=0.573 Sum_probs=133.3
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+...|++.+.||+|+||.||++.+. +..+|+|.++...... ..+.+|+.+++.++||||+++++++......|++|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4567899999999999999999886 6789999987654432 46889999999999999999999999989999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++++|.+++......+++..+..++.|++.|+.|||+++++|+||||+||+++.++ .++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~------~~~l~d~g~~~~~~ 151 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ------VVKVSDFGMTRFVL 151 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC------eEEECCCcceeecc
Confidence 99999999999987655688999999999999999999999999999999999999877 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=203.20 Aligned_cols=150 Identities=31% Similarity=0.548 Sum_probs=129.2
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--Cc--eEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~--~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
+..++|++.+.||+|+||.||+|.+. +. .+++|.++.. ........+.+|+.++.++ +|+||+++++++.....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45667999999999999999999874 33 4677776532 2344557788999999999 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 015237 317 LFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~ 381 (411)
+|++|||+++|+|.+++.... ..+++..++.++.|++.|++|||++||+||||||+|||++.++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~- 161 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY- 161 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-
Confidence 999999999999999997542 2478889999999999999999999999999999999999887
Q ss_pred cCCCccEEEEecccccc
Q 015237 382 RDSDIHCYLSNFLSIST 398 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~ 398 (411)
.+||+|||++..
T Consensus 162 -----~~kl~dfg~~~~ 173 (303)
T cd05088 162 -----VAKIADFGLSRG 173 (303)
T ss_pred -----cEEeCccccCcc
Confidence 589999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=201.40 Aligned_cols=150 Identities=24% Similarity=0.445 Sum_probs=128.0
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--Cc----eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+...+|++.+.||+|+||.||+|.+. ++ .+++|.+.... ......++..|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 34456888999999999999999884 33 47788875332 23344678889999999999999999998864 4
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..++++||+++|+|.+++......+++..+..++.||+.||.|||+++++||||||+|||+++++ .+||+|||+
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~------~~kl~Dfg~ 155 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS------IVQIADFGV 155 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC------cEEEcCCcc
Confidence 57899999999999999987666789999999999999999999999999999999999999887 589999999
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+..+
T Consensus 156 ~~~~ 159 (279)
T cd05111 156 ADLL 159 (279)
T ss_pred ceec
Confidence 9765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=197.58 Aligned_cols=152 Identities=30% Similarity=0.484 Sum_probs=134.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
|...+|+..+.||+|+||.||+|+.. + ..+|+|.++... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45567889999999999999999874 2 369999986543 33445778999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.|+||||+++++|.+++......+++..+..++.|++.|+.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~------~~kl~dfg~~ 154 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL------ECKVSDFGLS 154 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC------cEEECCCccc
Confidence 9999999999999999987666789999999999999999999999999999999999999877 5999999998
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
....
T Consensus 155 ~~~~ 158 (268)
T cd05063 155 RVLE 158 (268)
T ss_pred eecc
Confidence 7664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=200.94 Aligned_cols=151 Identities=28% Similarity=0.496 Sum_probs=132.3
Q ss_pred cCCceEEEEEEeecCceEEEEEEECC------------------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFS------------------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~------------------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI 304 (411)
....|++.++||+|+||.||++.... ..||+|.+.... .....+.+.+|+.++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 45678899999999999999987642 458999987653 33456789999999999999999
Q ss_pred eEEEeeeecCCeEEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 015237 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK----------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374 (411)
Q Consensus 305 V~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~----------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NI 374 (411)
+++++++...+..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999899999999999999999997653 1578899999999999999999999999999999999
Q ss_pred EEccCCCcCCCccEEEEecccccccc
Q 015237 375 LMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 375 Lid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++.++ .++|+|||.+..+.
T Consensus 162 li~~~~------~~~l~dfg~~~~~~ 181 (296)
T cd05051 162 LVGKNY------TIKIADFGMSRNLY 181 (296)
T ss_pred eecCCC------ceEEccccceeecc
Confidence 999987 58999999988653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-23 Score=198.01 Aligned_cols=152 Identities=30% Similarity=0.483 Sum_probs=132.7
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
++...+|.+.++||+|+||.||+|.+.. ..|+||...... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 5677789999999999999999998742 368999886543 24456789999999999999999999999876 4
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..|++|||+++|+|.+++......+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~------~~~l~d~g~ 153 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD------CVKLGDFGL 153 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC------CeEEccCce
Confidence 57899999999999999987655689999999999999999999999999999999999999887 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+....
T Consensus 154 ~~~~~ 158 (270)
T cd05056 154 SRYLE 158 (270)
T ss_pred eeecc
Confidence 87653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=198.14 Aligned_cols=140 Identities=33% Similarity=0.556 Sum_probs=123.1
Q ss_pred EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 252 KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999874 3469999987653 34455779999999999999999999999864 4689999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++......+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||+|||++..+
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~------~~kl~dfg~~~~~ 145 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH------YAKISDFGLSKAL 145 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC------cEEeccCCccccc
Confidence 99999986666789999999999999999999999999999999999999887 5899999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=198.57 Aligned_cols=146 Identities=25% Similarity=0.463 Sum_probs=123.7
Q ss_pred EEEeecCceEEEEEEECCc------------eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 251 HKIVSGSYCDLYKGAFFSQ------------DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~------------~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+.||+|+||.||+|.+... .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999988643 3788877654321 5778999999999999999999999988 7789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCc-CCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR-DSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~-k~~~~ikL~DFGla~ 397 (411)
+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.. .....+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999999998766578999999999999999999999999999999999999987622 111148999999998
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 157 ~~~ 159 (259)
T cd05037 157 TVL 159 (259)
T ss_pred ccc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=202.20 Aligned_cols=147 Identities=26% Similarity=0.368 Sum_probs=130.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|++.++||+|+||.||++.+. +..+|+|.+.... .......+.+|++++++++||||++++++|..++.+|++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 5889999999999999999875 5789999887543 344556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+|||++.++ .++|+|||++..+.
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~------~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG------EIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC------cEEEccCCCccccc
Confidence 99999999998764 68899999999999999999997 6899999999999999887 48999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=206.81 Aligned_cols=140 Identities=23% Similarity=0.331 Sum_probs=120.4
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc---CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV---RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
||+|+||.||+|... ++.||+|++..... .......+..|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 68999999975432 122234455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~------~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG------HIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC------CEEEecCCcCcCC
Confidence 99999987654 689999999999999999999999999999999999999988 5899999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=202.02 Aligned_cols=148 Identities=26% Similarity=0.415 Sum_probs=130.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|.+.++||+|+||.||+|++. ++.||+|.++..... .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 356899999999999999999875 688999998754322 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||++ ++|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++...
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~------~~kl~dfg~~~~~ 154 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG------ELKLADFGLARAK 154 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC------cEEECcCcchhcc
Confidence 9996 699999987666788999999999999999999999999999999999999988 5899999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=197.34 Aligned_cols=142 Identities=27% Similarity=0.475 Sum_probs=125.6
Q ss_pred EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 252 KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+||+|+||.||+|.+. ++.+|+|+++....+....+.+..|+.+++.++||||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999763 5789999998766555667889999999999999999999999864 4679999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..+..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~------~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH------YAKISDFGLSKALGA 147 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC------eEEECCCccccccCC
Confidence 9999997654 688999999999999999999999999999999999999877 589999999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=200.84 Aligned_cols=148 Identities=26% Similarity=0.452 Sum_probs=132.7
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||++.+. ++.||+|.++.. .....+.+.+|+.++++++||||+++++.+..+...|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 345788889999999999999885 688999998754 3344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+++++|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~------~~~l~d~g~~~~~ 153 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG------DVKLADFGVSAKN 153 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC------CEEEccCccchhh
Confidence 99999999999987655789999999999999999999999999999999999999888 5999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=205.52 Aligned_cols=145 Identities=22% Similarity=0.366 Sum_probs=127.2
Q ss_pred EEEEEeec--CceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 249 FEHKIVSG--SYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 249 ~~~~IG~G--sfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
+.++||+| +|+.||++... ++.||+|.++...........+.+|+.+++.++||||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999875 688999999876555555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 325 SGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 325 ~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|||++.++ .++++|||.+...
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~------~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG------KVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC------cEEEcccchhhcc
Confidence 999999999764 23588999999999999999999999999999999999999888 4788898865543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=194.86 Aligned_cols=148 Identities=24% Similarity=0.409 Sum_probs=130.7
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH---HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
+.|++.+.||+|+||.||++... ++.||+|.+....... ...+.+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 35788999999999999999764 6899999987553322 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|||+++++|.+++.... .++...+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++..+
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~------~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG------NVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------CEEEeecccceec
Confidence 999999999999997654 588889999999999999999999999999999999999887 5999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=202.86 Aligned_cols=152 Identities=24% Similarity=0.480 Sum_probs=130.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
|+...|++.++||+|+||.||+|.+. ++.||+|+++... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45566888899999999999999864 3679999997543 334456789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~---------------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~ 379 (411)
...++++||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998632 1236778889999999999999999999999999999999987
Q ss_pred CCcCCCccEEEEecccccccc
Q 015237 380 GVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 380 g~~k~~~~ikL~DFGla~~~~ 400 (411)
+ .+||+|||++....
T Consensus 161 ~------~~kl~Dfg~~~~~~ 175 (283)
T cd05091 161 L------NVKISDLGLFREVY 175 (283)
T ss_pred C------ceEecccccccccc
Confidence 7 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=198.02 Aligned_cols=149 Identities=23% Similarity=0.333 Sum_probs=134.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||+|++. ++.||+|++............+.+|+.+++.++||||+++++++.....+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999875 68999999987655455567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+ +++|.+++......+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||.+.....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~------~~~l~dfg~~~~~~~ 151 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG------VLKIADFGLARLFSE 151 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC------cEEEeeeeecccccC
Confidence 9 9999999977656789999999999999999999999999999999999999987 589999999887644
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=200.68 Aligned_cols=149 Identities=23% Similarity=0.347 Sum_probs=132.1
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC---HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+|++.+.||+|+||.||+|.+. ++.||||.++..... ......+..|+.+++.++|+||+++++++...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3778899999999999999875 689999999876543 33445678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+ +|+|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.+| .++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~------~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG------VLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC------CEEEccceeeeecc
Confidence 9999 9999999976544689999999999999999999999999999999999999988 58999999998764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 154 ~ 154 (298)
T cd07841 154 S 154 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=213.69 Aligned_cols=148 Identities=26% Similarity=0.391 Sum_probs=122.6
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-----
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----- 313 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----- 313 (411)
......|++.++||+|+||.||+|... ++.||||.+.... ....+|+.+|+.++||||+++++++..
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 345567999999999999999999874 6889999886542 234579999999999999999887632
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 314 ---PPRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 314 ---~~~l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
...+++||||++ ++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++. .
T Consensus 136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-----~ 209 (440)
T PTZ00036 136 NEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-----T 209 (440)
T ss_pred CCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-----c
Confidence 124789999996 578777753 2346889999999999999999999999999999999999987652 4
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
+||+|||+|+.+.
T Consensus 210 vkL~DFGla~~~~ 222 (440)
T PTZ00036 210 LKLCDFGSAKNLL 222 (440)
T ss_pred eeeeccccchhcc
Confidence 8999999998664
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=197.43 Aligned_cols=146 Identities=29% Similarity=0.492 Sum_probs=126.3
Q ss_pred ceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRL 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l 317 (411)
.|++.+.||+|+||.||.+.+. ++.||+|.++... .......+.+|+.++++++||||+++++++... ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3588999999999999887642 4679999987653 233456788999999999999999999988653 458
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|++|||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR------LVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC------cEEEeeccccc
Confidence 9999999999999999764 489999999999999999999999999999999999999887 58999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 156 ~~~ 158 (283)
T cd05080 156 AVP 158 (283)
T ss_pred ccC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=201.28 Aligned_cols=148 Identities=23% Similarity=0.393 Sum_probs=130.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.++||+|+||.||++++. ++.||+|.++...........+.+|+.+++.++||||+++++++.....+|+++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3788899999999999999985 68899999976543333345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+. ++|.+++......+++..+..++.||+.||.|||+++|+||||||+||+++.++ .++|+|||++..+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~------~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG------ELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC------cEEECccchhhccC
Confidence 95 689888876655789999999999999999999999999999999999999888 59999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-23 Score=198.65 Aligned_cols=147 Identities=22% Similarity=0.290 Sum_probs=128.4
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
|+..+.||+|+||.||++.+. ++.||+|.+...... ......+.+|+.+++.++|+||+.+++.+...+.+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999885 689999998765332 22345577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++...
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~------~~~l~Dfg~~~~~ 152 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG------HIRISDLGLAVHV 152 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC------CEEEeeccceeec
Confidence 99999999886543 3588899999999999999999999999999999999999887 5899999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=198.56 Aligned_cols=143 Identities=22% Similarity=0.322 Sum_probs=123.3
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||+|+||.||++... ++.||+|.+....... .....+..|++++++++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999875 6899999987543322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 330 YDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 330 ~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++..+..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~------~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG------NCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC------CEEEeeceeeeecCC
Confidence 98886543 3588888999999999999999999999999999999999888 589999999886643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=197.90 Aligned_cols=154 Identities=29% Similarity=0.495 Sum_probs=132.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
+....|++.+.||+|+||.||+|.+.+ ..|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 445678999999999999999998853 578999876443 233446789999999999999999999999988
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccE
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
...+++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||+++.++.. ..+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~---~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG---RVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCC---cce
Confidence 89999999999999999997653 247889999999999999999999999999999999999876632 248
Q ss_pred EEEeccccccc
Q 015237 389 YLSNFLSISTV 399 (411)
Q Consensus 389 kL~DFGla~~~ 399 (411)
||+|||++..+
T Consensus 159 kl~dfg~~~~~ 169 (277)
T cd05036 159 KIADFGMARDI 169 (277)
T ss_pred EeccCcccccc
Confidence 99999999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=197.94 Aligned_cols=148 Identities=25% Similarity=0.445 Sum_probs=125.5
Q ss_pred EEEeecCceEEEEEEECC--------------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 251 HKIVSGSYCDLYKGAFFS--------------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~--------------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
+.||+|+||.||+|++.. ..|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998531 258899876543 3345678899999999999999999999999889
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC-CCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD-SDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k-~~~~ikL~DFGl 395 (411)
.+++|||+++|+|..++......+++..++.++.||+.||.|||+++|+||||||+|||++.++..+ ....++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999999887666789999999999999999999999999999999999998876422 222489999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 159 ~~~~~ 163 (262)
T cd05077 159 PITVL 163 (262)
T ss_pred Ccccc
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=198.97 Aligned_cols=147 Identities=27% Similarity=0.416 Sum_probs=129.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.+.||+|+||.||+|... ++.||||.+...... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 56889999999999999999875 688999998754322 122456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+. ++|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++.+| .+||+|||++...
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~------~~kl~dfg~~~~~ 153 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG------ELKLADFGLARAK 153 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC------CEEECcccccccc
Confidence 996 599999987665789999999999999999999999999999999999999988 5999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=199.03 Aligned_cols=151 Identities=25% Similarity=0.503 Sum_probs=132.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
|.+..|.+.+.||+|+||.||++... +..+|+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45678999999999999999999752 245899988654 344567799999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~ 382 (411)
..+|++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-- 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-- 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--
Confidence 99999999999999999997543 2488999999999999999999999999999999999999888
Q ss_pred CCCccEEEEecccccccc
Q 015237 383 DSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 383 k~~~~ikL~DFGla~~~~ 400 (411)
.++|+|||++..+.
T Consensus 158 ----~~kl~dfg~~~~~~ 171 (288)
T cd05093 158 ----LVKIGDFGMSRDVY 171 (288)
T ss_pred ----cEEeccCCcccccc
Confidence 58999999997553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=206.16 Aligned_cols=147 Identities=22% Similarity=0.288 Sum_probs=126.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC------C
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------~ 315 (411)
..+|++.+.||+|+||.||++... ++.||||.+..........+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 467999999999999999999874 68899999976554555567788999999999999999999988643 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..|+||||+. +++.+++.. .++...+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~------~~kl~Dfg~ 165 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGL 165 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC------CEEEeeCcc
Confidence 5799999995 577777753 478888999999999999999999999999999999999888 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+....
T Consensus 166 ~~~~~ 170 (355)
T cd07874 166 ARTAG 170 (355)
T ss_pred cccCC
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=193.78 Aligned_cols=150 Identities=21% Similarity=0.370 Sum_probs=132.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
..|++.+.||+|+||.||+|... ++.||+|.++.... .....+.+.+|+.++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46899999999999999999885 78999999875432 3344678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 322 EFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||+++|+|.+++... ...++...++.++.+++.||.|||+.||+|+||||+||+++.++ .++|+|||.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~------~~~l~d~~~~~~ 155 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG------VVKLGDLGLGRF 155 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC------cEEEeccceeee
Confidence 999999999998642 33578899999999999999999999999999999999999888 589999999875
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 156 ~~ 157 (267)
T cd08224 156 FS 157 (267)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=191.71 Aligned_cols=148 Identities=21% Similarity=0.353 Sum_probs=130.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.++||+|+||.||++.+. ++.+|+|.++.... ....+.+.+|+.+++.++|+||+++++.+.....+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 3788999999999999999875 68899999875432 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++|+|.+++.... ..++...+..++.|++.||.|||++||+|+||||+||+++.++ .++++|||++..+.
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~------~~~l~dfg~~~~~~ 151 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG------KVKLGDFGSARLLT 151 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC------cEEEcccCcceeec
Confidence 99999999987643 3578899999999999999999999999999999999999888 58999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=199.07 Aligned_cols=148 Identities=26% Similarity=0.402 Sum_probs=130.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|++.++||+|+||.||+|.+. ++.||+|.+..........+.+.+|+.+++.++||||+++++++......|+||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5888999999999999999985 68899999876544434456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++|..+.... ..+++..++.++.|++.||.|||+.+++|+||+|+||++++++ .++|+|||++..+.
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~------~~~l~dfg~~~~~~ 151 (286)
T cd07846 82 VDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG------VVKLCDFGFARTLA 151 (286)
T ss_pred CCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC------cEEEEeeeeeeecc
Confidence 9988888776544 3589999999999999999999999999999999999999988 59999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=199.63 Aligned_cols=148 Identities=33% Similarity=0.542 Sum_probs=127.7
Q ss_pred CceEEEEEEeecCceEEEEEEECC----ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~~----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~I 319 (411)
+.|++.+.||+|+||.||+|.... ..+++|.++... .....+.+.+|+.++.++ +||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 568999999999999999998752 247888876432 334456789999999999 79999999999999889999
Q ss_pred EEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC
Q 015237 320 VTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~ 384 (411)
+|||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~---- 156 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL---- 156 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC----
Confidence 999999999999997642 2477889999999999999999999999999999999999887
Q ss_pred CccEEEEeccccccc
Q 015237 385 DIHCYLSNFLSISTV 399 (411)
Q Consensus 385 ~~~ikL~DFGla~~~ 399 (411)
.+||+|||++...
T Consensus 157 --~~kl~dfg~~~~~ 169 (297)
T cd05089 157 --ASKIADFGLSRGE 169 (297)
T ss_pred --eEEECCcCCCccc
Confidence 5899999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=202.67 Aligned_cols=145 Identities=19% Similarity=0.368 Sum_probs=118.2
Q ss_pred EEEEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEEEEEec
Q 015237 250 EHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIVTEF 323 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~IV~E~ 323 (411)
+++||+|+||.||+|... ++.||+|.+...... ..+.+|+.+|+.++||||+++++++.. ...+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 367999998765432 456789999999999999999998854 4568999999
Q ss_pred CCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 324 MSGGSIYDYLHKQK--------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 324 ~~gGsL~~~L~~~~--------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++... ..+||+|||+
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~--~~~kl~DfG~ 158 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER--GRVKIADMGF 158 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCc--CcEEEeecCc
Confidence 9 568988876421 2478888999999999999999999999999999999995432111 1599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+.+
T Consensus 159 a~~~~~ 164 (317)
T cd07868 159 ARLFNS 164 (317)
T ss_pred eeccCC
Confidence 976643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=219.56 Aligned_cols=154 Identities=29% Similarity=0.406 Sum_probs=134.2
Q ss_pred EEEEEeecCceEEEEEEEC--CceEEEEEeeccc-cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 249 FEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
=+..||.|+||.||.+++. .+.||||.+.-.. .+.+-++++..|+..|++++|||+|.+-|||......|+|||||
T Consensus 30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC- 108 (948)
T KOG0577|consen 30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC- 108 (948)
T ss_pred HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-
Confidence 3567999999999999875 5889999987543 34456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc---cc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI---LV 402 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~---~~ 402 (411)
-||-.|++.-.+.++.+-.+..|+.+.+.||.|||+.+.||||||+.|||+++.|. +||+|||+|+... +-
T Consensus 109 lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~------VKLaDFGSAsi~~PAnsF 182 (948)
T KOG0577|consen 109 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL------VKLADFGSASIMAPANSF 182 (948)
T ss_pred hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe------eeeccccchhhcCchhcc
Confidence 66999999877778999999999999999999999999999999999999999994 8999999999863 33
Q ss_pred eeeEEEE
Q 015237 403 IFSCILV 409 (411)
Q Consensus 403 ~~~~i~~ 409 (411)
+..+.|+
T Consensus 183 vGTPywM 189 (948)
T KOG0577|consen 183 VGTPYWM 189 (948)
T ss_pred cCCcccc
Confidence 4444443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=211.93 Aligned_cols=148 Identities=24% Similarity=0.367 Sum_probs=129.7
Q ss_pred EEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
.+.||+|.||.||-|+++ |++||||++.+..........+..|+.||+++.||.||.+.-.|+.++.++.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 468999999999999875 799999999987766666678999999999999999999999999999999999999 45
Q ss_pred CHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 328 SIY-DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 328 sL~-~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
++. -+|....+.+++.....+..||+.||.|||.+||+|+||||+|||+..... -.++||||||.|+.+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~---FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASP---FPQVKLCDFGFARIIGE 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCC---CCceeeccccceeecch
Confidence 654 456666778999999999999999999999999999999999999987642 22799999999988744
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=193.16 Aligned_cols=142 Identities=32% Similarity=0.579 Sum_probs=126.2
Q ss_pred EEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
+.||+|+||.||+|... ++.+|+|.++... .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999875 5789999987553 334456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 330 ~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.+++......+++..+..++.|++.+|.|+|++|++|+||||+||+++.++ .++|+|||++...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~------~~~l~d~g~~~~~ 143 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN------VLKISDFGMSRQE 143 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC------eEEECCCccceec
Confidence 999977655688999999999999999999999999999999999999888 5899999998754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=193.17 Aligned_cols=144 Identities=38% Similarity=0.659 Sum_probs=130.0
Q ss_pred EEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 251 HKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
+.||+|+||.||++... +..|++|.++...... ..+.+.+|+.+++.++|+||+++++++.....++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 36899999999999886 6789999998765433 46789999999999999999999999999899999999999
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 326 GGSIYDYLHKQ--------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 326 gGsL~~~L~~~--------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+++|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||.+.
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~------~~~l~dfg~~~ 153 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL------VVKISDFGLSR 153 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC------cEEEccccccc
Confidence 99999999876 35789999999999999999999999999999999999999987 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
....
T Consensus 154 ~~~~ 157 (262)
T cd00192 154 DVYD 157 (262)
T ss_pred cccc
Confidence 8755
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=196.63 Aligned_cols=144 Identities=28% Similarity=0.473 Sum_probs=126.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||+|.+. ++.||+|++.... .....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 5788899999999999999874 6889999987543 334456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|..+. .+++..+..++.|++.||.|||++||+|+||||+|||++.++ .++|+|||++..+..
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~------~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG------QVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC------CEEEeeCCcceeccc
Confidence 9999986542 467888999999999999999999999999999999999988 599999999976543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=198.86 Aligned_cols=151 Identities=25% Similarity=0.514 Sum_probs=131.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
+....|.+.+.||+|+||.||+|... +..||+|+++.... ....+.+.+|+++|+.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34567888999999999999999763 36799999875432 33457899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~ 381 (411)
...|++|||+++++|.+++...+ ..+++..+..++.|++.|+.|||++|++||||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~- 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL- 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence 99999999999999999997642 2467888999999999999999999999999999999999987
Q ss_pred cCCCccEEEEeccccccc
Q 015237 382 RDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~ 399 (411)
.++|+|||++..+
T Consensus 160 -----~~kl~d~g~~~~~ 172 (280)
T cd05049 160 -----VVKIGDFGMSRDV 172 (280)
T ss_pred -----eEEECCcccceec
Confidence 5999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=224.49 Aligned_cols=149 Identities=18% Similarity=0.312 Sum_probs=130.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+|++.++||+|+||.||+|.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46889999999999999999875 68999999976432 2345677999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 322 EFMSGGSIYDYLHKQ----------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 322 E~~~gGsL~~~L~~~----------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
||++||+|.+++... ...++...++.++.||+.||.|||++||+||||||+|||++.+| .++|+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg------~vKLi 155 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG------EVVIL 155 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC------CEEEE
Confidence 999999999998642 11345667889999999999999999999999999999999988 58999
Q ss_pred eccccccc
Q 015237 392 NFLSISTV 399 (411)
Q Consensus 392 DFGla~~~ 399 (411)
|||++...
T Consensus 156 DFGLAk~i 163 (932)
T PRK13184 156 DWGAAIFK 163 (932)
T ss_pred ecCcceec
Confidence 99999876
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=208.08 Aligned_cols=141 Identities=19% Similarity=0.314 Sum_probs=125.4
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
....|++.+.||+|+||.||+|++. ++.||+|+.... ....|+.++++++|+||+++++++......|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3456999999999999999999986 468999985432 234689999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||++ .++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~------~~kl~DfG~a~~ 206 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD------QVCIGDLGAAQF 206 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------CEEEecCccccc
Confidence 9999 5699999987666789999999999999999999999999999999999999888 589999999874
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=198.53 Aligned_cols=149 Identities=32% Similarity=0.507 Sum_probs=131.4
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+...|++.++||+|+||.||++... ++.||+|.++.... .....+.+|+.+++.++||||+++++.+...+.+|++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3456788889999999999999874 68899999876532 2335678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++|.+++...+ .+++..+..++.|++.|+.|||++|++|+||||+||+++.++ .++|+|||++..+.
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~------~~~l~dfg~~~~~~ 157 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG------HVKLADFGVSAQIT 157 (267)
T ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------CEEECcceeeeEcc
Confidence 99999999999987654 689999999999999999999999999999999999999887 58999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=197.65 Aligned_cols=148 Identities=24% Similarity=0.411 Sum_probs=122.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc---CCCceeEEEeeeec-----CC
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACTR-----PP 315 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~-----~~ 315 (411)
.|++.+.||+|+||.||++... ++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999885 68899999876433222234456777777665 79999999998864 34
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
.++++|||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~------~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG------QVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------CEEECccC
Confidence 5899999996 58999887643 3589999999999999999999999999999999999999888 58999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 154 ~~~~~~ 159 (288)
T cd07863 154 LARIYS 159 (288)
T ss_pred cccccc
Confidence 987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=193.12 Aligned_cols=148 Identities=25% Similarity=0.413 Sum_probs=128.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc---CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRL 317 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l 317 (411)
..|++.+.||+|+||.||.|... +..||||.+..... .....+.+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999875 68899999864321 123456789999999999999999999988763 468
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~------~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG------NVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC------CEEECcCcccc
Confidence 89999999999999997654 578888999999999999999999999999999999999887 58999999887
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 155 ~~ 156 (265)
T cd06652 155 RL 156 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=198.25 Aligned_cols=146 Identities=25% Similarity=0.329 Sum_probs=130.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+|++.+.||+|+||.||++... ++.|++|.+...... ......+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999876 578999998765432 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|++|++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~------~~~l~dfg~~~~ 150 (305)
T cd05609 82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG------HIKLTDFGLSKI 150 (305)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC------CEEEeeCCCccc
Confidence 999999999997654 688899999999999999999999999999999999999888 589999998863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=198.66 Aligned_cols=146 Identities=27% Similarity=0.509 Sum_probs=126.5
Q ss_pred eEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
|++.+.||+|+||.||+|.... ..+++|.+..... ......+.+|+.+++.++||||+++++.|...+..++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 6788999999999999998642 4688998865432 3334678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 015237 320 VTEFMSGGSIYDYLHKQK-----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~-----------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi 376 (411)
+|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999999999986531 236788889999999999999999999999999999999
Q ss_pred ccCCCcCCCccEEEEeccccccc
Q 015237 377 NENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 377 d~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++++ .+||+|||++..+
T Consensus 161 ~~~~------~~kl~dfg~~~~~ 177 (290)
T cd05045 161 AEGR------KMKISDFGLSRDV 177 (290)
T ss_pred cCCC------cEEeccccccccc
Confidence 9887 5899999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-23 Score=195.29 Aligned_cols=151 Identities=24% Similarity=0.408 Sum_probs=131.7
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
++.+.|+....||+|+||.||+|+.. .+.|++|.+.... .....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34567899999999999999999863 3569999886543 233567899999999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKC--------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDI 386 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~--------~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~ 386 (411)
...|+||||+++|+|.+++..... .+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~------ 154 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR------ 154 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC------
Confidence 899999999999999999976541 478999999999999999999999999999999999999988
Q ss_pred cEEEEeccccccc
Q 015237 387 HCYLSNFLSISTV 399 (411)
Q Consensus 387 ~ikL~DFGla~~~ 399 (411)
.++++|||++...
T Consensus 155 ~~~l~~~~~~~~~ 167 (275)
T cd05046 155 EVKVSLLSLSKDV 167 (275)
T ss_pred cEEEccccccccc
Confidence 5899999998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-25 Score=210.92 Aligned_cols=155 Identities=29% Similarity=0.420 Sum_probs=139.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+-|.+.++||+|+||.||++.++ |+.+|||.+..+. ..+++..|+.||++|+.|++|++||.+-....+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 34667889999999999999875 7999999987553 35889999999999999999999999988888999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc---
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV--- 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~--- 399 (411)
||..|++.++++.++..+.+..+..+....++||+|||...-||||||+.|||++.+| .+||+|||.|..+
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G------~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG------IAKLADFGVAGQLTDT 182 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc------hhhhhhccccchhhhh
Confidence 9999999999998888899999999999999999999999999999999999999999 5899999999876
Q ss_pred ----ccceeeEEEE
Q 015237 400 ----ILVIFSCILV 409 (411)
Q Consensus 400 ----~~~~~~~i~~ 409 (411)
++.+..++|+
T Consensus 183 MAKRNTVIGTPFWM 196 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWM 196 (502)
T ss_pred HHhhCccccCcccc
Confidence 4456666665
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=206.48 Aligned_cols=145 Identities=19% Similarity=0.356 Sum_probs=126.9
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
.+....|.+.++||+|+||.||++... +..||+|.+... ....+|+.+|++++||||+++++++.....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 445567999999999999999999764 367999988643 235679999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~------~~~l~DfG~a 232 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE------NAVLGDFGAA 232 (392)
T ss_pred EEEEehhc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC------CEEEccCccc
Confidence 99999999 57999998543 4689999999999999999999999999999999999999988 5899999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 233 ~~~~ 236 (392)
T PHA03207 233 CKLD 236 (392)
T ss_pred cccC
Confidence 7654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=195.59 Aligned_cols=141 Identities=25% Similarity=0.377 Sum_probs=121.0
Q ss_pred EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 252 KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
.||+|+||.||+|.+. +..+|+|.++.... ......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 5899999999999864 25689998876542 233457889999999999999999999999988999999999999
Q ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++.... ...++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||.+...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~------~~kL~dfg~~~~~ 150 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL------TVKIGDYGLSHNK 150 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC------cEEECCccccccc
Confidence 9999997542 1356677888999999999999999999999999999999877 5999999998653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=205.42 Aligned_cols=147 Identities=22% Similarity=0.287 Sum_probs=126.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC------C
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------~ 315 (411)
..+|++.+.||+|+||.||++... ++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999875 68899999976544445557788999999999999999999987543 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+||||+. ++|.+++.. .++...+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGL 172 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC------cEEEEeCCC
Confidence 5799999995 578887753 478888999999999999999999999999999999999888 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+....
T Consensus 173 a~~~~ 177 (364)
T cd07875 173 ARTAG 177 (364)
T ss_pred ccccC
Confidence 97653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=198.42 Aligned_cols=151 Identities=24% Similarity=0.446 Sum_probs=131.8
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
++..+|++.++||+|+||.||++.+. +..||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 55677999999999999999999763 4679999987543 344457799999999999999999999999998
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK---------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~---------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
...|++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 89999999999999999997532 136778889999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEeccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++.++ .++|+|||++..+
T Consensus 161 il~~~~~------~~~l~dfg~~~~~ 180 (288)
T cd05050 161 CLVGENM------VVKIADFGLSRNI 180 (288)
T ss_pred eEecCCC------ceEECccccceec
Confidence 9999888 5899999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=195.51 Aligned_cols=149 Identities=19% Similarity=0.331 Sum_probs=133.8
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
.|++.+.||+|+||.||++... ++.||+|++...... ....+.+.+|++++++++||||+++++.+..+..+|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4789999999999999999886 689999999765432 2456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+.|++|.+++... ..++...+..++.|++.||.|||+++++|+||||+||++++++ .++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~------~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG------HVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC------CEEEeecccccccCC
Confidence 99999999999876 3688999999999999999999999999999999999999988 589999999887644
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=196.31 Aligned_cols=147 Identities=27% Similarity=0.385 Sum_probs=127.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.+.||+|+||.||+|... ++.||+|.++.... ......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 56889999999999999999875 68999999875432 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+ ++++.+++......+++..+..++.|++.||.|||+++|+|+||||+|||++.++ .++|+|||++...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~------~~~l~Dfg~~~~~ 153 (291)
T cd07870 84 YM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG------ELKLADFGLARAK 153 (291)
T ss_pred cc-cCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC------cEEEecccccccc
Confidence 99 4788888766555678888899999999999999999999999999999999888 5999999988753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=194.51 Aligned_cols=149 Identities=24% Similarity=0.468 Sum_probs=130.4
Q ss_pred eEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccC----HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~----~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
|+.++.||+|+||.||++.. +++.||+|+++..... ....+.+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 66778999999999999986 3689999998754321 12457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++. .++|+|||.+..+.
T Consensus 82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-----~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-----RLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-----EEEEcccccccccc
Confidence 99999999999997654 6889999999999999999999999999999999999987652 48999999987764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 156 ~ 156 (268)
T cd06630 156 A 156 (268)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=193.49 Aligned_cols=146 Identities=28% Similarity=0.506 Sum_probs=128.8
Q ss_pred eEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccC----HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~----~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
|++.+.||+|+||.||+|... ++.+|+|.++..... ......+.+|+.+++.++|+||+++++++.....+|++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 677889999999999999774 678999998754321 233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++ .++|+|||++..+
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~------~~~l~dfg~~~~~ 152 (265)
T cd06631 82 EFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG------IIKLIDFGCARRL 152 (265)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC------eEEeccchhhHhh
Confidence 9999999999997654 588999999999999999999999999999999999999888 5999999998764
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-22 Score=193.10 Aligned_cols=152 Identities=23% Similarity=0.351 Sum_probs=129.7
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|++.........||+|+||.||+|.+. +..|++|.+.... ....+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 445555556678999999999999875 4679999886543 334567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGL--KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l--~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+++||+++++|.+++......+ +...+..++.|++.||.|||+++|+||||||+||+++.+.. .++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-----~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-----VVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-----eEEEecchhh
Confidence 9999999999999998754445 77888899999999999999999999999999999986331 5899999998
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
..+
T Consensus 157 ~~~ 159 (268)
T cd06624 157 KRL 159 (268)
T ss_pred eec
Confidence 754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=211.96 Aligned_cols=154 Identities=24% Similarity=0.397 Sum_probs=140.3
Q ss_pred CceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|.+.+.||+|.|..|-.+++ +|..||||++.+..++.-....+.+|++.|+.++|||||++|.+...+..+|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4588899999999999988764 69999999999988877777789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
+-.+|+|++|+-++...+.+....+++.||+.|+.|+|+..+|||||||+|+.+.+.- . -+||.|||++..|..+
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl----G-lVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL----G-LVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec----C-ceEeeeccccccCCCc
Confidence 9999999999999888899999999999999999999999999999999999986643 2 3899999999998664
Q ss_pred e
Q 015237 403 I 403 (411)
Q Consensus 403 ~ 403 (411)
.
T Consensus 173 ~ 173 (864)
T KOG4717|consen 173 K 173 (864)
T ss_pred c
Confidence 3
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=193.79 Aligned_cols=147 Identities=28% Similarity=0.471 Sum_probs=129.6
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-------HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-------~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
|.+.+.||+|+||.||+|... ++.||+|.+....... ...+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999874 5889999887543221 2346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+++|||+++++|.+++.... .++...+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~------~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG------GIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC------CEEecccCCCc
Confidence 99999999999999997654 688889999999999999999999999999999999999887 58999999988
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=196.02 Aligned_cols=145 Identities=28% Similarity=0.435 Sum_probs=128.8
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|++.++||+|+||.||+|.+. +..+++|.+... .....+.+.+|+.+++.++||||+++++.+......|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 566788999999999999886 567899988654 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++++|..++......+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~------~~kl~dfg~~~~~ 153 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG------DIKLADFGVSAKN 153 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC------CEEEccccccccc
Confidence 99999998876555789999999999999999999999999999999999999888 5999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=191.79 Aligned_cols=148 Identities=24% Similarity=0.466 Sum_probs=133.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||+|... ++.|++|.++.........+.+..|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999874 68899999987655545678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++|.+++.... .+++..+..++.|++.||.|||+++|+|+||+|+||+++.++ .+||+|||++....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~------~~kl~d~g~~~~~~ 150 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG------VIKLGDFGCAVKLK 150 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEEcccccccccC
Confidence 99999999997653 578889999999999999999999999999999999999987 59999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=190.53 Aligned_cols=151 Identities=19% Similarity=0.312 Sum_probs=133.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||++... ++.+|+|.+..........+.+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788999999999999998774 68899999987766556677899999999999999999999999988999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++. .++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-----~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-----VVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-----EEEEccCCCceecCC
Confidence 99999999998753 35889999999999999999999999999999999999986552 479999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-23 Score=196.46 Aligned_cols=151 Identities=25% Similarity=0.463 Sum_probs=131.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
|...++++.++||+|+||.||++... +..+|+|.++.. .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45678899999999999999998642 357889987644 344567899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK--------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~--------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g 380 (411)
...|++|||+++|+|.+++.... ..+++..++.++.|++.|+.|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997643 2478889999999999999999999999999999999999877
Q ss_pred CcCCCccEEEEecccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~~ 400 (411)
.+||+|||++..+.
T Consensus 160 ------~~kL~dfg~~~~~~ 173 (280)
T cd05092 160 ------VVKIGDFGMSRDIY 173 (280)
T ss_pred ------CEEECCCCceeEcC
Confidence 58999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=190.04 Aligned_cols=150 Identities=21% Similarity=0.356 Sum_probs=133.4
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|++.++||+|+||.+|.++.. ++.||+|.+..........+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999998874 68899999976655555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~------~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG------TIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC------CEEEeeccceeecCc
Confidence 99999999997653 3578889999999999999999999999999999999999887 589999999976633
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=198.48 Aligned_cols=147 Identities=27% Similarity=0.431 Sum_probs=130.4
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||++.+. ++.||+|.++... .......+.+|+.++++++|+||+++++++...+.+|+||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5788999999999999999886 6899999987542 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~--~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++ .++|+|||.+..+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~------~~~l~dfg~~~~~ 153 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG------QVKLCDFGVSGNL 153 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC------CEEEeecCCcccc
Confidence 9999999998764 2258999999999999999999996 5999999999999999887 5999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=193.46 Aligned_cols=143 Identities=29% Similarity=0.496 Sum_probs=127.3
Q ss_pred EEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 251 HKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
++||+|+||.||+|.+.. ..||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..++++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998742 36999999876543 556789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 326 GGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 326 gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+|+|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||++..+..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~------~~kl~dfg~~~~~~~ 149 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD------KVKIGDFGLMRALPQ 149 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC------EEEeccccccccccc
Confidence 999999998764 4688999999999999999999999999999999999999987 599999999987644
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=222.90 Aligned_cols=163 Identities=19% Similarity=0.327 Sum_probs=136.5
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR- 313 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~- 313 (411)
.+..++....|.+.++||+|+||.||++++. ++.||+|++............+..|+.+|+.++||||++++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445677778999999999999999999886 5789999998766666667789999999999999999999998854
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCcEEEccCCCc
Q 015237 314 -PPRLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRN-------NIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 314 -~~~l~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~-------gIIHRDLKp~NILid~~g~~ 382 (411)
...+||||||+++|+|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+|||++.....
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45699999999999999999753 23689999999999999999999984 49999999999999754210
Q ss_pred -----------CCCccEEEEeccccccc
Q 015237 383 -----------DSDIHCYLSNFLSISTV 399 (411)
Q Consensus 383 -----------k~~~~ikL~DFGla~~~ 399 (411)
.....+||+|||++..+
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l 192 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNI 192 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccc
Confidence 11224899999998765
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=196.85 Aligned_cols=146 Identities=24% Similarity=0.424 Sum_probs=130.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.++||+|+||.||++... ++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++......|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 56888999999999999999864 689999999765433 23668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++++|.+++.+. .+++..+..++.|++.||.|||+.+++||||||+|||++.++ .++|+|||++....
T Consensus 97 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~------~~~l~Dfg~~~~~~ 166 (297)
T cd06656 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG------SVKLTDFGFCAQIT 166 (297)
T ss_pred ccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEECcCccceEcc
Confidence 99999999999654 478889999999999999999999999999999999999888 58999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=196.43 Aligned_cols=151 Identities=25% Similarity=0.473 Sum_probs=130.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
+....|.+.+.||+|+||.||+|.+. +..+++|.++... ....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34567889999999999999999753 2458889886543 33446789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~ 379 (411)
...++||||+++++|.+++.... ..+++..++.++.||+.|+.|||+++|+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997642 237888999999999999999999999999999999999988
Q ss_pred CCcCCCccEEEEecccccccc
Q 015237 380 GVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 380 g~~k~~~~ikL~DFGla~~~~ 400 (411)
+ .++|+|||++....
T Consensus 160 ~------~~~l~dfg~a~~~~ 174 (291)
T cd05094 160 L------LVKIGDFGMSRDVY 174 (291)
T ss_pred C------cEEECCCCcccccC
Confidence 7 59999999987553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=189.51 Aligned_cols=149 Identities=23% Similarity=0.363 Sum_probs=130.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-CCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~~~l~IV~E 322 (411)
.|++.+.||.|+||.||++... ++.||+|.+..........+.+.+|+.++++++|+|++++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3789999999999999999875 5789999997765555556778999999999999999999998764 446899999
Q ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++++|.+++.... ..+++..+..++.|++.|+.|||++||+|+||||+||+++.++ .++|+|||++..+.
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~------~~~l~df~~~~~~~ 153 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN------IIKVGDLGIARVLE 153 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC------cEEEecccceEEec
Confidence 999999999998643 3589999999999999999999999999999999999999887 59999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=194.33 Aligned_cols=152 Identities=20% Similarity=0.413 Sum_probs=132.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECC------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-C
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-P 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~ 314 (411)
+..+.|++.+.||+|+||.||+|.+.. ..|++|.++.. ........+.+|+.++++++|+||+++++++.. +
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 567889999999999999999998753 77999988643 244456778999999999999999999998765 4
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
...++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+++.++ .
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~------~ 155 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL------Q 155 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC------c
Confidence 67899999999999999997642 3488999999999999999999999999999999999999887 5
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
+||+|||+++.+.
T Consensus 156 ~kl~d~g~~~~~~ 168 (280)
T cd05043 156 VKITDNALSRDLF 168 (280)
T ss_pred EEECCCCCccccc
Confidence 8999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=198.53 Aligned_cols=151 Identities=23% Similarity=0.318 Sum_probs=132.1
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l~IV 320 (411)
..|++.+.||+|+||.||+|++. ++.+++|.++...........+.+|+.++++++||||+++++++... ..+|++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 45888899999999999999986 68899999986654433445677899999999999999999998776 789999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+. ++|.+++......+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++..+.
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~------~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG------ILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC------cEEEeecCceeecc
Confidence 99996 599999887655689999999999999999999999999999999999999988 59999999988765
Q ss_pred cc
Q 015237 401 LV 402 (411)
Q Consensus 401 ~~ 402 (411)
..
T Consensus 158 ~~ 159 (293)
T cd07843 158 SP 159 (293)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=211.88 Aligned_cols=142 Identities=21% Similarity=0.293 Sum_probs=126.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+.+|++++|+||+++++++...+..|++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 446899999999999999999986 57899996422 23568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|++ .++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~------~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE------DICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC------CEEEcccCCceecc
Confidence 999 5799999877655799999999999999999999999999999999999999887 58999999997653
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=195.82 Aligned_cols=145 Identities=23% Similarity=0.430 Sum_probs=129.6
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.+.||+|+||.||+|... ++.|++|.+....... .+.+.+|+.+++.+.|+||+++++.+......|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 46888999999999999999864 6889999987654332 3668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++++|.+++... .++...+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++...
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~------~~kl~dfg~~~~~ 166 (296)
T cd06654 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------SVKLTDFGFCAQI 166 (296)
T ss_pred ccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------CEEECccccchhc
Confidence 99999999998653 478889999999999999999999999999999999999887 5899999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=190.61 Aligned_cols=148 Identities=39% Similarity=0.634 Sum_probs=131.5
Q ss_pred eEEEEEEeecCceEEEEEEECC------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+++.+.||.|+||.||++.+.. ..||+|.++.... ....+.+..|+.+++.++|+||+++++++......|++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998864 7799999976543 22457899999999999999999999999998999999
Q ss_pred EecCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~-l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||+++++|.+++...... +++..+..++.|++.|+.|||+.+++|+||||+||+++.++ .++|+|||.+...
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~------~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL------VVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC------eEEEcccCCceec
Confidence 9999999999999875544 89999999999999999999999999999999999999988 5999999999776
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 154 ~~ 155 (258)
T smart00219 154 YD 155 (258)
T ss_pred cc
Confidence 54
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-24 Score=220.42 Aligned_cols=156 Identities=27% Similarity=0.403 Sum_probs=139.1
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC---C--ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF---S--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
.--|+.+.+++.++||+|+||.|++|.|+ | -.||||+++.+.... ....|++|+.+|.+|+|+|+|++||+..+
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 34577888999999999999999999997 2 469999999887654 67899999999999999999999999987
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~-~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
..+.+|||+++.|||.+.|++ ....|....+..++.||+.||.||.++++|||||.++|+|+...- .+||||
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr------tVKI~D 255 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR------TVKICD 255 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc------eeeeec
Confidence 568999999999999999998 444688888999999999999999999999999999999998755 489999
Q ss_pred cccccccccc
Q 015237 393 FLSISTVILV 402 (411)
Q Consensus 393 FGla~~~~~~ 402 (411)
||+.+.+..+
T Consensus 256 FGLmRaLg~n 265 (1039)
T KOG0199|consen 256 FGLMRALGEN 265 (1039)
T ss_pred ccceeccCCC
Confidence 9999987554
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=193.63 Aligned_cols=149 Identities=21% Similarity=0.365 Sum_probs=128.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.++||.|+||.||+|... ++.||+|.+............+.+|+.+++.++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999875 6889999987654443445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|++ ++|.+++..... .+++..+..++.||+.||.|||+++++|+||||+||+++.++. .+||+|||++..+
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-----~~kl~dfg~~~~~ 153 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-----ALKLADFGLARAF 153 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-----EEEEccccccccc
Confidence 995 588888865432 3677888899999999999999999999999999999986552 5899999999765
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=192.20 Aligned_cols=147 Identities=26% Similarity=0.407 Sum_probs=124.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHH-HhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHI-MRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~i-L~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+|++.+.||+|+||.||++.+. ++.||||.++....... ...+..|+.+ ++..+||||+++++++.....+|++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5889999999999999999885 68999999976543332 3445556665 666789999999999999999999999
Q ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 323 FMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 323 ~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|++ |+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~------~~kl~dfg~~~~ 153 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG------QVKLCDFGISGY 153 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC------CEEEeecccccc
Confidence 995 6898887653 23588999999999999999999997 999999999999999988 599999999876
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 154 ~~ 155 (283)
T cd06617 154 LV 155 (283)
T ss_pred cc
Confidence 53
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=190.46 Aligned_cols=148 Identities=30% Similarity=0.479 Sum_probs=133.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||+|.+. ++.+++|.++.... .+.+.+|+.++++++|+||+++++.+.....+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 356888999999999999999886 58899999865421 578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+++++|.+++......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++..+..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~------~~~l~dfg~~~~~~~ 151 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG------QAKLADFGVSGQLTD 151 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC------cEEEcccccchhccc
Confidence 99999999999987666789999999999999999999999999999999999999988 589999999887644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=198.09 Aligned_cols=151 Identities=31% Similarity=0.560 Sum_probs=129.4
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--Cc----eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+...+|+..+.||+|+||.||+|.+. +. .||+|.+..... ......+.+|+.+++.++||||++++|+|...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34566788899999999999999874 33 579998865432 33345688999999999999999999998754
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..++++||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~------~~kL~Dfg~ 155 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN------HVKITDFGL 155 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC------ceEEccccc
Confidence 47799999999999999987665688999999999999999999999999999999999998877 589999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 156 ~~~~~ 160 (303)
T cd05110 156 ARLLE 160 (303)
T ss_pred ccccc
Confidence 98654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=195.93 Aligned_cols=150 Identities=28% Similarity=0.444 Sum_probs=128.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 315 (411)
.+.|++.++||+|+||.||++... ++.||||.+............+.+|+.++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 456899999999999999999875 689999998755433333345678999999999999999999986543
Q ss_pred --eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 316 --RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 316 --~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..|+||||+. ++|.+++......+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~------~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG------ILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC------cEEECcC
Confidence 4599999995 589888877655789999999999999999999999999999999999999888 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 164 g~~~~~~ 170 (310)
T cd07865 164 GLARAFS 170 (310)
T ss_pred CCccccc
Confidence 9997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=194.36 Aligned_cols=149 Identities=19% Similarity=0.377 Sum_probs=130.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+.|++.+.||+|+||.||++... ++.+|||.+..... .......+.+|+.+++.++|+||+++++++...+.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35778889999999999999864 68999998865432 3345578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 322 EFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~------~~~l~dfg~~~~ 155 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG------VVKLGDLGLGRF 155 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------CEEECcchhhhc
Confidence 999999999988642 33578899999999999999999999999999999999999887 599999998876
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
+
T Consensus 156 ~ 156 (267)
T cd08229 156 F 156 (267)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=189.05 Aligned_cols=149 Identities=30% Similarity=0.469 Sum_probs=133.1
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||.|+||.||+|... +..+++|++....... ..+.+.+|+.+++.++|+||+++++.+......|++||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 5888999999999999999874 5789999997655443 457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~--~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++++++ .++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~------~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG------SVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC------CEEEcccchHHHhcc
Confidence 99999999997642 3588999999999999999999999999999999999999887 599999999877654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=189.90 Aligned_cols=143 Identities=36% Similarity=0.621 Sum_probs=128.3
Q ss_pred EEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
++||+|+||.||++... ++.||+|.++..... .....+.+|+.++++++|+||+++++++......|+||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999876 789999998765443 4557799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 330 ~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.+++......++...+..++.+++.|+.|||+++++||||||+||+++.++ .++|+|||.+....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~------~~~l~d~g~~~~~~ 144 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN------VLKISDFGMSREEE 144 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC------cEEEeecccccccc
Confidence 999977655688899999999999999999999999999999999999888 59999999988654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=189.04 Aligned_cols=148 Identities=28% Similarity=0.488 Sum_probs=130.6
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc---CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
|+..+.||+|+||.||+|... ++.|++|.+..... .....+.+.+|+.+++.++|+||+++++++.....+|++|
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999875 68999999875432 2345567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+++++|.+++.... .+++..+..++.|++.|+.|||+.||+|+||+|+||+++.++ .+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~------~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG------VVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEEccCccceeccc
Confidence 9999999999997654 588899999999999999999999999999999999999887 599999999876543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=191.19 Aligned_cols=140 Identities=29% Similarity=0.556 Sum_probs=123.8
Q ss_pred EEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 251 HKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
++||+|+||.||+|.+.. ..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++.. ...+++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 468999999999998742 57999998766543 345678999999999999999999998864 46899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|+|.+++.... .+++..+..++.|++.||.|||.++++|+||||+|||++.++ .+||+|||++..+
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~------~~kl~df~~~~~~ 145 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH------QAKISDFGMSRAL 145 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC------cEEecccccccee
Confidence 999999998765 689999999999999999999999999999999999999888 5899999998866
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=195.93 Aligned_cols=148 Identities=24% Similarity=0.328 Sum_probs=132.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+|++.+.||+|+||.||++... ++.||+|.+....... ...+.+..|+.+++.++|+||+++++.+......|++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5888999999999999999885 5899999998765442 345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+.+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~~l~dfg~~~~~ 153 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG------HIMLSDFDLSKQS 153 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC------CEEEeecchhhcc
Confidence 999999999997653 3688999999999999999999999999999999999999888 5899999998765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=193.36 Aligned_cols=140 Identities=22% Similarity=0.410 Sum_probs=118.4
Q ss_pred EEeecCceEEEEEEEC-C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 252 KIVSGSYCDLYKGAFF-S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~-~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+||+|+||.||+|... + ..+++|.++... .....+.+.+|+.+++.++||||+++++.|......|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999753 2 245666665433 2334578999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 328 SIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 328 sL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+|.+++.... ..++...+..++.||+.||.|||+++++||||||+|||++.++ .++|+|||++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~------~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL------TVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc------cEEecccccccc
Confidence 9999997642 2356667889999999999999999999999999999999887 599999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=192.65 Aligned_cols=154 Identities=27% Similarity=0.418 Sum_probs=130.0
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeee--
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACT-- 312 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~-- 312 (411)
+.+.....+|++.+.||+|+||.||++... ++.+|+|+++.... ....+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 445556778899999999999999999874 68899999865321 235678899999999 6999999999874
Q ss_pred ---cCCeEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCc
Q 015237 313 ---RPPRLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDI 386 (411)
Q Consensus 313 ---~~~~l~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~ 386 (411)
..+.++++|||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~------ 161 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG------ 161 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC------
Confidence 345689999999999999987642 23578888999999999999999999999999999999999988
Q ss_pred cEEEEecccccccc
Q 015237 387 HCYLSNFLSISTVI 400 (411)
Q Consensus 387 ~ikL~DFGla~~~~ 400 (411)
.++|+|||++..+.
T Consensus 162 ~~kl~dfg~~~~~~ 175 (286)
T cd06638 162 GVKLVDFGVSAQLT 175 (286)
T ss_pred CEEEccCCceeecc
Confidence 48999999987653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=190.23 Aligned_cols=143 Identities=24% Similarity=0.440 Sum_probs=121.6
Q ss_pred EEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee-cCCeEEEEEecC
Q 015237 251 HKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLFIVTEFM 324 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~-~~~~l~IV~E~~ 324 (411)
+.||+|+||.||+|.+. ...||+|.+.... .....+.+.+|+.+++.++||||+++++++. .+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999863 2469999875432 2344567889999999999999999999875 455689999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
++|+|.+++......+.+..+..++.|++.|+.|||+++++||||||+|||++.++ .+||+|||++..+.
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~------~~kl~dfg~~~~~~ 149 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF------TVKVADFGLARDIY 149 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC------cEEECCcccccccc
Confidence 99999999987655577788889999999999999999999999999999999887 58999999997653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=193.84 Aligned_cols=149 Identities=19% Similarity=0.312 Sum_probs=129.7
Q ss_pred ceEEEEEEeecCceEEEEEEE-----CCceEEEEEeeccccC--HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
.|++.+.||+|+||.||.+.. .++.||+|+++..... ....+.+.+|+.+++.+ +|+||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 378899999999999999876 4688999998754321 12346688899999999 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~------~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC------CEEEeeCccce
Confidence 99999999999999997654 688899999999999999999999999999999999999887 58999999987
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 154 ~~~~ 157 (290)
T cd05613 154 EFHE 157 (290)
T ss_pred eccc
Confidence 7543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-24 Score=212.97 Aligned_cols=149 Identities=30% Similarity=0.468 Sum_probs=132.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|+..++||.|+||.||+|.+. ++.||||++..+.. +.....+++|+.+|.+++++||.++||.+..+..+||+||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34666689999999999999886 68899999987764 3456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||.||++.+.|+... .+.+..+..++++++.|+.|||.++.||||||++|||+.++| .+||+|||.+..+..
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g------~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG------DVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC------cEEEEecceeeeeec
Confidence 999999999997654 458888888999999999999999999999999999999998 599999999877643
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=193.67 Aligned_cols=149 Identities=26% Similarity=0.353 Sum_probs=130.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.++||+|+||.||+|.+. ++.||+|.++.........+.+.+|+.++++++|+||+++++++...+..|++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5889999999999999999885 68899999876544444567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
++++.+..+... ...++...+..++.||+.||.|||+++++|+||+|+||++++++ .++|+|||.+..+..
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~------~~kl~d~g~~~~~~~ 152 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG------VLKLCDFGFARALRA 152 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC------CEEEEeeecccccCC
Confidence 987666555543 34689999999999999999999999999999999999999887 599999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=192.19 Aligned_cols=147 Identities=29% Similarity=0.521 Sum_probs=126.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecC------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP------ 314 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~------ 314 (411)
...|++.+.||+|+||.||+|... ++.||+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 345777889999999999999875 57899999875432 235688899999998 799999999998652
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||++++++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~------~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA------EVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC------CEEEccC
Confidence 46899999999999999998743 3688999999999999999999999999999999999999988 5999999
Q ss_pred cccccc
Q 015237 394 LSISTV 399 (411)
Q Consensus 394 Gla~~~ 399 (411)
|++..+
T Consensus 156 g~~~~~ 161 (272)
T cd06637 156 GVSAQL 161 (272)
T ss_pred CCceec
Confidence 998764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-22 Score=188.07 Aligned_cols=150 Identities=22% Similarity=0.361 Sum_probs=131.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIVT 321 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~IV~ 321 (411)
.|++.+.||+|+||.||++... ++.||+|.+..........+.+..|+.+++.++|+||+++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3778899999999999999874 5889999998766666667789999999999999999999998753 45689999
Q ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 322 EFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLH-----RNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 322 E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLH-----s~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .+||+||
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~------~~kl~d~ 154 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN------NVKLGDF 154 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC------CEEEecc
Confidence 999999999999764 346889999999999999999999 89999999999999999887 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++.....
T Consensus 155 g~~~~~~~ 162 (265)
T cd08217 155 GLAKILGH 162 (265)
T ss_pred cccccccC
Confidence 99987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=196.41 Aligned_cols=152 Identities=24% Similarity=0.380 Sum_probs=130.6
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLF 318 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l~ 318 (411)
+.+.|++.+.||+|+||.||+|.+. ++.||+|.++...........+.+|+.++++++|+||+++++++... ..++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3467999999999999999999885 68999999976543333334567899999999999999999998754 5689
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+. ++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||.+..
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~------~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG------CLKIADFGLART 157 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------CEEECccceeee
Confidence 9999995 589998877555789999999999999999999999999999999999999888 589999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 158 ~~~ 160 (309)
T cd07845 158 YGL 160 (309)
T ss_pred cCC
Confidence 643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-22 Score=189.30 Aligned_cols=149 Identities=26% Similarity=0.450 Sum_probs=129.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc---cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH---LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRL 317 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l 317 (411)
..|.+.+.||+|+||.||+|... ++.||+|.+.... ........+.+|+.++++++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999874 6889999885432 1234456789999999999999999999998653 468
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~------~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG------NVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC------CEEECcccccc
Confidence 99999999999999997654 588899999999999999999999999999999999999887 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 155 ~~~ 157 (264)
T cd06653 155 RIQ 157 (264)
T ss_pred ccc
Confidence 653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=195.55 Aligned_cols=145 Identities=19% Similarity=0.359 Sum_probs=117.5
Q ss_pred EEEEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEEEEEec
Q 015237 250 EHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIVTEF 323 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~IV~E~ 323 (411)
+.+||+|+||.||+|+.. +..||+|.+...... ..+.+|+.+++.++||||+++++++.. ...+|++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999864 367999998765432 457789999999999999999998853 5678999999
Q ss_pred CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 324 MSGGSIYDYLHKQ--------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 324 ~~gGsL~~~L~~~--------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+. ++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+..++... ..+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~--~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER--GRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCC--CcEEEeeccc
Confidence 95 5888887532 12478888999999999999999999999999999999995432111 1589999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 159 a~~~~~ 164 (317)
T cd07867 159 ARLFNS 164 (317)
T ss_pred eeccCC
Confidence 986643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=195.88 Aligned_cols=152 Identities=23% Similarity=0.368 Sum_probs=130.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC----
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP---- 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~---- 315 (411)
.....|++.+.||+|+||.||+|... ++.||+|.++...........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34466888999999999999999985 688999999765433333456788999999999999999999987654
Q ss_pred ------eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ------~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.+|+++||+++ ++.+++......+++..+..++.|++.||.|||++||+|+||||+||++++++ .+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~------~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG------QIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------cEE
Confidence 79999999965 88888876655789999999999999999999999999999999999999988 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++..+.
T Consensus 157 l~dfg~~~~~~ 167 (302)
T cd07864 157 LADFGLARLYN 167 (302)
T ss_pred eCccccccccc
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=195.03 Aligned_cols=149 Identities=24% Similarity=0.377 Sum_probs=125.8
Q ss_pred EEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 251 HKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+.||+|+||.||+|... ...|++|.+.... ....+.+..|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 36899999999999763 2348888875442 334567889999999999999999999999988999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCC--ccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD--IHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~--~~ikL~DFGla~~~ 399 (411)
||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++.++..+.. ..++++|||.+..+
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999998766578999999999999999999999999999999999999887753211 13799999998765
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 159 ~~ 160 (258)
T cd05078 159 LP 160 (258)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=191.68 Aligned_cols=139 Identities=32% Similarity=0.562 Sum_probs=120.9
Q ss_pred EEeecCceEEEEEEECC----ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 252 KIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
.||+|+||.||+|...+ ..+++|.++... .....+.+.+|+.+++++ +||||+++++++.....+|++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999998753 357888876432 334456789999999999 899999999999999999999999999
Q ss_pred CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 327 GSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 327 GsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~------~~kl~ 154 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY------VAKIA 154 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC------eEEEC
Confidence 99999997542 1367889999999999999999999999999999999999887 58999
Q ss_pred eccccc
Q 015237 392 NFLSIS 397 (411)
Q Consensus 392 DFGla~ 397 (411)
|||++.
T Consensus 155 dfgl~~ 160 (270)
T cd05047 155 DFGLSR 160 (270)
T ss_pred CCCCcc
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=191.03 Aligned_cols=147 Identities=28% Similarity=0.435 Sum_probs=128.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC--------HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN--------ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~--------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.|...+.||+|+||.||+|... ++.||+|.++..... ....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3677889999999999999764 688999988643211 122456888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+++||||+++++|.+++.... .++...+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~------~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG------ICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC------eEEEeeccc
Confidence 9999999999999999998764 688899999999999999999999999999999999999888 599999999
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 155 ~~~~ 158 (272)
T cd06629 155 SKKS 158 (272)
T ss_pred cccc
Confidence 8764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=188.93 Aligned_cols=151 Identities=25% Similarity=0.425 Sum_probs=132.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|.+.+.||+|+||.||++..+ +..||+|.+..........+.+.+|+.+++.++|+||+++++.+.....+|+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3788999999999999999885 58899999977644444456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++..... .+++..+..++.|++.||.|||+++++|+||||+||++++++. .++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-----~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-----VAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-----eEEecccccchhccC
Confidence 999999999976543 5789999999999999999999999999999999999988763 479999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=201.05 Aligned_cols=142 Identities=19% Similarity=0.204 Sum_probs=113.7
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC---CceEEEEEeecccc---CHHHHHHHHHHHHHHhhcCCCceeE-EEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQ-FIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~l~HpNIV~-l~g~~~~~ 314 (411)
.-...|.+.+.||+|+||.||+|.+. ++.||||++..... .......+.+|+.+|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 44566999999999999999999874 56789998753311 2334567999999999999999984 5543
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL-KAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDL-Kp~NILid~~g~~k~~~~ikL~DF 393 (411)
+..||||||++|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.++ .+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~------~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG------EAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC------CEEEEEC
Confidence 35899999999999963 211 11 1467889999999999999999999 99999998877 5899999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|+|+.+..
T Consensus 157 GlA~~~~~ 164 (365)
T PRK09188 157 QLASVFRR 164 (365)
T ss_pred ccceeccc
Confidence 99997643
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=195.05 Aligned_cols=150 Identities=25% Similarity=0.407 Sum_probs=132.8
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
+..+.|++.++||+|+||.||++.+. ++.||+|++.... .....+.+.+|+++++.++||||+++++.+.....+|+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 34567888999999999999999886 7889999987543 23446788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||||+++++|.+++...+ .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~------~~~l~d~gl~~~ 153 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG------QIKLCDFGVSGE 153 (284)
T ss_pred EEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC------cEEEccCCcccc
Confidence 999999999999987654 68899999999999999999997 6899999999999999887 589999999875
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
+
T Consensus 154 ~ 154 (284)
T cd06620 154 L 154 (284)
T ss_pred h
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=192.59 Aligned_cols=146 Identities=24% Similarity=0.431 Sum_probs=130.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.++||.|+||.||+|... ++.|++|.+...... ..+.+.+|+.+++.++||||+++++++.....+|+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 56999999999999999999864 689999998754332 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..+.
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~------~~kl~dfg~~~~~~ 166 (296)
T cd06655 97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG------SVKLTDFGFCAQIT 166 (296)
T ss_pred ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEEccCccchhcc
Confidence 99999999998754 488999999999999999999999999999999999999888 59999999887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-22 Score=184.50 Aligned_cols=149 Identities=28% Similarity=0.492 Sum_probs=134.7
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||+++.. ++.|++|.+............+.+|+.++++++|+|++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3778899999999999999875 57899999987765555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++... ..+++..+..++.|++.|+.|||++||+|+||||+||+++.++ .++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~------~~~l~d~~~~~~~~~ 151 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG------VVKLADFGVATKLND 151 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC------CEEEeccccceecCC
Confidence 9999999999766 3689999999999999999999999999999999999999877 589999999987643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.9e-22 Score=185.03 Aligned_cols=151 Identities=24% Similarity=0.398 Sum_probs=136.3
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||.|+||.||++.+. ++.|++|++..........+.+.+|+++++.++|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999986 78999999987766556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++|.+++.... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~------~~~l~d~~~~~~~~ 154 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG------LVKLGDFGISKVLS 154 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC------cEEECCccceeecc
Confidence 99999999998752 5789999999999999999999999999999999999999877 58999999998764
Q ss_pred cc
Q 015237 401 LV 402 (411)
Q Consensus 401 ~~ 402 (411)
..
T Consensus 155 ~~ 156 (258)
T cd08215 155 ST 156 (258)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=188.62 Aligned_cols=147 Identities=24% Similarity=0.411 Sum_probs=127.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC---HHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLF 318 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~ 318 (411)
.|+..+.||+|+||.||++... +..|++|.+...... ......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5778899999999999999874 688999998754322 2344678899999999999999999998865 35789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++|||+++++|.+++.... .++....+.++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~------~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG------NVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC------CEEEccCCCccc
Confidence 9999999999999997654 588899999999999999999999999999999999999877 599999999875
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
+
T Consensus 156 ~ 156 (266)
T cd06651 156 L 156 (266)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=191.32 Aligned_cols=147 Identities=29% Similarity=0.491 Sum_probs=130.3
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|+..++||+|+||.||+|.+. ++.||+|+++.... ......+.+|+.+++.++|+||+++++++......|+||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4667788999999999999874 68899999875432 33457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++|+|.+++... .++...+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++..+..
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~------~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG------DVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC------CEEEcccccceeccC
Confidence 9999999998753 588889999999999999999999999999999999999887 589999999977643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=190.01 Aligned_cols=148 Identities=30% Similarity=0.505 Sum_probs=130.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.++||+|+||.||+|... ++.||+|++..... ....+.+.+|+.++++++||||+++++++......|+|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 34678889999999999999874 68899999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+++++|.+++... .+++..+..++.|++.|+.|||++|++|+||||+||+++.++ .++|+|||++..+..
T Consensus 83 ~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~------~~~l~dfg~~~~~~~ 153 (277)
T cd06641 83 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG------EVKLADFGVAGQLTD 153 (277)
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC------CEEEeecccceeccc
Confidence 99999999998653 588999999999999999999999999999999999999887 589999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=192.04 Aligned_cols=148 Identities=20% Similarity=0.318 Sum_probs=126.0
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCe-----E
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPR-----L 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~-----l 317 (411)
+|++.+.||+|+||.||+|.+. ++.||+|.++...........+.+|+.+++.+. ||||+++++++..... +
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5888999999999999999885 689999998765433333466888999999995 6999999999876655 8
Q ss_pred EEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCcCCCccEEEEe
Q 015237 318 FIVTEFMSGGSIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVRDSDIHCYLSN 392 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~-~g~~k~~~~ikL~D 392 (411)
|++|||+++ +|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||+++. ++ .+||+|
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~------~~kl~d 154 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG------LLKIAD 154 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC------eEEEee
Confidence 999999975 8998886542 24789999999999999999999999999999999999998 55 589999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||.+..+.
T Consensus 155 fg~~~~~~ 162 (295)
T cd07837 155 LGLGRAFS 162 (295)
T ss_pred cccceecC
Confidence 99988653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=190.43 Aligned_cols=146 Identities=25% Similarity=0.435 Sum_probs=128.0
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.++||.|++|.||+|+.. ++.||||+++..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788999999999999999985 688999998765322 2235577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~--~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++ .++|+|||++..+
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~------~~~l~d~g~~~~~ 150 (284)
T cd07836 80 MD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG------ELKLADFGLARAF 150 (284)
T ss_pred CC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC------cEEEeecchhhhh
Confidence 97 58999887653 3588999999999999999999999999999999999999888 5899999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=202.66 Aligned_cols=144 Identities=29% Similarity=0.597 Sum_probs=126.4
Q ss_pred CCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhh--cCCCceeEEEeeeecCC----eE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTRPP----RL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~--l~HpNIV~l~g~~~~~~----~l 317 (411)
..++++.+.||+|.||+||+|.|.|+.||||++.... .+.+.+|.+|++. ++|+||..|+++-.... ++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4678999999999999999999999999999996542 3668889998876 49999999998764432 59
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----C---CccccCCCCCcEEEccCCCcCCCccEE
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-----N---NIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-----~---gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
|+|++|-+.|||+|||... .++....++++..++.||.+||. + .|-|||||..|||+..+| .+.
T Consensus 285 wLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~------~C~ 356 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------TCC 356 (513)
T ss_pred EEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC------cEE
Confidence 9999999999999999874 58999999999999999999994 2 399999999999999999 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|+|+|.+..
T Consensus 357 IADLGLAv~h~ 367 (513)
T KOG2052|consen 357 IADLGLAVRHD 367 (513)
T ss_pred EeeceeeEEec
Confidence 99999998864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=189.99 Aligned_cols=148 Identities=28% Similarity=0.475 Sum_probs=125.7
Q ss_pred eEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 315 (411)
|++.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999863 478999999876555555677899999999999999999999886532
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~-----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
..++++||+.+|+|.+++.... ..++...+..++.|++.||.|||+++|+||||||+||+++.++ .+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~------~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM------TVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC------CEEE
Confidence 2478999999999998875321 2468888999999999999999999999999999999998877 5899
Q ss_pred Eecccccccc
Q 015237 391 SNFLSISTVI 400 (411)
Q Consensus 391 ~DFGla~~~~ 400 (411)
+|||++....
T Consensus 155 ~dfg~~~~~~ 164 (273)
T cd05074 155 ADFGLSKKIY 164 (273)
T ss_pred Cccccccccc
Confidence 9999988653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=193.35 Aligned_cols=151 Identities=20% Similarity=0.374 Sum_probs=125.2
Q ss_pred eEEEEEEeecCceEEEEEEE----CCceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAF----FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFI 319 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~----~~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l~I 319 (411)
|++.++||+|+||.||+|.. .++.||+|.+..... .......+.+|+.++++++||||+++++++... ..+|+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 78889999999999999988 458899999987431 122335678899999999999999999999887 78999
Q ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 320 VTEFMSGGSIYDYLHKQK----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
||||++ +++.+++.... ..++...++.++.|++.||.|||+++|+||||||+||+++.++.. .-.+||+|||+
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~--~~~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPE--RGVVKIGDLGL 158 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCc--cceEEECCCcc
Confidence 999995 57877775432 257888999999999999999999999999999999999983211 11599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 159 ~~~~~ 163 (316)
T cd07842 159 ARLFN 163 (316)
T ss_pred ccccC
Confidence 88764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=191.62 Aligned_cols=148 Identities=24% Similarity=0.453 Sum_probs=129.8
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|+..+.||.|+||.||+|+.. ++.||||.++...........+.+|++++++++||||+++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3788899999999999999885 68899999876543334446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+. ++|.+++... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++..+.
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~------~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG------AIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------CEEEeeccchhhcc
Confidence 95 6899988764 34688999999999999999999999999999999999999988 58999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=185.00 Aligned_cols=148 Identities=30% Similarity=0.428 Sum_probs=133.5
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||+++.. ++.|++|++...... .....+..|+.++..++|+||+++++++.....++++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5788899999999999999886 688999998766432 4457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++... ..++...++.++.|++.|+.|||+ ++++|+||+|+||+++.++ .++|+|||.+..+..
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~------~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG------EVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC------CEEEccCccceeccc
Confidence 9999999999865 468999999999999999999999 9999999999999999988 589999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=189.20 Aligned_cols=148 Identities=25% Similarity=0.400 Sum_probs=130.7
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeEEEEEe
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVTE 322 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l~IV~E 322 (411)
|++.++||+|+||.||+|... ++.+|+|.+............+.+|+.+++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999886 58899999987643334456788999999999999999999999887 78999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|++ ++|.+++......+++..++.++.||+.||.|||++|++|+||||+||++++++ .++|+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~------~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG------VLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC------CEEEccccceeeccC
Confidence 996 599998876645789999999999999999999999999999999999999988 589999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=228.55 Aligned_cols=154 Identities=22% Similarity=0.277 Sum_probs=139.2
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
..+..++|.+.+.||.|+||.|...+.+ ++.||+|++.+..+- .....-|..|-.||...+.+-|++++-+|.+..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3566778999999999999999999886 578999999875432 2334568889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+|||||+||+|..+|.+.. .+++.++..++..|..||+-||+.|+|||||||+|||+|..| ++||+|||+|
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G------HikLADFGsC 222 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG------HIKLADFGSC 222 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC------cEeeccchhH
Confidence 999999999999999999877 799999999999999999999999999999999999999999 7999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
-.+.
T Consensus 223 lkm~ 226 (1317)
T KOG0612|consen 223 LKMD 226 (1317)
T ss_pred HhcC
Confidence 8875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-24 Score=204.52 Aligned_cols=163 Identities=26% Similarity=0.427 Sum_probs=137.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec------
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------ 313 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~------ 313 (411)
+..+.|.-..+||+|.||+||+++.. ++.||+|++-.+.-.........+|+.+|..++|+|++.++..|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 44566777789999999999998765 5778988765443233344567899999999999999999988843
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 314 --PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 314 --~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
...+|+|+.+|+. +|.-+|......++...+.+++.++..||.|+|.+.|+|||+||+|+||+.+|+ +||+
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi------lklA 166 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI------LKLA 166 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce------EEee
Confidence 2348999999965 999999877667999999999999999999999999999999999999999994 9999
Q ss_pred eccccccc----------ccceeeEEEEcC
Q 015237 392 NFLSISTV----------ILVIFSCILVRA 411 (411)
Q Consensus 392 DFGla~~~----------~~~~~~~i~~ra 411 (411)
|||+++.+ .++.+.++|||-
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrp 196 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRP 196 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCC
Confidence 99999776 457888999983
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-22 Score=204.45 Aligned_cols=154 Identities=17% Similarity=0.286 Sum_probs=123.4
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC------CceeEEEeeee
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACT 312 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H------pNIV~l~g~~~ 312 (411)
++....|++.++||+|+||.||++.+. ++.||||+++... .....+..|+.+++.++| .+++++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 445678999999999999999999875 6789999996432 223456677887777755 45888998887
Q ss_pred cC-CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcC-------
Q 015237 313 RP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRD------- 383 (411)
Q Consensus 313 ~~-~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k------- 383 (411)
.. ..+|||||++ |++|.+++.+.+ .+++..+..++.||+.||.|||+ .|||||||||+|||++.++...
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 5789999998 889999987654 68999999999999999999998 5999999999999998766311
Q ss_pred ---CCccEEEEeccccccc
Q 015237 384 ---SDIHCYLSNFLSISTV 399 (411)
Q Consensus 384 ---~~~~ikL~DFGla~~~ 399 (411)
-...+||+|||++...
T Consensus 280 ~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cCCCCceEEECCCCccccC
Confidence 0124899999987643
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-21 Score=181.89 Aligned_cols=150 Identities=26% Similarity=0.408 Sum_probs=135.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--CeEEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PRLFIVT 321 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~l~IV~ 321 (411)
.|+..+.||+|++|.||+|... ++.|++|++..........+.+.+|+.++++++|+||+++++.+... ..++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677899999999999999986 68899999987654445567899999999999999999999999888 8899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||.+..+..
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~------~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG------VVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC------CEEEcccccEEeccc
Confidence 9999999999998765 789999999999999999999999999999999999999877 589999999887755
Q ss_pred c
Q 015237 402 V 402 (411)
Q Consensus 402 ~ 402 (411)
.
T Consensus 154 ~ 154 (260)
T cd06606 154 I 154 (260)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=187.20 Aligned_cols=142 Identities=20% Similarity=0.304 Sum_probs=127.4
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||.|+||.||+++.. ++.||+|++..... .....+.+.+|+.+++.++||||+++++.+..+..+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 78999999976543 234557799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 330 ~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.+++.+.. .++...+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~------~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG------YVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC------CEEEeeCCcccccCc
Confidence 99998754 588899999999999999999999999999999999999888 599999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=195.92 Aligned_cols=154 Identities=24% Similarity=0.389 Sum_probs=131.1
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|++ ...|++.+.||+|+||.||++... ++.||||.+............+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 9 TIWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 35666 355999999999999999999875 688999998654434444567889999999999999999999987543
Q ss_pred ------eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ------~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.+|+||||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~------~~k 158 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC------ELK 158 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------CEE
Confidence 358999999 78999888643 588999999999999999999999999999999999999887 589
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
|+|||.+.....
T Consensus 159 l~dfg~~~~~~~ 170 (343)
T cd07880 159 ILDFGLARQTDS 170 (343)
T ss_pred Eeeccccccccc
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=189.02 Aligned_cols=147 Identities=25% Similarity=0.488 Sum_probs=129.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC---CCceeEEEeeeecCCeEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~l~IV 320 (411)
.|++.+.||+|+||.||+|.+. ++.||+|.++.... ......+.+|+.+++.++ |||++++++++......|++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3677889999999999999974 68899999875432 334467889999999996 99999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~------~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG------NVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC------CEEEccCCceeecC
Confidence 9999999999998653 588999999999999999999999999999999999999887 58999999987764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 153 ~ 153 (277)
T cd06917 153 Q 153 (277)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-23 Score=189.47 Aligned_cols=146 Identities=17% Similarity=0.157 Sum_probs=110.5
Q ss_pred EEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHH------------------------HHHHHHHHHHHhhcCCCce
Q 015237 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENI------------------------RREFAQEVHIMRKVRHMNV 304 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~------------------------~~~~~~Ei~iL~~l~HpNI 304 (411)
.+.||+|+||.||+|... |+.||||+++........ ......|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 457999999999999875 789999999865321110 1223459999999987766
Q ss_pred eEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEccCCCcC
Q 015237 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 305 V~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yL-Hs~gIIHRDLKp~NILid~~g~~k 383 (411)
......... ..+|||||++|+++...+... ..++...+..++.|++.+|.|+ |+.||+||||||+|||+++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--- 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--- 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C---
Confidence 433322222 238999999887776553333 3688899999999999999999 7999999999999999984 4
Q ss_pred CCccEEEEecccccccccceee
Q 015237 384 SDIHCYLSNFLSISTVILVIFS 405 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~~~~~~ 405 (411)
.++|+|||+|.....+...
T Consensus 155 ---~v~LiDFG~a~~~~~~~~~ 173 (190)
T cd05147 155 ---KLYIIDVSQSVEHDHPHAL 173 (190)
T ss_pred ---cEEEEEccccccCCCcCHH
Confidence 4899999999876655443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=187.61 Aligned_cols=148 Identities=24% Similarity=0.389 Sum_probs=128.0
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIVT 321 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~IV~ 321 (411)
.|...++||.|++|.||++... ++.+|+|.+..... ......+.+|+++++.++||||++++++|.. ...+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5788999999999999999884 68899999875532 2445678999999999999999999998864 34689999
Q ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 322 EFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||+++++|.+++.. ....++...+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~------~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG------QVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC------eEEEeecccccc
Confidence 99999999988754 233578889999999999999999999999999999999999887 589999999876
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 155 ~~ 156 (287)
T cd06621 155 LV 156 (287)
T ss_pred cc
Confidence 54
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=189.77 Aligned_cols=148 Identities=28% Similarity=0.435 Sum_probs=132.3
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|++.+.||+|+||.||++... ++.||+|.+..... ......+.+|+.+++.++||||+++++.+.....+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4677789999999999999886 68899999876543 34557789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||.+..+.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~------~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG------QIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC------CEEEeecccchhhH
Confidence 99999999998764578999999999999999999999 9999999999999999987 58999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=191.48 Aligned_cols=148 Identities=29% Similarity=0.435 Sum_probs=129.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc-cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
..|++.++||+|+||.||+|... ++.||+|++.... ......+.+.+|+.+++.++||||++++++|......|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999874 6899999986543 23345567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+. |++.+++......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++ .++|+|||++...
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~------~~kL~dfg~~~~~ 165 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG------TVKLADFGSASLV 165 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC------CEEEeecCcceec
Confidence 9995 688888766555689999999999999999999999999999999999999988 5999999988654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=203.95 Aligned_cols=146 Identities=29% Similarity=0.498 Sum_probs=128.9
Q ss_pred cCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhh--cCCCceeEEEeeeecCC----e
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTRPP----R 316 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~--l~HpNIV~l~g~~~~~~----~ 316 (411)
....+++.+.||+|.||.||+|.+.++.||||++... ..+.|..|-.|... ++|+||++|+++-.... .
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 3556888999999999999999999999999998543 45788888888765 58999999999876655 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEccCCCcCCCcc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---------NIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~---------gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
+|||+||.+.|+|.+||+.+ .++|....+++..+++||.|||+. .|+|||||++|||+..++ .
T Consensus 283 ywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl------T 354 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL------T 354 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC------c
Confidence 99999999999999999875 489999999999999999999952 499999999999999888 6
Q ss_pred EEEEeccccccccc
Q 015237 388 CYLSNFLSISTVIL 401 (411)
Q Consensus 388 ikL~DFGla~~~~~ 401 (411)
+.|+|||+|..+..
T Consensus 355 ccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 355 CCIADFGLALRLEP 368 (534)
T ss_pred EEeeccceeEEecC
Confidence 99999999998854
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=198.18 Aligned_cols=148 Identities=24% Similarity=0.361 Sum_probs=128.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----CCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~~l~ 318 (411)
..|.+.+.||+|+||.||+|... ++.||+|++..........+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 56888899999999999999875 6899999987654333445678889999999999999999988753 35689
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+||+++.+| .+||+|||++..
T Consensus 85 lv~e~~-~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~------~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLM-ESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC------ELRIGDFGMARG 156 (334)
T ss_pred EEEehh-hhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------cEEeccccccee
Confidence 999999 469999987654 589999999999999999999999999999999999999988 589999999876
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 157 ~~ 158 (334)
T cd07855 157 LS 158 (334)
T ss_pred ec
Confidence 53
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=189.17 Aligned_cols=150 Identities=23% Similarity=0.392 Sum_probs=133.8
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV 320 (411)
++|.+.+.||+|+||.||++... ++.||+|++..... .......+.+|+.++++++ ||||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36889999999999999999884 68999999876433 2334567889999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||+++.+| .++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~------~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM------HIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC------CEEecCCccccccC
Confidence 99999999999998764 689999999999999999999999999999999999999888 58999999998765
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 154 ~ 154 (280)
T cd05581 154 P 154 (280)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=196.45 Aligned_cols=148 Identities=24% Similarity=0.335 Sum_probs=127.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-----CeEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRLF 318 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~l~ 318 (411)
.|++.+.||+|+||.||++... ++.||||.++...........+.+|+.+++.++|+||+++++++... ..+|
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 5889999999999999999875 68999999876433333345678899999999999999999988654 3489
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+++||+ +++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++..
T Consensus 86 lv~e~~-~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~------~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELM-DTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC------DLKICDFGLART 157 (337)
T ss_pred EEEeCC-CCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC------CEEECcCccccc
Confidence 999999 579999887654 689999999999999999999999999999999999999887 599999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
...
T Consensus 158 ~~~ 160 (337)
T cd07858 158 TSE 160 (337)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=195.70 Aligned_cols=148 Identities=22% Similarity=0.281 Sum_probs=127.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC------C
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------~ 315 (411)
...|+..+.||+|+||.||++... ++.||||++............+.+|+.+++.++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 356999999999999999999874 68999999875544444456788899999999999999999988643 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..|+||||+. ++|.+++... ++...+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~------~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGL 164 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC------CEEEccCcc
Confidence 5799999994 6898888643 78889999999999999999999999999999999999988 589999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+.....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=188.51 Aligned_cols=147 Identities=31% Similarity=0.492 Sum_probs=131.1
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.+.||+|+||.||+|... ++.||+|.+.... .......+.+|+.+++.++|+||+++++++.....+|+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5778889999999999999875 6889999987653 233346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||++++++ .++|+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~------~~~l~d~g~~~~~~~ 150 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG------DVKLADFGVSGQLTS 150 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------CEEEcccccceeecc
Confidence 9999999999765 589999999999999999999999999999999999999988 589999999877643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-24 Score=200.52 Aligned_cols=155 Identities=19% Similarity=0.307 Sum_probs=133.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|.+.+.||+|.|+.||++... |+.+|+|++.........-+.+.+|++|.+.++||||+++...+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 355777889999999999998664 789999999877666666788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+|.|++|..-+-.+ ..+++..+..++.||+.+|.|+|.+||||||+||.|+|+.... +.+ .+||+|||+|..+.+
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~--~~A-~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA--KGA-AVKLADFGLAIEVND 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc--CCC-ceeecccceEEEeCC
Confidence 999999997655444 2577888899999999999999999999999999999997654 222 589999999998864
Q ss_pred c
Q 015237 402 V 402 (411)
Q Consensus 402 ~ 402 (411)
.
T Consensus 166 g 166 (355)
T KOG0033|consen 166 G 166 (355)
T ss_pred c
Confidence 3
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=193.17 Aligned_cols=146 Identities=29% Similarity=0.508 Sum_probs=128.3
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|+..+.||+|+||.||+|.+. ++.||+|.++.... ....+.+.+|+.++++++||||+++++++......|+||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 555677999999999999874 57899999875432 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
++++|.+++... .+++..+..++.|++.|+.|||+++++|+||+|+||++++++ .++|+|||++..+..
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~------~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG------DVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC------CEEEccccccccccC
Confidence 999999998653 588899999999999999999999999999999999999888 589999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=187.01 Aligned_cols=142 Identities=26% Similarity=0.420 Sum_probs=126.9
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||+|+||.||++.+. ++.+++|.+..... .....+.+.+|+.++++++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999986 78999999976543 224556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 330 ~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~------~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG------HLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC------CEEEEecccchhccc
Confidence 99998765 689999999999999999999999999999999999999988 589999999876543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=207.38 Aligned_cols=153 Identities=20% Similarity=0.290 Sum_probs=136.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
..+.+.|..++.||-|+||+|.++.- +...||+|.+++... ..+.......|-.||..-..+-||++|-.|.+.+++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 56788899999999999999998854 357799999987643 334556678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||+|++||++..+|-+.+ -|.+..+..++.++..|+++.|..|+|||||||+|||||.+| .|||+|||+|.
T Consensus 705 YFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG------HIKLTDFGLCT 777 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG------HIKLTDFGLCT 777 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC------ceeeeeccccc
Confidence 99999999999999987765 688999999999999999999999999999999999999999 79999999998
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.|.
T Consensus 778 GfR 780 (1034)
T KOG0608|consen 778 GFR 780 (1034)
T ss_pred cce
Confidence 773
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=209.72 Aligned_cols=151 Identities=14% Similarity=0.278 Sum_probs=119.2
Q ss_pred CCceEEEEEEeecCceEEEEEEECC---ceEEEEEe---------------eccccCHHHHHHHHHHHHHHhhcCCCcee
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFFS---QDVAIKVL---------------TNEHLNENIRREFAQEVHIMRKVRHMNVV 305 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~~---~~VAIK~l---------------~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV 305 (411)
...|++.++||+|+||.||++.... ..+++|.+ +...........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4679999999999999999987542 12222211 00011223445688999999999999999
Q ss_pred EEEeeeecCCeEEEEEecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 015237 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC----GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 306 ~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~----~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~ 381 (411)
++++++...+..|+++|++ +++|.+++..... ......+..++.||+.||.|||++|||||||||+|||++.+|
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~- 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG- 304 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-
Confidence 9999999999999999999 5688888764321 233556778999999999999999999999999999999988
Q ss_pred cCCCccEEEEeccccccccc
Q 015237 382 RDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~~~ 401 (411)
.+||+|||++..+..
T Consensus 305 -----~vkL~DFGla~~~~~ 319 (501)
T PHA03210 305 -----KIVLGDFGTAMPFEK 319 (501)
T ss_pred -----CEEEEeCCCceecCc
Confidence 599999999986643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=185.54 Aligned_cols=147 Identities=30% Similarity=0.487 Sum_probs=128.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCC-----
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP----- 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~----- 315 (411)
.+.|++.+.||+|+||.||+|... ++.+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 467889999999999999999985 57899999876532 236789999999999 7999999999997644
Q ss_pred -eEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 316 -RLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 316 -~l~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.+|++|||+++++|.+++... +..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~------~~~l~ 155 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA------EVKLV 155 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC------eEEEC
Confidence 489999999999999988753 24688999999999999999999999999999999999999888 59999
Q ss_pred eccccccc
Q 015237 392 NFLSISTV 399 (411)
Q Consensus 392 DFGla~~~ 399 (411)
|||++...
T Consensus 156 d~~~~~~~ 163 (275)
T cd06608 156 DFGVSAQL 163 (275)
T ss_pred CCccceec
Confidence 99998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=188.35 Aligned_cols=141 Identities=21% Similarity=0.285 Sum_probs=123.5
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||+|+||.||++... ++.||+|++...... ......+..|+.+|+.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 689999998764322 22345577899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 330 YDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 330 ~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+..+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~------~~~l~dfg~~~~~ 145 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG------NVRISDLGLAVEL 145 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC------CEEEccCcchhhh
Confidence 99997654 2588999999999999999999999999999999999999988 5899999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=179.56 Aligned_cols=148 Identities=34% Similarity=0.561 Sum_probs=133.3
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|...+.||+|+||.||++... ++.+++|++..... ...+.+.+|+.+++.++|+||+++++++......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 677899999999999999986 68899999976543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
++++|.+++......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~------~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG------EVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC------eEEEeecccccccccc
Confidence 99999999987645789999999999999999999999999999999999999887 5999999998877543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=186.40 Aligned_cols=149 Identities=26% Similarity=0.405 Sum_probs=127.8
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecC-----
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP----- 314 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~----- 314 (411)
...+|.+.+.||+|+||.||++... ++.+|+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4567999999999999999999874 68899999865421 235677899999998 899999999998653
Q ss_pred CeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 315 PRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
...|+||||+++|+|.++++. ....+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~------~~kl~ 170 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG------GVKLV 170 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC------CEEEe
Confidence 358999999999999998864 234688999999999999999999999999999999999999887 58999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||++..+.
T Consensus 171 dfg~~~~~~ 179 (291)
T cd06639 171 DFGVSAQLT 179 (291)
T ss_pred ecccchhcc
Confidence 999987653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=190.16 Aligned_cols=146 Identities=25% Similarity=0.430 Sum_probs=129.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.+.||+|+||.||++... ++.|++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 57888999999999999999763 68899999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..+.
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~------~~kL~dfg~~~~~~ 166 (293)
T cd06647 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------SVKLTDFGFCAQIT 166 (293)
T ss_pred cCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC------CEEEccCcceeccc
Confidence 99999999999754 478889999999999999999999999999999999999887 58999999886553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=187.91 Aligned_cols=141 Identities=21% Similarity=0.277 Sum_probs=117.8
Q ss_pred EEeecCceEEEEEEEC--CceEEEEEeeccccCHH-HHHHHHHHHHHHh---hcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 252 KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN-IRREFAQEVHIMR---KVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~-~~~~~~~Ei~iL~---~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
.||+|+||.||++... ++.+|+|++........ ....+.+|..+++ ..+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3799999999999875 68899999976543221 1233444544333 3479999999999999899999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+++++ .++|+|||++..+
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~------~~~l~dfg~~~~~ 147 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG------HVRISDLGLACDF 147 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC------CEEEccCCcceec
Confidence 999999987654 689999999999999999999999999999999999999888 5999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=186.30 Aligned_cols=145 Identities=24% Similarity=0.371 Sum_probs=124.4
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecC--CeEEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRP--PRLFIVT 321 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~--~~l~IV~ 321 (411)
|++.++||+|+||.||+|... ++.||+|.++....... .....+|+.++.++. |+||+++++++... +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 567889999999999999874 68899999876532222 233457888999885 99999999999877 8899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+. |++.+++......+++..+..++.|++.||.|||+++++||||||+||+++. + .+||+|||++..+.
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~------~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D------ILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C------CeEEEecccccccc
Confidence 9995 6898888776557899999999999999999999999999999999999998 6 59999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=194.01 Aligned_cols=143 Identities=29% Similarity=0.423 Sum_probs=125.6
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
+.....||+|+||.||++... +..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..|+||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 344567999999999999874 6889999986542 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++++|.+++... .+++..+..++.||+.||.|||+++|+||||||+||++++++ .++|+|||++..+
T Consensus 102 ~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~------~~kL~dfg~~~~~ 168 (292)
T cd06658 102 EGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG------RIKLSDFGFCAQV 168 (292)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC------CEEEccCcchhhc
Confidence 999999988643 488899999999999999999999999999999999999888 5899999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=183.10 Aligned_cols=150 Identities=25% Similarity=0.368 Sum_probs=132.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+|++.++||.|+||.||++... ++.+++|.+............+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3788999999999999999875 57899999987655555567788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~------~~kl~d~g~~~~~~ 154 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND------LVKIGDLGISKVLK 154 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC------cEEEeeccchhhhc
Confidence 9999999998763 23588889999999999999999999999999999999999877 59999999987764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 155 ~ 155 (256)
T cd08530 155 K 155 (256)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=192.59 Aligned_cols=147 Identities=22% Similarity=0.324 Sum_probs=129.2
Q ss_pred EEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 248 KFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 248 ~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
.+++.+|.|+++.+|++..+++.||+|++............+.+|+.+++.++|+||+++++++......|++|||+++|
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 44556677788888888888899999999876555556678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 328 SIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 328 sL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.+| .++|+|||.+..+.
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~------~~kl~d~~~~~~~~ 152 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG------KVVLSGLRYSVSMI 152 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC------ceEEecCccceeec
Confidence 999999864 33588899999999999999999999999999999999999888 58999999887553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=187.62 Aligned_cols=147 Identities=32% Similarity=0.560 Sum_probs=123.6
Q ss_pred EEeecCceEEEEEEECC--------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 252 KIVSGSYCDLYKGAFFS--------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~--------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.||+|+||.||+|++.. +.+|||.+.... .......+.+|+.+++.++||||+++++++......+++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998752 569999886543 223456788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 324 MSGGSIYDYLHKQ------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 324 ~~gGsL~~~L~~~------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+++++|.+++... ...+++..++.++.|++.||.|||+++++|+||||+||+++.++.. ....++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~-~~~~~~l~dfg~~~ 159 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYD-ADRVVKIGDFGLAR 159 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCC-CCcceEECCccccc
Confidence 9999999999753 1247788899999999999999999999999999999999886621 12248999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 160 ~~~ 162 (269)
T cd05044 160 DIY 162 (269)
T ss_pred ccc
Confidence 653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=188.29 Aligned_cols=146 Identities=26% Similarity=0.466 Sum_probs=128.8
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|++.++||.|++|.||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++......|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 466789999999999999874 789999999766444444467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 325 SGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 325 ~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++..+
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~------~~~l~df~~~~~~ 149 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG------ALKLADFGLARAF 149 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC------cEEEeeccccccc
Confidence 569999987654 3588999999999999999999999999999999999999877 5999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-23 Score=214.28 Aligned_cols=150 Identities=28% Similarity=0.430 Sum_probs=132.1
Q ss_pred CCCCceeecCCceEEEEEEeecCceEEEEEEECC--ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 235 ~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
...+.|+|- ..||.|+||.||++..+. --.|.|++... +....+.+.-||.||..|.||+||+++++|.
T Consensus 29 nP~d~WeIi-------GELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 29 NPRDHWEII-------GELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred CHHHHHHHH-------hhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 446778874 467999999999997653 34577887654 4566788999999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
..+.+||..|||.||-+..++-.-+..++++++..++.|++.||.|||+++|||||||+.|||++-+| .++|+|
T Consensus 100 ~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG------dirLAD 173 (1187)
T KOG0579|consen 100 FENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG------DIRLAD 173 (1187)
T ss_pred ccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC------cEeeec
Confidence 99999999999999999998887777899999999999999999999999999999999999999999 699999
Q ss_pred ccccccc
Q 015237 393 FLSISTV 399 (411)
Q Consensus 393 FGla~~~ 399 (411)
||.+-..
T Consensus 174 FGVSAKn 180 (1187)
T KOG0579|consen 174 FGVSAKN 180 (1187)
T ss_pred ccccccc
Confidence 9987654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=185.86 Aligned_cols=148 Identities=28% Similarity=0.519 Sum_probs=127.0
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeec------
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR------ 313 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~------ 313 (411)
+...|++.+.||+|+||.||+|.+. ++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 4456788899999999999999885 5889999986542 2345688899999998 79999999999853
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
...+|++|||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~------~~~l~d 164 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA------EVKLVD 164 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEEee
Confidence 457899999999999999997643 3578888999999999999999999999999999999999888 489999
Q ss_pred ccccccc
Q 015237 393 FLSISTV 399 (411)
Q Consensus 393 FGla~~~ 399 (411)
||++..+
T Consensus 165 fg~~~~~ 171 (282)
T cd06636 165 FGVSAQL 171 (282)
T ss_pred Ccchhhh
Confidence 9998755
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=187.58 Aligned_cols=148 Identities=19% Similarity=0.324 Sum_probs=128.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccC--HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
.|++.+.||+|+||.||+++.. ++.||||+++..... ....+.+.+|+.++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3788999999999999998753 467999998754321 22345688999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~------~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG------HVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC------CEEEEECcccc
Confidence 99999999999999987654 688899999999999999999999999999999999999887 58999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 154 ~~~ 156 (288)
T cd05583 154 EFL 156 (288)
T ss_pred ccc
Confidence 653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=186.99 Aligned_cols=147 Identities=29% Similarity=0.498 Sum_probs=131.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.+.||+|+||.||++.+. ++.|++|++..... ....+..|+.+++.++|+||+++++.+......|+++|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 44777889999999999999986 68899999976533 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++++|.+++......++...+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~------~~~l~d~~~~~~~~ 167 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG------SVKLADFGFAAQLT 167 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC------CEEECccchhhhhc
Confidence 9999999999987654689999999999999999999999999999999999999888 58999999887554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=192.83 Aligned_cols=153 Identities=23% Similarity=0.376 Sum_probs=129.4
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP- 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~- 314 (411)
+.|++. ++|.+.+.||+|+||.||++... ++.||+|+++.........+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 11 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHhhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 346665 56999999999999999999764 68899999876543333456688999999999999999999988543
Q ss_pred -----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 315 -----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 315 -----~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
...|++++++ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~------~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC------ELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC------CEE
Confidence 3478899987 88999888653 488999999999999999999999999999999999999988 589
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++....
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999987653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=189.59 Aligned_cols=148 Identities=28% Similarity=0.449 Sum_probs=129.1
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
..|+..+.||+|+||.||+++.. ++.||+|.+..... .......+.+|+.+++.++|||++++++++......|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44777889999999999999874 68899999875432 3344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+. |++.+++......+++..+..++.|++.||.|||+++|+||||+|+||+++.++ .++|+|||++...
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~------~~kl~dfg~~~~~ 175 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG------QVKLADFGSASIA 175 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC------CEEEecCCCcccc
Confidence 9996 588888876655789999999999999999999999999999999999999887 5999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=191.83 Aligned_cols=148 Identities=24% Similarity=0.388 Sum_probs=129.3
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc------CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL------NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~------~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
|.-.+.||.|..+.|-++.+. ++++|+|++..... ....++...+|+.||+++ .||+|+++.++++.+..+
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 444567899999999988765 68999999864321 224566788999999998 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++|+|.|+.|.|+|||...- .+++....++++|+..|+.|||.++|+||||||+|||++++. ++||+|||.|.
T Consensus 99 FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~------~i~isDFGFa~ 171 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM------NIKISDFGFAC 171 (411)
T ss_pred hhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc------ceEEeccceee
Confidence 99999999999999998754 689999999999999999999999999999999999999998 69999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 172 ~l~~ 175 (411)
T KOG0599|consen 172 QLEP 175 (411)
T ss_pred ccCC
Confidence 8743
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=189.60 Aligned_cols=150 Identities=25% Similarity=0.417 Sum_probs=127.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------- 314 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------- 314 (411)
..+|++.++||+|+||.||++.+. ++.+|+|++............+.+|+.+++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 367999999999999999999885 68899999876543332334577899999999999999999987543
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 -PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 -~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|++|||+. +++..++......+++..+..++.|++.||.|||++||+|+||||+||++++++ .++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~------~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG------ILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------CEEECcC
Confidence 34799999995 578888776555799999999999999999999999999999999999999988 5899999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++....
T Consensus 160 g~~~~~~ 166 (311)
T cd07866 160 GLARPYD 166 (311)
T ss_pred ccchhcc
Confidence 9997653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=192.78 Aligned_cols=141 Identities=25% Similarity=0.393 Sum_probs=123.4
Q ss_pred EEEeec--CceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSG--SYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~G--sfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
..||.| +||.||++.+ .++.||+|++..........+.+.+|+.+++.++||||++++++|.....+|+++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 345666 9999999988 479999999987655555567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 327 GSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 327 GsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+++.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .++++|||.+.
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~------~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG------LVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC------cEEEechHHHh
Confidence 99999987653 2588899999999999999999999999999999999999887 48899987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=183.43 Aligned_cols=142 Identities=26% Similarity=0.370 Sum_probs=119.7
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHH-hhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIM-RKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL-~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.||+|+||.||++... ++.||+|+++..... ......+..|..++ ...+|+||+++++++.....+|++|||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999884 689999998754332 22223445555544 445899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++++++ .++|+|||++...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~------~~~l~dfg~~~~~ 147 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG------HLKLTDFGLSRNG 147 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC------cEEEeecccceec
Confidence 99999997654 688999999999999999999999999999999999999887 5899999988754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=192.38 Aligned_cols=146 Identities=24% Similarity=0.398 Sum_probs=124.8
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-----CeE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PRL 317 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~l 317 (411)
++|++.++||+|+||.||+|.+. ++.||+|+++.... ......+.+|+.++++++|+||+++++++... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 56899999999999999999874 68999999864322 23346678899999999999999999887543 358
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+++||+. ++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~------~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC------DLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC------CEEECccccee
Confidence 99999995 5888888643 589999999999999999999999999999999999999988 59999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 155 ~~~ 157 (336)
T cd07849 155 IAD 157 (336)
T ss_pred ecc
Confidence 653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=192.00 Aligned_cols=142 Identities=27% Similarity=0.394 Sum_probs=124.7
Q ss_pred EEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 248 ~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
....+||+|+||.||++... ++.||+|++..... ...+.+.+|+.+++.++||||+++++.+......|++|||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 33447999999999999874 68999999865432 234668899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..+
T Consensus 102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~------~~kL~dfg~~~~~ 167 (297)
T cd06659 102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG------RVKLSDFGFCAQI 167 (297)
T ss_pred CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC------cEEEeechhHhhc
Confidence 99999988653 488999999999999999999999999999999999999888 5899999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-21 Score=190.59 Aligned_cols=151 Identities=22% Similarity=0.376 Sum_probs=128.4
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-CC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PP 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~~ 315 (411)
.|++. ..|++.+.||.|+||.||++... ++.||+|++..........+.+.+|+.+++.++||||++++++|.. ..
T Consensus 5 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 5 VFEIT-NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eeccc-cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34443 45999999999999999999865 6889999886544333445678899999999999999999999865 55
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..|++|||+ +++|.+++... .++...+..++.|++.||.|||+++|+||||||+||++++++ .++|+|||.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~------~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC------DLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC------CEEeCcccc
Confidence 789999999 67999888643 478888889999999999999999999999999999999887 589999999
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 155 ~~~~ 158 (328)
T cd07856 155 ARIQ 158 (328)
T ss_pred cccc
Confidence 8754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=187.55 Aligned_cols=155 Identities=21% Similarity=0.352 Sum_probs=132.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~ 314 (411)
..|.++.+.|++.+.||+|+||.||+|.+. ++.||||.++..... .....+..|+.++.+. .||||++++++|...
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 457888899999999999999999999987 789999999765432 2345667788777666 499999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|++|||+ ++++.+++......+++..+..++.|++.||.|||+ ++|+||||+|+||++++++ .++|+||
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~------~~kL~df 159 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG------NVKLCDF 159 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC------CEEECcc
Confidence 9999999998 558888777655578899999999999999999997 6999999999999999887 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 160 g~~~~~~ 166 (296)
T cd06618 160 GISGRLV 166 (296)
T ss_pred ccchhcc
Confidence 9987653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=207.56 Aligned_cols=152 Identities=22% Similarity=0.409 Sum_probs=130.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc--CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe--E
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--L 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~--l 317 (411)
...+++...||+|+|-+||+|.+. |..||.-.++.... ++...++|..|+.+|+.|+|||||+||.+|.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 455688999999999999999875 66777665554433 34566899999999999999999999999987554 8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|||.|..|+|..|+++.+ ..+...++.|++||++||.|||++. |||||||.+||+|+.+.- .+||.|.|+
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G-----~VKIGDLGL 192 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG-----EVKIGDLGL 192 (632)
T ss_pred eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC-----ceeecchhH
Confidence 89999999999999999876 6888999999999999999999987 999999999999976542 699999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
|.....
T Consensus 193 Atl~r~ 198 (632)
T KOG0584|consen 193 ATLLRK 198 (632)
T ss_pred HHHhhc
Confidence 987644
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=193.78 Aligned_cols=144 Identities=24% Similarity=0.392 Sum_probs=127.6
Q ss_pred EEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCCC
Q 015237 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
.+.||+|+|+.|-.+.. ++++||||++.+. ....+.+..+|++++.+++ |+||++++++|++...+|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35799999999988754 5899999999776 3446788999999999995 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|...++++. .+++..+.++..+|+.||+|||.+||-||||||+|||-...+. +. -+|||||-+.+.+
T Consensus 161 GplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~--vs-PvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 161 GPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNK--VS-PVKICDFDLGSGI 229 (463)
T ss_pred chHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCC--cC-ceeeecccccccc
Confidence 99999998876 6999999999999999999999999999999999999876552 23 4899999988765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=185.50 Aligned_cols=142 Identities=20% Similarity=0.268 Sum_probs=117.7
Q ss_pred EEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHH---HHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 252 KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEV---HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei---~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
.||+|+||.||++... ++.||+|++....... .....+..|. .+++...||||+++++++...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999998774 6899999987654321 1112233343 34455689999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++..+.
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~------~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG------HVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC------CEEEccCcCccccC
Confidence 999999887654 689999999999999999999999999999999999999888 58999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=185.78 Aligned_cols=149 Identities=26% Similarity=0.427 Sum_probs=131.3
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|++.+.||+|++|.||++... ++.+++|.++...........+.+|+.+++.++|+||+++++++..+..++++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999875 688999998776544445577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
+ +++.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .++|+|||.+......
T Consensus 81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~------~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG------VLKLADFGLARSFGSP 151 (283)
T ss_pred C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC------cEEEeeeeeeEecCCC
Confidence 6 599998887655789999999999999999999999999999999999999887 5899999998776543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=192.31 Aligned_cols=149 Identities=26% Similarity=0.380 Sum_probs=130.9
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-----eEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-----RLF 318 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~l~ 318 (411)
+|++.+.||+|+||.||+|+.. ++.||||.+..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788999999999999999875 589999998765433445577999999999999999999999988765 789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++|||++ ++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++ .++|+|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~------~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC------DLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------CEEEcccCceEe
Confidence 9999996 58999987654 789999999999999999999999999999999999999987 599999999997
Q ss_pred cccc
Q 015237 399 VILV 402 (411)
Q Consensus 399 ~~~~ 402 (411)
....
T Consensus 153 ~~~~ 156 (330)
T cd07834 153 VDPD 156 (330)
T ss_pred eccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-23 Score=197.36 Aligned_cols=155 Identities=21% Similarity=0.315 Sum_probs=139.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
-.+..+++.+++.||+|.||.|..++-+ ++.+|||+++++.. ..+....-+.|-++|+.++||.+..+--.|..+..
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 3567788999999999999999998765 78999999998764 34555667889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||..||.|+-.|...+ .+++.....+..+|..||.|||+++||.||||.+|+|+|.+| .+||+|||++
T Consensus 243 lCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG------HIKitDFGLC 315 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG------HIKITDFGLC 315 (516)
T ss_pred EEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC------ceEeeecccc
Confidence 999999999999998887655 789999999999999999999999999999999999999999 6999999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
+.-+.
T Consensus 316 KE~I~ 320 (516)
T KOG0690|consen 316 KEEIK 320 (516)
T ss_pred hhccc
Confidence 87644
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=209.24 Aligned_cols=155 Identities=27% Similarity=0.537 Sum_probs=140.6
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
.||++.+.+++.+.+|+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 79999999999999999999999999753 246999999876544 5678899999999999 699999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
|+|+..+.+++|+||+..|+|..||+..+ ..++...++.++.||+.||+||++..+|||||.++|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998876 348888999999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEecccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+.++. .+|++|||+|+...
T Consensus 449 VLi~~~~------~~kIaDFGlar~~~ 469 (609)
T KOG0200|consen 449 VLITKNK------VIKIADFGLARDHY 469 (609)
T ss_pred EEecCCC------EEEEccccceeccC
Confidence 9999987 49999999999643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=182.37 Aligned_cols=147 Identities=25% Similarity=0.430 Sum_probs=125.9
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc---CCCceeEEEeeeecCCe-----
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACTRPPR----- 316 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~----- 316 (411)
|++.+.||+|+||.||+|.+. ++.||+|.++...........+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 577899999999999999986 68999999976543333445677788877666 59999999999987776
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
++++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~------~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG------QVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC------CEEEeccCc
Confidence 999999995 58999887653 2589999999999999999999999999999999999999987 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 154 ~~~~~ 158 (287)
T cd07838 154 ARIYS 158 (287)
T ss_pred ceecc
Confidence 87763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=189.21 Aligned_cols=147 Identities=20% Similarity=0.313 Sum_probs=124.1
Q ss_pred ceEEEEEEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeec----CCe
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR----PPR 316 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~----~~~ 316 (411)
.|++.+.||+|+||.||++.+. ++.||+|.+..........+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3788999999999999999886 45899999875433333456788899999999 59999999987543 245
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+++||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~------~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC------ELKICDFGLA 152 (332)
T ss_pred EEEEEecc-cCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC------CEEeCcCCCc
Confidence 78999999 469999886543 689999999999999999999999999999999999999988 5899999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 153 ~~~~ 156 (332)
T cd07857 153 RGFS 156 (332)
T ss_pred eecc
Confidence 8654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=182.55 Aligned_cols=149 Identities=20% Similarity=0.377 Sum_probs=126.8
Q ss_pred eEEEEEEeecCceEEEEEEEC---CceEEEEEeeccc--------cCHHHHHHHHHHHHHHhh-cCCCceeEEEeeeecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEH--------LNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRP 314 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~--------~~~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~ 314 (411)
|++.+.||+|+||.||+|.+. ++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 677889999999999999885 3789999886432 122345567889988875 7999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 315 PRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
+..|++|||+++++|.+++.. ....++...++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~------~~~l 155 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD------KVTI 155 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC------cEEE
Confidence 999999999999999998754 33468889999999999999999996 7899999999999999887 5999
Q ss_pred Eeccccccccc
Q 015237 391 SNFLSISTVIL 401 (411)
Q Consensus 391 ~DFGla~~~~~ 401 (411)
+|||.+.....
T Consensus 156 ~dfg~~~~~~~ 166 (269)
T cd08528 156 TDFGLAKQKQP 166 (269)
T ss_pred ecccceeeccc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=185.22 Aligned_cols=147 Identities=25% Similarity=0.428 Sum_probs=130.2
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|++.++||+|.||.||+|+.. ++.||+|++..........+.+..|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999886 689999999876433344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+ ++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||++++++ .++|+|||.+..+.
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~------~~~l~d~g~~~~~~ 149 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG------VLKLADFGLARAFG 149 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC------CEEEecCCcccccC
Confidence 6 599999987644689999999999999999999999999999999999999987 58999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=192.13 Aligned_cols=148 Identities=21% Similarity=0.336 Sum_probs=126.6
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecC--CeEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP--PRLFI 319 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~--~~l~I 319 (411)
..|++.+.||+|+||.||+|.+. ++.+|+|.+............+.+|+.+++++ +||||++++++|... ..+|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45778899999999999999875 68899998865433333446678899999999 999999999998643 46899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||++ ++|.+++... .+++.....++.||+.||.|||++||+||||||+||+++.++ .+||+|||.+..+
T Consensus 87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~------~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC------RVKLADFGLARSL 157 (337)
T ss_pred Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------cEEEeeccchhcc
Confidence 999996 6999988764 578888899999999999999999999999999999999988 5999999999865
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 158 ~~ 159 (337)
T cd07852 158 SE 159 (337)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=190.50 Aligned_cols=151 Identities=21% Similarity=0.346 Sum_probs=128.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHH------------HHHHHHHHHHHHhhcCCCceeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN------------IRREFAQEVHIMRKVRHMNVVQF 307 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~------------~~~~~~~Ei~iL~~l~HpNIV~l 307 (411)
+....+.+.+.||+|+||.||++... ++.||||+++....... ....+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 33444556778999999999999865 68899999876432210 11247789999999999999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
++++......|++|||+. |+|.+++.... .++......++.|++.||.|||++||+|+||||+||+++.++ .
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~------~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG------I 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC------C
Confidence 999999999999999995 69999987644 588999999999999999999999999999999999999888 5
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
++|+|||.+..+.
T Consensus 158 ~kl~dfg~~~~~~ 170 (335)
T PTZ00024 158 CKIADFGLARRYG 170 (335)
T ss_pred EEECCccceeecc
Confidence 8999999997664
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-21 Score=183.39 Aligned_cols=143 Identities=28% Similarity=0.416 Sum_probs=125.9
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|+..++||+|++|.||++... ++.+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 444679999999999999874 5889999886432 233466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++++|.+++.. ..++...+..++.|++.||.|||++||+||||+|+||+++.++ .++|+|||.+..+
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~~l~d~g~~~~~ 165 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG------RVKLSDFGFCAQV 165 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC------cEEEcccccchhh
Confidence 99999999976 3588899999999999999999999999999999999999888 5899999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=184.08 Aligned_cols=147 Identities=22% Similarity=0.361 Sum_probs=127.4
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
|++.+.||+|+||.||+|... ++.|+||.+....... ......+|+..+++++ |+||+++++++..+...|+||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567889999999999999985 5789999987653322 2234567899999998 99999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+ +|+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~------~~~l~d~~~~~~~~~ 151 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE------VVKIADFGLAREIRS 151 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC------CEEEeecccceeccC
Confidence 9 889999987754 4689999999999999999999999999999999999999988 599999999976643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=176.53 Aligned_cols=144 Identities=16% Similarity=0.159 Sum_probs=111.8
Q ss_pred EEEEeecCceEEEEEEEC-CceEEEEEeeccccCH------------------------HHHHHHHHHHHHHhhcCCCce
Q 015237 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE------------------------NIRREFAQEVHIMRKVRHMNV 304 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~------------------------~~~~~~~~Ei~iL~~l~HpNI 304 (411)
.+.||+|+||.||+|... |+.||||+++...... .....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999875 8999999998753110 012234679999999999987
Q ss_pred eEEEeeeecCCeEEEEEecCCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCc
Q 015237 305 VQFIGACTRPPRLFIVTEFMSGGSIYDY-LHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 305 V~l~g~~~~~~~l~IV~E~~~gGsL~~~-L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~ 382 (411)
.....+.... .||||||++|+++... +.. ..++......++.|++.++.++|+ +||+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-- 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-- 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--
Confidence 5443333222 4899999988755443 432 357788899999999999999999 9999999999999998 55
Q ss_pred CCCccEEEEeccccccccccee
Q 015237 383 DSDIHCYLSNFLSISTVILVIF 404 (411)
Q Consensus 383 k~~~~ikL~DFGla~~~~~~~~ 404 (411)
.++|+|||+|+.+..+..
T Consensus 155 ----~~~liDFG~a~~~~~~~~ 172 (190)
T cd05145 155 ----KPYIIDVSQAVELDHPNA 172 (190)
T ss_pred ----CEEEEEcccceecCCCCH
Confidence 589999999998866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-20 Score=184.81 Aligned_cols=146 Identities=27% Similarity=0.440 Sum_probs=127.4
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
+...++||+|+||.||+|+.. ++.|++|++..... .....+.+.+|+.+++.++|||++++++++......|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 68899999875433 334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+. |++.+++......+++..+..++.|++.|+.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~------~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG------QVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC------CEEEeecCCCccc
Confidence 95 688888876655789999999999999999999999999999999999999888 5899999988753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=184.84 Aligned_cols=149 Identities=24% Similarity=0.344 Sum_probs=124.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV 320 (411)
.++|...++||+|+||.||++.+. ++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 345667788999999999999885 688999998765432 34567889999999996 99999999999988899999
Q ss_pred EecCCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 321 TEFMSGGSIYDYLH---K-QKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 321 ~E~~~gGsL~~~L~---~-~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
|||+. +++.++.. . ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||+
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~------~~kl~dfg~ 154 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG------NIKLCDFGI 154 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC------cEEEeecch
Confidence 99984 46655432 2 22468899999999999999999997 4999999999999999887 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 155 ~~~~~ 159 (288)
T cd06616 155 SGQLV 159 (288)
T ss_pred hHHhc
Confidence 87653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=190.49 Aligned_cols=153 Identities=24% Similarity=0.388 Sum_probs=131.6
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|++.. .|++...||+|+||.||+|... ++.||+|++..........+.+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~~~-~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 9 TVWEVPD-RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ceecccC-ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 4567754 5899999999999999999885 588999998764433444566788999999999999999998876554
Q ss_pred e------EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 R------LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ~------l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
. .|+|+||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~------~~k 158 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC------ELK 158 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC------CEE
Confidence 4 89999999 77999998753 589999999999999999999999999999999999999988 589
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++....
T Consensus 159 L~dfg~~~~~~ 169 (343)
T cd07851 159 ILDFGLARHTD 169 (343)
T ss_pred Ecccccccccc
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=199.88 Aligned_cols=157 Identities=20% Similarity=0.309 Sum_probs=134.3
Q ss_pred Cceeec---CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHH------HHHHHHHHHHHhhcC---CCc
Q 015237 238 DVWEID---ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENI------RREFAQEVHIMRKVR---HMN 303 (411)
Q Consensus 238 ~~~ei~---~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~------~~~~~~Ei~iL~~l~---HpN 303 (411)
..||.. .+.|...+.+|+|+||.|+.+.++ ...|+||.+.++..-.+. .-..-.||+||..++ |+|
T Consensus 551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 356653 345788999999999999999997 368999999877532221 122567999999998 999
Q ss_pred eeEEEeeeecCCeEEEEEecC-CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCc
Q 015237 304 VVQFIGACTRPPRLFIVTEFM-SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 304 IV~l~g~~~~~~~l~IV~E~~-~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~ 382 (411)
|++++++|++++++||+||-- +|.+|++++.... .++++.+..|+.||+.|+++||++||||||||-+|+.++.+|.
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~- 708 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF- 708 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe-
Confidence 999999999999999999975 5778999998765 6999999999999999999999999999999999999999994
Q ss_pred CCCccEEEEeccccccccc
Q 015237 383 DSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 383 k~~~~ikL~DFGla~~~~~ 401 (411)
+||+|||+|.-..+
T Consensus 709 -----~klidfgsaa~~ks 722 (772)
T KOG1152|consen 709 -----VKLIDFGSAAYTKS 722 (772)
T ss_pred -----EEEeeccchhhhcC
Confidence 89999999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-22 Score=216.61 Aligned_cols=145 Identities=20% Similarity=0.356 Sum_probs=123.8
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC----------
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP---------- 314 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~---------- 314 (411)
+...+.||+|+||.||+++.+ |+.||||.+.... +......+.+|+..|.+++|||||++|.+|.+.
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 444678999999999999875 8999999998765 555567789999999999999999998765221
Q ss_pred --------------------------------------------------------------------------------
Q 015237 315 -------------------------------------------------------------------------------- 314 (411)
Q Consensus 315 -------------------------------------------------------------------------------- 314 (411)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred -----------------------------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 015237 315 -----------------------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365 (411)
Q Consensus 315 -----------------------------~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gII 365 (411)
..+||-||||+..++.+++..+...-.....++++++|+.||.|+|++|||
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI 719 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII 719 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence 137999999999888888876652224678899999999999999999999
Q ss_pred ccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 366 HRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 366 HRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||||||.||++++++ ++||.|||+|..
T Consensus 720 HRDLKP~NIFLd~~~------~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRN------SVKIGDFGLATD 746 (1351)
T ss_pred eccCCcceeEEcCCC------Ceeecccccchh
Confidence 999999999999888 699999999988
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=188.11 Aligned_cols=151 Identities=23% Similarity=0.379 Sum_probs=127.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|++. ..|.+.+.||+|+||.||+|.+. ++.||+|.++...........+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 457775 47899999999999999999874 689999998764433334466889999999999999999999986542
Q ss_pred ------eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ------~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.+|+||||+. .+|..++. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~------~~k 157 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC------ELK 157 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEE
Confidence 4699999995 47776652 3588899999999999999999999999999999999999988 599
Q ss_pred EEeccccccc
Q 015237 390 LSNFLSISTV 399 (411)
Q Consensus 390 L~DFGla~~~ 399 (411)
|+|||++...
T Consensus 158 L~dfg~~~~~ 167 (342)
T cd07879 158 ILDFGLARHA 167 (342)
T ss_pred EeeCCCCcCC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=184.30 Aligned_cols=142 Identities=28% Similarity=0.391 Sum_probs=124.7
Q ss_pred EEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 249 FEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
...+||+|+||.||++... ++.||||.+.... ......+.+|+.+++.++|+||+++++.+...+..|++|||+++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3467999999999999884 6889999875432 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||++++++ .++|+|||++..+.
T Consensus 102 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~------~~~l~dfg~~~~~~ 167 (292)
T cd06657 102 GALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG------RVKLSDFGFCAQVS 167 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------CEEEcccccceecc
Confidence 9999987543 478899999999999999999999999999999999999988 48999999886553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-22 Score=208.24 Aligned_cols=150 Identities=29% Similarity=0.481 Sum_probs=132.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
...++..++||+|+||.||+|.|- +-+||||++.... ....-.+++.|+.+|.+++|||+++++|+|.... +
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 344566789999999999999884 2479999986554 3344578999999999999999999999998765 8
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
.||++||++|+|.+|++.++..+.....+.|..||++||.|||.++++||||.++|+|+.+-. .+|+.|||+|+
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~------hvkitdfgla~ 846 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN------HVKITDFGLAK 846 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC------eEEEEecchhh
Confidence 899999999999999999988899999999999999999999999999999999999998766 69999999999
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
....
T Consensus 847 ll~~ 850 (1177)
T KOG1025|consen 847 LLAP 850 (1177)
T ss_pred ccCc
Confidence 8744
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=182.12 Aligned_cols=152 Identities=18% Similarity=0.281 Sum_probs=115.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHH---------HHHHHHHHHHHhhcCCCceeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENI---------RREFAQEVHIMRKVRHMNVVQ 306 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~---------~~~~~~Ei~iL~~l~HpNIV~ 306 (411)
++....|++.++||+|+||.||+|.+.+ ..+|+|+.......... ......+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 5667889999999999999999998753 35677764433211100 011233444566778999999
Q ss_pred EEeeeecCC----eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCc
Q 015237 307 FIGACTRPP----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 307 l~g~~~~~~----~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~ 382 (411)
+++++.... ..++++|++ ..++.+++.... ..++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-- 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-- 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--
Confidence 999775543 347888887 457777776543 467888899999999999999999999999999999998877
Q ss_pred CCCccEEEEecccccccc
Q 015237 383 DSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 383 k~~~~ikL~DFGla~~~~ 400 (411)
.++|+|||+|+.+.
T Consensus 164 ----~~~l~DFGla~~~~ 177 (294)
T PHA02882 164 ----RGYIIDYGIASHFI 177 (294)
T ss_pred ----cEEEEEcCCceeec
Confidence 58999999998763
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=199.96 Aligned_cols=142 Identities=25% Similarity=0.437 Sum_probs=126.0
Q ss_pred EEeecCceEEEEEEECC--ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
.||.|.||.||.|++.. ...|||.+... +....+.+..||.+-+.++|.|||+++|+|..++.+-|.||-.+||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 68999999999998864 56789988654 334567799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCcCCCccEEEEeccccccccc
Q 015237 330 YDYLHKQKCGL--KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 330 ~~~L~~~~~~l--~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~-~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.++|+..=+.+ .+..+-.+.+||++||.|||++.|||||||-+|+||+. .|+ +||+|||-++++.+
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGv------lKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGV------LKISDFGTSKRLAG 728 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccce------EEecccccchhhcc
Confidence 99998875566 77888899999999999999999999999999999976 554 89999999998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=179.04 Aligned_cols=154 Identities=18% Similarity=0.263 Sum_probs=135.3
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+..-|+.++|++.+++|+|+|+-||.+.. ++..||+|.+.... .+..+..++|+...++++|||++++++++..+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 44578999999999999999999998864 46889999987764 455678999999999999999999998875443
Q ss_pred -----eEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCCC
Q 015237 316 -----RLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 316 -----~l~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~~ 385 (411)
..||+++|...|||.+.+... +..+++..++.|+.+|++||++||+.. +.||||||+|||+++.+
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~----- 166 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG----- 166 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-----
Confidence 499999999999999988754 336899999999999999999999998 99999999999999977
Q ss_pred ccEEEEeccccccc
Q 015237 386 IHCYLSNFLSISTV 399 (411)
Q Consensus 386 ~~ikL~DFGla~~~ 399 (411)
.++|.|||++...
T Consensus 167 -~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 167 -LPVLMDLGSATQA 179 (302)
T ss_pred -ceEEEeccCcccc
Confidence 5899999999865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=176.47 Aligned_cols=142 Identities=24% Similarity=0.352 Sum_probs=126.5
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
||+|+||.||++... ++.+++|++...... ......+..|+.+++.++|+||+++++.+.....+|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999886 689999998765432 23456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 330 ~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.+++.... .+++..+..++.|++.|+.|||+++++|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~------~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG------HIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC------cEEEeecCcceeccc
Confidence 99998764 589999999999999999999999999999999999999988 489999999877544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=186.73 Aligned_cols=146 Identities=22% Similarity=0.321 Sum_probs=124.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------- 314 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------- 314 (411)
..+|++.+.||.|+||.||+|... ++.||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 367999999999999999999875 68999999876543 3346788999999999999999999776543
Q ss_pred -------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 315 -------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 315 -------~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
..+|++|||++ ++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++. .
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-----~ 153 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-----V 153 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-----e
Confidence 35899999996 6998888643 5889999999999999999999999999999999999986542 5
Q ss_pred EEEEeccccccc
Q 015237 388 CYLSNFLSISTV 399 (411)
Q Consensus 388 ikL~DFGla~~~ 399 (411)
++|+|||.+..+
T Consensus 154 ~kl~dfg~~~~~ 165 (342)
T cd07854 154 LKIGDFGLARIV 165 (342)
T ss_pred EEECCcccceec
Confidence 899999999765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=183.43 Aligned_cols=150 Identities=31% Similarity=0.445 Sum_probs=128.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|+..+.||+|+||.||+|+.. ++.+|+|.+..... .....+.+.+|+.+++.++|+|++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344666788999999999999875 57899999875322 334456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+. |++.+++......++...+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~------~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG------LVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC------cEEECCcccceeec
Confidence 99995 688888866555688999999999999999999999999999999999999887 59999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=179.35 Aligned_cols=148 Identities=24% Similarity=0.347 Sum_probs=124.0
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc---cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH---LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~---~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+|.+.++||+|+||.||++.+. +..+++|+++... ........+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999876 3456666665422 2223344577899999999999999999999988899999
Q ss_pred EecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 321 TEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.+ .++|+|||.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~-------~~~l~d~g~~~ 153 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-------LLKIGDFGVSR 153 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC-------CEeecccCcee
Confidence 999999999998864 23468999999999999999999999999999999999999753 38999999887
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 154 ~~~ 156 (260)
T cd08222 154 LLM 156 (260)
T ss_pred ecC
Confidence 653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=197.47 Aligned_cols=148 Identities=30% Similarity=0.490 Sum_probs=126.9
Q ss_pred CCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeec-----CC
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR-----PP 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~-----~~ 315 (411)
...+.|.+.||.|.+|.||+++. .++.+|+|++..... ..+++..|.+||+.. .|||++.|||++.. ++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 33455688999999999998865 478899999876542 235677888888877 79999999999853 46
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
.+|+|||||.|||..|+++.- +..+.+..+.+|++.++.|+.+||.+.+||||+|-.|||++++| .+||+|||
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~------~VKLvDFG 168 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA------EVKLVDFG 168 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC------cEEEeeee
Confidence 799999999999999999765 34689999999999999999999999999999999999999999 69999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
.+.-+.
T Consensus 169 vSaQld 174 (953)
T KOG0587|consen 169 VSAQLD 174 (953)
T ss_pred eeeeee
Confidence 987663
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=177.17 Aligned_cols=141 Identities=18% Similarity=0.319 Sum_probs=116.7
Q ss_pred eEEEEE--EeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEE
Q 015237 247 LKFEHK--IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 247 ~~~~~~--IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
+.+.+. ||+|+||.||++... +..+|+|.+........ |+.....+ +||||+++++++...+..|+||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 444444 599999999999875 67899999876533221 22222222 7999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++. .++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-----~~~l~dfg~~~~~~ 161 (267)
T PHA03390 89 DYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-----RIYLCDYGLCKIIG 161 (267)
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-----eEEEecCccceecC
Confidence 9999999999998764 7899999999999999999999999999999999999988772 48999999887653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=173.43 Aligned_cols=141 Identities=14% Similarity=0.221 Sum_probs=107.6
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-----CCCceeEEEeeeecCC---eEE-EE
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-----RHMNVVQFIGACTRPP---RLF-IV 320 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-----~HpNIV~l~g~~~~~~---~l~-IV 320 (411)
.+.||+|+||.||....... .+||++...... ..+.+.+|+.+++.+ .||||++++|++.++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999997322233 368888664322 346789999999999 5799999999998863 434 78
Q ss_pred Eec--CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 321 TEF--MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM-NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 321 ~E~--~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL-~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
||| +.+|+|.+++... .+++. ..++.+++.++ +|||+++|+||||||+|||++..+.. ...++|+||+.+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~--~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISES--EVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCC--CCcEEEEECCCCc
Confidence 999 5579999999653 35555 35678888887 99999999999999999999865421 2369999966665
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 55
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=193.03 Aligned_cols=153 Identities=20% Similarity=0.302 Sum_probs=118.5
Q ss_pred eecCCceEEEEEEeecCceEEEEEEE------------------CCceEEEEEeeccccCH------------HHHHHHH
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAF------------------FSQDVAIKVLTNEHLNE------------NIRREFA 290 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~------------------~~~~VAIK~l~~~~~~~------------~~~~~~~ 290 (411)
.+..++|.+.++||+|+||.||+|.+ .++.||||.++...... ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34677899999999999999999964 23579999986542110 0112234
Q ss_pred HHHHHHhhcCCCce-----eEEEeeeec--------CCeEEEEEecCCCCCHHHHHHhcCC-------------------
Q 015237 291 QEVHIMRKVRHMNV-----VQFIGACTR--------PPRLFIVTEFMSGGSIYDYLHKQKC------------------- 338 (411)
Q Consensus 291 ~Ei~iL~~l~HpNI-----V~l~g~~~~--------~~~l~IV~E~~~gGsL~~~L~~~~~------------------- 338 (411)
.|+.++.+++|.++ ++++++|.. .+..|+||||+++|+|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777777876654 677777753 3468999999999999999875321
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 339 ----GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 339 ----~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++..+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~------~~kL~DFGla~~~ 359 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG------QVKIIDFGAAVDM 359 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC------cEEEEeCcCcccc
Confidence 234567888999999999999999999999999999999887 5899999999654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=214.88 Aligned_cols=148 Identities=22% Similarity=0.392 Sum_probs=131.0
Q ss_pred EEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 248 ~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
+-+.+||.|.||.||.|... |.-.|+|-++...........+.+|..++..++|||+|++||+-.+.+..+|.||||+
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 34678999999999999764 7889999887665444555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
+|+|.+.+...+ ..++.....+..|++.|+.|||+.|||||||||+||+++.+|. +|+.|||+|..+.++
T Consensus 1318 ~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~------iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1318 GGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL------IKYGDFGSAVKIKNN 1387 (1509)
T ss_pred cCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc------EEeecccceeEecCc
Confidence 999999997654 5677777888999999999999999999999999999999994 999999999998765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=173.18 Aligned_cols=131 Identities=23% Similarity=0.299 Sum_probs=113.5
Q ss_pred cCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHH
Q 015237 256 GSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL 333 (411)
Q Consensus 256 Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L 333 (411)
|.||.||++... ++.||+|.++... .+.+|...+....||||+++++++......|++|||++||+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999875 6889999997642 2334555555667999999999999999999999999999999999
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 334 ~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.... .+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++++|||.+..+.
T Consensus 77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~~l~df~~~~~~~ 136 (237)
T cd05576 77 SKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG------HIQLTYFSRWSEVE 136 (237)
T ss_pred HHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC------CEEEecccchhccc
Confidence 7654 589999999999999999999999999999999999999988 58999999876553
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=187.98 Aligned_cols=156 Identities=19% Similarity=0.223 Sum_probs=138.5
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~ 315 (411)
....|....|+++++||+|+.+.||++...+ +.||+|.+.....+......|.+|+..|.+++ |.+||++|++-...+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4568899999999999999999999998764 77899888777777888899999999999994 999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+||||||- ..+|..+|++....++...+..+..|++.+++++|+.||||.||||+|+|+-. | .+||+|||.
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G------~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G------RLKLIDFGI 505 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e------eEEeeeech
Confidence 999999987 67999999987655555588889999999999999999999999999999854 3 489999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
|..+..
T Consensus 506 A~aI~~ 511 (677)
T KOG0596|consen 506 ANAIQP 511 (677)
T ss_pred hcccCc
Confidence 998754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-20 Score=170.85 Aligned_cols=154 Identities=24% Similarity=0.312 Sum_probs=131.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC-CceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~~~l 317 (411)
.|-...|++.++||+|+||++|.|... |+.||||+-+..... ..+..|..+.+.+++ ..|..+..+.++..+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 466778999999999999999999874 799999997655433 347789999999975 5677777778888888
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
.+||+.+ |.||.+++.-....++..+++.++.|++.-++|+|.+++|||||||+|+|+.-+-. ...+.|+|||+|+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh---~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRH---CNKLYLIDFGLAK 162 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccc---cceEEEEeccchh
Confidence 9999999 99999999887778999999999999999999999999999999999999964432 2378999999999
Q ss_pred ccccc
Q 015237 398 TVILV 402 (411)
Q Consensus 398 ~~~~~ 402 (411)
.+.+.
T Consensus 163 ky~d~ 167 (341)
T KOG1163|consen 163 KYRDI 167 (341)
T ss_pred hhccc
Confidence 98653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-19 Score=158.08 Aligned_cols=142 Identities=31% Similarity=0.568 Sum_probs=126.5
Q ss_pred EeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHH
Q 015237 253 IVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~ 330 (411)
||+|++|.||++... ++.+++|++....... ....+.+|+.+++.++|++|+++++++......++++|++.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999997 7899999998664322 3467999999999999999999999999988999999999989999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCcCCCccEEEEeccccccccc
Q 015237 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 331 ~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~-~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+++......++...+..++.+++.++.|||++|++|+||+|.||+++. ++ .++|+|||.+.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~------~~~l~d~~~~~~~~~ 145 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG------KVKLADFGLSKLLTS 145 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC------cEEEecCCceEEccC
Confidence 999876345889999999999999999999999999999999999998 55 599999999986644
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=187.03 Aligned_cols=157 Identities=20% Similarity=0.252 Sum_probs=136.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
|-+..+.++.-..||.|+||.||-+.. +|+-+|.|.+.+..... .-....+.|-.||.+++.+.||.+--+|++++.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 346667788889999999999998755 58899999987654322 223456889999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+|+|+..|.||+|.-.|...+ ..+++..++.++.+|+.||++||+.+||.|||||+|||+|+.| +++|+|.|+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G------hvRISDLGL 333 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG------HVRISDLGL 333 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC------CeEeeccce
Confidence 999999999999987776653 3799999999999999999999999999999999999999999 699999999
Q ss_pred ccccccc
Q 015237 396 ISTVILV 402 (411)
Q Consensus 396 a~~~~~~ 402 (411)
|..+...
T Consensus 334 Avei~~g 340 (591)
T KOG0986|consen 334 AVEIPEG 340 (591)
T ss_pred EEecCCC
Confidence 9988553
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=185.30 Aligned_cols=153 Identities=23% Similarity=0.346 Sum_probs=133.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECC--ceEEEEEeeccccC-HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.|...++.|+..||.|+||.|..+..+| +.+|||+++++..- .+..+--..|-++|... +-|.+++++.+|...+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 7888899999999999999999998775 67999999987532 22334456677777766 57899999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||+.||+|.-.++.-+ .+.++.+..++.+|+-||-|||++|||.||||.+|||+|.+| .+||+|||.+
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG------HiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG------HIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC------ceEeeecccc
Confidence 999999999999988887654 799999999999999999999999999999999999999999 6999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
+.-.
T Consensus 498 KEni 501 (683)
T KOG0696|consen 498 KENI 501 (683)
T ss_pred cccc
Confidence 8753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-21 Score=200.71 Aligned_cols=151 Identities=29% Similarity=0.460 Sum_probs=133.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
-+..+|.+..++|+|+||+||++++. ++..|+|+++.+..+ ...-+++|+-+++.++|||||.++|.+.....+||
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34567889999999999999999875 688999999877433 34667899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.||||.||+|.+.-+-. +.+++.++..+++..++|++|||++|-+|||||-+|||+++.| .+|++|||-+-.+
T Consensus 90 cMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g------DvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG------DVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC------ceeecccCchhhh
Confidence 99999999999876544 4788999999999999999999999999999999999999999 5899999998776
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 163 ta 164 (829)
T KOG0576|consen 163 TA 164 (829)
T ss_pred hh
Confidence 44
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-19 Score=161.76 Aligned_cols=149 Identities=30% Similarity=0.504 Sum_probs=131.6
Q ss_pred eEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|.+.+.||+|++|.||++... ++.+++|.+...... ...+.+.+|+..++.++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 457789999999999999886 488999999765432 24578999999999999999999999999888999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
++++|.+++......+++..+..++.+++.++.|||+++++|+||+|.||+++.++ .++|+|||.+..+...
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~------~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG------LVKLADFGLARFIHRD 151 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------CEEEeeCceeeEecCc
Confidence 99999999987653378899999999999999999999999999999999999876 5999999998877543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=169.74 Aligned_cols=158 Identities=23% Similarity=0.346 Sum_probs=132.9
Q ss_pred eeecCCceEEEEEEeecCceEEEEE--EECCceEEEEEeeccccCHHHHHHHHHHHHHHhh-cCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g--~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~~~ 316 (411)
.+++.+.+.-+..||.|+||.|-+- .+.|+-.|+|.+...- +.+..+.+++|+.+..+ ...|.+|.|||.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 6888888888999999999987554 4568999999997653 45567788899987554 479999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 317 LFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
+||.||.| ..||..|-++ .+..+++..+-+++..+..||.|||++ .+||||+||+||||+.+| ++|+||
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G------qVKiCD 192 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG------QVKICD 192 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC------cEEEcc
Confidence 99999999 5688776543 355789999999999999999999975 799999999999999999 799999
Q ss_pred cccccccccceee
Q 015237 393 FLSISTVILVIFS 405 (411)
Q Consensus 393 FGla~~~~~~~~~ 405 (411)
||.+.-+.+.+..
T Consensus 193 FGIsG~L~dSiAk 205 (282)
T KOG0984|consen 193 FGISGYLVDSIAK 205 (282)
T ss_pred cccceeehhhhHH
Confidence 9998877665543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-20 Score=177.20 Aligned_cols=140 Identities=23% Similarity=0.313 Sum_probs=119.1
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeec----CCeEEEEEec
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR----PPRLFIVTEF 323 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~----~~~l~IV~E~ 323 (411)
++||-|-.|.|-.+..+ ++.+|+|++... ....+|+++--.. .|||||++++++.. ..++.||||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 57999999999998775 689999998643 3456788775544 69999999998864 4568999999
Q ss_pred CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+||.|+..++.++. .+++..+..|+.||+.|+.|||+.+|-||||||+|+|...++.. ..+||+|||+|+.-.
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~n---a~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPN---APLKLTDFGFAKETQ 215 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCC---cceEecccccccccC
Confidence 999999999988753 59999999999999999999999999999999999999877632 258999999998754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.4e-21 Score=176.28 Aligned_cols=145 Identities=17% Similarity=0.312 Sum_probs=124.3
Q ss_pred cCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCC--eE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP--RL 317 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~--~l 317 (411)
..+.|++.+++|.|-|++||.|.. +++.++||++++-. .+.+.+|+.||+.+. ||||+++++...++. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 456788889999999999999974 46899999998653 366899999999996 999999999987654 47
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
.+++||..+.+...+.. .++...+..++.++++||+|||++||+|||+||.|++||.... .++|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-----kLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-----KLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-----eeeeeecchHh
Confidence 79999998877766553 4777889999999999999999999999999999999998764 58999999997
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
-+..
T Consensus 182 FYHp 185 (338)
T KOG0668|consen 182 FYHP 185 (338)
T ss_pred hcCC
Confidence 6643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=194.77 Aligned_cols=155 Identities=23% Similarity=0.291 Sum_probs=139.4
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECCce--EEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQD--VAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~--VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+..++++....||-|+||.|=....+++. +|+|++++.+. +....+.+..|-+||..++.|.||++|..|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 456677888889999999999999888765 89999988764 334556688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+.||-|-||.|+..|++++ .++......++..+++|++|||++|||.|||||+|++++.+| -+||.|||+|+
T Consensus 496 YmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G------y~KLVDFGFAK 568 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG------YLKLVDFGFAK 568 (732)
T ss_pred hhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC------ceEEeehhhHH
Confidence 99999999999999998876 799999999999999999999999999999999999999999 49999999999
Q ss_pred ccccc
Q 015237 398 TVILV 402 (411)
Q Consensus 398 ~~~~~ 402 (411)
.+.++
T Consensus 569 ki~~g 573 (732)
T KOG0614|consen 569 KIGSG 573 (732)
T ss_pred HhccC
Confidence 88654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-20 Score=175.49 Aligned_cols=155 Identities=23% Similarity=0.359 Sum_probs=132.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC--ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~ 316 (411)
...+.+++++...||+|+.|.||+.++.. .-.|||.+.... +.+..++++..+.++.+.. .|.||+.+|+|..+..
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 45566778888999999999999999874 889999997654 5556788889999887775 8999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|.||.| ..-+..+++.-...+++..+-++...+..||.||-. ++|||||+||+|||+|+.| ++||||||.
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G------niKlCDFGI 238 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG------NIKLCDFGI 238 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC------CEEeecccc
Confidence 99999999 445666676666678888888899999999999985 6799999999999999999 699999999
Q ss_pred ccccccc
Q 015237 396 ISTVILV 402 (411)
Q Consensus 396 a~~~~~~ 402 (411)
+..+...
T Consensus 239 sGrlvdS 245 (391)
T KOG0983|consen 239 SGRLVDS 245 (391)
T ss_pred cceeecc
Confidence 9887543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-21 Score=183.20 Aligned_cols=142 Identities=24% Similarity=0.384 Sum_probs=121.4
Q ss_pred EEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-----eEEEEEe
Q 015237 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-----RLFIVTE 322 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~l~IV~E 322 (411)
.+.||-|+||.||..++. ++.||+|.+..-..+-...+.+.+|+.+|..++|.|+...++...-+. .+|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 357999999999999875 688999998765444456688999999999999999999888765432 3789999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.| ..+|..++-... .++...++-+..||++||+|||+.+|.||||||.|+|++.|.+ +||||||+|+.-
T Consensus 138 Lm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv------LKICDFGLARve 206 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI------LKICDFGLARTW 206 (449)
T ss_pred HH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce------EEeccccccccc
Confidence 99 458888776544 6888889999999999999999999999999999999999995 899999999875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-19 Score=163.32 Aligned_cols=137 Identities=23% Similarity=0.379 Sum_probs=114.7
Q ss_pred EEEeecCceEEEEEEECCceEEEEEeeccccCH------HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecC
Q 015237 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~------~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
+.||+|++|.||+|.+.+..|++|+........ .....+.+|+.++..++|++|.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 578999999999999999999999876543211 12345788999999999999887777776677789999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|++|.+++.... . ....++.+++.+|.++|+.+++|+|++|+|||++ ++ .++++|||++...
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~------~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG------KIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC------CEEEEECCcccCC
Confidence 9999999986533 1 7788999999999999999999999999999998 44 4899999998753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=183.13 Aligned_cols=161 Identities=22% Similarity=0.294 Sum_probs=135.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC------CceeEEEeeeec
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTR 313 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H------pNIV~l~g~~~~ 313 (411)
+--..|.+....|+|-|+.|.+|.+. ++.||||+|... +-+.+.-+.|++||++|+. -++++|+..|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 33456667778999999999999885 689999999864 3344667889999999962 378999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.+++|||+|.+ .-+|.+.|++.+. .|....+..++.|+..||..|-.+||+|.||||+|||+++... .+|||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-----iLKLC 579 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-----ILKLC 579 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-----eeeec
Confidence 99999999998 6699999998643 5788889999999999999999999999999999999998764 58999
Q ss_pred eccccccc----ccceeeEEEEcC
Q 015237 392 NFLSISTV----ILVIFSCILVRA 411 (411)
Q Consensus 392 DFGla~~~----~~~~~~~i~~ra 411 (411)
|||+|+.+ +++.+.+=||||
T Consensus 580 DfGSA~~~~eneitPYLVSRFYRa 603 (752)
T KOG0670|consen 580 DFGSASFASENEITPYLVSRFYRA 603 (752)
T ss_pred cCccccccccccccHHHHHHhccC
Confidence 99999987 445555556665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-20 Score=176.76 Aligned_cols=159 Identities=22% Similarity=0.336 Sum_probs=131.1
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHH-HhhcCCCceeEEEeeeec
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHI-MRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~i-L~~l~HpNIV~l~g~~~~ 313 (411)
..-|++...+++-+..||.|+||.|++-.++ ++..|||.++.... ....++++.|... |+.-+.||||+|||++-.
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 4568899999999999999999999998876 68999999987654 3445678888775 555689999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccE
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHK----QKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~----~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
++..||.||+| ..||..+.+. +...+++..+-.+......||+||-. ..|||||+||+|||++..| .+
T Consensus 135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G------~v 207 (361)
T KOG1006|consen 135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG------DV 207 (361)
T ss_pred CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC------CE
Confidence 99999999999 5577554332 23458888888888888999999975 5799999999999999999 59
Q ss_pred EEEecccccccccce
Q 015237 389 YLSNFLSISTVILVI 403 (411)
Q Consensus 389 kL~DFGla~~~~~~~ 403 (411)
||||||.+.-+.+.+
T Consensus 208 KLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI 222 (361)
T ss_pred eeecccchHhHHHHH
Confidence 999999987765543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=185.96 Aligned_cols=147 Identities=14% Similarity=0.294 Sum_probs=105.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee----
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA---- 310 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~---- 310 (411)
....++|.+.++||+|+||.||+|++. +..||+|.+...... +....| . ++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e-~-l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE-R-VRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH-H-HHhhchhhHHHHHHhhhcc
Confidence 445677999999999999999999885 468999987643211 111111 1 111122222222211
Q ss_pred --eecCCeEEEEEecCCCCCHHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 015237 311 --CTRPPRLFIVTEFMSGGSIYDYLHKQKCGL-------------------KLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369 (411)
Q Consensus 311 --~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l-------------------~~~~i~~i~~qIa~gL~yLHs~gIIHRDL 369 (411)
+.....++|||||+.+++|.+++....... ....+..++.|++.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 245567999999999999999987543111 12345678999999999999999999999
Q ss_pred CCCcEEEccC-CCcCCCccEEEEeccccccc
Q 015237 370 KAANLLMNEN-GVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 370 Kp~NILid~~-g~~k~~~~ikL~DFGla~~~ 399 (411)
||+|||++.+ + .+||+|||+|..+
T Consensus 282 KP~NILl~~~~~------~~KL~DFGlA~~l 306 (566)
T PLN03225 282 KPQNIIFSEGSG------SFKIIDLGAAADL 306 (566)
T ss_pred CHHHEEEeCCCC------cEEEEeCCCcccc
Confidence 9999999864 4 5899999999754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=159.87 Aligned_cols=132 Identities=20% Similarity=0.325 Sum_probs=107.2
Q ss_pred EeecCceEEEEEEECCceEEEEEeeccccCH------HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~------~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
||+|+||.||+|.+.+..|++|......... .....+.+|+.+++.++|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7999999999999999999999965432211 1235678899999999988765544445555667999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++ .++++|||++...
T Consensus 82 ~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~------~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD------KLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC------cEEEEECCCCcCC
Confidence 99999876432 1 7889999999999999999999999999998 44 5899999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.2e-19 Score=173.69 Aligned_cols=165 Identities=19% Similarity=0.263 Sum_probs=135.5
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--C----ceeEEEeeeecC
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--M----NVVQFIGACTRP 314 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--p----NIV~l~g~~~~~ 314 (411)
-...|.+..++|+|+||.|-++.+. +..||||+++.- ...++...-|+++|+++.+ | -+|++.+||...
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3678999999999999999999876 578999999753 2345667789999999942 2 378899999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC------cC----
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV------RD---- 383 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~------~k---- 383 (411)
+++|||+|.+ |-|++++|..++. .++...+..++.|++.++.|||+++++|-||||+|||+-.... .+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 7899999988643 6889999999999999999999999999999999999854321 01
Q ss_pred --C--CccEEEEeccccccc---ccceeeEEEEcC
Q 015237 384 --S--DIHCYLSNFLSISTV---ILVIFSCILVRA 411 (411)
Q Consensus 384 --~--~~~ikL~DFGla~~~---~~~~~~~i~~ra 411 (411)
+ ...++++|||+|... -+.+++|==|||
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRA 277 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRA 277 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcceeeeccccCC
Confidence 1 357999999999875 345577666665
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=182.36 Aligned_cols=145 Identities=22% Similarity=0.317 Sum_probs=116.9
Q ss_pred ceeecCCceE---EEEEEeecCceEEEEEEECCceEEEEEeeccccC-----H-HHHHHHHHHHHHHhhcCCCceeEEEe
Q 015237 239 VWEIDASLLK---FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-----E-NIRREFAQEVHIMRKVRHMNVVQFIG 309 (411)
Q Consensus 239 ~~ei~~~~~~---~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~-----~-~~~~~~~~Ei~iL~~l~HpNIV~l~g 309 (411)
.|+....... ..++||+|+||.||+|.+.+..+++|........ . ...+.+.+|+.+++.++|++++..+.
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 4665554433 3789999999999999998877777654332211 1 12356889999999999999998887
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
++......++||||++|++|.+++. ....++.+++.+|.|||+.+++||||||+|||++ ++ .++
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~------~~~ 467 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD------RLY 467 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC------cEE
Confidence 7777777899999999999999885 2467889999999999999999999999999994 44 489
Q ss_pred EEeccccccc
Q 015237 390 LSNFLSISTV 399 (411)
Q Consensus 390 L~DFGla~~~ 399 (411)
|+|||++...
T Consensus 468 liDFGla~~~ 477 (535)
T PRK09605 468 LIDFGLGKYS 477 (535)
T ss_pred EEeCcccccC
Confidence 9999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-19 Score=187.97 Aligned_cols=161 Identities=21% Similarity=0.305 Sum_probs=125.6
Q ss_pred CCCceeecC------CceEEEEEEeecCceE-EEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015237 236 GIDVWEIDA------SLLKFEHKIVSGSYCD-LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (411)
Q Consensus 236 ~~~~~ei~~------~~~~~~~~IG~Gsfg~-Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 307 (411)
..+.|+... ..+.-.+.+|.|+-|+ ||+|.+.++.||||.+..+. .....+|+..|+.. +|||||++
T Consensus 494 ~~~~~~~~~~~v~~k~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRy 568 (903)
T KOG1027|consen 494 SLDGPEAGGKVVVGKLFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRY 568 (903)
T ss_pred cccccccccceeeeeeeeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEE
Confidence 345666653 1222245678898875 89999999999999986543 35578999999988 69999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcCCC--CCH-HHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG--LKL-PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~--l~~-~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~ 384 (411)
|+.-.+....||..|.| ..+|.+++...... ... ...+.+..|++.||.+||+.+||||||||.||||+... .+.
T Consensus 569 yc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~-~~~ 646 (903)
T KOG1027|consen 569 YCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS-ADG 646 (903)
T ss_pred EeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC-CCc
Confidence 99999999999999999 56999999873111 111 23467788999999999999999999999999998742 122
Q ss_pred CccEEEEecccccccccce
Q 015237 385 DIHCYLSNFLSISTVILVI 403 (411)
Q Consensus 385 ~~~ikL~DFGla~~~~~~~ 403 (411)
...++|+|||+++.+....
T Consensus 647 ~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 647 TLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred ceeEEecccccccccCCCc
Confidence 3469999999999986543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=195.13 Aligned_cols=126 Identities=22% Similarity=0.424 Sum_probs=109.6
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.++..+.||+|+||.||+|.+. +..||||.++.... ....|+.+|++++|||||+++|+|......|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 3455678999999999999874 68999999864321 123468889999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCcEEEccCCC
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH---RNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLH---s~gIIHRDLKp~NILid~~g~ 381 (411)
|++|+|.++++ .+++.....++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 765 ~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~ 821 (968)
T PLN00113 765 IEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821 (968)
T ss_pred CCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc
Confidence 99999999995 3788999999999999999999 679999999999999998774
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=166.60 Aligned_cols=158 Identities=18% Similarity=0.218 Sum_probs=135.7
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.-+-.-+|+++++||+|+||.++.|+. ++++||||.-...... ..+..|.+..+.| ..++|.+.|-+.....+
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 345667899999999999999999975 5899999986554433 3466788888877 46899998888888878
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
-.+|+|++ |.||.|++.-.+..|+..++..++.|++.-++|+|++.+|.|||||+|+||+..+..+-. .+.++|||+|
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n-~IhiiDFGmA 176 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDAN-VIHIIDFGMA 176 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCc-eEEEEeccch
Confidence 88999999 999999998888889999999999999999999999999999999999999988765544 5999999999
Q ss_pred cccccce
Q 015237 397 STVILVI 403 (411)
Q Consensus 397 ~~~~~~~ 403 (411)
+.+.++.
T Consensus 177 K~YrDp~ 183 (449)
T KOG1165|consen 177 KEYRDPK 183 (449)
T ss_pred hhhcCcc
Confidence 9987764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-19 Score=171.52 Aligned_cols=158 Identities=23% Similarity=0.304 Sum_probs=139.5
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhc-CCCceeEEEeeee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV-RHMNVVQFIGACT 312 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~ 312 (411)
...|.+....+.++..||.|+|..|..++.. .+-+|+|+++++..++ +.....+.|-.+.... +||.+|-++.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 3568899999999999999999999998775 5789999999887654 3344566777777665 7999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
....+++|.||.+||+|.-.++.++ .+++..+..+..+|+.||.|||++|||.||||.+|+|+|..| .+||+|
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg------hikltd 394 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG------HIKLTD 394 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC------ceeecc
Confidence 9999999999999999988887765 799999999999999999999999999999999999999999 699999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
+|.++.-+.
T Consensus 395 ygmcke~l~ 403 (593)
T KOG0695|consen 395 YGMCKEGLG 403 (593)
T ss_pred cchhhcCCC
Confidence 999987543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-18 Score=156.38 Aligned_cols=137 Identities=31% Similarity=0.538 Sum_probs=121.8
Q ss_pred CceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHH
Q 015237 257 SYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLH 334 (411)
Q Consensus 257 sfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~ 334 (411)
+||.||+|.+. ++.+++|++........ .+.+.+|+..+++++|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999986 48899999976543321 5789999999999999999999999998889999999999999999997
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 335 KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 335 ~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
... .++...+..++.+++.++.|||+.+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~------~~~l~d~~~~~~~~~ 139 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG------HVKLADFGLARQLDP 139 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC------cEEEccccceeeecc
Confidence 654 388899999999999999999999999999999999999887 599999999987654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=163.36 Aligned_cols=146 Identities=18% Similarity=0.228 Sum_probs=111.7
Q ss_pred CceEEEEEEeecCceEEEEEE-E--CCceEEEEEeeccccC--------------------H--HHHHHHHHHHHHHhhc
Q 015237 245 SLLKFEHKIVSGSYCDLYKGA-F--FSQDVAIKVLTNEHLN--------------------E--NIRREFAQEVHIMRKV 299 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~-~--~~~~VAIK~l~~~~~~--------------------~--~~~~~~~~Ei~iL~~l 299 (411)
..|.+.+.||+|+||.||+|. . .++.||+|+++..... . .....+.+|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 346778899999999999998 3 4799999999764311 0 0123467899999999
Q ss_pred CCC--ceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEE
Q 015237 300 RHM--NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN-IIHRDLKAANLLM 376 (411)
Q Consensus 300 ~Hp--NIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g-IIHRDLKp~NILi 376 (411)
.+. .+.++++. ...++||||++|++|..++.... .+.......++.|++.++.|||++| |+||||||+||++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 753 34455543 23589999998888876543322 4556667889999999999999999 9999999999999
Q ss_pred ccCCCcCCCccEEEEecccccccccc
Q 015237 377 NENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 377 d~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
+ ++ .++|+|||.|.....+
T Consensus 183 ~-~~------~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 183 H-DG------KVVIIDVSQSVELDHP 201 (237)
T ss_pred E-CC------CEEEEEChhhhccCCc
Confidence 8 44 5899999999865443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=156.07 Aligned_cols=133 Identities=15% Similarity=0.145 Sum_probs=106.1
Q ss_pred EEEEEeecCceEEEEEEECCceEEEEEeeccccC--HHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCC
Q 015237 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
....|++|+||+||.....+.+++.+.+.....- .-....+.+|+++|++++ |++|++++++ ...|++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 3567899999999988777788887777654331 112336889999999995 5889999886 34799999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL-KAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDL-Kp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|.+|.+.+... ...++.|++.++.++|++||+|||| ||+|||++.+| .++|+|||+|...
T Consensus 82 G~~L~~~~~~~--------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g------~i~LIDFG~A~~~ 142 (218)
T PRK12274 82 GAAMYQRPPRG--------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG------SPAVIDFQLAVRG 142 (218)
T ss_pred CccHHhhhhhh--------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC------CEEEEECCCceec
Confidence 98987544211 1346789999999999999999999 79999999887 5899999999854
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=158.09 Aligned_cols=143 Identities=10% Similarity=0.127 Sum_probs=116.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCH-HHHHH------HHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE-NIRRE------FAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~-~~~~~------~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
+-..+|+..+.+|.|+||.||.....+..+|||++.+..... ..... +.+|+..+.+++|++|..+..++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 346789999999999999999977777899999998664433 22223 67999999999999999998875532
Q ss_pred --------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCc
Q 015237 315 --------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDI 386 (411)
Q Consensus 315 --------~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~ 386 (411)
+..+|+|||++|.+|.++.. ++. ....+++.++..+|+.|++|||+||+||+++.+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g------ 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG------ 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC------
Confidence 35899999999999988742 222 2456899999999999999999999999998876
Q ss_pred cEEEEecccccccc
Q 015237 387 HCYLSNFLSISTVI 400 (411)
Q Consensus 387 ~ikL~DFGla~~~~ 400 (411)
++|+|||..+...
T Consensus 173 -i~liDfg~~~~~~ 185 (232)
T PRK10359 173 -LRIIDLSGKRCTA 185 (232)
T ss_pred -EEEEECCCccccc
Confidence 7899999987764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=165.35 Aligned_cols=148 Identities=22% Similarity=0.317 Sum_probs=123.2
Q ss_pred ceEEEEEEeecCceEEEEEEECC---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC----CceeEEEeee-ecCCeE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFFS---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH----MNVVQFIGAC-TRPPRL 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H----pNIV~l~g~~-~~~~~l 317 (411)
.|++.++||+|+||.||.+.... ..+|+|+......... ..+..|+.+|..+.. +++..+++.. .....-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 79999999999999999998764 3689998776432211 257789999988873 5889999888 477789
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
||||+.+ |.+|.++..... ..++..++++++.|++.+|+++|+.|++||||||+|++++..+..+. ..++|.|||+|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~-~~~~llDfGla 174 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEV-RTLYLLDFGLA 174 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCccc-ceEEEEecCCC
Confidence 9999998 899999886654 57999999999999999999999999999999999999987642111 25899999999
Q ss_pred c
Q 015237 397 S 397 (411)
Q Consensus 397 ~ 397 (411)
+
T Consensus 175 r 175 (322)
T KOG1164|consen 175 R 175 (322)
T ss_pred c
Confidence 9
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.6e-18 Score=155.19 Aligned_cols=139 Identities=18% Similarity=0.178 Sum_probs=108.0
Q ss_pred eEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCH--------------------HHHHHHHHHHHHHhhcCCC--c
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE--------------------NIRREFAQEVHIMRKVRHM--N 303 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~--------------------~~~~~~~~Ei~iL~~l~Hp--N 303 (411)
|.+.+.||+|+||.||++... ++.||||+++...... .....+..|+.++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 566788999999999999874 7899999976543110 0122367889999999877 4
Q ss_pred eeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 304 IV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
+...++. ...+++|||++|++|..+... .....++.+++.++.++|+.||+||||||+||++++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--- 162 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--- 162 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC---
Confidence 4555543 346899999999998765421 23467888999999999999999999999999999877
Q ss_pred CCccEEEEecccccccccc
Q 015237 384 SDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~~~ 402 (411)
.++|+|||.+..+...
T Consensus 163 ---~~~liDfg~~~~~~~~ 178 (198)
T cd05144 163 ---KIYIIDWPQMVSTDHP 178 (198)
T ss_pred ---cEEEEECCccccCCCc
Confidence 5899999999776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=167.92 Aligned_cols=156 Identities=22% Similarity=0.290 Sum_probs=129.4
Q ss_pred CceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------e
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------R 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------~ 316 (411)
.+|.-...+|.|.- .|..+.+ .+++||+|.+.....+....++..+|..+|..++|+||++++.+|+-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555667777776 4555544 3789999998776555555678899999999999999999999997543 4
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.|+|||+| .++|.+.+.. .++-..+..+..|++.|++|||+.||+||||||+||++..++ .+|++|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~------~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC------TLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh------heeeccchhh
Confidence 79999999 6699998873 467788899999999999999999999999999999999988 5999999999
Q ss_pred ccc-----ccceeeEEEEcC
Q 015237 397 STV-----ILVIFSCILVRA 411 (411)
Q Consensus 397 ~~~-----~~~~~~~i~~ra 411 (411)
.+- .++++.+=+|||
T Consensus 166 r~e~~~~~mtpyVvtRyyra 185 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRA 185 (369)
T ss_pred cccCcccccCchhheeeccC
Confidence 984 667888888887
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-18 Score=172.32 Aligned_cols=153 Identities=20% Similarity=0.304 Sum_probs=124.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc-c----CHHHHHHHHHHHHHHhhcCCCceeEEEeeee-cCCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-L----NENIRREFAQEVHIMRKVRHMNVVQFIGACT-RPPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~----~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~-~~~~ 316 (411)
.+|-++..||.|+|+.||++.+. .+.||+|+-.... + .++..+...+|..|-+.+.||-||++|++|. +...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 34555778999999999999775 4679999854321 1 1234456789999999999999999999996 4567
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+|-|+|||+|.+|.-||+.++ .+++..+..|+.||..||.||.... |||-||||.|||+-.... .. .+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta-cG--eIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA-CG--EIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc-cc--eeEeeecc
Confidence 999999999999998897665 7899999999999999999999765 999999999999954322 22 58999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
+++...+
T Consensus 619 LSKIMdd 625 (775)
T KOG1151|consen 619 LSKIMDD 625 (775)
T ss_pred hhhhccC
Confidence 9987643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-18 Score=162.27 Aligned_cols=148 Identities=18% Similarity=0.320 Sum_probs=122.7
Q ss_pred CceEEEEEEeecCceEEEEEEECC--ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEe-eeecCCeEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG-ACTRPPRLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g-~~~~~~~l~IV 320 (411)
+.|.+.+.+|+|.||.+..+.+++ +.+++|.+..... ..++|.+|...--.+ .|.||+.-|+ +|+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 457888999999999999999974 7799999876533 357888988754444 5899998775 57777888899
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+||++.|+|..-+... ++.+....+++.|++.|+.|+|++++||||||.+||||-.... -.+||||||+.....
T Consensus 101 qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df----~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF----YRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc----cEEEeeecccccccC
Confidence 9999999998877653 4888889999999999999999999999999999999965442 269999999987764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
+
T Consensus 175 ~ 175 (378)
T KOG1345|consen 175 T 175 (378)
T ss_pred c
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-18 Score=174.55 Aligned_cols=145 Identities=22% Similarity=0.373 Sum_probs=122.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|.+...+|.|+|+.|-++... ++..++|++.... ....+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 566788888999999999999775 6889999997662 2234677666655 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE-ccCCCcCCCccEEEEeccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM-NENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi-d~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||.+.|+-+.+.+.... .+. ..+..|+.+|+.++.|||++|+|||||||+|||+ +..| +++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g------~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG------HLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC------cEEEEEechhhhC
Confidence 99999998888776654 233 6777899999999999999999999999999999 4666 6999999999887
Q ss_pred ccc
Q 015237 400 ILV 402 (411)
Q Consensus 400 ~~~ 402 (411)
...
T Consensus 467 ~~~ 469 (612)
T KOG0603|consen 467 ERS 469 (612)
T ss_pred chh
Confidence 543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-16 Score=147.19 Aligned_cols=148 Identities=27% Similarity=0.427 Sum_probs=129.7
Q ss_pred eEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHH-HHHHHHHHHHHHhhcCCC-ceeEEEeeeecCCeEEEEEecC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHM-NVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~-~~~~~~~Ei~iL~~l~Hp-NIV~l~g~~~~~~~l~IV~E~~ 324 (411)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+.+++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 677889999999999999887 7899999987654442 578899999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 325 SGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 325 ~gGsL~~~L~~~~--~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.++++.+++.... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+. .++++|||.+..+.
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-----~~~l~dfg~~~~~~ 153 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-----VVKLIDFGLAKLLP 153 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-----eEEEeccCcceecC
Confidence 9999997776653 25888999999999999999999999999999999999998773 48999999998554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.2e-17 Score=162.43 Aligned_cols=134 Identities=24% Similarity=0.419 Sum_probs=114.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-----C---CceeEEEeee
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----H---MNVVQFIGAC 311 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-----H---pNIV~l~g~~ 311 (411)
+...+|.+.++||-|.|++||.+.++ .+-||+|+.+... ...+....||.+|++++ | ..||+|++.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34478999999999999999999887 4789999997652 34466788999999884 3 3699999999
Q ss_pred ec----CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccC
Q 015237 312 TR----PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNEN 379 (411)
Q Consensus 312 ~~----~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~ 379 (411)
.. +.++|||+|++ |-+|..+|.... ..++...++.|+.||+.||+|||. +||||-||||+|||+..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 64 45799999999 889999887753 369999999999999999999995 799999999999999665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-17 Score=165.70 Aligned_cols=141 Identities=23% Similarity=0.353 Sum_probs=122.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~ 318 (411)
..|+..++||+|+|+.||+++.. ...||+|.+..... ..++..|+++|..+ .+.||+.+.+++..+++.+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 44778899999999999998653 46799999876542 25688999999998 5899999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+|+||+++.+..++.. .++...+..++..++.||.++|.+||||||+||.|+|.+.... .-.|+|||+|..
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-----rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-----RGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-----CceEEechhHHH
Confidence 9999999999888885 3678899999999999999999999999999999999986543 467999999985
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=145.59 Aligned_cols=139 Identities=21% Similarity=0.259 Sum_probs=99.9
Q ss_pred EEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHH----------------------HHHHHHHHhhcCCC--ce
Q 015237 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRRE----------------------FAQEVHIMRKVRHM--NV 304 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~----------------------~~~Ei~iL~~l~Hp--NI 304 (411)
.+.||+|+||.||++... ++.||||+++........... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999887 799999998764322111111 13566666666443 24
Q ss_pred eEEEeeeecCCeEEEEEecCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCc
Q 015237 305 VQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 305 V~l~g~~~~~~~l~IV~E~~~gGsL~~-~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~ 382 (411)
.+.+++. ..+++|||++++++.. .+.... .. .....++.+++.++.++|. ++|+|+||||+||+++ ++
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-- 151 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-- 151 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence 4555432 3689999998854432 122111 11 5577899999999999999 9999999999999999 55
Q ss_pred CCCccEEEEecccccccccc
Q 015237 383 DSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 383 k~~~~ikL~DFGla~~~~~~ 402 (411)
.++|+|||++.....+
T Consensus 152 ----~~~liDfg~a~~~~~~ 167 (187)
T cd05119 152 ----KVYIIDVPQAVEIDHP 167 (187)
T ss_pred ----cEEEEECcccccccCc
Confidence 5899999999877654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=133.55 Aligned_cols=132 Identities=14% Similarity=0.182 Sum_probs=111.8
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--CceeEEEeeeecCCeEEEEEecCCCC
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
.+.||+|.++.||++...+..+++|....... ...+.+|+.+++.++| .+++++++++...+..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46799999999999999888999999866532 3578899999999976 58999999988888899999999887
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~---gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++..+ +......++.+++.++.++|.. +++|+|++|+||+++..+ .++++|||.+...
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~------~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK------ILGIIDWEYAGYG 139 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc------EEEEEecccccCC
Confidence 77544 4455667888999999999984 699999999999999855 5899999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-15 Score=146.03 Aligned_cols=138 Identities=15% Similarity=0.147 Sum_probs=106.6
Q ss_pred EEEe-ecCceEEEEEEECCceEEEEEeecccc-----------CHHHHHHHHHHHHHHhhcCCCce--eEEEeeeecCC-
Q 015237 251 HKIV-SGSYCDLYKGAFFSQDVAIKVLTNEHL-----------NENIRREFAQEVHIMRKVRHMNV--VQFIGACTRPP- 315 (411)
Q Consensus 251 ~~IG-~Gsfg~Vy~g~~~~~~VAIK~l~~~~~-----------~~~~~~~~~~Ei~iL~~l~HpNI--V~l~g~~~~~~- 315 (411)
..|| .|+.|.+|.....+..+++|....... +......+.+|+.++..++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4566 788888998888888999998864321 11233568899999999998875 67777643322
Q ss_pred ---eEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 316 ---RLFIVTEFMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 316 ---~l~IV~E~~~g-GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
..++|||+++| .+|.+++... .++.. .+.+++.++.+||++||+||||||+|||++.++ .++|+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~------~v~LI 184 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG------KFWLI 184 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC------CEEEE
Confidence 23599999997 6899888653 34443 356899999999999999999999999999876 58999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||.+....
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999988755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.5e-15 Score=164.22 Aligned_cols=157 Identities=22% Similarity=0.298 Sum_probs=122.8
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC---CCceeEEEeeee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACT 312 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~ 312 (411)
....++....|.+.+.||.|+||.||+|+.. ++.||+|+-++...-+ |.-=.+++.+|+ -+.|..+..+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 4567899999999999999999999999875 6899999988764321 111122333343 234555666666
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC-CccEEEE
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS-DIHCYLS 391 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~-~~~ikL~ 391 (411)
..+.-++|+||.+.|+|.+++...+ .+++..+..++.|++.-++.||..+|||+||||+|+||...-..+. ...++|+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 7777899999999999999998543 7899999999999999999999999999999999999965332222 3469999
Q ss_pred eccccccc
Q 015237 392 NFLSISTV 399 (411)
Q Consensus 392 DFGla~~~ 399 (411)
|||-+--+
T Consensus 844 DfG~siDm 851 (974)
T KOG1166|consen 844 DFGRSIDM 851 (974)
T ss_pred ecccceee
Confidence 99988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=141.43 Aligned_cols=142 Identities=16% Similarity=0.251 Sum_probs=97.9
Q ss_pred EEEeecCceEEEEEEEC-CceEEEEEeeccccCH--------------------------------HHH------HHHHH
Q 015237 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE--------------------------------NIR------REFAQ 291 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~--------------------------------~~~------~~~~~ 291 (411)
+.||+|++|.||+|+.. |+.||||+.++..... +.. -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46999999999999985 7999999987642100 000 02455
Q ss_pred HHHHHhhcC----CCceeEEEeee-ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHCCcc
Q 015237 292 EVHIMRKVR----HMNVVQFIGAC-TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK-GMNYLHRNNII 365 (411)
Q Consensus 292 Ei~iL~~l~----HpNIV~l~g~~-~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~-gL~yLHs~gII 365 (411)
|...+.+++ +.+-+.+-..+ ......+|||||++|++|.++......... ...++..++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 666655552 32223322222 223346899999999999988754322232 2345555555 46788999999
Q ss_pred ccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 366 HRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 366 HRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+|+||.||+++.+| .++++|||++..+..
T Consensus 280 H~D~hPgNilv~~~g------~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFVLKDG------KIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEECCCC------cEEEEeCCCeeECCH
Confidence 999999999999887 599999999988753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.8e-14 Score=137.60 Aligned_cols=157 Identities=16% Similarity=0.282 Sum_probs=127.8
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC------C-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF------S-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~------~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
+..+.+.++++...+-+|.||.||+|.|. + +.|-+|.++.. .++-....+++|...+..+.|||+.+..+++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 34456677788888999999999999664 2 55777877543 2444567789999999999999999999988
Q ss_pred ec-CCeEEEEEecCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 312 TR-PPRLFIVTEFMSGGSIYDYLHKQK-------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 312 ~~-~~~l~IV~E~~~gGsL~~~L~~~~-------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
.. ....+.++.++.-|+|..||...+ ..++..++..++.|++.||+|||..++||.||.++|++||+.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--- 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--- 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe---
Confidence 65 445788889998899999998322 2356667888999999999999999999999999999999874
Q ss_pred CCccEEEEecccccccccc
Q 015237 384 SDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~~~ 402 (411)
++||+|=.+++.+...
T Consensus 434 ---qVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 434 ---QVKLTDSALSRDLFPG 449 (563)
T ss_pred ---eEEeccchhccccCcc
Confidence 7999999998877543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-13 Score=131.35 Aligned_cols=166 Identities=25% Similarity=0.467 Sum_probs=138.7
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
--|+.+.+.+..+|.+...|+.|+|+|.+.++++|++..........+.|..|.-.|+-+.||||..++|+|..++++.+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 35777888899999999999999999999999999999887777777889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC-cc-ccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 320 VTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNN-II-HRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~g-II-HRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+..||+.|||+..|+.+.+ ..+..++.+++.++++||.|||+.. +| ---|....++||++-..+ +.++|--++
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltar----ismad~kfs 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTAR----ISMADTKFS 340 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhh----eecccceee
Confidence 9999999999999988754 4677889999999999999999865 33 345888999999987544 445665555
Q ss_pred cccccceeeEEEE
Q 015237 397 STVILVIFSCILV 409 (411)
Q Consensus 397 ~~~~~~~~~~i~~ 409 (411)
..-.+...++-|+
T Consensus 341 fqe~gr~y~pawm 353 (448)
T KOG0195|consen 341 FQEVGRAYSPAWM 353 (448)
T ss_pred eeccccccCcccC
Confidence 5555555555443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.5e-12 Score=114.50 Aligned_cols=129 Identities=14% Similarity=0.176 Sum_probs=96.4
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce-eEEEeeeecCCeEEEEEecCCCCC
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFMSGGS 328 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~~l~IV~E~~~gGs 328 (411)
.+.|+.|.++.+|+.+..+..|++|+....... ...+..|+.+++.+.+.++ .+++..... .-++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCc
Confidence 356789999999999998999999997654311 1345788999988865443 456655433 3579999999988
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI-----IHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 329 L~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gI-----IHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+.+. . .. ...+..+++.+|..||+.++ +|+|++|.||+++ ++ .++++|||.+..-
T Consensus 78 l~~~----~--~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~------~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTE----D--FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG------RLWLIDWEYAGMN 137 (170)
T ss_pred cccc----c--cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC------eEEEEecccccCC
Confidence 7543 0 11 12356789999999999885 9999999999998 33 4899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.1e-13 Score=149.72 Aligned_cols=100 Identities=13% Similarity=0.115 Sum_probs=79.7
Q ss_pred cCC-CceeEEEeee-------ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 015237 299 VRH-MNVVQFIGAC-------TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370 (411)
Q Consensus 299 l~H-pNIV~l~g~~-------~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLK 370 (411)
++| +||.+++++| .....++.++|++ +++|.++|......++...++.++.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777788877 2334678889988 679999998655568999999999999999999999999999999
Q ss_pred CCcEEEccCCCcC-------------CCccEEEEeccccccc
Q 015237 371 AANLLMNENGVRD-------------SDIHCYLSNFLSISTV 399 (411)
Q Consensus 371 p~NILid~~g~~k-------------~~~~ikL~DFGla~~~ 399 (411)
|+|||++..|..| ....+|++|||+++..
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 9999997644321 1235789999988753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-12 Score=137.82 Aligned_cols=147 Identities=15% Similarity=0.179 Sum_probs=92.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc---------------------------C-----HHHHHH--
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---------------------------N-----ENIRRE-- 288 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~---------------------------~-----~~~~~~-- 288 (411)
..|.. +.||+|++|.||+++.. |+.||||++++... + .+..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 33444 67999999999999885 79999999986520 0 011222
Q ss_pred ----HHHHHHHHhhcC----CCceeEEEeeeec-CCeEEEEEecCCCCCHHHH--HHhcCC---CCCHHHHHHHHHHHHH
Q 015237 289 ----FAQEVHIMRKVR----HMNVVQFIGACTR-PPRLFIVTEFMSGGSIYDY--LHKQKC---GLKLPLLLRVAIDVSK 354 (411)
Q Consensus 289 ----~~~Ei~iL~~l~----HpNIV~l~g~~~~-~~~l~IV~E~~~gGsL~~~--L~~~~~---~l~~~~i~~i~~qIa~ 354 (411)
+.+|...+.+++ +.+.+.+-..+.+ ...-+|||||+.|+++.++ +...+. .+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 344444444432 3333333222221 2346799999999999875 332221 12222233333343
Q ss_pred HHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 355 GMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 355 gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
...|++|+|+||.||+++.+|..+. .++++|||.+..+..
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~--~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENP--RYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCC--eEEEEecceEEECCH
Confidence 4589999999999999998874332 589999999988743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-11 Score=111.89 Aligned_cols=148 Identities=22% Similarity=0.244 Sum_probs=112.9
Q ss_pred EEEEEeecCceEEEEEEECCceEEEEEeeccccC-----H-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN-----E-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~-----~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
....|-||+-+.|+++.+.|+...||.-....+. . -.+++..+|+++|.+|.--.|....=++.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3567789999999999999999889875544321 1 245678999999999975555544444555556789999
Q ss_pred cCCC-CCHHHHHHhcCCCCCHHH-HHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSG-GSIYDYLHKQKCGLKLPL-LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~g-GsL~~~L~~~~~~l~~~~-i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|++| .++.+|+......-..+. ...++..|-..+.-||.++|||+||.++||++..+|... .+.++|||+++.-
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~---~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI---TPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC---ceEEEeecchhcc
Confidence 9965 378888887643333333 368889999999999999999999999999998887533 4589999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.3e-13 Score=141.22 Aligned_cols=147 Identities=19% Similarity=0.223 Sum_probs=113.3
Q ss_pred EEEEEEeecCceEEEEEEEC--CceEEEEEee----ccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLT----NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 248 ~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~----~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.....+|.|++|.++..... .+..+.|..+ ...........+..|+.+-..+.|+|++..+..+......+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 56778999999977766543 2223333222 22111222233777888888999999988887777666666669
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|||++ +|+.++.... .+....+..++.|++.|++|+|+.||-|||+|++|+++..+| .+|++|||.+.-+..
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g------~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG------ILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC------ceEEeecCcceeecc
Confidence 99999 9999997652 588888999999999999999999999999999999999999 489999999988754
Q ss_pred c
Q 015237 402 V 402 (411)
Q Consensus 402 ~ 402 (411)
+
T Consensus 473 ~ 473 (601)
T KOG0590|consen 473 P 473 (601)
T ss_pred C
Confidence 3
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.3e-12 Score=116.79 Aligned_cols=141 Identities=16% Similarity=0.189 Sum_probs=101.0
Q ss_pred EEEeecCceEEEEEEEC--------CceEEEEEeecccc-----------C---------HHHHHHH----HHHHHHHhh
Q 015237 251 HKIVSGSYCDLYKGAFF--------SQDVAIKVLTNEHL-----------N---------ENIRREF----AQEVHIMRK 298 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--------~~~VAIK~l~~~~~-----------~---------~~~~~~~----~~Ei~iL~~ 298 (411)
..||.|--+.||.|... +..+|||+.+.... + ...++.+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999654 26899999875310 0 0112233 389999999
Q ss_pred cCC--CceeEEEeeeecCCeEEEEEecCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcE
Q 015237 299 VRH--MNVVQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRDLKAANL 374 (411)
Q Consensus 299 l~H--pNIV~l~g~~~~~~~l~IV~E~~~gGsL~~-~L~~~~~~l~~~~i~~i~~qIa~gL~yL-Hs~gIIHRDLKp~NI 374 (411)
+.. -++.+.+++ ..-+|||||+.++.+.. .++.. .++......+..+++.+|..+ |+.|+||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 466777765 34689999996543322 23221 345556677789999999999 899999999999999
Q ss_pred EEccCCCcCCCccEEEEeccccccccccee
Q 015237 375 LMNENGVRDSDIHCYLSNFLSISTVILVIF 404 (411)
Q Consensus 375 Lid~~g~~k~~~~ikL~DFGla~~~~~~~~ 404 (411)
|++++ .++++|||.|....-+-.
T Consensus 157 L~~~~-------~v~iIDF~qav~~~hp~a 179 (197)
T cd05146 157 LWHDG-------KVWFIDVSQSVEPTHPHG 179 (197)
T ss_pred EEECC-------cEEEEECCCceeCCCCCH
Confidence 99753 489999999988755443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.9e-11 Score=109.51 Aligned_cols=132 Identities=22% Similarity=0.306 Sum_probs=102.1
Q ss_pred EEeecCceEEEEEEECCceEEEEEeecccc-CH----H-HHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCC
Q 015237 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHL-NE----N-IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~-~~----~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
.+++|+-+.+|.+.|.+.++.+|.-.+..+ .+ . ...+..+|+.++.+++--.|...+=+..++....|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 578899999999999887888887555433 12 1 23457889999999875555444444456667889999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|-.|.+++.... ..++..+-.-+.-||..||+|+||.++||++...+ +.++|||++..
T Consensus 83 G~~lkd~l~~~~--------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-------i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEAR--------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-------IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhcc--------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-------EEEEECCcccc
Confidence 888888887641 44566777778889999999999999999998776 89999999873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.2e-13 Score=139.28 Aligned_cols=152 Identities=24% Similarity=0.275 Sum_probs=127.1
Q ss_pred EeecCceEEEEE-----EECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCCC
Q 015237 253 IVSGSYCDLYKG-----AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 253 IG~Gsfg~Vy~g-----~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+|+|+||.|+.. ...++-+|+|++++.............|-.++..++ ||.++++..++..+..++++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 689999999864 334677999999876544333345667888888886 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccceee-
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILVIFS- 405 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~~~~- 405 (411)
|.|...+.+.. .+.+.....+...++.+++++|+.+|+|||+|++||+++.+| .+++.|||+++.+...-..
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G------hi~~tdfglske~v~~~~~c 154 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG------HIKLTDFGLSKEAVKEKIAC 154 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC------ccccCCchhhhHhHhhhhcc
Confidence 99988887654 566777778888999999999999999999999999999999 5899999999988765555
Q ss_pred -EEEEcC
Q 015237 406 -CILVRA 411 (411)
Q Consensus 406 -~i~~ra 411 (411)
++.|||
T Consensus 155 gt~eymA 161 (612)
T KOG0603|consen 155 GTYEYRA 161 (612)
T ss_pred cchhhhh
Confidence 666665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-10 Score=115.57 Aligned_cols=95 Identities=19% Similarity=0.290 Sum_probs=76.7
Q ss_pred CCCceeEEEeeeecC---------------------------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHH
Q 015237 300 RHMNVVQFIGACTRP---------------------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352 (411)
Q Consensus 300 ~HpNIV~l~g~~~~~---------------------------~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qI 352 (411)
+|||||++.++|.+. ..+|+||.-.. .+|.+|+..+. .+.....-+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999999887432 35899999884 59999998765 5666677788999
Q ss_pred HHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 353 SKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 353 a~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
++|+.|||++||-|||||.+|||+.-+... ...+.++|||++-.-
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~--~P~LVvaDFGCcLAd 395 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDE--IPQLVVADFGCCLAD 395 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCC--CcEEEEcccceeeec
Confidence 999999999999999999999998544321 225899999988653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-10 Score=103.74 Aligned_cols=139 Identities=17% Similarity=0.222 Sum_probs=100.9
Q ss_pred EEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--CceeEEEeeeecC---CeEEEEEecC
Q 015237 251 HKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRP---PRLFIVTEFM 324 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~---~~l~IV~E~~ 324 (411)
+.|+.|.++.+|+....+ +.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 467899999999998875 89999997654321 123568899999999875 3457777776653 2578999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR------------------------------------------- 361 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs------------------------------------------- 361 (411)
+|.++.+.+.. ..++......++.++++.|.+||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99887665421 134555555666666666666663
Q ss_pred -------------CCccccCCCCCcEEEccC--CCcCCCccEEEEecccccc
Q 015237 362 -------------NNIIHRDLKAANLLMNEN--GVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 -------------~gIIHRDLKp~NILid~~--g~~k~~~~ikL~DFGla~~ 398 (411)
..++|+|+++.||+++.+ + .+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~------~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPR------VVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCc------EEEEEecccccc
Confidence 236899999999999883 3 378999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.1e-09 Score=101.44 Aligned_cols=141 Identities=16% Similarity=0.119 Sum_probs=96.4
Q ss_pred ceEEEEEEECCceEEEEEeeccccCHHHH---------HHHHHHHHHHhhcCCCce--eEEEeeeec-----CCeEEEEE
Q 015237 258 YCDLYKGAFFSQDVAIKVLTNEHLNENIR---------REFAQEVHIMRKVRHMNV--VQFIGACTR-----PPRLFIVT 321 (411)
Q Consensus 258 fg~Vy~g~~~~~~VAIK~l~~~~~~~~~~---------~~~~~Ei~iL~~l~HpNI--V~l~g~~~~-----~~~l~IV~ 321 (411)
...|++..+.|+.|.||............ ..+.+|+..+..|...+| .+.+++... ...-+|||
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34466777778889999764432111001 137789998888853333 334444332 23478999
Q ss_pred ecCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC-CcCCCccEEEEecccccc
Q 015237 322 EFMSGG-SIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG-VRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gG-sL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g-~~k~~~~ikL~DFGla~~ 398 (411)
|++++. +|.+++... ....+......++.+++..+.-||..||+|+||++.|||++.+. .......+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 799988642 22345566778999999999999999999999999999998520 001123689999998854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.1e-09 Score=101.18 Aligned_cols=150 Identities=17% Similarity=0.255 Sum_probs=96.4
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCC----------CceeEEEeeee
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRH----------MNVVQFIGACT 312 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~H----------pNIV~l~g~~~ 312 (411)
.+..+..||.|+|+.||.+++. ++++|+|+....... ....+.+.+|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4677899999999999999996 599999998755422 2345667776655444322 11222222111
Q ss_pred ---------cC---C-----eEEEEEecCCCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 015237 313 ---------RP---P-----RLFIVTEFMSGGSIYDYLHK---QKCG---LKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369 (411)
Q Consensus 313 ---------~~---~-----~l~IV~E~~~gGsL~~~L~~---~~~~---l~~~~i~~i~~qIa~gL~yLHs~gIIHRDL 369 (411)
.. . +.+++|+-+ .++|.+++.. .... +.....+.+..|+++.+.+||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 246788887 5688887542 2211 112223456689999999999999999999
Q ss_pred CCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 370 KAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 370 Kp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
||+|++++.+| .++|.||+........
T Consensus 172 ~~~nfll~~~G------~v~Lg~F~~~~r~g~~ 198 (288)
T PF14531_consen 172 KPENFLLDQDG------GVFLGDFSSLVRAGTR 198 (288)
T ss_dssp SGGGEEE-TTS-------EEE--GGGEEETTEE
T ss_pred ceeeEEEcCCC------CEEEcChHHHeecCce
Confidence 99999999999 6999999887776543
|
|
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=98.97 E-value=1e-09 Score=84.50 Aligned_cols=67 Identities=66% Similarity=0.984 Sum_probs=63.8
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCccchHHHHHHHhhcc
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEI 206 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~~ 206 (411)
++||++.+-|||.|++.++..|+..|+||.+|..|+|.+||.||+|.|.+|..++++.|..++.+.+
T Consensus 1 ~~eI~V~~~Dr~gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 1 MHEITFAAGDKPKLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred CEEEEEEECCCcchHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 4799999999999999999999999999999999999999999999999999999999998887654
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.4e-09 Score=98.98 Aligned_cols=132 Identities=19% Similarity=0.230 Sum_probs=85.2
Q ss_pred EEEEEEEC-CceEEEEEeeccccC------------------------HHHHHHHHHHHHHHhhcCCC--ceeEEEeeee
Q 015237 260 DLYKGAFF-SQDVAIKVLTNEHLN------------------------ENIRREFAQEVHIMRKVRHM--NVVQFIGACT 312 (411)
Q Consensus 260 ~Vy~g~~~-~~~VAIK~l~~~~~~------------------------~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~~~ 312 (411)
.||.|... +..+|+|+.+....+ ........+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48888874 688999998753100 11234578899999999765 567777553
Q ss_pred cCCeEEEEEecCC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 313 RPPRLFIVTEFMS--GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY-LHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 313 ~~~~l~IV~E~~~--gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~y-LHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.-+|||||++ |..+..+. ... ++......++.+++..+.. +|..||+|+||.+.|||+++++ +.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~-------~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGK-------VY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTC-------EE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecce-------EE
Confidence 2479999997 54454433 222 1123345667777775555 5799999999999999998875 89
Q ss_pred EEecccccccccceee
Q 015237 390 LSNFLSISTVILVIFS 405 (411)
Q Consensus 390 L~DFGla~~~~~~~~~ 405 (411)
++|||.+.....+...
T Consensus 147 iIDf~qav~~~~p~a~ 162 (188)
T PF01163_consen 147 IIDFGQAVDSSHPNAE 162 (188)
T ss_dssp E--GTTEEETTSTTHH
T ss_pred EEecCcceecCCccHH
Confidence 9999999887655443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.4e-10 Score=124.31 Aligned_cols=144 Identities=17% Similarity=0.265 Sum_probs=114.4
Q ss_pred ceEEEEEEeecCceEEEEEEECCceEEEEEeecccc--CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
++...+.||++.|=.+.+|++..-.|+||++-+... +-..-.+-..|++ ...+++||.+.|.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 678889999999999999998866699999866542 2122223334444 5566999999998887777778899999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
..+ +|+|.+..+. .+..-+.+-|+.|++.|+.-+|..||+|+|||.+||||+.=+ =+.|+||..-+.
T Consensus 103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN------W~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN------WLYLTDFASFKP 169 (1431)
T ss_pred Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec------hhhhhcccccCC
Confidence 854 9999998765 466667777899999999999999999999999999998855 278999976543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.7e-09 Score=111.00 Aligned_cols=98 Identities=33% Similarity=0.522 Sum_probs=89.7
Q ss_pred HhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCcE
Q 015237 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI-IHRDLKAANL 374 (411)
Q Consensus 296 L~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gI-IHRDLKp~NI 374 (411)
|+.+.|.|+.+|+|.+..++..++|.+||..|+|.|.+......+++.....++++|+.||.|||.-.| .|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457899999999999999999999999999999999998876678888899999999999999998665 8999999999
Q ss_pred EEccCCCcCCCccEEEEeccccccc
Q 015237 375 LMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 375 Lid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+++... .+||+|||+....
T Consensus 81 lvd~~w------~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 81 LVDSRW------VLKLTDFGLNSLL 99 (484)
T ss_pred eeeeeE------EEEechhhhcccc
Confidence 999887 5999999998766
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=7.2e-08 Score=90.06 Aligned_cols=109 Identities=18% Similarity=0.290 Sum_probs=83.3
Q ss_pred HHHHHHHHHHhhcCCC--ceeEEEeeeecC----CeEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 015237 287 REFAQEVHIMRKVRHM--NVVQFIGACTRP----PRLFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359 (411)
Q Consensus 287 ~~~~~Ei~iL~~l~Hp--NIV~l~g~~~~~----~~l~IV~E~~~gG-sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yL 359 (411)
....+|...+..+... ...+.+++.... ...++|||++++. +|.+++.... ..+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence 4577888888777533 334555555432 2358999999874 7999987643 255666788899999999999
Q ss_pred HHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 360 HRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 360 Hs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|.+||+|+|+++.|||++.++ ....+.++||+.+..-
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~---~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDD---GQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCC---CceeEEEEcchhceeC
Confidence 999999999999999999876 2346899999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-10 Score=118.91 Aligned_cols=154 Identities=23% Similarity=0.375 Sum_probs=124.1
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~ 318 (411)
....|.+.+.||+|+|+.+-..... ...+|.|.+...............|..+-+.+. |+|++.+++....+...+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3455777777999999998876543 345677766655433344455666888877786 999999999999999999
Q ss_pred EEEecCCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 319 IVTEFMSGGSIYDYL-HKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 319 IV~E~~~gGsL~~~L-~~~~~~l~~~~i~~i~~qIa~gL~yLH-s~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+.++|..|+++.+.+ .......+......++.|+..++.|+| ..++.|||+||+|.+++..+. .++++|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-----~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-----ALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-----cccCCCchhh
Confidence 999999999999888 443325667778899999999999999 999999999999999999884 4889999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
..+..
T Consensus 173 t~~~~ 177 (601)
T KOG0590|consen 173 TAYRN 177 (601)
T ss_pred ccccc
Confidence 98754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-08 Score=104.26 Aligned_cols=152 Identities=20% Similarity=0.199 Sum_probs=119.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
....++.+..+||.|.|+.++..... +..|++|.+............-..|+.+...+ .|.+++.++..+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34556778899999999999987654 46788888876644333333445677666666 588999988888777788
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
||--|||.++++...+... ..+.+...+++..|++.++.++|++.++|+|+||+||++..+| +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-----~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-----FFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-----hhhhcccccccc
Confidence 8999999999987666322 2467778899999999999999999999999999999999876 357899999987
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
.+
T Consensus 416 ~~ 417 (524)
T KOG0601|consen 416 RL 417 (524)
T ss_pred cc
Confidence 64
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-08 Score=105.22 Aligned_cols=154 Identities=26% Similarity=0.243 Sum_probs=123.3
Q ss_pred cCCceEEEEEEee--cCceEEEEEEE----CCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCC
Q 015237 243 DASLLKFEHKIVS--GSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (411)
Q Consensus 243 ~~~~~~~~~~IG~--Gsfg~Vy~g~~----~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 315 (411)
....+.+...+|. |++|.+|.+.. .+..+|+|.-+...........-.+|+...+++ .|+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3344556778899 99999999866 257789988544332222234445677666666 4999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~----gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.+++-+|+| +.+|.++.......++...++....+... |+.++|+.+++|-|+||+||++..++. .+++.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-----s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-----SCKLT 265 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-----eeecC
Confidence 999999999 67999998877666888888888888888 999999999999999999999998852 68999
Q ss_pred ecccccccccc
Q 015237 392 NFLSISTVILV 402 (411)
Q Consensus 392 DFGla~~~~~~ 402 (411)
|||+...+-+.
T Consensus 266 df~~v~~i~~~ 276 (524)
T KOG0601|consen 266 DFGLVSKISDG 276 (524)
T ss_pred CcceeEEccCC
Confidence 99999887553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.6e-08 Score=108.47 Aligned_cols=109 Identities=28% Similarity=0.348 Sum_probs=77.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|..++.|..|+||.||..+++ .+.+|+|+-+..-+ .+- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccchh--------hhc--cccccCCccee-----------------
Confidence 45777889999999999999876 68899965432211 110 22222333332
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+-...++.-+ .++.. ++.+++|||+.||+|||+||+|+||+.-| .+|+.|||+.+..
T Consensus 136 ----gDc~tllk~~g-~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG------hiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG-PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG------HIKLTDFGLSKKG 193 (1205)
T ss_pred ----chhhhhcccCC-CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc------cccccchhhhhhh
Confidence 55555564432 34432 27799999999999999999999999988 6999999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.6e-07 Score=97.98 Aligned_cols=118 Identities=16% Similarity=0.291 Sum_probs=95.2
Q ss_pred CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHH
Q 015237 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347 (411)
Q Consensus 268 ~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~ 347 (411)
+.+|.|...+.... .......+-+.-|+.++||||++++..+...+.+|||||-+. .|..+++... ...+..
T Consensus 37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHH
Confidence 56777777665532 223446677888999999999999999999999999999983 6777786543 444556
Q ss_pred HHHHHHHHHHHHH-HCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 348 VAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 348 i~~qIa~gL~yLH-s~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
-+.||+.||.||| .++++|++|..+.|++++.| .+||.+|-.++..
T Consensus 109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G------eWkLggle~v~~~ 155 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG------EWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC------cEEEeeeEEEecc
Confidence 6789999999997 67899999999999999999 6999998877554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.8e-07 Score=94.89 Aligned_cols=143 Identities=18% Similarity=0.247 Sum_probs=93.9
Q ss_pred EEEeecCceEEEEEEEC-CceEEEEEeeccccC--------------------------------HHHHH------HHHH
Q 015237 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN--------------------------------ENIRR------EFAQ 291 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~--------------------------------~~~~~------~~~~ 291 (411)
+.|+++|-|.||+|+.. |+.||||+.++.-.. .+..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999998 899999999875210 00111 1445
Q ss_pred HHHHHhhcC-----CCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 015237 292 EVHIMRKVR-----HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366 (411)
Q Consensus 292 Ei~iL~~l~-----HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIH 366 (411)
|...+.+++ .+++.-..=++.....-.|+|||+.|..+.++........+...+.....++.- .-+=..|++|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhcCccc
Confidence 555555542 333322222222234568999999999998884333334664444333333322 2223479999
Q ss_pred cCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 367 RDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 367 RDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.|..|.||+++.+| .+.+.|||....+..
T Consensus 289 aDpHpGNi~v~~~g------~i~~lDfGi~g~l~~ 317 (517)
T COG0661 289 ADPHPGNILVRSDG------RIVLLDFGIVGRLDP 317 (517)
T ss_pred cCCCccceEEecCC------cEEEEcCcceecCCH
Confidence 99999999999998 589999999887644
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.6e-07 Score=87.52 Aligned_cols=139 Identities=19% Similarity=0.204 Sum_probs=98.3
Q ss_pred eEEEEEEeecCceEEEEEEEC-CceEEEEEeecccc------------------C--HHHHHHHHHHHHHHhhcCCC--c
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHL------------------N--ENIRREFAQEVHIMRKVRHM--N 303 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~------------------~--~~~~~~~~~Ei~iL~~l~Hp--N 303 (411)
..++++||-|--+.||.|... +.++|||.=+.... + .-.+....+|..+|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 356788999999999999886 79999997543211 1 11245578899999999654 6
Q ss_pred eeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 304 IV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
+.+.+++ +.-.+||||+.|-.|...-- +......+...|+.-+.-+-..||||+|+.+=||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg--- 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG--- 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC---
Confidence 7776665 45689999998866654321 1222333444455545444478999999999999999998
Q ss_pred CCccEEEEeccccccccc
Q 015237 384 SDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 384 ~~~~ikL~DFGla~~~~~ 401 (411)
.++++||--+....-
T Consensus 240 ---~~~vIDwPQ~v~~~h 254 (304)
T COG0478 240 ---DIVVIDWPQAVPISH 254 (304)
T ss_pred ---CEEEEeCcccccCCC
Confidence 599999976665433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.7e-07 Score=80.86 Aligned_cols=59 Identities=24% Similarity=0.242 Sum_probs=52.2
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+|.+++...+..+++..++.++.|++.||.|||+++ ||+|||++.++ .+|+ ||++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~------~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG------LLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc------ceee--ccceEee
Confidence 7999999876667999999999999999999999998 99999999888 3666 9988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=9.4e-06 Score=76.30 Aligned_cols=143 Identities=14% Similarity=0.110 Sum_probs=101.6
Q ss_pred eecCceEEEEEEECCceEEEEEeeccc---cC-HHHHHHHHHHHHHHhhcCCC--ceeEEEeee--ecC--CeEEEEEec
Q 015237 254 VSGSYCDLYKGAFFSQDVAIKVLTNEH---LN-ENIRREFAQEVHIMRKVRHM--NVVQFIGAC--TRP--PRLFIVTEF 323 (411)
Q Consensus 254 G~Gsfg~Vy~g~~~~~~VAIK~l~~~~---~~-~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~~--~~~--~~l~IV~E~ 323 (411)
|.|+.+.|++-.+.|+.+=+|....-. .- +.-...|.+|+..+..+..- .+.+...+. ..+ -.-+||||-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 568888899888777778888764210 00 22346799999999988532 244443211 111 236899998
Q ss_pred CCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSG-GSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~g-GsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+.| -+|.+++.... ...+......+..+++..+.-||+.|+.|+|+-+.||+++.+| .+.++++||-.++...
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g----~~~v~lIDlEk~r~~l 181 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG----KAEAGFLDLEKSRRRL 181 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC----CeeEEEEEhhccchhh
Confidence 853 58888886542 1345666678899999999999999999999999999998766 2368999997776543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.5e-06 Score=90.12 Aligned_cols=144 Identities=17% Similarity=0.256 Sum_probs=94.2
Q ss_pred EEEeecCceEEEEEEEC-CceEEEEEeeccccC-----------------------------HHHHHH------HHHHHH
Q 015237 251 HKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN-----------------------------ENIRRE------FAQEVH 294 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~-----------------------------~~~~~~------~~~Ei~ 294 (411)
+.||.-+.|.||+++.. |+.||||+.++.-.. ++..+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46899999999999886 688999998765211 111122 445554
Q ss_pred HHhhc----CCCc------eeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 015237 295 IMRKV----RHMN------VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364 (411)
Q Consensus 295 iL~~l----~HpN------IV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gI 364 (411)
...++ .|-+ |.++|-.++. .-.++||||.|..+.|.-.-....++...+..-+.+...-|-+ ..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcCC
Confidence 44333 3555 4444444433 3689999999988876433333346666554444443333333 3589
Q ss_pred cccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 365 IHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 365 IHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+|+|-.|.||+++.++ +....+.+.|||+...+.
T Consensus 323 fHaDPHPGNilv~~~~--~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNP--EGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ccCCCCCCcEEEecCC--CCCccEEEEccccccccc
Confidence 9999999999999765 344579999999987764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=76.34 Aligned_cols=141 Identities=14% Similarity=0.172 Sum_probs=94.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHH-HHH------HHHHHHHHHhhcCC---CceeEEEeee
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNEN-IRR------EFAQEVHIMRKVRH---MNVVQFIGAC 311 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~-~~~------~~~~Ei~iL~~l~H---pNIV~l~g~~ 311 (411)
+-...|+..+.+-......|.+-...++.+.+|..+......+ ... ...+++..+..++. .....++-+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3456678888888888888888888889999999876532111 111 12334444444432 2223333333
Q ss_pred ec-----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCc
Q 015237 312 TR-----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDI 386 (411)
Q Consensus 312 ~~-----~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~ 386 (411)
.. ....+++|||++|..|.++.. ++. .+...+..++.-+|+.|+.|+|..|.|++++.++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~------ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG------ 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc------
Confidence 22 234678999999988876542 222 2345677789999999999999999999999776
Q ss_pred cEEEEecccccc
Q 015237 387 HCYLSNFLSIST 398 (411)
Q Consensus 387 ~ikL~DFGla~~ 398 (411)
++++||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 78999976654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.8e-05 Score=75.19 Aligned_cols=72 Identities=15% Similarity=0.193 Sum_probs=53.9
Q ss_pred EEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc--eeEEEeeeecCCeEEEEEecCCCCC
Q 015237 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGACTRPPRLFIVTEFMSGGS 328 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN--IV~l~g~~~~~~~l~IV~E~~~gGs 328 (411)
..||+|..+.||+. .+..+++|...... . .....+|.++++.+..-. +.+.++++...+..+++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 35577888876533 2 234688999998886433 4677888877778899999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=3e-05 Score=71.64 Aligned_cols=78 Identities=13% Similarity=0.205 Sum_probs=57.2
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC--ceeEEEeeee---cCCeEEEEEecC
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGACT---RPPRLFIVTEFM 324 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~~~---~~~~l~IV~E~~ 324 (411)
.+.++.|..+.+|+....+..+++|..... .....+.+|..+++.+... .+.+++..+. .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467899999999999988889999997544 3446778898888888533 3566666442 334579999999
Q ss_pred CCCCHHH
Q 015237 325 SGGSIYD 331 (411)
Q Consensus 325 ~gGsL~~ 331 (411)
+|.++..
T Consensus 78 ~g~~~~~ 84 (239)
T PF01636_consen 78 PGRPLDD 84 (239)
T ss_dssp SSEEHHH
T ss_pred ccccccc
Confidence 9887776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.2e-05 Score=71.44 Aligned_cols=127 Identities=21% Similarity=0.277 Sum_probs=92.4
Q ss_pred CceEEEEEEeecCc-eEEEEEEECCceEEEEEeeccc----------cCH---------HHHHHHHHHHHHHhhcC---C
Q 015237 245 SLLKFEHKIVSGSY-CDLYKGAFFSQDVAIKVLTNEH----------LNE---------NIRREFAQEVHIMRKVR---H 301 (411)
Q Consensus 245 ~~~~~~~~IG~Gsf-g~Vy~g~~~~~~VAIK~l~~~~----------~~~---------~~~~~~~~Ei~iL~~l~---H 301 (411)
..+++++.||.|.- |.||+....|+.+|+|+.+.-. ... .....|..|.+...+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 9999999999999999933210 000 12235778888777664 4
Q ss_pred Cce--eEEEeeeecC------------------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 015237 302 MNV--VQFIGACTRP------------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361 (411)
Q Consensus 302 pNI--V~l~g~~~~~------------------~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs 361 (411)
.++ |+.+||..-. ....||.||.+... .+. ..-+.+|.+-|..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHHH
Confidence 566 9999987321 12467888876533 122 2234567788999999
Q ss_pred CCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 362 NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 362 ~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.||+-+|+|+.|.. +| +|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~G--------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---GG--------KLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---CC--------EEEecccC
Confidence 99999999999987 33 79999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.7e-05 Score=82.45 Aligned_cols=133 Identities=16% Similarity=0.203 Sum_probs=97.4
Q ss_pred ceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----CCeEEEEEecCCC-CCHH
Q 015237 258 YCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPRLFIVTEFMSG-GSIY 330 (411)
Q Consensus 258 fg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~~l~IV~E~~~g-GsL~ 330 (411)
-.+.|+++.+ |..|++|.+....... ......-+++++++.|+|+|+|..++.. ...+++|++|.++ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467888764 7889999984332110 1122345678899999999999998863 3468999999875 6787
Q ss_pred HHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 331 DYLHK--------------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 331 ~~L~~--------------~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
++--. .+...++..++.++.|+..||.++|+.|.--+-|.+.+||++.+. +++|+-.|..
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~------RIriS~C~i~ 440 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM------RIRISGCGIM 440 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc------eEEEecccce
Confidence 75422 122467788999999999999999999998899999999998775 3556555444
Q ss_pred cc
Q 015237 397 ST 398 (411)
Q Consensus 397 ~~ 398 (411)
-.
T Consensus 441 Dv 442 (655)
T KOG3741|consen 441 DV 442 (655)
T ss_pred ee
Confidence 33
|
|
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-06 Score=64.85 Aligned_cols=52 Identities=42% Similarity=0.650 Sum_probs=48.4
Q ss_pred eEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCc
Q 015237 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPL 192 (411)
Q Consensus 141 ~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~ 192 (411)
.|+.+.+-|||.|++.++..|+..|+||..|..|++.+|+.+|+|.|..+..
T Consensus 2 ~~i~v~~~Dr~gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~ 53 (73)
T cd04900 2 TEVFIYTPDRPGLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDG 53 (73)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCC
Confidence 4899999999999999999999999999999999999999999999976543
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.2e-06 Score=84.48 Aligned_cols=90 Identities=27% Similarity=0.473 Sum_probs=75.8
Q ss_pred HhhcCCCceeEEEeeeecCC-----eEEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Q 015237 296 MRKVRHMNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNN--II 365 (411)
Q Consensus 296 L~~l~HpNIV~l~g~~~~~~-----~l~IV~E~~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~g--II 365 (411)
|-++-|.||++|+.++.+.. ...+++|||.-|++.++|++-. ..+......+|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44557999999999986543 4788999999999999998642 24677788999999999999999986 99
Q ss_pred ccCCCCCcEEEccCCCcCCC
Q 015237 366 HRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 366 HRDLKp~NILid~~g~~k~~ 385 (411)
|+++..+.|++..+|..|++
T Consensus 201 hgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cCCcchhheeecCCceEEec
Confidence 99999999999999965543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.6e-05 Score=76.10 Aligned_cols=145 Identities=19% Similarity=0.162 Sum_probs=96.1
Q ss_pred EEEEeecCceEEEEEEEC-CceEEEEEeeccccCHH----------------------HHHHHHHHHHHHhhcC--CCce
Q 015237 250 EHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNEN----------------------IRREFAQEVHIMRKVR--HMNV 304 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~----------------------~~~~~~~Ei~iL~~l~--HpNI 304 (411)
...|.+|--+.||+|... +..+|+|+.+.....-. .......|..-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 347788888999998754 78999999986532110 0112345666666663 3344
Q ss_pred eEEEeeeecCCeEEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCc
Q 015237 305 VQFIGACTRPPRLFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVR 382 (411)
Q Consensus 305 V~l~g~~~~~~~l~IV~E~~~gG-sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~ 382 (411)
.+.+++.. -.|||||+... .-.-.|+.- .+.......+..++++.|.-|-. .++||+||..=|||+.+ |
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~-- 203 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-G-- 203 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-C--
Confidence 45555432 46899999432 112223221 23333566777888888888776 89999999999999994 4
Q ss_pred CCCccEEEEecccccccccceeeEE
Q 015237 383 DSDIHCYLSNFLSISTVILVIFSCI 407 (411)
Q Consensus 383 k~~~~ikL~DFGla~~~~~~~~~~i 407 (411)
.+.++|||-|.....+...++
T Consensus 204 ----~p~iID~~QaV~~~hp~a~e~ 224 (268)
T COG1718 204 ----EPYIIDVSQAVTIDHPNAFEF 224 (268)
T ss_pred ----eEEEEECccccccCCCchHHH
Confidence 389999999988766554443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-05 Score=72.37 Aligned_cols=136 Identities=24% Similarity=0.286 Sum_probs=94.8
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCcee-EEEeeeecCCeEEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV-QFIGACTRPPRLFIV 320 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV-~l~g~~~~~~~l~IV 320 (411)
......+..+.|+.|.+|.||.|.|.+.++|+|+-+.+.. +..+..|+++|..++-.++. ++|.+.. .++.
T Consensus 19 ~~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~ 90 (201)
T COG2112 19 EGKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIR 90 (201)
T ss_pred ccchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhh
Confidence 3344456677899999999999999999999999876643 46788999999998866653 4555433 4566
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CC-cEEEccCCCcCCCccEEEEecccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK-AA-NLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLK-p~-NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|||+.|-.|.+.-... +...+. .+++.---|-..||-|..|. |. ||++. ++ .+.|+||-.|+.
T Consensus 91 me~i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~------~~~iIDFd~At~ 155 (201)
T COG2112 91 MEYIDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR------DVYIIDFDSATF 155 (201)
T ss_pred hhhhcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEec-CC------cEEEEEccchhh
Confidence 9999887887655321 223333 33444333556789998884 44 55554 33 389999999984
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
-.
T Consensus 156 k~ 157 (201)
T COG2112 156 KK 157 (201)
T ss_pred cc
Confidence 43
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.2e-05 Score=72.65 Aligned_cols=75 Identities=15% Similarity=0.220 Sum_probs=53.7
Q ss_pred EEeecCc-eEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCCCCCH
Q 015237 252 KIVSGSY-CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 252 ~IG~Gsf-g~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~gGsL 329 (411)
.|..|.+ ..||+....+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 6789887666788888875432 234667888888873 34466788887766678999999998776
Q ss_pred HH
Q 015237 330 YD 331 (411)
Q Consensus 330 ~~ 331 (411)
..
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 54
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK05092 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.2e-05 Score=90.93 Aligned_cols=100 Identities=34% Similarity=0.446 Sum_probs=84.3
Q ss_pred HHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCcccccccccC
Q 015237 54 EDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCY 133 (411)
Q Consensus 54 ~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (411)
.+++.++|.+||.+|-+-..+ +++.-|-+++....+....|++.++. .+.
T Consensus 680 ~~~~~~~~~~~~~~yf~~~~~---~~i~~h~~~~~~~~~~~~~~~v~~~~---~~~------------------------ 729 (931)
T PRK05092 680 KADRDAYLARHYPAYWLAVDL---DTQARHARFIRDADDAGRPLATEVRP---DPA------------------------ 729 (931)
T ss_pred HHHHHHHHHhCCcHHhcCCCH---HHHHHHHHHHHhccccCCCcEEEEEe---cCC------------------------
Confidence 367888999999999998765 69999999998876644567766653 000
Q ss_pred CCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEe
Q 015237 134 PYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV 187 (411)
Q Consensus 134 ~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvv 187 (411)
...-+|+|.+-|||.|++.++..|+..|+||.+|..|+|.|||.+|+|.|
T Consensus 730 ----~~~t~v~I~~~Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V 779 (931)
T PRK05092 730 ----RGVTEVTVLAADHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWI 779 (931)
T ss_pred ----CCeEEEEEEeCCCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEE
Confidence 12349999999999999999999999999999999999999999999999
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.0001 Score=68.73 Aligned_cols=139 Identities=19% Similarity=0.277 Sum_probs=97.5
Q ss_pred EEEeecCceEEEEEEECCceEEEEEeeccc--------------cCHHHHHHHHHHHHHHhhcC------CCceeEEEee
Q 015237 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEH--------------LNENIRREFAQEVHIMRKVR------HMNVVQFIGA 310 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~--------------~~~~~~~~~~~Ei~iL~~l~------HpNIV~l~g~ 310 (411)
..||+|+.-.||.--. +...+||++.... ......++..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 4689999998887532 3567899988765 01112345666776665555 7889999999
Q ss_pred eecCCeEEEEEecCC------CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC
Q 015237 311 CTRPPRLFIVTEFMS------GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~------gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~ 384 (411)
..++..+.+|+|.+. .-+|.+++.... ++. . +...+-.-..||-+.+|+.+|++|.||++...+...
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~- 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE- 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc-
Confidence 999999999999873 246788885443 544 2 223333446788899999999999999998766433
Q ss_pred CccEEEEe-cccccc
Q 015237 385 DIHCYLSN-FLSIST 398 (411)
Q Consensus 385 ~~~ikL~D-FGla~~ 398 (411)
..+.|+| ||....
T Consensus 159 -~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 159 -FRLVLIDGLGEKEL 172 (199)
T ss_pred -eEEEEEeCCCCccc
Confidence 3578888 555444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.7e-05 Score=85.83 Aligned_cols=109 Identities=17% Similarity=0.243 Sum_probs=84.8
Q ss_pred hHHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 015237 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (411)
Q Consensus 53 ~~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (411)
=.+++.+++.+||.||-+--.+ +++.-|-+++....++.. |.+-++. .+... .
T Consensus 649 ~~~~~~~~~~~~~~~Y~l~~~~---~~I~~h~~~~~~~~~~~~-~~v~~~~---~~~~~--------------------~ 701 (895)
T PRK00275 649 DPDDAEQLWSQLGDDYFLRHTA---GDIAWHTEAILQHPDDGG-PLVLIKE---TTQRE--------------------F 701 (895)
T ss_pred CHHHHHHHHHhCCcHHhcCCCH---HHHHHHHHHHHhcccCCC-CeEEEEe---cCccC--------------------C
Confidence 3467889999999999998765 599999999987644443 4333432 11000 0
Q ss_pred CCCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCcc
Q 015237 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ 193 (411)
Q Consensus 133 ~~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~ 193 (411)
...-||++.+-|||.|++.++..|+..|+||..|..|+|.+||.||+|.|......
T Consensus 702 -----~~~t~V~V~~~DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~g~ 757 (895)
T PRK00275 702 -----EGGTQIFIYAPDQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGE 757 (895)
T ss_pred -----CCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCCCC
Confidence 12339999999999999999999999999999999999999999999999765544
|
|
| >PRK03059 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=5.7e-05 Score=84.73 Aligned_cols=103 Identities=28% Similarity=0.382 Sum_probs=82.1
Q ss_pred hHHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 015237 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (411)
Q Consensus 53 ~~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (411)
=.+.+.++|.++|.+|-+--.+ +++.-|-+++....+.. .|.+-++. .+.
T Consensus 626 ~~~~~~~~~~~~~~~Yf~~~~~---~~I~~h~~~~~~~~~~~-~~~v~~~~---~~~----------------------- 675 (856)
T PRK03059 626 PDDAHEALWDQLDVGYFLRHDA---ADIAWHTRHLYRHVDTD-TPIVRARL---SPA----------------------- 675 (856)
T ss_pred CHHHHHHHHHhCChHHhccCCH---HHHHHHHHHHHhcccCC-CCeEEEEe---cCC-----------------------
Confidence 4567889999999999987654 69999999997754322 34333332 110
Q ss_pred CCCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCC
Q 015237 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGW 190 (411)
Q Consensus 133 ~~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w 190 (411)
...-||++.+-|||.|++.++..|+..|+||..|..|+|.||+.||+|.|...
T Consensus 676 -----~~~~~v~i~~~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ld~f~V~~~ 728 (856)
T PRK03059 676 -----GEGLQVMVYTPDQPDLFARICGYFDRAGFSILDARVHTTRHGYALDTFQVLDP 728 (856)
T ss_pred -----CCeEEEEEEecCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeEEEEEEEeCC
Confidence 12339999999999999999999999999999999999999999999999643
|
|
| >PRK04374 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=82.73 Aligned_cols=105 Identities=16% Similarity=0.175 Sum_probs=82.9
Q ss_pred hHHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 015237 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (411)
Q Consensus 53 ~~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (411)
=.+++.++|.+||.||-+--.+ +++.-|-+++.... ...|.+-++-. .+
T Consensus 638 ~~~~~~~~~~~l~~~Y~~~~~~---~~I~~h~~~~~~~~--~~~~~v~~~~~--~~------------------------ 686 (869)
T PRK04374 638 DDATIDRQFAGMPDENFLRFRP---EQLAWQAASLIEVE--IGQTLVKARRA--VP------------------------ 686 (869)
T ss_pred CHHHHHHHHHhCCchhhcCCCH---HHHHHHHHHHHhcC--CCCCeEEEeee--cc------------------------
Confidence 4567889999999999988665 69999999997653 22233222110 00
Q ss_pred CCCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCc
Q 015237 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPL 192 (411)
Q Consensus 133 ~~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~ 192 (411)
....-||++.+-|||.|++.++..|+..|+||..|..|+|.||+.||+|.|.....
T Consensus 687 ----~~~~~~v~v~~~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ld~f~V~~~~~ 742 (869)
T PRK04374 687 ----DNDALEVFVYSPDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAIFDVFEVLPQDT 742 (869)
T ss_pred ----CCCeEEEEEEeCCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEEEEEEEEeCCCC
Confidence 01234999999999999999999999999999999999999999999999986554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00029 Score=79.05 Aligned_cols=78 Identities=14% Similarity=0.223 Sum_probs=55.9
Q ss_pred EEEEeecCceEEEEEEECC----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCce--eEEEeeeecC---CeEEE
Q 015237 250 EHKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNV--VQFIGACTRP---PRLFI 319 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNI--V~l~g~~~~~---~~l~I 319 (411)
.+.++.|.+..+|+-.+.+ ..+++|+....... .....+.+|+.+|+.+. |.++ .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4567889999999877653 46777876443211 11246789999999995 6665 7888888764 45789
Q ss_pred EEecCCCCC
Q 015237 320 VTEFMSGGS 328 (411)
Q Consensus 320 V~E~~~gGs 328 (411)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >PRK05007 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00015 Score=81.67 Aligned_cols=118 Identities=24% Similarity=0.313 Sum_probs=88.8
Q ss_pred hHHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 015237 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (411)
Q Consensus 53 ~~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (411)
=.+.+.++|.++|.+|-+--.+ +++.-|-+++..+.. ..|.+.++. .+ .
T Consensus 650 ~~~~~~~~~~~~~~~yf~~~~~---~~I~~h~~~~~~~~~--~~p~V~i~~---~~-----------------------~ 698 (884)
T PRK05007 650 DEEALHQIWSRCRADYFLRHTP---NQLAWHARHLLQHDL--DKPLVLLSK---QA-----------------------T 698 (884)
T ss_pred CHHHHHHHHHhCChHHhcCCCH---HHHHHHHHHHHhccC--CCCeEEEEe---cC-----------------------C
Confidence 3467888999999999987654 699999999977643 344444322 00 0
Q ss_pred CCCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCcc-----chHHHHHHHhhcc
Q 015237 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ-----ETEQLRNVLAKEI 206 (411)
Q Consensus 133 ~~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~-----~~~~l~~~l~~~~ 206 (411)
...-+|++.+-|||.|+..++..|+..|+||..|..|++.+|+.+|+|+|...... .-+.++..+.+.+
T Consensus 699 -----~~~t~V~V~a~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~alD~F~V~d~~g~~~~~~~~~~I~~~L~~aL 772 (884)
T PRK05007 699 -----RGGTEIFIWSPDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQVIRKALEQAL 772 (884)
T ss_pred -----CCeEEEEEEecCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeEEEEEEEECCCCCCCCHHHHHHHHHHHHHHH
Confidence 12349999999999999999999999999999999999999999999999654322 1223455555554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.76 E-value=5.4e-06 Score=85.90 Aligned_cols=77 Identities=21% Similarity=0.455 Sum_probs=66.6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~--~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.++||.|++|.-.+|.++|.... ...++...+.++.|++.|++| ++.+|||+||.||....+. .+||.|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~------q~kIgD 399 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD------QLKIGD 399 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch------hhhhhh
Confidence 36899999999999999997442 346777889999999999999 9999999999999998877 588999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||+.....
T Consensus 400 Fgl~ts~~ 407 (516)
T KOG1033|consen 400 FGLVTSQD 407 (516)
T ss_pred hhheeecc
Confidence 99987653
|
|
| >TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00019 Score=80.70 Aligned_cols=103 Identities=25% Similarity=0.371 Sum_probs=82.2
Q ss_pred HHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCcccccccccC
Q 015237 54 EDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCY 133 (411)
Q Consensus 54 ~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (411)
.+++..++.++|.+|-+-..+ +++.-|-+++..+.+... |.+.+. . ..
T Consensus 617 ~~~~~~~~~~~~~~y~~~~~~---~~I~~h~~~~~~~~~~~~-~~v~~~-----~--~~--------------------- 664 (850)
T TIGR01693 617 SNEAEVLWLRAYDDYFLRFTH---KEIAWHAESLRRALSSGG-PLALID-----G--TR--------------------- 664 (850)
T ss_pred HHHHHHHHHhCCchhhcCCCH---HHHHHHHHHHHhcccCCC-CEEEEe-----c--cC---------------------
Confidence 456788999999999998766 599999999988654322 332221 0 00
Q ss_pred CCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCC
Q 015237 134 PYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWP 191 (411)
Q Consensus 134 ~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~ 191 (411)
+...-+|++.+-|||.|+..++..|+..|+||..|..|+|.+|+.+|+|.|....
T Consensus 665 ---~~~~t~i~V~~~DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~ 719 (850)
T TIGR01693 665 ---PSGGTEVFIYAPDQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLF 719 (850)
T ss_pred ---CCCeEEEEEEeCCCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCC
Confidence 0123499999999999999999999999999999999999999999999996554
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family. |
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00011 Score=57.83 Aligned_cols=51 Identities=27% Similarity=0.412 Sum_probs=45.2
Q ss_pred EEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCcc
Q 015237 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQ 193 (411)
Q Consensus 143 ~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~ 193 (411)
+-+.+-|||.|+..++..|+..|++|..|..++|.+|+.+|+|.|......
T Consensus 3 ~ei~~~Dr~gLfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~ 53 (76)
T cd04927 3 LKLFCSDRKGLLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDAREL 53 (76)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCC
Confidence 345677999999999999999999999999999999999999999765433
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00035 Score=66.17 Aligned_cols=72 Identities=13% Similarity=0.224 Sum_probs=44.7
Q ss_pred EEEeecCce-EEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC---ceeEEEeeeecC---CeEEEEEec
Q 015237 251 HKIVSGSYC-DLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM---NVVQFIGACTRP---PRLFIVTEF 323 (411)
Q Consensus 251 ~~IG~Gsfg-~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp---NIV~l~g~~~~~---~~l~IV~E~ 323 (411)
+.|+.|+.. .||+. +..+.+|+.+... ....+.+|..+|+.+... -+.+.++..... +..|++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 356666666 48874 3457778754321 234688899999877532 344555544332 235889999
Q ss_pred CCCCCH
Q 015237 324 MSGGSI 329 (411)
Q Consensus 324 ~~gGsL 329 (411)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 988665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0003 Score=64.98 Aligned_cols=99 Identities=18% Similarity=0.317 Sum_probs=77.6
Q ss_pred HHHHHHHhhcCC-CceeEEEeeeecCCeEEEEEecCCCCCHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 015237 290 AQEVHIMRKVRH-MNVVQFIGACTRPPRLFIVTEFMSGGSIYDY---LHKQKCGLKLPLLLRVAIDVSKGMNYLHR---N 362 (411)
Q Consensus 290 ~~Ei~iL~~l~H-pNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~---L~~~~~~l~~~~i~~i~~qIa~gL~yLHs---~ 362 (411)
..|.-+|+.+++ +++++++|+|.. ++++||...+++... +..- ...+|....+++.+++..+++++. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 699999999953 568999977765421 1111 136889999999999999999987 3
Q ss_pred CccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 363 NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 363 gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.+.-.|++++|+-++++| .+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~------~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDG------RLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCC------cEEEEechhcchh
Confidence 477799999999999988 5899998777654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK01759 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00035 Score=78.57 Aligned_cols=101 Identities=26% Similarity=0.339 Sum_probs=80.6
Q ss_pred hHHHHHHHhccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCccccccccc
Q 015237 53 FEDDLWAHFYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSC 132 (411)
Q Consensus 53 ~~~~~~~hf~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (411)
=.+.+.++|.++|.+|-+-- .+++++-|-+++..... .|.+.++- . .
T Consensus 627 ~~~~~~~~~~~~~~~yf~~~---~~~~I~~h~~~~~~~~~---~~~V~i~~-----~--~-------------------- 673 (854)
T PRK01759 627 SETQIEQLWQRCPEDYFLRN---TPKQIAWHALLLLDFRG---DLLVKISN-----R--F-------------------- 673 (854)
T ss_pred CHHHHHHHHHhCCcHHhcCC---CHHHHHHHHHHHHhcCC---CCEEEEEe-----c--C--------------------
Confidence 45678889999999999954 45799999999866543 34433321 0 0
Q ss_pred CCCCCcceeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCC
Q 015237 133 YPYKKRLMHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGW 190 (411)
Q Consensus 133 ~~~~~~~~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w 190 (411)
+...-+|++.+-|||.|++.++..|+..|+||..|..|+|.+|+.+|+|.|...
T Consensus 674 ----~~~~t~V~V~~~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~alD~F~V~d~ 727 (854)
T PRK01759 674 ----SRGGTEIFIYCQDQANLFLKVVSTIGAKKLSIHDAQIITSQDGYVLDSFIVTEL 727 (854)
T ss_pred ----CCCeEEEEEEecCCccHHHHHHHHHHHCCCeEEEEEEEEccCCEEEEEEEEeCC
Confidence 012339999999999999999999999999999999999999999999999644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0017 Score=62.16 Aligned_cols=133 Identities=15% Similarity=0.174 Sum_probs=75.4
Q ss_pred EeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce-eEEEeeeecCCeEEEEEecCCCCCHHH
Q 015237 253 IVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFMSGGSIYD 331 (411)
Q Consensus 253 IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~~l~IV~E~~~gGsL~~ 331 (411)
+..|-...+|+....++.+++|........ ..-...+|..+++.+....+ .++++.+. -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 455777788988777788889875433211 10124678888888853322 44454432 368999998865431
Q ss_pred --------------HHHh---cC---CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCccccCCCCCc
Q 015237 332 --------------YLHK---QK---CGLKLP-LLLRVAIDV---------SKGMNYLHR--------NNIIHRDLKAAN 373 (411)
Q Consensus 332 --------------~L~~---~~---~~l~~~-~i~~i~~qI---------a~gL~yLHs--------~gIIHRDLKp~N 373 (411)
.+.+ .. ..+... .+..+..++ ..-+..+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1111 11 011111 111221111 111222221 247999999999
Q ss_pred EEEccCCCcCCCccEEEEecccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|++++++ ++++||..|..
T Consensus 158 il~~~~~-------~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-------LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-------CEEEeccccCc
Confidence 9999876 57999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0063 Score=57.17 Aligned_cols=72 Identities=17% Similarity=0.207 Sum_probs=46.5
Q ss_pred EEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
+.|..|-...+|+.... ++.|++|+....... .....+|+.+++.+. +.-..++++.+.. .++|||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 45677888899998765 467889976543211 112346888888884 3334556554432 379999988
Q ss_pred CCH
Q 015237 327 GSI 329 (411)
Q Consensus 327 GsL 329 (411)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0063 Score=59.99 Aligned_cols=138 Identities=17% Similarity=0.213 Sum_probs=79.1
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC--ceeEEEeee------ecCCeEEEEE
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGAC------TRPPRLFIVT 321 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~~------~~~~~l~IV~ 321 (411)
.+.++.|....+|+....+..+.+|+..... .. ..+..|..++..+... .+.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 4456677777889876655678888865421 11 3345566777666322 244544422 1235678999
Q ss_pred ecCCCCCHH-----------HH---HHhcCCCC--------CHHH---HH------------HHHHHHHHHHHHHHH---
Q 015237 322 EFMSGGSIY-----------DY---LHKQKCGL--------KLPL---LL------------RVAIDVSKGMNYLHR--- 361 (411)
Q Consensus 322 E~~~gGsL~-----------~~---L~~~~~~l--------~~~~---i~------------~i~~qIa~gL~yLHs--- 361 (411)
+|++|.++. .. ++.....+ .... .. .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999875431 11 11110011 0110 00 001123334555542
Q ss_pred ----CCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 362 ----NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 362 ----~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
.+++|+|+.+.|++++.++ ...++||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~------~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDS------VKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCc------eEEEeeccccc
Confidence 5799999999999999876 25799999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00091 Score=52.20 Aligned_cols=46 Identities=30% Similarity=0.507 Sum_probs=40.9
Q ss_pred EEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecC
Q 015237 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDG 189 (411)
Q Consensus 143 ~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~ 189 (411)
+.+.+-|||.|+..++..+++.|+||..|+.++. +|+.+|+|.|..
T Consensus 3 ~~v~~~Dr~gLl~~i~~~l~~~~lnI~~A~i~t~-~~~~~d~f~V~d 48 (74)
T cd04925 3 IELTGTDRPGLLSEVFAVLADLHCNVVEARAWTH-NGRLACVIYVRD 48 (74)
T ss_pred EEEEECCCCCHHHHHHHHHHHCCCcEEEEEEEEE-CCEEEEEEEEEc
Confidence 3456679999999999999999999999999955 999999999853
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0049 Score=60.05 Aligned_cols=138 Identities=14% Similarity=0.120 Sum_probs=81.4
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC--ceeEEEee------eecCCeEEEEE
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGA------CTRPPRLFIVT 321 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~------~~~~~~l~IV~ 321 (411)
.+.|..|....+|+....+..+++|+.... + ...+..|+.++..+.+. .+.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 345667777889987766678999987541 2 24566788888777432 24455442 12345578999
Q ss_pred ecCCCCCHHH-----------H---HHhcCCCC----------CHHHH--H--------HHHHHHHHHHHHHHH------
Q 015237 322 EFMSGGSIYD-----------Y---LHKQKCGL----------KLPLL--L--------RVAIDVSKGMNYLHR------ 361 (411)
Q Consensus 322 E~~~gGsL~~-----------~---L~~~~~~l----------~~~~i--~--------~i~~qIa~gL~yLHs------ 361 (411)
+|++|..+.. . ++.....+ .+... . .....+...+.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998866421 1 11100000 11000 0 011112334445443
Q ss_pred -CCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 362 -NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 -~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
.+++|+|+.|.|||++++++ +.++||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~------~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDEL------SGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCce------EEEeehhhhcC
Confidence 46999999999999998762 57999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.024 Score=55.92 Aligned_cols=73 Identities=10% Similarity=0.100 Sum_probs=43.0
Q ss_pred EEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC--ceeEEEee------eecCCeEEEEEe
Q 015237 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGA------CTRPPRLFIVTE 322 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~------~~~~~~l~IV~E 322 (411)
+.|+.|....+|+....+..+++|+.. . ... ..+..|+.++..+... .+.+.+.. ....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456677777889887666678999875 2 222 2333455555555311 23333321 122456789999
Q ss_pred cCCCCC
Q 015237 323 FMSGGS 328 (411)
Q Consensus 323 ~~~gGs 328 (411)
|++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 998864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.018 Score=59.45 Aligned_cols=76 Identities=12% Similarity=-0.046 Sum_probs=52.3
Q ss_pred EEEeecCceEEEEEEECC--ceEEEEEeecccc----C-HHHHHHHHHHHHHHhhcC---CCceeEEEeeeecCCeEEEE
Q 015237 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL----N-ENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~----~-~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~l~IV 320 (411)
+.||.|.+..||+....+ +.|.||.-.+... . .-...++..|...|+.+. ..++.+++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 468999999999998864 4899998542210 0 112355677888887762 346778887744 457899
Q ss_pred EecCCCCC
Q 015237 321 TEFMSGGS 328 (411)
Q Consensus 321 ~E~~~gGs 328 (411)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.00057 Score=76.27 Aligned_cols=150 Identities=21% Similarity=0.235 Sum_probs=102.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc-cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
.....+.+.+-+-+|+++.++...-. +...++|+..... ...+..+....+-.++-...+|.++.+.-.+.....++
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 44445566667889999998875432 2223344332221 11111233344444444456788887776666667799
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++++|..+++|...|+..+ .....-...+...+..+.+|||...++|+|++|.|+|+..+| ..+++|||..+.
T Consensus 881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g------h~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG------HRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccC------CcccCccccccc
Confidence 9999999999999988765 344444455666788899999999999999999999999999 578999985544
|
|
| >cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0045 Score=48.67 Aligned_cols=44 Identities=20% Similarity=0.359 Sum_probs=40.7
Q ss_pred EEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEe
Q 015237 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV 187 (411)
Q Consensus 143 ~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvv 187 (411)
|.+.+-|||+||..+...|++.|++|.-|+. +|.++...|+|+|
T Consensus 4 veV~~~DRpGLL~~i~~~l~~~~l~I~~A~I-~T~gera~D~FyV 47 (75)
T cd04897 4 VTVQCRDRPKLLFDVVCTLTDMDYVVFHATI-DTDGDDAHQEYYI 47 (75)
T ss_pred EEEEeCCcCcHHHHHHHHHHhCCeEEEEEEE-eecCceEEEEEEE
Confidence 4578999999999999999999999999995 8888899999999
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.02 Score=56.06 Aligned_cols=73 Identities=16% Similarity=0.237 Sum_probs=44.9
Q ss_pred EEEeecCceEEEEEEEC--------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc-eeEEEeeeecCCeEEEEE
Q 015237 251 HKIVSGSYCDLYKGAFF--------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~l~IV~ 321 (411)
+.+..|-...+|+.... ++.+++|+...... ......+|..++..+.... ..++++.+.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 34555666678877654 36889999654321 1134567888888774322 3456666542 3589
Q ss_pred ecCCCCCHH
Q 015237 322 EFMSGGSIY 330 (411)
Q Consensus 322 E~~~gGsL~ 330 (411)
||++|.++.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999876653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG2844 GlnD UTP:GlnB (protein PII) uridylyltransferase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.02 Score=62.83 Aligned_cols=97 Identities=31% Similarity=0.516 Sum_probs=76.8
Q ss_pred hccCCcceeeccCCcchhhhHhhHHHHHHhcCCCCCCeEEEEEEEEecCCCCCCCCccCCCCCcccccccccCCCCCcce
Q 015237 61 FYRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCYPYKKRLM 140 (411)
Q Consensus 61 f~~lp~~y~~~~~~~~~~dvl~h~~~l~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (411)
..+++..|-+-+.+ .||.-|-+.|-++ | ...|..-++. +.. ...
T Consensus 641 w~~~~~~yflr~~~---~~iawH~~~l~~~-~-~~~~Lv~~~~-r~~------------------------------~~~ 684 (867)
T COG2844 641 WARCYANYFLRHSA---RDIAWHARHLVRH-D-LGKPLVLISV-RPH------------------------------SGG 684 (867)
T ss_pred HHhccccceeecCH---HHHhHHHHHHHhh-h-ccCcceeeee-ccc------------------------------CCc
Confidence 34688999998886 5999999999988 4 3344433221 000 123
Q ss_pred eEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEec---CCCcc
Q 015237 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVD---GWPLQ 193 (411)
Q Consensus 141 ~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd---~w~~~ 193 (411)
-||++-+-|+|.|...+.+.++..|+||..|-.|+|.|||.||+|.|. |.+.+
T Consensus 685 teV~V~a~d~p~Lfa~v~~~~~~~g~~i~dAqi~tt~dG~alDtfiv~~~~g~~~~ 740 (867)
T COG2844 685 TEVFVYAPDRPRLFAVVCAALSRRGLSIVDAQIFTTRDGYALDTFIVLEPDGFPVE 740 (867)
T ss_pred eEEEEEcCCCccHHHHHHHHHccCCCceeeeEEEEccCCceeeeEEEecCCCCccc
Confidence 399999999999999999999999999999999999999999999876 55544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.017 Score=58.67 Aligned_cols=141 Identities=16% Similarity=0.241 Sum_probs=90.7
Q ss_pred EEEEEEeecCceEEEEEEEC-CceEEEEEeecccc----------------------CH-H-HHHHHHHHHHHHhhcCCC
Q 015237 248 KFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHL----------------------NE-N-IRREFAQEVHIMRKVRHM 302 (411)
Q Consensus 248 ~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~----------------------~~-~-~~~~~~~Ei~iL~~l~Hp 302 (411)
.+...|..|--..||.++-. |..+|||+.+..-+ ++ . ..-....|++-|++++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34557888999999999765 68899999875311 11 1 112245677778887655
Q ss_pred ceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEEccCCC
Q 015237 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL-HRNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 303 NIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yL-Hs~gIIHRDLKp~NILid~~g~ 381 (411)
.|...--.... .-.|||+|+ |++=+-.-.-....++...+..+-.|++.-|.-| +.++.||.||.-=|+|+.+..
T Consensus 227 GIP~PePIlLk--~hVLVM~Fl-Grdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~- 302 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFL-GRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK- 302 (520)
T ss_pred CCCCCCceeee--cceEeeeec-cCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE-
Confidence 44321111111 246899999 3332221111222466666767777777777766 568899999999999997654
Q ss_pred cCCCccEEEEecccccc
Q 015237 382 RDSDIHCYLSNFLSIST 398 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~ 398 (411)
++++|-+-+..
T Consensus 303 ------lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 ------LYIIDVSQSVE 313 (520)
T ss_pred ------EEEEEcccccc
Confidence 88999876554
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0026 Score=63.55 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=89.5
Q ss_pred eEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccC------------------H--HHHHHHHHHHHHHhhcC-CC-c
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN------------------E--NIRREFAQEVHIMRKVR-HM-N 303 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~------------------~--~~~~~~~~Ei~iL~~l~-Hp-N 303 (411)
+.++++||-|--+.||.+.+. |++.++|+=+....+ . -.+-...+|...|+.+. |. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 456788999999999998876 788888864322110 0 01233577888898885 32 2
Q ss_pred eeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 304 IV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
+.+.+++ +.-|+|||++.|-.|.+.-+- .+.+.+. ..+..-+--|-.+|+||+|..-=||++++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly---~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~--- 239 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPTLY---DDLMGLIVRLANHGLIHGDFNEFNIMVKDDD--- 239 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHHHH---HHHHHHHHHHHHcCceecccchheeEEecCC---
Confidence 4444544 357899999988777654322 2233332 2233334456679999999999999999877
Q ss_pred CCccEEEEecccccc
Q 015237 384 SDIHCYLSNFLSIST 398 (411)
Q Consensus 384 ~~~~ikL~DFGla~~ 398 (411)
.++++||--...
T Consensus 240 ---~i~vIDFPQmvS 251 (465)
T KOG2268|consen 240 ---KIVVIDFPQMVS 251 (465)
T ss_pred ---CEEEeechHhhc
Confidence 589999954433
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.1 Score=51.03 Aligned_cols=29 Identities=24% Similarity=0.484 Sum_probs=24.1
Q ss_pred CCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 362 NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 362 ~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
.+++|+|+.+.||+++.+ .+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~-------~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN-------EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCC-------cEEEEECcccc
Confidence 478999999999999873 36899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.046 Score=53.97 Aligned_cols=79 Identities=15% Similarity=0.082 Sum_probs=57.9
Q ss_pred eEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC---CceeEEEeeeec---CCeEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH---MNVVQFIGACTR---PPRLFIV 320 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H---pNIV~l~g~~~~---~~~l~IV 320 (411)
+.-.+.||.|..+.||+-...+..+.+|..+... . ...+..|...|+.+.- -.+.+.+++|.. .+..+||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3345678999999999987665567788854311 1 1468889999988853 357888888754 3568999
Q ss_pred EecCCCCCH
Q 015237 321 TEFMSGGSI 329 (411)
Q Consensus 321 ~E~~~gGsL 329 (411)
||+++|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988765
|
|
| >cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.012 Score=45.93 Aligned_cols=47 Identities=28% Similarity=0.483 Sum_probs=42.1
Q ss_pred EEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCC
Q 015237 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGW 190 (411)
Q Consensus 143 ~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w 190 (411)
+-+.+.|||.||..+...|.+.|++|.-|+. +|.++.-.|+|.|..-
T Consensus 4 iev~a~DRpGLL~~i~~~l~~~gl~I~~AkI-sT~Gerv~DvFyV~d~ 50 (72)
T cd04895 4 VKVDSARKPGILLEAVQVLTDLDLCITKAYI-SSDGGWFMDVFHVTDQ 50 (72)
T ss_pred EEEEECCcCCHHHHHHHHHHHCCcEEEEEEE-eecCCeEEEEEEEECC
Confidence 4567899999999999999999999999995 9999999999999543
|
This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.02 Score=44.29 Aligned_cols=49 Identities=27% Similarity=0.422 Sum_probs=43.9
Q ss_pred EEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCC
Q 015237 142 EITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWP 191 (411)
Q Consensus 142 e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~ 191 (411)
++++..-|||.+|..++..+++.|+||..+..|++ +++.+++|.|....
T Consensus 3 ri~V~~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~-~~~~~d~f~v~~~~ 51 (72)
T cd04926 3 RLELRTEDRVGLLSDVTRVFRENGLTVTRAEISTQ-GDMAVNVFYVTDAN 51 (72)
T ss_pred EEEEEECCccCHHHHHHHHHHHCCcEEEEEEEecC-CCeEEEEEEEECCC
Confidence 78889999999999999999999999999999765 78999999986543
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.019 Score=45.10 Aligned_cols=49 Identities=18% Similarity=0.186 Sum_probs=42.4
Q ss_pred EEeeCChhhHHHHHhhhccccCcccccccccc--cCCCceeEEEEecCCCcc
Q 015237 144 TISTNDKPKLLSQLTSLLSEIGLNIQEAHAFS--TVDGYSLDVFVVDGWPLQ 193 (411)
Q Consensus 144 ~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fs--t~~g~sldvfvvd~w~~~ 193 (411)
-+.+.|||.||..+...+.+.|++|.-|+. + |.++.-.|+|+|+.+...
T Consensus 4 ev~a~DRpGLL~~i~~~l~~~~l~i~~AkI-~~~T~Gerv~D~Fyv~~~g~k 54 (75)
T cd04896 4 QIRCVDQKGLLYDILRTSKDCNIQISYGRF-SSKVKGYREVDLFIVQSDGKK 54 (75)
T ss_pred EEEeCCcccHHHHHHHHHHHCCeEEEEEEE-ecCcccCEEEEEEEEeCCCCc
Confidence 467899999999999999999999999994 6 777888899999766644
|
This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.11 Score=52.45 Aligned_cols=80 Identities=11% Similarity=0.199 Sum_probs=47.7
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce-eEEEeeeecCC
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPP 315 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~ 315 (411)
+.+.+.+. .+..|-.-.+|+..+. ++.|++|+..... .... .-.+|..+++.+...++ .++++.+...
T Consensus 35 ~~~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g- 109 (344)
T PLN02236 35 DDEALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG- 109 (344)
T ss_pred CcCcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc-
Confidence 33444444 4445777788988653 2578889875432 1111 12568888888754333 4566666432
Q ss_pred eEEEEEecCCCCCHH
Q 015237 316 RLFIVTEFMSGGSIY 330 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~ 330 (411)
.|++|+++.++.
T Consensus 110 ---~v~efi~g~~l~ 121 (344)
T PLN02236 110 ---RVEEFIHARTLS 121 (344)
T ss_pred ---eEEEeeCCCCCC
Confidence 578999776653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.074 Score=54.14 Aligned_cols=73 Identities=10% Similarity=-0.098 Sum_probs=45.8
Q ss_pred EEeecCceEEEEEEECC--ceEEEEEeecccc----C-HHHHHHHHHHHHHHhhcC--CC-ceeEEEeeeecCCeEEEEE
Q 015237 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL----N-ENIRREFAQEVHIMRKVR--HM-NVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~----~-~~~~~~~~~Ei~iL~~l~--Hp-NIV~l~g~~~~~~~l~IV~ 321 (411)
.||.|....||++...+ +.|+||.-.+-.. + +-...+...|...|+... -| .+.++|.+- +....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence 47899999999998764 5799997542110 0 112234456777776653 23 466666553 34467999
Q ss_pred ecCCC
Q 015237 322 EFMSG 326 (411)
Q Consensus 322 E~~~g 326 (411)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.0035 Score=67.15 Aligned_cols=131 Identities=18% Similarity=0.186 Sum_probs=90.4
Q ss_pred EEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc-eeEEEeeeecCCeEEEEEecCCCC-C
Q 015237 252 KIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFIVTEFMSGG-S 328 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~l~IV~E~~~gG-s 328 (411)
..++|+++.++|.+... +....+.+... ....-++++|.+++||| .+..++-+..+...+|+++++.++ +
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 35789999999876543 22234444322 33456788999999999 788888888888999999999776 3
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 329 L~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
....+......+.......+.+.-+++++|+|+---+||| ||+..+.. .++.||+.+..+.
T Consensus 322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~-------~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE-------VKLLDFAVPPQLT 382 (829)
T ss_pred ccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc-------cccccccCCcccC
Confidence 3222221122234444555666677899999988778999 88887754 5788888776554
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.16 Score=50.85 Aligned_cols=136 Identities=15% Similarity=0.220 Sum_probs=76.7
Q ss_pred cCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--CceeEEEeeeecCC--eEEEEEecCCCCC---
Q 015237 256 GSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPP--RLFIVTEFMSGGS--- 328 (411)
Q Consensus 256 Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~--~l~IV~E~~~gGs--- 328 (411)
|..-..|.....++.+++. ...............+|..+|+.+.- .-+...++.|.... ..|.||+|++|..
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 4334455555556777777 33222222334556778888887743 23345567776654 6799999998722
Q ss_pred ---------------HHHHHHhcC-------------CCCCHHHHHHHHHH--------------HHHHHHHHHHC----
Q 015237 329 ---------------IYDYLHKQK-------------CGLKLPLLLRVAID--------------VSKGMNYLHRN---- 362 (411)
Q Consensus 329 ---------------L~~~L~~~~-------------~~l~~~~i~~i~~q--------------Ia~gL~yLHs~---- 362 (411)
|.++|..-. +......+.++..+ ...-..||+.+
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 122221100 00000111111111 22345566643
Q ss_pred ----CccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 363 ----NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 363 ----gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
.++|+|+.+.|++++..+. .-++||+++..
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~------~gVlDwe~~~l 228 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRP------TGVLDWELATL 228 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCe------eEEEecccccc
Confidence 3799999999999998873 67999988754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.47 Score=49.21 Aligned_cols=75 Identities=13% Similarity=0.007 Sum_probs=50.2
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeecccc--CH---HHHHHHHHHHHHHhhcC---CCceeEEEeeeecCCeEEEEE
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHL--NE---NIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~--~~---~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.||.|....||+....+..++||.-..... .. -...+-..|...|+.+. ..++.+++.++.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 55789999999999877667799998652211 00 01233344566665553 3578899998874 367889
Q ss_pred ecCCC
Q 015237 322 EFMSG 326 (411)
Q Consensus 322 E~~~g 326 (411)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99966
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.19 Score=49.15 Aligned_cols=31 Identities=19% Similarity=0.383 Sum_probs=24.6
Q ss_pred CccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 363 NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 363 gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
.++|+|+.+.|||++.++. -..++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-----~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-----VTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-----EEEEECcHhccc
Confidence 3899999999999986441 257999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.35 Score=47.77 Aligned_cols=76 Identities=17% Similarity=0.219 Sum_probs=48.3
Q ss_pred eEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC---CCceeEEEeeeecCCeEEEEEec
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
++-.+.|+.|....+|+....++.+.+|+-.... ...|..|..-|+.+. --.+.+.+++....+.-|++|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 4446678899999999988667899999986332 245777888887773 44577888888777777999999
Q ss_pred CCCC
Q 015237 324 MSGG 327 (411)
Q Consensus 324 ~~gG 327 (411)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.039 Score=40.86 Aligned_cols=60 Identities=27% Similarity=0.415 Sum_probs=44.6
Q ss_pred eEEEEeeCChhhHHHHHhhhccccCcccccccccccCCC--ceeEEEEecCCCccchHHHHHHHh
Q 015237 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDG--YSLDVFVVDGWPLQETEQLRNVLA 203 (411)
Q Consensus 141 ~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g--~sldvfvvd~w~~~~~~~l~~~l~ 203 (411)
|.+++..-|||.+|..++..|++.|.||...+.+++.++ +...++. ....+.+.+...++
T Consensus 1 ~~v~v~~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 62 (66)
T PF01842_consen 1 YRVRVIVPDRPGILADVTEILADHGINIDSISQSSDKDGVGIVFIVIV---VDEEDLEKLLEELE 62 (66)
T ss_dssp EEEEEEEETSTTHHHHHHHHHHHTTEEEEEEEEEEESSTTEEEEEEEE---EEGHGHHHHHHHHH
T ss_pred CEEEEEcCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCCceEEEEEEE---CCCCCHHHHHHHHH
Confidence 457888889999999999999999999999999999884 2333333 23445555555544
|
ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 411 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-25 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-25 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-24 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-20 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-20 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-04 | ||
| 3enh_A | 540 | Crystal Structure Of Cgi121BUD32KAE1 COMPLEX Length | 7e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-04 | ||
| 2vwb_A | 535 | Structure Of The Archaeal Kae1-Bud32 Fusion Protein | 7e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-04 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ENH|A Chain A, Crystal Structure Of Cgi121BUD32KAE1 COMPLEX Length = 540 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2VWB|A Chain A, Structure Of The Archaeal Kae1-Bud32 Fusion Protein Mj1130: A Model For The Eukaryotic Ekc-Keops Subcomplex Involved In Transcription And Telomere Homeostasis. Length = 535 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-70
Identities = 66/175 (37%), Positives = 103/175 (58%), Gaps = 5/175 (2%)
Query: 212 HHHVVYPVGEQEQSGINHVNI-PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD 270
HHH +P+ + + ++ A D +I L + KI +GS+ +++ + D
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 62
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VA+K+L + + EF +EV IM+++RH N+V F+GA T+PP L IVTE++S GS+Y
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 331 DYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGV 381
LHK +L L +A DV+KGMNYLH N I+HR+LK+ NLL+++
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 9e-69
Identities = 54/159 (33%), Positives = 91/159 (57%), Gaps = 2/159 (1%)
Query: 223 EQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN 282
++ +H + + D WEI + +I SGS+ +YKG + DVA+K+L
Sbjct: 2 KKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPT 60
Query: 283 ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL 342
+ F EV ++RK RH+N++ F+G T P L IVT++ G S+Y +LH + ++
Sbjct: 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEM 119
Query: 343 PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L+ +A ++GM+YLH +IIHRDLK+ N+ ++E+
Sbjct: 120 KKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT 158
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-68
Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 1/158 (0%)
Query: 228 NHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRR 287
+ + + W+I L+ I G + +Y G + +VAI+++ E NE+ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHG-RWHGEVAIRLIDIERDNEDQLK 74
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347
F +EV R+ RH NVV F+GAC PP L I+T G ++Y + K L + +
Sbjct: 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ 134
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
+A ++ KGM YLH I+H+DLK+ N+ + V +D
Sbjct: 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITD 172
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 6e-66
Identities = 41/142 (28%), Positives = 64/142 (45%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
S L + G + K + + +E +R F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
H NV++FIG + RL +TE++ GG++ + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 360 HRNNIIHRDLKAANLLMNENGV 381
H NIIHRDL + N L+ EN
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKN 146
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE--NIRREFAQEVHIM 296
+ EID + L E I G + +Y+ + +VA+K ++ + QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
++H N++ G C + P L +V EF GG + L ++ + +L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 357 NYLHRNN---IIHRDLKAANLLMNENGVRDSDIH 387
NYLH IIHRDLK++N+L+ + +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 40/147 (27%), Positives = 73/147 (49%), Gaps = 5/147 (3%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
ID L F K+ +L+KG + D+ +KVL + R+F +E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 300 RHMNVVQFIGACTRPP--RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGM 356
H NV+ +GAC PP ++T +M GS+Y+ LH+ + ++ A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 357 NYLH--RNNIIHRDLKAANLLMNENGV 381
+LH I L + +++++E+
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMT 151
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-60
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN-----IRREFA 290
+ + + +++E +I G + ++KG VAIK L +EF
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
+EV IM + H N+V+ G PP +V EF+ G +Y L + +K + LR+ +
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 351 DVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
D++ G+ Y+ N I+HRDL++ N+ + ++ + +++F
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD-ENAPVCAKVADF 173
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 45/147 (30%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
+ ID ++ E + G++ + K + ++DVAIK + +E+ R+ F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLSR 57
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK--CGLKLPLLLRVAIDVSKGM 356
V H N+V+ GAC P + +V E+ GGS+Y+ LH + + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 357 NYLHR---NNIIHRDLKAANLLMNENG 380
YLH +IHRDLK NLL+ G
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGG 142
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
V A ++ +I G Y +++ G + + VA+KV R E++
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIYQTVL 87
Query: 299 VRHMNVVQFIGACTRP----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+RH N++ FI A + +L+++T++ GS+YDYL L +L++A
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVS 145
Query: 355 GMNYLH--------RNNIIHRDLKAANLLMNENGV 381
G+ +LH + I HRDLK+ N+L+ +NG
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-48
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 19/160 (11%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHI 295
G + + L+ G + ++K ++ VA+K+ + + EV+
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS---WQNEYEVYS 71
Query: 296 MRKVRHMNVVQFIGACTRPP----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
+ ++H N++QFIGA R L+++T F GS+ D+L + L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAET 129
Query: 352 VSKGMNYLHRN----------NIIHRDLKAANLLMNENGV 381
+++G+ YLH + I HRD+K+ N+L+ N
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 244 ASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
A + + G Y ++++G++ ++VA+K+ ++ RE E++ +RH N
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKS-WFRE--TELYNTVMLRHEN 63
Query: 304 VVQFIGACTR----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
++ FI + +L+++T + GS+YDYL L LR+ + ++ G+ +L
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHL 121
Query: 360 H--------RNNIIHRDLKAANLLMNENGV 381
H + I HRDLK+ N+L+ +NG
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-47
Identities = 37/155 (23%), Positives = 82/155 (52%), Gaps = 17/155 (10%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK 298
V A + + I G + ++++G + ++VA+K+ ++ R E++
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVM 92
Query: 299 VRHMNVVQFIGACTR----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+RH N++ FI A + +L++V+++ GS++DYL++ + + ++++A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 355 GMNYLH--------RNNIIHRDLKAANLLMNENGV 381
G+ +LH + I HRDLK+ N+L+ +NG
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 23/158 (14%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR-- 297
+D LK I G Y +YKG+ + VA+KV + + R+ F E +I R
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVP 62
Query: 298 KVRHMNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
+ H N+ +FI R +V E+ GS+ YL R+A V
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSV 120
Query: 353 SKGMNYLH---------RNNIIHRDLKAANLLMNENGV 381
++G+ YLH + I HRDL + N+L+ +G
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 3/146 (2%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D W ++ L +I G++ +++ G + VA+K E L +++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARI 165
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+++ H N+V+ IG CT+ ++IV E + GG +L + L++ LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
M YL IHRDL A N L+ E V
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNV 251
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 50/146 (34%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
W ++ LK I G + D+ G + VA+K + N+ + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMT 69
Query: 298 KVRHMNVVQFIGACTR-PPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKG 355
++RH N+VQ +G L+IVTE+M+ GS+ DYL + L LL+ ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
M YL NN +HRDL A N+L++E+ V
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNV 155
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 7/151 (4%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFA 290
G + I + + G + ++Y+G + + VA+K + + + +F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM 61
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
E IM+ + H ++V+ IG P +I+ E G + YL + K LK+ L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ K M YL N +HRD+ N+L+
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPEC 151
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQE 292
+EI ++ I G + D+++G + S + VAIK ++++R +F QE
Sbjct: 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQE 66
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
MR+ H ++V+ IG T P ++I+ E + G + +L +K L L L+ A +
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
S + YL +HRD+ A N+L++ N
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDC 154
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 50/145 (34%), Positives = 80/145 (55%), Gaps = 4/145 (2%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIM 296
WEID L F ++ +G + + G + Q DVAIK++ ++E+ EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVM 73
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ H +VQ G CT+ +FI+TE+M+ G + +YL + + + LL + DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 357 NYLHRNNIIHRDLKAANLLMNENGV 381
YL +HRDL A N L+N+ GV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGV 158
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 53/143 (37%), Positives = 77/143 (53%), Gaps = 4/143 (2%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRK 298
W ID S L F +I SG + ++ G + ++ VAIK + ++E +F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
+ H +VQ G C + +VTEFM G + DYL Q+ LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
L +IHRDL A N L+ EN V
Sbjct: 120 LEEACVIHRDLAARNCLVGENQV 142
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-42
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLN-ENIRREFAQ 291
I L+ K+ GS+ + +G + + VA+K L + L+ +F +
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
EV+ M + H N+++ G PP + +VTE GS+ D L K + L L R A+
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
V++GM YL IHRDL A NLL+ +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDL 159
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-42
Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 4/143 (2%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIMRK 298
E+ + ++ SG + + G + Q DVA+K++ ++E+ EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
+ H +V+F G C++ ++IVTE++S G + +YL GL+ LL + DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
L + IHRDL A N L++ +
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLC 142
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 212 HHHVVYPVGEQEQSGINHVNIPAEGI--DVWEIDASLLKFEHKIVSGSYCDLYKGAF--- 266
HH P E + P + + EI S + + I +G + ++YKG
Sbjct: 9 HHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTS 68
Query: 267 ---FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VAIK L E R +F E IM + H N+++ G ++ + I+TE+
Sbjct: 69 SGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
M G++ +L ++ + L+ + ++ GM YL N +HRDL A N+L+N N V
Sbjct: 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 50/146 (34%), Positives = 78/146 (53%), Gaps = 6/146 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
W ++ LK I G + D+ G + VA+K + N+ + F E +M
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMT 241
Query: 298 KVRHMNVVQFIGACTR-PPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKG 355
++RH N+VQ +G L+IVTE+M+ GS+ DYL + L LL+ ++DV +
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
M YL NN +HRDL A N+L++E+ V
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNV 327
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 54/147 (36%), Positives = 89/147 (60%), Gaps = 6/147 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D WE++ + + +HK+ G Y ++Y+G + +S VA+K L + + EF +E +
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAV 62
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSK 354
M++++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + +LL +A +S
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGV 381
M YL + N IHRDL A N L+ EN +
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHL 149
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 49/149 (32%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQE 292
EI+AS + E I SG ++ G VAIK L E RR+F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSE 100
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM + H N+++ G TR IVTE+M GS+ +L + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
GM YL +HRDL A N+L++ N V
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLV 189
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 34/148 (22%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEV 293
+ L+ + SG + ++KG + + V IKV+ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHM 66
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS 353
+ + H ++V+ +G C L +VT+++ GS+ D++ + + L LLL + ++
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGV 381
KGM YL + ++HR+L A N+L+
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQ 153
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 42/146 (28%), Positives = 81/146 (55%), Gaps = 6/146 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIM 296
D WE+ LK ++ +G + +++ G + VA+K L ++ F E ++M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
++++H +V+ T+ P ++I+TE+M GS+ D+L L + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
M ++ N IHRDL+AAN+L+++
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLS 147
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-41
Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLNENIRREFAQE 292
E+DA+ + + + +G + ++ G VAIK L E RR+F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGE 96
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM + H N+++ G T+ + IVTE+M GS+ +L K + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ GM YL +HRDL A N+L+N N V
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLV 185
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 7/149 (4%)
Query: 238 DVWEIDASLLKFEHKIV-SGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQE 292
+D LL E K + SG++ + KG + + VA+K+L NE + ++ E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
++M+++ + +V+ IG C +V E G + YL + + +K ++ + V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQV 126
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
S GM YL +N +HRDL A N+L+
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHY 155
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 10/180 (5%)
Query: 210 ENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ 269
+HHH + + E D + + LKF ++ G++ + +
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPL 65
Query: 270 D------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVT 321
VA+K L + R+F +E+ I++ ++H N+V++ G C R L ++
Sbjct: 66 QDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
E++ GS+ DYL K K + LL+ + KGM YL IHRDL N+L+
Sbjct: 124 EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 53/155 (34%), Positives = 92/155 (59%), Gaps = 6/155 (3%)
Query: 230 VNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRR 287
+ + D WE++ + + +HK+ G Y ++Y+G + +S VA+K L + +
Sbjct: 205 IYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--- 261
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK-QKCGLKLPLLL 346
EF +E +M++++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + + +LL
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 321
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+A +S M YL + N IHR+L A N L+ EN +
Sbjct: 322 YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL 356
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 233 PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIR 286
PA +D + LK + G + + + + VA+K L N
Sbjct: 9 PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHI 67
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
+ +E+ I+R + H N+V++ G CT + ++ EF+ GS+ +YL K K + L
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L+ A+ + KGM+YL +HRDL A N+L+
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 164
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHI 295
+ + K + SG++ +YKG + + VAIK L E + +E E ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYV 70
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M V + +V + +G C + ++T+ M G + DY+ + K + LL + ++KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
MNYL ++HRDL A N+L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQH 155
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREF 289
G D + + LKF ++ G++ + + VA+K L + R+F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDF 58
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLR 347
+E+ I++ ++H N+V++ G C R L ++ E++ GS+ DYL K K + LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ KGM YL IHRDL N+L+
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG---------AFFSQDVAIKVLTNEHLNENIRREFA 290
+I L F + G++ ++KG +V +KVL H N F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFF 60
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
+ +M K+ H ++V G C +V EF+ GS+ YL K K + + L VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
++ M++L N +IH ++ A N+L+ R +
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKT 154
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF------SQDVAIKVLTNEHLNENIRREFAQ 291
D + LK+ ++ G++ + + VA+K L + ++ +R+F +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQR 73
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPR--LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
E+ I++ + +V++ G P R L +V E++ G + D+L + + L LL +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ KGM YL +HRDL A N+L+
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAH 165
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 7/149 (4%)
Query: 238 DVWEIDASLLKF-EHKIVSGSYCDLYKGAFFSQ----DVAIKVLTNEHLNENIRREFAQE 292
+ L + ++ G++ + +G + + DVAIKVL + E +E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMRE 60
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM ++ + +V+ IG C L +V E GG ++ +L ++ + + + + V
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
S GM YL N +HRDL A N+L+
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHY 148
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 18/181 (9%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF-- 266
+HHH G V G D LK + G + + +
Sbjct: 2 AHHHHH------HHHHHGALEVLFQGPG-DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDP 54
Query: 267 ----FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--LFIV 320
+ VA+K L R + QE+ I+R + H +++++ G C L +V
Sbjct: 55 TNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E++ GS+ DYL + + L LL A + +GM YLH + IHRDL A N+L++ +
Sbjct: 114 MEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR 171
Query: 381 V 381
+
Sbjct: 172 L 172
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 46/175 (26%), Positives = 92/175 (52%), Gaps = 9/175 (5%)
Query: 212 HHHVVYPVGEQEQSGINHVNIPAEGI---DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS 268
H+ G ++ + ++ + D WEI LK E K+ +G + +++ +
Sbjct: 152 DHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK 211
Query: 269 Q-DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
VA+K + ++ F E ++M+ ++H +V+ T+ P ++I+TEFM+ G
Sbjct: 212 HTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKG 267
Query: 328 SIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
S+ D+L + LP L+ + +++GM ++ + N IHRDL+AAN+L++ + V
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 322
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 12/158 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
D WEI L+ E K+ G + +++ G + + VAIK L ++ F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVM 316
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
+K+RH +VQ + P ++IVTE+MS GS+ D+L + L+LP L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
M Y+ R N +HRDL+AAN+L+ EN V C +++F
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLV------CKVADF 407
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 57/158 (36%), Positives = 90/158 (56%), Gaps = 12/158 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQ-DVAIKVLTNEHLNENIRREFAQEVHIM 296
D WEI L+ E K+ G + +++ G + VAIK L ++ F QE +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVM 233
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
+K+RH +VQ + P ++IVTE+MS GS+ D+L + L+LP L+ +A ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
M Y+ R N +HRDL+AAN+L+ EN V C +++F
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLV------CKVADF 324
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQE 292
+EI ++ I G + D+++G + S + VAIK ++++R +F QE
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQE 441
Query: 293 VHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
MR+ H ++V+ IG T P ++I+ E + G + +L +K L L L+ A +
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
S + YL +HRD+ A N+L++ N
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDC 529
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-37
Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 19/186 (10%)
Query: 211 NHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD 270
+HHH + G + ++ ID +LL + G + + +G +D
Sbjct: 4 SHHHHHHSSGLVPR----GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQED 59
Query: 271 -----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-----PPRLFIV 320
VA+K + ++ ++ EF E M+ H NV++ +G C P+ ++
Sbjct: 60 GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 321 TEFMSGGSIYDYL-----HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
FM G ++ YL + L LL+ +D++ GM YL N +HRDL A N +
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 376 MNENGV 381
+ ++
Sbjct: 180 LRDDMT 185
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHI 295
+ + K + SG++ +YKG + + VAIK L E + +E E ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYV 70
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M V + +V + +G C + ++T+ M G + DY+ + K + LL + ++KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
MNYL ++HRDL A N+L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQH 155
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 9/155 (5%)
Query: 235 EGIDVWEI--DASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRR 287
+ I + + + I G + +Y G + Q AIK L +
Sbjct: 9 AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVE 67
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLL 346
F +E +MR + H NV+ IG P ++ +M G + ++ + + L+
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ V++GM YL +HRDL A N +++E+
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 211 NHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--- 267
+HHH P +G D+ E+ + + G++ ++Y+G
Sbjct: 3 HHHHHHNP--NYCFAGKTS-----SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP 55
Query: 268 ----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VA+K L E +E +F E I+ K H N+V+ IG + FI+ E
Sbjct: 56 NDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114
Query: 324 MSGGSIYDYL------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
M+GG + +L Q L + LL VA D++ G YL N+ IHRD+ A N L+
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174
Query: 378 ENG 380
G
Sbjct: 175 CPG 177
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 16/165 (9%)
Query: 233 PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRR 287
E ++ I + G + + + +D VA+K+L + + +
Sbjct: 11 LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 288 EFAQEVHIMRKVRHMNVVQFIGACTR------PPRLFIVTEFMSGGSIYDYL-----HKQ 336
EF +E M++ H +V + +G R P ++ FM G ++ +L +
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 337 KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L L+R +D++ GM YL N IHRDL A N ++ E+
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQ 291
+ EI S ++F ++ + +YKG F +Q VAIK L + +R EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRH 61
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------HKQ 336
E + +++H NVV +G T+ L ++ + S G ++++L
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 337 KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
K L+ P + + ++ GM YL ++++H+DL N+L+ +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 166
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 7/149 (4%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEV 293
V + ++ F I G + +Y G D A+K L N + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 77
Query: 294 HIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM+ H NV+ +G C R +V +M G + +++ + + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+KGM YL +HRDL A N +++E
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFT 166
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 42/207 (20%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAF-- 266
++ HHH +H + +D + +KF+ I G++ + K
Sbjct: 1 MKKHHHH------------HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKK 48
Query: 267 --FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEF 323
D AIK + E+ +++ R+FA E+ ++ K+ H N++ +GAC L++ E+
Sbjct: 49 DGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107
Query: 324 MSGGSIYDYLHKQKCG---------------LKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G++ D+L K + L LL A DV++GM+YL + IHRD
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167
Query: 369 LKAANLLMNENGV---------RDSDI 386
L A N+L+ EN V R ++
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQEV 194
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 7/149 (4%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEV 293
V + ++ F I G + +Y G D A+K L N + +F E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 141
Query: 294 HIMRKVRHMNVVQFIGACTRP-PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM+ H NV+ +G C R +V +M G + +++ + + L+ + V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+KGM +L +HRDL A N +++E
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFT 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 24/168 (14%)
Query: 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRRE 288
GI V I + + ++ G++ ++ + VA+K L + L R++
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKD 63
Query: 289 FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL--------------- 333
F +E ++ ++H ++V+F G C L +V E+M G + +L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ K L L +L +A ++ GM YL + +HRDL N L+ N +
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 171
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
D+ E+ + + G++ ++Y+G VA+K L E +E +F
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL 122
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHK------QKCGLKLPL 344
E I+ K H N+V+ IG + FI+ E M+GG + +L + Q L +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
LL VA D++ G YL N+ IHRD+ A N L+ G
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFA 290
D WE+ + ++ GS+ +Y+G VAIK + NE + R EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 76
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------HKQKCGLK 341
E +M++ +VV+ +G ++ ++ E M+ G + YL +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L ++++A +++ GM YL+ N +HRDL A N ++ E+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 44/199 (22%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 204 KEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYK 263
K+ PK + ++ + I+ +P + WE + L+F + +G++ + +
Sbjct: 7 KQKPKYQVRWKIIESYEGNSYTFIDPTQLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 264 GAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315
F VA+K+L + + + E+ IM + +H N+V +GACT
Sbjct: 65 ATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123
Query: 316 RLFIVTEFMSGGSIYDYL-------------HKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
+ ++TE+ G + ++L LL + V++GM +L
Sbjct: 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK 183
Query: 363 NIIHRDLKAANLLMNENGV 381
N IHRD+ A N+L+ V
Sbjct: 184 NCIHRDVAARNVLLTNGHV 202
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 45/197 (22%), Positives = 83/197 (42%), Gaps = 8/197 (4%)
Query: 191 PLQETEQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDV-WEID-ASLLK 248
P + + L + P P+ + + P E D + +LL
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339
Query: 249 FEHKIVSGSYCDLYKGAFFSQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
+ ++ G++ + +G + + DVAIKVL + E +E IM ++ + +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYI 398
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V+ IG C L +V E GG ++ +L ++ + + + + VS GM YL N
Sbjct: 399 VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 365 IHRDLKAANLLMNENGV 381
+HR+L A N+L+
Sbjct: 458 VHRNLAARNVLLVNRHY 474
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 23/165 (13%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFA 290
V I + + ++ G++ ++ + VA+K L E +E+ R++F
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEA-SESARQDFQ 91
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL--------------HKQ 336
+E ++ ++H ++V+F G CT L +V E+M G + +L
Sbjct: 92 REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 337 KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L LL VA V+ GM YL + +HRDL N L+ + V
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 44/196 (22%), Positives = 85/196 (43%), Gaps = 30/196 (15%)
Query: 211 NHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--- 267
+HHH + + +G++ +P + WE L + G++ +
Sbjct: 5 HHHH--HHSQDPMLAGVSEYELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID 60
Query: 268 ------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
+ VA+K+L + E + E+ +M+ + +H N++ +GACT+ L+++
Sbjct: 61 KDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119
Query: 321 TEFMSGGSIYDYL---------------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
E+ S G++ +YL + + L+ +++GM YL I
Sbjct: 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179
Query: 366 HRDLKAANLLMNENGV 381
HRDL A N+L+ EN V
Sbjct: 180 HRDLAARNVLVTENNV 195
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-32
Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 26/169 (15%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE + L F + +G++ + + + + VA+K+L + R
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM 74
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------- 333
E+ ++ + HMN+V +GACT ++TE+ G + ++L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 334 -HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L L LL + V+KGM +L N IHRDL A N+L+ +
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-32
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 31/174 (17%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE L + G + + K F VA+K+L E+ + + R+
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLL 74
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL----------------- 333
E +++++V H +V++ GAC++ L ++ E+ GS+ +L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 334 ------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
H + L + L+ A +S+GM YL ++HRDL A N+L+ E
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE LK + G++ + + F + VA+K+L E + R
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM 78
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPR-LFIVTEFMSGGSIYDYL--------------- 333
E+ I+ + H+NVV +GACT+P L ++ EF G++ YL
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 334 HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
K L L L+ + V+KGM +L IHRDL A N+L++E V
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 43/216 (19%), Positives = 86/216 (39%), Gaps = 28/216 (12%)
Query: 191 PLQETEQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFE 250
+ + + + + P V + +G++ +P + WE L
Sbjct: 29 QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPED--PKWEFPRDKLTLG 86
Query: 251 HKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-R 300
+ G + + + VA+K+L + E + E+ +M+ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGK 145
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------HKQKCGLKLPLL 345
H N++ +GACT+ L+++ E+ S G++ +YL + + L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ +++GM YL IHRDL A N+L+ EN V
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 36/174 (20%), Positives = 71/174 (40%), Gaps = 31/174 (17%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
E + +++ I G++ +++ VA+K+L E + +++ +F
Sbjct: 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ 98
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL----------------- 333
+E +M + + N+V+ +G C + ++ E+M+ G + ++L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 334 ------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L +A V+ GM YL +HRDL N L+ EN V
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 212
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 31/174 (17%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFA 290
WE L+F + SG++ + + S VA+K+L E + + R
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALM 96
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL---------------- 333
E+ +M ++ H N+V +GACT ++++ E+ G + +YL
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 334 ------HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ L LL A V+KGM +L + +HRDL A N+L+ V
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 26/169 (15%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRRE 288
WE+ L + G++ + VA+K+L E +
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSD 120
Query: 289 FAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-------------- 333
E+ +M+ + +H N++ +GACT+ L+++ E+ S G++ +YL
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 334 -HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
H + L L+ A V++GM YL IHRDL A N+L+ E+ V
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
W I+ + + I SG+ + + VAIK + E ++ E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMS 68
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD-YLHKQKCGLKLPLLLR---VAI--- 350
+ H N+V + + L++V + +SGGS+ D H G +L +A
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+V +G+ YLH+N IHRD+KA N+L+ E+G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDG 158
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 247 LKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV 304
LKF+ +I GS+ +YKG + +VA L + L ++ R+ F +E +++ ++H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 305 VQFIGA----CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V+F + + +VTE M+ G++ YL + K +K+ +L + KG+ +LH
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 146
Query: 361 RNN--IIHRDLKAANLLMN-ENGV 381
IIHRDLK N+ + G
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGS 170
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 228 NHVNIPAEGIDVWEID-ASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNEN 284
+ V G+ + D L KI GS+ +++KG + VAIK++ E +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
I + QE+ ++ + V ++ G+ + +L+I+ E++ GGS D L L
Sbjct: 64 IE-DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQ 120
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ + ++ KG++YLH IHRD+KAAN+L++E+G
Sbjct: 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 156
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 221 EQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTN 278
++ HV + +VWEI ++ G++ +YK A KV+
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIET 54
Query: 279 EHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC 338
+ E ++ E+ I+ H +V+ +GA +L+I+ EF GG++ + +
Sbjct: 55 KSEEE--LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR 112
Query: 339 GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
GL P + V + + +N+LH IIHRDLKA N+LM G
Sbjct: 113 GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG 154
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 6/137 (4%)
Query: 246 LLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
+ K+ GSY +YK Q VAIK + E + I +E+ IM++ +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII----KEISIMQQCDSPH 85
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
VV++ G+ + L+IV E+ GS+ D + + L + + KG+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 364 IIHRDLKAANLLMNENG 380
IHRD+KA N+L+N G
Sbjct: 146 KIHRDIKAGNILLNTEG 162
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 33/170 (19%), Positives = 70/170 (41%), Gaps = 11/170 (6%)
Query: 229 HVNIPAEGIDVWEIDASLLKFEHKIVSG--SYCDLYKGAF--FSQDVAIKVLTNEHLNEN 284
N+ +G+ + + + I G + + + V ++ + E +
Sbjct: 9 MENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE 68
Query: 285 IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYL-HKQKCGLKLP 343
+ E+H+ + H N+V + L++VT FM+ GS D + G+
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128
Query: 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+ + V K ++Y+H +HR +KA+++L++ +G YLS
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG------KVYLSGL 172
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 11/183 (6%)
Query: 202 LAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDL 261
LAK + P E + + + + E + + + ++ GS+ ++
Sbjct: 16 LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSFGEV 74
Query: 262 YKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
++ A+K + E +E+ + +V GA P + I
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNI 127
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
E + GGS+ + + C L L +G+ YLH I+H D+KA N+L++ +
Sbjct: 128 FMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD 186
Query: 380 GVR 382
G R
Sbjct: 187 GSR 189
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 8/156 (5%)
Query: 252 KIVSGSYCDLYKGAFFSQD---VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307
KI SG + ++K D AIK + +EV+ + +H +VV++
Sbjct: 18 KIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL---PLLLRVAIDVSKGMNYLHRNNI 364
A + I E+ +GGS+ D + + + L + + V +G+ Y+H ++
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 365 IHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400
+H D+K +N+ ++ + ++ + + + V+
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 5/122 (4%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA--CTRPPRLFIVTEFMSG 326
AIKV N + + +E +++K+ H N+V+ T ++ EF
Sbjct: 35 DLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 327 GSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
GS+Y L + LP L V DV GMN+L N I+HR++K N++ S
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153
Query: 385 DI 386
Sbjct: 154 VY 155
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 32/138 (23%), Positives = 70/138 (50%), Gaps = 6/138 (4%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM 302
KI G+ +Y + Q+VAI+ + + + + E+ +MR+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNP 77
Query: 303 NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
N+V ++ + L++V E+++GGS+ D + + + + V + + + +LH N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 363 NIIHRDLKAANLLMNENG 380
+IHRD+K+ N+L+ +G
Sbjct: 136 QVIHRDIKSDNILLGMDG 153
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 36/131 (27%), Positives = 64/131 (48%), Gaps = 6/131 (4%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI GS + + VA+K++ + R EV IMR +H NVV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ L+++ EF+ GG++ D + + + L + V V + + YLH +IHRD+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 370 KAANLLMNENG 380
K+ ++L+ +G
Sbjct: 168 KSDSILLTLDG 178
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 5/122 (4%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA--CTRPPRLFIVTEFMSG 326
AIKV N + + +E +++K+ H N+V+ T ++ EF
Sbjct: 35 DLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 327 GSIYDYL--HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
GS+Y L GL L V DV GMN+L N I+HR++K N++ S
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153
Query: 385 DI 386
Sbjct: 154 VY 155
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 35/177 (19%), Positives = 77/177 (43%), Gaps = 18/177 (10%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKG--AF 266
+ +HHH + N+ + ++ + KI GS+
Sbjct: 1 MHHHHHH------SSGVDLGTENLYFQSMEKYVR-------LQKIGEGSFGKAILVKSTE 47
Query: 267 FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326
+ IK + ++ R E +EV ++ ++H N+VQ+ + L+IV ++ G
Sbjct: 48 DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 327 GSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
G ++ ++ QK G+ +L + + + ++H I+HRD+K+ N+ + ++G
Sbjct: 108 GDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 163
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIM 296
V E+ + ++ +G+ ++K + +A K++ E IR + +E+ ++
Sbjct: 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVL 85
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+ +V F GA + I E M GGS+ L K + +L +V+I V KG+
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGL 144
Query: 357 NYLHRN-NIIHRDLKAANLLMNENG 380
YL I+HRD+K +N+L+N G
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRG 169
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 39/122 (31%), Positives = 66/122 (54%), Gaps = 4/122 (3%)
Query: 262 YKGAFFSQDVAIKVLTNEHLNENI--RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319
YKG + VA+K L +++F QE+ +M K +H N+V+ +G + L +
Sbjct: 48 YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 107
Query: 320 VTEFMSGGSIYDYLHKQKCGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
V +M GS+ D L L + ++A + G+N+LH N+ IHRD+K+AN+L++
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167
Query: 378 EN 379
E
Sbjct: 168 EA 169
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 44/134 (32%), Positives = 71/134 (52%), Gaps = 6/134 (4%)
Query: 251 HKIVSGSYCDLYKG--AFFSQDVAIKV--LTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+I GS+ +Y S+ VAIK + + NE + + +EV ++K+RH N +Q
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTIQ 118
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ G R ++V E+ GS D L K L+ + V +G+ YLH +N+IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 367 RDLKAANLLMNENG 380
RD+KA N+L++E G
Sbjct: 178 RDVKAGNILLSEPG 191
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 40/140 (28%), Positives = 73/140 (52%), Gaps = 13/140 (9%)
Query: 251 HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307
+ +G+Y +YKG Q AIKV+ + + E QE+++++K H N+ +
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 308 IGA------CTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMNYLH 360
GA +L++V EF GS+ D + K LK + + ++ +G+++LH
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 361 RNNIIHRDLKAANLLMNENG 380
++ +IHRD+K N+L+ EN
Sbjct: 147 QHKVIHRDIKGQNVLLTENA 166
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 6/134 (4%)
Query: 252 KIVSGSYCDLYKGAFFSQD---VAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307
++ GSY +++K +D A+K + R EV KV +H V+
Sbjct: 64 RLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367
A L++ TE G S+ + L + D + +LH ++H
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 368 DLKAANLLMNENGV 381
D+K AN+ + G
Sbjct: 182 DVKPANIFLGPRGR 195
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
W+ A LK +I G+Y + K Q +A+K + + ++E +++ ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDV 73
Query: 296 -MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS--IYDYLHKQKCG-LKLPLLLRVAID 351
MR +VQF GA R +I E MS Y Y++ + +L ++ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 352 VSKGMNYLHRN-NIIHRDLKAANLLMNENG 380
K +N+L N IIHRD+K +N+L++ +G
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSG 163
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 32/154 (20%), Positives = 64/154 (41%), Gaps = 15/154 (9%)
Query: 239 VWEIDASLLKFEHKIVSGSY--CDLYKGAFFSQDVAIKVL--TNEHLNENIRREFAQEVH 294
+ ID F K+ G + DL +G A+K + + E +RE
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE----AD 78
Query: 295 IMRKVRHMNVVQFIGACTRPP----RLFIVTEFMSGGSIYDYL---HKQKCGLKLPLLLR 347
+ R H N+++ + C R +++ F G++++ + + L +L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 348 VAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ + + +G+ +H HRDLK N+L+ + G
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ 172
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 29/173 (16%), Positives = 68/173 (39%), Gaps = 12/173 (6%)
Query: 212 HHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QD 270
HHH + G + + + ++ I +I SG +++ Q
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSI-------LKQIGSGGSSKVFQVLNEKKQI 54
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGGS 328
AIK + E + + E+ + K++ +++ +++V E
Sbjct: 55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID 113
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ +L K+K + ++ + ++ +H++ I+H DLK AN L+ + +
Sbjct: 114 LNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML 165
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 8/135 (5%)
Query: 250 EHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
+ I G + +YKG VA+K T E EF E+ + RH ++V I
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--EEFETEIETLSFCRHPHLVSLI 101
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLL----LRVAIDVSKGMNYLHRNNI 364
G C + ++ ++M G++ +L+ + + L + I ++G++YLH I
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 365 IHRDLKAANLLMNEN 379
IHRD+K+ N+L++EN
Sbjct: 161 IHRDVKSINILLDEN 175
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 32/145 (22%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 245 SLLKFE--HKIVSGSYCDLYKGAFFS--QDVAIK-VLTNEHLNENIRREFAQEVHIMRKV 299
+L F KI G + ++Y+ A VA+K V + ++ R + +E+ +++++
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 300 RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLP--LLLRVAIDVSKGM 356
H NV+++ + L IV E G + + K +P + + + + +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 357 NYLHRNNIIHRDLKAANLLMNENGV 381
++H ++HRD+K AN+ + GV
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGV 174
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 37/146 (25%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHI-MR 297
E+ A L+ ++ G+Y + K Q +A+K + +N ++ ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGG--SIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
V V F GA R ++I E M Y + + + +L ++A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 356 MNYLHRN-NIIHRDLKAANLLMNENG 380
+ +LH ++IHRD+K +N+L+N G
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALG 147
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 30/125 (24%), Positives = 54/125 (43%), Gaps = 16/125 (12%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA-------------CTRPP 315
+ AIK + E EV ++ + H VV++ A +
Sbjct: 32 RYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
LFI E+ G++YD +H + + R+ + + ++Y+H IIHRDLK N+
Sbjct: 89 TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF 148
Query: 376 MNENG 380
++E+
Sbjct: 149 IDESR 153
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 27/117 (23%), Positives = 51/117 (43%), Gaps = 9/117 (7%)
Query: 269 QDVAIKV-----LTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
+VAIK+ + + + ++ E V I +++H ++++ +++V E
Sbjct: 37 LEVAIKMIDKKAMYKAGMVQRVQNE----VKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
G + YL + + GM YLH + I+HRDL +NLL+ N
Sbjct: 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM 149
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 23/130 (17%), Positives = 55/130 (42%), Gaps = 5/130 (3%)
Query: 255 SGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGAC 311
SG +++ Q AIK + E + + E+ + K++ +++
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371
+++V E + +L K+K + ++ + ++ +H++ I+H DLK
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136
Query: 372 ANLLMNENGV 381
AN L+ + +
Sbjct: 137 ANFLIVDGML 146
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 2/113 (1%)
Query: 269 QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ A K++ L + R + + E+ I R + H +VV F G +F+V E
Sbjct: 41 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
S+ + ++K L P + G YLHRN +IHRDLK NL +NE+
Sbjct: 101 SLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 152
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 2/113 (1%)
Query: 269 QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ A K++ L + R + + E+ I R + H +VV F G +F+V E
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
S+ + ++K L P + G YLHRN +IHRDLK NL +NE+
Sbjct: 127 SLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 31/150 (20%), Positives = 66/150 (44%), Gaps = 8/150 (5%)
Query: 237 IDVWEIDASLLKFEH--KIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQE 292
I A + E+ ++ SG+ ++K F +A+K + N+ + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMD 73
Query: 293 VHI-MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAID 351
+ + ++ +VQ G +FI E M + Q + +L ++ +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVA 132
Query: 352 VSKGMNYLH-RNNIIHRDLKAANLLMNENG 380
+ K + YL ++ +IHRD+K +N+L++E G
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERG 162
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 23/130 (17%), Positives = 55/130 (42%), Gaps = 5/130 (3%)
Query: 255 SGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGAC 311
SG +++ Q AIK + E + + E+ + K++ +++
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371
+++V E + +L K+K + ++ + ++ +H++ I+H DLK
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 372 ANLLMNENGV 381
AN L+ + +
Sbjct: 184 ANFLIVDGML 193
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 35/134 (26%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 255 SGSYCDLYKGAFFSQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
G+Y +Y G +AIK + + + +E+ + + ++H N+VQ++G+
Sbjct: 32 KGTYGIVYAG--RDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKL--PLLLRVAIDVSKGMNYLHRNNIIHRD 368
+ + I E + GGS+ L + LK + + +G+ YLH N I+HRD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 369 LKAAN-LLMNENGV 381
+K N L+ +GV
Sbjct: 148 IKGDNVLINTYSGV 161
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 8e-22
Identities = 38/120 (31%), Positives = 55/120 (45%), Gaps = 9/120 (7%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI------GACTRPPRLFIVTE 322
+ VAIK E +N R + E+ IM+K+ H NVV + E
Sbjct: 40 EQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 323 FMSGGSIYDYL--HKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ GG + YL + CGLK + + D+S + YLH N IIHRDLK N+++
Sbjct: 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP 158
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 25/131 (19%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA----------------CT 312
+ IK + NE RE V + K+ H+N+V + G +
Sbjct: 37 KTYVIKRVKYN--NEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLK 370
+ LFI EF G++ ++ K++ G KL L L + ++KG++Y+H +I+RDLK
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKKLINRDLK 149
Query: 371 AANLLMNENGV 381
+N+ + +
Sbjct: 150 PSNIFLVDTKQ 160
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 26/139 (18%), Positives = 56/139 (40%), Gaps = 31/139 (22%)
Query: 269 QDVAIKVL-------------------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
+ A+K + + ++ + E + I+ +++ + G
Sbjct: 55 KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE----LQIITDIKNEYCLTCEG 110
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHK-------QKCGLKLPLLLRVAIDVSKGMNYLH-R 361
T ++I+ E+M SI + C + + ++ + V +Y+H
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 362 NNIIHRDLKAANLLMNENG 380
NI HRD+K +N+LM++NG
Sbjct: 171 KNICHRDVKPSNILMDKNG 189
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 36/218 (16%), Positives = 78/218 (35%), Gaps = 27/218 (12%)
Query: 196 EQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVS 255
++L L + K + YP + Q + + E +++ + L+ H +
Sbjct: 24 DKLIFKLLSGLSKPVSS----YPNTFEWQCKLPAIKPKTE----FQLGSKLVYVHHLLGE 75
Query: 256 GSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI 308
G++ +Y+ Q +KV + E Q + ++ ++F
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT--QLMERLKPSMQHMFMKFY 133
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKC----GLKLPLLLRVAIDVSKGMNYLHRNNI 364
A +V E S G++ + ++ K + L++ A+ + + +H I
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193
Query: 365 IHRDLKAANLLMNENGVR-----DSDIHCYLSNF-LSI 396
IH D+K N ++ + D L + SI
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-20
Identities = 31/115 (26%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 271 VAIKVLTNEHLN-----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+A+KVL L +RRE + I +RH N+++ R++++ EF
Sbjct: 42 MALKVLFKSQLEKEGVEHQLRRE----IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
G +Y L K +++ ++Y H +IHRD+K NLLM G
Sbjct: 98 RGELYKELQKHGR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG 151
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 34/112 (30%), Positives = 59/112 (52%), Gaps = 1/112 (0%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
++VAIK++ LN ++ +EV IM+ + H N+V+ L+++ E+ SGG
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
++DYL +K + + Y H+ I+HRDLKA NLL++ +
Sbjct: 101 VFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM 151
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 10/117 (8%)
Query: 269 QDVAIKVLTNEHLN-----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
+A+KVL L +RRE V I +RH N+++ G R++++ E+
Sbjct: 35 FILALKVLFKAQLEKAGVEHQLRRE----VEIQSHLRHPNILRLYGYFHDATRVYLILEY 90
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
G++Y L K +++ ++Y H +IHRD+K NLL+ G
Sbjct: 91 APLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 146
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 28/152 (18%), Positives = 62/152 (40%), Gaps = 19/152 (12%)
Query: 248 KFE--HKIVSGSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN 303
FE + G + K + AIK + E R + +EV + K+ H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPG 64
Query: 304 VVQFIGAC------------TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVA 349
+V++ A + L+I + ++ D+++ + + + L +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ +++ + +LH ++HRDLK +N+ + V
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 156
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 40/125 (32%), Positives = 63/125 (50%), Gaps = 8/125 (6%)
Query: 262 YKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320
YKG VA+K L E + +F EV ++ H N+++ G C P +V
Sbjct: 47 YKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105
Query: 321 TEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLH---RNNIIHRDLKAANL 374
+M+ GS+ L + + L P R+A+ ++G+ YLH IIHRD+KAAN+
Sbjct: 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165
Query: 375 LMNEN 379
L++E
Sbjct: 166 LLDEE 170
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 269 QDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+ VA+K++ + ENI++E + I + + H NVV+F G ++ E+ S
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMN 377
GG ++D + + ++ G+ YLH I HRD+K NLL++
Sbjct: 89 GGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 378 ENG 380
E
Sbjct: 140 ERD 142
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 269 QDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
+ VA+K++ + ENI++E + I + + H NVV+F G ++ E+ S
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMN 377
GG ++D + + ++ G+ YLH I HRD+K NLL++
Sbjct: 89 GGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139
Query: 378 ENG 380
E
Sbjct: 140 ERD 142
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 33/133 (24%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 262 YKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
Y+G F ++DVA+K + E RE V ++R+ H NV+++ +I
Sbjct: 42 YRGMFDNRDVAVKRILPECF-SFADRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIA 96
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E ++ +Y+ ++ + + + G+ +LH NI+HRDLK N+L++
Sbjct: 97 IELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 381 VRDSDIHCYLSNF 393
I +S+F
Sbjct: 156 -AHGKIKAMISDF 167
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 31/125 (24%), Positives = 61/125 (48%), Gaps = 26/125 (20%)
Query: 269 QDVAIKVL-----TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VA+K+L + + I+RE + ++ RH ++++ + P F+V E+
Sbjct: 37 HKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLL 375
+SGG ++DY+ K RV ++ ++Y HR+ ++HRDLK N+L
Sbjct: 93 VSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143
Query: 376 MNENG 380
++ +
Sbjct: 144 LDAHM 148
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 22/121 (18%)
Query: 269 QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ VA+K + EN++RE + R +RH N+V+F P L I+ E+ SGG
Sbjct: 46 ELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
+Y+ + R + D ++ G++Y H I HRDLK N L++ +
Sbjct: 102 ELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152
Query: 380 G 380
Sbjct: 153 P 153
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 34/142 (23%), Positives = 64/142 (45%), Gaps = 12/142 (8%)
Query: 252 KIVSGSY--CDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
I +GSY C + + + K L + E ++ EV+++R+++H N+V++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 310 A--CTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLP--LLLRVAIDVSKGMNYLHR--- 361
L+IV E+ GG + + K L +LRV ++ + HR
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 362 --NNIIHRDLKAANLLMNENGV 381
+ ++HRDLK AN+ ++
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQN 154
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 31/133 (23%), Positives = 58/133 (43%), Gaps = 10/133 (7%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQF---I 308
K++ + ++ + E + +E + I++K+ H NVV+ +
Sbjct: 50 KLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE----IAILKKLDHPNVVKLVEVL 105
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
L++V E ++ G + + + L D+ KG+ YLH IIHRD
Sbjct: 106 DDPNED-HLYMVFELVNQGPVMEVPTLKP--LSEDQARFYFQDLIKGIEYLHYQKIIHRD 162
Query: 369 LKAANLLMNENGV 381
+K +NLL+ E+G
Sbjct: 163 IKPSNLLVGEDGH 175
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 26/125 (20%)
Query: 269 QDVAIKVLTNEHLN-----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
VA+K+L + + IRRE + ++ RH ++++ + P +F+V E+
Sbjct: 42 HKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLL 375
+SGG ++DY+ K R+ S+ G++Y HR+ ++HRDLK N+L
Sbjct: 98 VSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148
Query: 376 MNENG 380
++ +
Sbjct: 149 LDAHM 153
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 32/111 (28%), Positives = 64/111 (57%), Gaps = 1/111 (0%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
VAIK ++ +++ +E+ +++++RH N+V + C + R ++V EF+ +I
Sbjct: 53 VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TIL 111
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
D L GL ++ + + G+ + H +NIIHRD+K N+L++++GV
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV 162
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 34/136 (25%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 252 KIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
KI GSY ++K ++ VAIK + I++ +E+ ++++++H N+V
Sbjct: 10 KIGEGSYGVVFKC----RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ R RL +V E+ ++ L + + G+ L+ + + +N+ H++N I
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 366 HRDLKAANLLMNENGV 381
HRD+K N+L+ ++ V
Sbjct: 125 HRDVKPENILITKHSV 140
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 28/123 (22%), Positives = 58/123 (47%), Gaps = 18/123 (14%)
Query: 269 QDVAIKVLTNEHLN------ENIRREFAQEVHIMRKVRHMNVVQF---IGACTRPPRLFI 319
A+K+L + L N+++E + ++R++RH NV+Q + ++++
Sbjct: 31 CRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLRHKNVIQLVDVLYNEE-KQKMYM 85
Query: 320 VTEFMSGGS--IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
V E+ G + D + +++ + + G+ YLH I+H+D+K NLL+
Sbjct: 86 VMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143
Query: 378 ENG 380
G
Sbjct: 144 TGG 146
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 22/152 (14%)
Query: 247 LKFEHKIVSGSY--CDLYKGAFFSQDVAIKVL--TNEHLNENIRREFAQEVHIMRKVR-H 301
L+ + G + + ++ A+K L E N I +E V M+K+ H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE----VCFMKKLSGH 85
Query: 302 MNVVQFIGACTRPPR--------LFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAID 351
N+VQF A + ++TE G + ++L K + L +L++
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 352 VSKGMNYLHRNN--IIHRDLKAANLLMNENGV 381
+ + ++HR IIHRDLK NLL++ G
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 27/119 (22%), Positives = 55/119 (46%), Gaps = 8/119 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFA------QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
++V +K + E + E+ E E+ I+ +V H N+++ + +V E
Sbjct: 50 KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109
Query: 323 F-MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
SG ++ ++ + L PL + + + YL +IIHRD+K N+++ E+
Sbjct: 110 KHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 33/125 (26%), Positives = 62/125 (49%), Gaps = 27/125 (21%)
Query: 269 QDVAIKV-----LTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323
Q VA+K L ++ + RE + ++ +RH ++++ T P + +V E+
Sbjct: 35 QKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLL 375
+GG ++DY+ ++K R+ D + + Y HR+ I+HRDLK NLL
Sbjct: 91 -AGGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140
Query: 376 MNENG 380
+++N
Sbjct: 141 LDDNL 145
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 24/118 (20%), Positives = 53/118 (44%), Gaps = 8/118 (6%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHM--NVVQFIGACTRPPRLFIVTE 322
VAIK + + +++ EV +++KV V++ + RP ++ E
Sbjct: 69 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128
Query: 323 FMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
++D++ ++ L+ L V + + + H ++HRD+K N+L++ N
Sbjct: 129 RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 33/123 (26%), Positives = 65/123 (52%), Gaps = 18/123 (14%)
Query: 269 QDVAIKVL------TNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVT 321
+ A+K++ + E +R +E HI+R+V H +++ I + +F+V
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 322 EFMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
+ M G ++DYL ++ L ++R + + +++LH NNI+HRDLK N+L+
Sbjct: 180 DLMRKGELFDYLTEKV---ALSEKETRSIMR---SLLEAVSFLHANNIVHRDLKPENILL 233
Query: 377 NEN 379
++N
Sbjct: 234 DDN 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 26/143 (18%)
Query: 252 KIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRH 301
K+ G+Y +YK +D VA+K + + +E IR E+ +++++ H
Sbjct: 28 KVGEGTYGVVYKA----KDSQGRIVALKRIRLDAEDEGIPSTAIR-----EISLLKELHH 78
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNY 358
N+V I L +V EFM D L + K GL+ + + +G+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
H++ I+HRDLK NLL+N +G
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGA 157
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 23/117 (19%), Positives = 51/117 (43%), Gaps = 9/117 (7%)
Query: 270 DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFI-----GACTRPPRLFIVTEFM 324
V +K L + + + E + +V H ++VQ P +IV E++
Sbjct: 108 PVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
G S+ ++ L + + +++ ++YLH +++ DLK N+++ E +
Sbjct: 167 GGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 27/153 (17%)
Query: 248 KFE--HKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHIMRKV 299
K+E KI G++ +++K + VA+K + E+ E +E+ I++ +
Sbjct: 18 KYEKLAKIGQGTFGEVFKA----RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 300 RHMNVVQFIGACT--------RPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRV 348
+H NVV I C +++V +F +D L L + RV
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRV 129
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ G+ Y+HRN I+HRD+KAAN+L+ +GV
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 162
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 26/143 (18%)
Query: 252 KIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRH 301
KI G+Y +YK Q+ A+K + E +E IR E+ I+++++H
Sbjct: 9 KIGEGTYGVVYKA----QNNYGETFALKKIRLEKEDEGIPSTTIR-----EISILKELKH 59
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNY 358
N+V+ RL +V E + D L + GL+ + + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
H ++HRDLK NLL+N G
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGE 138
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 4e-15
Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 27/144 (18%)
Query: 252 KIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVR 300
KI G+Y ++K ++ VA+K + + +E +R E+ ++++++
Sbjct: 9 KIGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALR-----EICLLKELK 59
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMN 357
H N+V+ +L +V EF D Y L ++ + KG+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
+ H N++HRDLK NLL+N NG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGE 139
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 34/129 (26%)
Query: 271 VAIKVLTNEHLNEN--------IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
VAIK + H +E +R E+ +++++ H N++ + A + +V +
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-----EIKLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 323 FMSGGSIYD---YLHKQKCGLKLPL-------LLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
FM D + L L+ G+ YLH++ I+HRDLK
Sbjct: 93 FME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQ-------GLEYLHQHWILHRDLKPN 141
Query: 373 NLLMNENGV 381
NLL++ENGV
Sbjct: 142 NLLLDENGV 150
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 5e-15
Identities = 25/112 (22%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A K++ + L+ ++ +E I RK++H N+V+ + ++V + ++GG
Sbjct: 32 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM 376
+++ + ++ A + + Y H N I+HR+LK NLL+
Sbjct: 92 LFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL 138
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 29/123 (23%), Positives = 53/123 (43%), Gaps = 9/123 (7%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM-NVVQFIGACTRPPRLFIVTEFMSGG 327
Q+ A K L ++ R E E+ ++ + V+ + ++ E+ +GG
Sbjct: 55 QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENGVRD 383
I+ + + + I + K G+ YLH+NNI+H DLK N+L+ +
Sbjct: 115 EIFSLCLPELAEM---VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL-SSIYPL 170
Query: 384 SDI 386
DI
Sbjct: 171 GDI 173
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 32/124 (25%), Positives = 61/124 (49%), Gaps = 19/124 (15%)
Query: 269 QDVAIKV-------LTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
++ A+K+ + + +R +EV I+RKV H N++Q F+V
Sbjct: 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 321 TEFMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+ M G ++DYL ++ L ++R + + + LH+ NI+HRDLK N+L
Sbjct: 103 FDLMKKGELFDYLTEKV---TLSEKETRKIMR---ALLEVICALHKLNIVHRDLKPENIL 156
Query: 376 MNEN 379
++++
Sbjct: 157 LDDD 160
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 33/126 (26%), Positives = 62/126 (49%), Gaps = 13/126 (10%)
Query: 269 QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
++ A K + L+ + R E +EV+I+R++RH N++ + ++ E +
Sbjct: 31 KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENG 380
SGG ++D+L +++ L A K G++YLH I H DLK N+++ +
Sbjct: 91 SGGELFDFLAEKES-----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN 145
Query: 381 VRDSDI 386
V + I
Sbjct: 146 VPNPRI 151
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-15
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q+ A+KV+ +EV +++K+ H N+++ +IV E +GG
Sbjct: 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM 376
++D + K+K A + K G+ Y+H++NI+HRDLK N+L+
Sbjct: 108 LFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 29/138 (21%), Positives = 61/138 (44%), Gaps = 13/138 (9%)
Query: 262 YKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320
++G+F + VA+K + + + E + ++ + H NV+++ + T L+I
Sbjct: 33 FQGSFQGRPVAVKRMLIDFC-DIALME----IKLLTESDDHPNVIRYYCSETTDRFLYIA 87
Query: 321 TEFMSGGSIYDYLHKQKCGLKLPLLL------RVAIDVSKGMNYLHRNNIIHRDLKAANL 374
E ++ D + + + L + ++ G+ +LH IIHRDLK N+
Sbjct: 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146
Query: 375 LMNENGVRDSDIHCYLSN 392
L++ + +D N
Sbjct: 147 LVSTSSRFTADQQTGAEN 164
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN------IRREFAQEVHIMRKVRHMN 303
K+ G+Y +YKG VA+K + EH E IR EV +++ ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR-----EVSLLKDLKHAN 61
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
+V L +V E++ D YL + + + + +G+ Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 361 RNNIIHRDLKAANLLMNENGV 381
R ++HRDLK NLL+NE G
Sbjct: 118 RQKVLHRDLKPQNLLINERGE 138
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 25/112 (22%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A K++ + L+ ++ +E I RK++H N+V+ + ++V + ++GG
Sbjct: 55 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM 376
+++ + ++ A + + Y H N I+HR+LK NLL+
Sbjct: 115 LFEDIVAREF-----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL 161
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 34/112 (30%), Positives = 62/112 (55%), Gaps = 12/112 (10%)
Query: 269 QDVAIKVL--TNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMS 325
Q+ A+K++ H+ + RE V ++ + + H NV++ I R ++V E M
Sbjct: 39 QEYAVKIIEKQPGHIRSRVFRE----VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 326 GGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
GGSI ++HK++ L+ ++++ DV+ +++LH I HRDLK N+L
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKGIAHRDLKPENIL 143
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 21/112 (18%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ IK + + + + E+ +++ + H N+++ ++IV E GG
Sbjct: 48 LERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM 376
+ + + + K L ++ K + Y H +++H+DLK N+L
Sbjct: 107 LLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF 157
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 24/120 (20%), Positives = 47/120 (39%), Gaps = 10/120 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVR----HMNVVQFIGACTRPPRLFIV 320
VAIKV+ + + EV ++ KV H V++ + +V
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 321 TEF-MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
E + ++DY+ ++ L V + + H ++HRD+K N+L++
Sbjct: 117 LERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 2/113 (1%)
Query: 270 DVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
VAIK + E + F +EVH ++ H N+V I ++V E++ G +
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ +Y+ L + + + G+ + H I+HRD+K N+L++ N
Sbjct: 98 LSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 37/159 (23%), Positives = 63/159 (39%), Gaps = 15/159 (9%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFA 290
WE LK + G++ + + F D VA+K+L E + R
Sbjct: 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM 73
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPR-LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRV 348
E+ I+ + H+NVV +GACT+P L ++ EF G++ YL ++ +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR--NEFVPYKTK 131
Query: 349 AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387
+G +Y+ I DLK + + S
Sbjct: 132 GARFRQGKDYV---GAIPVDLKRRLDSITSSQSSASSGF 167
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 16/37 (43%), Positives = 23/37 (62%)
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L+ + V+KGM +L IHRDL A N+L++E V
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 231
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 26/107 (24%), Positives = 51/107 (47%), Gaps = 2/107 (1%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A K + H ++ + +E+ M +RH +V A + ++ EFMSGG
Sbjct: 183 NNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+++ + + + + V KG+ ++H NN +H DLK N++
Sbjct: 241 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 20/111 (18%), Positives = 53/111 (47%), Gaps = 9/111 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q+ A ++ + L+ ++ +E I R ++H N+V+ + + +++ + ++GG
Sbjct: 37 QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLL 375
+++ + ++ A + + + H+ ++HR+LK NLL
Sbjct: 97 LFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLL 142
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 23/113 (20%), Positives = 48/113 (42%), Gaps = 15/113 (13%)
Query: 269 QDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326
A K + + + ++E + IM+ + H N+++ +++V E +G
Sbjct: 35 IRRAAKKIPKYFVEDVDRFKQE----IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLL 375
G +++ + ++ A + K + Y H+ N+ HRDLK N L
Sbjct: 91 GELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 29/117 (24%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 269 QDVAIKVL------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
+ VAI+++ + E+ I++K+ H +++ +IV E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLE 219
Query: 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
M GG ++D + LK + + YLH N IIHRDLK N+L++
Sbjct: 220 LMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 9/112 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ AIK++ ++ + + +EV +++ + H N+++ ++V E GG
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLM 376
++D + + A + K G+ YLH++NI+HRDLK NLL+
Sbjct: 123 LFDEIIHRMK-----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL 169
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 17/127 (13%), Positives = 51/127 (40%), Gaps = 2/127 (1%)
Query: 257 SYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316
+ + ++ + + + + + ++ M N V + +
Sbjct: 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVY 135
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLP--LLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374
L+I + ++ D+++++ + L + I +++ + +LH ++HRDLK +N+
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 375 LMNENGV 381
+ V
Sbjct: 196 FFTMDDV 202
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 10/122 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
Q+ A+KV+ +EV +++K+ H N+++ +IV E +GG
Sbjct: 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
++D + K+K A + K G+ Y+H++NI+HRDLK N+L+ +D
Sbjct: 108 LFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDC 161
Query: 385 DI 386
DI
Sbjct: 162 DI 163
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 24/107 (22%), Positives = 53/107 (49%), Gaps = 2/107 (1%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+A K++ + + + E E+ +M ++ H N++Q A + +V E++ GG
Sbjct: 115 LKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
++D + + L + + +G+ ++H+ I+H DLK N+L
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 21/109 (19%), Positives = 50/109 (45%), Gaps = 5/109 (4%)
Query: 269 QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ K + + + +++E + I+ RH N++ + L ++ EF+SG
Sbjct: 31 KTYMAKFVKVKGTDQVLVKKE----ISILNIARHRNILHLHESFESMEELVMIFEFISGL 86
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
I++ ++ L ++ V + + +LH +NI H D++ N++
Sbjct: 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 29/118 (24%), Positives = 54/118 (45%), Gaps = 16/118 (13%)
Query: 269 QDVAIKV------LTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321
Q A+K+ ++ L+ E+++RE I ++H ++V+ + + L++V
Sbjct: 50 QQFAVKIVDVAKFTSSPGLSTEDLKRE----ASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLL 375
EFM G + + ++ VA + + Y H NNIIHRD+K +L
Sbjct: 106 EFMDGADLCFEI-VKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 31/122 (25%), Positives = 52/122 (42%), Gaps = 18/122 (14%)
Query: 269 QDVAIKVL------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322
+ VAIK++ + E+ I++K+ H +++ +IV E
Sbjct: 36 KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLE 94
Query: 323 FMSGGSIYDYLHKQKCGLKLP-----LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN 377
M GG ++D + K +L L + + YLH N IIHRDLK N+L++
Sbjct: 95 LMEGGELFDKVVGNK---RLKEATCKLYFY---QMLLAVQYLHENGIIHRDLKPENVLLS 148
Query: 378 EN 379
Sbjct: 149 SQ 150
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 14/112 (12%), Positives = 41/112 (36%), Gaps = 4/112 (3%)
Query: 270 DVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
VA+ + + L +++ +E + ++ V + + +V E++ GGS
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ + +R ++ + HR + + + ++ +G
Sbjct: 118 LQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG 166
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 7e-14
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 28/145 (19%)
Query: 252 KIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVR 300
KI G+Y +YK ++ VA+K + + E IR E+ +++++
Sbjct: 10 KIGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIR-----EISLLKELN 60
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKC-GLKLPLLLRVAIDVSKGM 356
H N+V+ + +L++V EF+ D ++ G+ LPL+ + +G+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 357 NYLHRNNIIHRDLKAANLLMNENGV 381
+ H + ++HRDLK NLL+N G
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGA 141
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 30/147 (20%), Positives = 65/147 (44%), Gaps = 27/147 (18%)
Query: 252 KIVSGSYCDLYKG----AFFSQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQ 306
K+ G+Y +YK +D A+K + ++ R E+ ++R+++H NV+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-----EIALLRELKHPNVIS 82
Query: 307 FIGACTRP--PRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSK------- 354
+++++ ++ +D + + +++ + K
Sbjct: 83 LQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 355 -GMNYLHRNNIIHRDLKAANLLMNENG 380
G++YLH N ++HRDLK AN+L+ G
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEG 165
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 19/108 (17%), Positives = 50/108 (46%), Gaps = 2/108 (1%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ K + + + + E+ IM ++ H ++ A + ++ EF+SGG
Sbjct: 77 RVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 134
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376
++D + + + ++ +G+ ++H ++I+H D+K N++
Sbjct: 135 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 13/126 (10%)
Query: 269 QDVAIKVLTNEHLNEN----IRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
+ A K + + R E +EV I+R+V H N++ + ++ E +
Sbjct: 38 LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENG 380
SGG ++D+L +++ L A K G+NYLH I H DLK N+++ +
Sbjct: 98 SGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
Query: 381 VRDSDI 386
+ I
Sbjct: 153 IPIPHI 158
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 13/126 (10%)
Query: 269 QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
+ A K + + R E +EV I+R+V H NV+ + ++ E +
Sbjct: 38 LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENG 380
SGG ++D+L +++ L A K G+NYLH I H DLK N+++ +
Sbjct: 98 SGGELFDFLAQKES-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN 152
Query: 381 VRDSDI 386
+ I
Sbjct: 153 IPIPHI 158
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 28/160 (17%), Positives = 48/160 (30%), Gaps = 44/160 (27%)
Query: 269 QDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
AIK++ + N EV +M+K+ H N+ + + +V E
Sbjct: 52 AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCH 111
Query: 326 GGSIYDYLHKQKCGLKLPLLL--------------------------------------- 346
GG + D L+ +
Sbjct: 112 GGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171
Query: 347 RVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDI 386
+ + ++YLH I HRD+K N L + N +I
Sbjct: 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK--SFEI 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 25/110 (22%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q A+K++ ++ + N ++E + ++ H N+V+ F+V E ++GG
Sbjct: 37 QAFAVKII-SKRMEANTQKE----ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91
Query: 328 SIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+++ + K+K + ++R + ++++H ++HRDLK NLL
Sbjct: 92 ELFERIKKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRDLKPENLL 138
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 29/112 (25%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 269 QDVAIKVLTNEHLNENIRRE-FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
Q+ A+KV++ + + +E +EV +++++ H N+++ ++V E +GG
Sbjct: 52 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 111
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLL 375
++D + +K A + + G+ Y+H+N I+HRDLK NLL
Sbjct: 112 ELFDEIISRKR-----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL 158
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 29/126 (23%), Positives = 56/126 (44%), Gaps = 13/126 (10%)
Query: 269 QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFM 324
A K + + R + +EV I+++++H NV+ + ++ E +
Sbjct: 37 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENG 380
+GG ++D+L +++ L A + K G+ YLH I H DLK N+++ +
Sbjct: 97 AGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 151
Query: 381 VRDSDI 386
V I
Sbjct: 152 VPKPRI 157
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 10/119 (8%)
Query: 270 DVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVV------QFIGACTRPPRLFIVTE 322
DVA+KVL + + + F +E + H +V + P +IV E
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP--YIVME 96
Query: 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
++ G ++ D +H + + + V D + +N+ H+N IIHRD+K AN++++
Sbjct: 97 YVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 154
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 43/192 (22%), Positives = 83/192 (43%), Gaps = 35/192 (18%)
Query: 209 VENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFE--HKIVSGSYCDLYKGAF 266
+ +HHH E + G +++ A S+ ++ K+ G+Y ++YK
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSA-----APSATSIDRYRRITKLGEGTYGEVYKA-- 53
Query: 267 FSQD------VAIKVLTNEHLNE-----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315
D VAIK + EH E IR EV ++++++H N+++
Sbjct: 54 --IDTVTNETVAIKRIRLEHEEEGVPGTAIR-----EVSLLKELQHRNIIELKSVIHHNH 106
Query: 316 RLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372
RL ++ E+ D Y+ K + + ++ + G+N+ H +HRDLK
Sbjct: 107 RLHLIFEYAE----NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQ 161
Query: 373 NLLMNENGVRDS 384
NLL++ + ++
Sbjct: 162 NLLLSVSDASET 173
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 29/122 (23%), Positives = 53/122 (43%), Gaps = 12/122 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
+ A+K + E+ +++K++H N+V ++V + +SGG
Sbjct: 35 KLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAANLLMNENGVRDS 384
++D + ++ + A V + + YLH N I+HRDLK NLL +S
Sbjct: 93 LFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENS 146
Query: 385 DI 386
I
Sbjct: 147 KI 148
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 35/145 (24%), Positives = 66/145 (45%), Gaps = 16/145 (11%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ E ++ G+ +Y+ + A+KVL + +R E + ++ ++ H N++
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLRLSHPNII 111
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHR 361
+ P + +V E ++GG ++D + ++ R A D K + YLH
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHE 166
Query: 362 NNIIHRDLKAANLLMNENGVRDSDI 386
N I+HRDLK NLL D+ +
Sbjct: 167 NGIVHRDLKPENLLYATPA-PDAPL 190
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 20/112 (17%), Positives = 47/112 (41%), Gaps = 2/112 (1%)
Query: 270 DVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
VA+K+++ + R +E +++ +VV +L++ ++G
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ L +Q L P + + + ++ H HRD+K N+L++ +
Sbjct: 121 LAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD 171
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 292 EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD---YLHKQKCGLKLPLLLRV 348
E+ +M++++H N+V+ +L +V EFM D Y+ + G L
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELN 108
Query: 349 AI-----DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ + +G+ + H N I+HRDLK NLL+N+ G
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ 146
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 29/122 (23%), Positives = 55/122 (45%), Gaps = 20/122 (16%)
Query: 269 QDVAIKVL-----------TNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317
+ AIKV+ + E E E+ +++ + H N+++
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK----GMNYLHRNNIIHRDLKAAN 373
++VTEF GG +++ + + A ++ K G+ YLH++NI+HRD+K N
Sbjct: 122 YLVTEFYEGGELFEQIINRHK-----FDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 374 LL 375
+L
Sbjct: 177 IL 178
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 20/114 (17%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRK-VRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
+ A+K++ + +R+ +E+ I+ + +H N++ +++VTE M GG
Sbjct: 48 MEFAVKII------DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 328 SIYDYLHKQKCGLKLPLLL------RVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+ D + +QK V ++K + YLH ++HRDLK +N+L
Sbjct: 102 ELLDKILRQKF-------FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL 148
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 30/134 (22%), Positives = 51/134 (38%), Gaps = 30/134 (22%)
Query: 272 AIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
AIK+L H+ I+ E +M ++ H V+ +L+ + G
Sbjct: 59 AIKILEKRHI---IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 115
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
+ Y+ K ++ + YLH IIHRDLK N+L+NE+
Sbjct: 116 ELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166
Query: 380 GVRDSDIHCYLSNF 393
H +++F
Sbjct: 167 M------HIQITDF 174
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 37/129 (28%), Positives = 56/129 (43%), Gaps = 32/129 (24%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-------RLFIV 320
S +VAIK + + +N RE + IMR V+H NVV + A L +V
Sbjct: 64 SDEVAIKKVLQDKRFKN--RE----LQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLV 116
Query: 321 TEFMSGGSIYDYL-HKQKCGLKLPL---------LLRVAIDVSKGMNYLHRNNIIHRDLK 370
E++ ++Y H K +P+ LLR + Y+H I HRD+K
Sbjct: 117 LEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSIGICHRDIK 168
Query: 371 AANLLMNEN 379
NLL++
Sbjct: 169 PQNLLLDPP 177
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 32/124 (25%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A K L + + + A E I+ KV VV A L +V M+GG +
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 331 DYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
+++ + G + A ++ G+ LHR I++RDLK N+L++++G H
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIR 326
Query: 390 LSNF 393
+S+
Sbjct: 327 ISDL 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 32/128 (25%), Positives = 55/128 (42%), Gaps = 32/128 (25%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR-------LFIVT 321
+ VAIK + + +N RE + IMRK+ H N+V+ + L +V
Sbjct: 80 ELVAIKKVLQDKRFKN--RE----LQIMRKLDHCNIVR-LRYFFYSSGEKKDEVYLNLVL 132
Query: 322 EFMSGGSIYDYL-HKQKCGLKLPL---------LLRVAIDVSKGMNYLHRNNIIHRDLKA 371
+++ ++Y H + LP+ L R + Y+H I HRD+K
Sbjct: 133 DYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------SLAYIHSFGICHRDIKP 184
Query: 372 ANLLMNEN 379
NLL++ +
Sbjct: 185 QNLLLDPD 192
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 27/116 (23%), Positives = 49/116 (42%), Gaps = 19/116 (16%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC----TRPPRLFIVTEF 323
Q A+K+L + + QEV + ++V + L I+ E
Sbjct: 55 QKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107
Query: 324 MSGGSIYDYLHKQKCGL----KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
M GG ++ + ++ + ++R D+ + +LH +NI HRD+K NLL
Sbjct: 108 MEGGELFSRIQERGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLL 160
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 19/116 (16%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC----TRPPRLFIVTEF 323
+ A+K+L + RRE V + + + ++V+ + L IV E
Sbjct: 88 EKFALKMLQDC---PKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 324 MSGGSIYDYLHKQKCGL----KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+ GG ++ + + + +++ + + + YLH NI HRD+K NLL
Sbjct: 141 LDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENLL 193
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 29/150 (19%)
Query: 252 KIVSGSYCDLYKG---AFFSQDVAIKVLTNEHLNE-----NIRREFAQEVHIMRKVR--- 300
+I G+Y ++K + VA+K + + E IR EV ++R +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-----EVAVLRHLETFE 72
Query: 301 HMNVVQFI-----GACTRPPRLFIVTEFMSGGSIYD---YLHKQK-CGLKLPLLLRVAID 351
H NVV+ R +L +V E + D YL K G+ + +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 352 VSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ +G+++LH + ++HRDLK N+L+ +G
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 27/134 (20%), Positives = 62/134 (46%), Gaps = 30/134 (22%)
Query: 272 AIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
A+K+L + + ++ + + E I++ V +V+ + L++V E+++GG
Sbjct: 70 AMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
++ +L + R + ++ YLH ++I+RDLK NLL+++
Sbjct: 127 EMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 380 GVRDSDIHCYLSNF 393
G + +++F
Sbjct: 178 G------YIQVTDF 185
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 16/102 (15%)
Query: 292 EVHIMRKVR---HMNVVQFIGACT-----RPPRLFIVTEFMSGGSIYD---YLHKQKC-G 339
EV ++R++ H NVV+ + C R ++ +V E + D YL K G
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPG 116
Query: 340 LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L + + +G+++LH N I+HRDLK N+L+ G
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 158
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 4e-11
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 34/136 (25%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM------RKVRHMNVVQFIGACTRPPRLFIVTEFMS 325
A+KVL E + +R + Q H V H +++ G ++F++ +++
Sbjct: 35 AMKVLKKEIV---VRLK--QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMN 377
GG ++ L +K R V+K + YLH +II+RDLK N+L++
Sbjct: 90 GGELFSLL--RKSQ-------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140
Query: 378 ENGVRDSDIHCYLSNF 393
+NG H +++F
Sbjct: 141 KNG------HIKITDF 150
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 26/116 (22%), Positives = 50/116 (43%), Gaps = 19/116 (16%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGAC----TRPPRLFIVTEF 323
+ A+K+L + RRE V + + + ++V+ + L IV E
Sbjct: 44 EKFALKMLQD---CPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96
Query: 324 MSGGSIYDYLHKQKCGL----KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375
+ GG ++ + + + +++ + + + YLH NI HRD+K NLL
Sbjct: 97 LDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSINIAHRDVKPENLL 149
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 26/132 (19%), Positives = 49/132 (37%), Gaps = 29/132 (21%)
Query: 269 QDVAIKVLTNEHLNENIRREF-----AQ----EVHIMRKVRHMNVVQFIGACTRPPR--- 316
VAIK + N + + E+ ++ H N++
Sbjct: 47 IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106
Query: 317 --LFIVTEFMSGGSIYDYLHKQKCGLK-------LPLLLRVAIDVSKGMNYLHRNNIIHR 367
L++VTE M + +H Q+ + + +L G++ LH ++HR
Sbjct: 107 HKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILL-------GLHVLHEAGVVHR 158
Query: 368 DLKAANLLMNEN 379
DL N+L+ +N
Sbjct: 159 DLHPGNILLADN 170
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 26/131 (19%), Positives = 55/131 (41%), Gaps = 23/131 (17%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K++ + + + E ++ + Q A L++V E+ GG +
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNENGVR 382
L K G ++P ++++ ++ +HR +HRD+K N+L++ G
Sbjct: 150 TLL--SKFGERIPA------EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-- 199
Query: 383 DSDIHCYLSNF 393
H L++F
Sbjct: 200 ----HIRLADF 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYD 331
A+KVL L R E I+ +V H +V+ A +L+++ +F+ GG ++
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 332 YLHKQKCGLKLPLLLRVAI---DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388
L K+ V +++ +++LH II+RDLK N+L++E G H
Sbjct: 116 RLSKEVM-FTEE---DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HI 165
Query: 389 YLSNF 393
L++F
Sbjct: 166 KLTDF 170
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A K L + L + + A E I+ KV +V A L +V M+GG I
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 331 DYLHKQKCGLKLPLLL--RV---AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
H P R + G+ +LH+ NII+RDLK N+L++++G
Sbjct: 274 --YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG----- 326
Query: 386 IHCYLSNF 393
+ +S+
Sbjct: 327 -NVRISDL 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 14/144 (9%), Positives = 37/144 (25%), Gaps = 32/144 (22%)
Query: 269 QDVAIKVLT-NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC---------------- 311
+D A+KV T + + + ++ + +
Sbjct: 88 EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPP 147
Query: 312 ----------TRPPRLFIVTEFMSG-----GSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
++ S S D+++ + + L + + +
Sbjct: 148 FAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 357 NYLHRNNIIHRDLKAANLLMNENG 380
L ++H NL + +G
Sbjct: 208 ANLQSKGLVHGHFTPDNLFIMPDG 231
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 32/134 (23%), Positives = 57/134 (42%), Gaps = 31/134 (23%)
Query: 272 AIKVLTNEHLNENIRRE----FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
A+K+L+ + I+R F +E IM VVQ A L++V E+M GG
Sbjct: 98 AMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
+ + + V ++ ++ +H IHRD+K N+L++++
Sbjct: 155 DLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204
Query: 380 GVRDSDIHCYLSNF 393
G H L++F
Sbjct: 205 G------HLKLADF 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 29/133 (21%), Positives = 51/133 (38%), Gaps = 39/133 (29%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----LFI 319
+ VAIK + + + E+ I+ ++ H +VV+ + L++
Sbjct: 79 RVVAIKKILRVFEDL----IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS------------KGMNYLHRNNIIHR 367
V E D K L R + ++ G+ Y+H I+HR
Sbjct: 135 VLEIAD----SD-FKK---------LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHR 180
Query: 368 DLKAANLLMNENG 380
DLK AN L+N++
Sbjct: 181 DLKPANCLVNQDC 193
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 26/123 (21%), Positives = 57/123 (46%), Gaps = 8/123 (6%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIY 330
A+K+L E + E +++ RH + A RL V E+ +GG ++
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390
+L +++ ++ + YLH ++++RD+K NL+++++G H +
Sbjct: 94 FHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKI 146
Query: 391 SNF 393
++F
Sbjct: 147 TDF 149
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 31/133 (23%), Positives = 58/133 (43%), Gaps = 28/133 (21%)
Query: 272 AIKVLTNEHLNENIRREFA---QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+K + + E R E +E+ IM+ + H +V + +F+V + + GG
Sbjct: 44 AMKYMNKQKCVE--RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGD 101
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNENG 380
+ H Q+ + K ++YL IIHRD+K N+L++E+G
Sbjct: 102 LR--YHLQQNV-------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG 152
Query: 381 VRDSDIHCYLSNF 393
H ++++F
Sbjct: 153 ------HVHITDF 159
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 27/126 (21%), Positives = 56/126 (44%), Gaps = 13/126 (10%)
Query: 272 AIKVLTNEHLNENIRRE----FAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGG 327
A+K+L + ++R F +E ++ + A L++V ++ GG
Sbjct: 103 AMKILNKWEM---LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387
+ L K + L + ++ ++ +H+ + +HRD+K N+LM+ NG H
Sbjct: 160 DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG------H 213
Query: 388 CYLSNF 393
L++F
Sbjct: 214 IRLADF 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+KV+ E +N++ ++ Q E H+ + H +V RLF V E+++GG +
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
++ +Q+ L + ++S +NYLH II+RDLK N+L++ G H
Sbjct: 98 MFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIK 150
Query: 390 LSNF 393
L+++
Sbjct: 151 LTDY 154
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 31/134 (23%), Positives = 53/134 (39%), Gaps = 43/134 (32%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----L 317
++VAIK + E L + E+ I+ +++ +++ L
Sbjct: 52 KNVAIKKVNRMFEDL------IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS------------KGMNYLHRNNII 365
+IV E D L K L + I ++ G N++H + II
Sbjct: 106 YIVLEIAD----SD-LKK---------LFKTPIFLTEEHIKTILYNLLLGENFIHESGII 151
Query: 366 HRDLKAANLLMNEN 379
HRDLK AN L+N++
Sbjct: 152 HRDLKPANCLLNQD 165
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 34/124 (27%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A++V+ E +N++ ++ Q E H+ + H +V RLF V E+++GG +
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
++ +Q+ L + ++S +NYLH II+RDLK N+L++ G H
Sbjct: 141 MFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIK 193
Query: 390 LSNF 393
L+++
Sbjct: 194 LTDY 197
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 8e-10
Identities = 34/128 (26%), Positives = 64/128 (50%), Gaps = 17/128 (13%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+KVL + N ++ A E +I+ +V+H +V I A +L+++ E++SGG
Sbjct: 49 AMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE 107
Query: 329 IYDYLHKQKCGLKLPLLLRVAI---DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
++ L ++ ++S + +LH+ II+RDLK N+++N G
Sbjct: 108 LFMQLEREGI-FMED---TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG----- 158
Query: 386 IHCYLSNF 393
H L++F
Sbjct: 159 -HVKLTDF 165
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 36/119 (30%), Positives = 64/119 (53%), Gaps = 11/119 (9%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVTE 322
Q VA+K++ N + R+ A+E+ I+ +R MNV+ + T + + E
Sbjct: 123 QHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179
Query: 323 FMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+S ++Y+ + K K G LPL+ + A + + ++ LH+N IIH DLK N+L+ + G
Sbjct: 180 LLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 34/130 (26%), Positives = 60/130 (46%), Gaps = 21/130 (16%)
Query: 272 AIKVLTNEHLNENIRREFAQEV-HIM--RKV-----RHMNVVQFIGACTRPPRLFIVTEF 323
A+KVL + + ++ +V M +++ H + Q P RLF V EF
Sbjct: 52 AVKVLKKDVILQD------DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105
Query: 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383
++GG + ++ K + A ++ + +LH II+RDLK N+L++ G
Sbjct: 106 VNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG--- 161
Query: 384 SDIHCYLSNF 393
HC L++F
Sbjct: 162 ---HCKLADF 168
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 28/126 (22%), Positives = 58/126 (46%), Gaps = 11/126 (8%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMN---VVQFIGACTRPPRLFIVTEFMSGG 327
A+K L + + A E ++ V + +V A P +L + + M+GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387
++ +L + + A ++ G+ ++H +++RDLK AN+L++E+G H
Sbjct: 278 DLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG------H 330
Query: 388 CYLSNF 393
+S+
Sbjct: 331 VRISDL 336
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/132 (25%), Positives = 56/132 (42%), Gaps = 40/132 (30%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------LF 318
+ VAIK L+ +E FA+ E+ +++ ++H NV+ + T +
Sbjct: 50 EKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
+V FM D L K + L +L+ G+ Y+H ++HR
Sbjct: 106 LVMPFMQ----TD-LQKI---MGLKFSEEKIQYLVYQMLK-------GLKYIHSAGVVHR 150
Query: 368 DLKAANLLMNEN 379
DLK NL +NE+
Sbjct: 151 DLKPGNLAVNED 162
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/134 (24%), Positives = 53/134 (39%), Gaps = 43/134 (32%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------ 316
VAIK L + FA+ E+ +++ +RH NV+ + T
Sbjct: 51 AKVAIKKLYRPFQSE------LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNII 365
++V FM G + + + L +L+ G+ Y+H II
Sbjct: 105 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLK-------GLRYIHAAGII 150
Query: 366 HRDLKAANLLMNEN 379
HRDLK NL +NE+
Sbjct: 151 HRDLKPGNLAVNED 164
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 27/124 (21%), Positives = 59/124 (47%), Gaps = 9/124 (7%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+K+L + + ++ E E ++ + + Q RL+ V E+++GG +
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
++ + K P + A +++ G+ +L II+RDLK N++++ G H
Sbjct: 430 MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIK 482
Query: 390 LSNF 393
+++F
Sbjct: 483 IADF 486
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 30/126 (23%), Positives = 59/126 (46%), Gaps = 13/126 (10%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGS 328
A+K+L E + + E A E +++ RH + + RL V E+ +GG
Sbjct: 177 AMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 234
Query: 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKAANLLMNENGVRDSDIH 387
++ +L +++ ++ ++YLH N+++RDLK NL++ D D H
Sbjct: 235 LFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML------DKDGH 287
Query: 388 CYLSNF 393
+++F
Sbjct: 288 IKITDF 293
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 35/132 (26%), Positives = 54/132 (40%), Gaps = 41/132 (31%)
Query: 269 QDVAIKVLTN-EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----LF 318
VAIK ++ EH + Q E+ I+ + RH N++ P ++
Sbjct: 53 VRVAIKKISPFEHQ------TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
IV + M +Y L Q L +LR G+ Y+H N++HR
Sbjct: 107 IVQDLM-ETDLYKLLKTQ------HLSNDHICYFLYQILR-------GLKYIHSANVLHR 152
Query: 368 DLKAANLLMNEN 379
DLK +NLL+N
Sbjct: 153 DLKPSNLLLNTT 164
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 29/132 (21%), Positives = 56/132 (42%), Gaps = 25/132 (18%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM--RKV-----RHMNVVQFIGACTRPPRLFIVTEFM 324
AIK L + + + + M ++V H + LF V E++
Sbjct: 46 AIKALKKDVV---LMDD--DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRV---AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+GG + ++ L R A ++ G+ +LH I++RDLK N+L++++G
Sbjct: 101 NGGDLMYHIQSCHK-FDLS---RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG- 155
Query: 382 RDSDIHCYLSNF 393
H +++F
Sbjct: 156 -----HIKIADF 162
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 27/124 (21%), Positives = 59/124 (47%), Gaps = 9/124 (7%)
Query: 272 AIKVLTNEHLNENIRREFAQ-EVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSI 329
A+K+L + + ++ E E ++ + + Q RL+ V E+++GG +
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 330 YDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
++ + K P + A +++ G+ +L II+RDLK N++++ G H
Sbjct: 109 MYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIK 161
Query: 390 LSNF 393
+++F
Sbjct: 162 IADF 165
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 35/132 (26%), Positives = 70/132 (53%), Gaps = 25/132 (18%)
Query: 272 AIKVLTNEHLNENIRREFAQEVHIM-------RKVRHMNVVQFIGACTRPPRLFIVTEFM 324
A+KVL + + ++++ +E HIM + V+H +V + +L+ V +++
Sbjct: 67 AVKVLQKKAI---LKKK--EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121
Query: 325 SGGSIYDYLHKQKCGLKLPLLLRV---AIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+GG ++ +L +++C P R A +++ + YLH NI++RDLK N+L++ G
Sbjct: 122 NGGELFYHLQRERC-FLEP---RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 176
Query: 382 RDSDIHCYLSNF 393
H L++F
Sbjct: 177 -----HIVLTDF 183
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 34/151 (22%), Positives = 62/151 (41%), Gaps = 13/151 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNV 304
+ KI G++ +L G + VAIK+ E + + E +++ +
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSR-APQLHLEYRFYKQLGSGDGI 67
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
Q +V E + G S+ D C L +L +AI + M Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLF--DLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 363 NIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
N+I+RD+K N L+ G + + ++ +F
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQV-IHIIDF 154
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 40/132 (30%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------LF 318
++VAIK L+ N+ A+ E+ +M+ V H N++ + T ++
Sbjct: 51 RNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
IV E M + L + +++ L +L G+ +LH IIHR
Sbjct: 107 IVMELMD----AN-LCQV---IQMELDHERMSYLLYQMLC-------GIKHLHSAGIIHR 151
Query: 368 DLKAANLLMNEN 379
DLK +N+++ +
Sbjct: 152 DLKPSNIVVKSD 163
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 28/126 (22%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------ 316
++VAIK L+ ++ A+ E+ +M+ V H N++ + T
Sbjct: 88 RNVAIKKLSRPFQNQ------THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141
Query: 317 LFIVTEFMS---GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373
+++V E M I L ++ L +L G+ +LH IIHRDLK +N
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIKHLHSAGIIHRDLKPSN 194
Query: 374 LLMNEN 379
+++ +
Sbjct: 195 IVVKSD 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 27/172 (15%), Positives = 65/172 (37%), Gaps = 37/172 (21%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEH---LNENIRREFAQEVHIMR 297
K I G + +Y S +KV +++ E + A + ++
Sbjct: 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97
Query: 298 KVRHMNVVQFIGACTRPPRL--------------FIVTEFMSGGSIYDYLHKQKCGLKLP 343
K ++++G P+ F++ + G + + +
Sbjct: 98 KWIRTRKLKYLGV----PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY--EANAKRFS 150
Query: 344 L--LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+L++++ + + Y+H + +H D+KA+NLL+ ++ D YL ++
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL---NYKNPD-QVYLVDY 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 29/131 (22%), Positives = 52/131 (39%), Gaps = 32/131 (24%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR--------LFIV 320
VAIK + + N RE Q + + + H N+VQ + + L +V
Sbjct: 49 MSVAIKKVIQDPRFRN--REL-QIMQDLAVLHHPNIVQ-LQSYFYTLGERDRRDIYLNVV 104
Query: 321 TEFMSGGSIYDYL-HKQKCGLKLPL---------LLRVAIDVSKGMNYLHRN--NIIHRD 368
E++ +++ + + + P L+R + LH N+ HRD
Sbjct: 105 MEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR-------SIGCLHLPSVNVCHRD 156
Query: 369 LKAANLLMNEN 379
+K N+L+NE
Sbjct: 157 IKPHNVLVNEA 167
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 29/151 (19%), Positives = 61/151 (40%), Gaps = 13/151 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNV 304
K +I GS+ +++G Q VAIK E + + E + + +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSD-APQLRDEYRTYKLLAGCTGI 68
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
+V + + G S+ D L CG K + + A + + +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL-GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 363 NIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
++++RD+K N L+ +++++ Y+ +F
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANM-IYVVDF 155
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 19/146 (13%), Positives = 48/146 (32%), Gaps = 35/146 (23%)
Query: 269 QDVAIKVL-TNEHLNENIRREFAQEVHIMRK----------------------VRHMNVV 305
+ + V E N ++ +EV +R V+
Sbjct: 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163
Query: 306 QFIGACTRPPRLFIVTEFMS-----------GGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+ I +++++ F G + + K L L++ + V +
Sbjct: 164 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIR 222
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENG 380
+ LH ++H L+ ++++++ G
Sbjct: 223 LLASLHHYGLVHTYLRPVDIVLDQRG 248
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 29/144 (20%), Positives = 62/144 (43%), Gaps = 12/144 (8%)
Query: 268 SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVT 321
+ VA+K++ N + E+ ++ + VQ + + IV
Sbjct: 40 GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96
Query: 322 EFMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
E + G S YD++ + +L + ++A + K +N+LH N + H DLK N+L ++
Sbjct: 97 ELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155
Query: 381 VRDSDIHCYLSNFLSI-STVILVI 403
++ + ++ + I V+
Sbjct: 156 YTEAYNPKIKRDERTLINPDIKVV 179
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 27/134 (20%), Positives = 56/134 (41%), Gaps = 28/134 (20%)
Query: 272 AIKVLTNEHLNENIRREFAQ---EVHIMRKVRHMN-VVQFIGACTRPPRLFIVTEFMSGG 327
A+KVL + + + E ++ +R +V A +L ++ ++++GG
Sbjct: 86 AMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 328 SIYDYLHKQKCGLKLPLLLRVAIDVSK--------GMNYLHRNNIIHRDLKAANLLMNEN 379
++ H + R + + +LH+ II+RD+K N+L++ N
Sbjct: 145 ELF--THLSQRE-------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 380 GVRDSDIHCYLSNF 393
G H L++F
Sbjct: 196 G------HVVLTDF 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 32/132 (24%), Positives = 57/132 (43%), Gaps = 39/132 (29%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR------LF 318
VA+K L+ + A+ E+ +++ ++H NV+ + T ++
Sbjct: 55 LRVAVKKLSRPFQSI----IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 319 IVTEFMSGGSIYDYLHKQKCGLKLPL-----------LLRVAIDVSKGMNYLHRNNIIHR 367
+VT M G + + + Q L +LR G+ Y+H +IIHR
Sbjct: 111 LVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILR-------GLKYIHSADIIHR 156
Query: 368 DLKAANLLMNEN 379
DLK +NL +NE+
Sbjct: 157 DLKPSNLAVNED 168
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 25/138 (18%), Positives = 59/138 (42%), Gaps = 25/138 (18%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----------HMNVVQ------FIGAC 311
VA+K++ ++ E+ ++++V ++++ G
Sbjct: 45 THVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDL 369
+ +V E + G ++ + K + G+ L + +++ + G++Y+HR IIH D+
Sbjct: 102 GVH--VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 158
Query: 370 KAANLLMNENGVRDSDIH 387
K N+LM ++ I
Sbjct: 159 KPENVLMEIVDSPENLIQ 176
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 32/135 (23%), Positives = 50/135 (37%), Gaps = 47/135 (34%)
Query: 269 QDVAIKVLTN-EHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-----LF 318
+ VAIK + + FA E+ I++ +H N++ ++
Sbjct: 37 EIVAIKKIEPFDKP------LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90
Query: 319 IVTEFM--------SGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNI 364
I+ E M S + D H Q +K LH +N+
Sbjct: 91 IIQELMQTDLHRVISTQMLSDD-HIQYFIYQTLRAVK----------------VLHGSNV 133
Query: 365 IHRDLKAANLLMNEN 379
IHRDLK +NLL+N N
Sbjct: 134 IHRDLKPSNLLINSN 148
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 27/117 (23%), Positives = 59/117 (50%), Gaps = 10/117 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM-----NVVQFIGACTRPPRLFIVTEF 323
+ A+KV+ N + R E I++K+++ N+V++ G + ++ E
Sbjct: 61 KYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117
Query: 324 MSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
+ G S+Y+ + + G + + I++ K +NYL + ++ H DLK N+L+++
Sbjct: 118 L-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 23/135 (17%), Positives = 53/135 (39%), Gaps = 22/135 (16%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFI 308
K+ G Y ++++ + + V +K+L + R E+ I+ +R N++
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENLRGGPNIITLA 97
Query: 309 GACTRPPRLF----IVTEFMSG--GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN 362
+ P + + +Y L + +L+ ++Y H
Sbjct: 98 -DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHSM 149
Query: 363 NIIHRDLKAANLLMN 377
I+HRD+K N++++
Sbjct: 150 GIMHRDVKPHNVMID 164
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 29/143 (20%), Positives = 55/143 (38%), Gaps = 12/143 (8%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVTE 322
VA+K++ N R E+++++K++ V + I E
Sbjct: 46 SQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102
Query: 323 FMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN-LLMNENG 380
+ G + +++L + LP + +A + + +LH N + H DLK N L +N
Sbjct: 103 LL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161
Query: 381 VRDSDIHCYLSNFLSISTVILVI 403
+ H +T I V
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVA 184
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNV 304
+ KI SGS+ D+Y G + ++VAIK+ + + + E I + ++ + +
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGI 67
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
+V E + G S+ D C K L +L +A + + Y+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELL-GPSLEDLF--NFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 363 NIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
N IHRD+K N LM G+ Y+ +F
Sbjct: 125 NFIHRDVKPDNFLM---GLGKKGNLVYIIDF 152
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 17/159 (10%), Positives = 48/159 (30%), Gaps = 41/159 (25%)
Query: 269 QDVAIKVLTNEHLN-----ENIRRE---------------------FAQEVHIMRKVRHM 302
+ + V + ++ E F +++ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 303 NVVQFIGACTRP--PRLFIVTEFMS------GGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
+++ F + M G + + K L L++ + V +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-LVHHARLQLTLQVIR 217
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+ LH ++H L+ ++++++ G +L+ F
Sbjct: 218 LLASLHHYGLVHTYLRPVDIVLDQRG------GVFLTGF 250
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 28/136 (20%), Positives = 54/136 (39%), Gaps = 50/136 (36%)
Query: 269 QDVAIKVLTN--EHLNENIRREFAQ----EVHIMRKVR-HMNVVQFIGACTRPPR---LF 318
+ VA+K + + ++ AQ E+ I+ ++ H N+V + R ++
Sbjct: 35 EVVAVKKIFDAFQN------STDAQRTFREIMILTELSGHENIVNLLNVL-RADNDRDVY 87
Query: 319 IVTEFMSGGSIYDYLHK----QKCGLKLPL-----------LLRVAIDVSKGMNYLHRNN 363
+V ++M D LH L L++ + YLH
Sbjct: 88 LVFDYME----TD-LHAVIRAN------ILEPVHKQYVVYQLIK-------VIKYLHSGG 129
Query: 364 IIHRDLKAANLLMNEN 379
++HRD+K +N+L+N
Sbjct: 130 LLHRDMKPSNILLNAE 145
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 248 KFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNV 304
+ KI SGS+ ++Y G +++VAIK+ + + + E I R ++ +
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE----SKIYRILQGGTGI 65
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPL--LLRVAIDVSKGMNYLHRN 362
+V + + G S+ D C KL L +L +A + + ++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 363 NIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+ +HRD+K N LM G+ Y+ +F
Sbjct: 123 SFLHRDIKPDNFLM---GLGRRANQVYIIDF 150
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 3e-07
Identities = 62/446 (13%), Positives = 123/446 (27%), Gaps = 132/446 (29%)
Query: 3 MGDTESSSSRAVDFVWSESKSRKQR-VKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHF 61
+ S S + ++ +R +K + Y L L ++
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL--------------LNVQ--- 254
Query: 62 YRLPSRYALDVNLERAEDVLMHKRLLHVARDPAATPAIEVRLVLVQGASTRHFSNLVHSG 121
+ A ++ ++L R T + A+T H S L H
Sbjct: 255 ---------NAKAWNAFNL--SCKILLTTRFKQVTDF-------LSAATTTHIS-LDHHS 295
Query: 122 ---SPRYLYTQFSCYPYKKRLMHEITISTNDKPKLLSQLTSL-LSEIGLNIQEAHAFSTV 177
+P + + Y + D P+ + LS I +I++ A
Sbjct: 296 MTLTPDEVKSLLLKY---------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-- 344
Query: 178 DGYSLDVFVVDGWPLQETEQLRNVLAKEI----PKVENHHH---VVYPVGEQEQSGINHV 230
D W ++L ++ + P V+P
Sbjct: 345 ----------DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP---------PSA 385
Query: 231 NIPAEGIDV-WE--------------IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKV 275
+IP + + W SL++ + K + S +Y ++ +K+
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY------LELKVKL 439
Query: 276 LTNEHLNE------NIRREFAQE------------VHIMRKVRHMNVVQFIGACTRPPRL 317
L+ NI + F + HI H+ ++ T +
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH---HLKNIEHPERMTLFRMV 496
Query: 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKA-ANLL 375
F+ F+ +D G L L + Y+ N R + A + L
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQ----QLKFYKPYICDNDPKYERLVNAILDFL 552
Query: 376 MNENGVRDSDIHCYLSNFLSISTVIL 401
+ S + + + L
Sbjct: 553 PKIEE------NLICSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 3e-07
Identities = 73/488 (14%), Positives = 140/488 (28%), Gaps = 164/488 (33%)
Query: 10 SSRAVDFVWSESKSRKQRVKVQVYNEILFRLKQSNEEETRQPYFEDDLWAHFYRLPSRYA 69
S +D + SK LF S +EE Q + E+ L ++ L S
Sbjct: 47 SKEEIDHII-MSKDAVSGTLR------LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 70 ---LDVNLERAEDVLMHKRL---------LHVARDPAATPAIEVR----------LVLVQ 107
++ + RL +V+R P +++R VL+
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ---PYLKLRQALLELRPAKNVLID 156
Query: 108 G----------AST-------RHFSNLVH------SGSPRY-------LYTQFSCYPYKK 137
G + SP L Q +
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP-NWTS 215
Query: 138 RLMHEITI--STNDKPKLLSQL-------TSLLSEIGLNIQEAHAFSTVDGY------SL 182
R H I + L +L LL + LN+Q A A++ + +
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNAFNLSCKILLTTR 273
Query: 183 DVFVVD---------------GWPLQETEQLRNVLAK-------EIPKVENHHH--VVYP 218
V D L E ++L K ++P+ + +
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 219 VGEQEQSGINHVNIPAEGIDVWE----------IDASLLKFEHKIVSGSYCDLYKGAFFS 268
+ E + G+ D W+ I++SL E + L + F
Sbjct: 333 IAESIRDGLAT-------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL---SVFP 382
Query: 269 QDVAI--KVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326
I +L + ++ + ++ K+ ++V+ +P I
Sbjct: 383 PSAHIPTILL--SLIWFDVIKSDVMV--VVNKLHKYSLVE-----KQPKESTI------- 426
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI----IHRDLKAANLLMNENGVR 382
SI ++ L L+V ++ LHR+ + I + + +L+
Sbjct: 427 -SIPS-IY---------LELKVKLE---NEYALHRSIVDHYNIPKTFDSDDLIPPYL--- 469
Query: 383 DSDIHCYL 390
D + ++
Sbjct: 470 DQYFYSHI 477
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 36/300 (12%), Positives = 76/300 (25%), Gaps = 103/300 (34%)
Query: 19 SESKSRKQRVKVQVYNEILFRLKQS----NEEETRQPY-----FEDD----------LWA 59
+ + K +++ ++ S E R+ + F +W
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 60 --------------------------HFYRLPSRYALDVNLERAEDVLMHKRLLHVARDP 93
+PS Y L++ ++ + +H+ ++
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY-LELKVKLENEYALHRSIVD----- 451
Query: 94 AATPAIEVRLVLVQGASTRHFSNLVHSGSPRYLYTQFSCYPYKKRLMHEITISTNDKPKL 153
+ + + Y Y + H I ++ L
Sbjct: 452 --------HYNIPKTFDSDDLIPPYLDQ---YFY-SHIGH-------HLKNIEHPERMTL 492
Query: 154 LSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVENHH 213
+ + I+ G L+ +QL+ I +N
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTL----------QQLKFYK-PYI--CDND- 538
Query: 214 HVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAI 273
P E+ + I L K E ++ Y DL + A ++D AI
Sbjct: 539 ----PKYERLVNAILDF---------------LPKIEENLICSKYTDLLRIALMAEDEAI 579
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 24/160 (15%), Positives = 52/160 (32%), Gaps = 64/160 (40%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ-EVHIMRKVRHMNVVQ--------------------- 306
+ A+K + + + E+ IM+ + H+N+++
Sbjct: 33 KRFALKKVLQD-------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85
Query: 307 -----------FIGACTRPPR------LFIVTEFMSGGSIYDYL-HKQKCGLKLPL---- 344
+ L ++ E++ +++ L + G +P+
Sbjct: 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLIS 144
Query: 345 -----LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379
L R + ++H I HRD+K NLL+N
Sbjct: 145 IYIYQLFR-------AVGFIHSLGICHRDIKPQNLLVNSK 177
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 33/136 (24%), Positives = 53/136 (38%), Gaps = 45/136 (33%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQ----EVHIMRKVRHMNVVQFIGACTRPPR-------- 316
+ VAIK + + + E+ I+R++ H N+V+
Sbjct: 37 KRVAIKKIVLTDP------QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90
Query: 317 ------LFIVTEFMSGGSIYDYLHK---------QKCGLKLPLLLRVAIDVSKGMNYLHR 361
++IV E+M D L + L + LLR G+ Y+H
Sbjct: 91 LTELNSVYIVQEYME----TD-LANVLEQGPLLEEHARLFMYQLLR-------GLKYIHS 138
Query: 362 NNIIHRDLKAANLLMN 377
N++HRDLK ANL +N
Sbjct: 139 ANVLHRDLKPANLFIN 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 25/168 (14%), Positives = 53/168 (31%), Gaps = 29/168 (17%)
Query: 248 KFEHKIVSGSYCDLYKG----------AFFSQDVAIKV------LTNEH--LNENIRREF 289
K + + LY+ Q ++K+ L NE +
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPRL-FIVTEFMSGGSIYDYLHKQKCGLK---LPLL 345
+ + + + +G + F+V + G S+ L +
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL--DVSPKHVLSERSV 161
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
L+VA + + +LH N +H ++ A N+ + D L+ +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFV---DPEDQS-QVTLAGY 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 36/169 (21%), Positives = 66/169 (39%), Gaps = 34/169 (20%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNE-HLNENIRREF-----AQEVHIMRKV 299
KI SG + +Y + + A V+ E N + E + ++K
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 300 RHMNVVQFIGACTRPPRL--------------FIVTEFMSGGSIYDYLHKQKCG-LKLPL 344
+ ++G P F+V E + G + + G K
Sbjct: 100 IERKQLDYLGI----PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS--GQNGTFKKST 152
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+L++ I + + Y+H N +H D+KAANLL+ G ++ D YL+++
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLL---GYKNPD-QVYLADY 197
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 28/117 (23%), Positives = 49/117 (41%), Gaps = 13/117 (11%)
Query: 269 QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH------MNVVQFIGACTRPPRLFIVTE 322
+ VAIK++ N + + EV ++ + +V L +V E
Sbjct: 80 EWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136
Query: 323 FMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRN--NIIHRDLKAANLLM 376
+S ++YD L G+ L L + A + + +L +IIH DLK N+L+
Sbjct: 137 MLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 34/140 (24%), Positives = 60/140 (42%), Gaps = 35/140 (25%)
Query: 271 VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--------VVQFIGA-----------C 311
VA+KV+ + E+ E+ +++ VR+ + VVQ + C
Sbjct: 65 VAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121
Query: 312 TRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDL 369
+V E + G + ++ K GL LP + ++ V +G++YLH IIH D+
Sbjct: 122 -------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 173
Query: 370 KAANLLMNENGVRDSDIHCY 389
K N+L+ V + I
Sbjct: 174 KPENILL---SVNEQYIRRL 190
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 2e-05
Identities = 28/175 (16%), Positives = 53/175 (30%), Gaps = 48/175 (27%)
Query: 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHL------NENIRREFAQEVHIMRKV------ 299
KI G + ++++ VAIK++ E ++ E E+ I +++
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 300 ---RHMNVVQFIGAC------------------------------TRPPRLFIVTEFMSG 326
R + + +LFIV EF G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG 380
G D + L + ++ + + HRDL N+L+ +
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 411 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.98 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.94 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.94 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.93 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.93 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.93 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.92 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.91 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.91 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.9 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.89 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.88 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.03 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 96.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.31 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 94.04 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 93.75 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.67 | |
| 1zpv_A | 91 | ACT domain protein; structural genomics, PSI, prot | 90.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.7 | |
| 2f1f_A | 164 | Acetolactate synthase isozyme III small subunit; f | 86.67 | |
| 2ko1_A | 88 | CTR148A, GTP pyrophosphokinase; homodimer, alpha+b | 85.89 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 83.71 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 82.75 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 81.4 | |
| 2pc6_A | 165 | Probable acetolactate synthase isozyme III (small; | 80.14 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=301.25 Aligned_cols=156 Identities=35% Similarity=0.598 Sum_probs=142.3
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
.+.|||+.+++++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||+++|+|.. +.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 46799999999999999999999999998765 69999998776677778899999999999999999999999875 46
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|||||||+||+|.++|......+++..++.++.||+.||.|||+++||||||||+|||+++++ .+||+|||+|
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~------~~Ki~DFGla 179 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL------TVKIGDFGLA 179 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE------EEEECCCSSC
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC------cEEEeeccCc
Confidence 8999999999999999988776899999999999999999999999999999999999999988 6999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
+...
T Consensus 180 ~~~~ 183 (307)
T 3omv_A 180 TVKS 183 (307)
T ss_dssp BC--
T ss_pred eecc
Confidence 7653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.08 Aligned_cols=155 Identities=25% Similarity=0.486 Sum_probs=138.3
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
.++|+.++|.+.++||+|+||.||+|++. ++.||||+++.. +....+.|.+|+.+|++++|||||+++|+|
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 35788999999999999999999999874 467999999754 455678899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC
Q 015237 312 TRPPRLFIVTEFMSGGSIYDYLHKQK------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN 379 (411)
Q Consensus 312 ~~~~~l~IV~E~~~gGsL~~~L~~~~------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~ 379 (411)
.+++.+|||||||++|+|.++|+..+ ..+++..++.++.||+.||.|||+++||||||||+|||++++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999999999997642 368999999999999999999999999999999999999998
Q ss_pred CCcCCCccEEEEeccccccccc
Q 015237 380 GVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 380 g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+ .+||+|||+|+.+..
T Consensus 165 ~------~~Ki~DFGla~~~~~ 180 (299)
T 4asz_A 165 L------LVKIGDFGMSRDVYS 180 (299)
T ss_dssp G------CEEECCCSCHHHHTG
T ss_pred C------cEEECCcccceecCC
Confidence 8 599999999986543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.53 Aligned_cols=156 Identities=26% Similarity=0.500 Sum_probs=138.9
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
..+||+.+.+++.++||+|+||.||+|.+. ++.||||+++... .....+.|.+|+.+|++++|||||+++|+
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 457899999999999999999999999873 4689999997553 33345789999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NIL 375 (411)
|..++.+|||||||++|+|.++|.... ..+++..++.++.||+.||.|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 999999999999999999999997532 35899999999999999999999999999999999999
Q ss_pred EccCCCcCCCccEEEEecccccccc
Q 015237 376 MNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 376 id~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++++ .+||+|||+|+.+.
T Consensus 178 l~~~~------~~Ki~DFGlar~~~ 196 (308)
T 4gt4_A 178 VYDKL------NVKISDLGLFREVY 196 (308)
T ss_dssp ECGGG------CEEECCSCCBCGGG
T ss_pred ECCCC------CEEECCcccceecc
Confidence 99988 59999999998763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=288.99 Aligned_cols=155 Identities=26% Similarity=0.452 Sum_probs=136.1
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
..++|+.+++.+.++||+|+||.||+|++. ++.||||+++.. +....+.|.+|+.+|++++|||||+++|+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 457888999999999999999999999874 467999999754 45567889999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK--------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM 376 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~--------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi 376 (411)
|.+.+.+|||||||++|+|.++++... ..+++..++.++.||+.||.|||+++||||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999997642 358899999999999999999999999999999999999
Q ss_pred ccCCCcCCCccEEEEecccccccc
Q 015237 377 NENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 377 d~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
++++ .+||+|||+|+.+.
T Consensus 192 ~~~~------~~Ki~DFGla~~~~ 209 (329)
T 4aoj_A 192 GQGL------VVKIGDFGMSRDIY 209 (329)
T ss_dssp ETTT------EEEECCCC------
T ss_pred CCCC------cEEEcccccceecc
Confidence 9988 69999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=292.07 Aligned_cols=152 Identities=21% Similarity=0.350 Sum_probs=134.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.++|+++++||+|+||.||+|++. ++.||||+++....+....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 357999999999999999999986 789999999988777777888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+||+|.++|...+. .+++..++.++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|+.+.
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG------TVQLGDFGIARVLN 176 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC------CEEECSTTEESCCC
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC------CEEEcccccceeec
Confidence 99999999999986543 578999999999999999999999999999999999999998 59999999998764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 177 ~ 177 (350)
T 4b9d_A 177 S 177 (350)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=283.50 Aligned_cols=151 Identities=24% Similarity=0.391 Sum_probs=136.7
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
..++|++++.||+|+||.||++++. ++.||||++.+.... ....+.+.+|+.+|++++|||||++++++.+++.+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3457999999999999999999986 689999999765431 2335679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||||+||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.+
T Consensus 110 vmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g------~vKl~DFGla~~~ 182 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM------HIQITDFGTAKVL 182 (311)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS------CEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC------CEEEEEcCCceec
Confidence 999999999999998765 699999999999999999999999999999999999999998 5999999999876
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 183 ~ 183 (311)
T 4aw0_A 183 S 183 (311)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=276.43 Aligned_cols=150 Identities=29% Similarity=0.505 Sum_probs=134.4
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----CCeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPRL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~~l 317 (411)
...|++.++||+|+||.||+|.+. +..||+|++..........+.|.+|+.+|++++|||||+++++|.. ...+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344689999999999999999986 6789999998877777777889999999999999999999999864 3568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcc-CCCcCCCccEEEEecc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNE-NGVRDSDIHCYLSNFL 394 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~-~g~~k~~~~ikL~DFG 394 (411)
|||||||+||+|.+++.+.. .+++..+..++.||+.||.|||++| ||||||||+|||++. +| .+||+|||
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g------~vKl~DFG 177 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG------SVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS------CEEECCTT
T ss_pred EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC------CEEEEeCc
Confidence 99999999999999998765 6999999999999999999999999 999999999999974 66 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
+|+...
T Consensus 178 la~~~~ 183 (290)
T 3fpq_A 178 LATLKR 183 (290)
T ss_dssp GGGGCC
T ss_pred CCEeCC
Confidence 997543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=285.61 Aligned_cols=147 Identities=28% Similarity=0.387 Sum_probs=134.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|++.++||+|+||.||+|++. ++.||||+++...... .+.+.+|+.+|++++|||||+++++|...+.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 466999999999999999999986 7899999997654332 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+||+|.+++... .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|..+.
T Consensus 151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------~vKl~DFGla~~~~ 221 (346)
T 4fih_A 151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG------RVKLSDFGFCAQVS 221 (346)
T ss_dssp CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC------CEEEecCcCceecC
Confidence 999999999999764 599999999999999999999999999999999999999998 59999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=284.42 Aligned_cols=157 Identities=29% Similarity=0.539 Sum_probs=138.7
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC-CceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~ 308 (411)
.+.|||+.++|+++++||+|+||.||+|.+.+ +.||||.++... .....+.|.+|+.+|++++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35799999999999999999999999998853 469999997654 34456789999999999975 8999999
Q ss_pred eeeecC-CeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 309 GACTRP-PRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 309 g~~~~~-~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
|+|..+ ..+|||||||++|+|.++|+... ..+++..++.++.||+.||.|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999764 56999999999999999997642 24789999999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEecccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++ .+||+|||+|+.+.
T Consensus 215 NILl~~~~------~vKi~DFGlar~~~ 236 (353)
T 4ase_A 215 NILLSEKN------VVKICDFGLARDIY 236 (353)
T ss_dssp GEEECGGG------CEEECCCGGGSCTT
T ss_pred ceeeCCCC------CEEECcchhhhhcc
Confidence 99999988 59999999998763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.05 Aligned_cols=153 Identities=25% Similarity=0.354 Sum_probs=131.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.++.++|++.+.||+|+||.||+++.. ++.||||+++...........+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 456678999999999999999999873 468999999876443333346889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g------~vKl~DFGl 172 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFGL 172 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS------CEEEESSEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC------CEEeccccc
Confidence 9999999999999999998765 699999999999999999999999999999999999999998 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
|+...
T Consensus 173 a~~~~ 177 (304)
T 3ubd_A 173 SKESI 177 (304)
T ss_dssp EEC--
T ss_pred ceecc
Confidence 98653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.59 Aligned_cols=149 Identities=28% Similarity=0.376 Sum_probs=135.1
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
+...|++.++||+|+||.||+|++. ++.||||++....... .+.+.+|+.+|+.++|||||+++++|...+.+|||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 4567999999999999999999986 7899999997654322 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||+||+|.+++... .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|..+.
T Consensus 227 mEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g------~vKl~DFGla~~~~ 298 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG------RVKLSDFGFCAQVS 298 (423)
T ss_dssp EECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC------CEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC------CEEEecCccceECC
Confidence 9999999999999764 499999999999999999999999999999999999999998 59999999998764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 299 ~ 299 (423)
T 4fie_A 299 K 299 (423)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=280.39 Aligned_cols=148 Identities=21% Similarity=0.312 Sum_probs=133.5
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
+......|++.++||+|+||.||+|++. ++.||||+++.+.. ..+|+.+|+.++|||||++++++.+.+.+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3445667999999999999999999986 78999999987643 24699999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||||||+||+|.++|+..+ .+++..+..++.||+.||.|||++|||||||||+|||++.+|. .+||+|||+|+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-----~vKl~DFGla~ 199 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-----RAALCDFGHAL 199 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-----CEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-----EEEEeeCCCCe
Confidence 99999999999999998765 6999999999999999999999999999999999999998873 48999999998
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 200 ~~~ 202 (336)
T 4g3f_A 200 CLQ 202 (336)
T ss_dssp EC-
T ss_pred Ecc
Confidence 764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=271.40 Aligned_cols=148 Identities=21% Similarity=0.424 Sum_probs=126.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+|++.+.||+|+||.||+|.+. ++.||||+++...... ...+.+.+|+.+|++++|||||++++++..++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999875 7899999998765432 34567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||| +|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~------~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL------NVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC------CEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC------CEEEeecCCCeecC
Confidence 999 789999998764 799999999999999999999999999999999999999988 59999999998654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=270.56 Aligned_cols=149 Identities=17% Similarity=0.314 Sum_probs=125.4
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC--------
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-------- 315 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-------- 315 (411)
+|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5899999999999999999986 7899999997654 3445678999999999999999999999986543
Q ss_pred ----eEEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 ----RLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ----~l~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.+|||||||+||+|.+++..... ..+...++.++.||+.||.|||++|||||||||+|||++.+| .+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~------~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD------VVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC------cEE
Confidence 47999999999999999986542 245667889999999999999999999999999999999998 599
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
|+|||+|+.+..
T Consensus 159 l~DFGla~~~~~ 170 (299)
T 4g31_A 159 VGDFGLVTAMDQ 170 (299)
T ss_dssp ECCCCCC-----
T ss_pred EccCccceecCC
Confidence 999999987643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=270.96 Aligned_cols=145 Identities=24% Similarity=0.496 Sum_probs=125.8
Q ss_pred CceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC----eEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----RLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~l~IV 320 (411)
.+|.+.++||+|+||.||+|+++++.||||+++.... ....+..|+..+.+++|||||+++|+|..++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4589999999999999999999999999999975431 1122345666677899999999999997653 58999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN--------NIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~--------gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
||||++|+|.++|+.. .+++..+.+++.|++.||.|||++ +||||||||+|||++.++ .+||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~------~~Ki~D 151 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------TCCIAD 151 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS------CEEECC
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC------CEEEEe
Confidence 9999999999999865 489999999999999999999987 899999999999999998 599999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||+|+...
T Consensus 152 FGla~~~~ 159 (303)
T 3hmm_A 152 LGLAVRHD 159 (303)
T ss_dssp CTTCEEEE
T ss_pred CCCCcccc
Confidence 99997654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=276.67 Aligned_cols=147 Identities=23% Similarity=0.362 Sum_probs=133.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec------CCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~------~~~ 316 (411)
++|+++++||+|+||.||+|++. ++.||||+++.........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999986 7899999998776666667789999999999999999999998754 357
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|||||||. |+|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~------~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC------ELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC------CEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC------CEEEeeccee
Confidence 999999995 68999997654 799999999999999999999999999999999999999998 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
+.+
T Consensus 206 ~~~ 208 (398)
T 4b99_A 206 RGL 208 (398)
T ss_dssp BCC
T ss_pred eec
Confidence 865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=269.68 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=178.8
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEecCCCccchHHHHHHHhhccccccCCC---
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVENHH--- 213 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~~~~~~~~~--- 213 (411)
...++|+++.++|.++...|. ..| |.||++. +.. .|+|+|..-+. .-+..+...+...
T Consensus 10 l~~~~wyhg~i~r~~a~~lL~----~~G~flvR~s~--~~~-~~~lsv~~~~~-----------~~h~~i~~~~~~~~~~ 71 (377)
T 3cbl_A 10 LHEQLWYHGAIPRAEVAELLV----HSGDFLVRESQ--GKQ-EYVLSVLWDGL-----------PRHFIIQSLDNLYRLE 71 (377)
T ss_dssp GGGCTTBCTTCCHHHHHHHCC----STTEEEEEECC----C-CEEEEC----------------CCEEEC----CCCCC-
T ss_pred cccCCccCCCCCHHHHHHHHh----cCCCEEEEEeC--CCC-cEEEEEEECCC-----------ccchhhccccceEEec
Confidence 567799999999999999664 457 9999987 444 89999864110 0011111111100
Q ss_pred ----Cccccc-------CcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc
Q 015237 214 ----HVVYPV-------GEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH 280 (411)
Q Consensus 214 ----~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~ 280 (411)
...... ..................+.|+++.++|++.++||+|+||.||+|++. ++.||||+++..
T Consensus 72 ~~~F~sl~~LI~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~- 150 (377)
T 3cbl_A 72 GEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET- 150 (377)
T ss_dssp ---CCSHHHHHHHHHHHTCCC-----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-
T ss_pred ceeccchHHHHHHHhhccCCcccccCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-
Confidence 000000 000000000000111235689999999999999999999999999996 688999998754
Q ss_pred cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 015237 281 LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360 (411)
Q Consensus 281 ~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLH 360 (411)
......+.+.+|+.+|++++||||++++++|...+.+|+||||+++|+|.+++...+..+++..++.++.|++.||.|||
T Consensus 151 ~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH 230 (377)
T 3cbl_A 151 LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230 (377)
T ss_dssp SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34455667999999999999999999999999999999999999999999999877656899999999999999999999
Q ss_pred HCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 361 RNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 361 s~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
++||+||||||+|||++.++ .+||+|||++.....
T Consensus 231 ~~~ivHrDlkp~Nil~~~~~------~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 231 SKCCIHRDLAARNCLVTEKN------VLKISDFGMSREEAD 265 (377)
T ss_dssp HTTEECSCCSGGGEEECTTC------CEEECCGGGCEECTT
T ss_pred HCCcCCcccCHHHEEEcCCC------cEEECcCCCceecCC
Confidence 99999999999999999888 599999999986543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=269.50 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=183.5
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEecCC------------------------Cc
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVDGW------------------------PL 192 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd~w------------------------~~ 192 (411)
...++|+++.+.|.+++..|...-...| |.||++. ++.+.|+|+|...++- ..
T Consensus 67 le~~~W~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~--~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~~~i~~~~~F 144 (454)
T 1qcf_A 67 LETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSE--TTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTF 144 (454)
T ss_dssp GGGSTTEETTCCHHHHHHHHHSTTCCTTCEEEEECS--SSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCEESSSSSCB
T ss_pred cccccccccccchhhhhhhhhcCCCCCceEEEEECc--CCCCeEEEEEEecccCCCCceEEEEEEEcCCCcEEEeCcccc
Confidence 5668999999999999998876666677 8999988 7788899999763210 00
Q ss_pred cchHHHHHHHhhccccccCCCCcccccCcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEEC-CceE
Q 015237 193 QETEQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDV 271 (411)
Q Consensus 193 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~V 271 (411)
.....+.....+. ..... .....+.. ..........+.|+++.+.|++.++||+|+||.||+|.+. +..|
T Consensus 145 ~sl~eLv~~y~~~---~~~l~---~~~~~~~~---~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~v 215 (454)
T 1qcf_A 145 STLQELVDHYKKG---NDGLC---QKLSVPCM---SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV 215 (454)
T ss_dssp SSHHHHHHHHTSS---CTTSS---SCCCSBCC---CCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEE
T ss_pred CCHHHHHHHHHhc---cCCcc---cccccccc---ccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEE
Confidence 0011111100000 00000 00000000 0000111235789999999999999999999999999997 5789
Q ss_pred EEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHH
Q 015237 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAI 350 (411)
Q Consensus 272 AIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~ 350 (411)
|||+++..... .+.+.+|+.+|++++||||+++++++. ...+|||||||++|+|.+++.... ..+++..++.++.
T Consensus 216 avK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 291 (454)
T 1qcf_A 216 AVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291 (454)
T ss_dssp EEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHH
T ss_pred EEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHH
Confidence 99999875433 467999999999999999999999987 557999999999999999997542 2588899999999
Q ss_pred HHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 351 qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+.||.|||+++|+||||||+|||++.++ .+||+|||++..+.
T Consensus 292 qi~~~l~~LH~~~ivHrDlkp~Nill~~~~------~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 292 QIAEGMAFIEQRNYIHRDLRAANILVSASL------VCKIADFGLARVIE 335 (454)
T ss_dssp HHHHHHHHHHHTTCCCSSCSGGGEEECTTC------CEEECSTTGGGGBC
T ss_pred HHHHHHHHHHhCCccCCCCCHHHEEECCCC------cEEEeeCCCceEcC
Confidence 999999999999999999999999999888 59999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=270.60 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=182.8
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEecCCCccc---------------------h
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVDGWPLQE---------------------T 195 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd~w~~~~---------------------~ 195 (411)
...++|+++.++|.++...|...-.+.| |.||++. ++.+.|+|+|...++..... -
T Consensus 62 le~~~w~~g~~~r~~ae~~L~~~~~~~G~FLvR~s~--~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~~~~~~~F 139 (452)
T 1fmk_A 62 IQAEEWYFGKITRRESERLLLNAENPRGTFLVRESE--TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQF 139 (452)
T ss_dssp GGGSTTEEETCCHHHHHHHHTCTTSCTTEEEEEECS--SSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSEE
T ss_pred ccccccccCCccHHHHHHHhccCCCCCceEEEEeCC--CCCCceEEEEEeeccCCCCcEEEEEEEEcCCCCEEEecCccc
Confidence 4567899999999999998877766778 8999988 67788999998644221000 0
Q ss_pred HHHHHHHhhccccccCCCCcccccCcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEE
Q 015237 196 EQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIK 274 (411)
Q Consensus 196 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK 274 (411)
..+...+..-............... .. ..........+.|+++.+.|++.++||+|+||.||+|.+.+ ..||||
T Consensus 140 ~Sl~~Li~~y~~~~~~l~~~l~~~~----~~-~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK 214 (452)
T 1fmk_A 140 NSLQQLVAYYSKHADGLCHRLTTVC----PT-SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK 214 (452)
T ss_dssp SSHHHHHHHHTTCCTTSSSCCCEEC----CC-CCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEE
T ss_pred CCHHHHHHHhhhccccchhhccccc----cc-cccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEE
Confidence 0011111100000000000000000 00 00001112356899999999999999999999999999985 679999
Q ss_pred EeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHH
Q 015237 275 VLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVS 353 (411)
Q Consensus 275 ~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa 353 (411)
+++..... .+.|.+|+.+|++++||||+++++++.. +.+|||||||++|+|.+++... ...+++..++.++.||+
T Consensus 215 ~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~ 290 (452)
T 1fmk_A 215 TLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290 (452)
T ss_dssp ECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHH
T ss_pred EeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHH
Confidence 99876543 3578999999999999999999999977 6799999999999999999764 23589999999999999
Q ss_pred HHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 354 KGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 354 ~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 291 ~~l~~LH~~~ivHrDlkp~Nill~~~~------~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 291 SGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLARLIE 331 (452)
T ss_dssp HHHHHHHHTTCCCSCCSGGGEEECGGG------CEEECCCCTTC---
T ss_pred HHHHHHHhCCeeCCCCChhhEEECCCC------CEEECCCccceecC
Confidence 999999999999999999999999887 59999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=272.13 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=184.5
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEecCCC------------------------c
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVDGWP------------------------L 192 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd~w~------------------------~ 192 (411)
...++|+++.+.|.+++..|...-+..| |.||+.. ++.+.|+|+|...+.-. +
T Consensus 145 l~~~~wy~g~i~r~~ae~~L~~~~~~~G~FLvR~S~--~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~i~~~~~F 222 (535)
T 2h8h_A 145 IQAEEWYFGKITRRESERLLLNAENPRGTFLVRESE--TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQF 222 (535)
T ss_dssp GGGSTTBCCSCCHHHHHHHHTCTTCCTTEEEEEECS--SSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSCEEEETTEEE
T ss_pred ccccceeccccCHHHHHHHhccCCCCCCeEEEEecC--CCCCcEEEEEEeeccCCCCceEEEEEEEcCCCcEEeeccccc
Confidence 5667999999999999998877666778 8999988 67788999998643211 0
Q ss_pred cchHHHHHHHhhccccccCCCCcccccCcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEECC-ceE
Q 015237 193 QETEQLRNVLAKEIPKVENHHHVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDV 271 (411)
Q Consensus 193 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~V 271 (411)
....+|.....+.. ........... .. ..........+.|+|+.+.|++.++||+|+||.||+|.+.+ ..|
T Consensus 223 ~SL~eLv~~y~~~~---~~~~~~l~~~~----~~-~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~v 294 (535)
T 2h8h_A 223 NSLQQLVAYYSKHA---DGLCHRLTTVC----PT-SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV 294 (535)
T ss_dssp SSHHHHHHHHHHCC---TTSSSCCCEEC----CC-CCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEE
T ss_pred cChHHhheeecccc---Ccccccccccc----cc-ccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceE
Confidence 00111111111100 00000000000 00 00001112357899999999999999999999999999985 679
Q ss_pred EEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHH
Q 015237 272 AIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAI 350 (411)
Q Consensus 272 AIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~ 350 (411)
|||+++..... .+.|.+|+.+|++++||||+++++++.. ..+|||||||.+|+|.+++... ...+++..++.++.
T Consensus 295 avK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 370 (535)
T 2h8h_A 295 AIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370 (535)
T ss_dssp EEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred EEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 99999876543 3578999999999999999999999977 6799999999999999999764 23589999999999
Q ss_pred HHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 351 qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+.||.|||+++|+||||||+|||++.++ .+||+|||++..+.
T Consensus 371 qi~~~L~~LH~~~ivHrDlkp~NIll~~~~------~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 371 QIASGMAYVERMNYVHRDLRAANILVGENL------VCKVADFGLARLIE 414 (535)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGG------CEEECCTTSTTTCC
T ss_pred HHHHHHHHHHhCCeeCCCCCHhhEEEcCCC------cEEEcccccceecC
Confidence 999999999999999999999999999887 59999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.58 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=183.6
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEe------------cCCCccc----hHHHHH
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVV------------DGWPLQE----TEQLRN 200 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvv------------d~w~~~~----~~~l~~ 200 (411)
.+.++|+++.+.|.++...|.. ...| |.||++. ++.+.|+|+|..- +|+..-. -..+..
T Consensus 102 le~~~wyhg~i~r~~ae~ll~~--~~~G~fLvR~s~--~~~~~~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~F~sl~e 177 (495)
T 1opk_A 102 LEKHSWYHGPVSRNAAEYLLSS--GINGSFLVRESE--SSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAE 177 (495)
T ss_dssp GGGSTTEEEECCHHHHHHHGGG--CCTTEEEEEECS--SSTTCEEEEEEETTEEEEEECEECTTSCEESSTTSCBSSHHH
T ss_pred ccchhhhccCCCHHHHHHHhhC--CCCceEEEEeCC--CCCCceEEEEeeCCeEEEEEEEecCCCceEeccCccchhHHH
Confidence 5678999999999999987654 3457 9999988 7788899998741 1110000 000111
Q ss_pred HHhhccccccCCC-CcccccCcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEee
Q 015237 201 VLAKEIPKVENHH-HVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLT 277 (411)
Q Consensus 201 ~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~ 277 (411)
.+........... ....+..... .+.........+.|++....|++.++||+|+||.||+|.+. +..||||+++
T Consensus 178 Lv~~~~~~~~g~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~ 254 (495)
T 1opk_A 178 LVHHHSTVADGLITTLHYPAPKRN---KPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254 (495)
T ss_dssp HHHHHTTCCTTSSSCCCEECCCCS---CCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECC
T ss_pred Hhhhhcccccccchhccccccccc---cccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEec
Confidence 1110000000000 0000000000 00000011235789999999999999999999999999997 6889999998
Q ss_pred ccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHH
Q 015237 278 NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGM 356 (411)
Q Consensus 278 ~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL 356 (411)
..... .+.|.+|+.+|++++||||++++++|.....+|||||||++|+|.+++.... ..+++..++.++.||+.||
T Consensus 255 ~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L 331 (495)
T 1opk_A 255 EDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331 (495)
T ss_dssp SSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHH
T ss_pred Ccccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHH
Confidence 66433 4679999999999999999999999999999999999999999999998743 3588999999999999999
Q ss_pred HHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 357 ~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 332 ~~LH~~~ivHrDlkp~NIll~~~~------~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 332 EYLEKKNFIHRNLAARNCLVGENH------LVKVADFGLSRLMTG 370 (495)
T ss_dssp HHHHHTTEECSCCSGGGEEECGGG------CEEECCTTCEECCTT
T ss_pred HHHHhCCcccCCCChhhEEECCCC------cEEEeecccceeccC
Confidence 999999999999999999999887 599999999987643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.84 Aligned_cols=142 Identities=21% Similarity=0.324 Sum_probs=126.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~ 318 (411)
+.|++.++||+|+||.||+|+.+ ++.||||.+..... ...+.+|+.+|+.+ +|||||++++++...+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45999999999999999999863 47899999876532 24678999999998 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccC-CCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNEN-GVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~-g~~k~~~~ikL~DFGla~ 397 (411)
||||||+||+|.+++. .+++..+..++.||+.||.|||++|||||||||+|||++.+ + .+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~------~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK------KYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT------EEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC------eEEECcCCCCc
Confidence 9999999999999983 48999999999999999999999999999999999999876 4 59999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 167 ~~~ 169 (361)
T 4f9c_A 167 GTH 169 (361)
T ss_dssp ECT
T ss_pred ccC
Confidence 543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=260.67 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=177.9
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEec-----------C-C------CccchHHH
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVD-----------G-W------PLQETEQL 198 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd-----------~-w------~~~~~~~l 198 (411)
...++|+++.+.|.++...|.. ...| |.||++. +..+.|+|+|..-. + | ......++
T Consensus 77 ~~~~~wyhg~i~r~~ae~~L~~--~~~G~FlvR~S~--~~~g~~~Lsv~~~~~v~H~~I~~~~~~~~i~~~~~F~sl~eL 152 (450)
T 1k9a_A 77 LSLMPWFHGKITREQAERLLYP--PETGLFLVREST--NYPGDYTLCVSCEGKVEHYRIMYHASKLSIDEEVYFENLMQL 152 (450)
T ss_dssp EESCTTBCTTCCHHHHHHHTCS--CCTTEEEEEECS--SSTTSEEEEEECSSSEEEEEEEEETTEEESSSSSCBSSHHHH
T ss_pred cccccccccCcCHHHhhhhhcc--CCCceEEEEecC--CCCCceEEEEEeCCeeeEEEEEecCCceEeccccccccHHHH
Confidence 3556899999999999997743 2347 8899987 55677888885311 0 0 00111111
Q ss_pred HHHHhhccccccCCC-CcccccCcccccCCccccCCCCCCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEee
Q 015237 199 RNVLAKEIPKVENHH-HVVYPVGEQEQSGINHVNIPAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLT 277 (411)
Q Consensus 199 ~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~ 277 (411)
........ .... ....+... .+ ..........+.|+++.+.|++.++||+|+||.||+|.+.++.||||+++
T Consensus 153 v~~y~~~~---~~~~~~l~~~~~~---~~-~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~ 225 (450)
T 1k9a_A 153 VEHYTTDA---DGLCTRLIKPKVM---EG-TVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK 225 (450)
T ss_dssp HHHHHHCC---TTSSSCCCEECCC---TT-CEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEES
T ss_pred Hhhhcccc---cchhhhccccccc---cC-cccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeC
Confidence 11110000 0000 00000000 00 00000000135799999999999999999999999999999999999998
Q ss_pred ccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-eEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHH
Q 015237 278 NEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKG 355 (411)
Q Consensus 278 ~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~g 355 (411)
... ..+.|.+|+.+|++++||||+++++++.... .+|||||||++|+|.+++...+. .++...++.++.||+.|
T Consensus 226 ~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~ 301 (450)
T 1k9a_A 226 NDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301 (450)
T ss_dssp SCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHH
T ss_pred Cch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence 654 2367899999999999999999999987655 79999999999999999987653 37899999999999999
Q ss_pred HHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 356 MNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 356 L~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 302 l~~LH~~~ivHrDlkp~Nill~~~~------~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 302 MEYLEGNNFVHRDLAARNVLVSEDN------VAKVSDFGLTKEAS 340 (450)
T ss_dssp HHHHHHTTEECSCCCGGGEEECTTS------CEEECCCTTCEECC
T ss_pred HHHHHhCCeeCCCCCHhhEEECCCC------CEEEeeCCCccccc
Confidence 9999999999999999999999888 59999999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=269.27 Aligned_cols=152 Identities=20% Similarity=0.311 Sum_probs=136.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.+|+.++|||||+++++|.....+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 57999999999999999999986 6899999997653 3445778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
||+||+|.++|....+.+++..+..++.||+.||.|||++||+||||||+|||++.+.. -.+||+|||+|..+...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~----~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS----NELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC----CCEEECCCSSCEECCTT
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCC----CCEEEeeccceeEccCC
Confidence 99999999999766667999999999999999999999999999999999999986521 15899999999887543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.14 Aligned_cols=152 Identities=19% Similarity=0.259 Sum_probs=131.8
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC----HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~----~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
..++|++.+.||+|+||.||+++.. ++.||||++++.... .........++.+++.++|||||+++++|.+...
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3456999999999999999999986 689999999765321 1122223344667778899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|||||||+||+|.++|.+.+ .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|
T Consensus 267 lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G------~vKL~DFGlA 339 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG------HVRISDLGLA 339 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS------CEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC------CEEeccccee
Confidence 999999999999999998765 699999999999999999999999999999999999999999 5999999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
..+..
T Consensus 340 ~~~~~ 344 (689)
T 3v5w_A 340 CDFSK 344 (689)
T ss_dssp EECSS
T ss_pred eecCC
Confidence 87644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=234.23 Aligned_cols=153 Identities=35% Similarity=0.559 Sum_probs=140.0
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
..|.++.++|++.+.||+|+||.||+|.+. ++.||+|++....... +.+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 569999999999999999999999999985 6789999998765443 568999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~kl~Dfg~~ 153 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------VIKVSDFGMT 153 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG------CEEECCTTGG
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC------CEEecccccc
Confidence 9999999999999999987766799999999999999999999999999999999999998887 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
...
T Consensus 154 ~~~ 156 (269)
T 4hcu_A 154 RFV 156 (269)
T ss_dssp GGB
T ss_pred ccc
Confidence 865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=242.37 Aligned_cols=160 Identities=39% Similarity=0.592 Sum_probs=139.6
Q ss_pred CCCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 235 ~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...+.|+++..+|++.++||+|+||.||+|++.++.||||++..........+.+.+|+.+|++++||||+++++++...
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34568999999999999999999999999999999999999988776777778899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
..+|+||||+++|+|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++.++ .+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~------~~kL 180 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY------TVKV 180 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC------CEEE
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC------cEEE
Confidence 999999999999999999976532 3889999999999999999999999 99999999999999988 5999
Q ss_pred Eecccccccc
Q 015237 391 SNFLSISTVI 400 (411)
Q Consensus 391 ~DFGla~~~~ 400 (411)
+|||++....
T Consensus 181 ~Dfg~a~~~~ 190 (309)
T 3p86_A 181 CDFGLSRLKA 190 (309)
T ss_dssp CCCC------
T ss_pred CCCCCCcccc
Confidence 9999997543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=268.73 Aligned_cols=155 Identities=28% Similarity=0.477 Sum_probs=137.5
Q ss_pred CceeecCCceEEEE-EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 238 DVWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 238 ~~~ei~~~~~~~~~-~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
..|+++...+.+.. +||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+|++++||||++++++|.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35778888888755 8999999999999773 468999999876655556688999999999999999999999997
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
. +..+||||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~------~~kL~D 512 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH------YAKISD 512 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------EEEECC
T ss_pred c-CCEEEEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC------CEEEEE
Confidence 5 45899999999999999997654 689999999999999999999999999999999999999988 599999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||++..+.
T Consensus 513 FGla~~~~ 520 (635)
T 4fl3_A 513 FGLSKALR 520 (635)
T ss_dssp TTHHHHTT
T ss_pred cCCccccc
Confidence 99998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=241.09 Aligned_cols=151 Identities=25% Similarity=0.441 Sum_probs=138.9
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
....|++.+.||+|+||.||+|.+. ++.||||++.....+....+.+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3456999999999999999999984 78999999988776777778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~------~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM------NIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC------CEEEeeccCceecC
Confidence 99999999999997764 699999999999999999999999999999999999999988 59999999997653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-28 Score=234.89 Aligned_cols=155 Identities=28% Similarity=0.420 Sum_probs=141.0
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
.+.+..++|++.++||+|+||.||++.+. ++.||+|++... +....+.+.+|+.+|++++||||+++++++.....
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence 35677889999999999999999999986 688999988543 45567889999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.|+||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg~~ 155 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK------NVVVADFGLA 155 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS------CEEECCCTTC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC------CEEEeecccc
Confidence 9999999999999999998666799999999999999999999999999999999999999888 5999999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
..+..
T Consensus 156 ~~~~~ 160 (310)
T 3s95_A 156 RLMVD 160 (310)
T ss_dssp EECC-
T ss_pred eeccc
Confidence 87643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=265.91 Aligned_cols=154 Identities=25% Similarity=0.425 Sum_probs=136.7
Q ss_pred ceeecCCceEEEE-EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 239 VWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~-~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
.|.+....+.+.+ +||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+|++++||||++++++|..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 5677888888877 8999999999999874 3579999997653 22345789999999999999999999999986
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
+.+|||||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~------~vkL~DF 480 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH------YAKISDF 480 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------EEEECCC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC------cEEEeec
Confidence 569999999999999999987666799999999999999999999999999999999999999988 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 481 Gla~~~~ 487 (613)
T 2ozo_A 481 GLSKALG 487 (613)
T ss_dssp STTTTCC
T ss_pred cCccccc
Confidence 9998763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=229.61 Aligned_cols=154 Identities=31% Similarity=0.525 Sum_probs=140.9
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.|++..++|++.+.||+|+||.||++.+.+ ..||+|+++...... +.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 578999999999999999999999999875 579999998765443 5689999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~~l~Dfg~~~ 152 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL------CVKVSDFGMTR 152 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC------CEEECCTTCEE
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC------CEEEccCccce
Confidence 999999999999999988765699999999999999999999999999999999999999888 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
....
T Consensus 153 ~~~~ 156 (268)
T 3sxs_A 153 YVLD 156 (268)
T ss_dssp ECCT
T ss_pred ecch
Confidence 6644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=232.41 Aligned_cols=155 Identities=33% Similarity=0.598 Sum_probs=139.1
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
...|+++.++|++.++||+|+||.||++.+.+ ..||+|+++...... +.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 56799999999999999999999999999874 689999998765443 56889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~------~~kl~Dfg~ 166 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------VVKVSDFGL 166 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS------CEEECSTTG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC------CEEEccccc
Confidence 99999999999999999987555799999999999999999999999999999999999999888 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 167 ~~~~~ 171 (283)
T 3gen_A 167 SRYVL 171 (283)
T ss_dssp GGGBC
T ss_pred ccccc
Confidence 98653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-28 Score=238.73 Aligned_cols=156 Identities=33% Similarity=0.451 Sum_probs=140.8
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
.+++....|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46888999999999999999999999984 3459999997543 45556789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
...+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------~~kl~Df 195 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL------VCKVSDF 195 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC------CEEECCC
Confidence 9999999999999999999987766799999999999999999999999999999999999999888 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 196 g~a~~~~~ 203 (325)
T 3kul_A 196 GLSRVLED 203 (325)
T ss_dssp SSCEECC-
T ss_pred Cccccccc
Confidence 99987643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=241.90 Aligned_cols=156 Identities=25% Similarity=0.516 Sum_probs=139.4
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 307 (411)
..|++..+.|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+|+.+ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 458899999999999999999999999873 2469999997653 445567899999999999 89999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
+++|...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999998753 24788999999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEecccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||++.+| .+||+|||++..+.
T Consensus 233 NIll~~~~------~~kl~DFG~a~~~~ 254 (370)
T 2psq_A 233 NVLVTENN------VMKIADFGLARDIN 254 (370)
T ss_dssp GEEECTTC------CEEECCCSSCEETT
T ss_pred hEEECCCC------CEEEccccCCcccC
Confidence 99999988 59999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=232.97 Aligned_cols=153 Identities=27% Similarity=0.494 Sum_probs=135.1
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
.++...+|++.++||+|+||.||++++ .++.||||++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 467888999999999999999999986 3678999998754 34556789999999999999999999999854
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 314 --PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 314 --~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
...+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~------~~kl~ 156 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN------RVKIG 156 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------EEEEC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC------eEEEc
Confidence 3568999999999999999988765699999999999999999999999999999999999999988 69999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||++..+.
T Consensus 157 Dfg~~~~~~ 165 (295)
T 3ugc_A 157 DFGLTKVLP 165 (295)
T ss_dssp CCCSCC---
T ss_pred cCccccccc
Confidence 999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=226.40 Aligned_cols=153 Identities=36% Similarity=0.575 Sum_probs=140.2
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.|.++.++|++.+.||+|+||.||++.+. ++.||+|++....... +.+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 58999999999999999999999999985 5789999998765443 5789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~------~~kl~dfg~~~ 152 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------VIKVSDFGMTR 152 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG------CEEECCTTGGG
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC------CEEEccccccc
Confidence 999999999999999988766789999999999999999999999999999999999999887 59999999998
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 153 ~~~ 155 (267)
T 3t9t_A 153 FVL 155 (267)
T ss_dssp GBC
T ss_pred ccc
Confidence 653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=238.03 Aligned_cols=156 Identities=29% Similarity=0.550 Sum_probs=138.1
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
...|+++.++|++.++||+|+||.||+|.+. ++.||||+++... .....+.+.+|+.+|+++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 5679999999999999999999999999863 3689999997653 344567799999999999 799999999
Q ss_pred eeeecCCe-EEEEEecCCCCCHHHHHHhcCC-------------------------------------------------
Q 015237 309 GACTRPPR-LFIVTEFMSGGSIYDYLHKQKC------------------------------------------------- 338 (411)
Q Consensus 309 g~~~~~~~-l~IV~E~~~gGsL~~~L~~~~~------------------------------------------------- 338 (411)
++|...+. +|+|||||++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987554 9999999999999999986532
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 339 ----------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 339 ----------------~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~------~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN------VVKICDFGLARDI 243 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------CEEECCCGGGSCT
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC------cEEEEeccceeee
Confidence 188889999999999999999999999999999999999887 5999999999865
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=239.33 Aligned_cols=153 Identities=17% Similarity=0.276 Sum_probs=134.8
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEE-------ECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC---CCcee
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGA-------FFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVV 305 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~-------~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV 305 (411)
....+++....|++.++||+|+||.||+|. ..++.||||+++... ...+..|+.+++.++ |+||+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhh
Confidence 356789999999999999999999999994 236889999997653 256778888888886 99999
Q ss_pred EEEeeeecCCeEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc---
Q 015237 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHK----QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE--- 378 (411)
Q Consensus 306 ~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~----~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~--- 378 (411)
++++++...+..|||||||++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 999999999999999999999999999975 2346999999999999999999999999999999999999988
Q ss_pred --------CCCcCCCccEEEEeccccccc
Q 015237 379 --------NGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 379 --------~g~~k~~~~ikL~DFGla~~~ 399 (411)
++ .+||+|||+|..+
T Consensus 211 ~~~~~~~~~~------~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 211 EQDDEDDLSA------GLALIDLGQSIDM 233 (365)
T ss_dssp CC------CT------TEEECCCTTCEEG
T ss_pred CccccccccC------CEEEeeCchhhhh
Confidence 44 6999999999654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=231.74 Aligned_cols=157 Identities=34% Similarity=0.630 Sum_probs=134.3
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..+.|||....|++.++||+|+||.||+|++.+ .||+|+++.........+.+.+|+.++++++||||+++++++. ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CC
Confidence 456789999999999999999999999998765 5999999877766777788999999999999999999999764 45
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..++||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~------~~kl~Dfg~ 166 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN------TVKIGDFGL 166 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT------EEEECCCC-
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC------CEEEcccee
Confidence 68999999999999999977666799999999999999999999999999999999999999988 699999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+....
T Consensus 167 ~~~~~ 171 (289)
T 3og7_A 167 ATEKS 171 (289)
T ss_dssp -----
T ss_pred ccccc
Confidence 97553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=229.75 Aligned_cols=159 Identities=28% Similarity=0.415 Sum_probs=139.2
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEECC---------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
+++..++|++.+.||+|+||.||+|.+.. ..||+|++.... ....+.+.+|+.+|++++||||++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 46788899999999999999999998753 469999997653 3345779999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCC--ccE
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD--IHC 388 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~--~~i 388 (411)
+...+..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.. ..+
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999999998876569999999999999999999999999999999999999998843321 128
Q ss_pred EEEecccccccc
Q 015237 389 YLSNFLSISTVI 400 (411)
Q Consensus 389 kL~DFGla~~~~ 400 (411)
||+|||++....
T Consensus 161 kl~Dfg~~~~~~ 172 (289)
T 4fvq_A 161 KLSDPGISITVL 172 (289)
T ss_dssp EECCCCSCTTTS
T ss_pred eeccCccccccc
Confidence 999999997653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-28 Score=235.33 Aligned_cols=156 Identities=23% Similarity=0.412 Sum_probs=140.5
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
..|++..+.|++.+.||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3578889999999999999999999999864 789999997653 44556789999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK-----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~-----------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHR 367 (411)
+.....+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999999999999998742 458899999999999999999999999999
Q ss_pred CCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 368 DLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 368 DLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||+|||++.++ .+||+|||++..+.
T Consensus 199 Dlkp~NIl~~~~~------~~kl~Dfg~~~~~~ 225 (343)
T 1luf_A 199 DLATRNCLVGENM------VVKIADFGLSRNIY 225 (343)
T ss_dssp CCSGGGEEECGGG------CEEECCCSCHHHHT
T ss_pred CCCcceEEECCCC------eEEEeecCCCcccc
Confidence 9999999999887 59999999997653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=238.61 Aligned_cols=157 Identities=26% Similarity=0.505 Sum_probs=141.2
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC---------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQ 306 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~ 306 (411)
...|++..+.|++.++||+|+||.||+|.+.+ ..||+|+++... .....+.+.+|+.+++.+ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 45699999999999999999999999998742 469999997653 445567899999999999 9999999
Q ss_pred EEeeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 015237 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (411)
Q Consensus 307 l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp 371 (411)
++++|...+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998754 2489999999999999999999999999999999
Q ss_pred CcEEEccCCCcCCCccEEEEecccccccc
Q 015237 372 ANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 372 ~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+|||++.++ .+||+|||++..+.
T Consensus 220 ~NIll~~~~------~~kL~DFG~a~~~~ 242 (382)
T 3tt0_A 220 RNVLVTEDN------VMKIADFGLARDIH 242 (382)
T ss_dssp GGEEECTTC------CEEECSCSCCCCSS
T ss_pred ceEEEcCCC------cEEEcccCcccccc
Confidence 999999888 59999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=228.68 Aligned_cols=149 Identities=25% Similarity=0.394 Sum_probs=135.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.++||+|+||.||+|.+. ++.||+|+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46999999999999999999985 6889999998776666666789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+. |++.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~------~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG------ELKLANFGLARAFG 152 (292)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTTCEECC
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------CEEEeecccceecC
Confidence 996 577777776666799999999999999999999999999999999999999988 59999999997653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=229.68 Aligned_cols=158 Identities=27% Similarity=0.490 Sum_probs=141.7
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
...|+++.++|++.+.||+|+||.||+|++. ++.||+|+++... .....+.+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 4679999999999999999999999999862 4689999997654 334567899999999999 999999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKC-----------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~-----------------~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp 371 (411)
+++...+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999987542 388999999999999999999999999999999
Q ss_pred CcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 372 ANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 372 ~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+|||++.++ .+||+|||++..+..
T Consensus 174 ~Nil~~~~~------~~kl~Dfg~~~~~~~ 197 (313)
T 1t46_A 174 RNILLTHGR------ITKICDFGLARDIKN 197 (313)
T ss_dssp GGEEEETTT------EEEECCCGGGSCTTS
T ss_pred ceEEEcCCC------CEEEccccccccccc
Confidence 999999888 599999999987644
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-28 Score=235.55 Aligned_cols=154 Identities=25% Similarity=0.425 Sum_probs=137.1
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
+...|.++...|++.++||+|+||.||+|++.++.||||+++... .....+.+|+.+|++++||||+++++++....
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 356789999999999999999999999999999999999997543 23345667999999999999999999998643
Q ss_pred ----eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCcEEEccCCC
Q 015237 316 ----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN----------NIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 316 ----~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~----------gIIHRDLKp~NILid~~g~ 381 (411)
.+|+||||+++|+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~- 168 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL- 168 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-
Confidence 479999999999999999765 489999999999999999999999 999999999999999887
Q ss_pred cCCCccEEEEecccccccc
Q 015237 382 RDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~~ 400 (411)
.+||+|||++..+.
T Consensus 169 -----~~kL~DFg~a~~~~ 182 (322)
T 3soc_A 169 -----TACIADFGLALKFE 182 (322)
T ss_dssp -----CEEECCCTTCEEEC
T ss_pred -----eEEEccCCcccccc
Confidence 59999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=237.88 Aligned_cols=151 Identities=18% Similarity=0.310 Sum_probs=135.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+..++|++.+.||+|+||.||+++.. ++.||+|+++.... .......+.+|+.+|+.++||||+++++++.....+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45578999999999999999999986 68999999976532 1223467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+++.
T Consensus 82 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g------~vkL~DFG~a~~ 154 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC------CEEEeeccchhh
Confidence 9999999999999998764 689999999999999999999999999999999999999988 599999999986
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
.
T Consensus 155 ~ 155 (337)
T 1o6l_A 155 G 155 (337)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=242.66 Aligned_cols=156 Identities=30% Similarity=0.480 Sum_probs=134.6
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
..+++...|++.+.||+|+||.||+|++. +..||||+++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 35788899999999999999999999875 4679999997653 45566789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
...+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------~~kl~Df 191 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL------VCKVSDF 191 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CEEECCC
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC------CEEECcC
Confidence 9999999999999999999987766799999999999999999999999999999999999999888 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 192 g~a~~~~~ 199 (373)
T 2qol_A 192 GLGRVLED 199 (373)
T ss_dssp --------
T ss_pred cccccccc
Confidence 99987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=228.27 Aligned_cols=157 Identities=27% Similarity=0.451 Sum_probs=131.8
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
...|++....|++.+.||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.++++++||||+++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 4568999999999999999999999999885 2459999986543 445667899999999999999999999998
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 312 ~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.. +..|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 86 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~kl~ 158 (281)
T 1mp8_A 86 TE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND------CVKLG 158 (281)
T ss_dssp CS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------EEEEC
T ss_pred cc-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC------CEEEC
Confidence 54 568999999999999999987766799999999999999999999999999999999999999888 69999
Q ss_pred eccccccccc
Q 015237 392 NFLSISTVIL 401 (411)
Q Consensus 392 DFGla~~~~~ 401 (411)
|||++..+..
T Consensus 159 Dfg~~~~~~~ 168 (281)
T 1mp8_A 159 DFGLSRYMED 168 (281)
T ss_dssp C---------
T ss_pred ccccccccCc
Confidence 9999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=235.02 Aligned_cols=156 Identities=27% Similarity=0.505 Sum_probs=136.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g 309 (411)
..|+++.+.|++.+.||+|+||.||+|++. +..||+|+++... .....+.+.+|+.+|+++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 479999999999999999999999999972 3579999997543 233457799999999999 8999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKC----------------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~~----------------------~l~~~~i~~i~~qIa~gL~yLHs~gIIHR 367 (411)
++...+.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999987542 27888999999999999999999999999
Q ss_pred CCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 368 DLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 368 DLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||+|||++.++ .+||+|||++..+.
T Consensus 197 Dikp~NIll~~~~------~~kL~Dfg~~~~~~ 223 (344)
T 1rjb_A 197 DLAARNVLVTHGK------VVKICDFGLARDIM 223 (344)
T ss_dssp TCSGGGEEEETTT------EEEECCCGGGSCGG
T ss_pred CCChhhEEEcCCC------cEEeCCCccCcccc
Confidence 9999999999888 69999999998664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=236.70 Aligned_cols=155 Identities=21% Similarity=0.346 Sum_probs=141.9
Q ss_pred ceeecCCceEEEEEEeec--CceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 239 VWEIDASLLKFEHKIVSG--SYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~G--sfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+......|++.++||+| +||.||++++. ++.||||+++.........+.+.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 355677889999999999 99999999986 68999999988776677778899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
+.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------~~kl~df 172 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG------KVYLSGL 172 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCG
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC------CEEEccc
Confidence 9999999999999999999875 24689999999999999999999999999999999999999888 5999999
Q ss_pred cccccc
Q 015237 394 LSISTV 399 (411)
Q Consensus 394 Gla~~~ 399 (411)
|++..+
T Consensus 173 g~~~~~ 178 (389)
T 3gni_B 173 RSNLSM 178 (389)
T ss_dssp GGCEEC
T ss_pred ccceee
Confidence 998655
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=228.36 Aligned_cols=152 Identities=22% Similarity=0.359 Sum_probs=137.0
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+-...|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 44577999999999999999999875 68899999865432 4456678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 88 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~------~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK------TLKIFDFGIAKA 160 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECCCSSSTT
T ss_pred EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------CEEEEeCCCccc
Confidence 9999999999999998765 689999999999999999999999999999999999999888 599999999986
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 161 ~~ 162 (294)
T 4eqm_A 161 LS 162 (294)
T ss_dssp C-
T ss_pred cc
Confidence 54
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=248.07 Aligned_cols=154 Identities=23% Similarity=0.320 Sum_probs=128.4
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-- 313 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-- 313 (411)
..|++. +.|++.+.||+|+||.||+|.+. ++.||||++.....+....+.+.+|+.+|+.++||||+++++++..
T Consensus 47 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 47 SDWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SSCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CcCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 346664 67999999999999999999875 6899999997765566667889999999999999999999999843
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 314 ---PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 314 ---~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
...+|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~------~~kl 197 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC------SVKV 197 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC------CEEE
T ss_pred cccCceEEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC------CEee
Confidence 35699999998 679999997653 699999999999999999999999999999999999999988 5999
Q ss_pred Eecccccccc
Q 015237 391 SNFLSISTVI 400 (411)
Q Consensus 391 ~DFGla~~~~ 400 (411)
+|||+|..+.
T Consensus 198 ~DFGla~~~~ 207 (458)
T 3rp9_A 198 CDFGLARTVD 207 (458)
T ss_dssp CCCTTCBCTT
T ss_pred cccccchhcc
Confidence 9999998763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=227.98 Aligned_cols=158 Identities=27% Similarity=0.485 Sum_probs=136.9
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
.+...+....|++.++||+|+||.||++++ .++.||+|+++... .....+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 444567788899999999999999999985 36889999997653 22334678999999999999999999999
Q ss_pred eecC--CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccE
Q 015237 311 CTRP--PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 311 ~~~~--~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
+... ..+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~ 165 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH------QV 165 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT------EE
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC------CE
Confidence 9876 668999999999999999977766799999999999999999999999999999999999999988 69
Q ss_pred EEEeccccccccc
Q 015237 389 YLSNFLSISTVIL 401 (411)
Q Consensus 389 kL~DFGla~~~~~ 401 (411)
||+|||++..+..
T Consensus 166 kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 166 KIGDFGLTKAIET 178 (302)
T ss_dssp EECCCTTCEECCT
T ss_pred EECcccccccccC
Confidence 9999999987644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=229.17 Aligned_cols=157 Identities=27% Similarity=0.489 Sum_probs=140.5
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEe
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g 309 (411)
...|+++...|++.+.||+|+||.||++.+. ++.||+|+++... .....+.+.+|+.+|+.++||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 3568999999999999999999999999873 2689999997543 4555678999999999999999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKC-----------------------GLKLPLLLRVAIDVSKGMNYLHRNNIIH 366 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~~-----------------------~l~~~~i~~i~~qIa~gL~yLHs~gIIH 366 (411)
++...+..|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999987532 3788899999999999999999999999
Q ss_pred cCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 367 RDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 367 RDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||||+|||++.++ .+||+|||++..+.
T Consensus 174 ~dikp~NIli~~~~------~~kl~Dfg~~~~~~ 201 (314)
T 2ivs_A 174 RDLAARNILVAEGR------KMKISDFGLSRDVY 201 (314)
T ss_dssp CCCSGGGEEEETTT------EEEECCCTTCEECT
T ss_pred cccchheEEEcCCC------CEEEcccccccccc
Confidence 99999999999888 59999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=229.78 Aligned_cols=150 Identities=18% Similarity=0.346 Sum_probs=129.6
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-------
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------- 315 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------- 315 (411)
.+|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+|++++||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 45899999999999999999986 6899999997654 3345678999999999999999999999985543
Q ss_pred --------------------------------------------------eEEEEEecCCCCCHHHHHHhcCC--CCCHH
Q 015237 316 --------------------------------------------------RLFIVTEFMSGGSIYDYLHKQKC--GLKLP 343 (411)
Q Consensus 316 --------------------------------------------------~l~IV~E~~~gGsL~~~L~~~~~--~l~~~ 343 (411)
.+|+|||||++|+|.+++..... ...+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999987542 35566
Q ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 344 LLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 344 ~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------~~kL~DfG~a~~~~~ 216 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD------VVKVGDFGLVTAMDQ 216 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEECCCTTCEECSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC------CEEEeecCccccccc
Confidence 7899999999999999999999999999999999888 599999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=247.27 Aligned_cols=156 Identities=19% Similarity=0.269 Sum_probs=137.7
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.+.+..++|++.++||+|+||.||+|++. ++.||+|+++...... .....+.+|..++..++||||++++++|....
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34667788999999999999999999986 5789999997542211 11234888999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+|||||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g------~vkL~DFGl 221 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG------HIRLADFGS 221 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC------CEEEcchhh
Confidence 99999999999999999987656799999999999999999999999999999999999999998 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
|..+.
T Consensus 222 a~~~~ 226 (437)
T 4aw2_A 222 CLKLM 226 (437)
T ss_dssp CEECC
T ss_pred hhhcc
Confidence 97653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=231.09 Aligned_cols=153 Identities=25% Similarity=0.343 Sum_probs=134.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
+.-.+.|++.++||+|+||.||++++. ++.||+|+++...........+.+|+.+|++++||||+++++++.....+|+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 444577999999999999999999985 6889999998765555556788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||++ |+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 97 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~------~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG------ALKLADFGLARAF 169 (311)
T ss_dssp EEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEECCCTTCEET
T ss_pred EEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC------CEEEccCcCceec
Confidence 999996 589999887766799999999999999999999999999999999999999988 5999999999865
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 170 ~ 170 (311)
T 3niz_A 170 G 170 (311)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=224.01 Aligned_cols=155 Identities=26% Similarity=0.447 Sum_probs=140.2
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC--Ce
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP--PR 316 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~ 316 (411)
.++++.+.|++.++||+|+||.||+|++.++.||+|+++.........+.+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3678889999999999999999999999999999999988776677778899999999999999999999999877 78
Q ss_pred EEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
+++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .++++||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~------~~~l~~~ 157 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM------TARISMA 157 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS------CEEEEGG
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc------ceeEEec
Confidence 9999999999999999987643 4899999999999999999999999 99999999999999888 4778877
Q ss_pred cccccc
Q 015237 394 LSISTV 399 (411)
Q Consensus 394 Gla~~~ 399 (411)
|++...
T Consensus 158 ~~~~~~ 163 (271)
T 3kmu_A 158 DVKFSF 163 (271)
T ss_dssp GSCCTT
T ss_pred cceeee
Confidence 776543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=236.76 Aligned_cols=152 Identities=24% Similarity=0.380 Sum_probs=133.5
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.+..++|++.+.||+|+||.||++++. ++.||||+++.... .....+.+.+|..+|+.+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 466678999999999999999999986 68899999986532 223346688999999988 79999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+|||||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g------~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC------CEEEccccce
Confidence 999999999999999998765 699999999999999999999999999999999999999998 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
...
T Consensus 172 ~~~ 174 (353)
T 3txo_A 172 KEG 174 (353)
T ss_dssp BCS
T ss_pred eec
Confidence 864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-27 Score=229.76 Aligned_cols=152 Identities=15% Similarity=0.220 Sum_probs=134.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.+.||+|+||.||++.+. ++.||+|+++... .....+.+|+.+|+.++||||+++++++.....+|+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 357999999999999999999986 6889999987542 33467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~----~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS----STIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC----CCEEECCCTTCEECCT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCC----CCEEEEECCCCeECCC
Confidence 999999999999876657999999999999999999999999999999999999987321 1599999999987754
Q ss_pred c
Q 015237 402 V 402 (411)
Q Consensus 402 ~ 402 (411)
.
T Consensus 157 ~ 157 (321)
T 1tki_A 157 G 157 (321)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=232.87 Aligned_cols=153 Identities=23% Similarity=0.349 Sum_probs=128.4
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEE-----CCceEEEEEeeccccC--HHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
.++..+.|++.+.||+|+||.||+++. .++.||+|+++..... ......+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 467788899999999999999999987 3688999999865432 233456889999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
..+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~------~~kl~D 164 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLTD 164 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS------CEEECC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC------cEEEEe
Confidence 9999999999999999999998764 688999999999999999999999999999999999999988 599999
Q ss_pred ccccccc
Q 015237 393 FLSISTV 399 (411)
Q Consensus 393 FGla~~~ 399 (411)
||++...
T Consensus 165 fg~~~~~ 171 (327)
T 3a62_A 165 FGLCKES 171 (327)
T ss_dssp CSCC---
T ss_pred CCccccc
Confidence 9998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=229.51 Aligned_cols=147 Identities=23% Similarity=0.422 Sum_probs=132.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|++.++||+|+||.||+|.+. ++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 456888999999999999999864 6899999997654332 366889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~------~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------SVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC------CEEEeeCCCceecC
Confidence 999999999999765 489999999999999999999999999999999999999988 59999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=233.06 Aligned_cols=151 Identities=25% Similarity=0.360 Sum_probs=136.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
+...+|++.+.||+|+||.||++++. ++.||+|+++.... .....+.+.+|..+++++ +||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45567999999999999999999986 68899999987654 344567788999999988 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++.
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g------~~kL~DFG~a~ 158 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGMCK 158 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCGGGCB
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC------CEEEEeccccc
Confidence 99999999999999998764 699999999999999999999999999999999999999988 59999999998
Q ss_pred cc
Q 015237 398 TV 399 (411)
Q Consensus 398 ~~ 399 (411)
..
T Consensus 159 ~~ 160 (345)
T 3a8x_A 159 EG 160 (345)
T ss_dssp CS
T ss_pred cc
Confidence 64
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=230.19 Aligned_cols=157 Identities=25% Similarity=0.469 Sum_probs=140.2
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEe
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g 309 (411)
.+.|++..+.|++.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 4679999999999999999999999999865 4679999997543 3445567999999999999999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g 380 (411)
++......|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999997632 3468899999999999999999999999999999999999888
Q ss_pred CcCCCccEEEEecccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~~ 400 (411)
.+||+|||++..+.
T Consensus 176 ------~~kl~Dfg~~~~~~ 189 (322)
T 1p4o_A 176 ------TVKIGDFGMTRDIY 189 (322)
T ss_dssp ------CEEECCTTCCCGGG
T ss_pred ------eEEECcCccccccc
Confidence 59999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=242.01 Aligned_cols=156 Identities=21% Similarity=0.342 Sum_probs=139.2
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
..+++..+.|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.+|+.++||||++++++|...
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 346788899999999999999999999986 57899999976432 112346788999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+|+||||+.||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g------~vkL~DFG 160 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG------HVHITDFN 160 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC------CEEEeccc
Confidence 99999999999999999998654 699999999999999999999999999999999999999998 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 161 ~a~~~~ 166 (384)
T 4fr4_A 161 IAAMLP 166 (384)
T ss_dssp TCEECC
T ss_pred eeeecc
Confidence 998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=234.39 Aligned_cols=154 Identities=18% Similarity=0.312 Sum_probs=138.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|++.+.||+|+||.||++.+. ++.||+|++..........+.+.+|+.+|+.++||||+++++++......|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999986 689999999887766666788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++..+..
T Consensus 108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~---~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK---GAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSST---TCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC---CCCEEEeecCcceEecC
Confidence 9999999999997654 6899999999999999999999999999999999999987652 12489999999987643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.24 Aligned_cols=156 Identities=19% Similarity=0.260 Sum_probs=138.6
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.+++..++|++.+.||+|+||.||+++.. ++.||||+++.... .....+.+.+|..++..++||||+++++++....
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 35667788999999999999999999985 78999999975432 1122345789999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+|||||+||+|.+++.+.+..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g------~vkL~DFGl 208 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG------HIRLADFGS 208 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC------CEEEeechh
Confidence 99999999999999999987655799999999999999999999999999999999999999988 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 209 a~~~~ 213 (412)
T 2vd5_A 209 CLKLR 213 (412)
T ss_dssp CEECC
T ss_pred heecc
Confidence 98764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=239.86 Aligned_cols=154 Identities=24% Similarity=0.347 Sum_probs=135.0
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhc-CCCceeEEEeeeecC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKV-RHMNVVQFIGACTRP 314 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~ 314 (411)
...+...+|++.++||+|+||.||++++. ++.||+|+++...... ...+.+.+|..+|.++ +||||+++++++...
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 34567788999999999999999999986 5789999998764432 3345688899999887 899999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+|+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g------~ikL~DFG 198 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYG 198 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC------CEEEeecc
Confidence 99999999999999999998765 699999999999999999999999999999999999999998 59999999
Q ss_pred ccccc
Q 015237 395 SISTV 399 (411)
Q Consensus 395 la~~~ 399 (411)
+|+..
T Consensus 199 la~~~ 203 (396)
T 4dc2_A 199 MCKEG 203 (396)
T ss_dssp TCBCC
T ss_pred eeeec
Confidence 99863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=241.82 Aligned_cols=156 Identities=22% Similarity=0.290 Sum_probs=136.8
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...|++ ...|++.+.||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 19 IKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp GGGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 445565 367999999999999999999886 58899999987655566678899999999999999999999999765
Q ss_pred -----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 315 -----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 315 -----~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
..+|+||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~------~~k 169 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC------SVK 169 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEE
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC------CEE
Confidence 57999999995 69999997653 699999999999999999999999999999999999999988 599
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
|+|||+|..+..
T Consensus 170 L~DFGla~~~~~ 181 (432)
T 3n9x_A 170 VCDFGLARTINS 181 (432)
T ss_dssp ECCCTTCEEC--
T ss_pred EccCCCcccccc
Confidence 999999987643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=225.13 Aligned_cols=155 Identities=28% Similarity=0.567 Sum_probs=138.2
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.++|++..+.|++.+.||+|+||.||+|.+.+ +.||+|+++..... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 46799999999999999999999999999874 68999999765433 3678999999999999999999999875 4
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~kl~Dfg 154 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL------SCKIADFG 154 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS------CEEECCCT
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC------CEEECCCc
Confidence 5899999999999999997542 2589999999999999999999999999999999999999887 59999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
++..+..
T Consensus 155 ~~~~~~~ 161 (279)
T 1qpc_A 155 LARLIED 161 (279)
T ss_dssp TCEECSS
T ss_pred ccccccC
Confidence 9987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=226.18 Aligned_cols=156 Identities=35% Similarity=0.633 Sum_probs=141.7
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+.|++...+|++.++||+|+||.||+|.+. ++.||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 5689999999999999999999999999987 6889999997643 2356789999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~~l~Df 155 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH------LVKVADF 155 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG------CEEECCC
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC------CEEEccC
Confidence 99999999999999999998753 3589999999999999999999999999999999999999887 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++.....
T Consensus 156 g~~~~~~~ 163 (288)
T 3kfa_A 156 GLSRLMTG 163 (288)
T ss_dssp CGGGTSCS
T ss_pred ccceeccC
Confidence 99987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=227.88 Aligned_cols=149 Identities=25% Similarity=0.377 Sum_probs=133.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
++|++.++||+|+||.||++.+. ++.||+|++..........+.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46999999999999999999986 68999999976544333446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++ +|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++..+.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG------ELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------CEEEeECccccccC
Confidence 964 99999987666799999999999999999999999999999999999999988 59999999997653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=237.50 Aligned_cols=158 Identities=28% Similarity=0.464 Sum_probs=138.2
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
+.+++....|++.++||+|+||.||+|.+. ++.||||+++... .......+.+|+.++++++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456888999999999999999999999864 3579999996543 34455678999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~ 384 (411)
+......|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|..
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~-- 220 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG-- 220 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT--
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC--
Confidence 999999999999999999999998754 348899999999999999999999999999999999999966531
Q ss_pred CccEEEEeccccccc
Q 015237 385 DIHCYLSNFLSISTV 399 (411)
Q Consensus 385 ~~~ikL~DFGla~~~ 399 (411)
..+||+|||++..+
T Consensus 221 -~~~kL~DFG~a~~~ 234 (367)
T 3l9p_A 221 -RVAKIGDFGMARDI 234 (367)
T ss_dssp -CCEEECCCHHHHHH
T ss_pred -ceEEECCCcccccc
Confidence 14899999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-27 Score=230.30 Aligned_cols=156 Identities=29% Similarity=0.466 Sum_probs=136.8
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
.+++..+.|++.+.||+|+||.||+|.+.. ..||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 468999999999999999999999998753 359999997553 4455678999999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.....|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------~~kl~D 190 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------VCKVSD 190 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CEEECC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC------cEEECC
Confidence 99999999999999999999987766799999999999999999999999999999999999999887 599999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||++..+..
T Consensus 191 fg~~~~~~~ 199 (333)
T 1mqb_A 191 FGLSRVLED 199 (333)
T ss_dssp CCC------
T ss_pred CCcchhhcc
Confidence 999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=232.34 Aligned_cols=152 Identities=23% Similarity=0.381 Sum_probs=135.2
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+...+|++.+.||+|+||.||+++.. ++.||+|+++...... ...+.+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34567999999999999999999985 6899999997653211 23456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++..
T Consensus 83 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g------~~kL~Dfg~a~~ 155 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG------HIKITDFGFAKY 155 (318)
T ss_dssp EEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS------CEEECCCSSCEE
T ss_pred EEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC------CEEEeecCccee
Confidence 9999999999999998754 689999999999999999999999999999999999999988 599999999986
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 156 ~~ 157 (318)
T 1fot_A 156 VP 157 (318)
T ss_dssp CS
T ss_pred cC
Confidence 54
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-27 Score=229.25 Aligned_cols=158 Identities=25% Similarity=0.497 Sum_probs=140.7
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQ 306 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~ 306 (411)
...|++..+.|++.+.||+|+||.||+|.+. ++.||+|+++... .....+.+.+|+.+++.+ +||||++
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 4579999999999999999999999999874 3579999997653 445567899999999999 8999999
Q ss_pred EEeeeecCCeEEEEEecCCCCCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 015237 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKA 371 (411)
Q Consensus 307 l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~---------------~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp 371 (411)
+++++...+.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 99999999999999999999999999986532 378899999999999999999999999999999
Q ss_pred CcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 372 ANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 372 ~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+|||++.++ .+||+|||++..+..
T Consensus 186 ~NIll~~~~------~~kL~Dfg~~~~~~~ 209 (334)
T 2pvf_A 186 RNVLVTENN------VMKIADFGLARDINN 209 (334)
T ss_dssp GGEEECTTC------CEEECCCTTCEECTT
T ss_pred ceEEEcCCC------CEEEccccccccccc
Confidence 999999888 599999999986543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=230.61 Aligned_cols=159 Identities=23% Similarity=0.406 Sum_probs=126.0
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
...+.+....|++.+.||+|+||.||+|.+.. ..||||+++.........+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34578888999999999999999999998753 2799999987655555678899999999999999999999999
Q ss_pred ecCCeE------EEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 015237 312 TRPPRL------FIVTEFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (411)
Q Consensus 312 ~~~~~l------~IV~E~~~gGsL~~~L~~~~-----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g 380 (411)
...... ++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 876654 99999999999999997542 1488999999999999999999999999999999999999887
Q ss_pred CcCCCccEEEEeccccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~~~ 401 (411)
.+||+|||++..+..
T Consensus 175 ------~~kl~Dfg~a~~~~~ 189 (323)
T 3qup_A 175 ------TVCVADFGLSRKIYS 189 (323)
T ss_dssp ------CEEECCCCC------
T ss_pred ------CEEEeeccccccccc
Confidence 599999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=243.87 Aligned_cols=155 Identities=21% Similarity=0.269 Sum_probs=136.2
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.+++....|++.++||+|+||.||++++. ++.||+|+++...... ...+.+.+|+.+|+.++||||++++++|....
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 45677788999999999999999999986 6789999997532111 11234788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g------~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG------HLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC------CEEEeccce
Confidence 999999999999999999764 489999999999999999999999999999999999999998 599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
|..+..
T Consensus 215 a~~~~~ 220 (410)
T 3v8s_A 215 CMKMNK 220 (410)
T ss_dssp CEECCT
T ss_pred eEeecc
Confidence 976543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-27 Score=228.50 Aligned_cols=157 Identities=25% Similarity=0.509 Sum_probs=140.0
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
.+.|+++.+.|++.+.||+|+||.||+|.+.+ ..||+|+++... .....+.+.+|+.+|+.+ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 35799999999999999999999999999853 369999997654 344567899999999999 899999999
Q ss_pred eeeecCCeEEEEEecCCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 015237 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQ-------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLL 375 (411)
Q Consensus 309 g~~~~~~~l~IV~E~~~gGsL~~~L~~~-------------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NIL 375 (411)
+++...+.+|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999764 235788999999999999999999999999999999999
Q ss_pred EccCCCcCCCccEEEEecccccccc
Q 015237 376 MNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 376 id~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
++.++ .+||+|||++..+.
T Consensus 197 ~~~~~------~~kl~Dfg~~~~~~ 215 (333)
T 2i1m_A 197 LTNGH------VAKIGDFGLARDIM 215 (333)
T ss_dssp EEGGG------EEEBCCCGGGCCGG
T ss_pred ECCCC------eEEECccccccccc
Confidence 99887 59999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-27 Score=233.48 Aligned_cols=155 Identities=23% Similarity=0.365 Sum_probs=135.7
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+.|++.+.||+|+||.||++.+. ++.||+|+++...... ...+.+.+|+.+|+.++||||+++++++.....+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356999999999999999999986 6899999998754321 1346789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++... ..+||+|||++.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~--~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI--PHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS--CCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc--cCEEEEecCCce
Confidence 99999999999999997654 699999999999999999999999999999999999998776321 248999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 168 ~~~~ 171 (361)
T 2yab_A 168 EIED 171 (361)
T ss_dssp ECCT
T ss_pred EcCC
Confidence 7643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-27 Score=233.17 Aligned_cols=152 Identities=20% Similarity=0.347 Sum_probs=133.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.+..++|++.+.||+|+||.||++++. ++.||||+++.... .......+..|..++..+ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 466778999999999999999999986 68899999976532 112245678899999887 99999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g------~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC------CEEEeEChhh
Confidence 999999999999999998754 689999999999999999999999999999999999999988 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
+..
T Consensus 166 ~~~ 168 (345)
T 1xjd_A 166 KEN 168 (345)
T ss_dssp BCC
T ss_pred hhc
Confidence 864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=241.86 Aligned_cols=154 Identities=18% Similarity=0.303 Sum_probs=128.3
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
.+.+..+.|++.++||+|+||.||++... ++.||||+++.... .......+.+|+.+|+.++||||++++++|...+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 45677788999999999999999999885 68999999986532 2334466889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
.+|||||||++|+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.+| .+||+|||
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~------~~kl~DFG 294 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG------HIKITDFG 294 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS------CEEECCCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC------CEEEccCC
Confidence 9999999999999999998765 68999999999999999999998 9999999999999999988 59999999
Q ss_pred ccccc
Q 015237 395 SISTV 399 (411)
Q Consensus 395 la~~~ 399 (411)
+|...
T Consensus 295 ~a~~~ 299 (446)
T 4ejn_A 295 LCKEG 299 (446)
T ss_dssp CCCTT
T ss_pred Cceec
Confidence 99764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=222.40 Aligned_cols=154 Identities=26% Similarity=0.432 Sum_probs=138.0
Q ss_pred ceeecCCceEEEE-EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 239 VWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~-~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
.|.++..+|.+.+ .||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 5788889999887 9999999999999863 5779999997653 4455678999999999999999999999995
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
.+..++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~kl~Df 154 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH------YAKISDF 154 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT------EEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC------CEEECcc
Confidence 4569999999999999999987666799999999999999999999999999999999999999888 6999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 155 g~~~~~~ 161 (287)
T 1u59_A 155 GLSKALG 161 (287)
T ss_dssp TTCEECT
T ss_pred cceeeec
Confidence 9998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=233.56 Aligned_cols=153 Identities=20% Similarity=0.283 Sum_probs=136.2
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
...++|++.+.||+|+||.||++++. ++.||+|+++..... ....+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34567999999999999999999986 689999999765321 123467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++..
T Consensus 118 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g------~~kL~DFg~a~~ 190 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG------YIQVTDFGFAKR 190 (350)
T ss_dssp EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTTCEE
T ss_pred EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC------CEEEccccccee
Confidence 9999999999999998764 689999999999999999999999999999999999999988 599999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 191 ~~~ 193 (350)
T 1rdq_E 191 VKG 193 (350)
T ss_dssp CSS
T ss_pred ccC
Confidence 644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-27 Score=239.61 Aligned_cols=154 Identities=15% Similarity=0.260 Sum_probs=135.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||++... ++.||+|++..........+.+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 356999999999999999999885 789999999887666666778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|||.||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+.. ...+||+|||++..+..
T Consensus 90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~---~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLK---GAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSST---TCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCC---CCcEEEccCceeEEecC
Confidence 9999999999998765 6999999999999999999999999999999999999985421 11599999999977643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=224.19 Aligned_cols=149 Identities=24% Similarity=0.350 Sum_probs=135.6
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.++||+|+||.||+|.+. ++.||+|++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46999999999999999999986 6899999998776666667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS------VIKLCDFGFARLLT 153 (311)
T ss_dssp CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTTCEECC
T ss_pred eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC------CEEEeeCCCchhcc
Confidence 999999988887554 689999999999999999999999999999999999999888 59999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=231.29 Aligned_cols=147 Identities=24% Similarity=0.403 Sum_probs=130.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.++||+|+||.||++.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 56999999999999999999886 68899999976532 2234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~------~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD------NLKISDFGLATVF 155 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCCTTCEEC
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC------CEEEEEeecccee
Confidence 999999999997653 689999999999999999999999999999999999999988 5999999999765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=224.21 Aligned_cols=156 Identities=28% Similarity=0.475 Sum_probs=135.3
Q ss_pred CceeecCCceEEEE-EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 238 DVWEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 238 ~~~ei~~~~~~~~~-~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
..+.++...|++.+ .||+|+||.||+|.+. ++.||||+++.........+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 45788899999998 9999999999999763 47899999987654555678899999999999999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
..+..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~------~~kl~D 160 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH------YAKISD 160 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT------EEEECC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC------cEEEcc
Confidence 4567899999999999999998754 689999999999999999999999999999999999999988 699999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||++..+..
T Consensus 161 fg~~~~~~~ 169 (291)
T 1xbb_A 161 FGLSKALRA 169 (291)
T ss_dssp CTTCEECCT
T ss_pred CCcceeecc
Confidence 999987643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=219.39 Aligned_cols=154 Identities=18% Similarity=0.312 Sum_probs=138.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||+|.+. ++.||+|++..........+.+.+|+.++++++||||+++++++......|+||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999886 689999999887777777788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++. ...+||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAK---GAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSST---TCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCC---CCcEEEeeceeeEEccc
Confidence 9999999999987764 6899999999999999999999999999999999999987663 12489999999976543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=220.70 Aligned_cols=156 Identities=23% Similarity=0.402 Sum_probs=137.8
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT 312 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 312 (411)
..|.+..+.|++.+.||+|+||.||+|.+.+ ..||+|+++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 4578889999999999999999999998753 349999987653 3445678999999999999999999999987
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.. ..|+||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~kl~D 156 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE------CVKLGD 156 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT------EEEECC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC------cEEeCc
Confidence 54 57999999999999999988766799999999999999999999999999999999999999988 699999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||++..+..
T Consensus 157 fg~~~~~~~ 165 (281)
T 3cc6_A 157 FGLSRYIED 165 (281)
T ss_dssp CCGGGCC--
T ss_pred cCCCccccc
Confidence 999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=220.57 Aligned_cols=159 Identities=28% Similarity=0.476 Sum_probs=128.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccC--HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+++..+|++.+.||+|+||.||+|.+.++.||+|+++..... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 577889999999999999999999999999999998765322 223467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEEccCCCc--CCCccEEEEec
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN---IIHRDLKAANLLMNENGVR--DSDIHCYLSNF 393 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g---IIHRDLKp~NILid~~g~~--k~~~~ikL~DF 393 (411)
+||||+++++|.+++... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.. .....+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999999643 5899999999999999999999999 8999999999999874211 01225999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 161 g~~~~~~~ 168 (271)
T 3dtc_A 161 GLAREWHR 168 (271)
T ss_dssp CC------
T ss_pred Cccccccc
Confidence 99976543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=226.65 Aligned_cols=152 Identities=27% Similarity=0.368 Sum_probs=128.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH------------------------HHHHHHHHHHHH
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE------------------------NIRREFAQEVHI 295 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~------------------------~~~~~~~~Ei~i 295 (411)
+....|++.+.||+|+||.||+|+.. ++.||||++....... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44567999999999999999999885 6889999997654211 123568999999
Q ss_pred HhhcCCCceeEEEeeeec--CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 296 MRKVRHMNVVQFIGACTR--PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 296 L~~l~HpNIV~l~g~~~~--~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
|++++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999986 5679999999999999886543 358999999999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEeccccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||++.++ .+||+|||++..+..
T Consensus 168 il~~~~~------~~kl~Dfg~~~~~~~ 189 (298)
T 2zv2_A 168 LLVGEDG------HIKIADFGVSNEFKG 189 (298)
T ss_dssp EEECTTS------CEEECCCTTCEECSS
T ss_pred EEECCCC------CEEEecCCCcccccc
Confidence 9999988 599999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=231.50 Aligned_cols=151 Identities=23% Similarity=0.288 Sum_probs=132.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
.....+|++.++||+|+||.||+++.. ++.||||++...... .+.+.+|+.+++.++||||+++++++.....+|
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 456678999999999999999999985 688999999765432 256889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.. .+||+|||++..
T Consensus 93 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~----~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP----RLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSC----CEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCc----eEEEeecCcccc
Confidence 9999999999999997755 69999999999999999999999999999999999999876631 389999999874
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
.
T Consensus 168 ~ 168 (361)
T 3uc3_A 168 S 168 (361)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=225.65 Aligned_cols=153 Identities=24% Similarity=0.368 Sum_probs=132.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC--eE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RL 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--~l 317 (411)
+....|++.++||+|+||.||+|.+. ++.||||+++..... ...+.+.+|+.+|++++||||+++++++.... .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44567999999999999999999987 689999999764422 22466789999999999999999999987655 78
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----ccCCCcCCCccEEEE
Q 015237 318 FIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVRDSDIHCYLS 391 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi----d~~g~~k~~~~ikL~ 391 (411)
|+||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~------~~kL~ 158 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS------VYKLT 158 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE------EEEEC
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc------eEEEc
Confidence 999999999999999986532 38999999999999999999999999999999999998 4444 58999
Q ss_pred eccccccccc
Q 015237 392 NFLSISTVIL 401 (411)
Q Consensus 392 DFGla~~~~~ 401 (411)
|||++..+..
T Consensus 159 Dfg~a~~~~~ 168 (319)
T 4euu_A 159 DFGAARELED 168 (319)
T ss_dssp CCTTCEECCT
T ss_pred cCCCceecCC
Confidence 9999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=217.94 Aligned_cols=157 Identities=19% Similarity=0.315 Sum_probs=134.7
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+|++.+.||+|+||.||+|.+. ++.||+|+++...........+.+|+.++..+ +||||+++++++...+.+|+||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56899999999999999999986 78999999987655555567889999999999 9999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC-------------CC
Q 015237 322 EFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD-------------SD 385 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k-------------~~ 385 (411)
||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+ ..
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999999997652 4689999999999999999999999999999999999998765221 12
Q ss_pred ccEEEEeccccccccc
Q 015237 386 IHCYLSNFLSISTVIL 401 (411)
Q Consensus 386 ~~ikL~DFGla~~~~~ 401 (411)
..+||+|||++.....
T Consensus 171 ~~~kl~Dfg~~~~~~~ 186 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISS 186 (289)
T ss_dssp CCEEECCCTTCEETTC
T ss_pred eEEEEcccccccccCC
Confidence 3589999999987644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=234.75 Aligned_cols=147 Identities=20% Similarity=0.333 Sum_probs=123.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCC--eEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPP--RLF 318 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~--~l~ 318 (411)
..+|++.++||+|+||.||+|.+. ++.||||++..........+.+.+|+.+|+.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 357999999999999999999885 689999999766556666778899999999997 999999999997544 699
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+|||||. |+|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 88 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~------~~kl~DFG~a~~ 158 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC------HVKVADFGLSRS 158 (388)
T ss_dssp EEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEECCCTTCEE
T ss_pred EEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC------CEEecCCccccc
Confidence 9999996 6999999764 589999999999999999999999999999999999999988 599999999986
Q ss_pred c
Q 015237 399 V 399 (411)
Q Consensus 399 ~ 399 (411)
+
T Consensus 159 ~ 159 (388)
T 3oz6_A 159 F 159 (388)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=224.24 Aligned_cols=153 Identities=21% Similarity=0.225 Sum_probs=134.6
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
++-...|++.++||+|+||.||+|.+. ++.||||++............+..|+..+..+ +||||++++++|.....+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344578999999999999999999986 68999999877655555555666777666665 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+ +++|.+++...+..+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~------~~kl~DFG~a~ 205 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG------RCKLGDFGLLV 205 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG------CEEECCCTTCE
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC------CEEEccceeee
Confidence 9999999 7899999988776799999999999999999999999999999999999999888 59999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 206 ~~~ 208 (311)
T 3p1a_A 206 ELG 208 (311)
T ss_dssp ECC
T ss_pred ecc
Confidence 664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=232.27 Aligned_cols=152 Identities=19% Similarity=0.305 Sum_probs=133.5
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 316 (411)
.+...+|++.+.||+|+||.||++++. ++.||||+++.... .....+.+..|..+|..+ +||||+++++++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456678999999999999999999986 47899999986532 112346688999999988 89999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g------~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC------cEEEEeCCcc
Confidence 999999999999999998764 699999999999999999999999999999999999999988 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
...
T Consensus 169 ~~~ 171 (353)
T 2i0e_A 169 KEN 171 (353)
T ss_dssp BCC
T ss_pred ccc
Confidence 864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-28 Score=240.85 Aligned_cols=158 Identities=17% Similarity=0.218 Sum_probs=128.8
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECCceEEEEEeecccc------CHHHHHHHHHHHHHHhhcC---------CCceeE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHL------NENIRREFAQEVHIMRKVR---------HMNVVQ 306 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~------~~~~~~~~~~Ei~iL~~l~---------HpNIV~ 306 (411)
+...+|++.++||+|+||.||+|+++++.||||+++.... .....+.+.+|+.+|+.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4567789999999999999999999999999999986542 1223467889999998886 777776
Q ss_pred EEeee-----------------ec-------------CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 015237 307 FIGAC-----------------TR-------------PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356 (411)
Q Consensus 307 l~g~~-----------------~~-------------~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL 356 (411)
+.+.+ .. ...+|||||||++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 66653 22 6789999999999987776644 3589999999999999999
Q ss_pred HHHH-HCCccccCCCCCcEEEccCCCcCC--------------CccEEEEeccccccccc
Q 015237 357 NYLH-RNNIIHRDLKAANLLMNENGVRDS--------------DIHCYLSNFLSISTVIL 401 (411)
Q Consensus 357 ~yLH-s~gIIHRDLKp~NILid~~g~~k~--------------~~~ikL~DFGla~~~~~ 401 (411)
.||| ++||+||||||+|||++.++.... ...+||+|||+|+.+..
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 9999 999999999999999998862211 12699999999987644
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=231.68 Aligned_cols=156 Identities=19% Similarity=0.259 Sum_probs=133.5
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC---HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
-.+.|++.+.||+|+||.||++.+. ++.||||++...... ....+.+.+|+.+|+.++||||+++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999885 689999999754211 11246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 318 FIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~---~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS---APVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTT---CCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCC---CcEEEecCc
Confidence 9999999999999888654 2348999999999999999999999999999999999999876521 248999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
++..+..
T Consensus 179 ~a~~~~~ 185 (351)
T 3c0i_A 179 VAIQLGE 185 (351)
T ss_dssp TCEECCT
T ss_pred ceeEecC
Confidence 9987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=226.03 Aligned_cols=153 Identities=20% Similarity=0.338 Sum_probs=134.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
..|++.+.||+|+||.||++.+. ++.||+|+++...... ...+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56899999999999999999986 6899999998654321 13467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++... ..+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~--~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK--PRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS--CCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC--CCEEEEECCCCeE
Confidence 9999999999999997654 689999999999999999999999999999999999998877322 2589999999987
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 168 ~~ 169 (326)
T 2y0a_A 168 ID 169 (326)
T ss_dssp CC
T ss_pred CC
Confidence 63
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=224.53 Aligned_cols=152 Identities=24% Similarity=0.444 Sum_probs=136.0
Q ss_pred eecCCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee--
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-- 312 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~-- 312 (411)
-+....|++.++||+|+||.||++++ .++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 36678899999999999999999986 3578999999765 3455677999999999999999999999886
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
....+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~------~~kl~D 170 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA------HVKIAD 170 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT------EEEECC
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC------CEEEcc
Confidence 45679999999999999999987655699999999999999999999999999999999999999988 699999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||++..+.
T Consensus 171 fg~~~~~~ 178 (327)
T 3lxl_A 171 FGLAKLLP 178 (327)
T ss_dssp GGGCEECC
T ss_pred cccceecc
Confidence 99998664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=227.11 Aligned_cols=152 Identities=20% Similarity=0.327 Sum_probs=131.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC---
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--- 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--- 315 (411)
.-.+.|++.+.||+|+||.||++.+. ++.||||+++.... +......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34567999999999999999999975 68999999987543 3455678999999999999999999999987543
Q ss_pred -eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 316 -RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 -~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg 161 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN------AVKVMDFG 161 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS------CEEECCCS
T ss_pred cccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC------CEEEeecc
Confidence 3499999999999999998764 689999999999999999999999999999999999999888 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 162 ~a~~~~ 167 (311)
T 3ork_A 162 IARAIA 167 (311)
T ss_dssp CC----
T ss_pred Cccccc
Confidence 997653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=223.87 Aligned_cols=157 Identities=29% Similarity=0.555 Sum_probs=138.0
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
...|++..+.|++.+.||+|+||.||+|.+. ++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4578999999999999999999999999863 3789999997653 344557799999999999 799999999
Q ss_pred eeeecCC-eEEEEEecCCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 309 GACTRPP-RLFIVTEFMSGGSIYDYLHKQKCG---------------LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 309 g~~~~~~-~l~IV~E~~~gGsL~~~L~~~~~~---------------l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
+++...+ .+|+||||+++|+|.+++...... +++..++.++.|++.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987654 499999999999999999875432 788999999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEecccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||++.++ .+||+|||++..+.
T Consensus 178 Nil~~~~~------~~kl~Dfg~~~~~~ 199 (316)
T 2xir_A 178 NILLSEKN------VVKICDFGLARDIY 199 (316)
T ss_dssp GEEECGGG------CEEECCCGGGSCTT
T ss_pred eEEECCCC------CEEECCCccccccc
Confidence 99999887 59999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=223.72 Aligned_cols=160 Identities=24% Similarity=0.440 Sum_probs=133.7
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
....+.++.+.|++.+.||+|+||.||+|++.. +.||+|+++.........+.+.+|+.++++++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 356788999999999999999999999998752 479999998776666667889999999999999999999999
Q ss_pred eecCC-----eEEEEEecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 015237 311 CTRPP-----RLFIVTEFMSGGSIYDYLHKQ-----KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (411)
Q Consensus 311 ~~~~~-----~l~IV~E~~~gGsL~~~L~~~-----~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g 380 (411)
+.... ..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 97654 359999999999999998532 23689999999999999999999999999999999999999888
Q ss_pred CcCCCccEEEEeccccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~~~ 401 (411)
.+||+|||++..+..
T Consensus 185 ------~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 185 ------TVCVADFGLSKKIYS 199 (313)
T ss_dssp ------CEEECSCSCC-----
T ss_pred ------cEEEeecCcceeccc
Confidence 599999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=227.24 Aligned_cols=154 Identities=21% Similarity=0.268 Sum_probs=133.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~ 318 (411)
+-...|++.+.||+|+||.||+|... ++.||||++...... +.+.+|+.+++.+ +||||+++++++......|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34577999999999999999999964 789999999765432 3578999999999 9999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++... ...+||+|||++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~-~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKT-QQVIHIIDFALAKE 159 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTC-TTSEEECCCTTCEE
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCC-CceEEEEEccccee
Confidence 999999 9999999987656799999999999999999999999999999999999999877311 11399999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 160 ~~~ 162 (330)
T 2izr_A 160 YID 162 (330)
T ss_dssp SBC
T ss_pred eec
Confidence 643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=222.43 Aligned_cols=154 Identities=33% Similarity=0.554 Sum_probs=132.3
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-C
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-P 315 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~ 315 (411)
...|.++.++|++.+.||+|+||.||++++.++.||+|+++... ..+.+.+|+.++++++||||+++++++... +
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 45689999999999999999999999999999999999997653 346789999999999999999999987554 4
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
.+|+||||+++|+|.+++..... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~~l~Dfg 162 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------VAKVSDFG 162 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------CEEECCCC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC------cEEEeecc
Confidence 79999999999999999986532 378899999999999999999999999999999999999888 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++....
T Consensus 163 ~~~~~~ 168 (278)
T 1byg_A 163 LTKEAS 168 (278)
T ss_dssp C-----
T ss_pred cccccc
Confidence 987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=230.84 Aligned_cols=149 Identities=23% Similarity=0.460 Sum_probs=132.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|++.+.||+|+||.||+|.+. ++.||+|++....... .....+.+|+.+|+.++||||+++++++..+..+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356999999999999999999984 6899999997543211 1235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+ +|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~------~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL------NVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC------CEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC------CEEEEEeccceecc
Confidence 9999 789999997764 699999999999999999999999999999999999999888 59999999997654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=222.71 Aligned_cols=153 Identities=27% Similarity=0.462 Sum_probs=135.5
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
..+....|++.++||+|+||.||++.+ .++.||||+++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 346666679999999999999999876 35789999998653 44556789999999999999999999999987
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 314 --PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 314 --~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
...+|+||||+++|+|.+++.... +++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~------~~kl~ 176 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR------LVKIG 176 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEEC
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC------CEEEC
Confidence 467899999999999999997654 89999999999999999999999999999999999999888 59999
Q ss_pred eccccccccc
Q 015237 392 NFLSISTVIL 401 (411)
Q Consensus 392 DFGla~~~~~ 401 (411)
|||++..+..
T Consensus 177 Dfg~a~~~~~ 186 (318)
T 3lxp_A 177 DFGLAKAVPE 186 (318)
T ss_dssp CGGGCEECCT
T ss_pred Cccccccccc
Confidence 9999987644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=232.77 Aligned_cols=152 Identities=23% Similarity=0.388 Sum_probs=127.1
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHH-HhhcCCCceeEEEeeeecCCe
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHI-MRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~i-L~~l~HpNIV~l~g~~~~~~~ 316 (411)
.+..++|++.+.||+|+||.||++++. ++.||||+++..... ......+.+|..+ ++.++||||+++++++.....
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 455678999999999999999999986 578999999876543 2334556777776 577899999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g------~ikL~DFG~a 186 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGLC 186 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECCCCBC
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC------CEEEeeCccc
Confidence 999999999999999998764 689999999999999999999999999999999999999988 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
...
T Consensus 187 ~~~ 189 (373)
T 2r5t_A 187 KEN 189 (373)
T ss_dssp GGG
T ss_pred ccc
Confidence 864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=233.21 Aligned_cols=153 Identities=25% Similarity=0.398 Sum_probs=130.1
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|++. ..|++.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 19 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SEECCB-SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeeec-ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 456664 67999999999999999999985 689999999766556666788999999999999999999999997653
Q ss_pred ------eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ------~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------~~k 168 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC------ELK 168 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEE
T ss_pred ccccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC------CEE
Confidence 469999999 88999999864 589999999999999999999999999999999999999988 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++....
T Consensus 169 l~Dfg~a~~~~ 179 (367)
T 1cm8_A 169 ILDFGLARQAD 179 (367)
T ss_dssp ECCCTTCEECC
T ss_pred EEeeecccccc
Confidence 99999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=230.55 Aligned_cols=151 Identities=15% Similarity=0.277 Sum_probs=134.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.+.||+|+||.||+|... ++.||+|++.... ......+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 57999999999999999999986 6889999997653 3344678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++..+..
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~----~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKA----SSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTC----CCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCC----CceEEEecccceecCC
Confidence 99999999999876657999999999999999999999999999999999999985431 1599999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-26 Score=217.03 Aligned_cols=154 Identities=29% Similarity=0.495 Sum_probs=136.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----C
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----P 314 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~ 314 (411)
..+...|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 345566899999999999999999986 5789999998877777778889999999999999999999998864 4
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEc-cCCCcCCCccEEEE
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMN-ENGVRDSDIHCYLS 391 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid-~~g~~k~~~~ikL~ 391 (411)
..+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++ .++ .+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~------~~kl~ 174 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG------SVKIG 174 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS------CEEEC
T ss_pred ceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC------CEEEe
Confidence 56899999999999999998754 6899999999999999999999999 99999999999997 566 59999
Q ss_pred eccccccccc
Q 015237 392 NFLSISTVIL 401 (411)
Q Consensus 392 DFGla~~~~~ 401 (411)
|||++.....
T Consensus 175 Dfg~~~~~~~ 184 (290)
T 1t4h_A 175 DLGLATLKRA 184 (290)
T ss_dssp CTTGGGGCCT
T ss_pred eCCCcccccc
Confidence 9999975433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=225.94 Aligned_cols=152 Identities=27% Similarity=0.483 Sum_probs=130.0
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--Cc----eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+...+|++.++||+|+||.||+|++. ++ +||+|.++... .....+.+.+|+.++++++||||++++++|...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 466788999999999999999999875 33 36888876433 233457799999999999999999999999876
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
. .++++||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~------~~kl~Dfg 162 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ------HVKITDFG 162 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT------EEEECCTT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC------CEEEccCc
Confidence 4 8899999999999999988777799999999999999999999999999999999999999988 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 163 ~a~~~~ 168 (327)
T 3poz_A 163 LAKLLG 168 (327)
T ss_dssp HHHHHT
T ss_pred ceeEcc
Confidence 998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=221.58 Aligned_cols=145 Identities=26% Similarity=0.553 Sum_probs=126.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhh--cCCCceeEEEeeeec----CC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTR----PP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~--l~HpNIV~l~g~~~~----~~ 315 (411)
+-.++|++.++||+|+||.||+|++.++.||||++.... ...+.+|.+++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 445679999999999999999999999999999986542 2456667777766 799999999998654 34
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH--------RNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLH--------s~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
.+|+||||+++|+|.++++.. .+++..++.++.|++.||.||| +++|+||||||+|||++.++ .
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~------~ 151 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG------Q 151 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS------C
T ss_pred eeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC------C
Confidence 589999999999999999643 5899999999999999999999 99999999999999999888 5
Q ss_pred EEEEeccccccc
Q 015237 388 CYLSNFLSISTV 399 (411)
Q Consensus 388 ikL~DFGla~~~ 399 (411)
+||+|||++...
T Consensus 152 ~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 152 CCIADLGLAVMH 163 (301)
T ss_dssp EEECCCTTCEEE
T ss_pred EEEeeCCCeeec
Confidence 999999999654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=221.73 Aligned_cols=155 Identities=19% Similarity=0.333 Sum_probs=136.1
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee--
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-- 312 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~-- 312 (411)
.+.+.++.++|++.+.||+|+||.||++... ++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4568899999999999999999999999974 689999998654 3455678999999999999999999999986
Q ss_pred --cCCeEEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 313 --RPPRLFIVTEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 313 --~~~~l~IV~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
.....|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~------~ 172 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG------Q 172 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS------C
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC------C
Confidence 345789999999999999999763 44689999999999999999999999999999999999999888 5
Q ss_pred EEEEeccccccc
Q 015237 388 CYLSNFLSISTV 399 (411)
Q Consensus 388 ikL~DFGla~~~ 399 (411)
+||+|||++...
T Consensus 173 ~kl~dfg~~~~~ 184 (317)
T 2buj_A 173 PVLMDLGSMNQA 184 (317)
T ss_dssp EEECCCSSCEES
T ss_pred EEEEecCcchhc
Confidence 999999987764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=218.57 Aligned_cols=150 Identities=21% Similarity=0.381 Sum_probs=134.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
..|++.+.||+|+||.||+|+.. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 46999999999999999999974 7899999997543211 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~------~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM------NIKIADFGLATQLK 163 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC------CEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC------CEEEEeecceeecc
Confidence 99999999999987766799999999999999999999999999999999999999888 59999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-26 Score=222.87 Aligned_cols=156 Identities=28% Similarity=0.489 Sum_probs=136.2
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEE------CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF------FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~------~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
+...+....|++.++||+|+||.||++++ .++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34567788899999999999999999986 3678999999764 334567899999999999999999999998
Q ss_pred ecCC--eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 312 TRPP--RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 312 ~~~~--~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.... .+++||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~------~~k 185 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN------RVK 185 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT------EEE
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC------cEE
Confidence 7644 68999999999999999988766799999999999999999999999999999999999999988 699
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
|+|||++..+..
T Consensus 186 L~Dfg~~~~~~~ 197 (326)
T 2w1i_A 186 IGDFGLTKVLPQ 197 (326)
T ss_dssp ECCCTTCEECCS
T ss_pred EecCcchhhccc
Confidence 999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-26 Score=225.12 Aligned_cols=152 Identities=18% Similarity=0.257 Sum_probs=136.4
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--CceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~~ 316 (411)
.++....|++.++||+|+||.||++... ++.||||++..........+.+.+|+.+|+.++| |||+++++++.....
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4677888999999999999999999875 5789999998776667777889999999999987 999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|||||+ .+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+++ + .+||+|||++
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~------~~kl~DFG~a 154 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G------MLKLIDFGIA 154 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T------EEEECCCSSS
T ss_pred EEEEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C------cEEEeecccc
Confidence 9999995 4889999998764 6899999999999999999999999999999999999973 4 4899999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 155 ~~~~ 158 (343)
T 3dbq_A 155 NQMQ 158 (343)
T ss_dssp CCC-
T ss_pred cccC
Confidence 8764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=219.00 Aligned_cols=155 Identities=24% Similarity=0.308 Sum_probs=126.6
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
|++..++|++.++||+|+||.||++.+ .++.||+|+++.........+.+.++...++.++||||+++++++...+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 678889999999999999999999998 478999999976644444444555666668889999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 318 FIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
|+||||++ |+|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~------~~kl~Df 154 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG------QVKMCDF 154 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC------CEEBCCC
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC------CEEEeec
Confidence 99999996 588887764 344799999999999999999999998 999999999999999888 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 155 g~~~~~~~ 162 (290)
T 3fme_A 155 GISGYLVD 162 (290)
T ss_dssp --------
T ss_pred CCcccccc
Confidence 99976543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-26 Score=219.35 Aligned_cols=150 Identities=23% Similarity=0.429 Sum_probs=130.8
Q ss_pred CceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee-cCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT-RPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~-~~~~l~ 318 (411)
..|++.++||+|+||.||+|++.. ..||+|.+.... .....+.+.+|+.++++++||||++++++|. ..+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 457889999999999999998742 358999987543 4455678999999999999999999999864 456789
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~------~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF------TVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC------CEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC------CEEECccccccc
Confidence 99999999999999987666789999999999999999999999999999999999999888 599999999986
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 178 ~~~ 180 (298)
T 3f66_A 178 MYD 180 (298)
T ss_dssp CSC
T ss_pred ccc
Confidence 543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-26 Score=218.44 Aligned_cols=155 Identities=23% Similarity=0.406 Sum_probs=133.0
Q ss_pred ceeecCCc--eEEEEEEeecCceEEEEEEEC--C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 239 VWEIDASL--LKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 239 ~~ei~~~~--~~~~~~IG~Gsfg~Vy~g~~~--~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
++.++... |++.++||+|+||.||+|.+. + ..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIM 91 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34555544 455799999999999999874 2 269999987543 445567899999999999999999999999
Q ss_pred ecCCeE-EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 312 TRPPRL-FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 312 ~~~~~l-~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
...+.. +++|||+.+|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||
T Consensus 92 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~------~~kl 165 (298)
T 3pls_A 92 LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF------TVKV 165 (298)
T ss_dssp CCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC------CEEE
T ss_pred ecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC------cEEe
Confidence 876655 999999999999999987666789999999999999999999999999999999999999888 5999
Q ss_pred Eecccccccc
Q 015237 391 SNFLSISTVI 400 (411)
Q Consensus 391 ~DFGla~~~~ 400 (411)
+|||++..+.
T Consensus 166 ~Dfg~~~~~~ 175 (298)
T 3pls_A 166 ADFGLARDIL 175 (298)
T ss_dssp CCTTSSCTTT
T ss_pred CcCCCccccc
Confidence 9999997553
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-26 Score=222.78 Aligned_cols=145 Identities=28% Similarity=0.403 Sum_probs=130.8
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.|+..++||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.+|+.++||||+++++++......|+||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 4777889999999999999985 789999999765432 246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+++|+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 124 ~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 124 LQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG------RVKLSDFGFCAQIS 192 (321)
T ss_dssp CCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC------cEEEeeeeeeeecc
Confidence 9999999998753 589999999999999999999999999999999999999888 59999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-26 Score=225.45 Aligned_cols=150 Identities=31% Similarity=0.445 Sum_probs=134.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|++.+.||+|+||.||+|+.. ++.||||++..... .....+.+.+|+.+|++++||||+++++++......|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 355899999999999999999974 68999999976543 234557799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+. |+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG------LVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT------EEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC------CEEEeeccCceecC
Confidence 99996 689998876666799999999999999999999999999999999999999988 69999999997653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=226.05 Aligned_cols=149 Identities=29% Similarity=0.466 Sum_probs=118.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.++||+|+||.||+|.+. ++.||+|+++.... ....+.+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 356899999999999999999875 68999999976532 222356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 322 EFMSGGSIYDYLHKQK-----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~-----~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
||++ |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~------~~kl~Dfg~~ 155 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG------QLKLGDFGLA 155 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEECCCSSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC------CEEECcCccc
Confidence 9996 69999987642 3588999999999999999999999999999999999999988 5999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 156 ~~~~ 159 (317)
T 2pmi_A 156 RAFG 159 (317)
T ss_dssp EETT
T ss_pred eecC
Confidence 8754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-26 Score=214.88 Aligned_cols=147 Identities=22% Similarity=0.376 Sum_probs=131.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.++||+|+||.||+|.+. +..||+|++....... .+.+.+|+.++++++||||+++++++......|+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 46899999999999999999986 4689999997654332 4678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---ccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi---d~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||++..+
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~------~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS------PLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC------CEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC------cEEEEecccceec
Confidence 999999999997764 68999999999999999999999999999999999999 5555 5999999999765
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 160 ~ 160 (277)
T 3f3z_A 160 K 160 (277)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-26 Score=225.70 Aligned_cols=152 Identities=26% Similarity=0.383 Sum_probs=138.4
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.++....|++.++||+|+||.||++.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 4677788999999999999999999997 6899999997653 455667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~------~~kl~Dfg~~ 179 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG------EIKLCDFGVS 179 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC------CEEECCCCCC
T ss_pred EEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC------CEEEEECCCC
Confidence 99999999999999998765 689999999999999999999996 999999999999999988 5999999998
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
..+
T Consensus 180 ~~~ 182 (360)
T 3eqc_A 180 GQL 182 (360)
T ss_dssp HHH
T ss_pred ccc
Confidence 754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=225.39 Aligned_cols=156 Identities=21% Similarity=0.378 Sum_probs=128.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
...+.|++.++||+|+||.||++.+. ++.||||+++.........+.+.+|+.+|+.++||||+++++++.....+|+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34457999999999999999999875 6899999998765555556778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++... ...+||+|||++..+
T Consensus 111 v~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE-TPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC------CCEEEECCTTHHHHH
T ss_pred EEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCc-cceEEECcCCCcccc
Confidence 999996 59999998765 689999999999999999999999999999999999996544211 115899999999765
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 188 ~ 188 (329)
T 3gbz_A 188 G 188 (329)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-26 Score=220.28 Aligned_cols=156 Identities=28% Similarity=0.469 Sum_probs=136.2
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeee-
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACT- 312 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~- 312 (411)
...|++...+|++.++||+|+||.||++.+ .++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 457899999999999999999999999998 4689999998654 3445577899999999996 999999999983
Q ss_pred -------cCCeEEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCC
Q 015237 313 -------RPPRLFIVTEFMSGGSIYDYLHK--QKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGV 381 (411)
Q Consensus 313 -------~~~~l~IV~E~~~gGsL~~~L~~--~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~ 381 (411)
....++++|||+ +|+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~- 175 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG- 175 (337)
T ss_dssp CTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-
T ss_pred cccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-
Confidence 344589999999 5799999875 2346999999999999999999999999 99999999999999988
Q ss_pred cCCCccEEEEeccccccccc
Q 015237 382 RDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~~~ 401 (411)
.+||+|||++..+..
T Consensus 176 -----~~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 176 -----TIKLCDFGSATTISH 190 (337)
T ss_dssp -----CEEBCCCTTCBCCSS
T ss_pred -----CEEEecCccceeccc
Confidence 599999999987643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-25 Score=216.14 Aligned_cols=150 Identities=25% Similarity=0.347 Sum_probs=135.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 456899999999999999999986 67899999976543 345567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL------EVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC------CEEEEeccCceecc
Confidence 99999999999987654 689999999999999999999999999999999999999888 59999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=218.27 Aligned_cols=152 Identities=21% Similarity=0.385 Sum_probs=133.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
...++|++.+.||+|+||.||++.+. ++.||+|++....... .....+.+|+.+++.++||||+++++++......|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34567999999999999999999986 4689999997643221 23466889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~------~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG------ELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS------CEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC------CEEEEecccccc
Confidence 9999999999999998764 689999999999999999999999999999999999999888 599999998865
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 159 ~~ 160 (279)
T 3fdn_A 159 AP 160 (279)
T ss_dssp C-
T ss_pred CC
Confidence 43
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.45 Aligned_cols=153 Identities=18% Similarity=0.327 Sum_probs=134.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEE-----CCceEEEEEeecccc--CHHHHHHHHHHHHHHhhc-CCCceeEEEeeee
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKV-RHMNVVQFIGACT 312 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~ 312 (411)
.+....|++.+.||+|+||.||+++. .++.||||+++.... .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 45567899999999999999999988 468999999875432 111234577899999999 6999999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
....+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~------~~kl~D 202 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTD 202 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEESC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC------cEEEee
Confidence 9999999999999999999998765 689999999999999999999999999999999999999888 599999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||++..+.
T Consensus 203 fG~a~~~~ 210 (355)
T 1vzo_A 203 FGLSKEFV 210 (355)
T ss_dssp SSEEEECC
T ss_pred CCCCeecc
Confidence 99998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-26 Score=216.86 Aligned_cols=158 Identities=27% Similarity=0.491 Sum_probs=135.0
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHH--H---HHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNEN--I---RREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~--~---~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
.+....|++.+.||+|+||.||+|++. ++.||+|++........ . .+.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 466788999999999999999999985 68899999876543221 1 1678999999999999999999999977
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.. ++||||+++|+|.+++......+++..++.++.|++.||.|||++| |+||||||+|||++.++.. ....+||+
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~-~~~~~kl~ 171 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN-APVCAKVA 171 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTT-CSCCEEEC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCC-CceeEEeC
Confidence 65 7999999999999999877667999999999999999999999999 9999999999999877631 12248999
Q ss_pred eccccccccc
Q 015237 392 NFLSISTVIL 401 (411)
Q Consensus 392 DFGla~~~~~ 401 (411)
|||++.....
T Consensus 172 Dfg~~~~~~~ 181 (287)
T 4f0f_A 172 DFGLSQQSVH 181 (287)
T ss_dssp CCTTCBCCSS
T ss_pred CCCccccccc
Confidence 9999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=221.43 Aligned_cols=150 Identities=25% Similarity=0.347 Sum_probs=135.9
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 567999999999999999999986 57899999976543 345667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+.
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~------~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL------EVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC------CEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC------CEEEeeccCceecc
Confidence 99999999999987754 689999999999999999999999999999999999999888 59999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-26 Score=215.47 Aligned_cols=154 Identities=20% Similarity=0.434 Sum_probs=136.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+....|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 455678999999999999999999986 789999999764321 12346789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~~l~dfg~~~ 159 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM------NAKIADFGLSN 159 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS------CEEECCCCGGG
T ss_pred EEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC------CEEEeeccccc
Confidence 99999999999999998764 689999999999999999999999999999999999999888 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
....
T Consensus 160 ~~~~ 163 (276)
T 2h6d_A 160 MMSD 163 (276)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7644
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=239.06 Aligned_cols=153 Identities=22% Similarity=0.458 Sum_probs=136.2
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+....|.+.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.+|+.++||||+++++++.....+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44567999999999999999999986 7899999997653211 23467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~------~vkL~DFG~a~~ 165 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM------NAKIADFGLSNM 165 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC------CEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC------CeEEEeccchhh
Confidence 9999999999999997654 699999999999999999999999999999999999999988 599999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 166 ~~~ 168 (476)
T 2y94_A 166 MSD 168 (476)
T ss_dssp CCT
T ss_pred ccc
Confidence 643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=222.96 Aligned_cols=153 Identities=24% Similarity=0.383 Sum_probs=135.4
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
....+.|++.+.||+|+||.||++.+. ++.||+|++..........+.+.+|+.+++.++||||+++++++.....+|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 445677999999999999999999986 689999999877666666778899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 101 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG------VVKLCDFGFART 173 (331)
T ss_dssp EEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECCCTTC--
T ss_pred EEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC------cEEEEeCCCcee
Confidence 9999999888888765443 699999999999999999999999999999999999999888 599999999976
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 174 ~~ 175 (331)
T 4aaa_A 174 LA 175 (331)
T ss_dssp --
T ss_pred ec
Confidence 53
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=237.30 Aligned_cols=148 Identities=22% Similarity=0.283 Sum_probs=127.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC------C
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP------P 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------~ 315 (411)
..+|++.++||+|+||.||++.+. ++.||||++..........+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999885 68899999987665666678899999999999999999999999654 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|||||||.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~------~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC------CEEEEEEEe
Confidence 57999999965 67777743 488999999999999999999999999999999999999988 599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
|.....
T Consensus 211 a~~~~~ 216 (464)
T 3ttj_A 211 ARTAGT 216 (464)
T ss_dssp C-----
T ss_pred eeecCC
Confidence 987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-26 Score=216.86 Aligned_cols=147 Identities=24% Similarity=0.390 Sum_probs=131.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec---------
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--------- 313 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--------- 313 (411)
+.|++.+.||+|+||.||+|+.. ++.||||++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 46899999999999999999985 689999999653 3445779999999999999999999998754
Q ss_pred ----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 314 ----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 314 ----~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
...+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~------~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR------NVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC------CEE
Confidence 3568999999999999999987665678889999999999999999999999999999999999888 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++..+.
T Consensus 157 l~dfg~~~~~~ 167 (303)
T 1zy4_A 157 IGDFGLAKNVH 167 (303)
T ss_dssp ECCCCCCSCTT
T ss_pred EeeCcchhhcc
Confidence 99999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=228.42 Aligned_cols=147 Identities=18% Similarity=0.296 Sum_probs=124.5
Q ss_pred EEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 249 FEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
..+.||+|+||.||+|... ++.||+|+++... ....+.+.+|+.+|++++||||+++++++...+.+||||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3678999999999999885 6899999998753 34457899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 327 GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 327 GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++..+..
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~----~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA----KQIKIIDFGLARRYKP 241 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT----TEEEECCCSSCEECCT
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC----CcEEEEeCCCceecCC
Confidence 9999999876557899999999999999999999999999999999999953221 1599999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=227.02 Aligned_cols=152 Identities=23% Similarity=0.439 Sum_probs=130.4
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--Cce----EEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~----VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+....|++.+.||+|+||.||+|.+. ++. ||+|.+..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG- 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 456778999999999999999999985 333 78887754321 1223457789999999999999999999874
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
...++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~------~~kl~Dfg 160 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS------QVQVADFG 160 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS------CEEECSCS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC------eEEECCCC
Confidence 569999999999999999987655788999999999999999999999999999999999999888 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 161 ~a~~~~ 166 (325)
T 3kex_A 161 VADLLP 166 (325)
T ss_dssp GGGGSC
T ss_pred cccccC
Confidence 998763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=236.04 Aligned_cols=154 Identities=21% Similarity=0.349 Sum_probs=130.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|++.++||+|+||.||+|++. +..||+|+++...........+.+|+.+|+.++||||++++++|.....+|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346999999999999999999986 688999999876544434567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|||++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..+. ...+||+|||++..+..
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK---DALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST---TCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCC---CCcEEEEECCCCeECCC
Confidence 9999999999987764 6899999999999999999999999999999999999987542 12489999999977643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=222.33 Aligned_cols=150 Identities=30% Similarity=0.484 Sum_probs=126.1
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHH--HhhcCCCceeEEEeeee---
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHI--MRKVRHMNVVQFIGACT--- 312 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~i--L~~l~HpNIV~l~g~~~--- 312 (411)
..+.++.+.|++.+.||+|+||.||+|++.++.||||++.... ...+..|..+ +..++||||+++++.+.
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 3467888999999999999999999999999999999997543 2334444444 45689999999998543
Q ss_pred --cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEEccCCC
Q 015237 313 --RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN---------NIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 313 --~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~---------gIIHRDLKp~NILid~~g~ 381 (411)
....+|+||||+++|+|.+++.... .++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~- 157 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG- 157 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-
Confidence 2336799999999999999997654 58888999999999999999999 999999999999999888
Q ss_pred cCCCccEEEEecccccccc
Q 015237 382 RDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~~ 400 (411)
.+||+|||++..+.
T Consensus 158 -----~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 158 -----TCVISDFGLSMRLT 171 (336)
T ss_dssp -----CEEECCCTTCEECS
T ss_pred -----cEEEeeccceeecc
Confidence 59999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=222.82 Aligned_cols=155 Identities=26% Similarity=0.450 Sum_probs=120.7
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEE--CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
.|.+....|++.+.||+|+||.||++.+ .++.||||++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4889999999999999999999999987 468999999875432 2335678899999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 317 LFIVTEFMSGGSIYDYLHK-------QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~-------~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~k 161 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG------SVQ 161 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC------CEE
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC------CEE
Confidence 9999999999999999975 233589999999999999999999999999999999999999888 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++..+.
T Consensus 162 l~dfg~~~~~~ 172 (303)
T 2vwi_A 162 IADFGVSAFLA 172 (303)
T ss_dssp ECCCHHHHHCC
T ss_pred EEeccchheec
Confidence 99999987653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-26 Score=217.54 Aligned_cols=153 Identities=17% Similarity=0.316 Sum_probs=131.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|.+.++||+|+||.||++... ++.||+|++...... ...+.+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 56999999999999999999986 688999999765422 234678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++. ...+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~---~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSP---HSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSST---TCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCC---CCCEEEEeeecceec
Confidence 99999999988653 346899999999999999999999999999999999999954321 115899999999765
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 178 ~~ 179 (285)
T 3is5_A 178 KS 179 (285)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=226.82 Aligned_cols=153 Identities=18% Similarity=0.253 Sum_probs=136.2
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC--CCceeEEEeeeecCC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--HMNVVQFIGACTRPP 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~~ 315 (411)
...+....|++.+.||+|+||.||++... ++.||||++..........+.+.+|+.+|+.++ ||||+++++++....
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 45667778999999999999999999876 688999999877666677788999999999996 599999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|||||+ .+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+++ + .+||+|||+
T Consensus 130 ~~~lv~E~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~------~~kl~DFG~ 200 (390)
T 2zmd_A 130 YIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G------MLKLIDFGI 200 (390)
T ss_dssp EEEEEEEC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S------CEEECCCSS
T ss_pred EEEEEEec-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C------eEEEEecCc
Confidence 99999994 5889999998765 6888899999999999999999999999999999999964 4 489999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 201 a~~~~ 205 (390)
T 2zmd_A 201 ANQMQ 205 (390)
T ss_dssp SCCC-
T ss_pred ccccc
Confidence 98764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=213.70 Aligned_cols=153 Identities=23% Similarity=0.408 Sum_probs=135.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+.|++.+.||+|+||.||++.+. ++.||+|+++...... ...+.+.+|+.++++++||||+++++++......|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999986 6899999998654321 13567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++... ..+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~--~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPN--PRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSS--CCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCC--CceEEEeccccee
Confidence 9999999999999997654 689999999999999999999999999999999999998876322 2589999999987
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 162 ~~ 163 (283)
T 3bhy_A 162 IE 163 (283)
T ss_dssp CC
T ss_pred cc
Confidence 64
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=215.66 Aligned_cols=151 Identities=25% Similarity=0.359 Sum_probs=133.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee--cCCeEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--RPPRLFI 319 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~--~~~~l~I 319 (411)
.++|++.+.||+|+||.||++.+. ++.||+|++..........+.+.+|+.++++++||||+++++++. ....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999985 688999999887666777788999999999999999999999874 4678999
Q ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 320 VTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNN-----IIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~g-----IIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~------~~kl~ 158 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ------NVKLG 158 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS------CEEEC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC------CEEEe
Confidence 999999999999997642 24899999999999999999999999 99999999999999888 59999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||++..+.
T Consensus 159 dfg~~~~~~ 167 (279)
T 2w5a_A 159 DFGLARILN 167 (279)
T ss_dssp CCCHHHHC-
T ss_pred cCchheeec
Confidence 999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=219.98 Aligned_cols=155 Identities=23% Similarity=0.366 Sum_probs=135.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+.|++.+.||+|+||.||++++. ++.||+|+++...... ...+.+.+|+.++++++||||+++++++.....+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356899999999999999999986 6899999998654321 1356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++... ..+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~--~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI--PHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS--CCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCc--CCEEEccCccce
Confidence 99999999999999997654 689999999999999999999999999999999999999877322 248999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 168 ~~~~ 171 (321)
T 2a2a_A 168 EIED 171 (321)
T ss_dssp ECCT
T ss_pred ecCc
Confidence 7643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=235.33 Aligned_cols=153 Identities=24% Similarity=0.410 Sum_probs=134.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|++.++||+|+||.||++.+. ++.||||++............+.+|+.+|++++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356999999999999999999986 689999999764333333567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++..+.
T Consensus 101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~---~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK---DCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSST---TCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCC---CCCEEEEECCcCeECC
Confidence 9999999999997765 6899999999999999999999999999999999999965431 1259999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=224.17 Aligned_cols=150 Identities=21% Similarity=0.346 Sum_probs=122.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+.-.+.|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.....+|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 344567999999999999999999996 5789999997643 2356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc---CCCcCCCccEEEEeccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~---~g~~k~~~~ikL~DFGl 395 (411)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++ .+||+|||+
T Consensus 125 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~------~~kl~Dfg~ 197 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA------PLKIADFGL 197 (349)
T ss_dssp EEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC------CEEECCCC-
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC------CEEEccCcc
Confidence 9999999999999997654 6899999999999999999999999999999999999975 44 599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 198 a~~~~~ 203 (349)
T 2w4o_A 198 SKIVEH 203 (349)
T ss_dssp ------
T ss_pred ccccCc
Confidence 986543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-26 Score=234.31 Aligned_cols=154 Identities=21% Similarity=0.389 Sum_probs=132.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-----------HHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-----------NIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-----------~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
...|++.++||+|+||.||+|.+. ++.||+|+++...... ...+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999986 5889999998654321 235678999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEE
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYL 390 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL 390 (411)
+.....+|+|||||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS---LLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC---CSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC---CccEEE
Confidence 999999999999999999999997764 6999999999999999999999999999999999999988763 225899
Q ss_pred Eeccccccccc
Q 015237 391 SNFLSISTVIL 401 (411)
Q Consensus 391 ~DFGla~~~~~ 401 (411)
+|||++..+..
T Consensus 191 ~Dfg~a~~~~~ 201 (504)
T 3q5i_A 191 VDFGLSSFFSK 201 (504)
T ss_dssp CCCTTCEECCT
T ss_pred EECCCCEEcCC
Confidence 99999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-26 Score=216.53 Aligned_cols=153 Identities=21% Similarity=0.382 Sum_probs=135.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+..+.|++.+.||+|+||.||+|.+. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 455677999999999999999999986 5789999997543211 2246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~kl~Dfg~~~ 162 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG------ELKIADFGWSV 162 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC------CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC------CEEEecccccc
Confidence 99999999999999998765 689999999999999999999999999999999999999888 59999999986
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 163 ~~~ 165 (284)
T 2vgo_A 163 HAP 165 (284)
T ss_dssp ECS
T ss_pred cCc
Confidence 553
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=230.47 Aligned_cols=153 Identities=23% Similarity=0.382 Sum_probs=121.7
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP- 314 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~- 314 (411)
..|++. ..|++.+.||+|+||.||+|.+. ++.||||++.....+....+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 468886 67999999999999999999875 68999999977655556677899999999999999999999998654
Q ss_pred -----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 315 -----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 315 -----~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
..+|++||++ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~------~~k 172 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC------ELK 172 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEE
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC------CEE
Confidence 5689999999 78999998763 589999999999999999999999999999999999999988 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++....
T Consensus 173 L~DFG~a~~~~ 183 (367)
T 2fst_X 173 ILDFGLARHTA 183 (367)
T ss_dssp ECC--------
T ss_pred Eeecccccccc
Confidence 99999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=214.72 Aligned_cols=155 Identities=16% Similarity=0.222 Sum_probs=135.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l 317 (411)
.+...+|++.+.||+|+||.||+|.+. ++.||||++...... +.+.+|+.+++.+ +|+||+++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 566778999999999999999999964 789999998755322 4578899999999 799999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.... ..+||+|||++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~-~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA-NMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTT-TCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCC-CeEEEEECcccc
Confidence 9999999 99999999887667999999999999999999999999999999999999988763221 249999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 160 ~~~~ 163 (298)
T 1csn_A 160 FYRD 163 (298)
T ss_dssp ESBC
T ss_pred cccc
Confidence 7644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=217.87 Aligned_cols=151 Identities=18% Similarity=0.290 Sum_probs=132.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
...|++.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999985 68899999976543 344567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~------~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD------FAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC------CEEEecCccCcccc
Confidence 99999999999998764 689999999999999999999999999999999999999888 59999999987654
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 186 ~ 186 (309)
T 2h34_A 186 D 186 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=217.95 Aligned_cols=148 Identities=27% Similarity=0.453 Sum_probs=131.2
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
..+.|++.+.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4567999999999999999999996 6889999987653 22346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~------~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG------DIRLADFGVSAK 166 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS------CEEECCCHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC------CEEEEECCCCcc
Confidence 999999999999987666799999999999999999999999999999999999999888 599999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=220.14 Aligned_cols=159 Identities=19% Similarity=0.319 Sum_probs=134.9
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-----CCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----HMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-----HpNIV~l~g~ 310 (411)
...++-...|++.++||+|+||.||+|++. ++.||||+++.. ......+..|+.+++.++ ||||++++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 344666789999999999999999999984 688999999743 334567788999999996 9999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCc-------
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR------- 382 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~------- 382 (411)
+.....+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+...
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 99999999999999 999999998764 358999999999999999999999999999999999999852110
Q ss_pred ------------CCCccEEEEecccccccc
Q 015237 383 ------------DSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 383 ------------k~~~~ikL~DFGla~~~~ 400 (411)
.....+||+|||++....
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~ 213 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred cccccccccccccCCCCEEEEeccCceecC
Confidence 002269999999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-26 Score=239.99 Aligned_cols=154 Identities=21% Similarity=0.278 Sum_probs=136.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+..+.|++.+.||+|+||.||++++. ++.||+|++....... .....+.+|+.+|+.++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 55677999999999999999999985 7899999997653211 22456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+|||||+||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||++.
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g------~vKL~DFGla~ 334 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIRISDLGLAV 334 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS------CEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC------CeEEEecccce
Confidence 9999999999999997653 2489999999999999999999999999999999999999988 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 335 ~~~~ 338 (576)
T 2acx_A 335 HVPE 338 (576)
T ss_dssp ECCT
T ss_pred eccc
Confidence 7643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.4e-26 Score=219.47 Aligned_cols=149 Identities=30% Similarity=0.523 Sum_probs=128.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
.++.++|++.+.||+|+||.||++++.++.||+|++... ...+.+.+|+.+|++++||||+++++++.. ..|+|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 467788999999999999999999999999999998643 235779999999999999999999999874 48999
Q ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 321 TEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHR---NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs---~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
|||+++|+|.+++..... .++...++.++.|++.||.|||+ +||+||||||+|||++.++. .+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~~kl~Dfg~ 152 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-----VLKICDFGT 152 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-----EEEECCCCC
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-----EEEEccccc
Confidence 999999999999986542 47888999999999999999999 89999999999999998773 379999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 153 ~~~~~ 157 (307)
T 2eva_A 153 ACDIQ 157 (307)
T ss_dssp -----
T ss_pred ccccc
Confidence 97654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-26 Score=221.33 Aligned_cols=158 Identities=28% Similarity=0.465 Sum_probs=135.4
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
+.+++....|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||++++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 446888999999999999999999999842 4679999996443 34556779999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~ 384 (411)
+......|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~-- 179 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG-- 179 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT--
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc--
Confidence 999999999999999999999998754 348889999999999999999999999999999999999865521
Q ss_pred CccEEEEeccccccc
Q 015237 385 DIHCYLSNFLSISTV 399 (411)
Q Consensus 385 ~~~ikL~DFGla~~~ 399 (411)
..+||+|||++..+
T Consensus 180 -~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 180 -RVAKIGDFGMARDI 193 (327)
T ss_dssp -CCEEECCCHHHHHH
T ss_pred -ceEEECcccccccc
Confidence 15899999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=215.41 Aligned_cols=152 Identities=20% Similarity=0.375 Sum_probs=128.5
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccc-cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
....|++.+.||+|+||.||+|... ++.||+|+++... ........+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3457999999999999999999974 7899999998643 345567789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 320 VTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
||||+++|+|.+++.. ....++...++.++.|++.||.|||++||+||||||+||+++.+| .+||+|||++
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~------~~kl~Dfg~~ 183 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG------VVKLGDLGLG 183 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECCC---
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC------CEEEEeccce
Confidence 9999999999999875 234689999999999999999999999999999999999999888 5999999998
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 184 ~~~~ 187 (310)
T 2wqm_A 184 RFFS 187 (310)
T ss_dssp ----
T ss_pred eeec
Confidence 7654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=228.86 Aligned_cols=152 Identities=24% Similarity=0.379 Sum_probs=131.5
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC--eE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP--RL 317 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--~l 317 (411)
+....|++.++||+|+||.||+|.+. ++.||||+++..... ...+.+.+|+.+|++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44567999999999999999999987 689999999764322 22466789999999999999999999998654 78
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----ccCCCcCCCccEEEE
Q 015237 318 FIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVRDSDIHCYLS 391 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi----d~~g~~k~~~~ikL~ 391 (411)
|+|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~------~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS------VYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE------EEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce------eEEEe
Confidence 999999999999999976532 38999999999999999999999999999999999998 4444 58999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||++..+.
T Consensus 159 DFG~a~~~~ 167 (396)
T 4eut_A 159 DFGAARELE 167 (396)
T ss_dssp CGGGCEECC
T ss_pred cCCCceEcc
Confidence 999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=224.81 Aligned_cols=150 Identities=28% Similarity=0.438 Sum_probs=131.7
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-------- 313 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-------- 313 (411)
.+.|++.++||+|+||.||+|++. ++.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999985 6899999987665444444678899999999999999999999876
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
.+.+|+||||+. |+|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~------~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG------VLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC------CEEEccc
Confidence 346899999996 588888877666799999999999999999999999999999999999999988 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 169 g~a~~~~ 175 (351)
T 3mi9_A 169 GLARAFS 175 (351)
T ss_dssp TTCEECC
T ss_pred hhccccc
Confidence 9997653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.8e-26 Score=218.32 Aligned_cols=150 Identities=25% Similarity=0.379 Sum_probs=129.1
Q ss_pred CceEEE-EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEE
Q 015237 245 SLLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 245 ~~~~~~-~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV 320 (411)
..|++. +.||+|+||.||++.+. ++.||||++..... ...+.+.+|+.+|.++ +||||+++++++...+.+|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 457774 67999999999999874 68999999976532 2346789999999985 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+||+|||++..+.
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~---~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQV---SPVKICDFDLGSGIK 165 (316)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSS---CSEEECCTTCCC---
T ss_pred EEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCc---CceEEEEccCccccc
Confidence 99999999999998764 68999999999999999999999999999999999999987631 138999999987653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.4e-26 Score=220.31 Aligned_cols=152 Identities=31% Similarity=0.538 Sum_probs=131.6
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--Cc--eEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQ--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~--~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 315 (411)
.++.++|++.+.||+|+||.||++++. +. .+|+|.++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 567788999999999999999999875 44 45999987532 233456789999999999 8999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g 380 (411)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997653 3689999999999999999999999999999999999999887
Q ss_pred CcCCCccEEEEeccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~ 399 (411)
.+||+|||++...
T Consensus 180 ------~~kL~Dfg~~~~~ 192 (327)
T 1fvr_A 180 ------VAKIADFGLSRGQ 192 (327)
T ss_dssp ------CEEECCTTCEESS
T ss_pred ------eEEEcccCcCccc
Confidence 5999999998743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=216.88 Aligned_cols=152 Identities=30% Similarity=0.430 Sum_probs=129.6
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+.....|++.+.||+|+||.||+|.+. ++.||+|++..... .+.+.+|+.+++.++||||+++++++.....+
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3566778999999999999999999986 68999999976542 25688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+||||+++|+|.+++......+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++.
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~kl~dfg~~~ 173 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG------HAKLADFGVAG 173 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCCTTCE
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC------CEEEeecccch
Confidence 999999999999999986666799999999999999999999999999999999999999888 59999999997
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 174 ~~~~ 177 (314)
T 3com_A 174 QLTD 177 (314)
T ss_dssp ECBT
T ss_pred hhhh
Confidence 6543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=224.49 Aligned_cols=148 Identities=26% Similarity=0.400 Sum_probs=128.8
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.++||+|+||.||+|.+. ++.||+|+++.... ......+.+|+.+|+.++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46999999999999999999986 68899999975432 1122245679999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG------ELKLADFGLARAKS 151 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC------CEEECSSSEEECC-
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC------CEEEccCccccccc
Confidence 996 699999988776799999999999999999999999999999999999999988 59999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-25 Score=213.25 Aligned_cols=150 Identities=23% Similarity=0.340 Sum_probs=134.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc---C----HHHHHHHHHHHHHHhhcC-CCceeEEEeeeec
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---N----ENIRREFAQEVHIMRKVR-HMNVVQFIGACTR 313 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~---~----~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~ 313 (411)
...|++.+.||+|+||.||+|.+. ++.||||+++.... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467999999999999999999985 68999999976531 1 234567889999999995 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
....|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------NIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC------cEEEecc
Confidence 999999999999999999998754 689999999999999999999999999999999999999988 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 169 g~~~~~~ 175 (298)
T 1phk_A 169 GFSCQLD 175 (298)
T ss_dssp TTCEECC
T ss_pred cchhhcC
Confidence 9997654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=214.26 Aligned_cols=147 Identities=24% Similarity=0.403 Sum_probs=132.6
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.+.||+|+||.||++.+. ++.||+|++..... ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46899999999999999999986 68999999976543 2345778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..+
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~kl~dfg~~~~~ 155 (276)
T 2yex_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD------NLKISDFGLATVF 155 (276)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCCTTCEEC
T ss_pred ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC------CEEEeeCCCcccc
Confidence 999999999987543 689999999999999999999999999999999999999888 5999999999765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=223.85 Aligned_cols=151 Identities=26% Similarity=0.432 Sum_probs=134.4
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
+.....|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 445577889999999999999999976 68999999876532 345779999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 320 VTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~------~~kl~Dfg~~ 186 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF------VPKITDFGIS 186 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC------CEEECCCTTC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC------CEEEeecccc
Confidence 999999999999986543 2488999999999999999999999999999999999999888 5999999999
Q ss_pred ccc
Q 015237 397 STV 399 (411)
Q Consensus 397 ~~~ 399 (411)
...
T Consensus 187 ~~~ 189 (321)
T 2qkw_B 187 KKG 189 (321)
T ss_dssp EEC
T ss_pred ccc
Confidence 764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=219.36 Aligned_cols=145 Identities=30% Similarity=0.569 Sum_probs=126.8
Q ss_pred cCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhc--CCCceeEEEeeeecC----Ce
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV--RHMNVVQFIGACTRP----PR 316 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l--~HpNIV~l~g~~~~~----~~ 316 (411)
-.+.|++.++||+|+||.||+|++.++.||||++.... ...+..|.+++... +||||+++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34679999999999999999999999999999986542 23445566666554 899999999999876 78
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEEccCCCcCCCccE
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN--------NIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~--------gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
+|+||||+++|+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~------~~ 181 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG------TC 181 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS------CE
T ss_pred eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC------CE
Confidence 99999999999999999765 489999999999999999999999 999999999999999888 59
Q ss_pred EEEecccccccc
Q 015237 389 YLSNFLSISTVI 400 (411)
Q Consensus 389 kL~DFGla~~~~ 400 (411)
||+|||++..+.
T Consensus 182 kl~Dfg~a~~~~ 193 (337)
T 3mdy_A 182 CIADLGLAVKFI 193 (337)
T ss_dssp EECCCTTCEECC
T ss_pred EEEeCCCceeec
Confidence 999999997653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=215.02 Aligned_cols=147 Identities=10% Similarity=0.132 Sum_probs=129.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+-...|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.++++++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45577999999999999999999987 689999999876543 456678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+||||++|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.+| .+||+++|...
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g------~~kl~~~~~~~ 177 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG------DVVLAYPATMP 177 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS------CEEECSCCCCT
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC------CEEEEeccccC
Confidence 999999999999999542 45567889999999999999999999999999999999998 47888776554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=216.88 Aligned_cols=146 Identities=30% Similarity=0.467 Sum_probs=130.3
Q ss_pred EEEEEeecCceEEEEEEECCceEEEEEeeccc--cCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEecCCC
Q 015237 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEH--LNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~--~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
.+++||+|+||.||+|.+.++.||+|++.... ......+.+.+|+.+++.++||||+++++++......|+||||+++
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 45789999999999999999999999987542 2234567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 327 GSIYDYLHKQ--KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 327 GsL~~~L~~~--~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF------TAKISDFGLARASE 184 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC------CEEECCCTTCEECC
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC------cEEEeecccccccc
Confidence 9999999753 23589999999999999999999999999999999999999887 59999999987653
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=215.88 Aligned_cols=150 Identities=24% Similarity=0.448 Sum_probs=129.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.++|++.+.||+|+||.||+|... ++.||||+++.........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 357999999999999999999986 689999999765433334467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+. |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..+.
T Consensus 82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~------~~kl~dfg~~~~~~ 154 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG------AIKLADFGLARAFG 154 (299)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECSTTHHHHHC
T ss_pred Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCC------CEEECcchhhhhcc
Confidence 9996 69999998763 3688999999999999999999999999999999999999988 59999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=228.58 Aligned_cols=148 Identities=24% Similarity=0.454 Sum_probs=124.3
Q ss_pred ceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-CCeEEE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRLFI 319 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~~~l~I 319 (411)
.|++.+.||+|+||.||+|++.. ..||+|.++... .....+.+.+|+.+|++++||||++++++|.. .+..|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 36788999999999999998742 358999986543 33456789999999999999999999998754 457899
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~------~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF------TVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CEEECCC------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC------CEEEeeccccccc
Confidence 9999999999999987766789999999999999999999999999999999999999888 5999999999865
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 243 ~ 243 (373)
T 3c1x_A 243 Y 243 (373)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=231.99 Aligned_cols=156 Identities=22% Similarity=0.389 Sum_probs=135.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.+-...|++.+.||+|+||.||++... ++.||||++...... ......+.+|+.+|++++||||+++++++.....+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345567999999999999999999985 689999999765432 23357799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|+|||||.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..+. ...+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSK---DANIRIIDFGLST 177 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSST---TCCEEECCTTHHH
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCC---CCcEEEEeeeeeE
Confidence 99999999999999997654 6899999999999999999999999999999999999953221 1159999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 178 ~~~ 180 (484)
T 3nyv_A 178 HFE 180 (484)
T ss_dssp HBC
T ss_pred Ecc
Confidence 654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=225.44 Aligned_cols=150 Identities=20% Similarity=0.329 Sum_probs=132.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH------HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~------~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
..|++.+.||+|+||.||+|.+. ++.||||+++...... ...+.+.+|+.+|++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 56999999999999999999875 6889999998764321 123457789999999999999999999999999
Q ss_pred EEEEEecCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGG-SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gG-sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+++||||+.+| +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------~~kL~Dfg~ 176 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF------TIKLIDFGS 176 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS------CEEECCCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC------cEEEeeccc
Confidence 99999999766 9999997654 699999999999999999999999999999999999999887 599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 177 a~~~~~ 182 (335)
T 3dls_A 177 AAYLER 182 (335)
T ss_dssp CEECCT
T ss_pred ceECCC
Confidence 987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.12 Aligned_cols=154 Identities=21% Similarity=0.290 Sum_probs=136.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+..+.|.+.+.||+|+||.||++++. ++.||+|++....... ...+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45567999999999999999999985 7899999997653221 22457889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 319 IVTEFMSGGSIYDYLHKQK---CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~---~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g------~vkL~DFGl 335 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG------NVRISDLGL 335 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS------CEEECCCTT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC------CEEEeecce
Confidence 9999999999999997642 3589999999999999999999999999999999999999998 599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 336 a~~~~~ 341 (543)
T 3c4z_A 336 AVELKA 341 (543)
T ss_dssp CEECCT
T ss_pred eeeccC
Confidence 987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=222.55 Aligned_cols=153 Identities=22% Similarity=0.319 Sum_probs=130.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc---CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL---NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
...|++.+.||+|+||.||+|.+. ++.||+|++..... +....+.+.+|+.+|+.++||||+++++++...+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 467999999999999999999886 57899999976432 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 015237 319 IVTEFMSGGSIYDYLHKQ---------------------------------------KCGLKLPLLLRVAIDVSKGMNYL 359 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~---------------------------------------~~~l~~~~i~~i~~qIa~gL~yL 359 (411)
+|||||+||+|.+++... ...+++..+..++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 00134667888999999999999
Q ss_pred HHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 360 HRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 360 Hs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|++||+||||||+|||++.++. ..+||+|||++..+.
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~----~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKS----FEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSS----CCEEECCCTTCEEGG
T ss_pred HHCCccccCCChhhEEEecCCC----ceEEEeecccccccc
Confidence 9999999999999999987652 258999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=214.25 Aligned_cols=151 Identities=28% Similarity=0.479 Sum_probs=134.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~I 319 (411)
-....|++.++||+|+||.||+|.+. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 34566999999999999999999885 689999999765432 235779999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~------~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG------EVKLADFGVAGQL 169 (303)
T ss_dssp EEECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC------CEEEeecccceec
Confidence 99999999999999653 589999999999999999999999999999999999999888 5999999999775
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 170 ~~ 171 (303)
T 3a7i_A 170 TD 171 (303)
T ss_dssp BT
T ss_pred Cc
Confidence 43
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=222.97 Aligned_cols=148 Identities=22% Similarity=0.352 Sum_probs=128.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV 320 (411)
.+.|++.+.||+|+||.||++.+. ++.||||+++..... ..+|+.+|.++ +||||+++++++.....+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 456999999999999999999986 688999999765432 34688888888 799999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+..+... ...+||+|||++..+.
T Consensus 95 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~--~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGN--PESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCS--GGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCC--cCeEEEEECCCcccCc
Confidence 99999999999997654 68999999999999999999999999999999999998554211 1248999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=215.31 Aligned_cols=155 Identities=30% Similarity=0.470 Sum_probs=128.9
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC---C--ceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF---S--QDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---~--~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
..+...+|++.++||+|+||.||+|++. + ..||+|+++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4677889999999999999999999874 2 25899998765432 3456789999999999999999999999987
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
.. .++||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~------~~kl~Df 165 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD------LVKIGDF 165 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT------EEEECCC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC------CEEEccc
Confidence 65 8999999999999999987655789999999999999999999999999999999999999988 6999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 166 g~~~~~~~ 173 (291)
T 1u46_A 166 GLMRALPQ 173 (291)
T ss_dssp TTCEECCC
T ss_pred cccccccc
Confidence 99987643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=220.33 Aligned_cols=152 Identities=27% Similarity=0.486 Sum_probs=129.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--Cce----EEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQD----VAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~----VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+...+|++.++||+|+||.||+|.+. ++. ||+|.+.... .....+.+.+|+.+++.++||||++++++|...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 466788999999999999999999985 343 5777765432 223457789999999999999999999999876
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
. .++++||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------~~kL~DfG 162 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ------HVKITDFG 162 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT------EEEECCTT
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC------CEEEccCc
Confidence 4 8899999999999999988776799999999999999999999999999999999999999988 59999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
++..+.
T Consensus 163 ~a~~~~ 168 (327)
T 3lzb_A 163 LAKLLG 168 (327)
T ss_dssp C-----
T ss_pred ceeEcc
Confidence 998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=230.49 Aligned_cols=154 Identities=12% Similarity=0.167 Sum_probs=125.9
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHH---HHHhhcCCCceeEEE----
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEV---HIMRKVRHMNVVQFI---- 308 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei---~iL~~l~HpNIV~l~---- 308 (411)
.|......|++.+.||+|+||.||+|++. ++.||||++..... .....+.+.+|+ .+|++++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 34555678999999999999999999864 78999999975432 334567899999 455566899999998
Q ss_pred ---eeeecCC-----------------eEEEEEecCCCCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHH
Q 015237 309 ---GACTRPP-----------------RLFIVTEFMSGGSIYDYLHKQKCGLK-------LPLLLRVAIDVSKGMNYLHR 361 (411)
Q Consensus 309 ---g~~~~~~-----------------~l~IV~E~~~gGsL~~~L~~~~~~l~-------~~~i~~i~~qIa~gL~yLHs 361 (411)
+++..++ ..||||||+ +|+|.+++.... .++ +..++.++.||+.||.|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 5555443 389999999 689999998653 233 47788899999999999999
Q ss_pred CCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 362 NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 362 ~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
+||+||||||+|||++.+| .+||+|||+|....
T Consensus 225 ~~ivHrDikp~NIll~~~~------~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRG------GVFLTGFEHLVRDG 257 (377)
T ss_dssp TTEECSCCCGGGEEECTTC------CEEECCGGGCEETT
T ss_pred CCeecCCCCHHHEEEcCCC------CEEEEechhheecC
Confidence 9999999999999999888 59999999998643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=228.66 Aligned_cols=156 Identities=33% Similarity=0.610 Sum_probs=137.0
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
....|+++.+.|++.+.||+|+||.||+|.+.+ .||+|+++.........+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 356899999999999999999999999999875 5999999865443333456788999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~------~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG------KVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---------CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC------CEEEeecCC
Confidence 99999999999999999987665789999999999999999999999999999999999998 34 489999998
Q ss_pred cccc
Q 015237 396 ISTV 399 (411)
Q Consensus 396 a~~~ 399 (411)
+...
T Consensus 176 ~~~~ 179 (319)
T 2y4i_B 176 FSIS 179 (319)
T ss_dssp CC--
T ss_pred cccc
Confidence 7654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=218.82 Aligned_cols=151 Identities=23% Similarity=0.343 Sum_probs=127.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC------HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN------ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
+.|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 56899999999999999999986 588999999765321 122345889999999999999999999997765
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~---~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE---DCLIKITDFGHS 164 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS---SCCEEECCCTTC
T ss_pred eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC---CCeEEEccCccc
Confidence 899999999999999997654 6899999999999999999999999999999999999987652 124899999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 165 ~~~~ 168 (322)
T 2ycf_A 165 KILG 168 (322)
T ss_dssp EECC
T ss_pred eecc
Confidence 8754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=225.40 Aligned_cols=157 Identities=27% Similarity=0.461 Sum_probs=136.3
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
...+++..+.|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 3456778889999999999999999999875 6889999997653221 1236889999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKC---GLKLPLLLRVAIDVSKGMNYLHRN---NIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~---~l~~~~i~~i~~qIa~gL~yLHs~---gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
..++||||+++|+|.+++..... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~------~~k 174 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF------EAV 174 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC------CEE
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC------CEE
Confidence 99999999999999999986532 489999999999999999999999 999999999999999887 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++..+.
T Consensus 175 l~Dfg~~~~~~ 185 (326)
T 3uim_A 175 VGDFGLAKLMD 185 (326)
T ss_dssp ECCCSSCEECC
T ss_pred eccCccccccC
Confidence 99999998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=225.32 Aligned_cols=153 Identities=18% Similarity=0.302 Sum_probs=127.2
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHH----H-----HHHHHHHHHHHhhcCCCce
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNEN----I-----RREFAQEVHIMRKVRHMNV 304 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~----~-----~~~~~~Ei~iL~~l~HpNI 304 (411)
++....|++.++||+|+||.||+|.+. ++.||||++........ . ...+..|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456779999999999999999999884 36799999876531110 0 1124456667788899999
Q ss_pred eEEEeeeecC----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc--c
Q 015237 305 VQFIGACTRP----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN--E 378 (411)
Q Consensus 305 V~l~g~~~~~----~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid--~ 378 (411)
+++++++... ...||||||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998764 4589999999 9999999988766799999999999999999999999999999999999998 5
Q ss_pred CCCcCCCccEEEEecccccccc
Q 015237 379 NGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 379 ~g~~k~~~~ikL~DFGla~~~~ 400 (411)
++ .+||+|||++..+.
T Consensus 190 ~~------~~kl~DFG~a~~~~ 205 (364)
T 3op5_A 190 PD------QVYLVDYGLAYRYC 205 (364)
T ss_dssp TT------CEEECCCTTCEESS
T ss_pred CC------eEEEEECCcceecc
Confidence 55 59999999997653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-25 Score=220.84 Aligned_cols=148 Identities=22% Similarity=0.282 Sum_probs=127.9
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 315 (411)
...|++.+.||+|+||.||+|... ++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999999999999885 688999999876556666778999999999999999999999997654
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+|+||||+. |+|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~------~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC------CEEEEEeec
Confidence 7899999995 588888852 488999999999999999999999999999999999999988 599999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+.....
T Consensus 174 a~~~~~ 179 (371)
T 2xrw_A 174 ARTAGT 179 (371)
T ss_dssp ------
T ss_pred cccccc
Confidence 987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=212.66 Aligned_cols=146 Identities=24% Similarity=0.422 Sum_probs=129.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-------- 313 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-------- 313 (411)
...|++.+.||+|+||.||++.+. ++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 356899999999999999999986 7899999997653 346789999999999999999998854
Q ss_pred --------CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCC
Q 015237 314 --------PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDS 384 (411)
Q Consensus 314 --------~~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~ 384 (411)
...+|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---- 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK---- 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT----
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC----
Confidence 34589999999999999999765 24689999999999999999999999999999999999999988
Q ss_pred CccEEEEeccccccccc
Q 015237 385 DIHCYLSNFLSISTVIL 401 (411)
Q Consensus 385 ~~~ikL~DFGla~~~~~ 401 (411)
.+||+|||++..+..
T Consensus 160 --~~kl~Dfg~~~~~~~ 174 (284)
T 2a19_B 160 --QVKIGDFGLVTSLKN 174 (284)
T ss_dssp --EEEECCCTTCEESSC
T ss_pred --CEEECcchhheeccc
Confidence 699999999887643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=212.03 Aligned_cols=153 Identities=24% Similarity=0.410 Sum_probs=135.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
...|++.++||+|+||.||++... ++.||+|++..........+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457999999999999999999985 689999999876544444577999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++..+.
T Consensus 101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~---~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEK---DCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST---TCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCC---cccEEEeccCcceeec
Confidence 9999999999987664 6899999999999999999999999999999999999987542 1258999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=222.44 Aligned_cols=150 Identities=26% Similarity=0.377 Sum_probs=126.4
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH---HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
...|++.+.||+|+||.||+|++. ++.||||+++...... ...+.+.+|+.+++.++||||+++++++.....+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467999999999999999999885 6889999997643221 22346889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+||||+.+ +|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.+| .+||+|||++..
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG------VLKLADFGLAKS 161 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEEECCCGGGST
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC------CEEEEeccccee
Confidence 99999965 89999987666788899999999999999999999999999999999999988 599999999987
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 162 ~~ 163 (346)
T 1ua2_A 162 FG 163 (346)
T ss_dssp TT
T ss_pred cc
Confidence 63
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=218.88 Aligned_cols=140 Identities=19% Similarity=0.350 Sum_probs=123.9
Q ss_pred EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCCCC
Q 015237 251 HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
+.||+|+||.||++.+. ++.||||++... ....+.+|+.+++.+. ||||+++++++......|+||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 67999999999999986 689999999654 2356788999999997 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 328 SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 328 sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++...
T Consensus 92 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~---~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 92 ELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEND---NLEIKIIDFGFARLK 159 (325)
T ss_dssp BHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-------CEEEECCCTTCEEC
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCC---cccEEEeccccceec
Confidence 9999998764 6999999999999999999999999999999999999987652 125899999999755
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=216.51 Aligned_cols=152 Identities=26% Similarity=0.402 Sum_probs=125.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC---HHHHHHHHHHHHHHhhcC---CCceeEEEeeeec
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN---ENIRREFAQEVHIMRKVR---HMNVVQFIGACTR 313 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~ 313 (411)
+..++|++.++||+|+||.||+|++. ++.||||+++..... ......+.+|+.+++.++ ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44668999999999999999999964 689999999754321 112245667887777664 9999999999976
Q ss_pred CC-----eEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 314 PP-----RLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 314 ~~-----~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
.. .++++|||+. |+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~------~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG------T 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS------C
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------C
Confidence 54 5899999995 699999987643 489999999999999999999999999999999999999888 5
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
+||+|||++..+.
T Consensus 159 ~kl~Dfg~a~~~~ 171 (308)
T 3g33_A 159 VKLADFGLARIYS 171 (308)
T ss_dssp EEECSCSCTTTST
T ss_pred EEEeeCccccccC
Confidence 9999999997653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-25 Score=219.74 Aligned_cols=149 Identities=25% Similarity=0.417 Sum_probs=133.6
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc--C----HHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCC
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL--N----ENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~--~----~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 315 (411)
..|++.+.||+|+||.||+|.+. ++.||||++..... . ....+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56999999999999999999985 78999999976531 1 13356788999999999 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~------~ikl~DfG~ 246 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM------QIRLSDFGF 246 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC------CEEEEecCc
Confidence 9999999999999999998654 689999999999999999999999999999999999999988 599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+..+.
T Consensus 247 ~~~~~ 251 (365)
T 2y7j_A 247 SCHLE 251 (365)
T ss_dssp CEECC
T ss_pred ccccC
Confidence 88664
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=213.28 Aligned_cols=148 Identities=22% Similarity=0.369 Sum_probs=129.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.+.||+|+||.||+++.. ++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 356899999999999999999985 78999999986532 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---ccCCCcCCCccEEEEecccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi---d~~g~~k~~~~ikL~DFGla~~ 398 (411)
||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||++ +.++ .+||+|||++..
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~------~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS------KIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC------CEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC------CEEEccCCccee
Confidence 9999999999997764 68999999999999999999999999999999999999 4444 599999999876
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 159 ~~ 160 (304)
T 2jam_A 159 EQ 160 (304)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-25 Score=214.39 Aligned_cols=153 Identities=28% Similarity=0.490 Sum_probs=132.8
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeec--
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR-- 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~-- 313 (411)
........|++.+.||+|+||.||+|++. ++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34456788999999999999999999984 789999999765332 35788999999999 89999999999976
Q ss_pred ----CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccE
Q 015237 314 ----PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 314 ----~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
...+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++ .+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------~~ 168 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA------EV 168 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC------CE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC------CE
Confidence 467999999999999999998753 3689999999999999999999999999999999999999888 59
Q ss_pred EEEecccccccc
Q 015237 389 YLSNFLSISTVI 400 (411)
Q Consensus 389 kL~DFGla~~~~ 400 (411)
||+|||++..+.
T Consensus 169 kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 169 KLVDFGVSAQLD 180 (326)
T ss_dssp EECCCTTTC---
T ss_pred EEeeCcCceecC
Confidence 999999987653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=238.83 Aligned_cols=157 Identities=27% Similarity=0.451 Sum_probs=139.9
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
...|++....|++.+.||+|+||.||+|.+. +..||||.++... .....+.+.+|+.+|++++||||+++++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4578999999999999999999999999985 2469999986543 445567899999999999999999999998
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 312 TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 312 ~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.. +.+|+||||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 461 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~------~vkL~ 533 (656)
T 2j0j_A 461 TE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND------CVKLG 533 (656)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------EEEEC
T ss_pred ec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC------CEEEE
Confidence 64 568999999999999999987766789999999999999999999999999999999999999988 69999
Q ss_pred eccccccccc
Q 015237 392 NFLSISTVIL 401 (411)
Q Consensus 392 DFGla~~~~~ 401 (411)
|||++..+..
T Consensus 534 DFG~a~~~~~ 543 (656)
T 2j0j_A 534 DFGLSRYMED 543 (656)
T ss_dssp CCCCCCSCCC
T ss_pred ecCCCeecCC
Confidence 9999987643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=217.31 Aligned_cols=146 Identities=26% Similarity=0.567 Sum_probs=130.7
Q ss_pred cCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhh--cCCCceeEEEeeeecCC----e
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRK--VRHMNVVQFIGACTRPP----R 316 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~--l~HpNIV~l~g~~~~~~----~ 316 (411)
-...|++.+.||+|+||.||+|++.++.||||++.... ...+.+|++++.. ++||||+++++++.... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34679999999999999999999999999999996542 3567889999887 78999999999998775 7
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEEccCCCcCCCccE
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH--------RNNIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLH--------s~gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
+|+||||+++|+|.+++... .+++..++.++.|++.||.||| +++|+||||||+|||++.++ .+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~------~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------TC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS------CE
T ss_pred eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC------CE
Confidence 99999999999999999764 4899999999999999999999 89999999999999999888 59
Q ss_pred EEEeccccccccc
Q 015237 389 YLSNFLSISTVIL 401 (411)
Q Consensus 389 kL~DFGla~~~~~ 401 (411)
||+|||++.....
T Consensus 187 kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 187 CIADLGLAVRHDS 199 (342)
T ss_dssp EECCCTTCEEEET
T ss_pred EEEECCCceeccc
Confidence 9999999976543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=226.00 Aligned_cols=155 Identities=12% Similarity=0.076 Sum_probs=116.1
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhc--CCCceeEEE------
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKV--RHMNVVQFI------ 308 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l--~HpNIV~l~------ 308 (411)
|......|++.++||+|+||.||+|.+. ++.||||+++..... ....+.+.+|+.+++.+ +||||++++
T Consensus 57 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp TTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred CCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 3444556999999999999999999985 688999999886542 34556778886555554 699988865
Q ss_pred -eeeecC-----------------CeEEEEEecCCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCc
Q 015237 309 -GACTRP-----------------PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLL------LRVAIDVSKGMNYLHRNNI 364 (411)
Q Consensus 309 -g~~~~~-----------------~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i------~~i~~qIa~gL~yLHs~gI 364 (411)
+++..+ ..+|||||||+ |+|.+++...+..+..... ..++.||+.||.|||++||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 333322 34899999997 8999999875434555555 6777999999999999999
Q ss_pred cccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 365 IHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 365 IHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+||||||+|||++.+| .+||+|||+|.....
T Consensus 216 vHrDikp~NIll~~~~------~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDG------RLMLGDVSALWKVGT 246 (371)
T ss_dssp EETTCSGGGEEECTTS------CEEECCGGGEEETTC
T ss_pred ccCcCCHHHEEECCCC------CEEEEecceeeecCC
Confidence 9999999999999988 599999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=227.74 Aligned_cols=154 Identities=22% Similarity=0.320 Sum_probs=129.9
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC------HHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN------ENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
-.+.|.+.++||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3578999999999999999999886 589999999865421 1222358899999999999999999999865
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+..|+|||||++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++. ...+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~---~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE---DCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSS---SCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCC---cceEEEeecc
Confidence 45899999999999999887654 6899999999999999999999999999999999999976552 1259999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
++..+..
T Consensus 288 ~a~~~~~ 294 (419)
T 3i6u_A 288 HSKILGE 294 (419)
T ss_dssp TTTSCC-
T ss_pred cceecCC
Confidence 9987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-25 Score=213.79 Aligned_cols=144 Identities=16% Similarity=0.294 Sum_probs=128.1
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeec--CCeE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTR--PPRL 317 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~--~~~l 317 (411)
....|++.++||+|+||.||+|.+. ++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 3567999999999999999999875 6899999997542 367889999999997 9999999999987 6679
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
++||||+.+++|.+++. .++...+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 109 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-----~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-----KLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-----EEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-----EEEEEeCCCce
Confidence 99999999999999884 3788999999999999999999999999999999999997763 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 180 ~~~ 182 (330)
T 3nsz_A 180 FYH 182 (330)
T ss_dssp ECC
T ss_pred EcC
Confidence 653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=223.67 Aligned_cols=148 Identities=19% Similarity=0.321 Sum_probs=123.1
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR---- 313 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~---- 313 (411)
|+.....|++.+.||+|+||.||+|.+. ++.||||++..... ...+|+.+|+.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 5677788999999999999999999885 68999999876532 23479999999999999999999843
Q ss_pred ----------------------------------CCeEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Q 015237 314 ----------------------------------PPRLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGM 356 (411)
Q Consensus 314 ----------------------------------~~~l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL 356 (411)
...+++||||++ |+|.+++.. ....+++..+..++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 334899999996 588877764 244699999999999999999
Q ss_pred HHHHHCCccccCCCCCcEEEc-cCCCcCCCccEEEEecccccccc
Q 015237 357 NYLHRNNIIHRDLKAANLLMN-ENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 357 ~yLHs~gIIHRDLKp~NILid-~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
.|||++||+||||||+|||++ .++ .+||+|||+|..+.
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~------~~kl~Dfg~a~~~~ 193 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDN------TLKLCDFGSAKKLI 193 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTT------EEEECCCTTCEECC
T ss_pred HHHHHCcCccCccCHHHEEEcCCCC------cEEEEECCCCcccC
Confidence 999999999999999999998 455 59999999998653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-25 Score=221.06 Aligned_cols=153 Identities=22% Similarity=0.372 Sum_probs=133.4
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...|++. ..|.+.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 4568876 68999999999999999999886 68999999987766666778899999999999999999999999877
Q ss_pred CeE------EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccE
Q 015237 315 PRL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 315 ~~l------~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
... |+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~------~~ 183 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC------EL 183 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CE
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC------CE
Confidence 654 99999995 68888773 3489999999999999999999999999999999999999988 59
Q ss_pred EEEecccccccc
Q 015237 389 YLSNFLSISTVI 400 (411)
Q Consensus 389 kL~DFGla~~~~ 400 (411)
||+|||++....
T Consensus 184 kL~Dfg~a~~~~ 195 (371)
T 4exu_A 184 KILDFGLARHAD 195 (371)
T ss_dssp EECSTTCC----
T ss_pred EEEecCcccccc
Confidence 999999997653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-25 Score=215.60 Aligned_cols=147 Identities=21% Similarity=0.304 Sum_probs=130.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-----Ce
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PR 316 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~ 316 (411)
.+.|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 467999999999999999999986 7899999996543 344567788999999999999999999988654 67
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.|+||||+. |+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~------~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC------DLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC------CEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC------cEEEEecccc
Confidence 999999995 6999999764 589999999999999999999999999999999999999888 5999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 160 ~~~~ 163 (353)
T 2b9h_A 160 RIID 163 (353)
T ss_dssp EECC
T ss_pred cccc
Confidence 8764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=211.71 Aligned_cols=155 Identities=23% Similarity=0.364 Sum_probs=133.0
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..+......+.....||+|+||.||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 345566666666678999999999999985 5789999997653 234577999999999999999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc-CCCcCCCccEEEEe
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE-NGVRDSDIHCYLSN 392 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~-~g~~k~~~~ikL~D 392 (411)
.+++||||+++++|.+++..... .+++..+..++.|++.||.|||++||+|+||||+||+++. ++ .+||+|
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~------~~kl~D 166 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG------VLKISD 166 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC------CEEECC
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC------CEEEee
Confidence 99999999999999999987633 4568888999999999999999999999999999999987 56 599999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||++..+.
T Consensus 167 fg~~~~~~ 174 (295)
T 2clq_A 167 FGTSKRLA 174 (295)
T ss_dssp TTTCEESC
T ss_pred cccccccC
Confidence 99998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=241.31 Aligned_cols=154 Identities=19% Similarity=0.286 Sum_probs=133.5
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecC
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP 314 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~ 314 (411)
.+.+...+|++.+.||+|+||.||++.+. ++.||||+++.... .....+.+..|..+|..+ +||||+++++++...
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34567788999999999999999999986 57899999986432 112345678899999987 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+||||||++||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+|||++.+| .+||+|||
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g------~ikL~DFG 487 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFG 487 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS------CEEECCCT
T ss_pred CEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC------cEEEeecc
Confidence 99999999999999999998765 699999999999999999999999999999999999999998 59999999
Q ss_pred ccccc
Q 015237 395 SISTV 399 (411)
Q Consensus 395 la~~~ 399 (411)
+|+..
T Consensus 488 la~~~ 492 (674)
T 3pfq_A 488 MCKEN 492 (674)
T ss_dssp TCEEC
T ss_pred eeecc
Confidence 99864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-25 Score=218.21 Aligned_cols=147 Identities=23% Similarity=0.351 Sum_probs=130.2
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC-----Ce
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP-----PR 316 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~ 316 (411)
...|++.+.||+|+||.||++.+. ++.||||++.... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 357999999999999999999886 6789999997543 344567899999999999999999999998654 36
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+||||+. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~------~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC------DLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC------CEEEEeCcce
Confidence 899999995 6999999764 489999999999999999999999999999999999999988 5999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
....
T Consensus 176 ~~~~ 179 (364)
T 3qyz_A 176 RVAD 179 (364)
T ss_dssp EECC
T ss_pred EecC
Confidence 8654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=222.44 Aligned_cols=155 Identities=22% Similarity=0.381 Sum_probs=136.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCH---------------HHHHHHHHHHHHHhhcCCCcee
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE---------------NIRREFAQEVHIMRKVRHMNVV 305 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~---------------~~~~~~~~Ei~iL~~l~HpNIV 305 (411)
.+....|++.+.||+|+||.||++.+.++.||||++....... ...+.+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 4456789999999999999999999988999999997653221 1126789999999999999999
Q ss_pred EEEeeeecCCeEEEEEecCCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEc
Q 015237 306 QFIGACTRPPRLFIVTEFMSGGSIYDY------LHKQ-KCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMN 377 (411)
Q Consensus 306 ~l~g~~~~~~~l~IV~E~~~gGsL~~~------L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid 377 (411)
++++++...+.+|+||||+++|+|.++ +... ...+++..++.++.|++.||.|||+ +||+||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999998 6543 3468999999999999999999999 9999999999999999
Q ss_pred cCCCcCCCccEEEEeccccccccc
Q 015237 378 ENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 378 ~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
.++ .+||+|||++..+..
T Consensus 187 ~~~------~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 187 KNG------RVKLSDFGESEYMVD 204 (348)
T ss_dssp TTS------CEEECCCTTCEECBT
T ss_pred CCC------cEEEecccccccccc
Confidence 888 599999999987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-25 Score=223.66 Aligned_cols=146 Identities=19% Similarity=0.264 Sum_probs=122.4
Q ss_pred CceEEE-EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHh-hcCCCceeEEEeeeec----CCe
Q 015237 245 SLLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMR-KVRHMNVVQFIGACTR----PPR 316 (411)
Q Consensus 245 ~~~~~~-~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~-~l~HpNIV~l~g~~~~----~~~ 316 (411)
..|.+. +.||+|+||.||++.+. ++.||||+++.. ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 345555 78999999999999986 688999999643 34678888874 4589999999998865 567
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+|||||||+||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP---NAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSST---TCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCC---CccEEEEeccc
Confidence 999999999999999998753 35899999999999999999999999999999999999987321 11599999999
Q ss_pred ccccc
Q 015237 396 ISTVI 400 (411)
Q Consensus 396 a~~~~ 400 (411)
+....
T Consensus 211 a~~~~ 215 (400)
T 1nxk_A 211 AKETT 215 (400)
T ss_dssp CEECC
T ss_pred ccccC
Confidence 98764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-25 Score=211.41 Aligned_cols=147 Identities=22% Similarity=0.308 Sum_probs=123.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee---------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--------- 312 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~--------- 312 (411)
.+.|++.+.||+|+||.||+|.+. ++.||+|++... +....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467999999999999999999986 689999998755 3455678999999999999999999999873
Q ss_pred -----cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCcc
Q 015237 313 -----RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIH 387 (411)
Q Consensus 313 -----~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ 387 (411)
....+|+||||+. |+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++. .
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-----~ 159 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL-----V 159 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT-----E
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-----e
Confidence 3467899999996 699999965 35899999999999999999999999999999999999975432 5
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
+||+|||++..+.
T Consensus 160 ~kl~Dfg~~~~~~ 172 (320)
T 2i6l_A 160 LKIGDFGLARIMD 172 (320)
T ss_dssp EEECCCTTCBCC-
T ss_pred EEEccCccccccC
Confidence 9999999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-25 Score=214.44 Aligned_cols=157 Identities=26% Similarity=0.360 Sum_probs=133.6
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHH-HHhhcCCCceeEEEeeeec
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVH-IMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~ 313 (411)
...|++..++|++.+.||+|+||.||+|.+. ++.||||+++.... ......+..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4679999999999999999999999999986 78999999976543 333455666665 7788899999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccE
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHK----QKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHC 388 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~----~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~i 388 (411)
.+..|+||||+. |+|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~------~~ 165 (327)
T 3aln_A 93 EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG------NI 165 (327)
T ss_dssp SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT------EE
T ss_pred CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC------CE
Confidence 999999999996 488887763 234689999999999999999999999 999999999999999888 69
Q ss_pred EEEeccccccccc
Q 015237 389 YLSNFLSISTVIL 401 (411)
Q Consensus 389 kL~DFGla~~~~~ 401 (411)
||+|||++..+..
T Consensus 166 kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 166 KLCDFGISGQLVD 178 (327)
T ss_dssp EECCCSSSCC---
T ss_pred EEccCCCceeccc
Confidence 9999999987643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-25 Score=211.20 Aligned_cols=146 Identities=20% Similarity=0.267 Sum_probs=124.5
Q ss_pred ceEEE-EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHH-hhcCCCceeEEEeeeec----CCeE
Q 015237 246 LLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIM-RKVRHMNVVQFIGACTR----PPRL 317 (411)
Q Consensus 246 ~~~~~-~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL-~~l~HpNIV~l~g~~~~----~~~l 317 (411)
.|.+. +.||+|+||.||++.+. ++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ...+
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 35555 78999999999999985 689999999643 3567888887 55699999999999876 6679
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP---NAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST---TCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCC---CCcEEEeccccc
Confidence 99999999999999998764 36899999999999999999999999999999999999998321 115999999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
....+
T Consensus 168 ~~~~~ 172 (299)
T 3m2w_A 168 KETTG 172 (299)
T ss_dssp EECTT
T ss_pred ccccc
Confidence 87654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=217.52 Aligned_cols=152 Identities=22% Similarity=0.331 Sum_probs=129.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeecccc---------CHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHL---------NENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~---------~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
+...+.|++.+.||+|+||.||+|... ++.||||++..... +....+.+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 445577999999999999999999875 68899999865432 23345789999999999999999999999
Q ss_pred ee-----cCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCC
Q 015237 311 CT-----RPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 311 ~~-----~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~ 385 (411)
+. ....+|+||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~----- 171 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN----- 171 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-----
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-----
Confidence 84 3346899999996 699999887666799999999999999999999999999999999999999888
Q ss_pred ccEEEEeccccccc
Q 015237 386 IHCYLSNFLSISTV 399 (411)
Q Consensus 386 ~~ikL~DFGla~~~ 399 (411)
.+||+|||++...
T Consensus 172 -~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 172 -DITICDFNLARED 184 (362)
T ss_dssp -CEEECCTTC----
T ss_pred -CEEEEecCccccc
Confidence 5999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=211.38 Aligned_cols=156 Identities=17% Similarity=0.247 Sum_probs=138.0
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC--CCceeEEEeeeec
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--HMNVVQFIGACTR 313 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~ 313 (411)
....++....|++.+.||+|+||.||++.+. ++.||||++..........+.+.+|+.++++++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 4567888999999999999999999999876 688999999877666667788999999999997 5999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
...+|+|||+ .+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+++ + .+||+||
T Consensus 100 ~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~------~~kL~Df 170 (313)
T 3cek_A 100 DQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G------MLKLIDF 170 (313)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T------EEEECCC
T ss_pred CCEEEEEEec-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C------eEEEeec
Confidence 9999999995 5889999998764 6899999999999999999999999999999999999964 4 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 171 g~~~~~~~ 178 (313)
T 3cek_A 171 GIANQMQP 178 (313)
T ss_dssp SSSCC---
T ss_pred cccccccC
Confidence 99987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=220.43 Aligned_cols=154 Identities=19% Similarity=0.264 Sum_probs=125.5
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC-----CceEEEEEeeccccCHH---------HHHHHHHHHHHHhhcCCCcee
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF-----SQDVAIKVLTNEHLNEN---------IRREFAQEVHIMRKVRHMNVV 305 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-----~~~VAIK~l~~~~~~~~---------~~~~~~~Ei~iL~~l~HpNIV 305 (411)
-++....|++.+.||+|+||.||+|.+. +..||||++........ ....+.+|+.+++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3456789999999999999999999984 47899999876532110 112367888999999999999
Q ss_pred EEEeeeec----CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 015237 306 QFIGACTR----PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 306 ~l~g~~~~----~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~ 381 (411)
++++++.. ...+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 99999987 67899999999 999999998765 7899999999999999999999999999999999999988762
Q ss_pred cCCCccEEEEeccccccc
Q 015237 382 RDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~ 399 (411)
. .+||+|||++..+
T Consensus 190 ~----~~kL~Dfg~a~~~ 203 (345)
T 2v62_A 190 D----QVYLADYGLSYRY 203 (345)
T ss_dssp T----SEEECCCTTCEES
T ss_pred C----cEEEEeCCCceec
Confidence 1 4899999999765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=210.31 Aligned_cols=157 Identities=20% Similarity=0.330 Sum_probs=127.1
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
...|.+...+|++.+.||+|+||.||+|.+. ++.||||++..........+.+..+..+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3568888899999999999999999999985 78999999987654444445555666678888999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
..+|+||||+ ++.+..+.......+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~------~~kl~df 169 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG------QIKLCDF 169 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS------CEEECCC
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC------CEEEEEC
Confidence 9999999999 6667666665555799999999999999999999995 999999999999999888 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 170 g~~~~~~ 176 (318)
T 2dyl_A 170 GISGRLV 176 (318)
T ss_dssp TTC----
T ss_pred CCchhcc
Confidence 9997653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=215.26 Aligned_cols=153 Identities=19% Similarity=0.331 Sum_probs=132.4
Q ss_pred cCCceEEE-EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEE
Q 015237 243 DASLLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 243 ~~~~~~~~-~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~ 318 (411)
-...|.+. ++||+|+||.||+|.+. ++.||+|+++...........+.+|+.+++.+. ||||+++++++.....+|
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 34556666 89999999999999986 689999999876554445678999999999994 699999999999999999
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc---CCCcCCCccEEEEecc
Q 015237 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVRDSDIHCYLSNFL 394 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~---~g~~k~~~~ikL~DFG 394 (411)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++. ++ .+||+|||
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~------~~kL~Dfg 179 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG------DIKIVDFG 179 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC------CEEECCGG
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC------cEEEeeCc
Confidence 999999999999998654 346899999999999999999999999999999999999987 44 59999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
++..+..
T Consensus 180 ~a~~~~~ 186 (327)
T 3lm5_A 180 MSRKIGH 186 (327)
T ss_dssp GCEEC--
T ss_pred cccccCC
Confidence 9987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=216.21 Aligned_cols=152 Identities=22% Similarity=0.371 Sum_probs=133.0
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|++. ..|.+.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 457775 57999999999999999999885 689999999876656666788999999999999999999999998765
Q ss_pred e------EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 R------LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ~------l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
. +|+||||+. |+|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~------~~k 166 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC------ELK 166 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC------CEE
T ss_pred ccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC------cEE
Confidence 4 499999996 688887742 489999999999999999999999999999999999999888 599
Q ss_pred EEecccccccc
Q 015237 390 LSNFLSISTVI 400 (411)
Q Consensus 390 L~DFGla~~~~ 400 (411)
|+|||++....
T Consensus 167 l~Dfg~~~~~~ 177 (353)
T 3coi_A 167 ILDFGLARHAD 177 (353)
T ss_dssp ECSTTCTTC--
T ss_pred EeecccccCCC
Confidence 99999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=212.19 Aligned_cols=150 Identities=25% Similarity=0.438 Sum_probs=127.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhc---CCCceeEEEeeee-----
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACT----- 312 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~----- 312 (411)
...|++.+.||+|+||.||++.+. ++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 467999999999999999999983 57899999976543322223566788777766 8999999999987
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
....+++||||+. |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~------~~kl~ 162 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG------QIKLA 162 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEEEC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC------CEEEe
Confidence 5567999999996 69999998754 3489999999999999999999999999999999999999988 59999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||++..+.
T Consensus 163 Dfg~~~~~~ 171 (326)
T 1blx_A 163 DFGLARIYS 171 (326)
T ss_dssp SCCSCCCCC
T ss_pred cCccccccc
Confidence 999997654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=207.10 Aligned_cols=147 Identities=25% Similarity=0.354 Sum_probs=124.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee-ecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC-TRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~-~~~~~l~IV 320 (411)
.+.|++.+.||+|+||.||+|++. ++.||||++...... ..+.+|+.+++.++|++++..++.+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 356999999999999999999974 689999987655322 3578899999999988877666655 667789999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---ccCCCcCCCccEEEEeccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi---d~~g~~k~~~~ikL~DFGla~ 397 (411)
|||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~------~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN------LVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT------CEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC------eEEEecCccce
Confidence 9999 999999998766679999999999999999999999999999999999999 6666 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 157 ~~~~ 160 (296)
T 4hgt_A 157 KYRD 160 (296)
T ss_dssp ECBC
T ss_pred eccC
Confidence 6543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=217.65 Aligned_cols=147 Identities=18% Similarity=0.216 Sum_probs=127.2
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC----------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeE-----
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF----------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ----- 306 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~----------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~----- 306 (411)
.....|++.+.||+|+||.||+|.+. ++.||+|++... +.+.+|+.++++++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhh
Confidence 44688999999999999999999875 578999999754 35789999999999999988
Q ss_pred ----------EEeeeec-CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 015237 307 ----------FIGACTR-PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANL 374 (411)
Q Consensus 307 ----------l~g~~~~-~~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NI 374 (411)
+++++.. ...+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5666665 67899999999 99999999875 34699999999999999999999999999999999999
Q ss_pred EEccCCCcCCCccEEEEecccccccc
Q 015237 375 LMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 375 Lid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|++.++. ..+||+|||++..+.
T Consensus 191 l~~~~~~----~~~kl~Dfg~a~~~~ 212 (352)
T 2jii_A 191 FVDPEDQ----SQVTLAGYGFAFRYC 212 (352)
T ss_dssp EEETTEE----EEEEECCGGGCBCSS
T ss_pred EEcCCCC----ceEEEecCcceeecc
Confidence 9998762 248999999997654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=214.26 Aligned_cols=157 Identities=20% Similarity=0.269 Sum_probs=124.4
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhc----CCCceeEE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKV----RHMNVVQF 307 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l----~HpNIV~l 307 (411)
...+.-.+.|++.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+.+++++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 445667788999999999999999999884 6889999997654322 1234467799999998 89999999
Q ss_pred EeeeecCCeEEEEEec-CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-cCCCcCCC
Q 015237 308 IGACTRPPRLFIVTEF-MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVRDSD 385 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~-~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid-~~g~~k~~ 385 (411)
++++...+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~----- 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG----- 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-----
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-----
Confidence 9999998999999999 78999999998754 689999999999999999999999999999999999998 666
Q ss_pred ccEEEEeccccccccc
Q 015237 386 IHCYLSNFLSISTVIL 401 (411)
Q Consensus 386 ~~ikL~DFGla~~~~~ 401 (411)
.+||+|||++..+..
T Consensus 178 -~~kl~dfg~~~~~~~ 192 (312)
T 2iwi_A 178 -CAKLIDFGSGALLHD 192 (312)
T ss_dssp -EEEECCCSSCEECCS
T ss_pred -eEEEEEcchhhhccc
Confidence 599999999887643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-24 Score=205.09 Aligned_cols=147 Identities=25% Similarity=0.353 Sum_probs=127.1
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee-ecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC-TRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~-~~~~~l~IV 320 (411)
.+.|++.+.||+|+||.||+|++. ++.||||++...... ..+.+|+.+++.++|++++..++.+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 467999999999999999999974 789999998765433 3588999999999988866655554 567788999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc---cCCCcCCCccEEEEeccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN---ENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid---~~g~~k~~~~ikL~DFGla~ 397 (411)
|||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++ .++ .+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~------~~kl~Dfg~~~ 156 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN------LVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT------CEEECCCTTCE
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC------eEEEeeCCCcc
Confidence 9999 9999999986666799999999999999999999999999999999999994 555 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 157 ~~~~ 160 (296)
T 3uzp_A 157 KYRD 160 (296)
T ss_dssp ECBC
T ss_pred cccc
Confidence 7543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-24 Score=208.24 Aligned_cols=156 Identities=19% Similarity=0.337 Sum_probs=132.0
Q ss_pred eecCCceEEEEEEeecCceEEEEEEE---CCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc------eeEEEeee
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAF---FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN------VVQFIGAC 311 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~---~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN------IV~l~g~~ 311 (411)
++-...|++.+.||+|+||.||++.+ .++.||||+++.. ....+.+.+|+.+++.++|+| |+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 44567899999999999999999987 3688999999753 344577889999999987664 99999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC-------
Q 015237 312 TRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD------- 383 (411)
Q Consensus 312 ~~~~~l~IV~E~~~gGsL~~~L~~~~~-~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k------- 383 (411)
...+.+|+||||+ +++|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++..+
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999999 8999999987642 588999999999999999999999999999999999998743110
Q ss_pred ------CCccEEEEecccccccc
Q 015237 384 ------SDIHCYLSNFLSISTVI 400 (411)
Q Consensus 384 ------~~~~ikL~DFGla~~~~ 400 (411)
....+||+|||++....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~ 188 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD 188 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT
T ss_pred cccccccCCCceEeeCcccccCc
Confidence 02258999999997643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-25 Score=210.58 Aligned_cols=149 Identities=21% Similarity=0.363 Sum_probs=127.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC--HHHHHHHHHHHHHHhhcCCCceeEEEeee--ecCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN--ENIRREFAQEVHIMRKVRHMNVVQFIGAC--TRPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~--~~~~~l~ 318 (411)
..|++.+.||+|+||.||++.+. ++.||+|+++..... ....+.+.+|+.+++.++||||+++++++ .....+|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 46888999999999999999885 578999999765321 23457799999999999999999999998 4456799
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
+||||+.++ |.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~------~~kl~dfg~~~ 157 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG------TLKISALGVAE 157 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCCTTCE
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC------cEEeecccccc
Confidence 999999765 77777664 34689999999999999999999999999999999999999888 59999999998
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
.+.
T Consensus 158 ~~~ 160 (305)
T 2wtk_C 158 ALH 160 (305)
T ss_dssp ECC
T ss_pred ccC
Confidence 754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=224.40 Aligned_cols=143 Identities=20% Similarity=0.425 Sum_probs=114.0
Q ss_pred eEE-EEEEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeee--cCCeEEE
Q 015237 247 LKF-EHKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACT--RPPRLFI 319 (411)
Q Consensus 247 ~~~-~~~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~--~~~~l~I 319 (411)
|.+ +++||+|+||.||+|++. ++.||||++...... ..+.+|+.+|+.++||||+++++++. ....+|+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 444 457999999999999975 578999999766443 45788999999999999999999994 4678999
Q ss_pred EEecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE----ccCCCcCCCcc
Q 015237 320 VTEFMSGGSIYDYLHKQK--------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM----NENGVRDSDIH 387 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~--------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi----d~~g~~k~~~~ 387 (411)
||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~------~ 170 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG------R 170 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT------C
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC------c
Confidence 999995 58988886421 148899999999999999999999999999999999999 4444 5
Q ss_pred EEEEecccccccc
Q 015237 388 CYLSNFLSISTVI 400 (411)
Q Consensus 388 ikL~DFGla~~~~ 400 (411)
+||+|||+|..+.
T Consensus 171 ~kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 171 VKIADMGFARLFN 183 (405)
T ss_dssp EEECCTTCCC---
T ss_pred EEEEECCCceecC
Confidence 9999999998664
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-24 Score=218.17 Aligned_cols=151 Identities=28% Similarity=0.414 Sum_probs=130.8
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc------CCCceeEEEeeeec
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV------RHMNVVQFIGACTR 313 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l------~HpNIV~l~g~~~~ 313 (411)
....+|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 34567999999999999999999886 589999999754 34456788899988887 57799999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
...+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~----~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR----SGIKVID 245 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS----CCEEECC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC----cceEEee
Confidence 99999999999 479999998764 35899999999999999999999999999999999999998873 1389999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||++....
T Consensus 246 FG~a~~~~ 253 (429)
T 3kvw_A 246 FGSSCYEH 253 (429)
T ss_dssp CTTCEETT
T ss_pred cccceecC
Confidence 99996543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=221.12 Aligned_cols=145 Identities=24% Similarity=0.342 Sum_probs=121.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec------CC
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PP 315 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~------~~ 315 (411)
...|++.+.||+|+||.||+|++. ++.||||++.... ..+.+|+.+|+.++||||++++++|.. ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 346899999999999999999995 6899999987543 123479999999999999999998843 22
Q ss_pred eEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 316 RLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.+++||||+++ ++.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-----~~kl~D 200 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-----VLKLCD 200 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-----EEEECC
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-----eEEecc
Confidence 47899999965 77766653 3446899999999999999999999999999999999999996642 489999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||+++.+.
T Consensus 201 FG~a~~~~ 208 (420)
T 1j1b_A 201 FGSAKQLV 208 (420)
T ss_dssp CTTCEECC
T ss_pred chhhhhcc
Confidence 99998653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=234.20 Aligned_cols=150 Identities=20% Similarity=0.288 Sum_probs=128.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe-
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR- 316 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~- 316 (411)
++-..+|++.++||+|+||.||++.+. ++.||||++.... .......+.+|+.+|++++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 455678999999999999999999984 5889999987543 34556778999999999999999999999987655
Q ss_pred ----EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 317 ----LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 317 ----l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-------~~kl~D 224 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-------QLKLID 224 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-------CEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-------cEEEEe
Confidence 7999999999999988754 58999999999999999999999999999999999999874 389999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||+++.+..
T Consensus 225 FG~a~~~~~ 233 (681)
T 2pzi_A 225 LGAVSRINS 233 (681)
T ss_dssp CTTCEETTC
T ss_pred cccchhccc
Confidence 999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=213.71 Aligned_cols=136 Identities=25% Similarity=0.440 Sum_probs=117.5
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC--------CCceeEEEee
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--------HMNVVQFIGA 310 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~--------HpNIV~l~g~ 310 (411)
++-...|++.++||+|+||.||+|++. ++.||||+++.. ....+.+.+|+.+|+.++ |+||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 344678999999999999999999875 688999999754 344577899999999985 7889999999
Q ss_pred ee----cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCC
Q 015237 311 CT----RPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG 380 (411)
Q Consensus 311 ~~----~~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g 380 (411)
+. ....+|+||||+ ++++.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 87 556799999999 677777776543 4699999999999999999999998 999999999999998765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-25 Score=223.95 Aligned_cols=157 Identities=22% Similarity=0.332 Sum_probs=130.5
Q ss_pred CCceeecCCceEEEEEEeecCceE-EEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCD-LYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~-Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~ 314 (411)
.+.+.+....|.+.+.||+|+||. +|++.+.++.||||++..... ..+.+|+.+|+.+ +||||+++++++...
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 456788888999999999999998 566677789999999976533 2356799999999 799999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
..+|||||||. |+|.+++......+....++.++.||+.||.|||++||+||||||+|||++.++. ...+.+||+|||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~-~~~~~~kL~DFG 168 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA-HGKIKAMISDFG 168 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT-TTBCCEEECCTT
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC-CCceeEEEeccc
Confidence 99999999995 6999999877655555567889999999999999999999999999999965431 112358999999
Q ss_pred cccccc
Q 015237 395 SISTVI 400 (411)
Q Consensus 395 la~~~~ 400 (411)
+|..+.
T Consensus 169 ~a~~~~ 174 (432)
T 3p23_A 169 LCKKLA 174 (432)
T ss_dssp EEECC-
T ss_pred ceeecc
Confidence 998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=213.00 Aligned_cols=157 Identities=21% Similarity=0.315 Sum_probs=133.5
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcC--CCceeEEEe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVR--HMNVVQFIG 309 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~--HpNIV~l~g 309 (411)
..++.-.+.|++.+.||+|+||.||+|.+. ++.||||+++...... ...+.+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 455677888999999999999999999885 6889999998654321 12245678999999996 599999999
Q ss_pred eeecCCeEEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-cCCCcCCCcc
Q 015237 310 ACTRPPRLFIVTEFMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVRDSDIH 387 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~g-GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid-~~g~~k~~~~ 387 (411)
++...+..++|||++.+ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++ .
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~------~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG------E 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT------E
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC------C
Confidence 99999999999999975 89999998754 689999999999999999999999999999999999998 556 5
Q ss_pred EEEEeccccccccc
Q 015237 388 CYLSNFLSISTVIL 401 (411)
Q Consensus 388 ikL~DFGla~~~~~ 401 (411)
+||+|||++..+..
T Consensus 189 ~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 189 LKLIDFGSGALLKD 202 (320)
T ss_dssp EEECCCTTCEECCS
T ss_pred EEEeeCcccccccc
Confidence 99999999987644
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=230.14 Aligned_cols=141 Identities=16% Similarity=0.252 Sum_probs=112.6
Q ss_pred EEEeecCceEEEEE--EECCceEEEEEeecccc--------CHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEE
Q 015237 251 HKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHL--------NENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g--~~~~~~VAIK~l~~~~~--------~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~I 319 (411)
...+.|++|....+ .+.|+.|++|++..... .+...++|.+|+++|+++ .|+||+++++++++.+.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34566777766544 34589999999986532 123456799999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||++|++|.++|...+ .++.. .|+.||+.||.|+|++|||||||||+|||++.+| .+||+|||+|+.+
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg------~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ------HARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS------CEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC------CEEEeecccCeeC
Confidence 999999999999998754 56654 5789999999999999999999999999999998 5999999999876
Q ss_pred cc
Q 015237 400 IL 401 (411)
Q Consensus 400 ~~ 401 (411)
..
T Consensus 390 ~~ 391 (569)
T 4azs_A 390 PQ 391 (569)
T ss_dssp C-
T ss_pred CC
Confidence 43
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=215.78 Aligned_cols=144 Identities=26% Similarity=0.349 Sum_probs=119.5
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC------
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP------ 315 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 315 (411)
....|++.+.||+|+||.||+|++. +..||+|.+..... ...+|+.+|+.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4456999999999999999999986 46699998865432 1236999999999999999999985433
Q ss_pred eEEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEc-cCCCcCCCccEEEE
Q 015237 316 RLFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMN-ENGVRDSDIHCYLS 391 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid-~~g~~k~~~~ikL~ 391 (411)
.+|+||||+++ ++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++ .++ .+||+
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~------~~kL~ 184 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG------VLKLI 184 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT------EEEEC
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC------cEEEe
Confidence 38899999976 44444332 234689999999999999999999999999999999999998 566 59999
Q ss_pred eccccccc
Q 015237 392 NFLSISTV 399 (411)
Q Consensus 392 DFGla~~~ 399 (411)
|||+|..+
T Consensus 185 DFG~a~~~ 192 (394)
T 4e7w_A 185 DFGSAKIL 192 (394)
T ss_dssp CCTTCEEC
T ss_pred eCCCcccc
Confidence 99999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-24 Score=209.27 Aligned_cols=157 Identities=17% Similarity=0.322 Sum_probs=132.8
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-----------CCceeE
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----------HMNVVQ 306 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpNIV~ 306 (411)
..+....|++.+.||+|+||.||+|++. ++.||||++... ......+.+|+.++++++ ||||++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 3567788999999999999999999974 689999999754 334567889999999886 899999
Q ss_pred EEeeeecCC----eEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEEccCC
Q 015237 307 FIGACTRPP----RLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRN-NIIHRDLKAANLLMNENG 380 (411)
Q Consensus 307 l~g~~~~~~----~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~-gIIHRDLKp~NILid~~g 380 (411)
+++++.... .++++|||+ +++|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999987643 789999999 899999998753 3589999999999999999999998 999999999999997654
Q ss_pred CcCCCccEEEEecccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~~ 400 (411)
.......+||+|||++..+.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~ 189 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYD 189 (373)
T ss_dssp TTTTEEEEEECCCTTCEETT
T ss_pred CCcCcceEEEcccccccccC
Confidence 32223369999999997654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-23 Score=206.44 Aligned_cols=149 Identities=19% Similarity=0.284 Sum_probs=120.0
Q ss_pred CCceEEE-EEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----CCe
Q 015237 244 ASLLKFE-HKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPR 316 (411)
Q Consensus 244 ~~~~~~~-~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~~ 316 (411)
.+.|.+. +.||+|+||.||+|.+. ++.||||++... ....+ .....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3457775 56999999999999987 789999999654 22122 22234566799999999999875 445
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~---~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEK---DAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSST---TCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCC---CceEEEecccc
Confidence 899999999999999998764 36899999999999999999999999999999999999987542 11489999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+.....
T Consensus 178 ~~~~~~ 183 (336)
T 3fhr_A 178 AKETTQ 183 (336)
T ss_dssp CEEC--
T ss_pred ceeccc
Confidence 986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=204.00 Aligned_cols=154 Identities=18% Similarity=0.313 Sum_probs=128.6
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--C-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc------eeEEEeeee
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--S-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN------VVQFIGACT 312 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN------IV~l~g~~~ 312 (411)
.-...|++.+.||+|+||.||++.+. + +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 34578999999999999999999985 3 68999999753 344567889999999998766 999999999
Q ss_pred cCCeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCc---------
Q 015237 313 RPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVR--------- 382 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~--------- 382 (411)
..+.+|+||||+ ++++.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++..+..
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999999 778888877654 468999999999999999999999999999999999999543210
Q ss_pred ----CCCccEEEEeccccccc
Q 015237 383 ----DSDIHCYLSNFLSISTV 399 (411)
Q Consensus 383 ----k~~~~ikL~DFGla~~~ 399 (411)
.....+||+|||++...
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~ 192 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFD 192 (355)
T ss_dssp CEEEESCCCEEECCCTTCEET
T ss_pred cccccCCCcEEEeecCccccc
Confidence 01126999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=218.67 Aligned_cols=147 Identities=22% Similarity=0.328 Sum_probs=127.6
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC-CceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~~~l~IV 320 (411)
...|++.++||+|+||.||+|.+. ++.||||++...... ..+.+|+.+++.++| ++|..+..++......|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 467999999999999999999985 789999998765433 347889999999987 5566666677778889999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEE---ccCCCcCCCccEEEEeccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLM---NENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILi---d~~g~~k~~~~ikL~DFGla~ 397 (411)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||++.
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~------~vkL~DFGla~ 154 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN------QVYIIDFGLAK 154 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT------CEEECCCTTCE
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC------eEEEEeCCcce
Confidence 9999 999999998766679999999999999999999999999999999999999 4555 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 155 ~~~~ 158 (483)
T 3sv0_A 155 KYRD 158 (483)
T ss_dssp ECBC
T ss_pred eccC
Confidence 7643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=207.52 Aligned_cols=151 Identities=21% Similarity=0.262 Sum_probs=115.0
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe-
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR- 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~- 316 (411)
.....+.|++.+.||+|+||.||+|++. ++.||||++...... .....+|+..++.++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3455678999999999999999999986 689999998654322 2346678888899999999999999865332
Q ss_pred ------EEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEcc-CCCcCC
Q 015237 317 ------LFIVTEFMSGGSIYDYLHK---QKCGLKLPLLLRVAIDVSKGMNYLH--RNNIIHRDLKAANLLMNE-NGVRDS 384 (411)
Q Consensus 317 ------l~IV~E~~~gGsL~~~L~~---~~~~l~~~~i~~i~~qIa~gL~yLH--s~gIIHRDLKp~NILid~-~g~~k~ 384 (411)
+|+||||+++ +|.+.+.. ....++...+..++.|++.||.||| ++||+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---- 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG---- 169 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT----
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC----
Confidence 8999999965 66555443 3346889999999999999999999 999999999999999987 66
Q ss_pred CccEEEEecccccccc
Q 015237 385 DIHCYLSNFLSISTVI 400 (411)
Q Consensus 385 ~~~ikL~DFGla~~~~ 400 (411)
.+||+|||++..+.
T Consensus 170 --~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 170 --TLKLCDFGSAKKLS 183 (360)
T ss_dssp --EEEECCCTTCBCCC
T ss_pred --cEEEeeCCCceecC
Confidence 69999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.4e-23 Score=204.04 Aligned_cols=150 Identities=23% Similarity=0.281 Sum_probs=127.6
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CC-----ceeEEEeeeecC
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HM-----NVVQFIGACTRP 314 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----NIV~l~g~~~~~ 314 (411)
-.++|++.++||+|+||.||+|.+. ++.||||+++.. ......+..|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 3578999999999999999999886 678999999754 344567888999988885 55 499999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLH--RNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLH--s~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
+.+|+||||+. |+|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++. ..+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~----~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR----SAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS----CCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC----CcEEEE
Confidence 99999999995 69999998764 36899999999999999999999 579999999999999964321 158999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||++..+.
T Consensus 204 DFG~a~~~~ 212 (382)
T 2vx3_A 204 DFGSSCQLG 212 (382)
T ss_dssp CCTTCEETT
T ss_pred eccCceecc
Confidence 999997764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=211.04 Aligned_cols=151 Identities=22% Similarity=0.281 Sum_probs=120.2
Q ss_pred CceEEEEEEeecCceEEEE-EEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYK-GAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~-g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.+...+.||+|+||.||. +...++.||||++..+. .+.+.+|+.+|+++ +||||+++++++.....+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3456678899999999964 45568999999987542 24578899999886 89999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCC------CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC-------cCCCccEE
Q 015237 323 FMSGGSIYDYLHKQKCGL------KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV-------RDSDIHCY 389 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l------~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~-------~k~~~~ik 389 (411)
||. |+|.+++....... ++..++.++.||+.||.|||++||+||||||+|||++.++. ......+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 995 69999998654211 22235679999999999999999999999999999986541 01223699
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
|+|||++..+..
T Consensus 169 L~DFG~a~~~~~ 180 (434)
T 2rio_A 169 ISDFGLCKKLDS 180 (434)
T ss_dssp ECCCTTCEECCC
T ss_pred EcccccceecCC
Confidence 999999987654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=221.12 Aligned_cols=135 Identities=21% Similarity=0.301 Sum_probs=109.2
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCH------HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNE------NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~------~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.+.||+|+||.||+|.+.++.+++|......... ...+.+.+|+.+|++++||||+++..++......||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 5689999999999998889999999876543321 1245689999999999999999555555566678999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.+..
T Consensus 421 ~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--------~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 421 INGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--------DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--------SEEECCCTTCEECCC
T ss_pred CCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--------eEEEEECccCEECCC
Confidence 999999999965 4688999999999999999999999999999987 389999999987754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.1e-23 Score=198.68 Aligned_cols=140 Identities=12% Similarity=0.100 Sum_probs=111.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCH----------------HHHHHHHHHHHHHhhcCCCceeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNE----------------NIRREFAQEVHIMRKVRHMNVVQ 306 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~----------------~~~~~~~~Ei~iL~~l~HpNIV~ 306 (411)
...|.+++.||+|+||.||+|.+. ++.||||+++...... .....+.+|+.+|++++| ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 445668899999999999999984 6899999997543211 235678999999999984 55
Q ss_pred EEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCc
Q 015237 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDI 386 (411)
Q Consensus 307 l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~ 386 (411)
+++++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+|||++ +|
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~------ 229 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE------ 229 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT------
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC------
Confidence 5554433 45799999999999988 421 12457899999999999999999999999999999 77
Q ss_pred cEEEEecccccccccc
Q 015237 387 HCYLSNFLSISTVILV 402 (411)
Q Consensus 387 ~ikL~DFGla~~~~~~ 402 (411)
.+||+|||+|.....+
T Consensus 230 ~vkl~DFG~a~~~~~~ 245 (282)
T 1zar_A 230 GIWIIDFPQSVEVGEE 245 (282)
T ss_dssp EEEECCCTTCEETTST
T ss_pred cEEEEECCCCeECCCC
Confidence 6999999999877554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=223.97 Aligned_cols=153 Identities=25% Similarity=0.377 Sum_probs=131.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec------CCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~------~~~ 316 (411)
..|++.++||+|+||.||+|.+. ++.||||+++.. ......+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 56888899999999999999874 689999998764 345566789999999999999999999999765 667
Q ss_pred EEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKC--GLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~--~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
.|+|||||+||+|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.++. ...+||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~---~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ---RLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS---SCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC---ceeEEEcccc
Confidence 8999999999999999987542 5888899999999999999999999999999999999998763 2358999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
++..+..
T Consensus 170 ~a~~~~~ 176 (676)
T 3qa8_A 170 YAKELDQ 176 (676)
T ss_dssp CCCBTTS
T ss_pred ccccccc
Confidence 9987643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=203.82 Aligned_cols=155 Identities=14% Similarity=0.143 Sum_probs=116.4
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCC-Ccee----------
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRH-MNVV---------- 305 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~H-pNIV---------- 305 (411)
+......|++.+.||+|+||.||+|++. ++.||||+++.... .....+.+.+|+.+++.++| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3445566889999999999999999987 79999999884332 22335678999999999987 2211
Q ss_pred -----------EEEeeeec-----CCeEEEEEecCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 015237 306 -----------QFIGACTR-----PPRLFIVTEFMSGGSIYDYLHK------QKCGLKLPLLLRVAIDVSKGMNYLHRNN 363 (411)
Q Consensus 306 -----------~l~g~~~~-----~~~l~IV~E~~~gGsL~~~L~~------~~~~l~~~~i~~i~~qIa~gL~yLHs~g 363 (411)
.+..++.. ...++++|+++ +++|.+++.. ....+++..++.++.||+.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11111111 22467888877 7899998852 1224667788899999999999999999
Q ss_pred ccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 364 IIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 364 IIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|+||||||+|||++.++ .+||+|||++.....
T Consensus 232 iiHrDiKp~NILl~~~~------~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRG------GVFLTGFEHLVRDGA 263 (413)
T ss_dssp EECSCCCGGGEEECTTC------CEEECCGGGCEETTE
T ss_pred cccCCcccceEEEecCC------eEEEEeccceeecCC
Confidence 99999999999999998 499999999876543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.5e-21 Score=181.62 Aligned_cols=141 Identities=16% Similarity=0.184 Sum_probs=108.2
Q ss_pred ceEEEEEEeecCceEEEEEEE--CCce--EEEEEeeccccC----------------------HHHHHHHHHHHHHHhhc
Q 015237 246 LLKFEHKIVSGSYCDLYKGAF--FSQD--VAIKVLTNEHLN----------------------ENIRREFAQEVHIMRKV 299 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~--~~~~--VAIK~l~~~~~~----------------------~~~~~~~~~Ei~iL~~l 299 (411)
.|.+.+.||+|+||.||+|.+ .++. ||||+++..... ......+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999988 6888 999997654211 01224688999999999
Q ss_pred CCCce--eEEEeeeecCCeEEEEEecCCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCC
Q 015237 300 RHMNV--VQFIGACTRPPRLFIVTEFMSG-G----SIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNIIHRDLKA 371 (411)
Q Consensus 300 ~HpNI--V~l~g~~~~~~~l~IV~E~~~g-G----sL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLH-s~gIIHRDLKp 371 (411)
.|+++ ..+++. ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88754 444443 247899999942 3 66665432 223456789999999999999 99999999999
Q ss_pred CcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 372 ANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 372 ~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
+|||++. .++|+|||+|.....+
T Consensus 200 ~NILl~~--------~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 200 YNIMYID--------KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp TSEEESS--------SEEECCCTTCEETTST
T ss_pred HHEEEcC--------cEEEEECcccccCCCc
Confidence 9999986 2899999999876544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-18 Score=174.35 Aligned_cols=144 Identities=15% Similarity=0.156 Sum_probs=102.6
Q ss_pred eEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccC---------------H-H----HHHHHHHHHHHHhhcCCCce-
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN---------------E-N----IRREFAQEVHIMRKVRHMNV- 304 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~---------------~-~----~~~~~~~Ei~iL~~l~HpNI- 304 (411)
|.++++||+|+||.||+|... |+.||||+++....+ . . .+....+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 889999999999999999875 789999998643111 0 0 01123456677777754443
Q ss_pred -eEEEeeeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcC
Q 015237 305 -VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRD 383 (411)
Q Consensus 305 -V~l~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k 383 (411)
.+.++.. ..+|||||+.|++|.++.. . +....++.|++.+|.|||++|||||||||.|||++++|...
T Consensus 177 vp~p~~~~----~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQS----RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEEE----TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeecc----CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2333321 2379999999888865432 1 23456789999999999999999999999999999877322
Q ss_pred ----CCccEEEEeccccccccc
Q 015237 384 ----SDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 384 ----~~~~ikL~DFGla~~~~~ 401 (411)
....+.++||+-+.....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETTS
T ss_pred cccccccceEEEEeCCcccCCC
Confidence 223488999998776543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.4e-12 Score=119.39 Aligned_cols=139 Identities=9% Similarity=0.030 Sum_probs=109.2
Q ss_pred ceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecC
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFM 324 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~ 324 (411)
.|++...++.|+++.||+....++.+++|+........ ...+.+|+.+|+.+. +..+.++++++...+..|+||||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 36777888889999999998778899999987532111 235888999999884 677889999998888999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 015237 325 SGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR------------------------------------------- 361 (411)
Q Consensus 325 ~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs------------------------------------------- 361 (411)
+|.+|.+.+.. ......++.+++.+|..||+
T Consensus 93 ~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99998775321 11234677889999999998
Q ss_pred ----------------CCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 362 ----------------NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 ----------------~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
..++|+|+++.|||++.++ .+.++||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~------~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK------VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE------EEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc------EEEEEEchhccc
Confidence 4489999999999997644 257999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.1e-10 Score=108.49 Aligned_cols=125 Identities=11% Similarity=0.117 Sum_probs=92.1
Q ss_pred eecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc--eeEEEeeeecCCeEEEEEecCCCCCHH
Q 015237 254 VSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGACTRPPRLFIVTEFMSGGSIY 330 (411)
Q Consensus 254 G~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN--IV~l~g~~~~~~~l~IV~E~~~gGsL~ 330 (411)
+.|+.+.||+.... +..+++|+..... ...+.+|+.+|+.+.+.+ +.++++++...+..|+||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 45667999998764 5679999976542 135778999999886444 567888888878899999999998873
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------------
Q 015237 331 DYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN----------------------------------------------- 363 (411)
Q Consensus 331 ~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g----------------------------------------------- 363 (411)
.. .... ..++.+++..|..||+..
T Consensus 104 --~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 104 --SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp --TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred --cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 21 1121 245666777777777643
Q ss_pred -----------ccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 364 -----------IIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 364 -----------IIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++|+|++|.|||++.++ .++|+|||.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~------~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGR------FSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTE------EEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCc------EEEEEcchhccc
Confidence 89999999999997654 256999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.6e-10 Score=112.64 Aligned_cols=141 Identities=16% Similarity=0.240 Sum_probs=105.0
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEee--ccccCHHHHHHHHHHHHHHhhcC--CCceeEEEeeeecC---CeEEEEEe
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLT--NEHLNENIRREFAQEVHIMRKVR--HMNVVQFIGACTRP---PRLFIVTE 322 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~--~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~---~~l~IV~E 322 (411)
.+.|+.|.++.+|+....+..+++|+.. ..... .....+.+|+.+|+.+. +..+.+++.++... +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4567899999999998878889999876 33211 12346788999999997 45678899988776 45899999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR----------------------------------------- 361 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs----------------------------------------- 361 (411)
|++|..+.+.. ...++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99987774311 1236677778889999999999997
Q ss_pred -----------------CCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 362 -----------------NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 -----------------~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
..++|+|+++.|||++.++. + .+.++||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~---v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-R---VLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-C---EEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-c---EEEEECcccccc
Confidence 35899999999999987752 1 258999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.52 E-value=3e-07 Score=88.51 Aligned_cols=132 Identities=17% Similarity=0.248 Sum_probs=94.1
Q ss_pred EEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCc--eeEEEeeeecCC---eEEEEEecCC
Q 015237 252 KIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMN--VVQFIGACTRPP---RLFIVTEFMS 325 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpN--IV~l~g~~~~~~---~l~IV~E~~~ 325 (411)
.++.|.+..+|+. +..+++|+.... .....+.+|..+|+.+. +.. +.+.+....... ..|+||++++
T Consensus 27 ~~~~G~~n~v~~v---~~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 27 ISGEGNDCIAYEI---NRDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp EEEECSSEEEEES---TTSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred ecCCCCcceEEEE---CCEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4789999999985 367899986432 33467889999998883 332 445555544333 3589999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 015237 326 GGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-------------------------------------------- 361 (411)
Q Consensus 326 gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-------------------------------------------- 361 (411)
|.++.+.... .++......++.+++..+..||+
T Consensus 100 G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9887653321 35666667777777777777775
Q ss_pred --------------CCccccCCCCCcEEEccC-CCcCCCccEEEEecccccc
Q 015237 362 --------------NNIIHRDLKAANLLMNEN-GVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 --------------~gIIHRDLKp~NILid~~-g~~k~~~~ikL~DFGla~~ 398 (411)
..++|+|+++.||+++.+ +. .+.++||+.+..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~-----~~~~iD~~~~~~ 223 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNT-----ICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTE-----EEEECCCTTCEE
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCC-----EEEEEeCCCCcc
Confidence 136999999999999874 21 378999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=6.5e-06 Score=79.59 Aligned_cols=74 Identities=11% Similarity=0.095 Sum_probs=54.8
Q ss_pred EEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC---ceeEEEeeee-cCCeEEEEEecCCC
Q 015237 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM---NVVQFIGACT-RPPRLFIVTEFMSG 326 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp---NIV~l~g~~~-~~~~l~IV~E~~~g 326 (411)
+.++.|....+|+. +..+++|+... ......+.+|..+|+.+.+. .+.+.+.++. ..+..|++||+++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 34678888899987 67899998532 23456789999999999652 3566666664 44567899999998
Q ss_pred CCHHH
Q 015237 327 GSIYD 331 (411)
Q Consensus 327 GsL~~ 331 (411)
.++.+
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 87765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.6e-05 Score=74.44 Aligned_cols=130 Identities=12% Similarity=0.121 Sum_probs=86.9
Q ss_pred EeecCce-EEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCCCCC
Q 015237 253 IVSGSYC-DLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMSGGS 328 (411)
Q Consensus 253 IG~Gsfg-~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~gGs 328 (411)
+..|..+ .||+-... +..+.+|+-... ....+.+|..+|+.+. +--+.++++++...+..|+|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4455554 68886553 467899986543 2356788999998884 3346788888988889999999999988
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 015237 329 IYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR----------------------------------------------- 361 (411)
Q Consensus 329 L~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs----------------------------------------------- 361 (411)
+.+...... .....+..++...|.-||+
T Consensus 107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 766543211 0111223333333333332
Q ss_pred ----C-------CccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 362 ----N-------NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 ----~-------gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
. .++|+|+.+.|||++.++ ...|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~------~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGK------LIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTE------EEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCe------EEEEEECccccc
Confidence 1 168999999999998765 257999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.3e-06 Score=81.90 Aligned_cols=80 Identities=13% Similarity=0.117 Sum_probs=55.1
Q ss_pred EEEEEE-eecCceEEEEEEEC--------CceEEEEEeeccc---cCHHHHHHHHHHHHHHhhcC-C--CceeEEEeeee
Q 015237 248 KFEHKI-VSGSYCDLYKGAFF--------SQDVAIKVLTNEH---LNENIRREFAQEVHIMRKVR-H--MNVVQFIGACT 312 (411)
Q Consensus 248 ~~~~~I-G~Gsfg~Vy~g~~~--------~~~VAIK~l~~~~---~~~~~~~~~~~Ei~iL~~l~-H--pNIV~l~g~~~ 312 (411)
...+.| +.|....+|+.... +..+++|+..... ... ...+.+|+.+|+.+. + -.+.+++.++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 335667 78888999987765 6788999865432 100 134677888888774 2 35677888776
Q ss_pred cC---CeEEEEEecCCCCCH
Q 015237 313 RP---PRLFIVTEFMSGGSI 329 (411)
Q Consensus 313 ~~---~~l~IV~E~~~gGsL 329 (411)
.. +..|+||||++|.++
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 54 356899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=4.5e-05 Score=73.33 Aligned_cols=73 Identities=18% Similarity=0.215 Sum_probs=42.3
Q ss_pred EEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC--CCceeEEEee------eecCCeEEEEEe
Q 015237 251 HKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR--HMNVVQFIGA------CTRPPRLFIVTE 322 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~------~~~~~~l~IV~E 322 (411)
+.|+.|..+.+|+....+..+++|+.... . ..+..|..+++.+. .-.+.+++.. ....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 35666788899998877767999998652 1 22334555555442 1123333331 123567899999
Q ss_pred cCCCCCH
Q 015237 323 FMSGGSI 329 (411)
Q Consensus 323 ~~~gGsL 329 (411)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9988643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.4e-05 Score=77.92 Aligned_cols=76 Identities=13% Similarity=-0.057 Sum_probs=48.9
Q ss_pred EEEEeecCceEEEEEEE--CCceEEEEEeecccc--CH---HHHHHHHHHHHHHhhcCC--C-ceeEEEeeeecCCeEEE
Q 015237 250 EHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHL--NE---NIRREFAQEVHIMRKVRH--M-NVVQFIGACTRPPRLFI 319 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~--~~~~VAIK~l~~~~~--~~---~~~~~~~~Ei~iL~~l~H--p-NIV~l~g~~~~~~~l~I 319 (411)
.+.||.|.++.||+++. .++.+++|....... .. .....+..|..+|+.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 34689999999999954 457899998754211 00 012346778888887742 3 345666543 334689
Q ss_pred EEecCCCC
Q 015237 320 VTEFMSGG 327 (411)
Q Consensus 320 V~E~~~gG 327 (411)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00075 Score=65.74 Aligned_cols=75 Identities=19% Similarity=0.204 Sum_probs=60.3
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC---CCceeEEEeeeecCCeEEEEEecCCC
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~l~IV~E~~~g 326 (411)
.+.|+.|.+..+|+....+..+++|+..... ...+..|...|+.+. ...+.+.+.++...+..|+||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 5678999999999987777889999876431 356888999988874 35688888888877889999999988
Q ss_pred CCH
Q 015237 327 GSI 329 (411)
Q Consensus 327 GsL 329 (411)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0005 Score=69.09 Aligned_cols=75 Identities=12% Similarity=-0.002 Sum_probs=45.5
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeecccc--CH-----HHHHHHHHHHHHHh-hcCCCceeEEEeeeecCCeEEEEE
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHL--NE-----NIRREFAQEVHIMR-KVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~--~~-----~~~~~~~~Ei~iL~-~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.||.|..+.||+....++.++||...+... .. ..+..+..|+..+. ......+.+++.+. .+..++||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 35678899999999976677899995332100 00 01223334443322 22334567777765 45679999
Q ss_pred ecC-CC
Q 015237 322 EFM-SG 326 (411)
Q Consensus 322 E~~-~g 326 (411)
|++ +|
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0037 Score=59.16 Aligned_cols=80 Identities=13% Similarity=0.057 Sum_probs=55.7
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC---CceeEEEeeeecCCeEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH---MNVVQFIGACTRPPRLF 318 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H---pNIV~l~g~~~~~~~l~ 318 (411)
....+.-.+.+|.|..+.||+.+.. |+.|.+|+........ ...|..|...|+.+.- --+.+.+++.. -+
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~ 86 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RT 86 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEeccC----ce
Confidence 3445566788999999999999876 6899999865443211 2357789999988742 13455665532 47
Q ss_pred EEEecCCCCC
Q 015237 319 IVTEFMSGGS 328 (411)
Q Consensus 319 IV~E~~~gGs 328 (411)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999997654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0018 Score=62.57 Aligned_cols=74 Identities=5% Similarity=0.034 Sum_probs=38.5
Q ss_pred EeecCceE-EEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--CceeEEEeeeecCCeEEEEEecCCCCC
Q 015237 253 IVSGSYCD-LYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGGS 328 (411)
Q Consensus 253 IG~Gsfg~-Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~~l~IV~E~~~gGs 328 (411)
|+.|.... +|+.... +..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+.+
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 33443333 5566553 56677776544320 223456666666632 23566776654443 78999997766
Q ss_pred HHHHH
Q 015237 329 IYDYL 333 (411)
Q Consensus 329 L~~~L 333 (411)
+.+++
T Consensus 99 l~~~l 103 (333)
T 3csv_A 99 FTEVI 103 (333)
T ss_dssp HHHHH
T ss_pred hHHHh
Confidence 65444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0052 Score=58.72 Aligned_cols=140 Identities=13% Similarity=0.125 Sum_probs=78.4
Q ss_pred EEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc--eeEEEee------eecCCeEEEE
Q 015237 249 FEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN--VVQFIGA------CTRPPRLFIV 320 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN--IV~l~g~------~~~~~~l~IV 320 (411)
-.+.|+.|....+|+....+..+++|+...... ...+..|+.+++.+...+ +.+++.. ....+..+++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 345678888889999887766899999865311 134556777777664212 3333321 1223567899
Q ss_pred EecCCCCCHH-----H---------HHHhcCCC--------CCHHHHHH---------------HHHHHHHHHHHHHH--
Q 015237 321 TEFMSGGSIY-----D---------YLHKQKCG--------LKLPLLLR---------------VAIDVSKGMNYLHR-- 361 (411)
Q Consensus 321 ~E~~~gGsL~-----~---------~L~~~~~~--------l~~~~i~~---------------i~~qIa~gL~yLHs-- 361 (411)
|+|++|..+. . -++..... ........ +...+...+.++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999875431 1 12211100 11111110 00113445555653
Q ss_pred -----CCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 362 -----NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 362 -----~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
.+++|+|+.+.|||++.++ .+.++||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~------~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDE------LSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTE------EEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCc------eEEEecchhccC
Confidence 3589999999999998764 247999987753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0001 Score=75.74 Aligned_cols=145 Identities=10% Similarity=0.053 Sum_probs=53.6
Q ss_pred EEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEecCCCccchHHHHHHHhhccccccCCCCcccccC
Q 015237 142 EITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEIPKVENHHHVVYPVG 220 (411)
Q Consensus 142 e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~ 220 (411)
.|+.+.++|.+++..|.. .-| |.||++. +..+.|+|+|..-+. ..+..|.. +.. ....
T Consensus 52 ~w~hg~i~r~~ae~lL~~---~~G~FLvR~S~--~~~g~~~Lsv~~~~~-----------v~H~~I~~-~g~----~~~~ 110 (463)
T 3cxl_A 52 REFHGMISREAADQLLIV---AEGSYLIRESQ--RQPGTYTLALRFGSQ-----------TRNFRLYY-DGK----HFVG 110 (463)
T ss_dssp TTBCCSCCHHHHHHHHTT---STTEEEEEECS--SSTTCEEEEEECSSS-----------EEEEECEE-SSS----EESS
T ss_pred cccccCCCHHHHHHHHcC---CCCeEEEeccC--CCCCCEEEEEEECCE-----------EEEEEEec-CCe----EEEC
Confidence 455999999999997743 457 9999998 677789999965110 01222222 110 0000
Q ss_pred cccccCCccccC--------CCCCCCceeecCCceEEEEEEeecCceEEEEEEECC--ceEEE------EEeeccccCHH
Q 015237 221 EQEQSGINHVNI--------PAEGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAI------KVLTNEHLNEN 284 (411)
Q Consensus 221 ~~~~~~~~~~~~--------~~~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~~VAI------K~l~~~~~~~~ 284 (411)
.....+...+.. ... ............+.++|| ||.||+|.+.+ .+||+ |..+....+.+
T Consensus 111 ~~~F~sl~~Lv~dGl~~~~~~~~-~~~~~l~~~i~~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e 186 (463)
T 3cxl_A 111 EKRFESIHDLVTDGLITLYIETK-AAEYIAKMTINPIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEK 186 (463)
T ss_dssp SCCBSCHHHHHHHHHHHHHHHHH-THHHHHHTTSSCSTTTSS---BCCC---------CCBGGGC---------------
T ss_pred CCccCCHHHHHHHHHHhhhccCC-CcchhhccccccccccCC---chhhhcccccccCCchhhhhccCcccccccccccc
Confidence 000000000000 000 000000000113344555 99999999975 58888 77766555555
Q ss_pred HHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 285 IRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 285 ~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
....+.+|..+++.++|||+++.+++.
T Consensus 187 ~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 187 RLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp --------------------CBCCCEE
T ss_pred ccccccccccccccccccccCCCcceE
Confidence 566789999999999999999988765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0042 Score=59.17 Aligned_cols=71 Identities=11% Similarity=0.162 Sum_probs=43.6
Q ss_pred EEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce-eEEEeeeecCCeEEEEEecC-CCC
Q 015237 250 EHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFM-SGG 327 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~~l~IV~E~~-~gG 327 (411)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .++++.+.. .-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence 567888999999998 67899987643110 0112457777776632222 466665433 346899999 654
Q ss_pred CH
Q 015237 328 SI 329 (411)
Q Consensus 328 sL 329 (411)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.033 Score=53.17 Aligned_cols=73 Identities=11% Similarity=0.053 Sum_probs=45.4
Q ss_pred EEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCC--ceeEEEee-----eecCCeEEEEEec
Q 015237 252 KIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHM--NVVQFIGA-----CTRPPRLFIVTEF 323 (411)
Q Consensus 252 ~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~-----~~~~~~l~IV~E~ 323 (411)
.++ |....+|+.... ++.+++|+......+. ..+..|..+++.+... .+++++.. ....+..+++|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 344 777789987654 4579999987543332 4566688877776421 23444433 1224566889999
Q ss_pred CCCCC
Q 015237 324 MSGGS 328 (411)
Q Consensus 324 ~~gGs 328 (411)
++|.+
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 97743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.28 E-value=0.011 Score=59.77 Aligned_cols=71 Identities=14% Similarity=0.170 Sum_probs=47.8
Q ss_pred EEEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc-eeEEEeeeecCCeEEE
Q 015237 250 EHKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFI 319 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~l~I 319 (411)
.+.|+.|-...+|+.... +..+.+|+..... . ...+..|..+++.+...+ ..++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 356788888999999874 3678999874321 1 134457888888874333 3677776643 38
Q ss_pred EEecCCCCC
Q 015237 320 VTEFMSGGS 328 (411)
Q Consensus 320 V~E~~~gGs 328 (411)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999997633
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0055 Score=60.09 Aligned_cols=71 Identities=13% Similarity=0.226 Sum_probs=42.0
Q ss_pred EEEeecCceEEEEEEECC----------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCc-eeEEEeeeecCCeEEE
Q 015237 251 HKIVSGSYCDLYKGAFFS----------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMN-VVQFIGACTRPPRLFI 319 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~~----------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~l~I 319 (411)
+.|+.|....+|+....+ ..+++|+..... .. ......|..+++.+...+ ..++++... -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence 456778888899987654 578888865431 11 112356888887774323 446666542 268
Q ss_pred EEecCCCCC
Q 015237 320 VTEFMSGGS 328 (411)
Q Consensus 320 V~E~~~gGs 328 (411)
||||++|.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.031 Score=55.73 Aligned_cols=139 Identities=12% Similarity=0.103 Sum_probs=76.8
Q ss_pred EEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEE
Q 015237 251 HKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV 320 (411)
+.|..|-...+|+.... ++.+.+|+...... ....+.+|..+++.+. +.-..++++.+.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 34566777788888763 36788888532211 1244568999988774 3333667777654 289
Q ss_pred EecCCCCCHH--------------HHHH---hcC----CCCC--HHHHHHHHHHHH-------------------HHHHH
Q 015237 321 TEFMSGGSIY--------------DYLH---KQK----CGLK--LPLLLRVAIDVS-------------------KGMNY 358 (411)
Q Consensus 321 ~E~~~gGsL~--------------~~L~---~~~----~~l~--~~~i~~i~~qIa-------------------~gL~y 358 (411)
|||++|.+|. +.|. ... .... +..+.++..++. ..+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999875442 1111 111 0111 234444544332 12333
Q ss_pred HH----HC----CccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 359 LH----RN----NIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 359 LH----s~----gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
|. .. .++|+|+.+.|||++.+.... -.+.++||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~--~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENA--DSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC-----CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCcc--CcEEEEecccCCc
Confidence 33 22 489999999999998761000 0478999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.50 E-value=0.082 Score=53.96 Aligned_cols=73 Identities=19% Similarity=0.063 Sum_probs=47.0
Q ss_pred EEEEeecCceEEEEEEECC--ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce-eEEEeeeecCCeEEEEEecCCC
Q 015237 250 EHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~~--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~~l~IV~E~~~g 326 (411)
.+.|+.|-...+|+....+ ..+++|+........ -.-.+|..+++.+...++ .++++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3467888889999998876 789999874421100 011478888888864444 57787773 2 259999987
Q ss_pred CCH
Q 015237 327 GSI 329 (411)
Q Consensus 327 GsL 329 (411)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.00 E-value=0.12 Score=50.14 Aligned_cols=67 Identities=15% Similarity=0.064 Sum_probs=41.8
Q ss_pred ecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC---CCceeEEEee------eecCCeEEEEEecCC
Q 015237 255 SGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR---HMNVVQFIGA------CTRPPRLFIVTEFMS 325 (411)
Q Consensus 255 ~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~------~~~~~~l~IV~E~~~ 325 (411)
.|....+|+....+..+++|+...... ..|+.+++.+. -|++.+.+.. ....+..+++|+|++
T Consensus 33 ~g~~N~vy~v~~~~g~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 33 ADTNAFAYQADSESKSYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp SCSSCEEEEEECSSCEEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred CccccceEEEEeCCCCEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 333678999876555899998766542 24555555542 1224454432 233567899999998
Q ss_pred CCCH
Q 015237 326 GGSI 329 (411)
Q Consensus 326 gGsL 329 (411)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8655
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=94.04 E-value=0.04 Score=49.27 Aligned_cols=64 Identities=16% Similarity=0.242 Sum_probs=50.6
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCccchHHHHHHHhhc
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~ 205 (411)
...+++..-|||.+++.++..|++.|+||.++..|.+.++|.+.+.+-.. ....+.++..+...
T Consensus 6 ~~~itv~~~DrpGiva~vt~~La~~g~NI~d~~~~~~~~~f~~~~~v~~~--~~~~~~l~~~L~~~ 69 (192)
T 1u8s_A 6 HLVITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLISGS--PSNITRVETTLPLL 69 (192)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEEEEC--HHHHHHHHHHHHHH
T ss_pred EEEEEEEcCCCCcHHHHHHHHHHHCCCCEEeeeeeecCCceEEEEEEecC--CCCHHHHHHHHHHH
Confidence 46899999999999999999999999999999999999999995444322 23445566555543
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=93.75 E-value=0.049 Score=49.05 Aligned_cols=48 Identities=13% Similarity=0.268 Sum_probs=43.9
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEe
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVV 187 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvv 187 (411)
...+|+.+-|||.+...++..|.+.|+||.++..|.+.++|.+.+.+-
T Consensus 5 ~~~ltv~~~DrpGiva~vs~~La~~g~NI~da~q~~~~~~f~m~~~v~ 52 (195)
T 2nyi_A 5 SFVVSVAGSDRVGIVHDFSWALKNISANVESSRMACLGGDFAMIVLVS 52 (195)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEEeCCCCcHHHHHHHHHHHCCCCEEEEEeEEECCeEEEEEEEE
Confidence 358999999999999999999999999999999999999999955553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.67 E-value=0.21 Score=50.52 Aligned_cols=71 Identities=14% Similarity=0.185 Sum_probs=44.5
Q ss_pred EEEeecCceEEEEEEEC---------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEE
Q 015237 251 HKIVSGSYCDLYKGAFF---------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 251 ~~IG~Gsfg~Vy~g~~~---------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV 320 (411)
+.+..|-...+|+.... ++.+++++..... .. .-...+|..+++.+. +.-..++++.+. -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 34566777888888776 5788999864421 10 011346888887774 322456665443 2789
Q ss_pred EecCCCCC
Q 015237 321 TEFMSGGS 328 (411)
Q Consensus 321 ~E~~~gGs 328 (411)
|||++|.+
T Consensus 149 ~efI~G~~ 156 (424)
T 3mes_A 149 EEFIDGEP 156 (424)
T ss_dssp EECCCSEE
T ss_pred EEEeCCcc
Confidence 99998855
|
| >1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7 | Back alignment and structure |
|---|
Probab=90.36 E-value=0.43 Score=36.68 Aligned_cols=65 Identities=25% Similarity=0.255 Sum_probs=47.8
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCccchHHHHHHHhhc
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~ 205 (411)
...+++...|||.++..++..+++.|.||.+...+... |...-.+.++.-.....+++...+.+.
T Consensus 5 ~~~l~v~~~DrpGila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~ 69 (91)
T 1zpv_A 5 KAIITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAF 69 (91)
T ss_dssp EEEEEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHH
T ss_pred eEEEEEEECCCCCHHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHH
Confidence 45799999999999999999999999999998887765 544433444322234566776666543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.70 E-value=1.7 Score=42.99 Aligned_cols=35 Identities=23% Similarity=0.255 Sum_probs=24.2
Q ss_pred ccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 364 IIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 364 IIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
++|+|+.+.|||+..+....-.-.++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999995432111112589999977653
|
| >2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=86.67 E-value=1 Score=39.47 Aligned_cols=62 Identities=21% Similarity=0.178 Sum_probs=47.7
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCC-CceeEEEEecCCCccchHHHHHHH
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLRNVL 202 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~-g~sldvfvvd~w~~~~~~~l~~~l 202 (411)
.|.+.+-..|||.+|++.+.++++.|+||..-.+..|.+ |++-=.++++ .....-+++...+
T Consensus 3 ~~~IsV~v~NrpGvLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~-~d~~~leqI~kqL 65 (164)
T 2f1f_A 3 RRILSVLLENESGALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTV-GDEKVLEQIEKQL 65 (164)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEE-SCHHHHHHHHHHH
T ss_pred EEEEEEEEeCCCcHHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEe-ccHHHHHHHHHHH
Confidence 478888889999999999999999999999888877775 8777777777 3333344444443
|
| >2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A | Back alignment and structure |
|---|
Probab=85.89 E-value=1.1 Score=33.78 Aligned_cols=48 Identities=21% Similarity=0.219 Sum_probs=36.4
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEec
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVD 188 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd 188 (411)
...+.+...|||.+|..++..+++.|.||......... ++..-++.++
T Consensus 5 ~~~l~v~~~Dr~G~L~~I~~~la~~~inI~~i~~~~~~-~~~~~~i~v~ 52 (88)
T 2ko1_A 5 LAGIRIVGEDKNGMTNQITGVISKFDTNIRTIVLNAKD-GIFTCNLMIF 52 (88)
T ss_dssp EEEEEEEEECCTTHHHHHHHHHTTSSSCEEEEEEEECS-SEEEEEEEEE
T ss_pred EEEEEEEEECCCcHHHHHHHHHHHCCCCeEEEEEEEcC-CEEEEEEEEE
Confidence 34678888999999999999999999999887765443 3444444444
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.71 E-value=0.36 Score=40.54 Aligned_cols=45 Identities=11% Similarity=0.106 Sum_probs=35.8
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEE
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFV 186 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfv 186 (411)
...++|+|..+.|.+++..| ...+..| |.||+.. +.. .|||+|..
T Consensus 12 l~~epWff~~isR~eAE~lL-~~~~~~GaFLVR~Se--~~~-~ySLSVR~ 57 (125)
T 3maz_A 12 LNPMPACFYTVSRKEATEML-QKNPSLGNMILRPGS--DSR-NYSITIRQ 57 (125)
T ss_dssp CCCCCTTBCCCCHHHHHHHH-HHCGGGCSEEEEECT--TSS-SEEEEEEE
T ss_pred ccCCCCCcCCCCHHHHHHHH-hccCCCCcEEEEeCC--CCC-CEEEEEEe
Confidence 55679999999999999755 4455577 8999986 444 89999976
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=82.75 E-value=0.58 Score=38.57 Aligned_cols=47 Identities=19% Similarity=0.162 Sum_probs=38.8
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEE
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFV 186 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfv 186 (411)
...++|+.+.++|.+++..|...-...| |.||++. +..+.|+|+|..
T Consensus 13 l~~~~WyhG~isR~eAe~lL~~~~~~~G~FLVR~S~--~~~g~y~LSv~~ 60 (121)
T 2dly_A 13 LQAEPWFFGAIKRADAEKQLLYSENQTGAFLIRESE--SQKGDFSLSVLD 60 (121)
T ss_dssp GGGCSSBCSSCCHHHHHHHHTSSSCCTTCEEEEECS--SSSSCEEEEEES
T ss_pred cCcCCccccCCCHHHHHHHHhcCCCCCCEEEEEcCC--CCCCceEEEEEE
Confidence 5667999999999999998766555567 9999988 677789999864
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=81.40 E-value=0.58 Score=37.34 Aligned_cols=47 Identities=23% Similarity=0.189 Sum_probs=38.7
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEE
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFV 186 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfv 186 (411)
+..++|+.+.++|.+++..|...-...| |.||++. +..+.|+|+|..
T Consensus 2 l~~~~Wyhg~isR~~Ae~lL~~~g~~~G~FLVR~S~--~~~g~~~LSv~~ 49 (106)
T 1aot_F 2 IQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESE--TTKGAYSLSIRD 49 (106)
T ss_dssp CCSSSSCCBSCCHHHHHHHHHTTTCCTTEECCBCBS--SSSSBBCCEEEC
T ss_pred CccCccCCCCCCHHHHHHHHhhCCCCCcEEEEEeCC--CCCCCEEEEEEe
Confidence 4456899999999999998876555678 9999988 667789999976
|
| >2pc6_A Probable acetolactate synthase isozyme III (small; regulatory subunit, structural genomi protein structure initiative; HET: MSE; 2.50A {Nitrosomonas europaea atcc 19718} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=80.14 E-value=1.8 Score=37.97 Aligned_cols=49 Identities=27% Similarity=0.326 Sum_probs=41.5
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCC-CceeEEEEec
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVD 188 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~-g~sldvfvvd 188 (411)
-|.+.+-..|||.+|++.+.++++.|+||..-.+..|.+ |++-=.++++
T Consensus 4 ~~~IsV~veNrpGvL~rI~~lfs~rg~NI~Sl~v~~t~d~g~sritivV~ 53 (165)
T 2pc6_A 4 RHIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTN 53 (165)
T ss_dssp EEEEEEEEECSTTHHHHHHHHHHHHTCCCCEEEEEECSSTTEEEEEEEEE
T ss_pred EEEEEEEEeCCCcHHHHHHHHHHHCCCcEEEEEEEecCCCCEEEEEEEEe
Confidence 478888889999999999999999999999888877774 7776666666
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 411 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-31 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-29 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-29 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-28 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-24 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-22 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-20 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-20 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-19 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-09 | |
| d1ygya3 | 78 | d.58.18.1 (A:452-529) Phosphoglycerate dehydrogena | 3e-05 | |
| d1sc6a3 | 84 | d.58.18.1 (A:327-410) Phosphoglycerate dehydrogena | 3e-05 | |
| d1y7pa2 | 77 | d.58.18.12 (A:2-78) Hypothetical protein AF1403, N | 9e-04 | |
| d2pc6a2 | 77 | d.58.18.6 (A:1-77) Acetolactate synthase small sub | 0.003 | |
| d1u8sa1 | 86 | d.58.18.5 (A:2-87) putative transcriptional repres | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 8e-41
Identities = 53/144 (36%), Positives = 85/144 (59%), Gaps = 2/144 (1%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMR 297
D WEI + +I SGS+ +YKG + DVA+K+L + F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 298 KVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
K RH+N++ F+G T P L IVT++ G S+Y +LH + ++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
YLH +IIHRDLK+ N+ ++E+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLT 142
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 5e-36
Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 6/144 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
W ++ LK I G + D+ G + VA+K + N+ + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQL 57
Query: 300 RHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSKGMN 357
RH N+VQ +G L+IVTE+M+ GS+ DYL + L LL+ ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
YL NN +HRDL A N+L++E+ V
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNV 141
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 42/146 (28%), Positives = 81/146 (55%), Gaps = 6/146 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIM 296
D WE+ LK ++ +G + +++ G + VA+K L ++ F E ++M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKG 355
++++H +V+ T+ P ++I+TE+M GS+ D+L L + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
M ++ N IHRDL+AAN+L+++
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLS 147
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 3e-32
Identities = 54/147 (36%), Positives = 88/147 (59%), Gaps = 6/147 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAF--FSQDVAIKVLTNEHLNENIRREFAQEVHI 295
D WE++ + + +HK+ G Y ++Y+G + +S VA+K L + EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAV 66
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG-LKLPLLLRVAIDVSK 354
M++++H N+VQ +G CTR P +I+TEFM+ G++ DYL + + +LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGV 381
M YL + N IHRDL A N L+ EN +
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHL 153
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 8e-32
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 26/169 (15%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFA 290
WE + L F + +G++ + + + VA+K+L + R
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALM 74
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK------------ 337
E+ ++ + HMN+V +GACT ++TE+ G + ++L +++
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 338 -----CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L LL + V+KGM +L N IHRDL A N+L+ +
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 54/146 (36%), Positives = 81/146 (55%), Gaps = 6/146 (4%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIM 296
D WEI L+ E K+ G + +++ G + VAIK L F QE +M
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVM 66
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLK-LPLLLRVAIDVSKG 355
+K+RH +VQ + P ++IVTE+MS GS+ D+L + LP L+ +A ++ G
Sbjct: 67 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
M Y+ R N +HRDL+AAN+L+ EN V
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLV 151
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 7e-31
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG-------AFFSQDVAIKVLTNEHLNENIRREFAQE 292
WE L+F + SG++ + S VA+K+L E + + R E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSE 90
Query: 293 VHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQK-------------- 337
+ +M ++ H N+V +GACT ++++ E+ G + +YL ++
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 338 --------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L LL A V+KGM +L + +HRDL A N+L+ V
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 202
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 2e-30
Identities = 52/141 (36%), Positives = 76/141 (53%), Gaps = 4/141 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD-VAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID S L F +I SG + ++ G + ++D VAIK + ++E +F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G C + +V EFM G + DYL Q+ LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 361 RNNIIHRDLKAANLLMNENGV 381
+IHRDL A N L+ EN V
Sbjct: 119 EACVIHRDLAARNCLVGENQV 139
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-30
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 4/136 (2%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ ++ G++ +YK A KV+ + +E ++ E+ I+ H N+V
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIV 72
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ + A L+I+ EF +GG++ + + + L + V +NYLH N II
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 366 HRDLKAANLLMNENGV 381
HRDLKA N+L +G
Sbjct: 133 HRDLKAGNILFTLDGD 148
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-30
Identities = 32/144 (22%), Positives = 63/144 (43%), Gaps = 6/144 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-ENIRREFAQEVHIM 296
W ++ + + G + ++Y +A+KVL L + + +EV I
Sbjct: 3 WALED--FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+RH N+++ G R++++ E+ G++Y L K +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANAL 119
Query: 357 NYLHRNNIIHRDLKAANLLMNENG 380
+Y H +IHRD+K NLL+ G
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAG 143
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 8e-30
Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 245 SLLKFEHKIVSGSYCDLYKGAFFS----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
+LL + ++ G++ + +G + DVAIKVL + + E +E IM ++
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 67
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
+ +V+ IG C + L +V E GG ++ +L ++ + + + + VS GM YL
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 361 RNNIIHRDLKAANLLMNENGV 381
N +HRDL A N+L+
Sbjct: 127 EKNFVHRDLAARNVLLVNRHY 147
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 9e-30
Identities = 47/141 (33%), Positives = 76/141 (53%), Gaps = 4/141 (2%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300
ID L F ++ +G + + G + DVAIK++ ++E EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLS 57
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H +VQ G CT+ +FI+TE+M+ G + +YL + + + LL + DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 361 RNNIIHRDLKAANLLMNENGV 381
+HRDL A N L+N+ GV
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV 138
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-29
Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 242 IDASLLKFEHK-IVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
+D LL E K + SG++ + KG + + VA+K+L NE + ++ E E ++M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 297 RKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
+++ + +V+ IG C +V E G + YL + + +K ++ + VS GM
Sbjct: 63 QQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120
Query: 357 NYLHRNNIIHRDLKAANLLMNENGV 381
YL +N +HRDL A N+L+
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHY 145
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (284), Expect = 3e-29
Identities = 50/147 (34%), Positives = 72/147 (48%), Gaps = 6/147 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVH 294
EID S +K E I +G + ++ G VAIK L E RR+F E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEAS 79
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
IM + H NV+ G T+ + I+TEFM GS+ +L + + L+ + ++
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGV 381
GM YL N +HRDL A N+L+N N V
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLV 166
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-29
Identities = 36/137 (26%), Positives = 70/137 (51%), Gaps = 5/137 (3%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ ++ +G+ ++K + +A K++ + + IR + +E+ ++ + +V
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-RNNI 364
F GA + I E M GGS+ L K + +L +V+I V KG+ YL ++ I
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 365 IHRDLKAANLLMNENGV 381
+HRD+K +N+L+N G
Sbjct: 127 MHRDVKPSNILVNSRGE 143
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 7e-29
Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 10/165 (6%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEVH 294
+EI ++ I G + D+++G + S + VAIK ++++R +F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEAL 60
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
MR+ H ++V+ IG T P ++I+ E + G + +L +K L L L+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENG-VRDSDIHCYLSNFLSIST 398
+ YL +HRD+ A N+L++ N V+ D LS ++ ST
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDST 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-28
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV 299
D LKF+ +I GS+ +YKG + +VA L + L ++ R+ F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 300 RHMNVVQFIGACTRPPR----LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
+H N+V+F + + + +VTE M+ G++ YL + K +K+ +L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKG 124
Query: 356 MNYLHRNN--IIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+ +LH IIHRDLK N+ + + +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFIT-----GPTGSVKIGDL 159
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-28
Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 4/136 (2%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ G+Y ++ + VA+K++ + + +E+ I + + H NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVV 66
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+F G ++ E+ SGG ++D + G+ P R + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 366 HRDLKAANLLMNENGV 381
HRD+K NLL++E
Sbjct: 126 HRDIKPENLLLDERDN 141
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 3e-28
Identities = 39/133 (29%), Positives = 69/133 (51%), Gaps = 4/133 (3%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN-IRREFAQEVHIMRKVRHMNVVQFI 308
+I GS+ +Y + VAIK ++ N ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 309 GACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368
G R ++V E+ G + +K L+ + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 369 LKAANLLMNENGV 381
+KA N+L++E G+
Sbjct: 141 VKAGNILLSEPGL 153
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 111 bits (279), Expect = 3e-28
Identities = 29/148 (19%), Positives = 64/148 (43%), Gaps = 8/148 (5%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
++ +G++ +++ + + A K + H ++ + +E+ M +RH +V
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLV 86
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
A + ++ EFMSGG +++ + + + + V KG+ ++H NN +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 366 HRDLKAANLLMNENGVRDSDIHCYLSNF 393
H DLK N++ L +F
Sbjct: 147 HLDLKPENIMFTT----KRSNELKLIDF 170
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 110 bits (275), Expect = 1e-27
Identities = 21/135 (15%), Positives = 60/135 (44%), Gaps = 4/135 (2%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
++ SG++ +++ + + K + + + + E+ IM ++ H ++
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 89
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
A + ++ EF+SGG ++D + + + ++ +G+ ++H ++I+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 366 HRDLKAANLLMNENG 380
H D+K N++
Sbjct: 150 HLDIKPENIMCETKK 164
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-27
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKG-------AFFSQDVAIKVLTNEHLNENIRREFA 290
D WE+ + ++ GS+ +Y+G VAIK + NE + R EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 71
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG---------LK 341
E +M++ +VV+ +G ++ ++ E M+ G + YL +
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 342 LPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L ++++A +++ GM YL+ N +HRDL A N ++ E+
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-27
Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLN-ENIRREFAQEVHIMRKVR 300
L+ K+ GS+ + +G + + VA+K L + L+ +F +EV+ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 301 HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
H N+++ G PP + +VTE GS+ D L K + L L R A+ V++GM YL
Sbjct: 70 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 361 RNNIIHRDLKAANLLMNENGV 381
IHRDL A NLL+ +
Sbjct: 129 SKRFIHRDLAARNLLLATRDL 149
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-27
Identities = 34/140 (24%), Positives = 73/140 (52%), Gaps = 7/140 (5%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+ +Y + Q+VAI+ + + + + E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLD 84
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+ L++V E+++GGS+ D + + + V + + + +LH N +IHRD+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQVIHRDI 142
Query: 370 KAANLLMNENG-VRDSDIHC 388
K+ N+L+ +G V+ +D
Sbjct: 143 KSDNILLGMDGSVKLTDFGF 162
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-27
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 7/148 (4%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEV 293
EI S + + I +G + ++YKG + VAIK L E R +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEA 60
Query: 294 HIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVS 353
IM + H N+++ G ++ + I+TE+M G++ +L ++ + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 354 KGMNYLHRNNIIHRDLKAANLLMNENGV 381
GM YL N +HRDL A N+L+N N V
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLV 148
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 7e-27
Identities = 35/146 (23%), Positives = 68/146 (46%), Gaps = 12/146 (8%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ + I +GSY K S + + K L + E ++ EV+++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 306 QFIGACTRPP--RLFIVTEFMSGGSIYDYLH---KQKCGLKLPLLLRVAIDVSKGMNYLH 360
++ L+IV E+ GG + + K++ L +LRV ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 361 R-----NNIIHRDLKAANLLMNENGV 381
R + ++HRDLK AN+ ++
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQN 152
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-26
Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 241 EIDASLLKFEHKIVSGSYCDLYKGAF----FSQDVAIKVLTNEHLNENIRREFAQEVHIM 296
+D + +KF+ I G++ + K D AIK + E+ +++ R+FA E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVL 64
Query: 297 RKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKC---------------GL 340
K+ H N++ +GAC L++ E+ G++ D+L K + L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 341 KLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
LL A DV++GM+YL + IHRDL A N+L+ EN V
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 7e-26
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 240 WEIDASLLKFEHKIVSGSYCDLYKG---------AFFSQDVAIKVLTNEHLNENIRREFA 290
WE+ L + G++ + VA+K+L E +
Sbjct: 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI 66
Query: 291 QEVHIMRKV-RHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCG---------- 339
E+ +M+ + +H N++ +GACT+ L+++ E+ S G++ +YL ++
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 340 -----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L+ A V++GM YL IHRDL A N+L+ E+ V
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 173
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 8e-26
Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-------VAIKVLTNEHLNENIRREFA 290
WE LK + G++ + + F D VA+K+L + R +
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 291 QEVHIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCG---------- 339
+ ++ H+NVV +GACT+P L ++ EF G++ YL ++
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 340 -----LKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L L+ + V+KGM +L IHRDL A N+L++E V
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 9e-26
Identities = 33/136 (24%), Positives = 57/136 (41%), Gaps = 4/136 (2%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNV 304
KF + GS+ + + ++ AIK+L H+ EN +E +M ++ H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
V+ +L+ + G + Y+ K ++ + YLH I
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 365 IHRDLKAANLLMNENG 380
IHRDLK N+L+NE+
Sbjct: 130 IHRDLKPENILLNEDM 145
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (257), Expect = 1e-25
Identities = 36/175 (20%), Positives = 72/175 (41%), Gaps = 31/175 (17%)
Query: 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREF 289
+ E + +++ I G++ +++ VA+K+L E + +++ +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADF 63
Query: 290 AQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQ------------- 336
+E +M + + N+V+ +G C + ++ E+M+ G + ++L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 337 ----------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
L L +A V+ GM YL +HRDL N L+ EN V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-25
Identities = 35/147 (23%), Positives = 80/147 (54%), Gaps = 17/147 (11%)
Query: 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQ 306
+ + I G + ++++G + ++VA+K+ ++ R E++ +RH N++
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILG 61
Query: 307 FIGACTRP----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH-- 360
FI A + +L++V+++ GS++DYL++ + + ++++A+ + G+ +LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHME 119
Query: 361 ------RNNIIHRDLKAANLLMNENGV 381
+ I HRDLK+ N+L+ +NG
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGT 146
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-25
Identities = 23/135 (17%), Positives = 56/135 (41%), Gaps = 5/135 (3%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ G + +++ S + K + + ++ +E+ I+ RH N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNIL 64
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ L ++ EF+SG I++ ++ L ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 366 HRDLKAANLLMNENG 380
H D++ N++
Sbjct: 125 HFDIRPENIIYQTRR 139
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 3e-24
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 7/147 (4%)
Query: 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQD-----VAIKVLTNEHLNENIRREFAQEV 293
V + ++ F I G + +Y G D A+K L N + +F E
Sbjct: 21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 79
Query: 294 HIMRKVRHMNVVQFIGACTRPP-RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDV 352
IM+ H NV+ +G C R +V +M G + +++ + + L+ + V
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 353 SKGMNYLHRNNIIHRDLKAANLLMNEN 379
+KGM +L +HRDL A N +++E
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEK 166
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 98.6 bits (245), Expect = 4e-24
Identities = 32/144 (22%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN-------ENIRREFAQEVHIMRK 298
+ + + G + + ++ A+K++ + +R +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 299 VR-HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
V H N++Q F+V + M G ++DYL ++ L ++ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVIC 124
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
LH+ NI+HRDLK N+L++++
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMN 148
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.6 bits (245), Expect = 7e-24
Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 7/148 (4%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
F + +G++ ++ + VAIK + + L E E+ ++ K++H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNIV 70
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
L+++ + +SGG ++D + ++ R+ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 366 HRDLKAANLLMNENGVRDSDIHCYLSNF 393
HRDLK NLL D D +S+F
Sbjct: 130 HRDLKPENLL---YYSLDEDSKIMISDF 154
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 30/154 (19%), Positives = 65/154 (42%), Gaps = 10/154 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLN----ENIRREFAQEVHIMRKVRH 301
I G + ++Y + A+K L + + E + + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
+V A P +L + + M+GG ++ +L + + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHN 125
Query: 362 NNIIHRDLKAANLLMNENG---VRDSDIHCYLSN 392
+++RDLK AN+L++E+G + D + C S
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 96.4 bits (239), Expect = 3e-23
Identities = 31/139 (22%), Positives = 62/139 (44%), Gaps = 8/139 (5%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNV 304
+ + G +++ +DVA+KVL + + + F +E + H +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 305 VQFIGAC----TRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLH 360
V P +IV E++ G ++ D +H + + + V D + +N+ H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 128
Query: 361 RNNIIHRDLKAANLLMNEN 379
+N IIHRD+K AN++++
Sbjct: 129 QNGIIHRDVKPANIMISAT 147
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 8e-23
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 8/146 (5%)
Query: 242 IDASLLKFEHKIVSGSYCDLYKGAFFSQD------VAIKVLTNEHLNENIRREFAQEVHI 295
+ + K + SG++ +YKG + + VAIK L E + +E E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYV 64
Query: 296 MRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKG 355
M V + +V + +G C + ++T+ M G + DY+ + K + LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 356 MNYLHRNNIIHRDLKAANLLMNENGV 381
MNYL ++HRDL A N+L+
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH 149
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 8e-23
Identities = 34/136 (25%), Positives = 66/136 (48%), Gaps = 2/136 (1%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ KI G+Y +YK + VA+K + + E + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ + +L++V EF+ G+ LPL+ + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 366 HRDLKAANLLMNENGV 381
HRDLK NLL+N G
Sbjct: 125 HRDLKPQNLLINTEGA 140
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.6 bits (232), Expect = 4e-22
Identities = 32/149 (21%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNE-NIRREFAQEVHIMRKVRHMNV 304
+ + +GS+ ++ + A+KVL E + E ++ V H +
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
++ G ++F++ +++ GG ++ ++ P+ A +V + YLH +I
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 365 IHRDLKAANLLMNENGVRDSDIHCYLSNF 393
I+RDLK N+L+++NG H +++F
Sbjct: 126 IYRDLKPENILLDKNG------HIKITDF 148
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 4e-22
Identities = 28/137 (20%), Positives = 59/137 (43%), Gaps = 5/137 (3%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRHMN 303
+ GS+ ++ F Q AIK L + + ++++ ++ + H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 304 VVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN 363
+ LF V E+++GG + ++ L A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKG 123
Query: 364 IIHRDLKAANLLMNENG 380
I++RDLK N+L++++G
Sbjct: 124 IVYRDLKLDNILLDKDG 140
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 91.5 bits (226), Expect = 2e-21
Identities = 36/131 (27%), Positives = 62/131 (47%), Gaps = 2/131 (1%)
Query: 252 KIVSGSYCDLYKGAF-FSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310
KI G+Y +YK + + A+K + E +E I +E+ I+++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 311 CTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLK 370
RL +V E + L + GL+ + + G+ Y H ++HRDLK
Sbjct: 69 IHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 371 AANLLMNENGV 381
NLL+N G
Sbjct: 128 PQNLLINREGE 138
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 2e-21
Identities = 32/153 (20%), Positives = 64/153 (41%), Gaps = 11/153 (7%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS---QDVAIKVLTNEHLNENIRREFAQEVHIMRK---VRH 301
+ +I G+Y ++K + VA+K + + E + +EV ++R H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 302 MNVVQFIGACTRPP-----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGM 356
NVV+ CT +L +V E + + G+ + + + +G+
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 357 NYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389
++LH + ++HRDLK N+L+ +G
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 3e-21
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN---IRREFAQEVHIMRKVRHMNVVQ 306
+ G + +YK + Q VAIK + H +E I R +E+ +++++ H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 307 FIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIH 366
+ A + +V +FM + + L + + +G+ YLH++ I+H
Sbjct: 65 LLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 367 RDLKAANLLMNENGV 381
RDLK NLL++ENGV
Sbjct: 124 RDLKPNNLLLDENGV 138
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 2e-20
Identities = 30/156 (19%), Positives = 59/156 (37%), Gaps = 8/156 (5%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENI----RREFAQEVHIMRKVR- 300
+ + SG + +Y G S VAIK + + +++ EV +++KV
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 301 -HMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
V++ + RP ++ E ++ L+ L V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 360 HRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395
H ++HRD+K N+L++ N I L
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-20
Identities = 31/146 (21%), Positives = 62/146 (42%), Gaps = 7/146 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNEN----IRREFAQEVHIMRKVRH 301
++ SG + + K S A K + + R + +EV I+++++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 302 MNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR 361
NV+ + ++ E ++GG ++D+L +++ L + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS 131
Query: 362 NNIIHRDLKAANLLMNENGVRDSDIH 387
I H DLK N+++ + V I
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIK 157
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 20/177 (11%)
Query: 230 VNIPAEGID-VWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIR 286
V P +G D E+ + K I +GS+ +Y+ + VAIK + + +
Sbjct: 7 VATPGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------K 57
Query: 287 REFAQEVHIMRKVRHMNVVQFIGACTRP------PRLFIVTEFMSGGSIYDYLHKQKCGL 340
R +E+ IMRK+ H N+V+ L +V +++ H +
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 341 KLPL--LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395
LP+ + + + + Y+H I HRD+K NLL++ + + L
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 6e-20
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 12/152 (7%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHI 295
WE+ ++ + + SG+Y + VAIK L +E + +E+ +
Sbjct: 12 TAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 296 MRKVRHMNVVQFIGACTRPPRL------FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVA 349
++ +RH NV+ + T L ++V FM G+ L K + L + +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 350 IDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ KG+ Y+H IIHRDLK NL +NE+
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE 159
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-19
Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 14/151 (9%)
Query: 239 VWEIDASLLKFE--HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVH 294
V+++ ++ I G+Y + VAIK ++ ++ + +E+
Sbjct: 3 VFDVGP---RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIK 58
Query: 295 IMRKVRHMNVVQFIGACTRPP----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
I+ + RH N++ P + + + G +Y L Q L +
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLY 116
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ +G+ Y+H N++HRDLK +NLL+N
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD 147
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.7 bits (214), Expect = 1e-19
Identities = 25/139 (17%), Positives = 51/139 (36%), Gaps = 15/139 (10%)
Query: 250 EHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQ 306
+ G + + + A+K+L + + +EV + + + ++V+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVR 69
Query: 307 FIGAC----TRPPRLFIVTEFMSGGSIYDYLHKQKC-GLKLPLLLRVAIDVSKGMNYLHR 361
+ L IV E + GG ++ + + + + + + YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 362 NNIIHRDLKAANLLMNENG 380
NI HRD+K NLL
Sbjct: 130 INIAHRDVKPENLLYTSKR 148
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 86.4 bits (213), Expect = 2e-19
Identities = 32/143 (22%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 244 ASLLKFE--HKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHL-NENIRREFAQEVHIMRK 298
A L +F+ + +GS+ + A+K+L + + E I++
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 299 VRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNY 358
V +V+ + L++V E+++GG ++ +L + P A + Y
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 359 LHRNNIIHRDLKAANLLMNENGV 381
LH ++I+RDLK NLL+++ G
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGY 179
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.7 bits (211), Expect = 2e-19
Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 6/135 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ KI SGS+ D+Y G + ++VAIK+ + + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGI 65
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
I C ++ + G S+ D + L +L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 366 HRDLKAANLLMNENG 380
HRD+K N LM
Sbjct: 126 HRDVKPDNFLMGLGK 140
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 3e-19
Identities = 25/136 (18%), Positives = 60/136 (44%), Gaps = 4/136 (2%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNV 304
+ + G++ + + A+K+L E + ++ E +++ RH +
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 305 VQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNI 364
A RL V E+ +GG ++ +L + + ++ + YLH ++
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 365 IHRDLKAANLLMNENG 380
++RD+K NL+++++G
Sbjct: 127 VYRDIKLENLMLDKDG 142
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (209), Expect = 3e-19
Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 3/132 (2%)
Query: 252 KIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIG 309
KI G+Y ++K + VA+K + + +E + +E+ ++++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDL 369
+L +V EF + ++ + KG+ + H N++HRDL
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 370 KAANLLMNENGV 381
K NLL+N NG
Sbjct: 128 KPQNLLINRNGE 139
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 8e-19
Identities = 39/144 (27%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
+ KI G++ +++K Q VA+K + E+ E +E+ I++ ++H NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 306 QFIGACTRPP--------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMN 357
I C +++V +F + L + RV + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131
Query: 358 YLHRNNIIHRDLKAANLLMNENGV 381
Y+HRN I+HRD+KAAN+L+ +GV
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGV 155
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 25/148 (16%), Positives = 55/148 (37%), Gaps = 7/148 (4%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
K +I GS+ +++G Q VAIK +R E+ + + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY----RTYKLLAGCTGI 63
Query: 306 QFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNII 365
+ + ++ + G S+ D L + + A + + +H +++
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 366 HRDLKAANLLMNENGVRDSDIHCYLSNF 393
+RD+K N L+ + Y+ +F
Sbjct: 124 YRDIKPDNFLIGRPN-SKNANMIYVVDF 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-17
Identities = 33/150 (22%), Positives = 67/150 (44%), Gaps = 10/150 (6%)
Query: 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS--QDVAIKVLTNEHLNENIRREFAQEVHI 295
+WE+ + + SG+Y + VA+K L+ + + +E+ +
Sbjct: 12 TIWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 296 MRKVRHMNVVQFIGACTRPPRL-----FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
++ ++H NV+ + T L + + G + + + QK L + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 128
Query: 351 DVSKGMNYLHRNNIIHRDLKAANLLMNENG 380
+ +G+ Y+H +IIHRDLK +NL +NE+
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDC 158
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 4e-17
Identities = 29/154 (18%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 248 KFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHL--NENIRREFAQEVHIMRKVR 300
+ + +G+Y ++ S + A+KVL + E ++ +R
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 301 HM-NVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYL 359
+V A +L ++ ++++GG ++ +L + + + ++ + +L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHL 145
Query: 360 HRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
H+ II+RD+K N+L++ NG H L++F
Sbjct: 146 HKLGIIYRDIKLENILLDSNG------HVVLTDF 173
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (189), Expect = 2e-16
Identities = 34/156 (21%), Positives = 67/156 (42%), Gaps = 15/156 (9%)
Query: 237 IDVWEIDASLLK---FEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQ 291
++V + ++LK I SG+ + A ++VAIK L+ N+ + +
Sbjct: 6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 65
Query: 292 EVHIMRKVRHMNVVQFIGACTRPP------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLL 345
E+ +M+ V H N++ + T +++V E M + L +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERM 121
Query: 346 LRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381
+ + G+ +LH IIHRDLK +N+++ +
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 74.1 bits (181), Expect = 2e-15
Identities = 27/171 (15%), Positives = 70/171 (40%), Gaps = 22/171 (12%)
Query: 238 DVWEIDASLLKFEH--------KIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRR 287
+ W+ ++ ++++ + K+ G Y ++++ ++ V +K+L ++
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KK 74
Query: 288 EFAQEVHIMRKVR-HMNVVQFIGACTRPP--RLFIVTEFMSGGSIYDYLHKQKCGLKLPL 344
+ +E+ I+ +R N++ P +V E ++ L
Sbjct: 75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYD 130
Query: 345 LLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395
+ ++ K ++Y H I+HRD+K N++++ + I L+ F
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.8 bits (146), Expect = 8e-11
Identities = 24/164 (14%), Positives = 62/164 (37%), Gaps = 21/164 (12%)
Query: 248 KFEHKIVSGSYCDLYKG--AFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVV 305
K+ G + ++ + VA+K++ ++ E+ ++++V +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 306 QFIGACTRPP---------------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAI 350
+ + +V E + + + G+ L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 351 DVSKGMNYLH-RNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393
+ G++Y+H R IIH D+K N+LM ++ I +++
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.4 bits (130), Expect = 3e-09
Identities = 19/151 (12%), Positives = 46/151 (30%), Gaps = 29/151 (19%)
Query: 252 KIVSGSYCDLYKGAFFS-QDVAIKVL----------------TNEHLNENIRREFAQEVH 294
+ G ++ + +K + H + R E
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 295 IMRKVRHMNVVQFIGACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSK 354
++K++ + V + ++ E + +Y + V + +
Sbjct: 67 ALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVRVENP--------DEVLDMILE 114
Query: 355 GMNYLHRNNIIHRDLKAANLLMNENGVRDSD 385
+ + I+H DL N+L++E G+ D
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGIWIID 145
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 78 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 39.8 bits (93), Expect = 3e-05
Identities = 12/63 (19%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQET-EQL 198
+ I D+P L ++ +LL G+NIQ A + + + +D + +
Sbjct: 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAI 63
Query: 199 RNV 201
Sbjct: 64 AAA 66
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} Length = 84 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Score = 39.7 bits (93), Expect = 3e-05
Identities = 10/63 (15%), Positives = 28/63 (44%), Gaps = 2/63 (3%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQET-EQL 198
+ ++P +L+ L + +E G+NI + ++ GY + D ++ + +
Sbjct: 12 RRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAM 71
Query: 199 RNV 201
+ +
Sbjct: 72 KAI 74
|
| >d1y7pa2 d.58.18.12 (A:2-78) Hypothetical protein AF1403, N-terminal domain {Archaeon Archaeoglobus fulgidus [TaxId: 2234]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: AF1403 N-terminal domain-like domain: Hypothetical protein AF1403, N-terminal domain species: Archaeon Archaeoglobus fulgidus [TaxId: 2234]
Score = 35.5 bits (82), Expect = 9e-04
Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
+ I +K +L LT++++E G NI A F G ++ E +L
Sbjct: 4 LRIIAENKIGVLRDLTTIIAEEGGNITFAQTFLIKHGEHEGKALIY--FEIEGGDFEKIL 61
Query: 203 AK--EIPKVEN 211
+ +
Sbjct: 62 ERVKTFDYIIE 72
|
| >d2pc6a2 d.58.18.6 (A:1-77) Acetolactate synthase small subunit, IlvH {Nitrosomonas europaea [TaxId: 915]} Length = 77 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: IlvH-like domain: Acetolactate synthase small subunit, IlvH species: Nitrosomonas europaea [TaxId: 915]
Score = 34.2 bits (79), Expect = 0.003
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVDGWPLQETEQLR 199
H I++ ++ LS++ L S G NI+ T D S V +G + EQ+
Sbjct: 3 HIISLLMENEAGALSRVAGLFSARGYNIESLSVAPTEDPTLSRMTLVTNGPD-EIVEQIT 61
Query: 200 NVLAKEIP--KVEN 211
L K I K+ +
Sbjct: 62 KQLNKLIEVVKLID 75
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} Length = 86 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Score = 34.0 bits (78), Expect = 0.004
Identities = 10/62 (16%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVL 202
IT D+P + +++ L+++ G NI + + ++ G ++ L
Sbjct: 8 ITAVGTDRPGICNEVVRLVTQAGCNI-IDSRIAMFGKEFTLLMLISG-SPSNITRVETTL 65
Query: 203 AK 204
Sbjct: 66 PL 67
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 411 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.98 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.98 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.98 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.98 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.98 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.59 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.32 | |
| d1zpva1 | 83 | UPF0237 protein SP0238 {Streptococcus pneumoniae [ | 92.75 | |
| d1u8sa1 | 86 | putative transcriptional repressor VC2159 {Vibrio | 91.16 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 91.08 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 90.12 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 89.7 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 89.15 | |
| d1ygya3 | 78 | Phosphoglycerate dehydrogenase, regulatory (C-term | 84.82 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 84.67 | |
| d1sc6a3 | 84 | Phosphoglycerate dehydrogenase, regulatory (C-term | 82.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-36 Score=288.40 Aligned_cols=155 Identities=35% Similarity=0.612 Sum_probs=141.2
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
|+|||+.++|++.++||+|+||.||+|++.+ .||||+++....+....+.|.+|+.+|++++|||||+++|++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 5799999999999999999999999998765 69999998776666677889999999999999999999999865 468
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||||||++|+|.+++...+..+++..++.++.||+.||.|||+++||||||||+|||++.++ .+||+|||+|.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~------~~Kl~DFGla~ 152 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL------TVKIGDFGLAT 152 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS------SEEECCCCCSC
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC------CEEEcccccee
Confidence 999999999999999987766799999999999999999999999999999999999999988 58999999997
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 153 ~~~ 155 (276)
T d1uwha_ 153 VKS 155 (276)
T ss_dssp C--
T ss_pred ecc
Confidence 653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-35 Score=285.47 Aligned_cols=157 Identities=35% Similarity=0.652 Sum_probs=143.2
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
..+.|||+.++|++.++||+|+||.||+|++. ++.||||+++..... .+.|.+|+.+|++++|||||+++|+|..
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 35789999999999999999999999999986 678999999765443 3679999999999999999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
.+.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+++++ .+||+|
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~------~~Kl~D 158 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH------LVKVAD 158 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------CEEECC
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC------cEEEcc
Confidence 99999999999999999999765 34689999999999999999999999999999999999999988 599999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||+|+.+..
T Consensus 159 FG~a~~~~~ 167 (287)
T d1opja_ 159 FGLSRLMTG 167 (287)
T ss_dssp CCCTTTCCS
T ss_pred ccceeecCC
Confidence 999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=275.32 Aligned_cols=156 Identities=28% Similarity=0.553 Sum_probs=139.3
Q ss_pred CCCceeecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 236 GIDVWEIDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 236 ~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
-.+.|||+.++|++.++||+|+||.||+|.++ ++.||||+++..... .+.|.+|+.+|++++|||||+++|++..
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 35789999999999999999999999999997 478999999765443 3579999999999999999999998865
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
+.+|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+++++ .+||+||
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~------~~Kl~DF 153 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL------SCKIADF 153 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS------CEEECCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc------ceeeccc
Confidence 46899999999999999876543 2589999999999999999999999999999999999999988 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|+|+.+..
T Consensus 154 Gla~~~~~ 161 (272)
T d1qpca_ 154 GLARLIED 161 (272)
T ss_dssp TTCEECSS
T ss_pred cceEEccC
Confidence 99987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-34 Score=269.50 Aligned_cols=151 Identities=34% Similarity=0.533 Sum_probs=133.3
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
|+.++|++.++||+|+||.||+|.+. ++.||||+++..... .++|.+|+.+|++++|||||+++|+|..++.+|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 56788999999999999999999996 578999999865444 36799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+++++ .+||+|||+|+.+.
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~------~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ------VIKVSDFGMTRFVL 152 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG------CEEECSCC------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC------CeEecccchheecc
Confidence 999999999999988776789999999999999999999999999999999999999988 59999999998764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 153 ~ 153 (263)
T d1sm2a_ 153 D 153 (263)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-34 Score=280.33 Aligned_cols=163 Identities=25% Similarity=0.354 Sum_probs=142.7
Q ss_pred eecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
||..++|++.++||+|+||.||+|++. ++.||+|+++... .....+.+.+|+.+|++++|||||+++++|..+..+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 566788999999999999999999986 6899999997653 3445678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
||||||+||+|.+++.+.+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.+| .+||+|||+|.
T Consensus 81 iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~------~vkl~DFGla~ 153 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG------EIKLCDFGVSG 153 (322)
T ss_dssp EEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC------CEEECCCCCCH
T ss_pred EEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC------CEEEeeCCCcc
Confidence 9999999999999998765 69999999999999999999997 5999999999999999998 59999999998
Q ss_pred cccc----ceeeEEEEcC
Q 015237 398 TVIL----VIFSCILVRA 411 (411)
Q Consensus 398 ~~~~----~~~~~i~~ra 411 (411)
.+.. ..+.+.+|||
T Consensus 154 ~~~~~~~~~~~GT~~Y~A 171 (322)
T d1s9ja_ 154 QLIDSMANSFVGTRSYMS 171 (322)
T ss_dssp HHHHHTC---CCSSCCCC
T ss_pred ccCCCccccccCCccccC
Confidence 7633 3344555554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-33 Score=273.12 Aligned_cols=155 Identities=34% Similarity=0.490 Sum_probs=133.3
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--C---ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--S---QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
++++.+.|++.++||+|+||.||+|++. + ..||||.+.... .....+.|.+|+.+|++++|||||+++|+|..+
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4677889999999999999999999985 2 258899886543 455667899999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~------~~Kl~DFG 173 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL------VCKVSDFG 173 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CEEECCC-
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC------cEEECCcc
Confidence 999999999999999999988766799999999999999999999999999999999999999988 59999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
+|+.+..
T Consensus 174 la~~~~~ 180 (299)
T d1jpaa_ 174 LSRFLED 180 (299)
T ss_dssp -------
T ss_pred cceEccC
Confidence 9987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=271.23 Aligned_cols=148 Identities=24% Similarity=0.395 Sum_probs=131.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.++||+|+||.||+|++. ++.||||+++.... .+..+.+.+|+.+|++++|||||++++++..++.+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35899999999999999999986 68999999976543 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++++| .+||+|||+|..+.
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~------~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD------NLKISDFGLATVFR 154 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC------CEEECCCTTCEECE
T ss_pred ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC------CEEEccchhheeec
Confidence 999999999997644 699999999999999999999999999999999999999988 59999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-33 Score=266.41 Aligned_cols=154 Identities=21% Similarity=0.415 Sum_probs=137.5
Q ss_pred eeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 240 WEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 240 ~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
|.+ ++|++.+.||+|+||.||+|++. ++.||+|++...... ....+.+.+|+.+|++++|||||++++++.+++.
T Consensus 3 ~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 3 WAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp CCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence 555 46999999999999999999986 688999999765332 2335678999999999999999999999999999
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|||||||++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~------~~kl~DFG~a 153 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG------ELKIADFGWS 153 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEECCCCSC
T ss_pred EEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC------CEeeccccee
Confidence 999999999999999998765 699999999999999999999999999999999999999988 5899999999
Q ss_pred cccccc
Q 015237 397 STVILV 402 (411)
Q Consensus 397 ~~~~~~ 402 (411)
....+.
T Consensus 154 ~~~~~~ 159 (263)
T d2j4za1 154 VHAPSS 159 (263)
T ss_dssp SCCCCC
T ss_pred eecCCC
Confidence 876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=271.36 Aligned_cols=147 Identities=27% Similarity=0.418 Sum_probs=134.1
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.++||+|+||.||+|++. ++.||||+++... ....+.+.+|+.+|++++|||||++++++..++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46899999999999999999986 6789999997653 2334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||+||+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|..+
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~------~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG------DIKLADFGVSAKN 160 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC------CEEEEechhhhcc
Confidence 9999999999887666799999999999999999999999999999999999999988 5899999999765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-33 Score=269.05 Aligned_cols=156 Identities=35% Similarity=0.615 Sum_probs=138.0
Q ss_pred CCCCceeecCCceEEEEEEeecCceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 235 EGIDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 235 ~~~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
...+.|||+.++|+++++||+|+||.||+|++.+ +.||||+++..... .+.|.+|+.+|++++|||||+++|+|..
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 3467899999999999999999999999999974 67999999766544 3679999999999999999999999965
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQ-KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~-~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
+.+|+|||||++|+|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~------~~kl~D 156 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------VCKVAD 156 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------CEEECC
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC------cEEEcc
Confidence 5689999999999999988754 33689999999999999999999999999999999999999988 599999
Q ss_pred cccccccc
Q 015237 393 FLSISTVI 400 (411)
Q Consensus 393 FGla~~~~ 400 (411)
||+|+.+.
T Consensus 157 fGla~~~~ 164 (285)
T d1fmka3 157 FGLARLIE 164 (285)
T ss_dssp CCTTC---
T ss_pred cchhhhcc
Confidence 99998664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-33 Score=273.35 Aligned_cols=157 Identities=26% Similarity=0.497 Sum_probs=136.3
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEe
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIG 309 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g 309 (411)
..|||+.++|+++++||+|+||.||+|++.+ ..||+|.+.... .......+.+|+.+|.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4699999999999999999999999998853 259999986543 233456789999999998 8999999999
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQK----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHR 367 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~----------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHR 367 (411)
+|...+.+|||||||++|+|.++|+... ..+++..++.++.||+.||.|||+++||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997653 247888999999999999999999999999
Q ss_pred CCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 368 DLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 368 DLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||||+|||++.++ .+||+|||+|+....
T Consensus 189 DlKp~Nill~~~~------~~Kl~DFGla~~~~~ 216 (325)
T d1rjba_ 189 DLAARNVLVTHGK------VVKICDFGLARDIMS 216 (325)
T ss_dssp TCSGGGEEEETTT------EEEECCCGGGSCGGG
T ss_pred cCchhccccccCC------eEEEeeccccccccC
Confidence 9999999999988 699999999987644
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-33 Score=268.88 Aligned_cols=146 Identities=23% Similarity=0.426 Sum_probs=133.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
..|++.++||+|+||.||+|.+. ++.||||+++...... .+.+.+|+.+|++++|||||++++++..++.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 45888999999999999999875 7899999998654332 4678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|..+.
T Consensus 98 y~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~------~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG------SVKLTDFGFCAQIT 167 (293)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCCTTCEECC
T ss_pred ecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC------cEeeccchhheeec
Confidence 99999999988764 599999999999999999999999999999999999999988 59999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-32 Score=262.01 Aligned_cols=151 Identities=28% Similarity=0.499 Sum_probs=134.4
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec----CCeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR----PPRL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~~l 317 (411)
...|++.++||+|+||.||+|++. ++.||+|.+..........+.+.+|+++|++++|||||++++++.. ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 345689999999999999999986 5789999998877777777889999999999999999999999864 4568
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEEcc-CCCcCCCccEEEEecc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNN--IIHRDLKAANLLMNE-NGVRDSDIHCYLSNFL 394 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~g--IIHRDLKp~NILid~-~g~~k~~~~ikL~DFG 394 (411)
|||||||++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++ .+||+|||
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~------~~Kl~DFG 160 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG------SVKIGDLG 160 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS------CEEECCTT
T ss_pred EEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC------CEEEeecC
Confidence 99999999999999998765 6999999999999999999999999 999999999999964 56 58999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
+|+....
T Consensus 161 la~~~~~ 167 (270)
T d1t4ha_ 161 LATLKRA 167 (270)
T ss_dssp GGGGCCT
T ss_pred cceeccC
Confidence 9986543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-33 Score=263.96 Aligned_cols=154 Identities=29% Similarity=0.472 Sum_probs=132.4
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR 313 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 313 (411)
+|||+.++|++++.||+|+||.||+|++.. ..||||.++... .....+.+.+|+.+|++++|||||+++|++..
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 599999999999999999999999998852 358888886543 45567789999999999999999999999964
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
+.+|||||||++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+||
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~------~~Kl~Df 152 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND------CVKLGDF 152 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT------EEEECC-
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC------cEEEccc
Confidence 579999999999999999888777899999999999999999999999999999999999999998 5999999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|+|..+.
T Consensus 153 G~a~~~~ 159 (273)
T d1mp8a_ 153 GLSRYME 159 (273)
T ss_dssp -------
T ss_pred hhheecc
Confidence 9998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-32 Score=264.96 Aligned_cols=154 Identities=26% Similarity=0.431 Sum_probs=137.2
Q ss_pred eeecCCceEEEE-EEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 240 WEIDASLLKFEH-KIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 240 ~ei~~~~~~~~~-~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
|-++.+++.+.+ +||+|+||.||+|.+. +..||||+++... .....+.|.+|+.+|++++|||||+++|+|..+
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 567888899988 5999999999999875 3469999997653 455677899999999999999999999999764
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
.+|||||||++|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~------~~Kl~DFG 154 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH------YAKISDFG 154 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT------EEEECCCT
T ss_pred -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC------ceeeccch
Confidence 58999999999999999977666799999999999999999999999999999999999999988 59999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
+|+.+..
T Consensus 155 la~~~~~ 161 (285)
T d1u59a_ 155 LSKALGA 161 (285)
T ss_dssp TCEECTT
T ss_pred hhhcccc
Confidence 9987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-32 Score=263.13 Aligned_cols=154 Identities=30% Similarity=0.480 Sum_probs=135.8
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECC------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
||+.+.|++.+.||+|+||.||+|.+.+ ..||||+++... .......|.+|+.+|++++|||||+++|+|...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 7888999999999999999999998853 369999997543 445567799999999999999999999999999
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecc
Q 015237 315 PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFL 394 (411)
Q Consensus 315 ~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFG 394 (411)
+.+++|||||.+|++.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~------~~Kl~DFG 155 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL------VCKVSDFG 155 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CEEECCCC
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC------eEEEcccc
Confidence 999999999999999999888777899999999999999999999999999999999999999988 59999999
Q ss_pred ccccccc
Q 015237 395 SISTVIL 401 (411)
Q Consensus 395 la~~~~~ 401 (411)
+|+.+..
T Consensus 156 la~~~~~ 162 (283)
T d1mqba_ 156 LSRVLED 162 (283)
T ss_dssp C------
T ss_pred hhhcccC
Confidence 9987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.4e-32 Score=263.68 Aligned_cols=151 Identities=28% Similarity=0.496 Sum_probs=129.6
Q ss_pred cCCceEEE-EEEeecCceEEEEEEEC----CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 243 DASLLKFE-HKIVSGSYCDLYKGAFF----SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 243 ~~~~~~~~-~~IG~Gsfg~Vy~g~~~----~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
+...+.+. ++||+|+||.||+|.+. ++.||||+++....+....+.|.+|+.+|++++|||||+++|+|..+ ..
T Consensus 4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~ 82 (277)
T d1xbba_ 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 82 (277)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence 44556665 46999999999999875 25799999987655556678899999999999999999999999754 57
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||||||++|+|.+++.... .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~------~~kl~DFGla~ 155 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH------YAKISDFGLSK 155 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT------EEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC------cccccchhhhh
Confidence 99999999999999998754 699999999999999999999999999999999999999998 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 156 ~~~~ 159 (277)
T d1xbba_ 156 ALRA 159 (277)
T ss_dssp ECCT
T ss_pred hccc
Confidence 7644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=262.00 Aligned_cols=151 Identities=32% Similarity=0.569 Sum_probs=137.8
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
++.++|++.++||+|+||.||+|+++ ++.||||.++...... +.|.+|+.++++++||||++++|+|..++.+++|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 45678999999999999999999997 4689999998765543 5799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+++|+|.+++......+++..+.+++.|++.||.|||++||+||||||+|||+++++ .+||+|||+|..+.
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~------~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG------VVKVSDFGLSRYVL 151 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC------CEEECCCSSCCBCS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC------cEEECcchhheecc
Confidence 999999999999887776899999999999999999999999999999999999999988 58999999998654
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 152 ~ 152 (258)
T d1k2pa_ 152 D 152 (258)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.2e-32 Score=265.80 Aligned_cols=150 Identities=24% Similarity=0.403 Sum_probs=135.4
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
.++|++++.||+|+||.||+|.+. ++.||||+++.... .....+.+.+|+.+|++++||||+++++++.+.+.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 456999999999999999999986 68999999976432 123346799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||+||+|.+++...+ .+++..+..++.|++.||.|||++|||||||||+|||++++| .+||+|||+|+.+.
T Consensus 87 mEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~------~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM------HIQITDFGTAKVLS 159 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS------CEEECCCTTCEECC
T ss_pred EEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc------eEEecccccceecc
Confidence 99999999999998765 699999999999999999999999999999999999999998 59999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.3e-32 Score=262.87 Aligned_cols=151 Identities=24% Similarity=0.355 Sum_probs=129.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--CCeEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR--PPRLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~~l~IV 320 (411)
++|++.+.||+|+||.||+|++. ++.||||++.....++...+.+.+|+++|++++|||||++++++.+ ...+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56999999999999999999986 6899999998887777777889999999999999999999999864 4568999
Q ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 321 TEFMSGGSIYDYLHKQ---KCGLKLPLLLRVAIDVSKGMNYLHRNN-----IIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~---~~~l~~~~i~~i~~qIa~gL~yLHs~g-----IIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
||||+||+|.+++.+. +..+++..++.++.||+.||.|||++| ||||||||+|||++.+| .+||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~------~vkl~D 157 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ------NVKLGD 157 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS------CEEECC
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC------cEEEee
Confidence 9999999999998753 346999999999999999999999876 99999999999999988 599999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||+|..+..
T Consensus 158 FG~a~~~~~ 166 (269)
T d2java1 158 FGLARILNH 166 (269)
T ss_dssp HHHHHHC--
T ss_pred ccceeeccc
Confidence 999987643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=4.3e-32 Score=264.47 Aligned_cols=149 Identities=29% Similarity=0.401 Sum_probs=134.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
..|+..++||+|+||.||+|++. ++.||||+++..... ....+.+.+|+.+|++++|||||++++++..++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999985 688999999876543 345677999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||.+|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~------~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG------LVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT------EEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC------CEEEeecccccccC
Confidence 999999887766554 4799999999999999999999999999999999999999988 59999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6.5e-32 Score=260.41 Aligned_cols=154 Identities=19% Similarity=0.347 Sum_probs=137.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
+.|++++.||+|+||.||+|++. ++.||||+++...... ...+.+.+|+.+|++++|||||++++++.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56999999999999999999986 6899999997654322 23577999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
||||||+||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|..+. .+||+|||+|..
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~--~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP--RIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSC--CEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCccc--ceEecchhhhhh
Confidence 9999999999999998765 6999999999999999999999999999999999999998885443 489999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 167 ~~~ 169 (293)
T d1jksa_ 167 IDF 169 (293)
T ss_dssp CTT
T ss_pred cCC
Confidence 643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=7.4e-32 Score=267.44 Aligned_cols=150 Identities=15% Similarity=0.277 Sum_probs=135.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++.++||+|+||.||+|.+. ++.||||+++... ....+.+.+|+.+|++++|||||++++++..+..+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46999999999999999999985 7899999997653 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc--CCCcCCCccEEEEecccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE--NGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~--~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||+||+|.+++......+++..+..++.||+.||.|||++|||||||||+|||++. +| .+||+|||+|..+.
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~------~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS------SVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC------CEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC------eEEEeecccceecC
Confidence 99999999988776667999999999999999999999999999999999999984 34 58999999998875
Q ss_pred cc
Q 015237 401 LV 402 (411)
Q Consensus 401 ~~ 402 (411)
..
T Consensus 181 ~~ 182 (352)
T d1koba_ 181 PD 182 (352)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=260.53 Aligned_cols=153 Identities=33% Similarity=0.562 Sum_probs=133.0
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-CCeE
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRL 317 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~~~l 317 (411)
.|||+.++|++.++||+|+||.||+|.++++.||||+++.+. ..+.+.+|+.+|++++||||++++|+|.. .+.+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 499999999999999999999999999999999999997653 23678999999999999999999999864 4568
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
|+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.+| .+||+|||++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~------~~kl~dfg~s 150 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------VAKVSDFGLT 150 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------CEEECCCCC-
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC------CEeecccccc
Confidence 99999999999999997653 2589999999999999999999999999999999999999998 5899999999
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
+....
T Consensus 151 ~~~~~ 155 (262)
T d1byga_ 151 KEASS 155 (262)
T ss_dssp -----
T ss_pred eecCC
Confidence 87543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=1.6e-31 Score=256.44 Aligned_cols=151 Identities=23% Similarity=0.331 Sum_probs=136.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-------HHHHHHHHHHHHHHhhcC-CCceeEEEeeeec
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-------ENIRREFAQEVHIMRKVR-HMNVVQFIGACTR 313 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-------~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~ 313 (411)
.++|++.+.||+|+||.||+|++. ++.||||+++..... ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 357999999999999999999984 689999999875432 234457899999999997 9999999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
++.+|||||||+||+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~------~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM------NIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC------CEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC------CeEEccc
Confidence 999999999999999999998765 799999999999999999999999999999999999999988 5899999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|++..+..
T Consensus 155 G~a~~~~~ 162 (277)
T d1phka_ 155 GFSCQLDP 162 (277)
T ss_dssp TTCEECCT
T ss_pred hheeEccC
Confidence 99987754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.5e-32 Score=262.51 Aligned_cols=157 Identities=25% Similarity=0.468 Sum_probs=140.2
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEee
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGA 310 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 310 (411)
+.|||+.++|++.++||+|+||.||+|.+. ++.||||+++... .......|.+|+.++++++||||++++|+
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 569999999999999999999999999875 3679999997543 44556779999999999999999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCC
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK---------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGV 381 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~---------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~ 381 (411)
|...+..++|||||++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~- 170 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF- 170 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-
Confidence 999999999999999999999987532 2468888999999999999999999999999999999999988
Q ss_pred cCCCccEEEEeccccccccc
Q 015237 382 RDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 382 ~k~~~~ikL~DFGla~~~~~ 401 (411)
.+||+|||+|..+..
T Consensus 171 -----~~Kl~DFGla~~~~~ 185 (308)
T d1p4oa_ 171 -----TVKIGDFGMTRDIYE 185 (308)
T ss_dssp -----CEEECCTTCCCGGGG
T ss_pred -----eEEEeecccceeccC
Confidence 599999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.5e-32 Score=266.89 Aligned_cols=152 Identities=18% Similarity=0.316 Sum_probs=137.0
Q ss_pred ecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEE
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLF 318 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~ 318 (411)
|..++|++.+.||+|+||.||+|+.. ++.||||+++.... .....+.+.+|+.+|++++||||+++++++.+...+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 44567999999999999999999985 78999999986532 1223567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+|||||+||+|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.
T Consensus 82 iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g------~vkl~DFG~a~~ 154 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCTTCBC
T ss_pred cceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC------CEEEeecccccc
Confidence 9999999999999998765 689999999999999999999999999999999999999998 599999999987
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
+.
T Consensus 155 ~~ 156 (337)
T d1o6la_ 155 GI 156 (337)
T ss_dssp SC
T ss_pred cc
Confidence 64
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=1.3e-31 Score=265.39 Aligned_cols=152 Identities=20% Similarity=0.311 Sum_probs=135.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|++++|||||++++++...+.+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46999999999999999999986 7899999997653 3445789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
||+||+|.+++....+.+++..+..++.||+.||.|||++|||||||||+|||++.++. ..+||+|||+|..+...
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~----~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS----NELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS----CCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC----CeEEEeecchheecccc
Confidence 99999999999766667999999999999999999999999999999999999965321 15899999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=261.71 Aligned_cols=152 Identities=15% Similarity=0.213 Sum_probs=135.8
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
+.|++++.||+|+||.||+|.+. ++.||||+++.... ....+.+|+.+|+.++|||||++++++...+.+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 56999999999999999999986 68899999976532 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVILV 402 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~~ 402 (411)
||+||+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~----~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS----STIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSC----CCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCc----eEEEEcccchhhccccC
Confidence 99999999999877657999999999999999999999999999999999999986552 25899999999887554
Q ss_pred e
Q 015237 403 I 403 (411)
Q Consensus 403 ~ 403 (411)
.
T Consensus 158 ~ 158 (321)
T d1tkia_ 158 D 158 (321)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=7.4e-32 Score=260.99 Aligned_cols=155 Identities=23% Similarity=0.423 Sum_probs=139.5
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGAC 311 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 311 (411)
.||++.++|++.++||+|+||.||+|++.+ +.||||+++... ..+..+.|.+|+.+|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 589999999999999999999999999853 579999987543 455678899999999999999999999999
Q ss_pred ecCCeEEEEEecCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 015237 312 TRPPRLFIVTEFMSGGSIYDYLHKQK-----------------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRD 368 (411)
Q Consensus 312 ~~~~~l~IV~E~~~gGsL~~~L~~~~-----------------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRD 368 (411)
......+++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999997532 1378889999999999999999999999999
Q ss_pred CCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 369 LKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 369 LKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
|||+|||++.++ .+||+|||+|+.+.
T Consensus 166 lKp~NILld~~~------~~Kl~DFGls~~~~ 191 (301)
T d1lufa_ 166 LATRNCLVGENM------VVKIADFGLSRNIY 191 (301)
T ss_dssp CSGGGEEECGGG------CEEECCCSCHHHHT
T ss_pred EcccceEECCCC------cEEEccchhheecc
Confidence 999999999887 59999999997653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.2e-31 Score=262.13 Aligned_cols=150 Identities=23% Similarity=0.373 Sum_probs=134.8
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.++||+|+||.||+|++. ++.||||+++..... ....+.+.+|+.+|+.++|||||++++++..++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999986 789999999765322 223567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|||+||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g------~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG------HIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS------CEEECCCSSCEECSS
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC------CEEEecCccceEecc
Confidence 9999999999887765 688999999999999999999999999999999999999998 599999999987644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.3e-32 Score=260.09 Aligned_cols=150 Identities=24% Similarity=0.449 Sum_probs=128.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.++||+|+||.||+|++. ++.||||+++.........+.+.+|+.+|++++|||||++++++..++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47999999999999999999986 6899999997665444456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHK-QKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~-~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||.+ ++.+++.. ....+++..+..++.||+.||.|||++|||||||||+|||++.++ .+||+|||.|+....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~------~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG------AIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC------cceeccCCcceeccC
Confidence 9954 55555544 345699999999999999999999999999999999999999888 589999999976643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.5e-31 Score=256.13 Aligned_cols=156 Identities=27% Similarity=0.507 Sum_probs=140.3
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC-------CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEee
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF-------SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGA 310 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~-------~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 310 (411)
.|||+.++|+++++||+|+||.||+|++. ++.||||+++... .......+.+|+.+++++ +|||||+++|+
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 69999999999999999999999999874 2579999998654 345567899999999999 69999999999
Q ss_pred eecCCeEEEEEecCCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 015237 311 CTRPPRLFIVTEFMSGGSIYDYLHKQK-----------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAAN 373 (411)
Q Consensus 311 ~~~~~~l~IV~E~~~gGsL~~~L~~~~-----------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~N 373 (411)
|.....+||+||||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999997643 247889999999999999999999999999999999
Q ss_pred EEEccCCCcCCCccEEEEeccccccccc
Q 015237 374 LLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 374 ILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||++.++ .+|++|||.++.+..
T Consensus 176 Il~~~~~------~~ki~DfG~~~~~~~ 197 (311)
T d1t46a_ 176 ILLTHGR------ITKICDFGLARDIKN 197 (311)
T ss_dssp EEEETTT------EEEECCCGGGSCTTS
T ss_pred ccccccC------cccccccchheeccC
Confidence 9999988 699999999987643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.6e-31 Score=260.05 Aligned_cols=149 Identities=22% Similarity=0.376 Sum_probs=122.8
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
.+.|++.+.||+|+||.||+|++. ++.||||++....... ..+.+.+|+.+|++++|||||++++++..++.+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356999999999999999999986 6889999998765432 3456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEcc---CCCcCCCccEEEEecccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNE---NGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~---~g~~k~~~~ikL~DFGla~~ 398 (411)
|||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+.. +| .+||+|||+|..
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~------~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS------KIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC------CEEECCC-----
T ss_pred eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCc------eEEEeccceeEE
Confidence 9999999999997654 7999999999999999999999999999999999999954 44 589999999986
Q ss_pred cc
Q 015237 399 VI 400 (411)
Q Consensus 399 ~~ 400 (411)
..
T Consensus 160 ~~ 161 (307)
T d1a06a_ 160 ED 161 (307)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=256.91 Aligned_cols=156 Identities=29% Similarity=0.548 Sum_probs=127.4
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEECC-------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEE
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFFS-------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFI 308 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 308 (411)
.+.|||+.++|++.++||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 46899999999999999999999999998742 579999997544 334456788888888777 689999999
Q ss_pred eeeecC-CeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 309 GACTRP-PRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 309 g~~~~~-~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
+++... ..+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 988654 46899999999999999997642 24788999999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEeccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
|||+++++ .+||+|||+|+.+
T Consensus 164 NILl~~~~------~~Kl~DFGla~~~ 184 (299)
T d1ywna1 164 NILLSEKN------VVKICDFGLARDI 184 (299)
T ss_dssp GEEECGGG------CEEECC------C
T ss_pred ceeECCCC------cEEEccCcchhhc
Confidence 99999988 5999999999764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-31 Score=253.55 Aligned_cols=153 Identities=30% Similarity=0.467 Sum_probs=128.1
Q ss_pred ecCCceEEEEEEeecCceEEEEEEECC-----ceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
|+.++|++.+.||+|+||.||+|++.+ ..||||+++.... .....+.|.+|+.+|++++||||++++|+|.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 567789999999999999999998752 3699999976543 23456789999999999999999999999976 4
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
.+++|||||++|++.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~------~vkl~DfGl 157 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD------LVKIGDFGL 157 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT------EEEECCCTT
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc------ceeeccchh
Confidence 68999999999999999888766799999999999999999999999999999999999999988 699999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 158 ~~~~~~ 163 (273)
T d1u46a_ 158 MRALPQ 163 (273)
T ss_dssp CEECCC
T ss_pred hhhccc
Confidence 997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=5.8e-31 Score=260.67 Aligned_cols=151 Identities=21% Similarity=0.285 Sum_probs=136.0
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~ 321 (411)
++|++.++||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.+|+.++|||||++++++.....+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46999999999999999999986 789999999754321 223467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+.||+|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|+.+.+
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g------~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG------YIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------CEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC------CEEeeeceeeeeccc
Confidence 9999999999998765 699999999999999999999999999999999999999988 599999999988754
Q ss_pred c
Q 015237 402 V 402 (411)
Q Consensus 402 ~ 402 (411)
.
T Consensus 194 ~ 194 (350)
T d1rdqe_ 194 R 194 (350)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8e-31 Score=253.60 Aligned_cols=157 Identities=26% Similarity=0.509 Sum_probs=135.0
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEECC---------ceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEE
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQF 307 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 307 (411)
..|+|+.++|.++++||+|+||.||+|++.+ ..||||+++.+. .......+.+|+.++.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 3499999999999999999999999998742 369999997654 444567789999999888 89999999
Q ss_pred EeeeecCCeEEEEEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 015237 308 IGACTRPPRLFIVTEFMSGGSIYDYLHKQK---------------CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAA 372 (411)
Q Consensus 308 ~g~~~~~~~l~IV~E~~~gGsL~~~L~~~~---------------~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~ 372 (411)
+++|..++.+|+|||||.+|+|.+++.... ..+++..++.++.||+.||.|||+++||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999997653 24899999999999999999999999999999999
Q ss_pred cEEEccCCCcCCCccEEEEeccccccccc
Q 015237 373 NLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 373 NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|||++.++ .+||+|||++..+..
T Consensus 165 NiLl~~~~------~~kl~dfg~~~~~~~ 187 (299)
T d1fgka_ 165 NVLVTEDN------VMKIADFGLARDIHH 187 (299)
T ss_dssp GEEECTTC------CEEECSTTCCCCGGG
T ss_pred ceeecCCC------CeEeccchhhccccc
Confidence 99999998 589999999987643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-30 Score=252.86 Aligned_cols=150 Identities=27% Similarity=0.489 Sum_probs=130.5
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--Cc----eEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCe
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQ----DVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPR 316 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 316 (411)
..++|++.++||+|+||.||+|.+. ++ .||+|.++... +....+.|.+|+.+|++++|||||+++|+|..+ .
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 4456999999999999999999885 32 58999886543 333457899999999999999999999999875 5
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
.++++||+.+|+|.+++......+++..++.++.||+.||.|||+++||||||||+|||++.++ .+||+|||+|
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~------~~kl~DFGla 158 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ------HVKITDFGLA 158 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT------EEEECCCSHH
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC------CeEeeccccc
Confidence 7888999999999999988877899999999999999999999999999999999999999988 6999999999
Q ss_pred cccc
Q 015237 397 STVI 400 (411)
Q Consensus 397 ~~~~ 400 (411)
..+.
T Consensus 159 ~~~~ 162 (317)
T d1xkka_ 159 KLLG 162 (317)
T ss_dssp HHTT
T ss_pred eecc
Confidence 8764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.6e-30 Score=258.73 Aligned_cols=151 Identities=19% Similarity=0.234 Sum_probs=130.5
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH-HHHHHHH---HHHHHHhhcCCCceeEEEeeeecCCeE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE-NIRREFA---QEVHIMRKVRHMNVVQFIGACTRPPRL 317 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~-~~~~~~~---~Ei~iL~~l~HpNIV~l~g~~~~~~~l 317 (411)
.++|++.+.||+|+||.||+|++. ++.||||++....... .....+. .|+.+++.++|||||++++++..++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 467999999999999999999985 7899999997543221 1122233 446777788899999999999999999
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||||||+||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+||+|||+|.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g------~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG------HVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS------CEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC------cEEEeeeceee
Confidence 99999999999999998764 689999999999999999999999999999999999999988 59999999998
Q ss_pred cccc
Q 015237 398 TVIL 401 (411)
Q Consensus 398 ~~~~ 401 (411)
.+..
T Consensus 156 ~~~~ 159 (364)
T d1omwa3 156 DFSK 159 (364)
T ss_dssp ECSS
T ss_pred ecCC
Confidence 7644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=253.76 Aligned_cols=153 Identities=31% Similarity=0.521 Sum_probs=132.3
Q ss_pred eecCCceEEEEEEeecCceEEEEEEECC--c--eEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeecCC
Q 015237 241 EIDASLLKFEHKIVSGSYCDLYKGAFFS--Q--DVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTRPP 315 (411)
Q Consensus 241 ei~~~~~~~~~~IG~Gsfg~Vy~g~~~~--~--~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 315 (411)
.|+.++|+++++||+|+||.||+|++.+ . .||||.++... .....+.|.+|+.+|+++ +|||||+++|+|...+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4677899999999999999999999863 3 57888876443 233457799999999998 7999999999999999
Q ss_pred eEEEEEecCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCC
Q 015237 316 RLFIVTEFMSGGSIYDYLHKQ---------------KCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENG 380 (411)
Q Consensus 316 ~l~IV~E~~~gGsL~~~L~~~---------------~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g 380 (411)
.+||||||+++|+|.++|+.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 24689999999999999999999999999999999999999887
Q ss_pred CcCCCccEEEEecccccccc
Q 015237 381 VRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 381 ~~k~~~~ikL~DFGla~~~~ 400 (411)
.+||+|||+|+...
T Consensus 165 ------~~kl~DfG~a~~~~ 178 (309)
T d1fvra_ 165 ------VAKIADFGLSRGQE 178 (309)
T ss_dssp ------CEEECCTTCEESSC
T ss_pred ------ceEEcccccccccc
Confidence 59999999997654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1.3e-30 Score=249.55 Aligned_cols=150 Identities=24% Similarity=0.336 Sum_probs=133.1
Q ss_pred CceEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
++|++.++||+|+||.||+|+++ ++.||||+++.........+.+.+|+.+|++++||||+++++++..++..|++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 47999999999999999999987 68999999977654444457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
+.++.+..+. .....+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||.|.....
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~------~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG------ELKIADFGLARAFGI 152 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS------CEEECCTTHHHHHCC
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC------CEEecccccceeccc
Confidence 9765555554 4445799999999999999999999999999999999999999988 589999999987644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-30 Score=252.16 Aligned_cols=149 Identities=21% Similarity=0.348 Sum_probs=130.9
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccC-HHHHHHHHHHHHHHh-hcCCCceeEEEeeeecCCeEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLN-ENIRREFAQEVHIMR-KVRHMNVVQFIGACTRPPRLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~-~l~HpNIV~l~g~~~~~~~l~IV 320 (411)
++|.+++.||+|+||.||+|++. ++.||||+++..... ....+.+..|..++. .++|||||++++++..++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46999999999999999999985 789999999764321 122355667777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++++| .+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~------~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS------CEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC------ceeccccchhhhcc
Confidence 99999999999998765 689999999999999999999999999999999999999988 58999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=5.2e-30 Score=244.68 Aligned_cols=149 Identities=21% Similarity=0.345 Sum_probs=133.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeecccc-CHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC----eE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHL-NENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----RL 317 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~l 317 (411)
++|++.+.||+|+||.||+|.+. ++.||||+++.... +....+.+.+|+.+|+.++||||+++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56999999999999999999985 78999999987654 3456678999999999999999999999987543 48
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccc
Q 015237 318 FIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIS 397 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~ 397 (411)
|||||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+++|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~------~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN------AVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS------CEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc------cceeehhhhhh
Confidence 99999999999999987765 699999999999999999999999999999999999999988 58999999987
Q ss_pred ccc
Q 015237 398 TVI 400 (411)
Q Consensus 398 ~~~ 400 (411)
...
T Consensus 160 ~~~ 162 (277)
T d1o6ya_ 160 AIA 162 (277)
T ss_dssp ECC
T ss_pred hhc
Confidence 653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.8e-30 Score=248.06 Aligned_cols=148 Identities=24% Similarity=0.436 Sum_probs=130.7
Q ss_pred eEEEEEEeecCceEEEEEEECC-----ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec-CCeEEEE
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFS-----QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-PPRLFIV 320 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-~~~l~IV 320 (411)
+.+.++||+|+||+||+|++.. ..||||.++.. .+....+.|.+|+.+|++++||||++++|+|.. ++.+++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 4567899999999999999853 25899998643 245667889999999999999999999999865 5689999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccccc
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVI 400 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~ 400 (411)
||||++|+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+++++ .+||+|||+++.+.
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~------~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF------TVKVADFGLARDMY 181 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC------CEEECSSGGGCCTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC------CEEEecccchhhcc
Confidence 999999999999987776788899999999999999999999999999999999999887 59999999998764
Q ss_pred c
Q 015237 401 L 401 (411)
Q Consensus 401 ~ 401 (411)
.
T Consensus 182 ~ 182 (311)
T d1r0pa_ 182 D 182 (311)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=251.23 Aligned_cols=146 Identities=26% Similarity=0.350 Sum_probs=122.6
Q ss_pred EEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH---HHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEec
Q 015237 249 FEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE---NIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTEF 323 (411)
Q Consensus 249 ~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~---~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E~ 323 (411)
.+++||+|+||.||+|++. ++.||||+++...... ...+.+.+|+.+|++++|||||++++++...+.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999885 6899999997654322 2345689999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 324 MSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 324 ~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
|.++++..+. .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~------~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG------VLKLADFGLAKSFGS 152 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEEECCCGGGSTTTS
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC------ccccccCccccccCC
Confidence 9876665544 4444788999999999999999999999999999999999999988 589999999987644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=242.80 Aligned_cols=150 Identities=24% Similarity=0.352 Sum_probs=136.4
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCCeEEEEEe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPPRLFIVTE 322 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~l~IV~E 322 (411)
++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.+|+.++||||+++++++......++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46999999999999999999986 6789999998776666677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 323 FMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 323 ~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
++.++++..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|..+..
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~------~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG------ELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC------CEEECCCTTCEECCS
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC------ceeeeecchhhcccC
Confidence 99998888877654 4789999999999999999999999999999999999999888 589999999987644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.8e-30 Score=250.78 Aligned_cols=154 Identities=25% Similarity=0.390 Sum_probs=132.0
Q ss_pred CceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC
Q 015237 238 DVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP 315 (411)
Q Consensus 238 ~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 315 (411)
..|++ .+.|++.++||+|+||.||+|++. ++.||||+++....+....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 46888 568999999999999999999986 789999999877666777788999999999999999999999997654
Q ss_pred ------eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 316 ------RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 316 ------~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
.+||||||| +++|..+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~------~~k 161 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC------ELK 161 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEE
T ss_pred cccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc------ccc
Confidence 479999999 67888877654 599999999999999999999999999999999999999998 589
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
++|||+|.....
T Consensus 162 l~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 162 ILDFGLARQADS 173 (346)
T ss_dssp ECCCTTCEECCS
T ss_pred cccccceeccCC
Confidence 999999988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=246.31 Aligned_cols=146 Identities=24% Similarity=0.493 Sum_probs=124.9
Q ss_pred CceEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC----eEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP----RLFIV 320 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~l~IV 320 (411)
.+|.+.++||+|+||.||+|+++++.||||+++... ........|+..+.+++|||||+++|+|.... .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 568899999999999999999999999999997543 11122334555566789999999999997643 58999
Q ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCcEEEccCCCcCCCccEEEEe
Q 015237 321 TEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHR--------NNIIHRDLKAANLLMNENGVRDSDIHCYLSN 392 (411)
Q Consensus 321 ~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs--------~gIIHRDLKp~NILid~~g~~k~~~~ikL~D 392 (411)
||||++|+|.+++++. .+++...+.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~------~~Kl~D 151 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG------TCCIAD 151 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS------CEEECC
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC------CeEEEe
Confidence 9999999999999875 48999999999999999999996 5999999999999999988 599999
Q ss_pred ccccccccc
Q 015237 393 FLSISTVIL 401 (411)
Q Consensus 393 FGla~~~~~ 401 (411)
||++..+..
T Consensus 152 FGl~~~~~~ 160 (303)
T d1vjya_ 152 LGLAVRHDS 160 (303)
T ss_dssp CTTCEEEET
T ss_pred cCccccccC
Confidence 999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.8e-30 Score=242.82 Aligned_cols=152 Identities=21% Similarity=0.319 Sum_probs=130.3
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCH----HHHHHHHHHHHHHhhcC--CCceeEEEeeeecCCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNE----NIRREFAQEVHIMRKVR--HMNVVQFIGACTRPPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~~~ 316 (411)
++|++++.||+|+||.||+|++. ++.||||+++...... .....+.+|+.+|++++ |||||++++++..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46999999999999999999986 6899999997654321 11234678999999996 8999999999999999
Q ss_pred EEEEEecCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSG-GSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~g-GsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+|+||||+.+ +++.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-----~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-----ELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-----EEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-----eEEECcccc
Confidence 9999999975 67888887654 6999999999999999999999999999999999999986531 599999999
Q ss_pred ccccccc
Q 015237 396 ISTVILV 402 (411)
Q Consensus 396 a~~~~~~ 402 (411)
|......
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9876443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-29 Score=247.61 Aligned_cols=147 Identities=19% Similarity=0.259 Sum_probs=124.8
Q ss_pred CceEEEE-EEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhc-CCCceeEEEeeeec----CCe
Q 015237 245 SLLKFEH-KIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV-RHMNVVQFIGACTR----PPR 316 (411)
Q Consensus 245 ~~~~~~~-~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~----~~~ 316 (411)
+.|++.+ .||+|+||.||+|++. ++.||||+++.. ..+.+|+.++.++ +|||||+++++|.. ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4587765 5999999999999985 689999999653 4567899987654 89999999999864 456
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQK-CGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~-~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
+|||||||+||+|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~---~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN---AILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTT---CCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccc---ccccccccce
Confidence 999999999999999998753 368999999999999999999999999999999999999864421 1489999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
|+.+..
T Consensus 161 a~~~~~ 166 (335)
T d2ozaa1 161 AKETTS 166 (335)
T ss_dssp CEECCC
T ss_pred eeeccC
Confidence 987643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-29 Score=246.38 Aligned_cols=151 Identities=23% Similarity=0.368 Sum_probs=127.0
Q ss_pred ceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecCC-
Q 015237 239 VWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRPP- 315 (411)
Q Consensus 239 ~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~- 315 (411)
.|+|.. +|++.++||+|+||.||+|+.. ++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 3 VFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 466654 4999999999999999999986 7899999997644 3455678999999999999999999999986542
Q ss_pred ----eEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEE
Q 015237 316 ----RLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLS 391 (411)
Q Consensus 316 ----~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~ 391 (411)
.+|++ +++.+|+|.+++... .+++..+..++.||+.||+|||++|||||||||+|||++.+| .+||+
T Consensus 81 ~~~~~~~l~-~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~------~~kl~ 151 (345)
T d1pmea_ 81 EQMKDVYLV-THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC------DLKIC 151 (345)
T ss_dssp TTCCCEEEE-EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC------CEEEC
T ss_pred cccceEEEE-EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC------CEEEc
Confidence 34555 555699999999765 489999999999999999999999999999999999999988 59999
Q ss_pred ecccccccc
Q 015237 392 NFLSISTVI 400 (411)
Q Consensus 392 DFGla~~~~ 400 (411)
|||+|..+.
T Consensus 152 DfG~a~~~~ 160 (345)
T d1pmea_ 152 DFGLARVAD 160 (345)
T ss_dssp CCTTCEECC
T ss_pred ccCceeecc
Confidence 999997653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-29 Score=246.40 Aligned_cols=156 Identities=21% Similarity=0.300 Sum_probs=133.0
Q ss_pred CCceeecCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeecC
Q 015237 237 IDVWEIDASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTRP 314 (411)
Q Consensus 237 ~~~~ei~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 314 (411)
.+.|+++ ++|++.++||+|+||.||+|++. ++.||||+++....+....+.+.+|+.+|++++|||||++++++...
T Consensus 11 ~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp SSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence 5679985 67999999999999999999885 78999999987766666677899999999999999999999998643
Q ss_pred -----CeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 315 -----PRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 315 -----~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
...+++|+|+.||+|.+++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~------~~k 161 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC------ELK 161 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEE
T ss_pred cccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc------ccc
Confidence 2345666777799999999654 599999999999999999999999999999999999999998 589
Q ss_pred EEeccccccccc
Q 015237 390 LSNFLSISTVIL 401 (411)
Q Consensus 390 L~DFGla~~~~~ 401 (411)
++|||++.....
T Consensus 162 l~dfg~a~~~~~ 173 (348)
T d2gfsa1 162 ILDFGLARHTDD 173 (348)
T ss_dssp ECCC----CCTG
T ss_pred ccccchhcccCc
Confidence 999999876643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=8.2e-29 Score=241.47 Aligned_cols=144 Identities=16% Similarity=0.275 Sum_probs=126.3
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeec--CCeEE
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTR--PPRLF 318 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~--~~~l~ 318 (411)
.++|++.++||+|+||.||+|++. ++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 457999999999999999999986 7899999997543 356889999999995 9999999999874 45699
Q ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccccc
Q 015237 319 IVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSIST 398 (411)
Q Consensus 319 IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~ 398 (411)
+|||||.+|+|.++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|..
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-----~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-----KLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-----EEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-----eeeeccccccee
Confidence 999999999987654 25899999999999999999999999999999999999987663 489999999987
Q ss_pred ccc
Q 015237 399 VIL 401 (411)
Q Consensus 399 ~~~ 401 (411)
+..
T Consensus 180 ~~~ 182 (328)
T d3bqca1 180 YHP 182 (328)
T ss_dssp CCT
T ss_pred ccC
Confidence 643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-29 Score=244.42 Aligned_cols=145 Identities=23% Similarity=0.291 Sum_probs=121.2
Q ss_pred ceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec------CCeE
Q 015237 246 LLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPRL 317 (411)
Q Consensus 246 ~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~------~~~l 317 (411)
.|+..++||+|+||+||+|++. ++.||||+++.+.. .+.+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5888999999999999999996 68999999976542 23479999999999999999999853 3458
Q ss_pred EEEEecCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccc
Q 015237 318 FIVTEFMSGGSIYDYLH--KQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLS 395 (411)
Q Consensus 318 ~IV~E~~~gGsL~~~L~--~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGl 395 (411)
|||||||+++.+..+.. .....+++..+..++.||+.||+|||++||+||||||+|||++.++. .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-----~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-----VLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-----CEEECCCTT
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-----ceeEecccc
Confidence 99999997654333322 23446999999999999999999999999999999999999998763 589999999
Q ss_pred cccccc
Q 015237 396 ISTVIL 401 (411)
Q Consensus 396 a~~~~~ 401 (411)
+..+..
T Consensus 170 a~~~~~ 175 (350)
T d1q5ka_ 170 AKQLVR 175 (350)
T ss_dssp CEECCT
T ss_pred hhhccC
Confidence 987643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.3e-29 Score=243.61 Aligned_cols=153 Identities=18% Similarity=0.331 Sum_probs=133.9
Q ss_pred ecCCceEEEEEEeecCceEEEEEEE-----CCceEEEEEeecccc--CHHHHHHHHHHHHHHhhcCC-CceeEEEeeeec
Q 015237 242 IDASLLKFEHKIVSGSYCDLYKGAF-----FSQDVAIKVLTNEHL--NENIRREFAQEVHIMRKVRH-MNVVQFIGACTR 313 (411)
Q Consensus 242 i~~~~~~~~~~IG~Gsfg~Vy~g~~-----~~~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~ 313 (411)
+..++|++.++||+|+||.||+|.. +++.||||+++.... +....+.+.+|+.+|++++| |||+++++++..
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3457799999999999999999987 257899999875432 11234568899999999977 899999999999
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
...+|++||||.+|+|.+++...+ .+.+..+..++.||+.||.|||++||+||||||+|||++.+| .+||+||
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~------~vkL~DF 173 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTDF 173 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS------CEEESCS
T ss_pred CCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC------CEEEeec
Confidence 999999999999999999998775 578899999999999999999999999999999999999998 5999999
Q ss_pred cccccccc
Q 015237 394 LSISTVIL 401 (411)
Q Consensus 394 Gla~~~~~ 401 (411)
|+|..+..
T Consensus 174 G~a~~~~~ 181 (322)
T d1vzoa_ 174 GLSKEFVA 181 (322)
T ss_dssp SEEEECCG
T ss_pred cchhhhcc
Confidence 99987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-28 Score=237.97 Aligned_cols=150 Identities=28% Similarity=0.421 Sum_probs=125.9
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec--------
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR-------- 313 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-------- 313 (411)
.++|++.++||+|+||.||+|++. ++.||||++..+.......+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367999999999999999999986 6899999987765544455778999999999999999999998854
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
...+|+|||||.++.+. ........+++..+..++.|++.||.|||++||+||||||+|||++.++ .+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~------~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG------VLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS------CEEECCC
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC------cEEeeec
Confidence 34689999999765554 4444445789999999999999999999999999999999999999998 5899999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++..+.
T Consensus 162 g~~~~~~ 168 (318)
T d3blha1 162 GLARAFS 168 (318)
T ss_dssp TTCEECC
T ss_pred ceeeecc
Confidence 9997653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=236.86 Aligned_cols=150 Identities=23% Similarity=0.366 Sum_probs=125.7
Q ss_pred CceEEEEEEeecCceEEEEEEEC---CceEEEEEeeccccCHHHHHHHHHHHHHHhhc---CCCceeEEEeeeec-----
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF---SQDVAIKVLTNEHLNENIRREFAQEVHIMRKV---RHMNVVQFIGACTR----- 313 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~---~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~----- 313 (411)
++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 57999999999999999999984 45799999976544433334566788877766 79999999999853
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEec
Q 015237 314 PPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNF 393 (411)
Q Consensus 314 ~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DF 393 (411)
...+|++||||.++.+..........+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~------~~kl~df 160 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG------QIKLADF 160 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC------CEEECSC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC------Ceeecch
Confidence 3468999999987776655555555799999999999999999999999999999999999999988 5899999
Q ss_pred ccccccc
Q 015237 394 LSISTVI 400 (411)
Q Consensus 394 Gla~~~~ 400 (411)
|++....
T Consensus 161 g~~~~~~ 167 (305)
T d1blxa_ 161 GLARIYS 167 (305)
T ss_dssp CSCCCCC
T ss_pred hhhhhhc
Confidence 9988653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=3e-27 Score=227.65 Aligned_cols=152 Identities=16% Similarity=0.224 Sum_probs=131.1
Q ss_pred cCCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC-CceeEEEeeeecCCeEEE
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH-MNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~~~l~I 319 (411)
-..+|+++++||+|+||.||+|++. ++.||||+++..... ..+.+|+++++.++| +||+.+++++......|+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3567999999999999999999986 689999998765322 346788899999975 899999999999999999
Q ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccc
Q 015237 320 VTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTV 399 (411)
Q Consensus 320 V~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~ 399 (411)
||||+ +++|.+++......++...+..++.|++.||.|||++|||||||||+|||++.+.... ...+||+|||+|..+
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~-~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN-ANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT-TTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccccc-CCceEEcccceeEEc
Confidence 99999 7899999988776899999999999999999999999999999999999998643211 125999999999876
Q ss_pred c
Q 015237 400 I 400 (411)
Q Consensus 400 ~ 400 (411)
.
T Consensus 157 ~ 157 (293)
T d1csna_ 157 R 157 (293)
T ss_dssp B
T ss_pred c
Confidence 4
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=3.5e-27 Score=226.94 Aligned_cols=149 Identities=23% Similarity=0.280 Sum_probs=125.5
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce-eEEEeeeecCCeEEEEE
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV-VQFIGACTRPPRLFIVT 321 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~~l~IV~ 321 (411)
++|++.++||+|+||.||+|++. ++.||||++...... ..+.+|+++++.++|+|+ +.+.+++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 46999999999999999999986 689999998765433 357889999999987765 45556667788899999
Q ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEeccccccccc
Q 015237 322 EFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSISTVIL 401 (411)
Q Consensus 322 E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla~~~~~ 401 (411)
||+ +|++.+.+......+++..+..++.|++.||+|||++|||||||||+|||++..+. ...+||+|||+|+.+..
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~---~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK---GNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGG---TTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCC---CceeeeeccCcceeccc
Confidence 999 67888887776668999999999999999999999999999999999999865432 22599999999987643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.4e-27 Score=234.17 Aligned_cols=147 Identities=22% Similarity=0.281 Sum_probs=124.2
Q ss_pred CceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCceeEEEeeeec------CCe
Q 015237 245 SLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNVVQFIGACTR------PPR 316 (411)
Q Consensus 245 ~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~------~~~ 316 (411)
.+|++.++||+|+||.||+|.+. ++.||||+++....+....+.+.+|+.+|++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46999999999999999999986 7899999998877777777889999999999999999999999964 367
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEEEEecccc
Q 015237 317 LFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCYLSNFLSI 396 (411)
Q Consensus 317 l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ikL~DFGla 396 (411)
+|+|||||.+ ++.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~------~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC------CEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc------ceeeechhhh
Confidence 9999999965 5555553 3589999999999999999999999999999999999999988 5899999998
Q ss_pred ccccc
Q 015237 397 STVIL 401 (411)
Q Consensus 397 ~~~~~ 401 (411)
.....
T Consensus 167 ~~~~~ 171 (355)
T d2b1pa1 167 RTAGT 171 (355)
T ss_dssp -----
T ss_pred hcccc
Confidence 77644
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.3e-23 Score=187.53 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=107.8
Q ss_pred eEEEEEEeecCceEEEEEEEC-CceEEEEEeeccccC----------------HHHHHHHHHHHHHHhhcCCCceeEEEe
Q 015237 247 LKFEHKIVSGSYCDLYKGAFF-SQDVAIKVLTNEHLN----------------ENIRREFAQEVHIMRKVRHMNVVQFIG 309 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~-~~~VAIK~l~~~~~~----------------~~~~~~~~~Ei~iL~~l~HpNIV~l~g 309 (411)
+.++++||+|+||.||+|+.. ++.||||+++..... .........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 357899999999999999875 789999997643211 112344567899999999999999887
Q ss_pred eeecCCeEEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEEccCCCcCCCccEE
Q 015237 310 ACTRPPRLFIVTEFMSGGSIYDYLHKQKCGLKLPLLLRVAIDVSKGMNYLHRNNIIHRDLKAANLLMNENGVRDSDIHCY 389 (411)
Q Consensus 310 ~~~~~~~l~IV~E~~~gGsL~~~L~~~~~~l~~~~i~~i~~qIa~gL~yLHs~gIIHRDLKp~NILid~~g~~k~~~~ik 389 (411)
+.. .+++|||+++..+.+ ++......++.|++.++.|||++||+||||||+|||+++++ ++
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-------~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-------IW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-------EE
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-------EE
Confidence 643 379999998765432 33444567899999999999999999999999999999765 78
Q ss_pred EEecccccccccc
Q 015237 390 LSNFLSISTVILV 402 (411)
Q Consensus 390 L~DFGla~~~~~~ 402 (411)
|+|||.|.....+
T Consensus 143 liDFG~a~~~~~~ 155 (191)
T d1zara2 143 IIDFPQSVEVGEE 155 (191)
T ss_dssp ECCCTTCEETTST
T ss_pred EEECCCcccCCCC
Confidence 9999999776533
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.88 E-value=7.4e-23 Score=200.57 Aligned_cols=156 Identities=17% Similarity=0.314 Sum_probs=123.0
Q ss_pred CCceEEEEEEeecCceEEEEEEEC--CceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-----------CCceeEEEee
Q 015237 244 ASLLKFEHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-----------HMNVVQFIGA 310 (411)
Q Consensus 244 ~~~~~~~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpNIV~l~g~ 310 (411)
..+|+++++||+|+||.||+|++. ++.||||+++.+. ...+.+.+|+.+++.++ |+||++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 356999999999999999999985 7899999997653 33466788999988775 5789999988
Q ss_pred eec--CCeEEEEEecCCCCC-HHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEEccCCCcCCC
Q 015237 311 CTR--PPRLFIVTEFMSGGS-IYDYLH-KQKCGLKLPLLLRVAIDVSKGMNYLHR-NNIIHRDLKAANLLMNENGVRDSD 385 (411)
Q Consensus 311 ~~~--~~~l~IV~E~~~gGs-L~~~L~-~~~~~l~~~~i~~i~~qIa~gL~yLHs-~gIIHRDLKp~NILid~~g~~k~~ 385 (411)
+.. ....+++++++..+. ...... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.....
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 345667777664443 333332 233468899999999999999999998 899999999999999887755555
Q ss_pred ccEEEEecccccccccc
Q 015237 386 IHCYLSNFLSISTVILV 402 (411)
Q Consensus 386 ~~ikL~DFGla~~~~~~ 402 (411)
..++++|||.|......
T Consensus 169 ~~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEEECCCTTCEETTBC
T ss_pred ceeeEeecccccccccc
Confidence 56999999999876443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=1.4e-06 Score=79.10 Aligned_cols=84 Identities=10% Similarity=0.012 Sum_probs=58.6
Q ss_pred eEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeeecCCeEEEEEecCC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACTRPPRLFIVTEFMS 325 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~l~IV~E~~~ 325 (411)
+++.+..+.++.+.||+....++.+.+|+........ ...+.+|..+++.+. +--+.+++.++..++..|+||++++
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred eEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 4445444445557899987777888999876543211 234677888887763 4346778888888888999999998
Q ss_pred CCCHHHH
Q 015237 326 GGSIYDY 332 (411)
Q Consensus 326 gGsL~~~ 332 (411)
|.++.+.
T Consensus 94 G~~~~~~ 100 (263)
T d1j7la_ 94 GVLCSEE 100 (263)
T ss_dssp SEEHHHH
T ss_pred ccccccc
Confidence 8777543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.59 E-value=0.00012 Score=65.50 Aligned_cols=73 Identities=11% Similarity=0.142 Sum_probs=50.5
Q ss_pred EEeecC-ceEEEEEEECC-ceEEEEEeeccccCHHHHHHHHHHHHHHhhcCC--CceeEEEeeeecCCeEEEEEecCCCC
Q 015237 252 KIVSGS-YCDLYKGAFFS-QDVAIKVLTNEHLNENIRREFAQEVHIMRKVRH--MNVVQFIGACTRPPRLFIVTEFMSGG 327 (411)
Q Consensus 252 ~IG~Gs-fg~Vy~g~~~~-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~~l~IV~E~~~gG 327 (411)
.+..|. -+.||+....+ ..+.+|....... ..+..|...|+.+.. -.+.+++.++..++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 334454 36789887764 5678898765432 236678887777643 33667888888888899999999875
Q ss_pred CH
Q 015237 328 SI 329 (411)
Q Consensus 328 sL 329 (411)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.13 E-value=0.00051 Score=66.37 Aligned_cols=77 Identities=14% Similarity=-0.036 Sum_probs=47.6
Q ss_pred EEEEeecCceEEEEEEEC--CceEEEEEeeccc-cC----HHHHHHHHHHHHHHhhcC-C--CceeEEEeeeecCCeEEE
Q 015237 250 EHKIVSGSYCDLYKGAFF--SQDVAIKVLTNEH-LN----ENIRREFAQEVHIMRKVR-H--MNVVQFIGACTRPPRLFI 319 (411)
Q Consensus 250 ~~~IG~Gsfg~Vy~g~~~--~~~VAIK~l~~~~-~~----~~~~~~~~~Ei~iL~~l~-H--pNIV~l~g~~~~~~~l~I 319 (411)
.+.||.|....||+.+.. ++.+++|.-.+.. .. .....+...|...|+.+. + ..+.+++.+... ..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEE
Confidence 345799999999998653 5678999754321 00 001123456777777662 2 456777766543 4578
Q ss_pred EEecCCCCC
Q 015237 320 VTEFMSGGS 328 (411)
Q Consensus 320 V~E~~~gGs 328 (411)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.53 E-value=0.019 Score=53.20 Aligned_cols=65 Identities=12% Similarity=0.100 Sum_probs=41.9
Q ss_pred eEEEEEEEC-CceEEEEEeeccccCHHHHHHHHHHHHHHhhcCCCce--eEEEe-----eeecCCeEEEEEecCCC
Q 015237 259 CDLYKGAFF-SQDVAIKVLTNEHLNENIRREFAQEVHIMRKVRHMNV--VQFIG-----ACTRPPRLFIVTEFMSG 326 (411)
Q Consensus 259 g~Vy~g~~~-~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~HpNI--V~l~g-----~~~~~~~l~IV~E~~~g 326 (411)
-.||+.+.. |+.|++|+.++...+. +.+..|...|..+...+| +..+. .+...+..+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 478988764 6789999988765443 456778888877642222 11111 22345668889999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.58 E-value=0.047 Score=51.76 Aligned_cols=78 Identities=15% Similarity=0.178 Sum_probs=49.9
Q ss_pred cCCceEEEEEEeecCceEEEEEEECC---------ceEEEEEeeccccCHHHHHHHHHHHHHHhhcC-CCceeEEEeeee
Q 015237 243 DASLLKFEHKIVSGSYCDLYKGAFFS---------QDVAIKVLTNEHLNENIRREFAQEVHIMRKVR-HMNVVQFIGACT 312 (411)
Q Consensus 243 ~~~~~~~~~~IG~Gsfg~Vy~g~~~~---------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~ 312 (411)
+.+.+++ +.|+.|-.-.+|+..... +.|.+++... .... ....+|..+++.+. +.-..++++++.
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE---SHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh---hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 4445555 467778888899987642 3566776542 2121 23457888888874 433457888875
Q ss_pred cCCeEEEEEecCCCCCH
Q 015237 313 RPPRLFIVTEFMSGGSI 329 (411)
Q Consensus 313 ~~~~l~IV~E~~~gGsL 329 (411)
. .+|+||++|.++
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 3 589999976433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.32 E-value=0.068 Score=48.54 Aligned_cols=50 Identities=8% Similarity=0.087 Sum_probs=29.6
Q ss_pred eEEEEEEeecCceEEEEEEECCceEEEEEeeccccCHHHHHHHHHHHHHHhhcC
Q 015237 247 LKFEHKIVSGSYCDLYKGAFFSQDVAIKVLTNEHLNENIRREFAQEVHIMRKVR 300 (411)
Q Consensus 247 ~~~~~~IG~Gsfg~Vy~g~~~~~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~l~ 300 (411)
+.-.+.|..|---+.|+.+..+..+++|+..... + ..++..|+.+|..+.
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~---~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLA 69 (316)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHH
T ss_pred ceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC-C---HHHHHHHHHHHHhhh
Confidence 3334566677777889988877789999985432 1 134455666666664
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Probab=92.75 E-value=0.071 Score=39.28 Aligned_cols=63 Identities=22% Similarity=0.280 Sum_probs=48.2
Q ss_pred EEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCccchHHHHHHHhhcc
Q 015237 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKEI 206 (411)
Q Consensus 143 ~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~~ 206 (411)
+|+..-|||.++..++..|++.|.||.+..-++..+-|.+.+.+--+. ..+.+.++..+..-.
T Consensus 5 itv~g~DrpGiVa~vt~~l~~~g~NI~d~~q~~~~~~f~~~~~v~~~~-~~~~~~l~~~l~~la 67 (83)
T d1zpva1 5 ITVVGKDKSGIVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVVSSDE-KQDFTYLRNEFEAFG 67 (83)
T ss_dssp EEEEESCCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEEEESS-CCCHHHHHHHHHHHH
T ss_pred EEEEcCCCCCHHHHHHHHHHHCCCeEEEEEeEEeCCEEEEEEEEEEec-CCCHHHHHHHHHHHH
Confidence 789999999999999999999999999999887777777765543222 223566776665543
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=91.16 E-value=0.067 Score=39.81 Aligned_cols=61 Identities=16% Similarity=0.260 Sum_probs=46.6
Q ss_pred EEEeeCChhhHHHHHhhhccccCcccccccccccCCCceeEEEEecCCCccchHHHHHHHhhc
Q 015237 143 ITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVDGYSLDVFVVDGWPLQETEQLRNVLAKE 205 (411)
Q Consensus 143 ~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~g~sldvfvvd~w~~~~~~~l~~~l~~~ 205 (411)
||+..-|||.++..++..+++.|.||.+..-+...+-|.+-..+- |+....+.+...+.+-
T Consensus 8 itv~G~DrpGiva~vt~~l~~~g~NI~d~~~~~~~~~~~~~~~v~--~~~~~~~~l~~~L~~l 68 (86)
T d1u8sa1 8 ITAVGTDRPGICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLIS--GSPSNITRVETTLPLL 68 (86)
T ss_dssp EEEEEECCTTHHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEEE--ECHHHHHHHHHHHHHH
T ss_pred EEEEeCCCChHHHHHHHHHHHCCCeEEEeEeEEECCeeEEEEEEE--cCcccHHHHHHHHHHH
Confidence 788899999999999999999999999999877766666655543 3434556666555443
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.08 E-value=0.044 Score=43.03 Aligned_cols=48 Identities=21% Similarity=0.202 Sum_probs=40.4
Q ss_pred CcceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEE
Q 015237 137 KRLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFV 186 (411)
Q Consensus 137 ~~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfv 186 (411)
+++.++|+++.++|..+++.|.......| |.||+.. +..++|.|+|.+
T Consensus 8 ~l~~e~Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~--~~~g~~~Lsv~~ 56 (114)
T d1blja_ 8 TLEVEKWFFRTISRKDAERQLLAPMNKAGSFLIRESE--SNKGAFSLSVKD 56 (114)
T ss_dssp CSCCSSSBCCSCCHHHHHHHHSSTTCCTTCEEBCBCT--TCSSCEEEEECB
T ss_pred ccccCCCcCCCCCHHHHHHHHHhcCCCCceEEEeccC--CCCCCeEEEEEe
Confidence 46778999999999999998866666678 9999987 778899999864
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.12 E-value=0.054 Score=41.68 Aligned_cols=49 Identities=24% Similarity=0.196 Sum_probs=40.5
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEec
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVD 188 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd 188 (411)
++.++|+++.++|.+++..|.......| |.||++. +..+.|+|++...+
T Consensus 3 l~~~~Wy~g~i~R~eAe~~L~~~g~~~G~FLVR~S~--~~~g~~~Lsv~~~~ 52 (104)
T d1g83a2 3 IQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESE--TTKGAYSLSIRDWD 52 (104)
T ss_dssp GGGSSSBCTTCCHHHHHHHHHSTTCCTTCEEEEECS--SSTTCEEEEEEEEC
T ss_pred cccCCCcCCCCCHHHHHHHHHhcCCCCCcEEEeccC--CCCCCeEEEEEEee
Confidence 6678999999999999998866655678 9999987 67778999998743
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.70 E-value=0.087 Score=40.64 Aligned_cols=48 Identities=17% Similarity=0.117 Sum_probs=39.3
Q ss_pred cceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEe
Q 015237 138 RLMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVV 187 (411)
Q Consensus 138 ~~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvv 187 (411)
++..+|+++.++|..++..|.......| |.||+.. +..+.|+|++..-
T Consensus 2 l~~~~Wy~g~i~R~eAe~lL~~~~~~~G~FLVR~S~--~~~g~y~LSv~~~ 50 (106)
T d1o48a_ 2 IQAEEWYFGKITRRESERLLLNAENPRGTFLVRESE--TTKGAYCLSVSDF 50 (106)
T ss_dssp GGGSTTEEESCCHHHHHHHHCCTTCCTTCEEEEECS--SSTTCEEEEEEEE
T ss_pred cccCCccCCCCCHHHHHHHHHhcCCCCCcEEEEccc--CCCCCEEEEEEec
Confidence 5677999999999999997765555567 9999987 6777899999763
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.15 E-value=0.088 Score=40.30 Aligned_cols=45 Identities=22% Similarity=0.203 Sum_probs=37.6
Q ss_pred eEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEe
Q 015237 141 HEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVV 187 (411)
Q Consensus 141 ~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvv 187 (411)
+||+++.++|..+++.|.......| |.||+.. ++.+.|+|+|.+.
T Consensus 1 e~Wy~g~isR~eAe~~L~~~~~~~G~FLVR~S~--~~~g~~~Lsv~~~ 46 (103)
T d1qcfa2 1 EEWFFKGISRKDAERQLLAPGNMLGSFMIRDSE--TTKGSYSLSVRDY 46 (103)
T ss_dssp STTEETTCCHHHHHHHHHSTTCCTTCEEEEECS--SSTTSEEEEEEEE
T ss_pred CCccCCCCCHHHHHHHHhhcCCCCCcEEEEccC--CCCCCeEEEEEec
Confidence 4799999999999998865555677 9999988 7778899999764
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=84.82 E-value=1.1 Score=32.33 Aligned_cols=59 Identities=22% Similarity=0.294 Sum_probs=46.1
Q ss_pred eEEEEeeCChhhHHHHHhhhccccCcccccccccc-cCCCceeEEEEecCCCccchHHHHHHH
Q 015237 141 HEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFS-TVDGYSLDVFVVDGWPLQETEQLRNVL 202 (411)
Q Consensus 141 ~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fs-t~~g~sldvfvvd~w~~~~~~~l~~~l 202 (411)
|=.++-..|||..+.+.+..|++-|.||...+... ..+|+..-+..+|+-. .+++.+.+
T Consensus 4 ~~L~i~~~D~PGvi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~---~~~vl~~I 63 (78)
T d1ygya3 4 INLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDV---PDDVRTAI 63 (78)
T ss_dssp EEEEEEESCCTTHHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCC---CHHHHHHH
T ss_pred eEEEEEeCCcCCHHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCc---cHHHHHHH
Confidence 55678889999999999999999999999888764 4567788888888643 44444443
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.67 E-value=0.16 Score=38.95 Aligned_cols=48 Identities=23% Similarity=0.155 Sum_probs=38.2
Q ss_pred ceeEEEEeeCChhhHHHHHhhhccccC-cccccccccccCCCceeEEEEec
Q 015237 139 LMHEITISTNDKPKLLSQLTSLLSEIG-LNIQEAHAFSTVDGYSLDVFVVD 188 (411)
Q Consensus 139 ~~~e~~~~~~d~~klls~l~~~l~~~g-l~i~ea~~Fst~~g~sldvfvvd 188 (411)
+.++|+++.++|..+++.|......-| |.||.+. +..+.|+|+|.+.+
T Consensus 2 e~~pWy~g~isR~eAe~~L~~~~~~~GtFLVR~S~--~~~g~~~lsv~~~~ 50 (105)
T d1lkka_ 2 EPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESE--STAGSFSLSVRDFD 50 (105)
T ss_dssp CCCTTBCTTCCHHHHHHHHTSTTCCTTCEEEEECS--SSTTCEEEEEEEEE
T ss_pred ccCCccCCCCCHHHHHHHHHhcCCCCCcEEEEccC--CCCCCEEEEEEEcc
Confidence 346899999999999998865555667 9999877 66778999997643
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Probab=82.25 E-value=0.67 Score=33.88 Aligned_cols=49 Identities=20% Similarity=0.363 Sum_probs=39.4
Q ss_pred eeEEEEeeCChhhHHHHHhhhccccCcccccccccccCC-CceeEEEEec
Q 015237 140 MHEITISTNDKPKLLSQLTSLLSEIGLNIQEAHAFSTVD-GYSLDVFVVD 188 (411)
Q Consensus 140 ~~e~~~~~~d~~klls~l~~~l~~~gl~i~ea~~Fst~~-g~sldvfvvd 188 (411)
-|=+++..-|+|..|.+.+..+++-|.||.+-+.-+..+ ||.+-++.+|
T Consensus 11 ~~rl~i~~~d~PGvla~I~~~l~~~~iNI~~~~~~~~~~~~~a~~~i~~D 60 (84)
T d1sc6a3 11 GRRLMHIHENRPGVLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEAD 60 (84)
T ss_dssp SEEEEEEEESCTTHHHHHHHHHHHTTCEEEEEEEEECSSEEEEEEEEECC
T ss_pred CeEEEEEeCCcCCHHHHHHHHHHHcCCCHHHhccccCCCCcEEEEEEECC
Confidence 367888899999999999999999999999987766654 6666554433
|